Citrus Sinensis ID: 017270
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | 2.2.26 [Sep-21-2011] | |||||||
| Q39011 | 380 | Shaggy-related protein ki | yes | no | 1.0 | 0.984 | 0.930 | 0.0 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.997 | 0.905 | 0.895 | 0.0 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.973 | 0.894 | 0.909 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.970 | 0.885 | 0.824 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.970 | 0.887 | 0.793 | 1e-179 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.978 | 0.903 | 0.794 | 1e-178 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.978 | 0.894 | 0.781 | 1e-177 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.978 | 0.890 | 0.783 | 1e-176 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.975 | 0.888 | 0.778 | 1e-176 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.978 | 0.890 | 0.768 | 1e-174 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 362/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/373 (89%), Positives = 360/373 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
MSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+V
Sbjct: 39 MSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESV 98
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRVL
Sbjct: 99 AIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVL 158
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDFG
Sbjct: 159 KHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFG 218
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+
Sbjct: 219 SAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENS 278
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 279 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 338
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+HV
Sbjct: 339 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHV 398
Query: 361 KRQLGLNFLHPAG 373
+RQ+ F AG
Sbjct: 399 RRQMNGGFPFQAG 411
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 707 bits (1825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/364 (90%), Positives = 354/364 (97%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
MSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+V
Sbjct: 37 MSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESV 96
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRVL
Sbjct: 97 AIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVL 156
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDFG
Sbjct: 157 RHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 216
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+
Sbjct: 217 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENS 276
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 277 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 336
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+HV
Sbjct: 337 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHV 396
Query: 361 KRQL 364
+RQ+
Sbjct: 397 RRQM 400
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/364 (82%), Positives = 332/364 (91%), Gaps = 1/364 (0%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGETV
Sbjct: 41 MEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETV 100
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV
Sbjct: 101 AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVS 160
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 161 KHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFG 220
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 221 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESG 280
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLLQ
Sbjct: 281 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQ 340
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPDH
Sbjct: 341 YSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDH 400
Query: 360 VKRQ 363
++Q
Sbjct: 401 ARKQ 404
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1617), Expect = e-179, Method: Compositional matrix adjust.
Identities = 289/364 (79%), Positives = 330/364 (90%), Gaps = 1/364 (0%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETV
Sbjct: 40 MEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETV 99
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+
Sbjct: 100 AIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI 159
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 160 KHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESG 279
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 339
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H
Sbjct: 340 YSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEH 399
Query: 360 VKRQ 363
++Q
Sbjct: 400 ARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 625 bits (1612), Expect = e-178, Method: Compositional matrix adjust.
Identities = 294/370 (79%), Positives = 331/370 (89%), Gaps = 4/370 (1%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETV
Sbjct: 36 MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETV 95
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+
Sbjct: 96 AIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI 155
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 156 KHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFG 215
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 216 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESG 275
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 276 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 335
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H
Sbjct: 336 YSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEH 395
Query: 360 VKRQ---LGL 366
++Q LGL
Sbjct: 396 ARKQCPWLGL 405
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1598), Expect = e-177, Method: Compositional matrix adjust.
Identities = 289/370 (78%), Positives = 330/370 (89%), Gaps = 4/370 (1%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
+ AA+VDG+ TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCLETGETV
Sbjct: 40 IEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETV 99
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ MR++DHPNV+ LKHCFFSTT K+E++LNLV+EYVPE+++RV+
Sbjct: 100 AIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVI 159
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQRMPLI VKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 160 KHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESG 279
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 280 VDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 339
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRCTALEA H FFDELR+PN RLPNGR LPPLFNFK EL G S E + KL+P+H
Sbjct: 340 YSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEH 399
Query: 360 VKRQ---LGL 366
++Q LGL
Sbjct: 400 ARKQCPSLGL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1593), Expect = e-176, Method: Compositional matrix adjust.
Identities = 290/370 (78%), Positives = 327/370 (88%), Gaps = 4/370 (1%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETV
Sbjct: 42 MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETV 101
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+
Sbjct: 102 AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI 161
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS NQRMP+IYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 162 KHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFG 221
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFPGE
Sbjct: 222 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERG 281
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMP EA+DL SRLLQ
Sbjct: 282 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQ 341
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRC AL+ HPFFDELR+PNARLP GR LPPLFNFK EL G E + KL+P+H
Sbjct: 342 YSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEH 401
Query: 360 VKRQ---LGL 366
++Q LGL
Sbjct: 402 ARKQCPFLGL 411
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 617 bits (1591), Expect = e-176, Method: Compositional matrix adjust.
Identities = 285/366 (77%), Positives = 326/366 (89%), Gaps = 1/366 (0%)
Query: 2 SAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVA 61
+A +VDG+ TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 42 AATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 101
Query: 62 IKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLK 121
IKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++ RV++
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIR 161
Query: 122 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181
HY+ NQRMP+IYVKLY+YQI R LAYIH VCHRD+KPQNLLV+P THQ+KICDFGS
Sbjct: 162 HYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGS 221
Query: 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241
AK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLFPGE+ V
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGV 281
Query: 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 301
DQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 341
Query: 302 SPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHV 360
SP+LR TALEA HPF+D++R+PN RLPNGR LPPLFNFK EL G E++ KL+P H
Sbjct: 342 SPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHA 401
Query: 361 KRQLGL 366
++Q L
Sbjct: 402 RKQCAL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 611 bits (1575), Expect = e-174, Method: Compositional matrix adjust.
Identities = 282/367 (76%), Positives = 322/367 (87%), Gaps = 1/367 (0%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A VVDG+ GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCLETGETV
Sbjct: 41 MEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETV 100
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ MR++DHPNV++LKHCFFSTT K+EL+LNLV+E+VPE+++RV+
Sbjct: 101 AIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVI 160
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
+HYS NQRMPLIYVKLY+YQI R LAYIH V HRD+KPQNLLV+P THQ+K+CDFG
Sbjct: 161 RHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFG 220
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYT++IDIWSAGCVL ELLLGQPLFPG +
Sbjct: 221 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASG 280
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQ
Sbjct: 281 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQ 340
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LR TALEA HPFFDELR+PN RLPNGR LPPLFNFK EL G E++ KL+P H
Sbjct: 341 YSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSH 400
Query: 360 VKRQLGL 366
++Q L
Sbjct: 401 ARKQCSL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| 359483773 | 380 | PREDICTED: shaggy-related protein kinase | 1.0 | 0.984 | 0.941 | 0.0 | |
| 224116828 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 0.984 | 0.943 | 0.0 | |
| 255562450 | 380 | Glycogen synthase kinase-3 beta, putativ | 1.0 | 0.984 | 0.938 | 0.0 | |
| 297804284 | 380 | hypothetical protein ARALYDRAFT_914806 [ | 1.0 | 0.984 | 0.933 | 0.0 | |
| 15233984 | 380 | Shaggy-related protein kinase eta [Arabi | 1.0 | 0.984 | 0.930 | 0.0 | |
| 1161512 | 380 | shaggy-like kinase etha [Arabidopsis tha | 1.0 | 0.984 | 0.925 | 0.0 | |
| 312281491 | 380 | unnamed protein product [Thellungiella h | 1.0 | 0.984 | 0.930 | 0.0 | |
| 227204507 | 374 | AT4G18710 [Arabidopsis thaliana] | 1.0 | 1.0 | 0.930 | 0.0 | |
| 224079065 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 0.984 | 0.930 | 0.0 | |
| 18700188 | 380 | AT4g18710/F28A21_120 [Arabidopsis thalia | 1.0 | 0.984 | 0.927 | 0.0 |
| >gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/374 (94%), Positives = 366/374 (97%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
+SA VVDG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 ISAPVVDGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE+MYRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETMYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS+A QRMPLIYVKLYTYQIFRGLAYIH+VP VCHRDLKPQNLLVDPLTHQVK+CDFG
Sbjct: 127 KHYSNAKQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQVKLCDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPSYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIP+HV
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPEHV 366
Query: 361 KRQLGLNFLHPAGT 374
+RQ+GL+F HPAGT
Sbjct: 367 RRQIGLSFFHPAGT 380
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/374 (94%), Positives = 361/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M+A V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MNARVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT NELFLNLVMEYVPESMYRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTDNNELFLNLVMEYVPESMYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS+A Q MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK+CDFG
Sbjct: 127 KHYSNAKQAMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKLCDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF GENA
Sbjct: 187 SAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFSGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIPDHV
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPALFNFKQELNGASPELVNKLIPDHV 366
Query: 361 KRQLGLNFLHPAGT 374
KRQ+GLN +H AGT
Sbjct: 367 KRQMGLNLMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/374 (93%), Positives = 363/374 (97%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M+A VVD +D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MAARVVDSNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRVL
Sbjct: 67 AIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS+A Q MPL+YVKLY YQIFRGLAYIHTVP VCHRDLKPQN+LVDPLTHQVK+CDFG
Sbjct: 127 KHYSNAKQTMPLVYVKLYMYQIFRGLAYIHTVPGVCHRDLKPQNILVDPLTHQVKLCDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL+GASPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELNGASPELVNKLIPDHM 366
Query: 361 KRQLGLNFLHPAGT 374
KRQ+GLNFLH AGT
Sbjct: 367 KRQMGLNFLHLAGT 380
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/374 (93%), Positives = 362/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++GASPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGASPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 362/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/374 (92%), Positives = 364/374 (97%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTT K+ELFLNLVMEYVPE++YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTEKDELFLNLVMEYVPETLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY+YQIFRGLAYIH+ P VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYSYQIFRGLAYIHSCPGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GE NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEPNISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDF+FPQIKAHPWHK+FHKRMPPEA+DLASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFKFPQIKAHPWHKIFHKRMPPEAVDLASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEVAGSSPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312281491|dbj|BAJ33611.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 361/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVRGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++ ASPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAAASPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|227204507|dbj|BAH57105.1| AT4G18710 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 362/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 1 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 120
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 121 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 180
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 181 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 241 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 300
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 360
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 361 KRQLGLSFLNQSGT 374
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/374 (93%), Positives = 360/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M+ V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCLETGETV
Sbjct: 7 MTTRVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPESMYRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPESMYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS+A Q MPLIYVKLY YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTHQVK+CDFG
Sbjct: 127 KHYSNAKQTMPLIYVKLYMYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHQVKLCDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLV+IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 247 VDQLVDIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNKLIP+HV
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPSLFNFKQELNGASPELVNKLIPEHV 366
Query: 361 KRQLGLNFLHPAGT 374
KRQ+GLNF+H AGT
Sbjct: 367 KRQMGLNFMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18700188|gb|AAL77705.1| AT4g18710/F28A21_120 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/374 (92%), Positives = 361/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDE REPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDEHREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 374 | ||||||
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 1.0 | 0.984 | 0.930 | 2.8e-192 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.997 | 0.905 | 0.895 | 1.5e-186 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.973 | 0.894 | 0.909 | 1.5e-184 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.970 | 0.885 | 0.824 | 2e-166 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.970 | 0.887 | 0.793 | 1.2e-163 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.978 | 0.903 | 0.794 | 1.9e-163 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.959 | 0.760 | 0.766 | 2.6e-157 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.978 | 0.869 | 0.722 | 2.3e-151 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.967 | 0.826 | 0.696 | 4.8e-142 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.967 | 0.859 | 0.636 | 2e-127 |
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1863 (660.9 bits), Expect = 2.8e-192, P = 2.8e-192
Identities = 348/374 (93%), Positives = 362/374 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV
Sbjct: 7 MPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPES+YRVL
Sbjct: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVL 126
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQVKICDFG
Sbjct: 127 KHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFG 186
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA
Sbjct: 187 SAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID ASRLLQ
Sbjct: 247 VDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQ 306
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNKLIPDH+
Sbjct: 307 YSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNKLIPDHI 366
Query: 361 KRQLGLNFLHPAGT 374
KRQLGL+FL+ +GT
Sbjct: 367 KRQLGLSFLNQSGT 380
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1809 (641.9 bits), Expect = 1.5e-186, P = 1.5e-186
Identities = 334/373 (89%), Positives = 360/373 (96%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
MSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+V
Sbjct: 39 MSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESV 98
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++YRVL
Sbjct: 99 AIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVL 158
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+CDFG
Sbjct: 159 KHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFG 218
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+
Sbjct: 219 SAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENS 278
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 279 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 338
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LIP+HV
Sbjct: 339 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHV 398
Query: 361 KRQLGLNFLHPAG 373
+RQ+ F AG
Sbjct: 399 RRQMNGGFPFQAG 411
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1790 (635.2 bits), Expect = 1.5e-184, P = 1.5e-184
Identities = 331/364 (90%), Positives = 354/364 (97%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
MSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+V
Sbjct: 37 MSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESV 96
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++YRVL
Sbjct: 97 AIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVL 156
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+CDFG
Sbjct: 157 RHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 216
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+
Sbjct: 217 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENS 276
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ
Sbjct: 277 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 336
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHV 360
YSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP+HV
Sbjct: 337 YSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHV 396
Query: 361 KRQL 364
+RQ+
Sbjct: 397 RRQM 400
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1619 (575.0 bits), Expect = 2.0e-166, P = 2.0e-166
Identities = 300/364 (82%), Positives = 332/364 (91%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETGETV
Sbjct: 41 MEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETV 100
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++YRV
Sbjct: 101 AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVS 160
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 161 KHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFG 220
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPGE+
Sbjct: 221 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESG 280
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SRLLQ
Sbjct: 281 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQ 340
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++KLIPDH
Sbjct: 341 YSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDH 400
Query: 360 VKRQ 363
++Q
Sbjct: 401 ARKQ 404
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1593 (565.8 bits), Expect = 1.2e-163, P = 1.2e-163
Identities = 289/364 (79%), Positives = 330/364 (90%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETV
Sbjct: 40 MEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETV 99
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+
Sbjct: 100 AIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI 159
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 160 KHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESG 279
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 339
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H
Sbjct: 340 YSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEH 399
Query: 360 VKRQ 363
++Q
Sbjct: 400 ARKQ 403
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1591 (565.1 bits), Expect = 1.9e-163, P = 1.9e-163
Identities = 294/370 (79%), Positives = 331/370 (89%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETV
Sbjct: 36 MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETV 95
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+++RV+
Sbjct: 96 AIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI 155
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+CDFG
Sbjct: 156 KHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFG 215
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+
Sbjct: 216 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESG 275
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 276 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 335
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL+P+H
Sbjct: 336 YSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEH 395
Query: 360 VKRQ---LGL 366
++Q LGL
Sbjct: 396 ARKQCPWLGL 405
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1533 (544.7 bits), Expect = 2.6e-157, P = 2.6e-157
Identities = 276/360 (76%), Positives = 320/360 (88%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M VV+GS TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETGE V
Sbjct: 105 METTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQV 164
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ+MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++YR
Sbjct: 165 AIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRAS 224
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
KHY+ NQ MP+I+V+LYTYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KICDFG
Sbjct: 225 KHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFG 284
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK L+ GE NISYICSR+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPGE+
Sbjct: 285 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESG 344
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
+DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQ
Sbjct: 345 IDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 404
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRCTALEACAHPFFD+LR+PN LPNGR LPPLFNF QEL+GAS EL +LIP H
Sbjct: 405 YSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAH 464
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 265/367 (72%), Positives = 315/367 (85%)
Query: 5 VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKK 64
++DG+ GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct: 54 IIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKK 113
Query: 65 VLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS 124
VLQD+RYKNRELQ+M+++DHPN ++LKH FFS T E++LNLV+E+VPE++ RV + YS
Sbjct: 114 VLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYS 173
Query: 125 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184
NQ MPLIYVKLYTYQI R LAYIH +CHRD+KPQNLLV+P THQ+KICDFGSAK
Sbjct: 174 RTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKV 233
Query: 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 244
L+ GE N+SYICSR+YRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct: 234 LVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 293
Query: 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 304
VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL R QYSP+
Sbjct: 294 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPN 353
Query: 305 LRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 363
LRCTALEAC HP FDELR+PN RLPNGRPLPPLFNFK QELSG PE+VN+L+P+H ++Q
Sbjct: 354 LRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQ 413
Query: 364 LGLNFLH 370
LH
Sbjct: 414 NLFMALH 420
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 253/363 (69%), Positives = 306/363 (84%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
M ++ G+ +G II+T G N + +TISY AE V+GTGSFG+VFQAKCLET E V
Sbjct: 76 MDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKV 135
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL 120
AIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT K+EL+LNLV+EYVPE++YR
Sbjct: 136 AIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRAS 195
Query: 121 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
+ Y+ NQ MPLIY++LYTYQI R + Y+H V VCHRD+KPQNLLV+ +TH+VKICDFG
Sbjct: 196 RSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFG 255
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
SAK LI GE NISYICSR+YRAPELIFGATEYT++ID+WS GCV+AEL LG PLFPGE +
Sbjct: 256 SAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETS 315
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DLASRLLQ
Sbjct: 316 VDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQ 375
Query: 301 YSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDH 359
YSP+LRCTALEACAHPFFD+LR+P A LPNGR LPPLF+F QEL+GAS EL ++LIP+H
Sbjct: 376 YSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEH 435
Query: 360 VKR 362
++
Sbjct: 436 ARK 438
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 236/371 (63%), Positives = 299/371 (80%)
Query: 7 DGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL 66
DGS T +++T G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVL
Sbjct: 33 DGSKVTT--VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 67 QDRRYKNRELQLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSS 125
QD+R+KNRELQ+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
A Q +P++YVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL
Sbjct: 149 AKQTLPMVYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 305
EIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 306 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQL 364
R T LEACAH FFDELREPN +LPNGR P LFNF QELS ++P L + LIP H + Q
Sbjct: 328 RLTPLEACAHSFFDELREPNVKLPNGREKPSLFNFTTQELS-SNPTLASILIPAHARNQA 386
Query: 365 GLNF-LHPAGT 374
G + +P+ T
Sbjct: 387 GASTPTNPSAT 397
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7939 | 0.9705 | 0.8875 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7945 | 0.9786 | 0.9037 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5546 | 0.9278 | 0.8966 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9093 | 0.9732 | 0.8943 | no | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6222 | 0.8582 | 0.8941 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8954 | 0.9973 | 0.9053 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9304 | 1.0 | 0.9842 | yes | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7220 | 0.9786 | 0.8693 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5202 | 0.8502 | 0.8594 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6547 | 0.8155 | 0.8425 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7275 | 0.9786 | 0.8714 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7810 | 0.9786 | 0.8948 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9331 | 0.8309 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6142 | 0.8903 | 0.7130 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7837 | 0.9786 | 0.8905 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7683 | 0.9786 | 0.8905 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7786 | 0.9759 | 0.8880 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7541 | 0.9652 | 0.7713 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9331 | 0.8309 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8241 | 0.9705 | 0.8853 | no | no |
| Q91757 | GSK3B_XENLA | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6320 | 0.9411 | 0.8380 | N/A | no |
| Q5YJC2 | GSK3B_SPECI | 2, ., 7, ., 1, 1, ., 1 | 0.6373 | 0.9331 | 0.8309 | N/A | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9331 | 0.8309 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.993 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_XI0770 | hypothetical protein (381 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 374 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-137 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-91 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-82 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-76 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-75 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-75 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-74 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-73 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-71 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-69 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-69 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-68 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-68 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-61 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-60 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-60 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-60 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-60 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-59 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-59 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-59 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-59 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-59 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-58 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-58 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-58 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-58 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-57 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-55 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-55 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-50 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-50 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-50 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-49 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-49 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-47 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-43 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-41 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-40 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-38 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-37 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-36 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-34 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-34 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 399 bits (1025), Expect = e-137
Identities = 176/333 (52%), Positives = 242/333 (72%), Gaps = 6/333 (1%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 92
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 93 CFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+++ KNE +FLN+VME++P+++++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H+ +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYICSRFYRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
+FP +K KVF K P +AI+ S+ L+Y P R +EA A PFFD+LR+P +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 330 NG-RPLPPLFNF-KQELSGASPELVNKLIPDHV 360
LP LFNF E+ S K+IP
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (707), Expect = 7e-91
Identities = 114/307 (37%), Positives = 177/307 (57%), Gaps = 24/307 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 88 ISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
I L S N++++ V E + +++V+K Q + +++ + YQI RG
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYR 201
L Y+H+ V HRDLKP N+LV+ +KICDFG A+ + E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
APEL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 262 M-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + ++ P+ P K+F PEAIDL ++L + P R TA EA AHP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 319 DELREPN 325
+L +P
Sbjct: 293 AQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 2e-87
Identities = 108/292 (36%), Positives = 171/292 (58%), Gaps = 29/292 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 91
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
++ +L+L V EY + + L + +K YQ+ RGLAY H+
Sbjct: 65 DVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHS 116
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 208
R+ HRDLKPQN+L++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPNY 266
+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+Y
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FP+ KV R+ PE IDL S++LQY+P+ R +A EA HP+F
Sbjct: 233 KP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-85
Identities = 117/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 91
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 208
+ HRDLKP NLL+ +KI DFG A+ L + E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 265
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
Y FP+ K P ++F PEA+DL LL Y PS R +A EA HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 2e-82
Identities = 109/294 (37%), Positives = 165/294 (56%), Gaps = 20/294 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRVMDHPNV 87
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 206
+ H+ + HRDLKP+NLL++ +K+ DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 265
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 266 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
F FP+ P K+F P+A+DL S++L Y P R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 2e-81
Identities = 100/291 (34%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 88
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L F L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207
Y+H+ + HRDLKP+N+L+D VK+ DFG A+QL GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ PEA DL +LL P R TA EA HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 7e-78
Identities = 98/289 (33%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 90
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F + L LVMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGA 209
+ + HRDLKP+N+L+D VKI DFG AK+L+ + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + EA DL + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 4e-76
Identities = 109/296 (36%), Positives = 171/296 (57%), Gaps = 32/296 (10%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRVMDHPNVIS 89
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L ++ +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
LK F +EL+ V EY+ ++Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHI 115
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H HRDLKP+NLLV VKI DFG A+++ + Y+ +R+YRAPE++ +
Sbjct: 116 HKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 262
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FRFPQ H++ PEAIDL +L++ P R TA +A HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-75
Identities = 106/299 (35%), Positives = 161/299 (53%), Gaps = 29/299 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDH 84
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
PN+I L F K+ +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYR 201
GL Y+H + HRDLKP NLL+ +K+ DFG A+ G N +R+YR
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
APEL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 262 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ P+Y +F+ P ++F +A+DL RLL +P+ R TA +A HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 8e-75
Identities = 89/293 (30%), Positives = 156/293 (53%), Gaps = 26/293 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
S K +++ V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 VTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 154 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 208
+ HRD+K N+L++ + +K+ DFG A+ + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 265
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + + + + F + P A+DL +LL P R +A +A H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 8e-74
Identities = 102/291 (35%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 92
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F K L+L V EYV ++ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGAT 210
+ HRD+KP+N+LV + +K+CDFG A+ L A A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 268
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 269 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FP+ + + ++ A+D L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 3e-73
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 26/305 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 85
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI L F +S + + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH+ + HRDLKP N+ V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 265 ----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
NY PQ+ + +VF P AIDL ++L P R TA EA AHP+ E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 321 LREPN 325
+P
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 1e-71
Identities = 114/332 (34%), Positives = 178/332 (53%), Gaps = 36/332 (10%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 87 VISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
+I + + S N++++ V E + +Y+++K +N +++ + YQI R
Sbjct: 65 IIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQYFLYQILR 117
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFY 200
GL YIH+ V HRDLKP NLL++ +KICDFG A+ + Y+ +R+Y
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
RAPE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235
Query: 261 CM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
C+ + ++ P PW+K+F P+A+DL ++L ++P R T EA AHP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 318 ----FDELREPNARLPNGRPLPPLFNFKQELS 345
D EP A P P F +L
Sbjct: 295 LEQYHDPSDEPVAE----EPFPFDFELFDDLP 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 3e-69
Identities = 118/333 (35%), Positives = 186/333 (55%), Gaps = 21/333 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
I++K + + +V E + ++++++ ++Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLK 122
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 206
YIH+ V HRDLKP NLL++ +KICDFG A+ G+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 265
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++ + N
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 266 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ P + ++F P AIDL ++L + PS R T EA AHP+ L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 324 PNARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
P+ P F+F E + E + +LI
Sbjct: 300 PSDEPVCQTP----FSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-69
Identities = 105/309 (33%), Positives = 173/309 (55%), Gaps = 31/309 (10%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQLMRVM-DH 84
Y + +G G++GIV++A T E VA+KK+ D R + RE+ ++ + DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
PN++ L + ++N+ + LV EY+ ++ V++ AN ++ + YQ+ +
Sbjct: 67 PNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQLLK 118
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YICSR 198
L YIH+ V HRDLKP N+L++ VK+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 259 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
I + + P P ++ + +A+DL +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 316 PFFDELREP 324
P+ + P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 1e-68
Identities = 118/344 (34%), Positives = 180/344 (52%), Gaps = 32/344 (9%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPN 86
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 87 VISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
+I+++ F + +VM+ M L H ++Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRF 199
GL YIH+ V HRDLKP NLLV+ ++I DFG A+ L + Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 260 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
+ Y P+ + PW K+F K PEA+DL S++LQ+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 316 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 359
PF + +P+ + PP F+F E S E + + I
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 8e-68
Identities = 103/291 (35%), Positives = 164/291 (56%), Gaps = 26/291 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 151
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 210
RV HRDLKPQNLL+D +K+ DFG A+ + + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 267
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FP+ KV + + +DL S++L Y P+ R +A A HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 4e-61
Identities = 121/326 (37%), Positives = 181/326 (55%), Gaps = 27/326 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+R++ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ +KH + + + +V E + +++V+K AN + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAP 203
YIHT V HRDLKP+N+L + ++KICDFG A+ Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 204 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 260
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 317
N + K P F ++ P P A+ L RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 318 FDELREPNARLPNGRPLPPL-FNFKQ 342
F L + R P+ +P+ L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 5e-61
Identities = 109/290 (37%), Positives = 171/290 (58%), Gaps = 21/290 (7%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKH 92
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F K L+L V E+V ++ L+ Y + + V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS- 118
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 211
+ HRD+KP+N+LV + VK+CDFG A+ L A GE Y+ +R+YRAPEL+ G T+
Sbjct: 119 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 269
Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 270 RFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
R P++K P K F K + +DLA + L+ P R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 2e-60
Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 29/303 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQI 142
+ L+ S E L LV EY+ + KH S+ N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYR 201
RG+AY H+ RV HRDLKPQNLL+D T+ +K+ DFG A+ I + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 262 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
+ P+Y FP+ V + P +DL S++L+ PS R TA A H +F
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 320 ELR 322
+L
Sbjct: 289 DLG 291
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-60
Identities = 97/289 (33%), Positives = 152/289 (52%), Gaps = 25/289 (8%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVM-DHPNVISLKH 92
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R + HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIH 150
F + L LV E + ++Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ HRD+KP+N+L+ +K+ DFGS + + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 269
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FP K K+ E +DL +LL Y P R TA +A HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 5e-60
Identities = 115/306 (37%), Positives = 168/306 (54%), Gaps = 29/306 (9%)
Query: 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVM 82
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 142
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 202
RGL Y+H+ V HRDLKP N+L++ +KICDFG A+ I Y+ +R+YRA
Sbjct: 118 LRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 263 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
T RF P+ + P+ + F K P AIDL ++L + P R +A EA AHP+
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
Query: 319 DELREP 324
+P
Sbjct: 292 APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 6e-60
Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 46/303 (15%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD---HPN 86
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
++H+ R+ HRDLKPQN+LV QVKI DFG A+ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229
Query: 267 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 315
+P+ + P F + E +DL ++L ++P R +A EA H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 316 PFF 318
P+F
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-59
Identities = 108/290 (37%), Positives = 166/290 (57%), Gaps = 24/290 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 94
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYVKLYTYQIFRGLAYIHT 151
T +K L LV EY M + LK Y + + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 210
RV HRDLKPQNLL++ ++K+ DFG A+ I + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 268
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT ++ P Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
FP+ ++F P IDL RLLQ +P LR +A +A HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 111/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)
Query: 40 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 90
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 149
F K+ + L+ +Y +++++K + A + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 150 HTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAGEANISYICSRF 199
H+ V HRDLKP N+LV P VKI D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 250
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 251 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 301
LGTPT ++ I+ M P Y DF+ ++ K K + DL +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 302 SPSLRCTALEACAHPFF 318
P+ R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 4e-59
Identities = 100/293 (34%), Positives = 158/293 (53%), Gaps = 19/293 (6%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 94 FFSTTSKN-ELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
KN + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 210
V HRDLKPQNLLVD +KI D G + I ++ I + +YRAPE++ G+T
Sbjct: 129 HG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 271 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
FPQ K + + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 8e-59
Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)
Query: 43 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHCFFS 96
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 97 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 156
+ +++++ VMEYV + +++ Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 157 HRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGATE 211
HRDLK NLL L + +KICDFG A++ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT + P +++
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239
Query: 272 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ K + K F + DL +RLL Y P+ R +A +A HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 9e-59
Identities = 107/298 (35%), Positives = 174/298 (58%), Gaps = 40/298 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ +N+L+L V E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 208
RV HRDLKPQNLL++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT- 267
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP + P T
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230
Query: 268 --DFR--FPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFF 318
D++ FP+ + KV +PP + DL S++L Y P+ R +A A AHPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 31/306 (10%)
Query: 40 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-VMDHPNVI 88
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 89 SLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L NEL+L E + ++++++ + Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLK 119
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICSRFYRA 202
YIH+ V HRDLKP NLLV+ ++KICDFG A+ + Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 261
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E + R
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 262 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
+P ++ P I P+ +F P A+DL +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 320 ELREPN 325
+P+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 3e-58
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 27/305 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDHP 85
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI L F S S +E LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 264 ---PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
+Y P+ + +F + P+A+DL ++L+ R TA EA HP+FD
Sbjct: 245 KAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
Query: 321 LREPN 325
R+ +
Sbjct: 303 FRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 4e-58
Identities = 108/299 (36%), Positives = 164/299 (54%), Gaps = 26/299 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHPNVISLK 91
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 92 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F S + LVM ++ + +++KH + R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 136 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 266
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ + NY
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+ P+ + + + P A+++ ++L R TA EA AHP+F+E +P
Sbjct: 252 VK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-58
Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 22/297 (7%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 87
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 146
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 205
AY H RV HRDLKPQNLL+ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR--CM 262
+ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 263 NPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
NP + + FP P + P +LA + LQY P R +A EA HP+F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 24/290 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 212
V HRDLKPQNLL++ ++K+ DFG A+ I + + + +YR P+++FGA Y
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 213 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 269
+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P+Y +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 270 -RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+P + V ++ DL LL +P R +A EA HP+F
Sbjct: 238 PMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 109/304 (35%), Positives = 157/304 (51%), Gaps = 46/304 (15%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+ +FL VMEY + + +L + + VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHE-N 127
Query: 154 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--------SRFYRAP 203
+ HRDLK NLL LT + +KI DFG A+ + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 259
EL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGF 236
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHP 316
+ P F P+ P++ + HK P EA + L + LL Y P R TA EA
Sbjct: 237 SDL-PLVGKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
Query: 317 FFDE 320
+F E
Sbjct: 292 YFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 4e-55
Identities = 91/310 (29%), Positives = 161/310 (51%), Gaps = 38/310 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRVMDHPNVIS 89
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 90 LKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI----C 196
Q+ RGL YIH+ V HRDLKP N+ ++ +KI DFG A+ + ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 253
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 308
R E+ + P++ ++ + +P PEA+D ++L ++P R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 309 ALEACAHPFF 318
A EA HP+
Sbjct: 294 AEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 6e-55
Identities = 100/295 (33%), Positives = 165/295 (55%), Gaps = 33/295 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 89
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGL 146
L+ ++ L+L + E++ SM LK Y Q M VK Y YQI +G+
Sbjct: 64 LQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 205
+ H+ RV HRDLKPQNLL+D +K+ DFG A+ I + + +YRAPE+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 263
+ G+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P+Y + FP+ K + K + + +DL ++L Y P+ R +A +A HP+F
Sbjct: 233 PDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 3e-54
Identities = 95/291 (32%), Positives = 157/291 (53%), Gaps = 25/291 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 93
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
F + + L+LV EY ++ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 212
HRD+KP+N+L+ Q+K+CDFG A+ L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 270
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I N + F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235
Query: 271 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 318
I + + P A+ LQ P+ R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-53
Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 46/291 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLK 91
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ S + + LN+ +EYV S L ++P ++ YT QI GLAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIF 207
+ + HRD+K N+LVD VK+ DFG AK+L GE S + ++ APE+I
Sbjct: 119 S-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
G EY + DIWS GC + E+ G+P + + I G P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P+I H + EA D + L+ P R TA E HPF
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 40/247 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 94
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
++E L LVMEY S+ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEY 212
+ HRDLKP+N+L+D +VK+ DFG +K L + ++ + I + Y APE++ G Y
Sbjct: 113 -IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 271
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 272 PQIKAHP 278
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-51
Identities = 104/315 (33%), Positives = 150/315 (47%), Gaps = 51/315 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRV 81
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
+ H N++ L + F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANISYIC 196
I GL +H HRDL P N+ ++ KI DFG A++ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 197 SR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 247 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 303
I ++LGTP + + + + P YT+F + K K +AIDL LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301
Query: 304 SLRCTALEACAHPFF 318
R +A EA H +F
Sbjct: 302 LERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 2e-50
Identities = 106/304 (34%), Positives = 165/304 (54%), Gaps = 24/304 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 88 ISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
I L F TS NE++L V + + ++K Q++ +V+ YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH+ + HRDLKP N+ V+ +++I DFG A+Q A + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 265 NYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ P + K+F + P AIDL ++L R +A EA AHP+F +
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 322 REPN 325
+P
Sbjct: 305 HDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 3e-50
Identities = 93/342 (27%), Positives = 141/342 (41%), Gaps = 46/342 (13%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 85
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
I + FF ++E L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-------SYICSR 198
L Y+H+ + HRD+KP+N+L+D VK+ DFG AK L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 199 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 253
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313
P A P + + A DL +LL P R ++
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 314 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKL 355
+H L+ + L + + L + L++ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 5e-50
Identities = 106/294 (36%), Positives = 164/294 (55%), Gaps = 28/294 (9%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 92
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F + +L+L V EYV ++M +L+ + +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSYIYQLIKAIHWCHK- 118
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YICSRFYRAPELIFGAT 210
+ HRD+KP+NLL+ +K+CDFG A+ L G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 268
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 269 FRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
RFP + HP + +R + +DL LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 7e-50
Identities = 95/311 (30%), Positives = 151/311 (48%), Gaps = 49/311 (15%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVISL 90
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 91 KHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
S + +++ V Y+ + +L S I K Y Q+ G
Sbjct: 73 IDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEG 127
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIAGEANISY-- 194
+ Y+H + HRD+K N+L+D +KI DFG A+ + G Y
Sbjct: 128 INYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 195 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
+ +R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K+ GT
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 254 PTREEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRC 307
PT E P + + + + + F ++ PE +DL S+LL P R
Sbjct: 246 PTEETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRL 300
Query: 308 TALEACAHPFF 318
TA +A HP+F
Sbjct: 301 TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 5e-49
Identities = 98/307 (31%), Positives = 166/307 (54%), Gaps = 21/307 (6%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 146
++L + S L LV EY+ + LK Y + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 205
Y H +V HRDLKPQNLL++ ++K+ DFG A+ + I + + + + +YR P++
Sbjct: 118 NYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 263
+ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E + N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ + +P+ +A H R+ + +L S+LLQ+ R +A EA HP+F L E
Sbjct: 236 EEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
Query: 324 PNARLPN 330
+LP+
Sbjct: 295 RIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 9e-49
Identities = 106/326 (32%), Positives = 170/326 (52%), Gaps = 43/326 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 85
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+I L + F S E + LVME + ++ +V+ ++RM + YQ+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL-----LYQMLC 129
Query: 145 GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
G+ ++H+ + HRDLKP N++V T +KI DFG A+ Y+ +R+YRAP
Sbjct: 130 GIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E + +
Sbjct: 187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 264 P---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCT 308
P NY + R P+ + + ++F +K +A DL S++L P R +
Sbjct: 246 PTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 309 ALEACAHPF----FDELREPNARLPN 330
+A HP+ +D E A P
Sbjct: 305 VDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 1e-48
Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 91
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 92 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F S E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 266
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++ NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
Q+ + VF P A+DL ++L R TA +A AH +F + +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 37/307 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRVMDHPNVI 88
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 89 S--------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140
S F E+++ V E M L + Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSR 198
QI RGL Y+H+ + HRD+KP NLLV+ +KICDFG A+ E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
+YRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 315
+R P V + EA+ L R+L + P R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 316 PFFDELR 322
P+ DE R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-47
Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 20/296 (6%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 87
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L + + L V EY+ + + + + + V+L+ +Q+ RGLA
Sbjct: 66 VLLHDIIHTKET-----LTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 206
YIH + HRDLKPQNLL+ L ++K+ DFG A+ + I + S + + +YR P+++
Sbjct: 118 YIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN-- 263
GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + ++
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 264 PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
PNY F K V+ + PP+A DLAS++L P R +A +A HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 100/299 (33%), Positives = 164/299 (54%), Gaps = 23/299 (7%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 146
++L + S L LV EY+ + LK Y M + VK++ YQI RGL
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 205
AY H +V HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 118 AYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 266 --YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ ++ FP+ K P + H R+ E I+L ++ LQY R +A EA H +F L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 98/296 (33%), Positives = 161/296 (54%), Gaps = 23/296 (7%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 146
++L H T E L LV EY+ LK Y + M + VK++ +Q+ RGL
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 205
+Y H ++ HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 SYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN 263
+ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234
Query: 264 PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + FPQ +A P + H R+ + IDL S LL Y R +A A H +F
Sbjct: 235 EEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-45
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ K+EL++ VME+ S+ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 153 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ HRD+K N+L LT +VK+ DFG + QL +A + + + ++ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y DIWS G EL G+P + + L +I G P R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P W F D + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 40 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRVMDHPNVISLKH 92
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 93 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F T K L LV+EY P E L + S R + Y +I L Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGA 209
++ + +RDLKP+N+L+D H +K+ DFG AK+L + + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 318
RFP + + PEA DL S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 89/303 (29%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 92
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 93 CFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQRMPLIYVKLYTYQIF 143
K++ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYR 201
GL Y H HRD+K N+L++ Q+K+ DFG A+ + E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 314
+ P+ + P K + +R +P A+DL +L PS RCTA EA
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 315 HPF 317
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I F L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPEL 205
Y+H+ ++ HRD+KPQN+ + VK+ DFG +K L + + + + +Y +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
Y DIWS GCVL EL + F GEN + +L K+L + + +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
Y E +L S LLQ P R + + PF
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 30/300 (10%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH- 92
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++++ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 93 CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN--ISYICSRFYRAPEL 205
++ HRD+K N+L+ +K+ DFG A+ + N + + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E + P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250
Query: 266 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ PQ K ++ P A+DL +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-39
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 24/292 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVM---DHPN 86
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
++H + HRDLKP+N+LV QVK+ DFG A+ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
F P V + L +L ++P R +A A HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 97/302 (32%), Positives = 157/302 (51%), Gaps = 26/302 (8%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 87
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L + + L LV EYV + + + + + VKL+ +Q+ RGL+
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLS 117
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 206
YIH + HRDLKPQNLL+ T ++K+ DFG A+ + + + + + +YR P+++
Sbjct: 118 YIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN-- 263
G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 264 PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
P++ RF W+K+ + A DLAS+LLQ P R +A A +H +F
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 320 EL 321
+L
Sbjct: 293 DL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 101/314 (32%), Positives = 163/314 (51%), Gaps = 35/314 (11%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 85
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+ISL + F S E + LVME + ++ +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 265 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 310
NY + R PQ + ++F + P +A DL S++L P R +
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310
Query: 311 EACAHPFFDELREP 324
EA HP+ +P
Sbjct: 311 EALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 88/290 (30%), Positives = 137/290 (47%), Gaps = 48/290 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRVMDHPNVI 88
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ T + E L + +E VP S+ ++LK Y S P ++LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLE 116
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207
Y+H HRD+K N+LVD VK+ DFG AKQ++ S+ S ++ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 88/320 (27%), Positives = 133/320 (41%), Gaps = 77/320 (24%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRVMDH 84
+ +++G GSF V AK ET + AI K+L R+ Y E L R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
P +I L + F ++E L V+EY P + + ++ Y S +++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRF 199
L Y+H+ + HRDLKP+N+L+D H +KI DFG+AK L
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 200 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 302
+I+K ++ FP PP+A DL +LL
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 303 PSLRCTALEAC----AHPFF 318
P R E AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 101/314 (32%), Positives = 165/314 (52%), Gaps = 35/314 (11%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 85
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+ISL + F S E + LVME + ++ +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 130
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 265 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 310
NY + R P+ + K+F + P +A DL S++L P+ R +
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 311 EACAHPFFDELREP 324
EA HP+ + +P
Sbjct: 307 EALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-37
Identities = 101/326 (30%), Positives = 167/326 (51%), Gaps = 41/326 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 85
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+I L + F S E + +VME + ++ +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 265 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 310
Y + R P+ + + K+F + P +A DL S++L S R +
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 311 EACAHPFFD------ELREPNARLPN 330
EA HP+ + E P ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 54/292 (18%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHC 93
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F+ +++V+EY+ S+ +LK ++P + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIF 207
+ HRD+KP NLL++ +VKI DFG +K L N C+ F Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 265
G + Y+ + DIWS G L E LG+ P P +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+ PE D S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-36
Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 27/294 (9%)
Query: 40 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRVMD---HPNVIS 89
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 90 L-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 318
P+ H ++ + +L LL ++P+ R +A A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 3e-34
Identities = 79/288 (27%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKH 92
++G G+FG+V++ LETG+ VAIK++ L+ + + +E+ L++ + HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ L +++EY S+ +++K + + + V +Y YQ+ +GLAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 210
V HRD+K N+L VK+ DFG A +L + S + + ++ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
+T+ DIWS GC + ELL G P + N + L I++ + +
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP---P 218
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P + + PE D + Q P+LR TA + HP+
Sbjct: 219 LP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKHC 93
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ ++ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ + ++ + MEY ++ +L+H + + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS- 117
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPELIF 207
+ HRD+KP N+ +D +K+ DFG A +L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 208 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
G + + DIWS GCV+ E+ G+ + + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P ++ PE D R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 107/316 (33%), Positives = 157/316 (49%), Gaps = 44/316 (13%)
Query: 40 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 95
VG G++G V++AK + + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 150
S + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 151 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 203
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 254
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 255 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 302
E+I+ M + T DFR IK HKV + +A L +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 303 PSLRCTALEACAHPFF 318
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 105/314 (33%), Positives = 158/314 (50%), Gaps = 40/314 (12%)
Query: 40 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 95
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 150
S + + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 151 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 203
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 254
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 255 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 304
E+IR M P Y DFR K K ++ P++ L +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 305 LRCTALEACAHPFF 318
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 90/296 (30%), Positives = 133/296 (44%), Gaps = 59/296 (19%)
Query: 43 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISLKHCFF 95
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 96 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
S K L+L VMEY+P + +L++ S ++ + ++Y +I L Y+H+
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSRF-----YRAPEL 205
+ HRDLKP N+L+D H +K+ DFG +K + + R Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
I G ++ ++D WS GC+L E L+G P F GE EEI N
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 318
+P+ + EAIDL S+LL P R A E HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKH 92
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 93 CFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F++ ++ + MEY+ S+ ++LK R+P + + +GL Y+H
Sbjct: 67 AFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE 118
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
++ HRD+KP N+LV+ Q+K+CDFG + QL+ A +++ + Y APE I G +
Sbjct: 119 KHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-ND 175
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNY 266
Y+ DIWS G L EL G+ +P EN + L I+ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP-- 221
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P++ + + P+ D + L P R + E HPF
Sbjct: 222 -----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-32
Identities = 82/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNV 87
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I +T + NL +E++ S+ +L Y + + + + YT Q+ RGL
Sbjct: 66 I---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANISYICSRFYR 201
+Y+H ++ HRD+K NLL+D +++I DFG+A +L AGE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 96
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF- 68
Query: 97 TTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
+L+ +VMEY S+ ++K N+ + + YQ +GL Y+H+ +
Sbjct: 69 --KNTDLW--IVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTT 214
HRD+K N+L++ Q K+ DFG + QL A + I + F+ APE+I Y
Sbjct: 121 IHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178
Query: 215 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 274
DIWS G E+ G+P + + + + I P P
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP-------PPT 218
Query: 275 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ P ++ PE D + L P R +A++ HPF
Sbjct: 219 LSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 37 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRG 145
+ L T + L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----YR 201
+ Y+ + HRDL +N LV VKI DFG ++ L + Y + R
Sbjct: 116 MEYLESK-NFIHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYKVKGGKLPIR 169
Query: 202 --APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 249
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 170 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 60/296 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 90
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F +++ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H++ V +RDLKP+NLL+D + +KI DFG AK++ + +C + Y APE+I
Sbjct: 117 LHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 318
RFP P+A DL LLQ + R L+ HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 37 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
+ L T + L+ +VMEY+ L Y N+ ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--APE 204
Y+ + + HRDL +N LV VKI DFG ++ L + R APE
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 205 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
+ ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 174 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK-------------- 217
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+R PQ PPE DL + P R T F EL E
Sbjct: 218 ---NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT---------FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRVMDHPNVISLKHCFF 95
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 96 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIYVKLYTYQIFRGLAYIHT 151
+EL++ VMEY+ S+ ++ RM + YV ++ +GL Y+H+
Sbjct: 86 V---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAYVCR---EVLQGLEYLHS 134
Query: 152 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 208
+ HRD+K N+L L+ VK+ DFG A QL ++ S + + ++ APE+I
Sbjct: 135 QNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
+Y +DIWS G + E+ G+P + E + L I G P +
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN---------- 238
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
W F D ++ L P R +A E HPF
Sbjct: 239 -------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 79
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLY 138
+ +DH N++ E +L++ +EYVP S+ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISYI 195
T Q+ GLAY+H+ + HRDLK NLLVD KI DFG +K+ + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 196 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
S F+ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224
Query: 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314
+ A P + P A+D + +P R TA E
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
Query: 315 HPF 317
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 58/291 (19%)
Query: 43 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQ---LMRVMDHPNVISLKHCF 94
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 95 FSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+S SK+ L+L VMEY+ S+ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ HRD+KP+NLL+D H +K+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVG 169
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
+ D WS GCV+ E L G P F E D + + I R +N
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 318
W + + PEA+DL +RLL P+ R A E +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 67/308 (21%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 80
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 139
+ H N++ S + LN+ +EYVP S+ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 192
QI +GL Y+H + HRD+K N+LVD +KI DFG +K+L EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 193 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
S S F+ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309
+ + P+I ++ + EAID + + + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 310 LEACAHPF 317
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RVMDHPNVISL 90
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ L ++MEY R L ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGA 209
V V HRD+K N+LV T VK+CDFG A L + +++ + ++ APE+I
Sbjct: 119 KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 92
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F L+L MEYVP +R L + + + + Y ++F + +H +
Sbjct: 69 AF---QDDEYLYL--AMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 212
HRDLKP+N L+D H +K+ DFG +K ++ AN S + S Y APE++ G Y
Sbjct: 121 G-YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGY 175
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272
++D WS GC+L E L G P F G + + T R P Y D RF
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF- 227
Query: 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ EA DL ++L+ + + HPFF E+
Sbjct: 228 -------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRVMDHPN 86
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
VI F NE LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI---ENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPE 204
L ++H+ R+ HRD+KP N+ + T VK+ D G + + A S + + +Y +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 92
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 152 V----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 204
V HRDLKP N+ +D + VK+ DFG AK L G + +Y+ + +Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 53/311 (17%)
Query: 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 77
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 137
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVHKKPLQEVEIAAI-- 120
Query: 138 YTYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
+ +GLAY+H+ R+ HRD+K N LL +P VK+ DFGSA + AN S++
Sbjct: 121 -CHGALQGLAYLHSHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVG 173
Query: 197 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
+ ++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 228
Query: 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314
N + P + ++ W F +D LQ P R ++ E
Sbjct: 229 --------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEELLK 266
Query: 315 HPFFDELREPN 325
H F R P
Sbjct: 267 HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 85/319 (26%), Positives = 132/319 (41%), Gaps = 77/319 (24%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISLK 91
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 92 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ F ++E L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------- 199
+ + HRD+KP N+L+D H +K+ DFG K++ + Y+
Sbjct: 119 KLGFI-HRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 200 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
L E T +I +N RFP + PEAIDL RLL
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 301 YSPSLR-CTALEACAHPFF 318
P R + E +HPFF
Sbjct: 271 -DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 88
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
C +++ L++ MEY+P S+ LK Y + + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 203
Y+H+ + HRD+K N+L D VK+ DFG++K+L +G S + ++ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E+I G Y D+WS GC + E+L +P + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
PQ+ +H + P+A + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHPNVISLKH 92
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 93 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F K++ ++ ++MEY E L + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ +RDLKP+NLL+D VK+ DFG AK+L +G+ ++ + Y APE+I
Sbjct: 111 NR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y S+D WS G +L ELL G+P F GE+ D + +I N
Sbjct: 169 -YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE--- 214
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 319
FP + A DL +LL+ +P R L+ H +F+
Sbjct: 215 FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRVMDHPNV 87
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
L H F T K+ LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L ++H + +RDLK N+L+D H +KI DFG K+ I G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 319
+ R+P + + EA + L +P R L HPFF
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 320 EL 321
E+
Sbjct: 257 EI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHC 93
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F +EL+ LVM Y+ S+ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 152 VPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EANISYICSRFYRAPEL 205
++ HRD+K N+L+ VKI DFG + L G + +++ + + APE+
Sbjct: 121 NGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ Y DIWS G EL G + + L+ ++ N
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P ++ +K + K + S LQ PS R TA E H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 38 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA 147
L T L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE 204
Y+ + V HRDL +N LV VKI DFG ++ + + + + APE
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 205 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 94
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 95 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 154 RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 212
++ HRDLK N LLV VKI D G +K L A + I + Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 97/335 (28%), Positives = 148/335 (44%), Gaps = 64/335 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 89
+V+G GSFG V A+ T E AIK + +D ++ +++ RV+ +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L H F + +K LF VMEY+ L + ++ R + Y +I GL ++
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
H + +RDLK N+L+D H +KI DFG K+ + GE S C + Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
+Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR--------- 212
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPNAR 327
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWE 257
Query: 328 LPNGRPLPPLF-----------NFKQELSGASPEL 351
R +PP F NF +E + L
Sbjct: 258 RLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 37/297 (12%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 94
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
NE + + ME++ S+ R+ K +P+ + + GL Y++ V
Sbjct: 73 L-----NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVH 123
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 213
R+ HRD+KP N+LV+ Q+K+CDFG + +LI A+ +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 214 TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272
D+WS G + EL LG+ P D + + +L
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNARL 328
QI P ++ P + D L P+ R T + CA PF LR N L
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 58/294 (19%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 95
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 96 STTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
S +++L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 152 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 208
++ HRD+K N+L LT VK+ DFG + QL A A S+I + ++ APE+
Sbjct: 120 TGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 209 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
A E Y DIW+ G EL QP P + + ++ L ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219
Query: 265 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+F P++K W VFH D + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y RVVG G+FGIV + + V IK++ +R E Q+++++ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I F + L +VMEY P ++ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
++HT + HRDLK QN+L+D VKI DFG +K L + + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 53/294 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 88
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
F + L ++MEY S +LK ++ Y+ ++ GL
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLE 112
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAP 203
Y+H HRD+K N+L+ VK+ DFG + QL + +S ++ + F+ AP
Sbjct: 113 YLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAP 167
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E+I + Y DIWS G EL G+P + + L I K N
Sbjct: 168 EVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NN 214
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P P ++ + + K F D S L P R +A E H F
Sbjct: 215 P-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 38 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 89
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQRMPLIYVKLYTY 140
L T + L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 200
QI +G+ Y+ + + HRDL +N LV VKI DFG ++ + + +Y
Sbjct: 113 QIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 201 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 93
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F+S E+ ++ ME++ S+ +VLK R+P + + + RGL Y+
Sbjct: 68 FYS---DGEI--SICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 212
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 267
T DIWS G L E+ +G+ P +A E+ + G P +E R ++ +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 268 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
D P I P K+ E D + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 93/336 (27%), Positives = 146/336 (43%), Gaps = 66/336 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 89
+++G GSFG VF A+ T + AIK + +D + +++ RV+ +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L H + + +K LF VMEY+ + M+ + + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G +Y TS+D WS G +L E+L+GQ F G + + + IR NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 325
+ + EA D+ +L P R + HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256
Query: 326 ARLPNGRPLPPL----------FNFKQELSGASPEL 351
+ L PP NF +E P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 37/218 (16%)
Query: 37 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRVMDHPNVISLK 91
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69
Query: 92 HCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+ + S+N F + ME VP S + LK + YT QI
Sbjct: 70 --YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------IIFYTKQIL 118
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 199
GL Y+H ++ HRD+K N+LV+ + VKI DFG++K+L A I+ F
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTL 173
Query: 200 -YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 235
Y APE+I G Y DIWS GC + E+ G+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 97/337 (28%), Positives = 153/337 (45%), Gaps = 68/337 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 89
+V+G GSFG V A+ GE A+K + +D + +++ RV+ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L +C F T K LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++H+ + +RDLK N+++D H +KI DFG K+ + G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 325
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 326 ARLPNGRPLPPLF-----------NFKQELSGASPEL 351
R L P F NF +E P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 90
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ F ++E + LV++ + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ + HRD+KP N+L+D H V I DF A ++ S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y+ ++D WS G E L G+ + G + R++IR
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 318
Q A + EAID ++LL+ P R + HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISLK--HCFF 95
G G++G+V + + + TG +A+K++ + + K +L+ +D IS++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLD----ISMRSVDCPY 61
Query: 96 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ T LF + ME + S+ + K +P + I + L Y+H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 212 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
Y D+WS G + EL G+ FP ++ ++ +V+ P+
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS------------- 225
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328
PQ+ A ++ PE D ++ L+ + R E HPFF+ N +
Sbjct: 226 ---PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274
Query: 329 P 329
Sbjct: 275 A 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 38 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNV 87
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
+ K ++ L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 199
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y + F
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIF 177
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVDQLV 245
+ APE + + + S D+WS G L EL + L G+ V +L+
Sbjct: 178 WYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 246 EIIK 249
E++K
Sbjct: 237 ELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 5e-23
Identities = 99/326 (30%), Positives = 145/326 (44%), Gaps = 61/326 (18%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 90
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
K C+ E LVMEY S +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 151 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
+ + HRD+K N LL +P QVK+ DFGSA IA AN S++ + ++ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGTPYWMAPEVILAM 196
Query: 210 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
E Y +D+WS G EL +P NA+ L I + N +
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327
P ++++ W F + LQ P R T+ E H F LRE
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283
Query: 328 LPNGRPLPPLFNFKQELSGASPELVN 353
RP L + Q A EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-23
Identities = 90/324 (27%), Positives = 137/324 (42%), Gaps = 61/324 (18%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKH 92
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
C+ + LVMEY S +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 153 PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
+ HRD+K N LL +P QVK+ DFGSA + AN S++ + ++ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGTPYWMAPEVILAMDE 194
Query: 212 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y +D+WS G EL +P NA+ L I + N +
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NDS---- 237
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
P ++++ W F LQ P R + E H F +
Sbjct: 238 --PTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDF----------VR 277
Query: 330 NGRPLPPLFNFKQELSGASPELVN 353
RP L + Q A EL N
Sbjct: 278 RDRPARVLIDLIQRTKDAVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRVMDHPNVISLKHCF 94
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
F + + + MEY+ L A + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGA 209
+ HRD+KP N+LV+ QVK+CDFG + L+A A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQN 181
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 266
YT D+WS G + E+ LG+ +P E N QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+ +A D ++ L P+ R T + HP+ + + +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 90
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ C+ E LVMEY S +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 151 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
+ + HRD+K N LL +P VK+ DFGSA I AN ++ + ++ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAM 186
Query: 210 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-22
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 93
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ S +EL++ VME++ ++ ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 153 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGA 209
V HRD+K ++L LT +VK+ DFG Q+ S + + ++ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y T +DIWS G ++ E++ G+P + E + + + IR P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
P++K HKV P R+L P+ R TA E HPF + P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 93/343 (27%), Positives = 144/343 (41%), Gaps = 66/343 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 88
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L H F T K L V++YV E + + + + P + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASAL 109
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ Y ++D W G VL E+L G P F + ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDEL 321
+ A L LLQ + R A LE H FF +
Sbjct: 219 IS---------------------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257
Query: 322 REPNARLPNGRPLPPLFNFK----QELSGASPELVNKLIPDHV 360
N + + P FN +L PE + +P+ V
Sbjct: 258 ---NWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 52/312 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 91
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIH 150
+ F + L LVM + + H + + P Y QI GL ++H
Sbjct: 60 YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
R+ +RDLKP+N+L+D + V+I D G A +L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325
+ + PEA DL LLQ P R +A E HP F +L
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263
Query: 326 ARLPNGRPLPPL 337
RL G PP
Sbjct: 264 -RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRVMDHPNVISLKHC 93
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT 210
++ HRD+K NL +D VKI D G AK L AN + + + +Y +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELC-EDK 176
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
Y D+W+ G VL E G+ F N +++II+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRVMDHPNVI 88
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ T ++ +++ ME+VP S+ +L + +P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-------CSRFY 200
Y+H V HRD+K N+++ P +K+ DFG A++L + ++ + ++
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 95
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 96 STTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+S + + + MEY +S+Y +V K ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ ++ HRD+KP N+L+ QVK+CDFG + +L+ A ++ + FY APE I G
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP 179
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT----------- 255
Y+ + D+WS G L E+ + FP E +L+ I + P
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 256 REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 288
EE + C+ + T P + HPW K K+
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 92
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
T ++ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 210
+ +RDLKP+N+L+D H +K+ DFG AK+L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 88
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
C + L++ ME++P S+ LK Y + + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 203
Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 87
Y+ RV+G G+FG + E V K+V L RR E+ ++ ++ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I+ + F + L + MEY ++Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--SRFYRA 202
+YIH + HRD+K N+ LT +K+ DFG +K L E +++ + +Y +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PEL G +Y DIW+ GCVL ELL + F N ++ +V+I +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
NYT E I L LLQ P R TA E P
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 99/345 (28%), Positives = 145/345 (42%), Gaps = 78/345 (22%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRVMDHPNV 87
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+L HC F T K+ LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L ++H V +RDLK N+L+D H K+ DFG K+ I + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 317
+ D +P W + EA+ + + +P+ R C A + HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 318 FDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 351
F +E + L R + P F NF Q+ + P L
Sbjct: 257 F---KEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVL 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 85
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI F NE LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI---EDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 203
L ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 238
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 50/312 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H R+ +RDLKP+N+L+D H ++I D G A ++ GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
YT S D W GC++ E++ G+ F E +K REE+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 324
++K + + ++ A + +LL P R C A E AHPFF
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269
Query: 325 NARLPNGRPLPP 336
RL G PP
Sbjct: 270 -KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 83/311 (26%), Positives = 135/311 (43%), Gaps = 65/311 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISL 90
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
C F T L +VMEYV +LK+ + +P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYL 117
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRF---- 199
H V HRDLKP NLL+ + H +K+ DFG +K + E +I F
Sbjct: 118 HNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 200 ------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
Y APE+I Y +D W+ G +L E L+G F G+ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 310
++I P + +P +A DL SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 311 EACAHPFFDEL 321
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 53/302 (17%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRVMDHP 85
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L V P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+++L H F T +K L+L+++YV + + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 203
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E +Y C Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 204 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
E+I G + + ++D WS G + ELL G F + + EI + R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFD 319
K+ P F K M EA D +LL+ P R A E HPFF
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 320 EL 321
+
Sbjct: 271 GI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 27/242 (11%)
Query: 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVM 82
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 141
H ++ C + E L + MEY+P S+ LK Y + + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICS 197
I G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
++ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 258 EI 259
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 27/213 (12%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMRVM-DHPNVISLKHCF 94
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 95 F---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ ++L+ LVME S+ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 151 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 206
+V HRD+K QN+L LT +VK+ DFG + QL + G N ++I + ++ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TFIGTPYWMAPEVI 185
Query: 207 FGATE------YTTSIDIWSAGCVLAELLLGQP 233
A + Y D+WS G EL G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)
Query: 40 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 89
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 148
K +S +N L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------AGEANISYICSR 198
+ R HRDL +N+LV+ VKI DFG K L GE+ I
Sbjct: 124 L-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAEL 228
F+ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 85/284 (29%), Positives = 130/284 (45%), Gaps = 47/284 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 88
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L H F TT K L V+++V E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
Y+H++ + +RDLKP+N+L+D H V + DFG K+ IA + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII-KVL----GTPTR---- 256
I Y ++D W G VL E+L G P F + + I+ K L G
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226
Query: 257 -----EEIRCMNPNYTDFRFPQIKAHP------WHKVFHKRMPP 289
E+ R + F +I+ HP W + K++PP
Sbjct: 227 LEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 22/221 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 94
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+S +++ ME++ S+ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 213
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 214 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 94/320 (29%), Positives = 137/320 (42%), Gaps = 58/320 (18%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 91
+G GSFG V Q + +T A+K + + E+ L +V + P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
FS S +L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 ---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 210
V +RDLKP+N+L+D H + +CDFG K + + + C + Y APEL+ G
Sbjct: 112 F-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
YT ++D W+ G +L E+L G P F EN V+++ K+L P R
Sbjct: 170 -YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LR 211
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNAR 327
FP +A DL LL P+ R A E HPFF +L +
Sbjct: 212 FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KK 257
Query: 328 LPNGRPLPPLFNFKQELSGA 347
L PP FK +S A
Sbjct: 258 LLMKGIQPP---FKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 85
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI F NE LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFI---EDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAP 203
+ ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 238
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 92/339 (27%), Positives = 146/339 (43%), Gaps = 69/339 (20%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LM---RV------MDHPNVI 88
V+G G FG V A+ +TGE AIK + + E++ LM R+ HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+L CF T + F VMEY + M + S + Y + GL
Sbjct: 66 NLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
Y+H ++ +RDLK NLL+D VKI DFG K+ + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E+R
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 318
+P + EAI + RLL+ +P R + E A PFF
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
Query: 319 ---DEL---REPNARLPNGRPLPPLFNFKQELSGASPEL 351
D+L + +P + + NF +E + +P L
Sbjct: 263 INWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVL 301
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 88
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
C K L++ +EY+P S+ LK Y + + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 203
Y+H+ + HRD+K N+L D VK+ DFG++K++ ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 98/345 (28%), Positives = 146/345 (42%), Gaps = 70/345 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRVMDHPNV 87
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
L CF + + LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L ++H + +RDLK N+L+D H K+ DFG K+ I S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 318
V+ + +A+D+ + +P++R L HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 319 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 363
EL + N R + P F + + S E V+ PD +K
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIK----SREDVSNFDPDFIKED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-19
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 91
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGL 146
F S LF+ VMEY + M R+ + S +Q + + QI GL
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------ILSWFVQISLGL 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 204
+IH ++ HRD+K QN+ + K+ DFG A+QL ++Y C + +Y +PE
Sbjct: 115 KHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
I Y DIWS GCVL EL + F G N + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNV 87
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I+ A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEI
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEI----- 212
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 318
RFP + + PEA L + LL+ P R A E H FF
Sbjct: 213 -----RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 94
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+S +++ ME++ S+ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 213
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 214 TSIDIWSAGCVLAELLLGQPLFPGENA 240
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISLK 91
V+G GSFG V A+ T E AIK + +D ++ +++ RV+ P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
H F T + L VMEYV + MY + + + P + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
H+ + +RDLK N+++D H +KI DFG K+ I G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 38 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 146
K C + + L L+MEYVP R + KH + Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FY 200
AY+H+ HRDL +N+L+D VKI DFG AK + G Y F+
Sbjct: 121 AYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 176
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL 229
A E + S D+WS G L ELL
Sbjct: 177 YAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 92/345 (26%), Positives = 150/345 (43%), Gaps = 74/345 (21%)
Query: 38 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRVMD 83
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVKLYT 139
P +++L H F T +K L+L+++YV M+ L ++S V+ Y+
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYS 111
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 198
+I L ++H + + +RD+K +N+L+D H V + DFG +K+ ++ E +Y C
Sbjct: 112 GEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGT 169
Query: 199 F-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y APE+I G + ++D WS G ++ ELL G F E + E+ +R
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRR 222
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--- 314
++C P F + PEA DL +LL+ P R A A
Sbjct: 223 ILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264
Query: 315 --HPFFDEL-------REPNARL-PNGRPLPPLFNFKQELSGASP 349
HPFF L R+ N P+ R + NF +E + P
Sbjct: 265 KEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTT 98
+G G+FG V + +G +A+K++ R E + R+ MD V+ C +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 99 SKNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
LF + ME + S+ + K+ Y +P + + L Y+
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATE 211
++ HRD+KP N+L+D +K+CDFG + QL+ A R Y APE I
Sbjct: 128 KIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 256
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 66/297 (22%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRVMDHPNVISLK 91
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F +N ++ ++E+V + H A R P K Y ++ Y+H+
Sbjct: 85 CSF---QDENRVY--FLLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
+ +RDLKP+NLL+D H VK+ DFG AK++ + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEI---RCMNPNY 266
+ ++D W+ G +L E + G P F + TP R E+I R PN+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILAGRLKFPNW 237
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 318
D R A DL LLQ + R L+ HP+F
Sbjct: 238 FDGR--------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 91
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRGL 146
H F T + L VMEYV + MY + Q++ Y +I GL
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEPQAVFYAAEISVGL 114
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPEL 205
++H + +RDLK N+++D H +KI DFG K+ ++ G ++ + Y APE+
Sbjct: 115 FFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 81
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 140
+ +PN+++ F +ELF+ VMEY+ S+ V+ ++ +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV-----CR 122
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 199
+ + L ++H +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 260 RCMNPNYTDF 269
++P + DF
Sbjct: 239 EKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 43/294 (14%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 93
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL- 114
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 213
++ HRD+KP N+LV+ QVK+CDFG + QL+ A +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 214 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 272
D+WS G EL LG+ +P +I K G+ ++ +C+ D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218
Query: 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326
+ + + F + ++ ++ P R HPF + + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 69/250 (27%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 81
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 140
HPN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 199
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 260 RCMNPNYTDF 269
++ + DF
Sbjct: 239 EKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 87/356 (24%), Positives = 133/356 (37%), Gaps = 103/356 (28%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 90
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYTYQIFRGLA 147
+ F ++E +L L+MEY+P M +L + + Y+ + L
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------IAGEANIS 193
YIH RD+KP NLL+D H +K+ DFG L +
Sbjct: 122 YIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 194 YICSRF-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAEL 228
+I Y APE +F T Y D WS G ++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEM 232
Query: 229 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 288
L+G P F +N + +I +N T +FP +
Sbjct: 233 LVGYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLS 267
Query: 289 PEAIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPLPP 336
PEA DL RL R E +HPFF + +RE A P+ P
Sbjct: 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 86/313 (27%), Positives = 134/313 (42%), Gaps = 50/313 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + + +K+ L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
YT S D W+ GC+L E++ GQ F Q + IK REE+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324
+K + + ++ P+A L LL P R A E HP F ++
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 325 NARLPNGRPLPPL 337
RL G PP
Sbjct: 269 FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 59/299 (19%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRVMDHP 85
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
++ L F T K L L++EY+ + H M Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 204
L ++H + +RDLKP+N+L+D H VK+ DFG K+ I C Y APE
Sbjct: 113 LEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
I + + ++D WS G ++ ++L G P F EN + +I+K + P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 318
Y + PEA DL +LL+ +PS R A E +HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 40 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 91
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
K E + LVME P + + LK + +P+ +K +Q+ G+AY+
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112
Query: 151 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 201
+ HRDL +N LLV+ HQ KI DFG ++ L AG S +YR
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 202 ----APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 233
APE I +++ D+WS G L E G
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 61/255 (23%), Positives = 120/255 (47%), Gaps = 38/255 (14%)
Query: 40 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-VMD 83
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 140
HPN++ ++ T +N+ L +VM+ + + +H++S QR +
Sbjct: 68 HPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 200
Q+ L Y+H R+ HRDL P N+++ +V I DFG AKQ S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 259
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 260 ---------RCMNPN 265
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 64/299 (21%)
Query: 41 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKHC 93
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 94 FFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI--YVKLYTYQIFRGLA 147
+F E L +++E+ +S+ L+ L ++ Q+ L
Sbjct: 71 YF-----YENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALN 117
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI 206
++H+ +V HRDLK N+L+ L VK+ DFG SAK + ++I + ++ APE++
Sbjct: 118 FLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 207 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
F Y DIWS G L EL +P P + ++ + ++K+L +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP------- 225
Query: 263 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
P + W F+ D L P R TA E HPF +
Sbjct: 226 ---------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 45/296 (15%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 94
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
S EL++ +ME++ + + N+ + + + L Y+H+
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 213
V HRD+K ++L+ L +VK+ DFG Q+ S + + ++ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 214 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 273
T +DIWS G ++ E++ G+P + ++ V + + R+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234
Query: 274 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
K HK+ P D R+L P R TA E HPF + P +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT--------Y 140
+ K F + + L +VMEY Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPEDTILQWFV 107
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEANISYICS 197
Q+ G+ +IH RV HRD+K +N+ LT +VK+ DFGSA+ L + G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 228
+Y PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRVMDHPNV 87
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 204
L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C Y APE
Sbjct: 111 LDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 257
++ +T S D WS G ++ E+L G F G++ + + I+K LG P +
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 258 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 289
+R + NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 95
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
S +++L++ ME+ + + H + + YV T Q GL Y+H+ ++
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSKGKM 128
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 211
HRD+K N+L+ H VK+ DFG + Q+ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 212 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y DIW+ G EL QP + + L + K ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227
Query: 271 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P++K W FH L +P R TA + HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 87
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 318
F + + PEA L S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H +RDLKP+N+L+D H ++I D G A ++ GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
YT S D W GC++ E++ GQ F G E +K REE+ D
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 324
R + + +V+ + EA + LL P R C A E HPFF +
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268
Query: 325 NARLPNGRPLPPL 337
RL G PP
Sbjct: 269 FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
+V+G GSFG V A+ + A+K + + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L H F T K L V++Y+ E Y + + R + Y +I L
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
Y ++D W G VL E+L G P F N + I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 87/352 (24%), Positives = 146/352 (41%), Gaps = 100/352 (28%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 90
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ F ++ +L L+ME++P + +L Y + ++ + + Y + + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGEANISYICS 197
H + + HRD+KP N+L+D H +K+ DFG ++L+ G++N + I +
Sbjct: 118 HKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 198 RF------------------------------------YRAPELIFGATEYTTSIDIWSA 221
R Y APE IF Y D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 222 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 281
G ++ E L+G P F EN+ + +II RE + FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH---- 274
Query: 282 VFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNA 326
+ EA DL RL+ + + R A E +HPFF D +R+ A
Sbjct: 275 -----LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 94
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
+ L +++E+ P + P I ++ Q+ L Y+H++ +
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSM-K 130
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFGAT--- 210
+ HRDLK N+L+ L +K+ DFG SAK + + S+I + ++ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 211 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 265
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 266 YTDFRFPQIKAHP 278
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 85/311 (27%), Positives = 144/311 (46%), Gaps = 49/311 (15%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 80
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSR 198
+ R L+Y+H V HRD+K ++L+ ++K+ DFG Q ++ E S + +
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVGTP 182
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
++ APE+I Y T +DIWS G ++ E++ G+P + E P +
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQA 226
Query: 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+R + N P++K HKV + +DL +L PS R TA E HPF
Sbjct: 227 MRRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 319 DELREPNARLP 329
P+ +P
Sbjct: 276 KLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RVMDHPN---VIS 89
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + + +K+ L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
R+ +RDLKP+N+L+D H ++I D G A Q+ GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLF 235
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 88
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L H F T K L V++YV E + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
Y+H++ + +RDLKP+N+L+D H V + DFG K+ + E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 249
+ Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 289
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 76/304 (25%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 85
+V+GTG++G VF + + ++G+ A+K ++Q + +V++H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIVLA 117
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 203
L ++H + + +RD+K +N+L+D H V + DFG +K+ E +Y C Y AP
Sbjct: 118 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 204 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI----------- 224
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPF 317
+K+ P + + M A D+ RLL P R A E HPF
Sbjct: 225 -----------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 318 FDEL 321
F ++
Sbjct: 271 FQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 34 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDH 84
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 202
G+ Y+H R+ HRDLK +N+ + + +KI DFG ++ L+ + ++ + +Y +
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------- 222
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
P+ + + + +L PSLR +A E +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 85/313 (27%), Positives = 142/313 (45%), Gaps = 53/313 (16%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 80
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYIC 196
+ + L+ +H V HRD+K ++L LTH +VK+ DFG Q ++ E S +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVG 178
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256
+ ++ APELI Y +DIWS G ++ E++ G+P + E P
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 222
Query: 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
+ ++ + N P++K HKV P RLL P+ R TA E HP
Sbjct: 223 KAMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHP 271
Query: 317 FFDELREPNARLP 329
F + P+ +P
Sbjct: 272 FLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 92/341 (26%), Positives = 148/341 (43%), Gaps = 56/341 (16%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RVMDHPNVISLKH 92
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 93 C--FFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+F + + + +VM +Y P + ++KH +++ + I +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDYF 247
Query: 150 HTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQLIAGEANISY 194
HT + H DLKP+N+L VDP+T++ V+ICD G + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAI 305
Query: 195 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 253
+ +R YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 254 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 301
P+ RC Y + P H ++ R E I DL LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424
Query: 302 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRP-LPP 336
R A + HP ++ E R+ PN P+ R L P
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 81/309 (26%), Positives = 144/309 (46%), Gaps = 48/309 (15%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 81
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 140
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 199
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ-- 236
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
NP +R+ D +R L+ R +A E HPF
Sbjct: 237 ---NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL- 272
Query: 320 ELREPNARL 328
+L +P + L
Sbjct: 273 KLAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 59/315 (18%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLK 91
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ F K+ L+L VMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELI- 206
H + V HRD+KP+N+L+D H +K+ DFGSA +L A + S + + Y APE++
Sbjct: 119 HQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 207 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 263 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
N+ F +FP+ ++ + +DL LL R C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 322 REPNARLPNGRPLPP 336
N R LPP
Sbjct: 270 DWNNIR----NSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 38 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 205
+ R+ HRDL +N+LV H VKI DFG AK L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 206 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 246
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRVMDHPNVIS 89
+G G+FG V+Q + +T A+K + + +E L + + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
LK FS + ++L+L V +Y+ E + + K + R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++H + +RDLKP+N+L+D H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
YT +D WS G ++ E+ G F E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 81
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 140
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 199
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 124 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 260 RCMNPNYTDF 269
++ + DF
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 85/350 (24%), Positives = 146/350 (41%), Gaps = 80/350 (22%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 89
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L CF T S+ LF V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++H + +RDLK N+L+D H +K+ D+G K+ I S C + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII--KVLGTPTR 256
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I K + P
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-- 225
Query: 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 314
R +KA K F + P E L C
Sbjct: 226 -------------RSLSVKASSVLKGFLNKDPKE-------------RLGCHPQTGFRDI 259
Query: 315 --HPFFD----ELREPNARLPNGRPLPP-------LFNFKQELSGASPEL 351
HPFF +L E LP P P L NF + + +L
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLP---PYKPNIESDRDLDNFDPQFTDEPVQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH------- 92
+G+G+ G V++ + +TG +A+K++ RR N+E + R++ +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKE-ENKRILMDLDVVLKSHDCPYIVK 78
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHT 151
C+ + +++F+ ME + + ++LK +P I K+ T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 210
V HRD+KP N+L+D + VK+CDFG + +L+ +A S C+ Y APE I
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-YMAPERIDPPD 190
Query: 211 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
+Y D+WS G L EL GQ FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 89
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L CF + E L V+EYV L + +++P + + Y+ +I L Y+
Sbjct: 61 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 208
H + +RDLK N+L+D H +K+ D+G K+ L G+ ++ + Y APE++ G
Sbjct: 113 HE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 248
+Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 87
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ + + F T K L+L+ + Y + +H + M + Y +I GL
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 250
Y +S D +S GC+L +LL G F ++ +D++ + V
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 251 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 292
L + C+ + + P ++ W VF ++ PP I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 95
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
S S+ +L+ + MEY + + H + + + YV T Q GLAY+H+ ++
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSKGKM 128
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 211
HRD+K N+L+ VK+ DFG A ++ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 212 -YTTSIDIWSAGCVLAELLLGQP 233
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 91
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
H F T + L VMEYV + MY++ + R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
H+ + +RDLK N+++D H +KI DFG K+ + C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 30/295 (10%)
Query: 43 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC- 133
Query: 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162
+V+ + +Y L + ++ +P+ + QI GL Y+H R+ HRD+K
Sbjct: 134 ----MVLPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 163 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 222
+N+ ++ + QV I D G+A+ + A + + APE + +Y + DIWSAG
Sbjct: 186 ENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 223 CVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEIRCMNPNYT 267
VL E+L P ++ L++II L P R + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 268 DFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
++ + + + + F + +P + L ++L + ++R +A E +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 84
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQI 142
++ L ++ S+ E +V EY+ + S+ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 199
G+AY+ + HRDL +N+LV KI DFG A+ LI + + ++F
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREGAKFPIK 169
Query: 200 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH--------PNVIS 89
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 206
++H + +RDLK N+L+D H +K+ D+G K+ + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 256
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 90
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
K+ F T + L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 318
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 45/252 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRVMDHPNV 87
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 88 ISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQI 142
+ F + ++ L ++ME+ + ++ + K + + + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 143 FRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV---------KICDFG 180
LAY H + RV HRDLKPQN+ + +T Q KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 181 SAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 237
+K + G ++++ C + +Y +PEL+ T+ Y D+W+ GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 238 ENAVDQLVEIIK 249
N QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 91
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ F S T L LVM + + Y + Y+ + + + V Y+ QI G+ ++
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
H++ + +RD+KP+N+L+D ++ D G A +L G+ + Y APE I
Sbjct: 112 HSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLF 235
Y+ +D ++ GC + E++ G+ F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 38 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 147
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 200
Y+ + V HRDL +N+LV+ HQVKI DFG K + E + Y + F+
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL 229
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 85/317 (26%), Positives = 126/317 (39%), Gaps = 58/317 (18%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 91
+G G FG V + TG+ A KK+ + R K + + L +V H I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F T K +L L + + + Y + + N P YT QI GL ++H
Sbjct: 59 AYAFQT--KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 210
R+ +RDLKP+N+L+D + V+I D G A +L G++ Y + + APEL+ G
Sbjct: 116 -RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
EY S+D ++ G L E++ + F GE KV ++ I + Y D
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVTYPD 222
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFFDEL 321
+ P + LL P R C L HP F +L
Sbjct: 223 -----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLFRDL 263
Query: 322 REPNARLPNGRPLPPLF 338
N R LPP F
Sbjct: 264 ---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 86
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+++ + + + L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPE 204
L Y+H + HRDLK QN+ + T+ +K+ D G A+ L + + I + +Y +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 205 LIFGATEYTTSIDIWSAGCVLAEL 228
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 94
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 95 FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ +N L+ +++E+ V M + + + +++ Q L Y+
Sbjct: 72 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 208
H ++ HRDLK N+L L +K+ DFG SAK + S+I + ++ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 209 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 260
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 261 CMNPNYTDF 269
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 90
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
K+ F +K+ L VMEYV E + + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H+ ++ +RDLK +NL++D H +KI DFG K+ I A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCF 94
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 95 FSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F S ++ L LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH-A 139
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF--- 207
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 140 HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197
Query: 208 -GATEYTTSIDIWSAGCVLAELLLGQP 233
Y DIWS G E+ G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 143
+ + F + L +VM+Y Y N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISYICSRFY 200
L ++H ++ HRD+K QN+ LT +K+ DFG A+ L + E + I + +Y
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVMDHPN---VISL 90
+V+G G+FG V + + + A+K + + K + +M H N ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
H F +++ +L +VMEY+P L +N +P + + YT ++ L IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPEL 205
++ + HRD+KP N+L+D H +K+ DFG+ ++ +AN C Y +PE+
Sbjct: 160 SMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214
Query: 206 IF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241
+ G Y D WS G L E+L+G F ++ V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 87
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ + + F T K L+L+ + Y + +H + + M + Y +I GL
Sbjct: 60 VCMTYAF-HTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 243
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 86
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
V+ L + F +++ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 202
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y +
Sbjct: 155 LDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGTPDYIS 211
Query: 203 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 57/248 (22%)
Query: 40 VGTGSFGIVFQAK-----CLETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPNVI 88
+G G+FG V +A+ TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 89 SLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIYV 135
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 136 KLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 194
+ YQ+ RG+ ++ + + C HRDL +N+LV H +KI DFG A+ +I +
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFGLAR-------DIHH 184
Query: 195 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 241
I +YR APE +F YT D+WS G +L E+ LG +PG V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 240
Query: 242 DQLVEIIK 249
++L +++K
Sbjct: 241 EELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 86
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
V+ L C F +++ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 201
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y
Sbjct: 155 LDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDTAVGTPDYI 210
Query: 202 APELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
+PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 38 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPNVIS 89
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L F K+E +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
++ + +RDLKP+NLL+D +K+ DFG AK + + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLF 235
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNVISLKH 92
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 153 PRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------APE 204
+ C HRDL +N LV + +KI DFG +++ E Y S + APE
Sbjct: 112 -KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPE 165
Query: 205 -LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
L +G YT+ D+WS G +L E LG +PG
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHPNVISL 90
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL------------------------ 185
H + V +RDLKP+N+L+ H + + DF +KQ
Sbjct: 120 HLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 186 ------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
+ S++ + Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 299
+ I+K + FP + A DL +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 300 QYSPSLRC----TALEACAHPFFD 319
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 46/284 (16%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 94
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
T L ++MEY+ L ++ +K +I +GL Y+H+ +
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 213
+ HRD+K N+L+ VK+ DFG A QL + +++ + F+ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 214 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 273
+ DIWS G EL G+P P + M+P F P+
Sbjct: 180 SKADIWSLGITAIELAKGEP--PNSD----------------------MHPMRVLFLIPK 215
Query: 274 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
F K + L PS R TA E H F
Sbjct: 216 NNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 40 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 91
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 92 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ +V E P S+ L+ A + + Y QI G+ Y+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------AP 203
+ R HRDL +N+L+ +VKI DFG + L E + Y+ + AP
Sbjct: 115 S-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-MEEHLKVPFAWCAP 169
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 247
E + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 65/326 (19%), Positives = 107/326 (32%), Gaps = 52/326 (15%)
Query: 38 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVIS 89
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVKLYTYQIFRGLA 147
F +EL++ V + L H+ +P + + + L
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 206
YIH+ + HR +K ++L+ +V + + +I G+ L
Sbjct: 116 YIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 207 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 254
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 255 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 304
+ + R N + + + LQ P
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 305 LRCTALEACAHPFFDELREPNARLPN 330
R +A + H FF + + N L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 94
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 151
T L ++MEY+ S +L + PL ++ T +I +GL Y+H+
Sbjct: 72 LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 119
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 210
++ HRD+K N+L+ +VK+ DFG A QL + + ++ + F+ APE+I +
Sbjct: 120 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 176
Query: 211 EYTTSIDIWSAGCVLAELLLGQP 233
Y + DIWS G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 94
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 95 FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIHT 151
T L ++MEY+ S +LK PL Y+ +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLK-------PGPLEETYIATILREILKGLDYLHS 119
Query: 152 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG 208
R HRD+K N+L L+ Q VK+ DFG A QL + +++ + F+ APE+I
Sbjct: 120 -ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-K 174
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQP 233
+ Y DIWS G EL G+P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVM-DHPN 86
+ +G G+FG V +A ++ VA+K + R EL++M + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 144
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 145 GLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 200
G+A++ + + C HRDL +N+L+ VKICDFG A+ ++ + +R +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVM 82
P + ++ +G G++G VF+ + G A+K +L + E++ L +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
DHPNV+ ++ KN L LV+E S+ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICS 197
GL ++H V + HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 198 RFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 233
F+ APE+I + Y D+WS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 38 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRVMDHPNVIS 89
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 148
L ++N ++ +VME P L+ Y N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 149 IHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 202
+ + R HRD+ +N+LV P VK+ DFG ++ L E Y S+ + A
Sbjct: 123 LESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 203 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 239
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 95
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 96 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
KN ++ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 207
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 208 --GATEYTTSIDIWSAGCVLAELLLGQP 233
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 94
+G G++G V++ + G A+K +L + E++ L + +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+ L LV+E S+ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 154 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 209
R+ HRD+K N+L LT + VK+ DFG + QL + N S + + F+ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 203
Query: 210 TEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
+Y S D+WS G EL G P + V L +I
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRVMDHPNVI 88
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 89 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
Y+ R+ HRDL +N+LV H VKI DFG AK L A E + + A
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL 229
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 33/234 (14%)
Query: 18 STTIGGKNGEPKQTISYMA-ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----R 69
S++ P S ERV +G+G+ G V++ TG A+K + + R
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 70 RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR 129
R RE++++R ++HPNV+ H F + ++ L + E + + + + R
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175
Query: 130 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IA 187
QI G+AY+H + HRD+KP NLL++ VKI DFG ++ L
Sbjct: 176 -----------QILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTM 222
Query: 188 GEANISYICSRFYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 236
N S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 223 DPCN-SSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 97
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 98 T----SKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
T ++E +L LVM+Y V + +L + R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL 121
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF--- 207
HRD+KP N+L+D H +++ DFGS K G S + + Y +PE++
Sbjct: 122 -HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 208 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 43 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162
F L++ +Y Y +A + + + + + R + Y+H R+ HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 163 QNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFY--------RAPELIFGATEY 212
+N+ ++ H +C DFG+A + AN ++Y APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 213 TTSIDIWSAGCVLAELLLGQ 232
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISL 90
+V+G G+FG V K TG+ A+K + + K E R V+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 91 KHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ F ++E L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYR 201
H + V HRD+KP N+L+D H +++ DFGS +L+A ++N++ YI +
Sbjct: 119 HQLGYV-HRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 87
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 137
I L + S++ L L++EY + Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 138 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183
+ +QI RG+ Y+ + V HRDL +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 184 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 138 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
Y++Q+ +G+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 197 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 252
+R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 298
+E R P+YT Q WH +R P +L L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRVMDHPNVI 88
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L S T + LV + +P H N L+ + QI +G+ Y
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--WCVQIAKGMMY 124
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 205
+ R+ HRDL +N+LV H VKI DFG A+ L E + + + A E
Sbjct: 125 LEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 206 IFGATEYTTSIDIWSAGCVLAELLL--GQP 233
I ++T D+WS G + EL+ G+P
Sbjct: 183 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRVMDHPNVISLKH 92
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 150
F+ S E ++ E + + S+ L+ + LI + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLE 121
Query: 151 TVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPE 204
HRDL +N+LV + L K+ DFG A+ + ++ + I Y + APE
Sbjct: 122 E-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK----WTAPE 174
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 246
++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 138 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 197 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 252
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 300
++ R P +I W +R +++ LLQ
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 69/267 (25%), Positives = 101/267 (37%), Gaps = 63/267 (23%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 76
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-----------MYRVLKHYSS 125
+L+ H N++ +V EY+ LK S
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQ 184
+ L + QI G+ Y+ HRDL +N LV L VKI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRD 171
Query: 185 LIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL-- 230
+ Y +YR PE I +TT D+WS G VL E+
Sbjct: 172 V--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYG 221
Query: 231 GQPLFPGENAVDQLVEIIK---VLGTP 254
QP + N ++++E I +L P
Sbjct: 222 KQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 65/270 (24%)
Query: 27 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 73
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 74 RELQLMRVMDHPNVISL--------KHC-FFSTTSKNELFLNLVMEYVPESMYRVLKHYS 124
+E +LM + HPN++ L C F + +L LV P S V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHS--DVGAESG 113
Query: 125 SANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182
+ L QI G+ Y+ + HRDL +N LV VKI DFG +
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLS 171
Query: 183 KQLIAGEANISYICSRFYR------------APELI-FGATEYTTSIDIWSAGCVLAELL 229
+ + + + +YR PE I +G ++TT DIWS G VL E+
Sbjct: 172 RDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIF 220
Query: 230 -LG-QPLFPGENAVDQLVEIIK---VLGTP 254
G QP + N +++E+I+ +L P
Sbjct: 221 SYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 55/235 (23%)
Query: 37 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--------SSANQRMPLIYVKLY 138
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 139 TY--QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYI 195
+I G+AY+ + HRDL +N +V + LT VKI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 196 CSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ +YR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 135
QLM+ D+PN I L ++S T+ L +M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEV 111
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
K Q+ L +H + H D+K +N+L D ++ +CD+G K I G Y
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYD 167
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI-------- 247
+ Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 168 GTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQ 224
Query: 248 -----IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 279
IK + + ++ M N NY + +I HP+
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 54/281 (19%)
Query: 40 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 86
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 135
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 136 KLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 138 DLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNID 191
Query: 194 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 245
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 286
+++K G + C N Y R WH + R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 138 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 197 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 252
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWH 280
+E R P Y I WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 58/282 (20%)
Query: 38 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRVMDHPN 86
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK---LYTYQI 142
++ L ++ME + + L+ PL+ +K +
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEANISYICSR 198
+G Y+ + HRDL +N LV + VKI DFG A+ + S
Sbjct: 116 AKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SD 165
Query: 199 FYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 244
+YR APE L+ G +TT D+WS G ++ E+L LGQ +P N + L
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 286
+ R P + Q+ + W + +R
Sbjct: 224 QHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 46/278 (16%)
Query: 55 ETGETVAIKKVLQD-----RRYK--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167
V EYVP R L+ +A+ +P Q+ LA H + HRDLKPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 168 DP--LTHQVKICDFGSAKQLI-AGEANIS-------YICSRFYRAPELIFGATEYTTSID 217
+ K+ DFG L +A+++ + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 218 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 276
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 277 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 311
HP +V K + P + A L + +L AL
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 77
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 78 LMRVMDHPNVISL--------KHC----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 125
LM DHPN++ L C + + NE + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 126 ANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183
+PL + Q+ G+AY+ V HRDL +N LV VKI DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSR 178
Query: 184 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 228
+ + + A+ + + PE IF YTT D+W+ G VL E+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 38/246 (15%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQ 77
P+++I + + +G G FG V+ K L+ G T++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 136
LM+ + H ++ L ++ +K E + ++ EY+ + S+ LK S ++ L +
Sbjct: 54 LMKTLQHDKLVRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLI 106
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
++ QI G+AYI + HRDL+ N+LV KI DFG A+ +I +
Sbjct: 107 DFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREG 163
Query: 197 SRF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 251
++F + APE I FG+ +T D+WS G +L E++ G+ +PG + D + + +
Sbjct: 164 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
Query: 252 GTPTRE 257
P E
Sbjct: 222 RMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 34 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRVMDHPNVI 88
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 89 SLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPL--IYVKLYTYQ 141
KH F S ++L L +MEY + + + + LK + +P V L YQ
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQ 177
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSR 198
I L +H+ ++ HRDLK N+ + P T +K+ DFG +KQ ++ + S+ +
Sbjct: 178 IVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237
+Y APEL + Y+ D+WS G +L ELL F G
Sbjct: 236 YYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRVMDHPNVI 88
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 89 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
L C ST + LV + +P Y L Y N+ R+ + + QI +G+
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
+Y+ V R+ HRDL +N+LV H VKI DFG A+ L E + + A
Sbjct: 123 SYLEEV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL 229
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 39 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 88
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYT--YQI 142
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRF 199
G+ ++ R HRDL +N LV +VK+ +K + E + I R
Sbjct: 127 ALGMDHLSNA-RFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNSEYYKLRNALIPLR- 183
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAEL 228
+ APE + +++T D+WS G ++ E+
Sbjct: 184 WLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNVIS 89
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFRG 145
L + LV+ +P + L+++ + P LI L Q+ +G
Sbjct: 61 LLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 205
+ Y+ + + HRDL +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 206 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
+ C +P Y ++ WH R P +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
+V+G G+FG V K L+ + V K+L R E ++ D+ + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + F +N L+L VM+Y +L S R+P + Y ++ + +
Sbjct: 66 LHYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF 207
H + V HRD+KP N+L+D + +++ DFGS +L+ S + + Y +PE++
Sbjct: 119 HQLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 208 ----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 88
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L+ +K+ + ++ EY+ S+ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY------ICSRFY 200
Y+ + V HRDL +N+LV+ ++ V K+ DFG +++L ++ +Y I R +
Sbjct: 121 YLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIR-W 174
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL 229
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 138 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 195
+TYQ+ RG+ ++ + HRDL +N+L L VKICDFG A+ I ++N
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296
Query: 196 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
S F + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 70/315 (22%)
Query: 40 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVMD-HPN 86
+G G FG V +A+ + TVA+K + + K+ E++LM+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 135
+I+L T + L++ ++EY + R Y+ ++P L +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 136 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
L + YQ+ RG+ Y+ + R HRDL +N+LV + +KI DFG A+ G +I
Sbjct: 135 DLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDID 188
Query: 194 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 245
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 289
+++ RE R P+ + WH V +R +
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 290 EAIDLASRLLQYSPS 304
E +DL+ QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y RV+G+G+ G V AK + GE A+K V D+ E+ + D ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 88 ISLKHCFFSTTSKNE---LFLNLVMEYVPESMYRV-LKHYSSANQRMPLIYVKLYTYQIF 143
+ F +N L + LV++Y R +K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFY 200
+ ++H+ + HRD+K N+L+ VK+ DFG +K ++ + ++ + +Y
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
APE I+ Y+ D++S G +L ELL + F GEN
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 37 ERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN 86
E+ +G G FG V+ A K ++ G +++++ L E +M+ + H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
++ L + +K +++ + E++ + S+ LK S + PL + ++ QI G
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEG 114
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRA 202
+A+I + HRDL+ N+LV KI DFG A+ +I + ++F + A
Sbjct: 115 MAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 171
Query: 203 PELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
PE I FG+ +T D+WS G +L E++ G+ +PG
Sbjct: 172 PEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 71/316 (22%)
Query: 40 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 86
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 135
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 136 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
L + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 135 DLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNID 188
Query: 194 Y----ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 245
Y R + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 288
+++K E R P I WH V +R
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 289 PEAIDLASRLLQYSPS 304
E +DL+ QYSP
Sbjct: 300 DEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 138 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 195
++YQ+ +G++++ HRDL +N+L LTH KICDFG A+ I ++N Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271
Query: 196 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 248
R APE IF YT D+WS G +L E+ LG +PG + ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 279
K E R ++P I W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 43 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 99
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 159
+ + + +VM ++ Y + +PL ++ LAY+H + HRD
Sbjct: 156 RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRD 210
Query: 160 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTT 214
+K +N+ +D + V + DFG+A +L + C + +PEL+ Y
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266
Query: 215 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 273
DIWSAG VL E+ + LF + K + R IRCM + FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PLEFPQ 315
|
Length = 392 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHC 93
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPE-LIFGA 209
HRDL +N LV + +KI DFG ++Q I + + I + + APE L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYG- 169
Query: 210 TEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
Y++ D+WS G +L E LG +PG
Sbjct: 170 -RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 88
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 89 SLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L+ T S+ + + ME +S R + + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVGMLRGIAAGMK 120
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYR 201
Y+ + V HRDL +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELL 229
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVISLKHCFFS 96
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL--LGVV 69
Query: 97 TTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 70 LQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KN 122
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 211
HRDL +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 123 FVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 212 YTTSIDIWSAGCVLAEL 228
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 94 FFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 150
++ + E + +M+Y S+ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIF 207
+ HRDL +N+LV + K+ DFG A+ + + ++F + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 208 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 84
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
P ++ L ++ ++ +++ + EY+ S+ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 200
G+A+I + HRDL+ N+LV KI DFG A+ LI + ++F +
Sbjct: 113 EGMAFIERKNYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGAKFPIKW 169
Query: 201 RAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 TAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 138 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
++ Q+ +G+ ++ + + C HRD+ +N+L+ KICDFG A+ I ++N Y+
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270
Query: 197 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 96
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 97 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
++ F ++ E++ +L + N Q + + + QI + Y+ +
Sbjct: 70 VCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 212
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE + ++
Sbjct: 127 -HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 182
Query: 213 TTSIDIWSAGCVLAEL-LLGQPLFPG 237
+ D+W+ G +L E+ G +PG
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 27/226 (11%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVI 88
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L ++ S+ +++ V EY+ + S+ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 148 YIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
YI + + HRDL+ N+LV D L KI DFG A+ LI + ++F + AP
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAP 172
Query: 204 EL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 247
E ++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 173 EAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRVMDHPNV 87
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 88 ISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+ L F +S ++ +V M++ + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ Y R + P
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YYRQGRIAKMP 178
Query: 204 ELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 240
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 179 -VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 58/246 (23%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 90
+V+G G+FG V + +TG A+K + + + ++ +R D V+ +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F+S K L+L +ME++P + M ++K + + + + Y + +
Sbjct: 67 ---FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDA 116
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---------------------------- 180
IH + + HRD+KP NLL+D H VK+ DFG
Sbjct: 117 IHQLGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 181 ---SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 232
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 233 PLFPGE 238
P F E
Sbjct: 234 PPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 93
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 94 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F+S K L+L +ME++P + M ++K + + + Y + + IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 180
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 181 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 235
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 236 PGE 238
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 127 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184
N+ L Y+ L ++YQ+ G+ ++ + V HRDL +N+L+ VKICDFG A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288
Query: 185 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 239
++ IS S F + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 288
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 84/331 (25%), Positives = 134/331 (40%), Gaps = 85/331 (25%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 77
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI 133
+M+ +V+ L SK + L +VME + +S R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 134 YVK---LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
++ +I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 191 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 236
+YR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 296
N +Q+++ + M+ Y D P P DL
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 297 RLLQYSPSLRCTALEACA------HPFFDEL 321
Q++P +R T LE HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 54/255 (21%)
Query: 37 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 87
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 134
+ F+ + + +V EY+ P++M V A + L
Sbjct: 70 VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 135 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 194
+ QI G+ Y+ + V HRDL +N LV VKI DFG ++ + +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 195 ICSRFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP-GEN 239
+ +YR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 240 AVDQLVEIIKVLGTP 254
V + + +VL P
Sbjct: 233 EVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 88
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L+ T SK + +V EY+ S+ L+ + + +I + I G+
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMK 120
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRA 202
Y+ + V HRDL +N+LV+ K+ DFG ++ ++ + +Y + A
Sbjct: 121 YLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTA 177
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELL 229
PE I ++T++ D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 66
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
++ S+ +++ V EY+ + S+ LK R+P + QI G+AY+ +
Sbjct: 67 -YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVERM 121
Query: 153 PRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 207
V HRDL+ N+LV + L K+ DFG A+ LI + ++F + APE ++
Sbjct: 122 NYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 208 GATEYTTSIDIWSAGCVLAELLL-GQPLFPG 237
G +T D+WS G +L EL G+ +PG
Sbjct: 178 G--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 38 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 88
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 89 SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
L + +K L + +V M++ + ++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 201
G+ Y+ + HRDL +N +++ V + DFG +K++ +G+ S+ +
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIKVL--GTPTRE 257
A E + YTT D+W+ G + E++ GQ + G EN+ EI L G ++
Sbjct: 183 ALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIKGNRLKQ 236
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 298
C+ Y ++ W R P L +L
Sbjct: 237 PPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 40 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 90
+G G+FG VF A+C E + + K L++ R+ RE +L+ V+ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK------HYSSANQRMPLIYVKL-----Y 138
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 198
QI G+ Y+ ++ V HRDL +N LV VKI DFG ++ + + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 199 FYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 229
+YR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 63/268 (23%), Positives = 116/268 (43%), Gaps = 35/268 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCFF 95
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 96 STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 211
V HRDL +N LV VK+ DFG + + + S ++F + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271
Y++ D+WS G ++ E + + P EN + E+++ + R P
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230
Query: 272 PQIKAHPWHKVFHKRMPPEAIDLASRLL 299
++ H W + PE S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 65/225 (28%)
Query: 114 ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 165
+S++ VL+H + S +P VK + ++ L +H VC RDL P N+
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116
Query: 166 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 222
L+D H +++ F ++ GEA Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169
Query: 223 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHP 278
+L ELL G+ L + C +P+ +T P+
Sbjct: 170 AILFELLTGKTL------------------------VEC-HPSGINTHTTLNIPEW---- 200
Query: 279 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-----AHPFF 318
+ EA L +LLQ++P+ R A A +HPFF
Sbjct: 201 --------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 88
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVK-- 136
+L ++ +L L +EY P RVL+ ++ AN + +
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 137 -LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 194
+ + RG+ Y+ + + HRDL +N+LV + KI DFG S Q + + +
Sbjct: 127 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 195 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)
Query: 40 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 86
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 133
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 134 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
+ YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 141 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKK 198
Query: 194 YICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 249
R + APE +F YT D+WS G +L E+ LG +PG V++L +++K
Sbjct: 199 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLK 256
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 286
G + C N Y R WH V +R
Sbjct: 257 E-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 60/199 (30%)
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISL-------KHCFFSTTSKNELFLNLVMEYVP 113
A +D +E++++ + PN+ L ++MEY+
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLC------------MIMEYME 102
Query: 114 E-------SMYRVLKHYSSANQRMP----LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162
+ + N + L+Y+ QI G+ Y+ ++ V HRDL
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLAT 158
Query: 163 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY----RAP--------ELIFGAT 210
+N LV + +KI DFG ++ L + + +Y RAP E +
Sbjct: 159 RNCLVGKN-YTIKIADFGMSRNLYSSD---------YYRVQGRAPLPIRWMAWESVLL-G 207
Query: 211 EYTTSIDIWSAGCVLAELL 229
++TT D+W+ G L E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 58/263 (22%)
Query: 74 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQ 128
E M+ DHPNV+ L T ++E + + V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 129 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188
+P + + I G+ Y+ + HRDL +N +++ V + DFG +K++ G
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNG 165
Query: 189 EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 240
+ Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 166 D---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
EI L R + PP+ +D
Sbjct: 222 -----EIYDYLRQGNR----------------------------LKQPPDCLDGL----- 243
Query: 301 YSPSLRCTALEACAHPFFDELRE 323
YS C L P F+ LR
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 40 VGTGSFGIVFQA--KCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 91
+G+G+FG V + K + VAIK VL++ K+ RE ++M +D+P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ L LVME K S + + V +Q+ G+ Y+
Sbjct: 62 GVCEAEA------LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 152 VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 203
V HRDL +N LLV+ H KI DFG +K L A + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL 229
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRVMDHPNVI 88
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 89 SLKH-CFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
L C ++ L LV + P + V +H S + + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN----WCVQIAKG 121
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSR 198
+ Y+ R+ HR+L +N+L+ V+I DFG A K+ E +
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPI---K 176
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ ++FG YT D+WS G + E++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVI 88
+++M E +G+G FG+V K VAIK + + + E ++M + HP ++
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQ-IFRGL 146
L + T + L++ V E M L +Y Q + L Q + G+
Sbjct: 63 QL---YGVCTQQKPLYI------VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
Y+ + HRDL +N LV T VK+ DFG + ++ E S ++F + P
Sbjct: 114 EYLERNSFI-HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170
Query: 204 ELIFGATEYTTSIDIWSAGCVLAEL 228
E +F ++Y++ D+WS G ++ E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 80
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 81 V-MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM 130
+ HPN++ L FS S ++L LVM + + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 131 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGE 189
P +V + T QI G+ ++ + V H+DL +N+LV D L VKI D G +++ A +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAAD 178
Query: 190 ----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
S + R+ +++G +++ DIWS G VL E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 57/225 (25%), Positives = 81/225 (36%), Gaps = 79/225 (35%)
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 199
QI L +H+ V HRD+KPQN++ + KI D G+A L G I+YI F
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 200 ----YRAPELIFGATEYTTS---------------------------IDIWSAGCVLAEL 228
Y APE +Y S DI+SAG L
Sbjct: 319 LDPRYAAPE------QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----L 367
Query: 229 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 288
+ Q FP + L++ R+ R D+ W K+ R
Sbjct: 368 IFLQMAFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRAS 409
Query: 289 P------EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 319
P E +DL ++++ R +A A AHP+FD
Sbjct: 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRV---MDHPNVISL 90
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--------------ESMYRVLKHYSSANQRMPLIYVK 136
+S S + + M Y+ ES+ + L +S + I+ K
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS-IFHK 121
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGE 189
I + Y+H+ V HRDLKP N+L+ L +V I D+G+A L+ +
Sbjct: 122 -----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 190 ANISYICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ IC Y APE + G + S DI++ G +L ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 96
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 97 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 156
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFI 122
Query: 157 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 213
HRDL +N LVD VK+ DFG ++ ++ E S + S+F + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 214 TSIDIWSAGCVLAEL 228
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 96
++G G FG V Q + TG+ VA+K + D + E +M + H N++ L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL----LG 66
Query: 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
N L++ VME + + ++ L+ + + +I + ++ + G+ Y+ + ++
Sbjct: 67 VILHNGLYI--VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES-KKL 121
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 212
HRDL +N+LV K+ DFG A+ G N S+ + APE + ++
Sbjct: 122 VHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEAL-KHKKF 174
Query: 213 TTSIDIWSAGCVLAELL-LGQPLFP 236
++ D+WS G +L E+ G+ +P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 43 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPNVISLK------HCFF 95
G+FG V+ + + A+K V + D KN Q V + ++L H ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALALSKSPFIVHLYY 71
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
S S N ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
+ HRDLKP N+L+ H +K+ DFG +K + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 96
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
S+ +++ V E++ + S+ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 156 CHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL-IFGAT 210
HRDL+ N+LV D L KI DFG A+ LI + ++F + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG-- 178
Query: 211 EYTTSIDIWSAGCVLAELLL-GQPLFPG 237
+T D+WS G +L EL+ G+ +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 39 VVGTGSFGIVFQAKCLETG----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVIS 89
++ G+FG +F ++ E V +K V +E L+ + H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY------SSAN--QRMPLIYVKLYTYQ 141
+ H + P + LK + AN Q + + Q
Sbjct: 73 ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----- 196
I G++Y+H V H+D+ +N ++D QVKI D ++ L + Y C
Sbjct: 126 IACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDNE 179
Query: 197 SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 232
+R + A E + EY+++ D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L+ T K + + ME ++ + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 203
+ + V HRDL +N+LV+ + K+ DFG ++ ++ + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL 229
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 35/236 (14%)
Query: 40 VGTGSFGIVFQA--KCLETGETVAIKKVLQ----DRRYKN---RELQLMRVMDHPNVISL 90
+G+G+FG V + K ++ +TVA+K +L+ D K+ RE +M+ +D+P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ E ++ LVME + L + N+ + + +Q+ G+ Y+
Sbjct: 62 -----IGICEAESWM-LVMEL---AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 203
V HRDL +N+L+ H KI DFG +K L A E +Y ++ + AP
Sbjct: 113 ETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAP 167
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIKVLGTPTR 256
E + ++++ D+WS G ++ E GQ + G N V Q++E + + P R
Sbjct: 168 ECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 37 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 87
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY-------SSANQRMPLIYVKLY- 138
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 139 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 197
QI G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 125 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 198 RFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 243
+YR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 244 LVEII---KVLGTP 254
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 70/341 (20%), Positives = 123/341 (36%), Gaps = 103/341 (30%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 90
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
++S K+ L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 149 IHTVPRVCHRDLK--------------------------------------------PQN 164
+H + + HRD+K P
Sbjct: 117 VHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 165 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 224
+ ++K + +Q A+ S + + Y APE++ T YT D WS G +
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAH-SLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 233
Query: 225 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 284
L E+L+GQP F + TP +++ +N W H
Sbjct: 234 LYEMLVGQPPFLAD--------------TPAETQLKVIN---------------WETTLH 264
Query: 285 ----KRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF 318
++ EA DL RL R A E AHPFF
Sbjct: 265 IPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
Y APE++ YT D WS G +L E+L+GQP F + TPT ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPF 317
+ +N T PQ+K + PEA+DL ++L + R A + AHPF
Sbjct: 259 KVINWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 318 FDEL 321
F E+
Sbjct: 308 FSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 88
E V+G G+FG V +A + G AIK + + D R EL+++ ++ HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQ 141
+L +N +L + +EY P RVL+ A + L + Q
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-TDPAFAKEHGTASTLTSQQ 120
Query: 142 IFR-------GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFG-SAKQLIAGEANI 192
+ + G+ Y+ + + HRDL +N+LV + L KI DFG S + + + +
Sbjct: 121 LLQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTM 177
Query: 193 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ R+ L + YTT D+WS G +L E++
Sbjct: 178 GRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L ++S K+ L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180
+H + + HRD+KP N+L+D L +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILID-LDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 60 VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 114
VA+K + D R E+++M + +PN+I L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 115 -------SMYRVLKHYSSANQ-----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162
S + ++ AN L+Y+ + QI G+ Y+ ++ V HRDL
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV---QIASGMKYLASLNFV-HRDLAT 157
Query: 163 QNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDI 218
+N LV + +KI DFG ++ L +G+ + + R+ ++ G ++TT+ D+
Sbjct: 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDV 214
Query: 219 WSAGCVLAELL 229
W+ G L E+
Sbjct: 215 WAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 40 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RVMDHPNVIS-L 90
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM------PLIYVKLYTYQIFR 144
C S LV+E+ P LK+Y +N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 145 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 200
GL ++H + H DL +N L L+ VKI D+G A + + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 201 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 228
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 96
+G+G FG+V K + VAIK + + ++ E ++M + HPN++ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----YG 66
Query: 97 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTY----QIFRGLAYIH 150
+K + +V EY + + N + + + + Y+
Sbjct: 67 VCTKQRP-IFIVTEY--------MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS---RF---YRAPE 204
+ HRDL +N LV + VK+ DFG A+ ++ + Y S +F + PE
Sbjct: 118 S-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPE 171
Query: 205 LIFGATEYTTSIDIWSAGCVLAEL 228
+F + +++ D+WS G ++ E+
Sbjct: 172 -VFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 256
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 257 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 301
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 302 SPS 304
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 75 ELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 132
E +L+R + HP V++L T LV+ +Y L + + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-------- 182
V Q+ + YIH + HRD+K +N+LV+ IC DFG+A
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWS 315
Query: 183 ---KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQP 233
IAG + + APE++ G YT S+DIWSAG V+ E L
Sbjct: 316 TPFHYGIAGTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366
Query: 234 LFPGENAVD-QLVEIIK 249
D Q++ II+
Sbjct: 367 RGDERRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHCF 94
+G G+FG VF + VA+K + K + LQ R++ HPN++ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHTVP 153
T K ++ +VME V + ++ LI + G+ Y+ +
Sbjct: 60 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQM---VENAAAGMEYLES-- 112
Query: 154 RVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPE-LIF 207
+ C HRDL +N LV + +KI DFG +++ + A + I + + APE L +
Sbjct: 113 KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNY 170
Query: 208 GATEYTTSIDIWSAGCVLAE 227
G Y++ D+WS G +L E
Sbjct: 171 G--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 200
QI G+ Y+ ++ V HRDL +N LV +KI DFG ++ L AG+ +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 201 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 245
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 246 E 246
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 90
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
++S K+ L+ VM+Y+P M +L RM + L + I +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAV 114
Query: 150 HTVPRV--CHRDLKPQNLLVDPLTHQVKICDFG 180
+V ++ HRD+KP N+L+D H +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 39 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVISL 90
V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 91 KHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQIF 143
++ +L L +EY P RVL+ A L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLSSQQLL 115
Query: 144 R-------GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 195
G+ Y+ + + HRDL +N+LV + KI DFG S Q + + + +
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
R+ L + YTT+ D+WS G +L E++
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 45/222 (20%), Positives = 90/222 (40%), Gaps = 35/222 (15%)
Query: 25 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 66
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 67 QDRRY-KNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLVM-EYVPESMYRVLKH 122
+ Y ++ + +DH + C + + ++ ++ E + E+ + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 123 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182
N+ LI K + L YIH + H D+KP+N++VD ++ I D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 224
I +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHIEY-----SKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 135 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188
+K Q+ GL +H + + HRD+KP+NLLV + QVKI DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 62/311 (19%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 56 TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109
TGE V ++++ + + EL + ++ +HPN++ + F + NEL++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---DNELWVVTSF 80
Query: 110 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169
+ + H+ + + Y+ + + L YIH + V HR +K ++L+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHMGYV-HRSVKASHILIS- 135
Query: 170 LTHQVKICDFGSAKQLI--AGEANISYICSRF------YRAPELIFGATE-YTTSIDIWS 220
+ +V + S +I + + ++ + +PE++ + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 221 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 261
G EL G F A L+E + +L T T EE+
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255
Query: 262 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
+ + R + +HP+++ F P + LQ +P R +A H FF
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
Query: 320 EL-REPNARLP 329
++ R + LP
Sbjct: 312 QIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 38 RVVGTGSFGIVFQ--AKCL---ETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 87
R +G GSFG+V++ AK + E VAIK V + + R E +M+ + +V
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRM---PLIYVKLYTY 140
+ L S+ + L ++ME + +S R L+ N L +
Sbjct: 72 VRL----LGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 196
+I G+AY++ + HRDL +N +V VKI DFG + + + +
Sbjct: 127 EIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 233
R+ L G +TT D+WS G VL E+ L QP
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 196
QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L +G+ + +
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229
R+ ++ G ++TT+ D+W+ G L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.64 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| PLN02236 | 344 | choline kinase | 97.04 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.03 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.86 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.78 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.51 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.4 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 93.44 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.27 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.43 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.2 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-74 Score=497.73 Aligned_cols=361 Identities=70% Similarity=1.175 Sum_probs=344.9
Q ss_pred cccceEEeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeec
Q 017270 12 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLK 91 (374)
Q Consensus 12 ~~~~~~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (374)
..+.+..++..+....+...-.|.-.+.+|+|+||.||.|....+++.||||++..+.+...+|+.+|+.++|||||++.
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~ 83 (364)
T KOG0658|consen 4 ESGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLL 83 (364)
T ss_pred cceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEE
Confidence 45667788888888888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
.+|....+.+..++.+||||++.+|.+.++++...+..++...++-|.+||++||.|||+ .||+||||||.|+|+|.++
T Consensus 84 ~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~t 162 (364)
T KOG0658|consen 84 YFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDT 162 (364)
T ss_pred EEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCC
Confidence 999777666677889999999999999999988889999999999999999999999999 7999999999999999988
Q ss_pred CcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017270 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 251 (374)
+.+||||||.|+....++...++.+|++|+|||.++|...|+.+.||||.||++.||+.|++.|+|.+..+++..|++.+
T Consensus 163 g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 163 GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCC
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 331 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~ 331 (374)
|.|+.+.+.++++++.+..+|+++..+|...+....++++.||+.++|+++|.+|.++.|+|.||||..+++++..++++
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g 322 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNG 322 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhcCCCHHHHhhhcHHHHhhhcCCCCCCCCC
Q 017270 332 RPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 373 (374)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (374)
.++|++++|.....+..++..+.++|.+...+.+....|.++
T Consensus 323 ~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~~ 364 (364)
T KOG0658|consen 323 RPLPPLFNFKRAELGISPELVNVLIPEHLREQEKDKILCESA 364 (364)
T ss_pred CcCCCccCchHHHhccchHHHHhhccHhhhhhccccccccCC
Confidence 999999999999999999999999999999999988877653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-63 Score=441.41 Aligned_cols=283 Identities=37% Similarity=0.658 Sum_probs=255.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcC-CCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|.+++.||.|+||.||+|+.+.+|+.||||++.+.-. ...||++.|++|+ |||||++.+++.+.. .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 45799999999999999999999999999999998855422 2238999999998 999999999995432 2
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+|||||+.+|+++++.+ +..|++..++.|++||+.||+|+|+ +|+.||||||||||+.. ...|||+|||+|+
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLAR 158 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEeccccccc
Confidence 69999999999999999863 7889999999999999999999999 89999999999999996 6789999999999
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 262 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 262 (374)
........+.++.|+||+|||+++....|+.+.|||++|||++|+.+-++.|+|.++.+++.+|++.+|+|..+.|..-
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 9988888889999999999999998889999999999999999999999999999999999999999999998877652
Q ss_pred -CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 263 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...-..+.+|+....++...++. .++++.+||.+||.|||.+||||.|+|+||||+.-.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 13334578899888888888887 999999999999999999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-62 Score=411.70 Aligned_cols=281 Identities=35% Similarity=0.678 Sum_probs=248.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+.|+.+..+|+|+||+||+|+++.||+.||||++..... ...+|+++|++|+|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999965432 335899999999999999999999 666669
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|+|||+.++++.+.. ....++...++.|++|++.|+.|+|+ ++++||||||+|||++. ++.+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence 99999999988888775 34568999999999999999999999 89999999999999996 889999999999988
Q ss_pred c-cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH--Hhhc
Q 017270 186 I-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE--IRCM 262 (374)
Q Consensus 186 ~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 262 (374)
. .+...+.++.|.||+|||.+.|...|+.++||||+||++.||++|.+.|++..+.+++..|...+|.-.+.. +-..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 445556789999999999999988899999999999999999999999999999999999999999776654 4455
Q ss_pred CcCCcCCCCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 263 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 263 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
++-|...++|+... ++++..++ +++.-+.||+++||..||.+|++.+|+|.||||.++..
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 67788888888655 45666665 47889999999999999999999999999999976543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-61 Score=416.51 Aligned_cols=318 Identities=39% Similarity=0.668 Sum_probs=269.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
...|...+.||.|+||.|..|.++.||+.||||++.. ......+|+++|+.++|+||+.+.+++.......-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3467778999999999999999999999999999852 1234458999999999999999999987644455566
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|+|+|+++.+|..+++ .+..+++..++.+++||+.||+|+|+ .+++||||||+|++++. ++.+||+|||+|+.
T Consensus 101 vYiV~elMetDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHHhhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceee
Confidence 99999999988888776 45569999999999999999999999 79999999999999997 88899999999997
Q ss_pred ccc---CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 185 LIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 185 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
... ....+.++.|.||+|||+++....|+.+.||||+|||+.||++|++.|+|.+..+++..|++.+|+|+.+.+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 754 33446788999999999998888999999999999999999999999999999999999999999999988876
Q ss_pred cCcCCc---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 017270 262 MNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 338 (374)
Q Consensus 262 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
...... -..+|..+..+|...|+ ++++.+.||+.+||.+||.+|+|++|+|.||||..+.++....... +.+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~----~~~ 329 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ----PIF 329 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC----CCC
Confidence 652211 12578888999999998 6999999999999999999999999999999999998876553221 111
Q ss_pred CchhhhcCCCHHHHhhhcHHHHh
Q 017270 339 NFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.. .+.. .+.+.+++++..++.
T Consensus 330 ~~-~~~~-~~~~~~r~~i~~e~~ 350 (359)
T KOG0660|consen 330 DS-FEHE-LTEEELRELIYKEIL 350 (359)
T ss_pred cc-cccc-ccHHHHHHHHHHHHH
Confidence 11 2222 667778888877755
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-60 Score=393.40 Aligned_cols=278 Identities=39% Similarity=0.718 Sum_probs=244.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+|...+.||+|.||.||+|++..||+.||||++.... ....+|+++|+.++|+||+.++++|.. ...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCce
Confidence 47999999999999999999999999999999995432 234589999999999999999999944 3448
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
.+|+||++.+|...++. ....++...++.|+.+++.|++|||+ +.|+||||||.|+|+++ ++.+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence 89999999999988875 56789999999999999999999999 89999999999999997 889999999999987
Q ss_pred ccCCCcce-eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017270 186 IAGEANIS-YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263 (374)
Q Consensus 186 ~~~~~~~~-~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 263 (374)
.......+ .+.|.||+|||.++|...|+..+||||.|||+.||+.|.+.|++.++.+++..|.+.+|+|..+.|+++.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 65544433 4789999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred -cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
++|.++. ..+..+....|+ ..+.++.||+.+||.+||.+|+|+.|+|+||||+...
T Consensus 232 lpdY~~~~--~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 232 LPDYVKIQ--QFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred cccHHHHh--cCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 5565554 333444444554 4788899999999999999999999999999999743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-61 Score=421.76 Aligned_cols=257 Identities=31% Similarity=0.491 Sum_probs=213.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----------chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----------YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.+.|.+.+.||+|+||.|.+|..+.||+.||||++.++.. ...+|+++|++|+|||||+++++|
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 3568999999999999999999999999999999965421 224899999999999999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEE
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI 176 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl 176 (374)
....+.|+||||++| .|.+.+- .++.+.+..-+.+++||+.|++|||+ .||+||||||+|||+..+ +..+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEe
Confidence 444448999999996 4554443 56788889899999999999999999 799999999999999742 367999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGT 253 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 253 (374)
+|||+|+.........+.+|||.|.|||++.+. ..+..++|+||+||+||.+++|.+||.+..... ...+|.+
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 999999988777778899999999999999543 234558999999999999999999998765444 3333333
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+. +....+.++++++++||.+||..||++|||++|+|+||||+...
T Consensus 397 -------------G~y~--------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 -------------GRYA--------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------Cccc--------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 1111 12223456899999999999999999999999999999999654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-59 Score=398.88 Aligned_cols=290 Identities=32% Similarity=0.564 Sum_probs=254.1
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
+.....+.|+.+..|++|+||.||+|+++.|++.||+|++..+.. ...+|+.+|.+.+|||||.+.++.....-
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 344566799999999999999999999999999999999965432 22489999999999999999998865443
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
. .+|+|||||+.+|.+++.. -..+|...+++.++.|++.|++|||. +.|+||||||+|+|++. .|.+||+||
T Consensus 150 d---~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDF 221 (419)
T KOG0663|consen 150 D---KIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADF 221 (419)
T ss_pred c---eeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEeccc
Confidence 2 3889999999998888875 34789999999999999999999999 89999999999999995 889999999
Q ss_pred ccccccccCCCc-ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+|+.+...... +..+.|.||+|||+++|...|+.++||||+|||+.||+++.+.|++....+++.+|.+.+|.|....
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 999988766544 4567799999999999999999999999999999999999999999999999999999999999998
Q ss_pred HhhcC--cCCcCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 259 IRCMN--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 259 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
|+... +.+..+.++..+-.+++..|... +++...+|++.+|.+||.+|+||+|+|+|+||.....
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 88654 44445667777777777777664 7899999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-59 Score=427.49 Aligned_cols=253 Identities=33% Similarity=0.559 Sum_probs=224.2
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
..|.. .+|...+.||+|||++||.+++..+|+.||+|++.+. +....+|+++.+.|+|||||+++++|
T Consensus 13 ~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F---- 87 (592)
T KOG0575|consen 13 EDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF---- 87 (592)
T ss_pred ecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe----
Confidence 33444 5799999999999999999999999999999999763 23445899999999999999999999
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
++..++|||.|+|. ++|.++++ ..+.++|.+++.++.||+.||.|||+ ++|+|||||..|+|++. +..|||+
T Consensus 88 -EDs~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIg 160 (592)
T KOG0575|consen 88 -EDSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIG 160 (592)
T ss_pred -ecCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEec
Confidence 67777999999999 56666655 45789999999999999999999999 79999999999999996 7789999
Q ss_pred eeccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 178 DFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 178 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
|||+|...... +...+.+|||.|.|||++.. ...+..+||||+|||||.||.|++||...+..+.+.+|..
T Consensus 161 DFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------- 232 (592)
T KOG0575|consen 161 DFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------- 232 (592)
T ss_pred ccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------
Confidence 99999987744 67789999999999999974 4589999999999999999999999999998888888876
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.++.+| ..+|.+++|||.+||..||.+|||++++|.|+||+.
T Consensus 233 ----------~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----------NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----------cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 344444 368999999999999999999999999999999943
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=434.05 Aligned_cols=331 Identities=52% Similarity=0.974 Sum_probs=285.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCC---CCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---KNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~l 107 (374)
..+|.+.+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++|..... ....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 357999999999999999999999999999999997776667789999999999999999988754331 33456889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887766677889999999999999999999999 79999999999999997566799999999987665
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+++.++.|..+.+..+.+++.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 55555678899999999987766789999999999999999999999999999999999999999999999988888888
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCC-CCCCCCCCCchh-hhc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPLPPLFNFKQ-ELS 345 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~ 345 (374)
+..++......+...++...++++++||.+||++||.+|||+.|+|+||||..+++....++. ...+|.++++.. +..
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK 383 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence 888888888888888888899999999999999999999999999999999998876544443 345667777764 444
Q ss_pred CCCHHHHhhhcHHHHhh
Q 017270 346 GASPELVNKLIPDHVKR 362 (374)
Q Consensus 346 ~~~~~~~~~~~~~~~~~ 362 (374)
+..++....+++.....
T Consensus 384 ~~~~~~~~~~~~~~~~~ 400 (440)
T PTZ00036 384 EMSDACRRKIIPKCTYE 400 (440)
T ss_pred hCCHHHHHHHhhHHHHH
Confidence 67777777776654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-58 Score=414.14 Aligned_cols=285 Identities=36% Similarity=0.601 Sum_probs=244.0
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.|...+.|+.++.||+|+||.||+|++..||+.||+|++..+. ....+|+.+|++|+||||+++.+......
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~-- 189 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL-- 189 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--
Confidence 3456678999999999999999999999999999999996543 33469999999999999999999886542
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+|+|||+.+|..++.. ..-.|++.+++.|+.||+.||+|||+ +||+|||||.+|||||. ++.+||+|||
T Consensus 190 -~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFG 263 (560)
T KOG0600|consen 190 -SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFG 263 (560)
T ss_pred -CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEecccc
Confidence 234999999999988777763 45689999999999999999999999 89999999999999995 8899999999
Q ss_pred cccccccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 181 SAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 181 ~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
+|+.+.... ..+..+.|.||+|||+++|...|+.++|+||+||||.||++|++.|++.++.+++.+|.+..|.|....
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999776554 345678899999999999999999999999999999999999999999999999999999999999998
Q ss_pred HhhcCcC-CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 259 IRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 259 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
|...... +..+.-..--...+.+.| ..+++.+.+|+..||+.||.+|.||.++|+|+||..
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 8743322 222222222233444443 468999999999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=397.81 Aligned_cols=258 Identities=30% Similarity=0.502 Sum_probs=223.8
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
....++|++++.||+|+||+||+++.+.|++.||+|++.+.. .....|..+|..++||.||+++..| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 345679999999999999999999999999999999886543 2334799999999999999999999 6
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+...+|+|+||+.| .|...|. ..+.|+|..++.|+.+|+.||.|||+ +||+||||||+|||+|. .|.++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecc
Confidence 66669999999997 5555444 56889999999999999999999999 79999999999999996 888999999
Q ss_pred ccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++..... ....+.+||+.|||||++.+. .|+..+|+||||+++|+|++|.+||.+.+..+...+|.+.-.
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------ 242 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------ 242 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------
Confidence 999955443 455668999999999999876 599999999999999999999999999999998888876310
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCccccccCCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPN 325 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----s~~e~l~hp~~~~~~~~~ 325 (374)
...+..++++++|||+++|+.||++|. ++.++.+||||..++|..
T Consensus 243 ----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 243 ----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred ----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 011233799999999999999999996 688999999999998875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-57 Score=409.90 Aligned_cols=257 Identities=33% Similarity=0.578 Sum_probs=226.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
...+|.+++.||+|+|++|++|+++.+++.||||++.+.. ....+|..+|..| .||.|++++..| ++
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 3468999999999999999999999999999999886543 3445799999999 899999999999 55
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
+..+|+|+||++ |.|++++..+ +.|++..++.|+.||+.||+|||+ +|||||||||+|||+|. ++.++|+|||
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDFG 219 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDFG 219 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeecc
Confidence 555999999999 6888888754 779999999999999999999999 79999999999999996 8889999999
Q ss_pred cccccccCCC--------------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017270 181 SAKQLIAGEA--------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246 (374)
Q Consensus 181 ~a~~~~~~~~--------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 246 (374)
.|+.+..... ..+++||..|.+||++. ....++.+|+|+||||+|+|+.|.+||.+.+..-.+++
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK 298 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 9986643211 14689999999999995 45589999999999999999999999999999999999
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCC
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~ 326 (374)
|++. ++.| ++.+++.++|||+++|..||.+|+|+++|.+||||.++.|.+.
T Consensus 299 I~~l-----------------~y~f------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 299 IQAL-----------------DYEF------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred HHHh-----------------cccC------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 9983 3443 4568999999999999999999999999999999999999874
Q ss_pred C
Q 017270 327 R 327 (374)
Q Consensus 327 ~ 327 (374)
+
T Consensus 350 w 350 (604)
T KOG0592|consen 350 W 350 (604)
T ss_pred h
Confidence 4
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-57 Score=392.54 Aligned_cols=255 Identities=31% Similarity=0.566 Sum_probs=214.6
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
+.+.++.||+|..|+||+|+|+.|++.+|+|++..+ ++...+|+++++..+||+||++|++|+.... .++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 677889999999999999999999999999999332 2344589999999999999999999966442 4889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||+| +|...+. ..++++|..+..++.++++||.|||+.++|+||||||+|||+++ .+.|||||||.++...
T Consensus 156 ~mEYMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGILV 230 (364)
T ss_pred ehhhcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHhh
Confidence 9999996 5555554 33789999999999999999999995379999999999999997 8999999999999776
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHhh
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
.. ...+++||..|||||.+.+. .|+.++||||||+.++|+++|+.||... +..+.+..|+. +.|+
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP------ 300 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPP------ 300 (364)
T ss_pred hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCC------
Confidence 65 56789999999999999765 5999999999999999999999999874 34445554443 1111
Q ss_pred cCcCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~ 326 (374)
. ++. .+|+++++||.+||++||.+|+|+.|+++|||+++....+.
T Consensus 301 -----------~---------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v 346 (364)
T KOG0581|consen 301 -----------R---------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV 346 (364)
T ss_pred -----------C---------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence 0 222 27999999999999999999999999999999998765543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=374.03 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=225.3
Q ss_pred CCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeec
Q 017270 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFST 97 (374)
Q Consensus 25 ~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (374)
.+.|-...+|++++.||.|+||+|.+++++.+|..||+|++.++. .....|..+|+.+.||.+++++..|
T Consensus 37 ~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--- 113 (355)
T KOG0616|consen 37 PQNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--- 113 (355)
T ss_pred CCCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee---
Confidence 344455679999999999999999999999999999999886653 2234799999999999999999888
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
.+..++|+||||++| .|.+.++ ..++|++..++.|+.||+.||+|||+ ++|++|||||+|||+|. +|.+||
T Consensus 114 --~d~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKi 185 (355)
T KOG0616|consen 114 --KDNSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKI 185 (355)
T ss_pred --ccCCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEE
Confidence 555669999999997 4555554 56789999999999999999999999 79999999999999997 888999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+|||.|+..... ..+.+|||.|+|||++.. ..|+.++|+|||||++|||+.|.+||...+....+.+|++
T Consensus 186 tDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~------- 255 (355)
T KOG0616|consen 186 TDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE------- 255 (355)
T ss_pred EeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh-------
Confidence 999999976544 678899999999999965 5599999999999999999999999999999999999988
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
.++.+ +..++++++|||+++|+.|-.+|. ...++.+||||+.+.|..
T Consensus 256 ----------~~v~f------------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 256 ----------GKVKF------------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred ----------CcccC------------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 23333 346899999999999999999994 578999999999988864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=400.08 Aligned_cols=270 Identities=30% Similarity=0.489 Sum_probs=224.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|.+++.||+|+||.||+|+.+.||..||+|++.+..- ....|..+|...++|+||+++..| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 45799999999999999999999999999999999976542 234688899999999999999999 677
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
.++|+||||++| ++..+|. ....|++.+++.|+.+++.|++.||+ .|++||||||+|+|||. .|.+||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeeccccc
Confidence 779999999996 4555554 56789999999999999999999999 79999999999999997 88899999999
Q ss_pred cccccc------------------------CC-----C-------------------cceeeeeccccchhhhhCCCCCC
Q 017270 182 AKQLIA------------------------GE-----A-------------------NISYICSRFYRAPELIFGATEYT 213 (374)
Q Consensus 182 a~~~~~------------------------~~-----~-------------------~~~~~~t~~y~aPE~l~~~~~~~ 213 (374)
+.-... .. . ..+.+|||.|+|||++.+.. |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 842210 00 0 01457999999999998765 99
Q ss_pred CchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHH
Q 017270 214 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 293 (374)
Q Consensus 214 ~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (374)
..+|+||||||+||||.|.+||.+.+..+...+|+..-. .+.+|. ....+++++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~----------~~~~s~eA~D 421 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPE----------EVDLSDEAKD 421 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCC----------cCcccHHHHH
Confidence 999999999999999999999999999999999987311 111221 1246899999
Q ss_pred HHHhhcCcCCCCCCC---HHHHhcCCccccccCCCCCCCCCCCCCCC
Q 017270 294 LASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRPLPPL 337 (374)
Q Consensus 294 li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~~~~~~~~~~~~~~ 337 (374)
||.+||+ ||++|.. ++||..||||+.+.|...+-.....+|.+
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v 467 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQV 467 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCC
Confidence 9999999 9999985 89999999999999987654444444433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-55 Score=380.67 Aligned_cols=293 Identities=34% Similarity=0.683 Sum_probs=247.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCc-eeeeceeeeecCC-CCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPN-VISLKHCFFSTTS-KNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~ 102 (374)
...|..++.||+|+||+||+|+++.+|+.||+|++.-+.. ...+|+.+++.++|+| ||.+++++..... ...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4578888999999999999999999999999999964432 3369999999999999 9999999855441 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+++||||+..+|...+.........++...++.+++||+.||.|||+ ++|+||||||+|||+++ ++.+||+|||+|
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence 4689999999998888887644333467778999999999999999999 89999999999999997 899999999999
Q ss_pred cccc-cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+... ........++|.+|+|||+++|...|+...||||+|||++||+++++.|++..+.+++..|.+.+|+|..+.|+.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8655 333455678899999999999998899999999999999999999999999999999999999999999998885
Q ss_pred cC--cCCcCCCCCCCC-CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCC
Q 017270 262 MN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 262 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
.. +.|.. .++... ...+....+ +.+++..|++.+||+.||.+|.|+..+|.||||..+......
T Consensus 248 v~~~~~~k~-~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~ 314 (323)
T KOG0594|consen 248 VSSLPDYKA-PFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ 314 (323)
T ss_pred ccccccccc-cCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence 54 33332 455554 344444443 456899999999999999999999999999999987655433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-55 Score=402.70 Aligned_cols=255 Identities=34% Similarity=0.546 Sum_probs=226.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.+-|++++.||.|+.|.|.+|+|..||+..|||++.+. ...+++|+-+|+.+.|||++.+++++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 45699999999999999999999999999999999776 45567999999999999999999999 6677
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|.||++| .|.+.+. ..+++++.++.++++||+.|+.|||. .+|+||||||+|+|+|. .++|||+|||+|
T Consensus 86 ~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMA 159 (786)
T ss_pred eEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeecccee
Confidence 79999999995 5555544 56899999999999999999999999 69999999999999997 555999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.....+....+.+|+|.|.|||++.|..+.+.++||||+|||||.|++|+.||.+.+-...+.++.+
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------- 226 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------- 226 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------
Confidence 9877777778899999999999999888779999999999999999999999997776666666655
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
+.|.+| ..++++++|||++||..||++|+|.+||++|||+.+.....
T Consensus 227 ----G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 227 ----GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ----CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 334444 46899999999999999999999999999999999876543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=396.75 Aligned_cols=280 Identities=36% Similarity=0.608 Sum_probs=230.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhcC-C-----CceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD-H-----PNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.|.+.||+|+||.|.+|.+..|++.||||++....... ..|+++|..|+ | -|+|+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 8999999999999999999999999999999997765544 36899999886 3 4899999999 4445
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc-CCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~-~~~~~ikl~Dfg~a 182 (374)
++|||+|+++.+|+++++... ...++...++.++.||+.||.+||+ .||||+||||||||+. .....|||+|||.|
T Consensus 262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 599999999999999999643 3559999999999999999999999 7999999999999985 33457999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ..+++.+.+|+|||+++|.+ |+.+.||||||||++||++|.+.|++.+..+++..|++.+|.|+...+...
T Consensus 339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 754333 33899999999999999865 999999999999999999999999999999999999999999999887643
Q ss_pred CcCCcCCCC----CC-----------------------------C-CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017270 263 NPNYTDFRF----PQ-----------------------------I-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 308 (374)
Q Consensus 263 ~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 308 (374)
......+.- +. - ....+.......-...+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 322111111 00 0 1122222222223356799999999999999999
Q ss_pred HHHHhcCCccccccC
Q 017270 309 ALEACAHPFFDELRE 323 (374)
Q Consensus 309 ~~e~l~hp~~~~~~~ 323 (374)
+.++|+||||.....
T Consensus 496 p~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhcCcccccccc
Confidence 999999999986433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=376.90 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=218.1
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|.+.+.||.|+||+||+|+++.++..||||.+.+.. .....|+++|+.++|||||.+++++ ...
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence 45679999999999999999999999999999999997653 2235799999999999999999998 445
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--C---CcEEE
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--T---HQVKI 176 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~---~~ikl 176 (374)
.++|+|||||.| +|...++ ..+.+++..++.++.||+.||++||+ ++|+||||||+|||++.. + -.+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 569999999995 6666665 45689999999999999999999999 899999999999999752 1 46999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+|||+|+.........+.+|+|.|||||++.. ..|+.|+|+||+|+|+|+|++|+.||...+..+.+..+.+.-.
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---- 231 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---- 231 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence 99999999888777788999999999999964 4599999999999999999999999999988887765443111
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
....++..+++.+.+|+...|+.+|.+|.+..+-+.||++..
T Consensus 232 ----------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ----------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ----------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 111123346778889999999999999999999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=363.40 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=219.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|.+-+.||+|+|+.|+++.+..||+.+|+|++.. +....++|+.+-+.|+||||+++.+.+ +..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 456789999999999999999999999999999997742 224456899999999999999999888 667
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Df 179 (374)
.+.|+|+|++.| .|...+-. ...++|..+..++.||+.||.|+|. +||||||+||+|+++.+. +--+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence 789999999997 44444432 2568999999999999999999999 899999999999999642 235999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|+|.....+.......|||.|+|||++... .|+..+|||++|||||.|+.|.+||.+.+....++.|++
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~---------- 226 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA---------- 226 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc----------
Confidence 999988866666778999999999999654 599999999999999999999999999988888888877
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.++.++. ..++++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 227 -------g~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 -------GAYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -------cccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 2333322 123568999999999999999999999999999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=396.38 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=222.0
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|+++++||+|.||+|++|..+.+++.||||.+.++.... ..|..++... +||.+++++.+| +
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence 34568999999999999999999999999999999987764333 3577777666 499999999999 6
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...++|+||||+.|+. +.+ ......|++..++.|+++++.||+|||+ +||||||||.+|||+|. .|.+||+|||
T Consensus 440 T~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADFG 513 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADFG 513 (694)
T ss_pred cCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEecccc
Confidence 6777999999999874 222 2345789999999999999999999999 89999999999999997 7789999999
Q ss_pred cccccc-cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 181 SAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 181 ~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+++... .+....+++|||.|+|||++.+. .|+.++|+|||||+||||+.|..||++.+..+....|+.
T Consensus 514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------- 582 (694)
T KOG0694|consen 514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------- 582 (694)
T ss_pred cccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------
Confidence 999766 44556789999999999999765 599999999999999999999999999999999998887
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 325 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~ 325 (374)
.+..+ +..+|.++.++++++|.+||++|.. ++++..||||+.+.|..
T Consensus 583 -------d~~~y------------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 583 -------DEVRY------------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred -------CCCCC------------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 23333 3458999999999999999999995 57999999999998864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=389.63 Aligned_cols=253 Identities=33% Similarity=0.506 Sum_probs=218.0
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhcC-CCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMD-HPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 98 (374)
...++|.+.+.||+|+||+|++|.+..++..||+|++.+. .....+|+.+++.++ ||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence 3456899999999999999999999999999999966543 123347999999999 99999999999
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....+|+|||||.| .|++.+. ..+++.|..++.++.||+.|++|||+ +||+||||||+|||++.+.+.+||+
T Consensus 90 -~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 90 -ATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred -ecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence 334449999999996 6666665 36889999999999999999999999 7999999999999999733889999
Q ss_pred eecccccc-ccCCCcceeeeeccccchhhhhCCC-CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 178 DFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 178 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|||++... .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+....+.+|.+
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999977 3556667899999999999997765 446899999999999999999999999887777777655
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCC-ChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..+.+| ..+ |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 238 -----------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -----------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 233333 336 999999999999999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=368.69 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=214.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhcCCCceeeece-eeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKH-CFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~~~ 103 (374)
..+|+|++.||.|.||+||++.+..+|+.+|.|.+.- .+....+|+.+|++|+|||||++++ .| . +++.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f-~---~~~e 93 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF-I---EDNE 93 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh-h---ccch
Confidence 3479999999999999999999999999999998842 2334458999999999999999987 44 1 3334
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CC--eEeecCCCCcEEEcCCCCcEEEEee
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PR--VCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~--ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.++||||||+ |+|...+++++.....++|..+|.++.|++.||..||+. .. |+||||||.||+++. +|.+||+||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDf 172 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDF 172 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccc
Confidence 4889999999 689999999999999999999999999999999999981 13 899999999999996 889999999
Q ss_pred ccccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++.+..... ..+++|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.+.+-.+.-.+|.+.--.|.+
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-- 249 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--
Confidence 99998765543 3578999999999999765 5999999999999999999999999999777777766663111111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
....|.++..+|.-|++.||+.||+. +|++.++..
T Consensus 250 -------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 250 -------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred -------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 02468999999999999999999986 566655443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=371.63 Aligned_cols=277 Identities=33% Similarity=0.649 Sum_probs=231.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||.|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 468999999999999999999999999999999885322 2345799999999999999999988 334468
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeec
Confidence 99999999988777653 34568899999999999999999999 79999999999999996 788999999998754
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 263 (374)
.... ......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+..+.++...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3322 22345679999999998766668999999999999999999999999999999999999999999988877543
Q ss_pred -cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+..+.++.....++... ...++++++|||++||++||.+|||++|+++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2333444454444444433 24588999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=366.04 Aligned_cols=274 Identities=26% Similarity=0.450 Sum_probs=227.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
...+++++.||.|.-|+||+|+.+.++..+|+|++.++. .+...|.+||..++||.++.+|..| +.+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 357999999999999999999999999999999997653 2334689999999999999999999 7777
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+.|+|||||+|+-+..+.+ +..+..|++..++.|+.+++.||+|||.+ |||+|||||+||||-+ +|.|-|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvre-dGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVRE-DGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEec-CCcEEeeeccccc
Confidence 8999999999754444443 34678899999999999999999999995 9999999999999996 7889999999974
Q ss_pred cccc---------------------------------C------------------------CCcceeeeeccccchhhh
Q 017270 184 QLIA---------------------------------G------------------------EANISYICSRFYRAPELI 206 (374)
Q Consensus 184 ~~~~---------------------------------~------------------------~~~~~~~~t~~y~aPE~l 206 (374)
.... . ....+++||-.|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 2210 0 011245789999999999
Q ss_pred hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccC
Q 017270 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 286 (374)
Q Consensus 207 ~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (374)
.|.. .+.++|+|+|||.+|||+.|..||.+.+..+.+.+|+. .+..||.. ..
T Consensus 308 ~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------~~ 359 (459)
T KOG0610|consen 308 RGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------PE 359 (459)
T ss_pred ecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------Cc
Confidence 8765 79999999999999999999999999999999988876 22333331 14
Q ss_pred CChhHHHHHHhhcCcCCCCCCC----HHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 287 MPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 287 ~~~~~~~li~~~L~~dp~~R~s----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
++..++|||+++|.+||++|+. |.||.+||||++++|...+......+|...+.
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 7889999999999999999998 99999999999999996665544445554443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=366.38 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=209.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..+|...+.||+|+||+||++.+..+|..+|+|.+... .....+|+.+|+.++|||||++++....... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence 45799999999999999999999999999999998765 3345799999999999999999886422211 4688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+.|||+++ +|.+.+..+ +..+++..++.+..||+.||+|||+ +||+||||||+|||++..++.+||+|||+++..
T Consensus 93 i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999995 666666642 2279999999999999999999999 899999999999999964578999999999876
Q ss_pred cc----CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
.. ........||+.|||||++........++|||||||++.||+||.+||... .....+..+...-
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence 53 222346789999999999964322345999999999999999999999873 3333333332210
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
..| .++..+|+++++||.+||.+||++||||+++|+|||.+.-..
T Consensus 240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 011 245668999999999999999999999999999999986443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=378.89 Aligned_cols=249 Identities=30% Similarity=0.563 Sum_probs=217.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+..+. ..+|+++++.++|||||.+++.| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 5899999999999999999999999999999998765443 35899999999999999999999 666679
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|+|||.|+|..++. .++.++|+.++.++.|++.||.|||+ ++|.|||+||.|||++. ++.+|+||||+|+..
T Consensus 77 ~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence 9999999998888776 57889999999999999999999999 79999999999999996 889999999999977
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..+.. ..+..|||.|||||++.+ ..|+..+|+||+|||+|||++|++||....-.+....|... |
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---------- 216 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---------- 216 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C----------
Confidence 65443 345678999999999975 56999999999999999999999999887766666655541 1
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.. .+..++..+.+|+..+|.+||.+|+|..+++.|||.++-
T Consensus 217 ----v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 217 ----VK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----CC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11 123589999999999999999999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=367.02 Aligned_cols=283 Identities=33% Similarity=0.580 Sum_probs=221.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|.+.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 468999999999999999999999999999999885432 23457999999999999999999883 34458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence 99999999988777653 34568999999999999999999999 79999999999999996 788999999998754
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 3222 22345678999999998766668999999999999999999999998754 445666777777777655544321
Q ss_pred --cCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 264 --PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+.+....+.......+...+.. ..++.+.+||.+||++||.+|||+.|+++||||+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 1111111111111222222211 35678999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=370.11 Aligned_cols=318 Identities=37% Similarity=0.644 Sum_probs=240.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5999999999999999999999999999999885321 2245799999999999999999988655444445689
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||||+++|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence 999999988877765 34569999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCCC----cceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 187 AGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 187 ~~~~----~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
.... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1245789999999998542 4589999999999999999999999999888888888888888887765543
Q ss_pred cCcCCcC-C--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 017270 262 MNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 338 (374)
Q Consensus 262 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
....... + .+......++...+ ..+++.+.++|.+||+.||++|||++|+++||||+.+...... +...+.+..
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~~- 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITKL- 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCccccc-
Confidence 2211000 0 00111111222222 2478899999999999999999999999999999987664322 223333322
Q ss_pred CchhhhcCCCHHHHhhhcHHH
Q 017270 339 NFKQELSGASPELVNKLIPDH 359 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~ 359 (374)
.+.-+....+.+.+..++.++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~ 332 (338)
T cd07859 312 EFEFERRRLTKEDVRELIYRE 332 (338)
T ss_pred cccHHHHhcCHHHHHHHHHHH
Confidence 333334455556666655554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=366.41 Aligned_cols=263 Identities=28% Similarity=0.444 Sum_probs=216.7
Q ss_pred CCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------------cchHHHHHHHHhcCC
Q 017270 23 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRVMDH 84 (374)
Q Consensus 23 ~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------------~~~~~e~~~l~~l~h 84 (374)
.....-.+.++|++.+.||+|.||+|.+|++..+++.||||++.+.. ....+|+.+|+++.|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 33444567789999999999999999999999999999999985432 123479999999999
Q ss_pred CceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCC
Q 017270 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 163 (374)
Q Consensus 85 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~-l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~ 163 (374)
||||+++++.-+ .....+|+|+|||..+ -+.. ...... +++.++|.|+.+++.||+|||. +||+||||||+
T Consensus 168 ~nVV~LiEvLDD---P~s~~~YlVley~s~G---~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPs 239 (576)
T KOG0585|consen 168 PNVVKLIEVLDD---PESDKLYLVLEYCSKG---EVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPS 239 (576)
T ss_pred cCeeEEEEeecC---cccCceEEEEEeccCC---cccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchh
Confidence 999999998844 3344599999999954 1111 223444 9999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeeccccccccCC------CcceeeeeccccchhhhhCC---CCCCCchhhHhHHHHHHHHHhCCCC
Q 017270 164 NLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPL 234 (374)
Q Consensus 164 NIll~~~~~~ikl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~p 234 (374)
|+|+++ ++.+||+|||.+....... .....+|||.|+|||.+.+. ...+.+.||||+||+||.|+.|+.|
T Consensus 240 NLLl~~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 240 NLLLSS-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred heEEcC-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 999997 7899999999997653221 12347899999999998762 2347899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 235 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 235 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
|-+....+.+.+|++ ....+|.. ..+.++++|||.+||++||++|+++.++..
T Consensus 319 F~~~~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 319 FFDDFELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cccchHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 999999999999887 22233321 136889999999999999999999999999
Q ss_pred CCccccc
Q 017270 315 HPFFDEL 321 (374)
Q Consensus 315 hp~~~~~ 321 (374)
|||...-
T Consensus 372 Hpwvt~~ 378 (576)
T KOG0585|consen 372 HPWVTRD 378 (576)
T ss_pred cceeccC
Confidence 9999763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=358.61 Aligned_cols=281 Identities=25% Similarity=0.430 Sum_probs=230.8
Q ss_pred EEeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeec
Q 017270 17 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLK 91 (374)
Q Consensus 17 ~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~ 91 (374)
...+...+...|.....|.+...||.|..++||+|++..+++.||||++.-+. ....+|+..++.++||||++++
T Consensus 11 ~~~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 11 LPSASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred ccccccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEE
Confidence 34556667788888999999999999999999999999999999999985432 3456899999999999999999
Q ss_pred eeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 170 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~ 170 (374)
.+|....+ +|+||.||. |+++++++.+-.. .+.|..++.|+.+++.||.|||. +|.+|||||+.|||++.
T Consensus 91 ~sFvv~~~-----LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~- 161 (516)
T KOG0582|consen 91 CSFVVDSE-----LWVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS- 161 (516)
T ss_pred EEEEecce-----eEEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-
Confidence 99965554 999999999 6888888876544 49999999999999999999999 79999999999999996
Q ss_pred CCcEEEEeeccccccccCCCc-----ceeeeeccccchhhh-hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHH
Q 017270 171 THQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 244 (374)
Q Consensus 171 ~~~ikl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~l-~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~ 244 (374)
+|.|||+|||.+......... .+..|||+|||||++ .....|+.|+||||||++..||.+|..||....+.+.+
T Consensus 162 dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 162 DGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred CCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 899999999988755443321 345889999999995 34456999999999999999999999999999888776
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 245 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
...++ +.|+..... ..+.. -...++..++.+|..||++||.+|||++++|+|+||+..+..
T Consensus 242 l~tLq--n~pp~~~t~---------------~~~~d--~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 242 LLTLQ--NDPPTLLTS---------------GLDKD--EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHHhc--CCCCCcccc---------------cCChH--HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 55443 433311100 00000 112467799999999999999999999999999999986654
Q ss_pred C
Q 017270 325 N 325 (374)
Q Consensus 325 ~ 325 (374)
+
T Consensus 303 ~ 303 (516)
T KOG0582|consen 303 E 303 (516)
T ss_pred h
Confidence 3
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=320.60 Aligned_cols=278 Identities=35% Similarity=0.645 Sum_probs=237.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.|.-.+.||+|.||+||+|++..+++.||+|.+.-+. ....+|+.+++.++|.|||+++++. ..+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 5667789999999999999999999999999986442 2345899999999999999999987 4444588
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|+|||...|...+. .-++.+..+.++.++.|++.||.|+|+ +++.||||||.|+|++. ++.+|++|||+++.+.
T Consensus 78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcC
Confidence 999999998776665 357889999999999999999999999 79999999999999996 8999999999998654
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
-.-. ....+.|.+|++|.+++|..-|+...|+||.|||+.|+.. |++.|++.+..+++..|...+|.|..+.|+.+..
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 3332 2345679999999999999889999999999999999996 9999999999999999999999999999987763
Q ss_pred CCcCCCCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 265 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 265 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
--.-..+|.... ..|.++.+ +++...+||++++|.-+|.+|++++++++||||...
T Consensus 233 lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 322223344333 35666554 588899999999999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=373.32 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=216.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...|...+.||+|+.|.||.|+...+++.||||.+.... .....|+.+|+..+|+|||.+++.|..... ++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eE
Confidence 357889999999999999999999999999999985443 344589999999999999999999965533 99
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||++| +|.+.+. ...++|.++..++.+++.||+|||. +||+|||||.+|||++. ++.+||+|||++..+
T Consensus 347 VVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeecc
Confidence 99999996 5555544 3559999999999999999999999 89999999999999996 788999999999887
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ...+.+|||+|||||++. ...|++++||||||++++||+-|.+||-..+....+..|.. .|+|...
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------- 490 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------- 490 (550)
T ss_pred ccccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------
Confidence 7655 456789999999999995 45699999999999999999999999998887777766654 3443321
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.++.+|++++||+.+||+.|+.+|++|.|+|+||||+.
T Consensus 491 ------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 23469999999999999999999999999999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=346.89 Aligned_cols=258 Identities=31% Similarity=0.508 Sum_probs=221.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
...|.-.+.||.|..++|.+|.++.+|+.+|+|++.... ....+|+.+|+++ .||+|+++.++|
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--- 92 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--- 92 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence 357888999999999999999999999999999883211 1223699999988 699999999999
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
+.+.++++|+|.|+ |.|.+.+. ..-.+++...+.++.||+.|+.|||. ++||||||||+|||++. +.++||
T Consensus 93 --es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~i 164 (411)
T KOG0599|consen 93 --ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKI 164 (411)
T ss_pred --cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEE
Confidence 77778999999999 66666665 56779999999999999999999999 89999999999999995 888999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhh-----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 251 (374)
+|||+|.....+......+|||.|.|||.+. +.+.|+..+|+|++|||||.|+.|.+||-.....-++..|++.
T Consensus 165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG- 243 (411)
T KOG0599|consen 165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG- 243 (411)
T ss_pred eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc-
Confidence 9999999999888888999999999999983 3456899999999999999999999999888877788888772
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.+.|. ..-+.++|...+|||.+||+.||++|+|+.|+|.||||..+-..
T Consensus 244 ----------------kyqF~--------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 244 ----------------KYQFR--------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ----------------ccccC--------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 22221 11224589999999999999999999999999999999776544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=356.43 Aligned_cols=276 Identities=36% Similarity=0.698 Sum_probs=221.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|.+.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47999999999999999999999999999999885432 2335799999999999999999988 344468
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL 150 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence 99999999887666543 34579999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+.+..+.+..+..+...+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 4322 12245689999999998654 48999999999999999999999999988888777777777766655443221
Q ss_pred --cCCcCCCCCCC-CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 --PNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+....++.. ....+...+...+|.++.+||++||++||++|||++++|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 22222222221 11223334445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=359.82 Aligned_cols=283 Identities=33% Similarity=0.650 Sum_probs=231.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|.+.+.||+|+||+||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 78 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKS 78 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCe
Confidence 3468999999999999999999999999999999885332 23347999999999999999999884 3345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 153 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (309)
T ss_pred EEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcccccee
Confidence 899999999988776653 34568999999999999999999999 79999999999999996 77899999999875
Q ss_pred cccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.+....++...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 43322 22335678999999998766668999999999999999999999999999889999999999998887776543
Q ss_pred c--CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 264 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 264 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
. .+..+.++......+.... ..+++++++||.+||+.||.+|||++|+++||||+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred chhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 2 1222333433333333322 358899999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=357.13 Aligned_cols=280 Identities=34% Similarity=0.587 Sum_probs=222.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-CcEEEEEEeeccc------cchHHHHHHHHhc---CCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~ 101 (374)
.+|++.+.||+|+||+||+|++..+ ++.||+|.+.... ....+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3799999999999999999998654 6789999875322 1234577777665 6999999999885443344
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...+++||||++++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccc
Confidence 5568899999999888777642 23458999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+.++.+..+.+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9865544444456789999999998654 589999999999999999999999999999999999998888777665543
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
... .....+......++... ...+++.+++|+.+||+.||++|||+.++|+||||
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVA-LPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhc-ccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211 11111222222233333 23588999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=363.41 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=220.8
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcC-CCceeeeceeeeecCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMD-HPNVISLKHCFFSTTS 99 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (374)
......|.+.+.||.|.||+||+|.++.||+.+|+|.+.+... ...+|+.+|+.+. |||||.++++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----- 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----- 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 3455689999999999999999999999999999999976543 4568999999998 99999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC---CcEE
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVK 175 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~---~~ik 175 (374)
++...+++|||+|.| .|.+.+... .+++..+..++.|++.|++|||+ .||+||||||+|+|+.... +.+|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEE
Confidence 444569999999995 666666543 39999999999999999999999 7999999999999996532 3799
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++|||++............+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+......++...
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----- 253 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----- 253 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----
Confidence 999999998777666677899999999999954 56999999999999999999999999999988887766652
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
++.+ ....+..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus 254 ------------~~~f--------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 254 ------------DFDF--------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ------------CCCC--------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 1111 1112345899999999999999999999999999999998753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=365.65 Aligned_cols=287 Identities=32% Similarity=0.558 Sum_probs=227.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4579999999999999999999999999999999885432 223478999999999999999988743322 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+||||+++++...+. ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence 4578999999998777664 247889999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++++..+.+..+.+...
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 865444334456789999999999654 5899999999999999999999999999999999999998888876654433
Q ss_pred CcC----------CcCCCCCCC---CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 263 NPN----------YTDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 263 ~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
.+. +..+.+... ...++........+..+++||.+||+.||.+|||++++|+||||..+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 211 111111100 001111112223467899999999999999999999999999998765554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=352.88 Aligned_cols=279 Identities=30% Similarity=0.547 Sum_probs=222.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhc---CCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999885421 1234677777665 799999999988655444556
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++||||+.+++...+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence 68899999999887777542 23458999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 66544444456778999999998654 58999999999999999999999999998888888888888877665554211
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
. .....+......++.. ....+++.+.+||.+||++||.+|||+.+++.||||
T Consensus 236 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0111111112222222 223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=366.98 Aligned_cols=284 Identities=33% Similarity=0.556 Sum_probs=225.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999885421 2345799999999999999999988543322223588
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||+.++|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence 999999988777664 35679999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... .....+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3221 22346788999999997766689999999999999999999999999999999999999999888765543211
Q ss_pred CCcCCCCCCC-CCCChhh--hcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 265 NYTDFRFPQI-KAHPWHK--VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 265 ~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.......... ....+.. .+....++++.+||.+||++||.+|||+.|+++||||...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 1000000000 0000111 12345688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=365.82 Aligned_cols=286 Identities=32% Similarity=0.554 Sum_probs=224.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4579999999999999999999999999999999885431 223479999999999999999998853332 122
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+||||+++++...+. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 3478999999998776653 348889999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+........
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 765444444456789999999998654 5899999999999999999999999999988888888888888776543322
Q ss_pred C----------cCCcCCCCCCC-CCC--ChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 N----------PNYTDFRFPQI-KAH--PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~----------~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. +.+....+... ... +.........++++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1 11111110000 000 00011122357889999999999999999999999999999865444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=359.59 Aligned_cols=269 Identities=28% Similarity=0.449 Sum_probs=235.6
Q ss_pred CCcccceEEeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcC
Q 017270 10 DHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMD 83 (374)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~ 83 (374)
..+.|.+..+.+.| -|.+.+.||+|-|++|.+|+|..||+.||||++.+... ...+|+.+|+..+
T Consensus 5 ~~~~g~i~DgkIAG---------LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ 75 (864)
T KOG4717|consen 5 GFKRGHIYDGKIAG---------LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ 75 (864)
T ss_pred ccccccccccceee---------eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc
Confidence 34455555555444 79999999999999999999999999999999976542 3348999999999
Q ss_pred CCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCC
Q 017270 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162 (374)
Q Consensus 84 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp 162 (374)
|||||++|++. .....+|+|+|+-++ +|++++.. ....+.|..++.|+.||+.|+.|+|++ ++|||||||
T Consensus 76 HpNiVRLYEVi-----DTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKP 146 (864)
T KOG4717|consen 76 HPNIVRLYEVI-----DTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKP 146 (864)
T ss_pred CcCeeeeeehh-----cccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCc
Confidence 99999999988 444459999999885 88888764 456799999999999999999999995 999999999
Q ss_pred CcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH
Q 017270 163 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242 (374)
Q Consensus 163 ~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~ 242 (374)
+|+.+-+.-|-+||.|||++..+..+....+.+|+..|.|||+++|..+-.+++||||||||||-|++|++||...++.+
T Consensus 147 ENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 147 ENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred ceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 99998776889999999999999988888899999999999999998877899999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+..|+.+ .|. ++..++.+++|||..||..||.+|.|.++|..|+|++...
T Consensus 227 TLTmImDC-----------------KYt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 227 TLTMIMDC-----------------KYT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hhhhhhcc-----------------ccc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999884 122 2346899999999999999999999999999999999876
Q ss_pred CCC
Q 017270 323 EPN 325 (374)
Q Consensus 323 ~~~ 325 (374)
...
T Consensus 278 ~~~ 280 (864)
T KOG4717|consen 278 RGL 280 (864)
T ss_pred CCc
Confidence 553
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=362.99 Aligned_cols=286 Identities=33% Similarity=0.567 Sum_probs=226.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4569999999999999999999999999999999885432 223468999999999999999998854332 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
...|+||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence 3578999999998776654 248889999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.+..+.+...
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 865444444456789999999998654 5899999999999999999999999999988888889888888876655433
Q ss_pred CcC----------CcCCCCCCCCC---CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 NPN----------YTDFRFPQIKA---HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.+. +....++..-. .+.........+.++++||.+||+.||++|||+.|+|+||||..+.++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 221 11111111100 011112223456789999999999999999999999999999866443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=328.73 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=220.9
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|.+.+.||.|-||.||+|+.++++-.||+|++.+.. ....+|+++...|+||||+++++.|. +
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----D 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----c
Confidence 45679999999999999999999999999999999986653 33458999999999999999999994 4
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....|+++||.. |.++..|.. ....++++...+.|+.|++.|+.|+|. ++++||||||+|+|++. .+.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCC
Confidence 445999999998 577777763 245679999999999999999999999 89999999999999996 8889999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
-+.... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||.+....+.+.+|.+.
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------- 237 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------- 237 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------
Confidence 997654 5556688999999999999654 5899999999999999999999999999988888888772
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
++. ++..++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus 238 -------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 -------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 222 334689999999999999999999999999999999753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=352.06 Aligned_cols=284 Identities=32% Similarity=0.624 Sum_probs=231.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCe
Confidence 4568999999999999999999999999999999885332 23457999999999999999999983 3445
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||++++|...+.. ....+++..++.++.||+.||+|||+ +||+|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhc
Confidence 899999999988777653 34568999999999999999999999 79999999999999996 77899999999875
Q ss_pred cccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+...++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 43322 22234668899999998766668899999999999999999999999999888888888888888877665432
Q ss_pred c--CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 264 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. .+....++....... ......+++.+++||.+||+.||.+|||++|+++||||+.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 234 SNEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 1 222233333222222 22334688999999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=350.38 Aligned_cols=248 Identities=28% Similarity=0.484 Sum_probs=219.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..+|++.+.||.|.||+|-+|+....|+.||||.+.++. ..+.+|+++|..|+||||+.++++| ++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 358999999999999999999999999999999886653 2345899999999999999999999 6666
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+.|||||.. |.|++.+. ..+.+++.+++.++.||+.|+.|||. ++++|||||.+|||+|. ++++||+|||++
T Consensus 127 KIvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGLS 200 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGLS 200 (668)
T ss_pred eEEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccchh
Confidence 6999999998 46777766 45789999999999999999999999 89999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
..+.......+++|+|.|.+||++.|.++-++.+|-|||||+||.|+.|..||.+.+....+.+|..
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~------------- 267 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR------------- 267 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc-------------
Confidence 9888888888999999999999998877668999999999999999999999999998888777755
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
..|.-| .-+..+.-||++||-.+|++|.|++++-+|=|++
T Consensus 268 ----GaYrEP-------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 268 ----GAYREP-------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----ccccCC-------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 222222 2467889999999999999999999999998775
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=354.56 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=209.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47999999999999999999999999999999885422 2345799999999999999998877 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence 8999999985 6666654 34578999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------- 213 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------------- 213 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 65432 234578999999999865 45899999999999999999999999988776666655441
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
.. .++..+++.+++||++||+.||.+|++ ++++++||||+.+.+.
T Consensus 214 ----~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ----KL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ----Cc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 00 123346889999999999999999995 9999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=338.79 Aligned_cols=288 Identities=38% Similarity=0.629 Sum_probs=230.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCC----cEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
.....|++.+.||+|+||.||+|....++ +.+|||++..+. ...-+|+.+++.++|||++.+..+|...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 34468999999999999999999765553 368999986542 2345899999999999999999998642
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC---CCcE
Q 017270 99 SKNELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQV 174 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~-~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~---~~~i 174 (374)
+..+++++||.+.+|+++++.++.. ...++...++.+++||+.|+.|||+ +=|+||||||.|||+..+ .|.|
T Consensus 100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCee
Confidence 4559999999999999999876543 3468999999999999999999999 899999999999999752 3789
Q ss_pred EEEeeccccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---------hH
Q 017270 175 KICDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AV 241 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---------~~ 241 (374)
||+|||+++.+...-. ....+.|.+|+|||.++|...|+.+.|||++|||+.||++-.+.|.+.. ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999999998765432 2245679999999999999999999999999999999999999997643 35
Q ss_pred HHHHHHHHHhCCCCHHHHhhcC--cCCcC----CCCCCCCCCChhhhcc--cCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 242 DQLVEIIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+++..|++.+|.|....|+.+. +.+.. ++........+...+. +.-++.+.+|+.+||++||-+|+|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 7899999999999999888654 22210 1101111111222222 22456699999999999999999999999
Q ss_pred cCCccccc
Q 017270 314 AHPFFDEL 321 (374)
Q Consensus 314 ~hp~~~~~ 321 (374)
+|+||..-
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=337.47 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=214.2
Q ss_pred cccceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.+++|.+. ++||-|-.|+|..|.++.|++.+|+|++ .+.....+|+++--.. .|||||.++++|... -.+..++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL-~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL-LDSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHH-hcCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCceeeEe
Confidence 56788886 6899999999999999999999999966 4555667888875444 699999999998332 256778999
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeeccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQ 184 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~a~~ 184 (374)
|||+++| .|++.+.. ..+..|+|.++..|+.||..|+.|||+ .+|.||||||+|+|+.. .+..+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999996 56665553 345679999999999999999999999 59999999999999963 245799999999998
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 260 (374)
........+.+.||+|.|||++ |...|+..+|+||+|||+|.|++|.+||.+.... .+-.+|..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------- 281 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------- 281 (400)
T ss_pred cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-----------
Confidence 7766667778889999999998 6777999999999999999999999999887542 12222222
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..|.||. .. ++.+|+.++|+|+++|..+|++|.|++++++|||+....
T Consensus 282 ------gqy~FP~---pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 282 ------GQYEFPE---PE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ------cCccCCC---hh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 2233332 11 234899999999999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=357.35 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=209.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|.+.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++. +.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cC
Confidence 4578999999999999999999999999999999886432 22457999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+||||+.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccC
Confidence 458999999986 5655554 34678999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9865332 2346789999999998654 4799999999999999999999999887776655554431
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..++..+++||.+||+.||.+|++ ++++++||||++..+.
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 011 12347889999999999999999997 7999999999886544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=357.80 Aligned_cols=285 Identities=36% Similarity=0.632 Sum_probs=227.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
.++|.+.+.||.|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999999999999999886432 223479999999999999999988743321 2223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+++++++++|...+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~ 166 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLAR 166 (343)
T ss_pred cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccce
Confidence 478999999888766554 3569999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+....
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6543 23346789999999998765668999999999999999999999999998888888888888887766554332
Q ss_pred cCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 264 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 264 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
..... ..++......+...+ ...++.+.+||.+||+.||.+|||+.|+++||||.....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 21110 011222222222222 24678899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=349.05 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=206.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|++.+.||+|+||+||+|.+..+++.||+|.+.+.. ....+|+.+++.++|++|+++.+++ .....+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 4788999999999999999999999999999885432 1234699999999999999999888 334458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+++ +|...+.. .....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence 999999986 55444432 223468999999999999999999999 79999999999999996 77899999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------- 220 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence 5444333456789999999999654 58999999999999999999999998765433333222211110
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
...++..+++++.+||++||+.||.+||+ ++++++||||..+++.
T Consensus 221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01123457999999999999999999997 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=357.15 Aligned_cols=246 Identities=28% Similarity=0.457 Sum_probs=202.9
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999886432 1234688999999999999999888 34446899999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC-
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 188 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~- 188 (374)
|+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence 9986 5545444 35679999999999999999999999 79999999999999996 788999999998754322
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 23345678999999999865 45899999999999999999999999887766555444321 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+||.+||+.||++|| ++.++++||||..+.+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2345799999999999999999999 89999999999887554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=361.28 Aligned_cols=275 Identities=23% Similarity=0.342 Sum_probs=212.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeec
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
.+|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+.+++.++||||++++++|.. ....++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEec
Confidence 579999999999999999999999999999997543 345689999999999999999998843 3458899999
Q ss_pred ccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC--C
Q 017270 112 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--E 189 (374)
Q Consensus 112 ~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~--~ 189 (374)
+.++|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...... .
T Consensus 165 ~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCccccccccccc
Confidence 99887776653 4568999999999999999999999 79999999999999996 778999999999753322 1
Q ss_pred CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 190 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 190 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +....+..+++..|.++.......
T Consensus 239 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2234578999999999865 45899999999999999999999877543 234566777777666543211000
Q ss_pred Cc----CC----cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 263 NP----NY----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 263 ~~----~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.. .+ ............|.... .++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHh--hhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00 00 00000000111222221 3677899999999999999999999999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=350.49 Aligned_cols=278 Identities=33% Similarity=0.566 Sum_probs=211.2
Q ss_pred eeeeecCCCceEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
.+.||+|+||+||+|+++ .+++.||+|.+.... ....+|+.+++.++||||+++++++... ....+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 467999999999999975 467899999886543 2345899999999999999999887432 234588999999
Q ss_pred cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc---CCCCcEEEEeeccccc
Q 017270 113 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 184 (374)
Q Consensus 113 ~g~l~~~l~~~~~-----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~---~~~~~ikl~Dfg~a~~ 184 (374)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988877754221 12358999999999999999999999 7999999999999994 2356899999999986
Q ss_pred cccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 017270 185 LIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 251 (374)
Q Consensus 185 ~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 251 (374)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+... ...+..+.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54322 123457799999999997766689999999999999999999999975432 35677788888
Q ss_pred CCCCHHHHhhcCcCCc------CC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 252 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+....+........ .+ .........+........+.++.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8887766654321000 00 0000000011111112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=359.46 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=206.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.++..++|+||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47999999999999999999999999999999986532 2234689999999999999999988 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+|||||+| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence 8999999986 5665554 34679999999999999999999999 79999999999999996 7889999999987
Q ss_pred ccccCC------------------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHH
Q 017270 184 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 227 (374)
Q Consensus 184 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ 227 (374)
...... .....+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 228 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence 532210 01235789999999999654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--
Q 017270 228 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL-- 305 (374)
Q Consensus 228 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~-- 305 (374)
|++|..||.+.+..+...++...... ..+|. ...+++++++||.+|+. +|.+
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~ 282 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRI 282 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence 99999999988877776666542110 01111 01368999999999876 4544
Q ss_pred -CCCHHHHhcCCccccccCCC
Q 017270 306 -RCTALEACAHPFFDELREPN 325 (374)
Q Consensus 306 -R~s~~e~l~hp~~~~~~~~~ 325 (374)
||+++|+++||||+++.+..
T Consensus 283 ~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 283 GAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCCHHHHhCCCCCCCCCHHH
Confidence 58999999999999876653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=342.88 Aligned_cols=276 Identities=35% Similarity=0.576 Sum_probs=219.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++. +...++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 5899999999999999999999999999999885431 23357999999999999999999883 344589
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|+||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence 9999999987776653 34679999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... .....+++.|+|||.+.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 3222 22345688999999987766679999999999999999998777 566677778888888888777665543321
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.-....++..............+++++.+||.+||+.||.+|||+++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111222211111122334589999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.57 Aligned_cols=252 Identities=28% Similarity=0.430 Sum_probs=208.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCC-cEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+.. ....+|+.+++.++||||+++++++. +
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 4568999999999999999999876654 689999885432 22346999999999999999999883 3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecCC
Confidence 4458999999975 6666654 34679999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++..... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.+..
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 9976432 23456789999999999654 48999999999999999999999999887766665554310
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++.+.++|++||+.||.+|+ +++++++||||+++.+.
T Consensus 245 --------~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 245 --------IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred --------CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01 2334788999999999999999996 89999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=358.30 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=207.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||.|+||+||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999999999999986432 1234699999999999999999988 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+|||||.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence 9999999985 5555554 34579999999999999999999999 79999999999999996 7889999999986
Q ss_pred ccccCC---------------------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHH
Q 017270 184 QLIAGE---------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 224 (374)
Q Consensus 184 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvi 224 (374)
...... ...+.+||+.|+|||++.+ ..++.++|||||||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 228 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVI 228 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhH
Confidence 542211 0012468999999999855 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCC
Q 017270 225 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 304 (374)
Q Consensus 225 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 304 (374)
+|+|++|..||.+.+..+....+.+... ...++. ...+++++++||.+||. ||.
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~ 282 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAE 282 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHh
Confidence 9999999999998887766655543110 001111 11368999999999997 999
Q ss_pred CCCC---HHHHhcCCccccccCC
Q 017270 305 LRCT---ALEACAHPFFDELREP 324 (374)
Q Consensus 305 ~R~s---~~e~l~hp~~~~~~~~ 324 (374)
+|++ +.++++||||+...+.
T Consensus 283 ~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 283 RRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred hcCCCCCHHHHhcCCCcCCCCHH
Confidence 9998 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=336.43 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=219.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-------~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
-.++|..+++||+|.||+|-+|+.+.+++.||||++.++..... .|-.+|+..+||.+..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 45789999999999999999999999999999998877654433 467799999999999998888 556
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+||||..|+ |...+ .....+++...+.|-.+|+.||.|||+ ++||+||||.+|+|+|. ++.|||+|||+
T Consensus 241 drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGL 314 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGL 314 (516)
T ss_pred ceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeeccc
Confidence 6699999999975 33333 346779999999999999999999999 89999999999999997 78899999999
Q ss_pred cccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 182 AKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 182 a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.... +....+++|||.|+|||++. ...|+.++|+|.+||++|||++|+.||...+....+..|+-
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------- 382 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------- 382 (516)
T ss_pred chhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------
Confidence 986544 34556889999999999994 56799999999999999999999999999988877776654
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
.+.. |+..++++++.|+..+|.+||.+|. .+.|+.+|+||..+.|..
T Consensus 383 ------ed~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 383 ------EDLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred ------hhcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 2233 4457999999999999999999998 478999999999998864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=352.33 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=210.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 37999999999999999999999999999999986432 2234689999999999999999888 34446
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence 8999999985 6666654 34678999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------- 217 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL--------- 217 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------
Confidence 5543 23456789999999999655 58999999999999999999999999887776665554321100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
..+... .....+++++.+||.+||..+|.+||+++++++||||.+..+.
T Consensus 218 ------~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 218 ------QRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred ------cCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 000000 0002468999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=363.69 Aligned_cols=282 Identities=24% Similarity=0.374 Sum_probs=211.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCC------ceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. ++++++++|.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 368999999999999999999999999999999885432 2234577787777554 57888777632 2
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC---------
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--------- 172 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~--------- 172 (374)
...+|+|||+++++|.+.+.. ...+++..++.++.||+.||+|||+..||+||||||+|||++..+.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 335889999999888877653 3579999999999999999999997139999999999999985321
Q ss_pred ------cEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017270 173 ------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246 (374)
Q Consensus 173 ------~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 246 (374)
.+||+|||.+.... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 59999999875322 223456789999999999764 589999999999999999999999999998888888
Q ss_pred HHHHhCCCCHHHHhhcCcC-----CcCCC--CCCCCCCChhhhc-----c-cCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 247 IIKVLGTPTREEIRCMNPN-----YTDFR--FPQIKAHPWHKVF-----H-KRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~-----~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+.+.+|.++.......... +.... .+......+.... . ...++.+.|||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 8888887765433211000 00000 0000000000000 0 01246788999999999999999999999
Q ss_pred cCCccccccC
Q 017270 314 AHPFFDELRE 323 (374)
Q Consensus 314 ~hp~~~~~~~ 323 (374)
+||||.+...
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.39 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=202.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|.+++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 6899999999999999999999999999999986432 22347999999999999999999883 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|||||+| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence 999999986 5655554 34578999999999999999999999 79999999999999996 78899999999753
Q ss_pred cccCC------------------------------------------------CcceeeeeccccchhhhhCCCCCCCch
Q 017270 185 LIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTSI 216 (374)
Q Consensus 185 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~ 216 (374)
..... ...+..||+.|+|||++.+ ..++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCcc
Confidence 21000 0123468999999999865 4589999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHH
Q 017270 217 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 296 (374)
Q Consensus 217 DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (374)
|||||||++|+|++|..||...+..+....++..... ..++. ...+++++++||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999887766555544431110 01110 1247899999999
Q ss_pred hhcCc--CCCCCCCHHHHhcCCccccccCC
Q 017270 297 RLLQY--SPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 297 ~~L~~--dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+||+. ++..|++++++++||||+.+.+.
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 97655 44459999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=358.97 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=204.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+++.||.|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++||||+++++++ .+..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47999999999999999999999999999999886432 2234689999999999999999988 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||++| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence 9999999985 6666554 34678999999999999999999999 79999999999999996 7889999999986
Q ss_pred ccccCCC------------------------------------------------cceeeeeccccchhhhhCCCCCCCc
Q 017270 184 QLIAGEA------------------------------------------------NISYICSRFYRAPELIFGATEYTTS 215 (374)
Q Consensus 184 ~~~~~~~------------------------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~ 215 (374)
....... .....||+.|+|||++.+ ..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 228 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCc
Confidence 3211000 012468999999999865 458999
Q ss_pred hhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHH
Q 017270 216 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 295 (374)
Q Consensus 216 ~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (374)
+|||||||++|+|++|..||.+.+..+.+..+..... ...++. ...++.++.+||
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli 283 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLI 283 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHH
Confidence 9999999999999999999998877666655543100 011111 113688999999
Q ss_pred HhhcCcCCCCC---CCHHHHhcCCccccccC
Q 017270 296 SRLLQYSPSLR---CTALEACAHPFFDELRE 323 (374)
Q Consensus 296 ~~~L~~dp~~R---~s~~e~l~hp~~~~~~~ 323 (374)
.+||+ +|.+| +|+.++++||||+...+
T Consensus 284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99998 67765 59999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=339.18 Aligned_cols=276 Identities=34% Similarity=0.659 Sum_probs=218.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|++|.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ....+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 5899999999999999999999999999999875321 23457999999999999999999884 334589
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||+++++.+.+... ..+..+++..++.++.||+.||+|||+ +|++||||+|+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 99999998877776542 234679999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 264 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 264 (374)
.... .....+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.........+.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 2221 22345688999999987666678999999999999999999999999888777777777777665554432110
Q ss_pred -CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
++. ..++......... ....+++++.+||++||+.||.+|||+.++++||||
T Consensus 233 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYK-NTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHH-hhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 0111111111111 233589999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.11 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=204.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+|.+++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 6899999999999999999999999999999886532 23457999999999999999999984 34459
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|||||++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence 999999986 5666554 23578999999999999999999999 79999999999999996 78899999999753
Q ss_pred cccC------------------------------------------------CCcceeeeeccccchhhhhCCCCCCCch
Q 017270 185 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI 216 (374)
Q Consensus 185 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~ 216 (374)
.... ....+..||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001124689999999998654 589999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHH
Q 017270 217 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 296 (374)
Q Consensus 217 DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (374)
|||||||++|+|++|+.||.+.+..+...++...... ..+| ....+++++.++|.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence 9999999999999999999988776665555431110 0011 01247899999999
Q ss_pred hhcCcCCCCCCC---HHHHhcCCccccccCC
Q 017270 297 RLLQYSPSLRCT---ALEACAHPFFDELREP 324 (374)
Q Consensus 297 ~~L~~dp~~R~s---~~e~l~hp~~~~~~~~ 324 (374)
+|+ .||.+|++ ++++++||||+.+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 986 59999997 9999999999887554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=353.45 Aligned_cols=256 Identities=31% Similarity=0.519 Sum_probs=210.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||+||+|++..+++.||||++.+.. ....+|+.++..++|+||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 47999999999999999999999999999999986432 2335789999999999999999888 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence 9999999985 66666653 3679999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCC------------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 184 QLIAGE------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 184 ~~~~~~------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence 654332 12345689999999999654 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHH
Q 017270 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEA 312 (374)
Q Consensus 234 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~e~ 312 (374)
||...+.......+...... ..++. ...+++++.+||.+||. ||.+|++ ++++
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 229 PFYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred CCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 99988876666555441110 01111 11268999999999998 9999999 9999
Q ss_pred hcCCccccccCCC
Q 017270 313 CAHPFFDELREPN 325 (374)
Q Consensus 313 l~hp~~~~~~~~~ 325 (374)
++||||+.+.+..
T Consensus 283 l~hp~~~~~~~~~ 295 (350)
T cd05573 283 KSHPFFKGIDWEN 295 (350)
T ss_pred hcCCCcCCCCHHH
Confidence 9999999876653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.74 Aligned_cols=319 Identities=35% Similarity=0.636 Sum_probs=243.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..+|.+.+.||.|+||+||+|.+..+++.||||.+... .....+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999999999999999987542 122346999999999999999999875443333345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|+|+||++++|.+.+. ....+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence 89999999988777665 34679999999999999999999999 79999999999999996 77899999999986
Q ss_pred cccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+.+..+.+..+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5433 222345678899999998654558999999999999999999999999988888888888888877766553221
Q ss_pred cC-CcCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 264 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 264 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
.. ...+ ..+......+.. ....+++++.+||++||+.||++|||++++++||||..++....... .+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~----~~~~~~~ 312 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV----CQTPFSF 312 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc----CCCccch
Confidence 11 0000 011111111122 22458999999999999999999999999999999998876654322 1223344
Q ss_pred hhhhcCCCHHHHhhhcHHHH
Q 017270 341 KQELSGASPELVNKLIPDHV 360 (374)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~ 360 (374)
+-+..+.+.+.+.+++-++.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 313 DFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred hhhhhhcCHHHHHHHHHHHH
Confidence 44444466666666655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=350.02 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=222.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.++|..++.+|+|+||.+++++++..++.|++|++.-. ++....|+.+++++.|||||.+.+.|. .+..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 46899999999999999999999999999999998533 334568999999999999999999883 33334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
++|||+||+| ++.+.+...+ +..|+++.++.|+.|++.|++|||+ ++|+|||||+.||+++. ++.|||+|||+|+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAK 154 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhh
Confidence 9999999996 6666666533 5789999999999999999999999 89999999999999997 6668999999999
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ...+.+|||+|++||++.+ .+|+.|+|||||||++|||++-+++|.+.+......+|.+....|.
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 887766 6678999999999999965 5699999999999999999999999999999999999988654443
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+...+.+++.+|..||..+|..||++.++|.+|.+....
T Consensus 227 ---------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 227 ---------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred ---------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 334789999999999999999999999999999987543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=377.11 Aligned_cols=269 Identities=27% Similarity=0.460 Sum_probs=227.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|.|+++||+|+||.|.+++++.|++.||+|++.+- ...+..|..+|-.-+.+-|+.++..| +++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 46899999999999999999999999999999988652 23456788898888899999999999 7888
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
++|+||||++| +|..++..+ .++++.++++|+.+|+.||.-||++ |+|||||||+|||+|. .|.|||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccchhH
Confidence 89999999985 677777642 3899999999999999999999995 9999999999999996 788999999999
Q ss_pred cccccCCC--cceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 183 KQLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 183 ~~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
-.+...+. ....+|||.|.|||++.. ...|+..+|+||+||++|||+.|..||+...-.+.+.+|+..-
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----- 297 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----- 297 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence 87765443 345789999999999842 2468999999999999999999999999999999999998731
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCccccccCCCCCCCCCCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRP 333 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~~~~~~~~~~ 333 (374)
..+.||.. ..+|+++++||.++++ +|+.|.+ ++++.+||||.++.|.+.+-...+.
T Consensus 298 ----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~ 356 (1317)
T KOG0612|consen 298 ----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV 356 (1317)
T ss_pred ----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence 12233321 2489999999999998 8999998 9999999999999997655433333
Q ss_pred CCC
Q 017270 334 LPP 336 (374)
Q Consensus 334 ~~~ 336 (374)
+|.
T Consensus 357 vPe 359 (1317)
T KOG0612|consen 357 VPE 359 (1317)
T ss_pred CCc
Confidence 443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=346.32 Aligned_cols=243 Identities=30% Similarity=0.519 Sum_probs=200.0
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ ......|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999999999999999886432 1234689999999999999999888 3344589999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC-CC
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 190 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-~~ 190 (374)
++ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence 86 5655554 34679999999999999999999999 79999999999999996 788999999998754322 22
Q ss_pred cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCC
Q 017270 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 270 (374)
.....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 150 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~- 210 (312)
T cd05585 150 TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL- 210 (312)
T ss_pred cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC-
Confidence 334578999999999965 45899999999999999999999999987766655554431 00
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCccccccC
Q 017270 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELRE 323 (374)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~ 323 (374)
.++..+++++.+||.+||+.||.+|| ++.++++||||....+
T Consensus 211 -----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 211 -----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred -----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 12345789999999999999999997 5899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.04 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=203.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+|++++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 7999999999999999999999999999999885421 2345799999999999999999988 344569
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|||||++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence 999999985 6666664 34578999999999999999999999 79999999999999996 78899999999753
Q ss_pred cccC--------------------------------------------CCcceeeeeccccchhhhhCCCCCCCchhhHh
Q 017270 185 LIAG--------------------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWS 220 (374)
Q Consensus 185 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~Diws 220 (374)
+... .......||+.|+|||++.+ ..++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence 2100 00113468999999999865 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcC
Q 017270 221 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300 (374)
Q Consensus 221 lGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 300 (374)
|||++|+|++|+.||.+.+..+....+...... ..++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence 999999999999999988766655444321000 0011 11247899999999977
Q ss_pred cCCCCCC---CHHHHhcCCccccccCC
Q 017270 301 YSPSLRC---TALEACAHPFFDELREP 324 (374)
Q Consensus 301 ~dp~~R~---s~~e~l~hp~~~~~~~~ 324 (374)
.||.+|+ |++++++||||+.+...
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 5999999 99999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=348.82 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=200.8
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999886532 1234688999999999999998888 34445899999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC-
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 188 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~- 188 (374)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence 9986 5544443 34679999999999999999999999 79999999999999996 788999999998754322
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.. ..
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------ED 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CC
Confidence 222345689999999998654 589999999999999999999999988776554443322 01
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||....+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 2345789999999999999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=345.83 Aligned_cols=246 Identities=29% Similarity=0.495 Sum_probs=200.6
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++.+.. .....|..++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999886432 1223577777765 699999999988 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence 99986 5554443 34679999999999999999999999 79999999999999996 788999999998754322
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----------------- 211 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 211 (320)
T ss_pred CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 22334578999999999864 45899999999999999999999999988877666555431
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||++||+.||.+|+++ +++++||||..+.+.
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 212 EVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred CCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 000 223478999999999999999999998 999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=343.64 Aligned_cols=287 Identities=36% Similarity=0.694 Sum_probs=227.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++..........
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3468999999999999999999999999999999885321 12346999999999999999998875444344456
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.|+|+||+.+++...+. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceee
Confidence 88999999998776654 3579999999999999999999999 79999999999999996 78899999999876
Q ss_pred cccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
....... ....+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+.......+...++.+..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 234678899999998665568999999999999999999999999988888888888888877766554
Q ss_pred hcCcCCcC-C--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 261 CMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 261 ~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
........ + ..+.....++.... ..+++++.+||.+||+.||++|||+.++++||||+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 32211100 0 11111222222222 3468899999999999999999999999999999987665
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=352.05 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=210.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 34578999999999999999999999999999999886421 2234789999999999999999888 44
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+||||++| +|.+.+. ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG 187 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEecc
Confidence 4569999999985 5665554 2458899999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC--cceeeeeccccchhhhhCC---CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEA--NISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+.++......
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-- 265 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS-- 265 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc--
Confidence 9976543221 2345789999999998543 23789999999999999999999999988877666665541110
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 324 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~ 324 (374)
..++. ...++.++.+||.+||+.+|.+ |+|++++++||||++..+.
T Consensus 266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 266 -------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred -------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 11111 1137899999999999999988 9999999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=347.43 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=201.7
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||++++++|. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999999999999886432 12236889999999999999998883 3445899999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence 9986 5544443 34679999999999999999999999 79999999999999996 7889999999987533222
Q ss_pred -CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 190 -ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 190 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 22345689999999998654 5899999999999999999999999887766655544321 1
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||.+..+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2345789999999999999999998 89999999999886643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=336.49 Aligned_cols=286 Identities=34% Similarity=0.592 Sum_probs=224.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+. |+||+++++++......+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999999999999999875432 23457999999995 699999999886544434456
Q ss_pred EEEEeecccchHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~-~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +||+||||+|+||+++.+++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8899999999888877643322 4568999999999999999999999 7999999999999999657789999999987
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+....+.++.+..+.+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543322 1223456888999999866566799999999999999999999999998888888888887777665544322
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
........++......... ....+++++.+||.+||..||.+||+++|++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1111111122211111111 2235789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.20 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=208.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|++..+++.||+|.+.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence 34578999999999999999999999999999999885421 2244799999999999999999988 44
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+|||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG 187 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecc
Confidence 4569999999985 66665542 358999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC--cceeeeeccccchhhhhCCC---CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++........ ..+..||+.|+|||++.+.. .++.++|+||+||++|+|++|..||.+.+....+.+++.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS-- 265 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--
Confidence 9986543222 23457899999999986532 3788999999999999999999999988877666666542111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 323 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~ 323 (374)
..++. ...++..+++++.+||+.++.+ |+|++++++||||+...+
T Consensus 266 -------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 -------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 01111 1136889999999999865544 889999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=345.44 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=204.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCC-ceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 104 (374)
+|++.+.||+|+||.||+|++..+++.||+|++.++. .....|..++..++|+ +|+.+++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 5899999999999999999999999999999886432 1234678888888765 5778877773 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence 8999999985 5555554 34578999999999999999999999 79999999999999996 7789999999987
Q ss_pred cccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 4322 2223346789999999999654 48999999999999999999999999888776666554310
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~~ 324 (374)
. .++..+++++.+++.+||..||.+|++. +++++||||+.+++.
T Consensus 218 ------~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 218 ------V------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred ------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 0 1223578999999999999999999976 899999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=339.01 Aligned_cols=284 Identities=35% Similarity=0.563 Sum_probs=226.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 4568999999999999999999999999999999885332 12347999999999999999999874322 23
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++||||+.++|.+.+... ...+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~ 156 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLAR 156 (309)
T ss_pred eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceee
Confidence 47899999998887777642 3678999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....++..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 654332 2223345788999999876666899999999999999999999999999999999999998888776655432
Q ss_pred Cc--CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 263 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 263 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.. ....+..+......+...+ ..+++.+.+||.+||++||++|||+++++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 21 1111222221111222211 23688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=349.74 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=210.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 37999999999999999999999999999999986532 2345788999999999999999887 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence 8999999975 66666653 23579999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCCc--ceeeeeccccchhhhhC-----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 184 QLIAGEAN--ISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 184 ~~~~~~~~--~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
........ ....+|+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--- 227 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF--- 227 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---
Confidence 65443322 23467999999999853 345789999999999999999999999888777666655542100
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
..++. ...+++++.+||.+||+ ||.+|||++++++||||..+.+..
T Consensus 228 ------------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 228 ------------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred ------------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 01111 12478999999999998 999999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=345.63 Aligned_cols=249 Identities=29% Similarity=0.491 Sum_probs=202.1
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH---HhcCCCceeeeceeeeecCCCCce
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+|+.++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 788999999999999999999999999999986432 1222454444 4668999999999883 344
Q ss_pred EEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+||||++++ |...+. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence 589999999974 433332 3579999999999999999999999 79999999999999996 788999999998
Q ss_pred cccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
...... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~----------- 216 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND----------- 216 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 753322 22334678999999999865 45899999999999999999999999988877666655441
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. .++..+++.+.+||.+||+.||.+|| ++.++++||||+++.+.
T Consensus 217 ------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 217 ------EV------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred ------CC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 00 12235789999999999999999999 69999999999886543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=347.49 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=210.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...|+..+.||+|+||.||+|.+..+++.||||++.-+. ....+|+.+|..++++||.++|+.|+.... +
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence 347888899999999999999999999999999986443 234579999999999999999999966555 8
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++||||.| ++.+.++ .+..+.+..+..++.+++.|+.|||. ++.+|||||+.|||+.. .+.+||+|||.+..
T Consensus 87 wiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeee
Confidence 999999996 5555554 45566899999999999999999999 79999999999999997 68899999999987
Q ss_pred cccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... ..+++|||+|||||++. ...|+.++||||||++.+||++|.+|+.....+..+..|-+.
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~------------- 226 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS------------- 226 (467)
T ss_pred eechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC-------------
Confidence 655433 36899999999999997 456999999999999999999999999887765443333220
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.. ..+...+++.+++||..||.+||+.||||.++|+|+|++.
T Consensus 227 -----------~P----P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 227 -----------AP----PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----------CC----CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 00 0112347899999999999999999999999999999986
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=343.73 Aligned_cols=286 Identities=33% Similarity=0.581 Sum_probs=224.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
...+|++.+.||+|+||+||+|.+..+++.||+|.+.+.. ....+|+.+++.++|+||++++++|..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4568999999999999999999999999999999885421 123469999999999999999998753322 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
...|+||||+.+++.+.+.. .+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 35789999999988776652 28899999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+......++.+.++.+..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 865444333445678899999998654 5899999999999999999999999999988889999988888876544432
Q ss_pred CcCCcCCC--CCCCCCCChhhhc------------ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 NPNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
......+. .+.....++...+ +...++.+++||.+||+.||++|||+.|+|.||||+.+-++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 21111110 0001111111111 22356789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=333.82 Aligned_cols=276 Identities=42% Similarity=0.752 Sum_probs=227.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|++|.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 5899999999999999999999999999999886443 23457999999999999999999883 344589
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence 9999997788777653 23679999999999999999999999 79999999999999996 7889999999988654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 263 (374)
.... .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+......+..+.+..+.+....++...
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4331 2345678899999998666667899999999999999999999999988888888888888888776665432
Q ss_pred -cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 264 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
..+....++......+...+ ...+..+.+||.+||..||++|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 22333334433333444333 34679999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=339.16 Aligned_cols=278 Identities=32% Similarity=0.570 Sum_probs=208.2
Q ss_pred eeeeecCCCceEEEEEECC--CCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
...||+|+||+||+|++.. ++..||+|.+.... ....+|+.+++.++||||+++++++... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3579999999999999654 56889999886543 2345799999999999999999987542 234588999999
Q ss_pred cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc---CCCCcEEEEeeccccc
Q 017270 113 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 184 (374)
Q Consensus 113 ~g~l~~~l~~~~~-----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~---~~~~~ikl~Dfg~a~~ 184 (374)
++++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||++. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 9988877753221 22358999999999999999999999 7999999999999994 2356899999999986
Q ss_pred cccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 017270 185 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 251 (374)
Q Consensus 185 ~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 251 (374)
...... .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||..... ...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543221 23456799999999987666689999999999999999999999975432 34566677777
Q ss_pred CCCCHHHHhhcCc--CCcCC----CCCCCCCCC---hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 252 GTPTREEIRCMNP--NYTDF----RFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 252 ~~~~~~~~~~~~~--~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+....+..... .+... ......... .........+..+++||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7776655543211 11000 000000000 0111112356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=348.40 Aligned_cols=278 Identities=26% Similarity=0.408 Sum_probs=207.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
..+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++|+||+++++++.. ....++|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEE
Confidence 34799999999999999999999999999999975433 34579999999999999999998843 334889999
Q ss_pred cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC
Q 017270 111 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190 (374)
Q Consensus 111 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~ 190 (374)
++.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||++........
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence 999988877653 45679999999999999999999999 79999999999999996 77899999999975444444
Q ss_pred cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCCh---------HHHHHHHHHHhCCCCHHHHh
Q 017270 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENA---------VDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~ 260 (374)
.....||+.|+|||++.+. .++.++|||||||++|+|+++ ..+|..... ...+..++..++..+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999998654 589999999999999999985 455543221 22344444444433221110
Q ss_pred hcCcCC-c-CCCCCCCCCCC---hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNY-T-DFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~-~-~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
...... . ...+......+ +...-..+++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 0 00000000001 1111112568889999999999999999999999999999863
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=336.11 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=200.1
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||+|+||+||+|.+..+++.||+|++.+.. .....|+.+++.++|+||+++.+++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999886432 1224689999999999999998887 3344589999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC-
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 190 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~- 190 (374)
++ +|...+......+..+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence 86 5555554433445679999999999999999999999 79999999999999996 77899999999976543322
Q ss_pred cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCC
Q 017270 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 270 (374)
.....+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||...........+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence 2345688999999999654 58999999999999999999999998754332222222110000
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
...++..+++++.+++.+||+.||++|| +++++++||||+.+.+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012345789999999999999999999 88999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=343.73 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=201.3
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|++..+++.||+|++.++. .....|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 46999999999999999999999999986532 1223577777765 7999999999883 344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence 99986 5555544 34678999999999999999999999 79999999999999996 788999999998754322
Q ss_pred C-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2 2334568999999999854 45899999999999999999999999988877766665441
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-------CHHHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||+.||.+|+ +++++++||||..+.+.
T Consensus 212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 011 2234689999999999999999999 99999999999886554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=335.52 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=207.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|++.+.||+|+||+||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4889999999999999999999999999999886432 1234699999999999999999887 333458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 999999985 55544432 233569999999999999999999999 79999999999999996 78899999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------- 220 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence 544433344578899999999865 458999999999999999999999998876544433333221100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
...++..+++.+.+||.+||..||.+|| +++++++||||....+.
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 0012234789999999999999999999 99999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=346.01 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=201.4
Q ss_pred ceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
+|++.+.||+|+||+||+|++. .+++.||+|++.+.. ....+|+.+++.+ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 5899999999999999999864 478999999886421 1234688899999 589999998887 4
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+++||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence 44558899999986 6655554 34679999999999999999999999 79999999999999996 778999999
Q ss_pred ccccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 180 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 180 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|++........ .....||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 99976543322 234578999999999976555789999999999999999999999754322111111111000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
. ...++..+++.+.+||.+||+.||++|| +++++++||||+...+.
T Consensus 226 ----~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 226 ----C-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred ----C-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 0112335789999999999999999999 88999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=342.34 Aligned_cols=251 Identities=29% Similarity=0.432 Sum_probs=204.6
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhc-CCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
+|.+.+.||+|+||+||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 58999999999999999999999999999998865321 123466666666 578899998887 33445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence 8999999985 5655554 34578999999999999999999999 79999999999999996 7889999999987
Q ss_pred cccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 222334578999999999965 458999999999999999999999999888777666655410
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+|+.+||+.||.+|++ ..++++||||+.+.+.
T Consensus 218 ------~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 218 ------VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred ------CC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01 23357899999999999999999998 4899999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=349.88 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=206.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.++..++|++|+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999886421 2234688999999999999999988 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+|||||+| +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence 8999999986 5666554 34679999999999999999999999 79999999999999996 7889999999986
Q ss_pred ccccCC------------------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHH
Q 017270 184 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 227 (374)
Q Consensus 184 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ 227 (374)
...... ...+.+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye 228 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence 432110 01134689999999998654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC
Q 017270 228 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307 (374)
Q Consensus 228 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 307 (374)
|++|..||.+.+.......+..... ...++. ...+++++++||.+|+. ||.+|+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~ 282 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRI 282 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcC
Confidence 9999999998887766665543100 001110 01268899999999874 999998
Q ss_pred ---CHHHHhcCCccccccCCC
Q 017270 308 ---TALEACAHPFFDELREPN 325 (374)
Q Consensus 308 ---s~~e~l~hp~~~~~~~~~ 325 (374)
+++++++||||+++.+..
T Consensus 283 ~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 283 GSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCCHHHHhcCCCCCCCCHHH
Confidence 489999999999887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=341.20 Aligned_cols=245 Identities=29% Similarity=0.497 Sum_probs=200.2
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999886532 1223677788777 699999999988 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||++| +|...+. ....+++..+..++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence 99986 5544443 34579999999999999999999999 79999999999999996 788999999998753222
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345689999999999654 5899999999999999999999999887766555544331
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCccccccC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE 323 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~ 323 (374)
.. .++..++.++.+||.+||+.||.+|||+ .++++||||+...+
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 00 1223478999999999999999999999 99999999988765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=337.86 Aligned_cols=245 Identities=31% Similarity=0.464 Sum_probs=200.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcE-EEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~-vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
....+.+.||+|+||+||++..+ |+. ||+|++.... ....+|+.+|.+++|||||++++++..... .
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----S 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----c
Confidence 35566777999999999999874 455 9999886432 356689999999999999999999843321 4
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-eEeecCCCCcEEEcCCCC-cEEEEeecc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTH-QVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-ivH~dlkp~NIll~~~~~-~ikl~Dfg~ 181 (374)
+++||||+++ +|..++... ....++...+..++.||+.|++|||+ ++ ||||||||+|||++. ++ .+||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCcc
Confidence 8899999995 666666532 46789999999999999999999999 79 999999999999997 65 899999999
Q ss_pred ccccccC-CCcceeeeeccccchhhhhC-CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 182 AKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 182 a~~~~~~-~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
++..... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........+.....+|.
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 9865543 23334788999999999974 35699999999999999999999999999988655555554322222
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
++...++.+.+|+.+||..||.+||+..+++
T Consensus 267 -----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 267 -----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred -----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 2334789999999999999999999998875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=339.52 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=206.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 47999999999999999999999999999999986421 2234688899999999999999988 34456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence 9999999975 66666643 34579999999999999999999999 79999999999999986 7889999999987
Q ss_pred ccccCCCc--ceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 184 QLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 184 ~~~~~~~~--~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
........ ....||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+....+....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH---- 226 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence 65433222 23468999999999853 234788999999999999999999999888776666555431110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~ 324 (374)
+.++. ....+++.+++||++||+.++.+ |++++++++||||..+++.
T Consensus 227 -----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 227 -----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred -----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 00110 11237899999999999875554 7899999999999887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.43 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=200.1
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999886532 1224688899999999999999888 34445899999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC-
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 188 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~- 188 (374)
|+++ +|...+. ....+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence 9996 4444443 34679999999999999999999996249999999999999996 788999999998753322
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345789999999998654 5899999999999999999999999887765554443320 0
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||.+..+.
T Consensus 213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 2335789999999999999999997 89999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=343.87 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=198.4
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHH-HHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|.+..+|+.||+|++.+... ....|. .+++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999864321 111233 3567889999999998883 344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence 99986 5555544 35679999999999999999999999 79999999999999996 788999999998754332
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 22334568999999999865 45899999999999999999999999988776665555431 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~~ 324 (374)
. .++..+++.+.++|.+||+.||.+||++ .++++||||....+.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 213 -L------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred -C------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 0123478999999999999999999987 699999999886653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=330.69 Aligned_cols=277 Identities=35% Similarity=0.665 Sum_probs=219.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 468999999999999999999999899999999885432 2234799999999999999999988 344468
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+.++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence 99999999988776653 23478999999999999999999999 79999999999999996 788999999998754
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+.+..+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 3221 11223467889999998765668899999999999999999999998765 566777777777877776655433
Q ss_pred cC--CcCCCCCCCCCCChhhhcccCCC--hhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 PN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.. +....++.....+....+. .++ .++.+++.+||+.||.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 21 2222222222222222222 244 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.57 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=207.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 44579999999999999999999999999999999885421 2234789999999999999999888 34
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+|||||+| +|...+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCC
Confidence 4569999999985 5655554 2458999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC--cceeeeeccccchhhhhCCC---CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+......+++.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-- 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--
Confidence 9986543322 23467899999999986432 3789999999999999999999999988877666666542110
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 323 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~ 323 (374)
..++. ...++..+++||.+||..++.+ |++++++++||||++..+
T Consensus 266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 -------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 01111 1247899999999999844433 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=339.80 Aligned_cols=246 Identities=29% Similarity=0.498 Sum_probs=198.0
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-cCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|++..+|+.||+|.+.+.. .....|..++.. ++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999886432 122356666665 4899999999988 4445699999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc-
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 187 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~- 187 (374)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||+++....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence 99986 5555544 34678999999999999999999999 79999999999999996 77899999999874322
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~------------- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP------------- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 2223346789999999999654 5899999999999999999999999888766555443321 00
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-~e~l~hp~~~~~~~~ 324 (374)
.++..++.++++||.+||+.||++|+++ +++++||||+...+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 0123478899999999999999999997 589999999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=339.58 Aligned_cols=276 Identities=26% Similarity=0.444 Sum_probs=205.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+|+++++.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 468999999999999999999999999999999886432 234579999999999999999998843 3348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+++ +|.+.+. ....+++..++.++.|++.||.|||+.++|+||||||+||+++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence 899999996 6666554 34568999999999999999999998236999999999999996 78899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh---
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC--- 261 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 261 (374)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+... + ++.+.......
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGEPH 227 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCCcc
Confidence 5332 22345689999999998654 58999999999999999999999998776544322 2 22211100000
Q ss_pred -cCcC---C----cCCCCCCCC------------CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 -MNPN---Y----TDFRFPQIK------------AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 -~~~~---~----~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+. . ......... .......-...+++++++||.+||++||++|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 0 000000000 0000000012468899999999999999999999999999999864
Q ss_pred c
Q 017270 322 R 322 (374)
Q Consensus 322 ~ 322 (374)
.
T Consensus 308 ~ 308 (331)
T cd06649 308 E 308 (331)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=328.14 Aligned_cols=276 Identities=34% Similarity=0.647 Sum_probs=215.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+.+++.++|+|++++++++. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 47999999999999999999999999999999885432 22357999999999999999999883 34458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||++++++..+.. ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07847 76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence 89999999876555432 34569999999999999999999999 79999999999999996 778999999999866
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+.+..+....+............
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 5443 223455788899999987656688999999999999999999999998887777777666555443322111110
Q ss_pred C--CcCCCCCCC-CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 N--YTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
. +.....+.. ...++.. ....++..+.+||.+||+.||++|||+.|++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 011111111 1111222 223578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.15 Aligned_cols=309 Identities=35% Similarity=0.658 Sum_probs=238.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+|.+.+.||.|++|.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 68999999999999999999999999999999886432 12346899999999999999998774333 334568
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEecccccceee
Confidence 8999999987766654 34569999999999999999999999 79999999999999996 888999999998765
Q ss_pred ccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
..... .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....|.++...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 1234678899999998665568999999999999999999999999998888888888888888776654
Q ss_pred hcCcCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCC
Q 017270 261 CMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPL 337 (374)
Q Consensus 261 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~ 337 (374)
........ -.++.....+|... ....++++.++|.+||+.||++|||+++++.||||.....+.... ...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~----~~~~~ 312 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP----TCPPP 312 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc----cCCCC
Confidence 32211100 01222222333332 234789999999999999999999999999999999876664332 12244
Q ss_pred CCchhhhcCCCHHHH
Q 017270 338 FNFKQELSGASPELV 352 (374)
Q Consensus 338 ~~~~~~~~~~~~~~~ 352 (374)
.+++.+....+.+.+
T Consensus 313 ~~~~~~~~~~~~~~~ 327 (334)
T cd07855 313 FDFDFEAIELSREQL 327 (334)
T ss_pred CCCChhhhhcChhhH
Confidence 455544444444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=341.45 Aligned_cols=247 Identities=26% Similarity=0.480 Sum_probs=195.8
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 1234688888888 799999999988 3444589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc-
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 187 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~- 187 (374)
||++| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence 99986 5554443 34679999999999999999999999 79999999999999996 78899999999875322
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 259 (374)
........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 223345678999999999965 4589999999999999999999999963211 1111111110
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCccccccCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 324 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~~~~~ 324 (374)
.... ++..++..+.+||++||+.||.+|+| ++++++||||..+.+.
T Consensus 220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 0001 23357899999999999999999997 7899999999886553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=332.40 Aligned_cols=280 Identities=35% Similarity=0.627 Sum_probs=225.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ...+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 4589999999999999999999999999999998853321 2247999999999999999999875432 245
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~ 155 (293)
T cd07843 81 IYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLARE 155 (293)
T ss_pred EEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceee
Confidence 899999999888777653 23468999999999999999999999 79999999999999996 78899999999886
Q ss_pred cccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||......+.+.++....+.+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 5543 222345668889999998765557899999999999999999999999998888888888888888776665332
Q ss_pred --cCCcCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 --PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+..............+...++.. +++.+.++|++||+.||++|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111222222334444444 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=344.32 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=197.2
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHH-HHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+|+.||+|++.+... ....|. .+++.++||||+++++.+ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 469999999999999999999999998864321 112333 356778999999999888 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence 99986 4544443 45679999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----------------- 211 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----------------- 211 (325)
T ss_pred CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22345678999999999865 45899999999999999999999999988776666555431
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCccccccC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 323 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~ 323 (374)
.. .+....+..+.++|++||+.||.+||++ .++++||||....+
T Consensus 212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00 0122468899999999999999999976 59999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=330.31 Aligned_cols=281 Identities=36% Similarity=0.664 Sum_probs=221.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||.|++|+||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++. +....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 57999999999999999999999999999999885432 23457999999999999999999883 34458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||+++++.+.+.. .....+++..++.++.||+.||+|||+ ++++||||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999999887776653 223446888999999999999999999 799999999999999865678999999999754
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 263 (374)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+.+.++....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3222 12334668899999998765568899999999999999999999999988888888888877777665544211
Q ss_pred -cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+.+ ...++...... .......+++++.+++.+||+.||++||++.++++||||.++.
T Consensus 234 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDY-KSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhh-hhhcccCCCCC-HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 011 00111111111 1112345789999999999999999999999999999999864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=330.78 Aligned_cols=280 Identities=36% Similarity=0.642 Sum_probs=222.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc---------hHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ...|+.+++.++|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 588999999999999999999999999999998654322 246899999999999999999884 344
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++||||+.++|.+.+.. ....+++..++.++.||+.||.|||+ +||+|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence 6899999997777777653 12379999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
....... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 6544322 223456788999999866566899999999999999999999999988888888888887777766555432
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
...-...........+... .....+..+.+||.+||.+||.+|||+.|++.||||++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 2111111111111122222 22346889999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=328.28 Aligned_cols=275 Identities=35% Similarity=0.636 Sum_probs=218.7
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|++.+.||+|+||.||+|.+..+++.||+|.+.+... ...+|+.+++++. |+|++++++++.+. ....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 7889999999999999999999999999998864321 1235888888885 99999999988543 1135899
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||+++++.+.+.. ....+++..++.++.|++.||+|||+ +|++||||+|+||+++. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 999999988877653 23578999999999999999999999 79999999999999995 7899999999986654
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-C
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y 266 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 266 (374)
........+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+.+..+.+..+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444344567889999998765556789999999999999999999999999888888888887777766443322111 1
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+.++......+.. ....++..+.+||.+||.+||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 122233222222222 223578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=340.13 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=200.2
Q ss_pred eeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 37 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++.||+|+||.||+|++. .+++.||+|.+.+.. ....+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence 367999999999999864 468899999886421 12346999999999999999999883 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence 999999996 5555544 34678899999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~------------- 215 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------------- 215 (323)
T ss_pred cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 43322 23345689999999998654 4789999999999999999999999988776665555431
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 323 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~ 323 (374)
... ++..+++++.+||.+||+.||++|| +++++++||||....+
T Consensus 216 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 216 ----KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001 2234789999999999999999999 8999999999987644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.27 Aligned_cols=246 Identities=30% Similarity=0.523 Sum_probs=198.3
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-cCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|.+..+++.||+|.+.... .....|..++.. ++||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999886532 122356667765 58999999999883 334589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|...+. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence 99985 6655554 34578999999999999999999999 79999999999999996 778999999998753322
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~------------- 213 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP------------- 213 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 223456789999999998654 5899999999999999999999999888766555443220 00
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-e~l~hp~~~~~~~~ 324 (374)
.++..++.++++||.+||+.||.+|+++. ++++||||+.+.+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 01223688999999999999999999996 89999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=309.70 Aligned_cols=283 Identities=31% Similarity=0.592 Sum_probs=237.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.++|++.+.+|+|.|+.||.|.+..+++.++||++..- ...+.+|+++|+.|. ||||+++.++..++.+.. ..+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chhH
Confidence 46899999999999999999999999999999988543 345679999999996 999999999986655433 6699
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
+||++..-...+- +.++...++.++.||+.||.|||+ .||+|||+||.|+++|.....++|+|+|+|..+..+
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999975333332 458888999999999999999999 699999999999999987788999999999998888
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhh-----c
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRC-----M 262 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~-----~ 262 (374)
......+.+.+|..||.+..-+.|+.+-|+|||||++..|+..+.| |.+.++.+++.+|.+.+|+......-. +
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 7777788899999999998878899999999999999999997766 578899999999999999876544321 2
Q ss_pred CcCCcCCCCCCCCCCChhhhccc----CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
++.+.++ +......+|...++. -+++++.||+.++|.+|-++|+||.|++.||||..+...
T Consensus 267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 3333322 234456677776654 367999999999999999999999999999999876554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=338.18 Aligned_cols=245 Identities=31% Similarity=0.509 Sum_probs=197.2
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHh-cCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++..+.. ....|..++.. .+||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999998864321 12245555554 4899999999888 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||++| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence 99986 5555443 34679999999999999999999999 79999999999999996 788999999999754332
Q ss_pred C-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R-------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence 2 23345789999999998654 4899999999999999999999999988876665554321 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCccccccC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 323 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-~e~l~hp~~~~~~~ 323 (374)
..++..++.++.+||.+||+.||.+||++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01223478899999999999999999986 58899999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=338.03 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||+||++++..+++.||+|++.+.. ....+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999999999999999885421 1234688899999999999999888 34445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence 8999999985 66666653 24578999999999999999999999 79999999999999995 7889999999987
Q ss_pred ccccCCC--cceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 184 QLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 184 ~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----- 225 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----- 225 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence 5433222 123568999999999852 34578999999999999999999999998887777666554211
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 325 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~~ 325 (374)
...++. ....+++++++||++||+.++.+ |++++++++||||.++.+..
T Consensus 226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 011111 11247899999999999776555 68999999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=329.00 Aligned_cols=281 Identities=28% Similarity=0.510 Sum_probs=220.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhcCC--C----ceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDH--P----NVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~ 101 (374)
.++|.+++.+|+|+||+|-.+.+..++..||||++..- +....-|+++|.++.+ | -+|.+.++| +.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 56999999999999999999999999999999977432 3334468999999842 1 266777777 66
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC------------
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 169 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~------------ 169 (374)
....|||+|.++-++.+.+... .-.+++...++.+.+||+.+++|||+ .+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 6679999999998998888742 34679999999999999999999999 69999999999999842
Q ss_pred -------CCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH
Q 017270 170 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242 (374)
Q Consensus 170 -------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~ 242 (374)
.+..|+|+|||.|... .....+.+.|..|+|||+++|-+ ++.++||||+||||+|+.+|...|+..++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1235899999999743 34446778899999999998865 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhc-C--------cCCcCCCCCC------CCCCChhhhccc--CCChhHHHHHHhhcCcCCCC
Q 017270 243 QLVEIIKVLGTPTREEIRCM-N--------PNYTDFRFPQ------IKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSL 305 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~-~--------~~~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~ 305 (374)
.+..+..++|..+...+... . .+|.+..... -...++...... ....++.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 99888888897776665544 1 1111111100 011222222211 11235899999999999999
Q ss_pred CCCHHHHhcCCcccccc
Q 017270 306 RCTALEACAHPFFDELR 322 (374)
Q Consensus 306 R~s~~e~l~hp~~~~~~ 322 (374)
|+|+.|+|.||||+.+.
T Consensus 397 RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 397 RITLREALSHPFFARLT 413 (415)
T ss_pred cccHHHHhcCHHhhcCC
Confidence 99999999999998754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.52 Aligned_cols=263 Identities=28% Similarity=0.406 Sum_probs=217.9
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
|...+.|+.-++||+|+||.|+-|..+.||+-||.|++.+.+. ....|..+|..++.+.||.+-..| +
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----e 255 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----E 255 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----c
Confidence 4455678899999999999999999999999999998865432 223688999999999999998888 4
Q ss_pred CceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+|+..|+|+ |.-.+. ...+..|++..++.|+.+|+.||++||+ .+||+|||||+|||+|. .|.++|+|+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISDL 331 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISDL 331 (591)
T ss_pred CCCceEEEEEeecCCceeEEee--ccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeecc
Confidence 444599999999975 322222 1233589999999999999999999999 79999999999999995 788999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|+|..+..+......+||.+|||||++.+. .|+...|+|||||++|+|+.|+.||..........++-+.....
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----- 405 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----- 405 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence 999988888887788999999999999654 49999999999999999999999998765544333333321111
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
...+++++|+++++|++.+|++||.+|. +++++.+||||+.++|..
T Consensus 406 --------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 406 --------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred --------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 1224567999999999999999999998 568999999999998874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=329.96 Aligned_cols=275 Identities=36% Similarity=0.683 Sum_probs=219.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||.|++|.||+|++..+++.||||.+..+. ....+|+++++.++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4899999999999999999999999999999885432 2345799999999999999999987 3344588
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||+.+++...+.. .....+++..++.++.|++.||+|||+ ++++|+||+|+||+++. ++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence 9999999887776653 234578999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 264 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 264 (374)
.... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+.++.+..+.+....++....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3222 22345678899999886655578899999999999999999999999888888888888888776554432110
Q ss_pred -CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.+ ...++......+... ...++++++++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDY-KPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHH-HhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 012222222222222 23478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=352.45 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=213.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC---CC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 101 (374)
..+|++.+.||+|+||+||+|++..+++.||||.+.... ....+|+.++..++|+|++++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 469999999999999999999999999999999885432 223468889999999999998877643221 12
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||+. |+|.+.+.........+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEecc
Confidence 235789999998 47877777655556789999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccC---CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 181 SAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 181 ~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----- 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----- 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 99765432 12234678999999999965 4589999999999999999999999998876665554443100
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..++..+++++.+|+.+||+.||.+||++.++++|||++.+.
T Consensus 263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 012345789999999999999999999999999999987653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.50 Aligned_cols=278 Identities=23% Similarity=0.346 Sum_probs=212.2
Q ss_pred cceeeeeeeecCCCceEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
.+|.+++.||.|+||.||+|... .+++.||+|.+... ....+|+.+++.++||||+++++++ .....+|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence 47999999999999999999764 35678999987654 3456899999999999999999988 3344589999
Q ss_pred ecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 110 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 110 e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
|++.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCccc
Confidence 999998877763 34679999999999999999999999 79999999999999996 7889999999987554332
Q ss_pred C---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 190 A---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 190 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....+..+++.++..+........
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2 2345789999999998654 58999999999999999999999997653 345666677666544322111000
Q ss_pred c----CCcCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 P----NYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
. .+..+.........+...+ ...++.++.+||.+||.+||++|||+.|+|+||||.+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 0000111100000111111 124678899999999999999999999999999998643
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=332.69 Aligned_cols=282 Identities=38% Similarity=0.641 Sum_probs=216.9
Q ss_pred ceeeeeeeecCCCceEEEEEECC--CCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999886532 2335799999999999999999988542 224
Q ss_pred EEEEEeecccchHHHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC---CCCcEEEEee
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDF 179 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~-~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~---~~~~ikl~Df 179 (374)
.+++||||+++++.+.+....... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++. .++.+||+||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 589999999998887776544433 379999999999999999999999 79999999999999984 2567999999
Q ss_pred ccccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 017270 180 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE 246 (374)
Q Consensus 180 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---------~~~~~ 246 (374)
|++........ .....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 223466888999999877666899999999999999999999999865432 35666
Q ss_pred HHHHhCCCCHHHHhhcC--cCCcC----CCCCCCCCCChhhhccc--CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 247 IIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
++..++.+....+.... +.+.. ..............+.. ..+.++.+++.+||+.||++|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 77777766665443221 11111 00001110111111112 578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=316.50 Aligned_cols=285 Identities=29% Similarity=0.529 Sum_probs=232.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecC---CCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT---SKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~ 101 (374)
...|.-...||+|.||.||+|+++.+|+.||+|++..+. ....+|+++|..|+|+|++.+++.+-... ..+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 347888899999999999999999999999998774321 22358999999999999999988774333 234
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...+|+||.+|..+|..++.. ...+++...+..++.+++.||.|+|. +.|+|||+||.|+|++. ++.+||+|||+
T Consensus 96 r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeecccc
Confidence 456899999999888877764 44679999999999999999999999 79999999999999996 88999999999
Q ss_pred ccccccCC-----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++.+.... .....+.|.+|++||.++|...|+++.|||..|||+.+|.+|.+.|.++....++..|-...|....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97654322 2234567999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHhhcC--cCCcCCCCCCCCCCC---hhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 257 EEIRCMN--PNYTDFRFPQIKAHP---WHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 257 ~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
+-|++++ +-|.....+.+.... ..+... -.-++++.||+.+||..||.+|++++++|+|.||..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 8888654 223333223222222 111111 123568999999999999999999999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=346.24 Aligned_cols=275 Identities=24% Similarity=0.350 Sum_probs=206.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++|+|||++++++.. ....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence 4589999999999999999999999999999996432 234589999999999999999998743 334889999
Q ss_pred cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC
Q 017270 111 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190 (374)
Q Consensus 111 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~ 190 (374)
++.++|...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 999888877653 23479999999999999999999999 79999999999999996 77899999999976533221
Q ss_pred ---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCC-CCC------ChHHHHHHHHHHhCCCCHHH--
Q 017270 191 ---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGE------NAVDQLVEIIKVLGTPTREE-- 258 (374)
Q Consensus 191 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf-~~~------~~~~~~~~i~~~~~~~~~~~-- 258 (374)
.....||+.|+|||++.+. .++.++|||||||++|||++|..|+ ... .....+..+++..+......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2235689999999999654 5899999999999999999987554 322 11234555554433221110
Q ss_pred ------HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 259 ------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 259 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.............+......|.... .++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000111222223343322 46789999999999999999999999999999974
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=335.81 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=203.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 104 (374)
+|++.+.||+|+||+||+|++..+|+.||+|++.++. .....|..++..+. |++|+++++++ .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 4788999999999999999999999999999886532 12235777887776 46777888877 33345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||++| +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence 8999999985 5555443 34679999999999999999999999 79999999999999996 7889999999987
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------ 216 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------ 216 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 543222 2334568999999999865 45899999999999999999999999988877666665541
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..++.++.+++.+||+.||.+|++ ..++++||||+.+.+.
T Consensus 217 -----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 217 -----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred -----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 001 22347889999999999999999997 5799999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=338.60 Aligned_cols=246 Identities=26% Similarity=0.477 Sum_probs=193.6
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986532 1234677777666 8999999999883 344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc-
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 187 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~- 187 (374)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence 99996 4544443 34679999999999999999999999 79999999999999996 78899999999875332
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCCHHHH
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~ 259 (374)
........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.... ....+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 2223346789999999999654 58999999999999999999999995321 11111111110
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCccccccC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 323 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~~~~ 323 (374)
... .++..++..+.+||.+||+.||.+|++ ++++++||||+.+.+
T Consensus 220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 000 123457899999999999999999998 589999999988755
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=327.00 Aligned_cols=252 Identities=35% Similarity=0.578 Sum_probs=204.7
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch------HHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|++++.||+|+||+||+|.+..+++.||+|.+....... .+|+.+++.++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997654221 248899999999999999998854 445889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc-
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL- 185 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~- 185 (374)
|||++.+ +|.+.+. ....+++..++.++.||+.||.+||+ +||+|+||||+||+++. ++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence 9999997 7777776 34678999999999999999999999 79999999999999995 888999999999753
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
..........+++.|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 222333456779999999998634568999999999999999999999999885444444444332221111100
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.....++.+.++|.+||+.||++|||+.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000123799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=338.72 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=198.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
....+|.+.+.||+|+||+||+|++..+++.||||++.... ....+|+++++.++|+||+++++++ ....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 34568999999999999999999999999999999885432 2345799999999999999999988 3444
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++||||+.++.+. ......+..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 146 ~~~lv~e~~~~~~L~-------~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCccc-------ccccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccce
Confidence 589999999975321 12345678888999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
...... ......||..|+|||++.. ....+.++|||||||++|+|++|+.||......+....+.......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---- 292 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence 654322 2234578999999998732 1234568999999999999999999997433221111111100000
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.......++.++++||.+||+.||++|||+.|+++||||..-.
T Consensus 293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0001234788999999999999999999999999999998753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=340.98 Aligned_cols=245 Identities=27% Similarity=0.488 Sum_probs=196.4
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHhc---CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVM---DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
||+|+||+||+|++..+++.||+|++.+.... ...|..++..+ +||||++++.++ .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 69999999999999999999999998643211 12355565554 699999999888 3444589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99985 5555544 35679999999999999999999999 79999999999999996 788999999998754332
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22335678999999999876556899999999999999999999999887766555544321
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCccccccC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELRE 323 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----s~~e~l~hp~~~~~~~ 323 (374)
...++ ...+++++.+||++||+.||.+|| ++.++++||||....+
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 11111 113688999999999999999998 7999999999987653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=339.60 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=201.6
Q ss_pred eeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 37 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
++.||+|+||.||++++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++. ....+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEE
Confidence 367999999999999863 578999999886432 22346899999999999999999883 3445899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 76 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccC
Confidence 9999985 6655553 34679999999999999999999999 79999999999999996 7789999999987654
Q ss_pred cC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+.+.
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--------------- 213 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--------------- 213 (318)
T ss_pred CCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---------------
Confidence 33 22334678999999999865 45789999999999999999999999988776666555431
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++.+.+||++||+.||++||+ +++++.||||..+.+.
T Consensus 214 --~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 214 --KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred --CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 011 22347899999999999999999999 7789999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.91 Aligned_cols=278 Identities=35% Similarity=0.620 Sum_probs=214.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence 468999999999999999999999999999999885432 12357999999999999999999883 33458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||+.+++...+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence 89999999887766543 33567888899999999999999999 79999999999999996 788999999998754
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+ ..+.+.++....+.|.........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3222 12334568899999998665567889999999999999999999997654 446666777777776655433221
Q ss_pred --cCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 --PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+....++............. ..++.+.+++.+||+.||.+|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1222111111111111111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=349.47 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=209.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-CcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+..+. ....+|+.+++.++|||||++++.+.. ...+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEE
Confidence 34599999999999999999998877 7889998764332 233469999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||++| +|.+.+........++++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~ 218 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCcee
Confidence 999999984 7777776555556779999999999999999999999 79999999999999996 78899999999986
Q ss_pred cccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 185 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 185 ~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------- 289 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 543321 234568999999999865 45899999999999999999999999888776666555431000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.++..++.++.+||.+||+.||++||++++++.|||++.+
T Consensus 290 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 --------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred --------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0123478899999999999999999999999999999753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=362.14 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=213.5
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.+...++|.+++.||.|+||+||+|++..+++.+|+|.+.... .....|+.+++.++|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de--- 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK--- 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---
Confidence 3456679999999999999999999999999999999885431 2234799999999999999999988543
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC------CCeEeecCCCCcEEEcCC---
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------PRVCHRDLKPQNLLVDPL--- 170 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~------~~ivH~dlkp~NIll~~~--- 170 (374)
....+|+||||+++ +|...+.........+++..++.|+.||+.||.|||+. ++|+||||||+|||++..
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 23458899999985 78777776555567899999999999999999999982 139999999999999631
Q ss_pred -------------CCcEEEEeeccccccccCCCcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCC
Q 017270 171 -------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 236 (374)
Q Consensus 171 -------------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~ 236 (374)
...+||+|||++.............+|+.|+|||++.+. ..++.++||||||||+|+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 234899999999865444444456789999999998643 347899999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 237 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
..+....+...+... +. ++ ....+.++.+||.+||+.||.+||++.|+|.||
T Consensus 245 ~~~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 245 KANNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred cCCcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 766555444333210 00 00 013588999999999999999999999999999
Q ss_pred ccccccCC
Q 017270 317 FFDELREP 324 (374)
Q Consensus 317 ~~~~~~~~ 324 (374)
|+..+..+
T Consensus 297 ~ik~i~~p 304 (1021)
T PTZ00266 297 IIKNVGPP 304 (1021)
T ss_pred HHhhcCCC
Confidence 99876543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=327.94 Aligned_cols=285 Identities=29% Similarity=0.514 Sum_probs=218.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC---
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 99 (374)
...++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999999999999999885432 122469999999999999999998754332
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
......++||||+.+++...+.. ....+++..++.++.||+.||+|||+ +|++|+||||+||+++. ++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 163 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADF 163 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcC
Confidence 22345789999999987776653 33468999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCc-----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|++......... ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+.......+....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999765432211 234567889999998665557899999999999999999999999988877777777766665
Q ss_pred CHHHHhhcC--cCCcCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 255 TREEIRCMN--PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 255 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+.++... ..+....++........... ....+..+.+||.+||..||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 554433221 11111122221111111111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=335.18 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=207.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||+||++++..+++.||+|.+.+.. ....+|+.++..++|++|+++++++ .+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999886421 1234688899999999999999988 44456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.|+||||+.| +|...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence 8999999985 66666643 24578999999999999999999999 79999999999999996 7789999999997
Q ss_pred ccccCCCc--ceeeeeccccchhhhhCC----CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 184 QLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 184 ~~~~~~~~--~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
........ ....||+.|+|||++.+. ..++.++||||+||++|+|++|+.||...+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---- 226 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence 65433221 234689999999998542 34788999999999999999999999988776666555431110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 325 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~~ 325 (374)
..++. ....+++++++||.+||+.++.+ |++++++++||||+.+.+..
T Consensus 227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 00111 11246899999999999976655 56899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.92 Aligned_cols=288 Identities=38% Similarity=0.699 Sum_probs=232.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||.|++|.||+|++..+++.||||++.... ....+|+.+++.++|+||+++.+++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999999899999999885432 2345799999999999999999988554433334589
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||+++++.+.+. ....+++..++.++.||+.||++||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence 999999987766665 34489999999999999999999999 79999999999999996 7889999999998665
Q ss_pred cCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 187 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 187 ~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
... ......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+....+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2334567889999999876546899999999999999999999999999999999999998888887665422
Q ss_pred CcC-CcCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCC
Q 017270 263 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 263 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
... ...+ ..+.....++...+ ..+++.+.+||.+||++||.+|||+++++.||||++++.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 111 1111 11222223333333 3478999999999999999999999999999999998776433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.98 Aligned_cols=317 Identities=35% Similarity=0.615 Sum_probs=241.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|.+.+.||+|++|.||+|++..+++.||+|++.... ....+|+.+++.++|+|++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999999999999999875421 223469999999999999999887743322 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
...++|+||++++|.+.+.. .++++..++.++.|++.||.|||+ .||+||||+|+||+++. ++.++|+|||++
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEcccccc
Confidence 34889999998888776652 579999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+.+..+.+....+...
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 765332 234567888999999866556789999999999999999999999998888888888888777776554433
Q ss_pred CcCCc-CC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCC
Q 017270 263 NPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 339 (374)
Q Consensus 263 ~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
..... .+ ..+......+...+ ...++.+.+||.+||+.||.+|||+.++++||||..+..+.. .+.++..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~-----~~~~~~~~ 317 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED-----EPVAPPYD 317 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc-----cccccccC
Confidence 21110 00 01111112222222 246899999999999999999999999999999998755532 22234444
Q ss_pred chhhhcCCCHHHHhhhcHHHHh
Q 017270 340 FKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..-.-.+....+++.++..++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07851 318 QSFESRDLTVDEWKELVYKEIM 339 (343)
T ss_pred cchhhhhcCHHHHHHHhHHHHH
Confidence 3334445666677777666554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.81 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=203.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|++++.+.+.+. ....+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3788899999999999999999999999999885432 12346899999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||+.| +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence 999999985 56555542 223468999999999999999999999 79999999999999996 77899999999876
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........+++.|+|||++.+. .++.++|+||+||++|+|++|..||..................
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------- 219 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 219 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence 5443333445789999999998654 5899999999999999999999999865432111111110000
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
....++..+++++.+|+.+||+.||++||| ++|+++||||+.+.+.
T Consensus 220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 001123457889999999999999999999 9999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.40 Aligned_cols=276 Identities=36% Similarity=0.664 Sum_probs=222.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
+|++.+.||.|++|.||+|++..+|+.||||.+.... ....+|+.+++.++|+||+++++.+.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 5899999999999999999999999999999886432 233479999999999999999998843 334889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||+++++.+.+.... ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence 99999998877775422 23568999999999999999999999 79999999999999996 78899999999975433
Q ss_pred CCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017270 188 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266 (374)
Q Consensus 188 ~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 266 (374)
... .....+++.|++||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+.+..+.+....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 221 2234568889999998766667899999999999999999999999988888888888888877776655333 11
Q ss_pred cC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 267 TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 267 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.. ..++......... +...+++.+.+++.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1222222222222 223468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=336.62 Aligned_cols=245 Identities=27% Similarity=0.456 Sum_probs=197.6
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++.+... ...+| ..+++.++|+||+++++++ .....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 469999999999999999999999998864321 11122 3356788999999999888 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence 99996 5555544 34678899999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 22345678999999999865 45899999999999999999999999988777666555431 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH----HHhcCCccccccC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELRE 323 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~----e~l~hp~~~~~~~ 323 (374)
. .+...+++.+.++|.+||+.||.+|+++. ++++|+||....+
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 -L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 0 01235789999999999999999999875 8999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=316.60 Aligned_cols=319 Identities=32% Similarity=0.539 Sum_probs=247.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCC-Cce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 103 (374)
..+|.-++.+|.|+- .|-.|.+.-+++.||+|++... .+...+|..++..++|+||++++.+|...... ...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 348999999999998 7888999999999999988433 34456899999999999999999998544332 223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+|||++..+|...+. ..+.-..++.+++|++.|++|||+ .||+||||||+||++.. ++.+||.|||+|+
T Consensus 95 e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhc
Confidence 488999999998888776 346778899999999999999999 79999999999999996 8899999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.....-..+.++.|.+|+|||++.+.+ |...+||||+|||+.||++|...|++.+..++..++.+.+|.|.+.....+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 644443455688899999999998876 9999999999999999999999999999999999999999999998777554
Q ss_pred cCCcCC--CCCCCCCCChhhhccc-----------CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 017270 264 PNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 330 (374)
Q Consensus 264 ~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~ 330 (374)
+.-..+ ..|+.....+.+.|++ .-+..++|++.+||..||++|.|++++|+|||++-+-.. ....
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~--~ev~ 323 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP--DEVE 323 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc--cccc
Confidence 221111 1122122222222221 123468999999999999999999999999999833222 2111
Q ss_pred CCCCCCCCCchhhhcCCCHHHHhhhcHHHHhh
Q 017270 331 GRPLPPLFNFKQELSGASPELVNKLIPDHVKR 362 (374)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (374)
. +.|+.....-+..+.+++.+..++-+++++
T Consensus 324 a-p~pe~~d~~~d~~~~t~~e~ke~If~ev~~ 354 (369)
T KOG0665|consen 324 A-PPPEIYDKQLDEREHTIEEWKELIFKEVQR 354 (369)
T ss_pred C-CCCchhhhhcccccCCHHHHHHHHHHHHHh
Confidence 2 222233333445566688888777777664
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.72 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=196.7
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||+|+||.||++.+..+|+.||+|.+.... .....|+++++.++||||+++.+++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885422 1223589999999999999998888 3445689999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
+| +|...+.. .....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence 86 55555432 233458899999999999999999999 79999999999999996 778999999998765544333
Q ss_pred ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCC
Q 017270 192 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271 (374)
Q Consensus 192 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 271 (374)
....+++.|+|||++.+.. ++.++|+||+||++|+|++|..||...........+....-. .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence 3456789999999986554 899999999999999999999999765432221122111000 00000
Q ss_pred CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCccccccCC
Q 017270 272 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 324 (374)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~~ 324 (374)
....+++++++||.+||++||.+||++ ++++.||||+.+.++
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 012478999999999999999999999 778899999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=331.76 Aligned_cols=282 Identities=36% Similarity=0.573 Sum_probs=222.3
Q ss_pred CCccccceee-eeeeecCCCceEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHhcCCCce
Q 017270 27 EPKQTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRVMDHPNV 87 (374)
Q Consensus 27 ~p~~~~~y~i-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~~i 87 (374)
.....++|.. .+.||.|+||+||+|.+..+++.||+|++..... ...+|+++++.++|+||
T Consensus 3 ~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred ccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 3455678875 5779999999999999999999999998854321 23479999999999999
Q ss_pred eeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 88 v~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
+++++++. ...+.++||||+.+++.+.+. ....+++..+..++.|++.||+|||+ +|++|+||+|+||++
T Consensus 83 v~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill 152 (335)
T PTZ00024 83 MGLVDVYV-----EGDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFI 152 (335)
T ss_pred eeeeEEEe-----cCCcEEEEEeccccCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEE
Confidence 99999883 334589999999998877765 34568999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccC---------------CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCC
Q 017270 168 DPLTHQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 232 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~ 232 (374)
+. ++.++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|+|++|.
T Consensus 153 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 153 NS-KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred CC-CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 96 778999999998754411 11112345788999999876666799999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH
Q 017270 233 PLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310 (374)
Q Consensus 233 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ 310 (374)
+||.+.+..+.+..+.+..+.+....++... +.+.. +.......... .....+.++.++|.+||+.||++|||++
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--cCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 9999999888888888888877765443221 01111 11111111111 1234688999999999999999999999
Q ss_pred HHhcCCcccccc
Q 017270 311 EACAHPFFDELR 322 (374)
Q Consensus 311 e~l~hp~~~~~~ 322 (374)
+++.||||+...
T Consensus 309 ~~l~~~~~~~~~ 320 (335)
T PTZ00024 309 EALKHEYFKSDP 320 (335)
T ss_pred HHhcCcccCCCC
Confidence 999999998653
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=334.22 Aligned_cols=247 Identities=25% Similarity=0.449 Sum_probs=195.6
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +|++|+.+++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 1234678888777 699999999988 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc-
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 187 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~- 187 (374)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence 99986 5554443 34579999999999999999999999 79999999999999996 77899999999875332
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+.+.+.. .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K-------- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence 223345678999999999865 458999999999999999999999996421 11222222110 0
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~~~~~ 324 (374)
.. .++..++..+.++|.+||+.||.+|++ .+++++||||+.+.+.
T Consensus 219 ------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 219 ------PI------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 00 123357899999999999999999998 5799999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=332.93 Aligned_cols=287 Identities=31% Similarity=0.545 Sum_probs=217.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCC------
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------ 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------ 100 (374)
..+|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999999999999999885432 2345799999999999999999876432211
Q ss_pred ---CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 101 ---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 101 ---~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....|+||||++++|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..+..++|+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence 123578999999987766553 3468999999999999999999999 7999999999999998657789999
Q ss_pred eeccccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 178 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 178 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
|||.+........ .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+....+.+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 122356888999998866556889999999999999999999999988877777776665444
Q ss_pred CCHHHHhhcCcCCcCC-C-CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 254 PTREEIRCMNPNYTDF-R-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+............... . .......+... +...++.++++||.+||+.||.+|||+++++.||||+.+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 3332222111000000 0 00011112222 223578999999999999999999999999999999876433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=325.95 Aligned_cols=282 Identities=32% Similarity=0.613 Sum_probs=221.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC---C
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---K 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~ 100 (374)
..++|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3679999999999999999999999999999999885321 134579999999999999999987754332 2
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....+++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg 160 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFG 160 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCc
Confidence 2346889999999887666653 34579999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC------------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017270 181 SAKQLIAGEA------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248 (374)
Q Consensus 181 ~a~~~~~~~~------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 248 (374)
++........ .....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9975433221 1223568889999998665568999999999999999999999999998888888888
Q ss_pred HHhCCCCHHHHhhcC--cCCcC-CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 249 KVLGTPTREEIRCMN--PNYTD-FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...+.+....+.... +.... ...... .......+ ..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCC-CccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877776655444321 11111 011111 11122222 2466889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=335.10 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=196.5
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|++..+++.||+|++.+... ...+| ..+++.++||||+++++.+ .+....|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999998864321 11223 3467889999999999887 3344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc-
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 187 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~- 187 (374)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence 99986 5544443 34678999999999999999999999 79999999999999996 78899999999875322
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 222334578999999999865 45899999999999999999999999988766555544331 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~~ 324 (374)
. .++...+..+.++|.+||+.||.+|+++ .++++||||..+.+.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 213 -L------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred -C------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 0 0223468899999999999999999975 599999999876553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=329.41 Aligned_cols=287 Identities=37% Similarity=0.634 Sum_probs=225.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCC--CcEEEEEEeeccc------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.+ +|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 8999999875421 2234689999988 5999999988653321 2234
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++++||++++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence 478999999988777665 35679999999999999999999999 79999999999999996 7789999999997
Q ss_pred ccccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
....... .....+|+.|+|||.+.+...++.++|+||+||++|+|++|.+||...+....+..++..++.+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 12346788999999986655689999999999999999999999999988889999999999887765
Q ss_pred HhhcCcCC-cC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCC
Q 017270 259 IRCMNPNY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 259 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
+....... .. ..........+... ....+..+.+|+.+||+.||.+|||+.+++.||||+.++++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~ 304 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence 54332110 00 01111111222222 23468899999999999999999999999999999998776433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=344.53 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=213.5
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
+..+.|.|+..||.|+||+||+|.++.++-..|.|++.... ....-|++||..++||+||++++.|+....
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk----- 103 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK----- 103 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----
Confidence 34467999999999999999999999888888888774332 122358999999999999999998865444
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++|+.|||+|+-.+-+. ..-+..+++.+++.+++|++.||.|||+ ++|+|||||..|||+.- +|.|+|+|||.+..
T Consensus 104 LwiliEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAK 179 (1187)
T ss_pred eEEEEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeeccccccc
Confidence 89999999986555444 2356789999999999999999999999 79999999999999996 78899999999865
Q ss_pred ccc-CCCcceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 185 LIA-GEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 185 ~~~-~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
... .....+++|||+|||||+.. ...+|++++||||||++|.+|..+.+|-...+.+..+.+|.+.-. |.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-PT---- 254 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PT---- 254 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-Cc----
Confidence 432 23345789999999999973 456799999999999999999999999999999998888876211 10
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
-.-+.+.+..+.||+.+||.+||..||++.++|+||||.++
T Consensus 255 ---------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 255 ---------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ---------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 00123457788999999999999999999999999999864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=338.65 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=222.1
Q ss_pred CCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 25 ~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
...++..+.|.+.+.||+|.|++|.+|++..|+..||||.+.+.. ....+|+++++.++|||||+++.+....
T Consensus 49 ~~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~- 127 (596)
T KOG0586|consen 49 TDDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE- 127 (596)
T ss_pred ccccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-
Confidence 367788889999999999999999999999999999999886643 2245899999999999999999998443
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 99 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
..+|+||||+.++ .+.++...++++.+..++.++.|++.|++|||+ ++|+|||||++|||++. +..+||+|
T Consensus 128 ----~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaD 198 (596)
T KOG0586|consen 128 ----ATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIAD 198 (596)
T ss_pred ----ceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeec
Confidence 3499999999963 333444567888899999999999999999999 89999999999999996 66799999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++..+.......+.+|++.|.|||++.|....++.+|+||+|+++|.|+.|..||.+.+-.+.-...+.
T Consensus 199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--------- 269 (596)
T KOG0586|consen 199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--------- 269 (596)
T ss_pred cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------
Confidence 99999998888888999999999999998888779999999999999999999999998764432222111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
..++ ++--++.++.++|+++|.++|.+|++.+++..|.|.......
T Consensus 270 --------gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 270 --------GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1111 122478999999999999999999999999999999876555
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=322.42 Aligned_cols=277 Identities=35% Similarity=0.667 Sum_probs=214.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+++++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 47999999999999999999999899999999875432 1234799999999999999999988 444568
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||++++++..+.. ....+++..++.++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL 150 (286)
T ss_pred EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence 99999999865554432 34568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 263 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 263 (374)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|.+||......+....+....+......-....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 43322 2335678899999998665567889999999999999999999999888777777777665543322111111
Q ss_pred -cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.......+......-.......++..+.+|+.+||+.||++||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011111222111111111234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.89 Aligned_cols=283 Identities=37% Similarity=0.638 Sum_probs=222.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 104 (374)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 58999999999999999999999999999999885421 123479999999999999999998754322 12234
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++|+||+..++.... ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence 6899999987654432 2468999999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..++...+.+..........
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 432 223456788999999986655588999999999999999999999999888888888888877776655443221
Q ss_pred CC-cC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 265 NY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 265 ~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
.. .. ...+......+...+ ...++++.+||.+||+.||.+||++++++.||||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 10 00 011222222222222 24788999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=332.46 Aligned_cols=278 Identities=27% Similarity=0.442 Sum_probs=203.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+|+++++.++|+||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 368999999999999999999999999999999875432 234579999999999999999999843 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+.+ +|.+.+. ....+++..++.++.|++.||.|||+.++++||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchh
Confidence 999999985 6666664 34568999999999999999999997237999999999999996 77899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--LGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 262 (374)
.... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||......+.. .+... .+.+........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcc
Confidence 4332 22335678999999998654 5899999999999999999999999876543322 11110 011100000000
Q ss_pred C-c------CCcCCCCCC---------CCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 263 N-P------NYTDFRFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 263 ~-~------~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
. . .+.....+. +........-...++.++++||.+||++||++|||+.|++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0 0 000000000 000000000012367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=331.44 Aligned_cols=291 Identities=34% Similarity=0.673 Sum_probs=229.1
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
+...++|.+.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +|+||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~ 79 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---E 79 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---C
Confidence 45667999999999999999999999989999999988542 12234699999999 99999999988733 2
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
+...+|+||||++++|...+.. ..+++..++.++.||+.||.|||+ +||+||||+|+||+++. ++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeecc
Confidence 2345889999999887766642 278889999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCC------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 181 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 181 ~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
++....... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 997654332 12235678899999988665667899999999999999999999999988888888888888777
Q ss_pred CHHHHhhcCcCCcCC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCC
Q 017270 255 TREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~ 329 (374)
....+..+....... ..+..........+ ..++.++.+||.+||+.||++|||+.++++||||+.+..+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~ 309 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV 309 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCC
Confidence 765544332111111 01111112222222 237899999999999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.96 Aligned_cols=277 Identities=35% Similarity=0.673 Sum_probs=221.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 37999999999999999999999999999999875321 234579999999999999999999844 3358
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||++++++..+.. ....+++..++.++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~ 150 (288)
T cd07833 76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL 150 (288)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence 89999999876665542 34568999999999999999999999 79999999999999996 788999999998866
Q ss_pred ccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......++..|+|||++.+...++.++|+||+|+++|+|++|.+||.+....+.+..+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 5443 23345678899999999766468999999999999999999999999888777777777766655554333222
Q ss_pred --cCCcCCCCCCCC-CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 264 --PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 264 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+....++... ...+...++..+++++.+||++||..||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 111111222221 1223334555569999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=322.61 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=206.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|+..+.||.|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++|+|++.+.+.+. .....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 4788899999999999999999999999999885432 12346999999999999999988873 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence 999999996 45444432 223469999999999999999999999 79999999999999996 67899999999876
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........
T Consensus 152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05632 152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--------- 221 (285)
T ss_pred cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence 5443333455789999999998654 589999999999999999999999988766544444433211110
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
..+...+++++.+|+.+||+.||.+||+ +.+++.||||+.....
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0123357889999999999999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=321.38 Aligned_cols=274 Identities=35% Similarity=0.675 Sum_probs=218.3
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+.+++.++|+|++++++.+. +....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999999999999999886432 22457999999999999999999883 3355899
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
+|||++++|.+.+... ....+++..+..++.|++.||+|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence 9999988877776532 12468999999999999999999999 79999999999999997 88899999999875432
Q ss_pred CCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--c
Q 017270 188 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 264 (374)
Q Consensus 188 ~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~ 264 (374)
... .....+++.|+|||++.+...++.++|+||||+++|+|++|.+||...+....+.++.+..+.+....+.... +
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 221 1233558889999988665557899999999999999999999999988888888888887877766543221 1
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
++. ..++......... ....+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 110 0122211111111 234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=322.08 Aligned_cols=274 Identities=39% Similarity=0.734 Sum_probs=223.1
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|.+.+.||.|++|.||+|.+..+++.+++|.+..... ...+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 6788999999999999999998999999998854432 23478999999999999999998843 345889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|+||+++++.+.+.. ....+++..++.++.|++.||.|||+ ++|+|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence 999999988777654 23679999999999999999999999 79999999999999996 77899999999876544
Q ss_pred CC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 017270 188 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 264 (374)
Q Consensus 188 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 264 (374)
.. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 222345678899999987664689999999999999999999999999998888888888888877666554432
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
......++......... ....++.++.+||.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 12222333322222222 234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=322.49 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=203.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|+||.||+|.+..+|+.||||.+..... ....|.. .++.++||||+++++.+.. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 479999999999999999999999999999998865421 1223444 4667789999999998843 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|++|||++++|.+.+.........+++..++.++.||+.||+|||+ + +++||||||+||+++. ++.+||+|||++..
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~ 153 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY 153 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence 8999999998888877655555789999999999999999999998 7 9999999999999996 77899999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCC---CCCCCchhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...........++..|+|||.+.+. ..++.++|+||+||++|+|++|+.||.... ..+.+..+... ...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----- 226 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP----- 226 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-----
Confidence 5433333335678889999988542 346889999999999999999999996532 22333322221 000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+ ....+|+++.+||.+||..||.+||+++++++||||....
T Consensus 227 ---------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 ---------QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ---------CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 00 0123688999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=324.98 Aligned_cols=261 Identities=29% Similarity=0.495 Sum_probs=211.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.+|++.+.||+|++|+||+|.+..+++.||+|.+..... ...+|+++++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 379999999999999999999999999999998865432 234689999999999999999887 34456
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.|+||||+.| +|.+.+.. .....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence 8999999986 66666542 234679999999999999999999999 79999999999999996 7789999999986
Q ss_pred ccccCCC------------------------------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 184 QLIAGEA------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 184 ~~~~~~~------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
....... .....||..|+|||++.+. .++.++||||||+++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCC
Confidence 5432111 1123578889999998654 47999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC----H
Q 017270 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----A 309 (374)
Q Consensus 234 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~ 309 (374)
||.+.+....+..+... ...++. ...++..+.++|.+||+.||++||| +
T Consensus 231 pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 231 PFKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred CCCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 99888776665554421 000110 1126889999999999999999999 9
Q ss_pred HHHhcCCccccccCCCCCCC
Q 017270 310 LEACAHPFFDELREPNARLP 329 (374)
Q Consensus 310 ~e~l~hp~~~~~~~~~~~~~ 329 (374)
+++++||||+..+++..+..
T Consensus 284 ~~ll~~~~~~~~~~~~~~~~ 303 (316)
T cd05574 284 AEIKQHPFFRGVNWALIRHT 303 (316)
T ss_pred HHHHcCchhhcCChhhcccC
Confidence 99999999999888766653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=318.20 Aligned_cols=248 Identities=28% Similarity=0.495 Sum_probs=201.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
++|.+.+.||+|++|.||.|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 47999999999999999999999999999999875432 12356899999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++|+||+++ +|.+.+. ....+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence 469999999986 5655554 34568999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+......... ....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+.......+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----- 224 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT----- 224 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-----
Confidence 8754332111 234567889999998654 489999999999999999999999987655544433322100
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...++..++..+.++|.+||..||.+|||+.++++||||
T Consensus 225 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 111334578999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=330.29 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=195.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|++++.||+||.+.||++.. .+.+.||+|++.... .....|+.+|.+|+ |.+||+++++= -++.++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCceE
Confidence 799999999999999999985 445667777663322 22347999999995 89999999865 346679
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||-+-+|-..|... ...++.-+++.|..|++.|++++|+ +||||.||||.|+|+. .|.+||+|||+|...
T Consensus 436 YmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhccc
Confidence 999999888888888753 2334444899999999999999999 7999999999999998 678999999999876
Q ss_pred ccCCC---cceeeeeccccchhhhhCCC----------CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 186 IAGEA---NISYICSRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 186 ~~~~~---~~~~~~t~~y~aPE~l~~~~----------~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
..... ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..... .+.++.. +.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~a-I~ 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHA-IT 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHh-hc
Confidence 65543 34678999999999984321 156899999999999999999999965431 1222221 11
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.|. .++.||.++ -..++.++++.||++||.+|||+.++|+|||+.-
T Consensus 587 ~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 587 DPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 121 233444432 1234999999999999999999999999999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=319.99 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=207.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.+ +|||++++++++..........++
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 678999999999999999999999999999999885432 2334688889888 899999999988654433345688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ ++++||||||+||+++. ++.+||+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchhc
Confidence 99999985 6766666544456779999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCC----CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
..... .....++..|+|||.+.... .++.++|+||+||++|+|++|+.||...+....+..+.+. .+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~----- 251 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PPP----- 251 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CCC-----
Confidence 43322 22346788899999974332 2678999999999999999999999877655544433221 000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
....+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 252 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 -------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0001223577899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=324.50 Aligned_cols=285 Identities=35% Similarity=0.592 Sum_probs=223.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 468999999999999999999999999999999885432 223469999999999999999988743322 2223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..|++++++++++.+.+. ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence 478999999887766554 2468999999999999999999999 79999999999999996 7789999999987
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||...+....+..+....+.+.........
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5432 22345678899999998665568899999999999999999999999888888888888877777665554332
Q ss_pred cCCcCC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 264 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 264 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
...... ..+......+... ....++++++||.+||+.||.+|+++.++++||||.++..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 111000 0111111111111 124688999999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.87 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=208.2
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhc-CCCceeeeceeeeecCCCCce
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+...++|++.+.||+|+||+||+|.+..+++.+|+|++.... .....|+.+++.+ +|+||+++++++.........
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 345679999999999999999999999999999999875432 2345688999998 699999999988655444556
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~ 171 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVS 171 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCce
Confidence 78999999985 6666666544456679999999999999999999999 79999999999999996 677999999998
Q ss_pred cccccCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 183 KQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
....... ......+++.|+|||++.. ...++.++|+||+||++|+|++|..||........+..+... .+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~--- 246 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP--- 246 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC---
Confidence 7654322 2234467899999998742 234788999999999999999999999876544333222110 00
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ ....+...+..+.+||.+||+.||++|||+.|+++||||
T Consensus 247 --------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 --------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 000122357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.26 Aligned_cols=277 Identities=31% Similarity=0.605 Sum_probs=219.1
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 788999999999999999999999999999986542 12346999999999999999999884331 245889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||+++++.+.+.. ....+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence 999999887776653 23579999999999999999999999 79999999999999996 78899999999986544
Q ss_pred CCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 188 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 188 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... .....++..|+|||.+.+...++.++||||||+++|+|++|..||...+....+..+.+..+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 331 223456788999998766556899999999999999999999999999888888888887777766555432211
Q ss_pred --CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+................+...+++.+.+++.+||+.||++||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11111111111112222333348999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=309.63 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=204.1
Q ss_pred cceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+-|.+. +.||+|+|+.|--|....||..||||++.+.. ....+|++++... .|+||++++++| +++..+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 456664 68999999999999999999999999997653 3445899999888 599999999999 666669
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC--cEEEEeeccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 182 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~--~ikl~Dfg~a 182 (374)
|+|||-+.| .|+..+. ....|++.++.++..+|+.||.|||. +||.||||||+|||....+. -+||+||.+.
T Consensus 152 YLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccc
Confidence 999999986 5666555 35679999999999999999999999 89999999999999864222 4999999997
Q ss_pred cccccC--------CCcceeeeeccccchhhh----hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh----------
Q 017270 183 KQLIAG--------EANISYICSRFYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------- 240 (374)
Q Consensus 183 ~~~~~~--------~~~~~~~~t~~y~aPE~l----~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------- 240 (374)
...... +...+.+|+..|||||++ .....|+.++|.||||||+|.|++|.+||.+.-.
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 543211 123356778889999996 2244689999999999999999999999976421
Q ss_pred -----HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+..|.+ ..|.||. ..| ..+|.+++|||+.+|..|+.+|.++.++++|
T Consensus 307 Cr~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111222222 2333443 122 2489999999999999999999999999999
Q ss_pred CccccccCC
Q 017270 316 PFFDELREP 324 (374)
Q Consensus 316 p~~~~~~~~ 324 (374)
||++.....
T Consensus 362 Pw~~~~~~e 370 (463)
T KOG0607|consen 362 PWVQRCAPE 370 (463)
T ss_pred ccccccchh
Confidence 999986543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.91 Aligned_cols=275 Identities=40% Similarity=0.703 Sum_probs=222.1
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|.+.+.||.|++|+||+|....+++.||||.+..... ...+|+..++.++ |+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 7889999999999999999988999999998854322 2246888999999 9999999998843 445889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||+.+++.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 9999988888777642 23578999999999999999999999 79999999999999996 78899999999986655
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--C
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--N 265 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~ 265 (374)
........++..|+|||.+.+...++.++|+||||+++++|++|.+||......+.+.++...++.+....+..... .
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44444566788999999886655689999999999999999999999999998888999988888887665543221 1
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.....++..........++ ..+..+.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1112222222222222222 347899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=303.11 Aligned_cols=264 Identities=24% Similarity=0.405 Sum_probs=214.1
Q ss_pred CCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchH-----HHHHH-HHhcCCCceeeeceeeeec
Q 017270 24 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQL-MRVMDHPNVISLKHCFFST 97 (374)
Q Consensus 24 ~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-----~e~~~-l~~l~h~~iv~~~~~~~~~ 97 (374)
....+...++..++..||.|+.|.|++++.+.+|...|||.+.......+ ..+.+ ++..++|+||+.+++|...
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 34455566677889999999999999999999999999999965532221 12222 2233589999999999765
Q ss_pred CCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 98 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.+ +++.||.+..-+..+++. ..++++|..+-.+..-++.||.||.+.+||+|||+||+|||+|. .|.+|||
T Consensus 164 ~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlC 234 (391)
T KOG0983|consen 164 TD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLC 234 (391)
T ss_pred ch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEee
Confidence 55 778999998655555553 34679999999999999999999999779999999999999996 8899999
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCC
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTP 254 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~ 254 (374)
|||++....+........|.+.|||||.+.- ...|+.++||||||+.++||.||+.||.+.+ +.+.+.++.+. .|
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--eP 312 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EP 312 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CC
Confidence 9999998888877778889999999999832 3468899999999999999999999999864 56777777662 11
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+. ++ ....+|+.+++|+..||.+|+.+||.-.++|+|||+..+.
T Consensus 313 P~--------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 313 PL--------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CC--------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 10 00 1124799999999999999999999999999999998754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.08 Aligned_cols=250 Identities=30% Similarity=0.514 Sum_probs=207.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 47999999999999999999999999999999885432 22346899999999999999999883 3445
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.+||+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence 899999996 566666653 4679999999999999999999999 79999999999999996 7789999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. +.+
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~--------- 215 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKV--------- 215 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc---------
Confidence 65443 2345678899999998654 578999999999999999999999988775554444432 100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.++..+++.++++|.+||+.||.+|+ +++++++||||+.+.+.
T Consensus 216 ------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 216 ------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 02234688999999999999999999 99999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=299.10 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=205.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.+|+|.+.||+|||+.||++++..++..||+|++.... ....+|++..++++|||++++++.............|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 48999999999999999999999999999999985433 34458999999999999999998876666667778999
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 108 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 108 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++|.. |++.+.+......+..+++.++..|+.+|+.||++||+ .. ++||||||.|||+.. .+.++|.|||.+..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQ 178 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCccc
Confidence 999988 67999998877777899999999999999999999999 68 999999999999995 78999999999875
Q ss_pred cccCCC----------cceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 185 LIAGEA----------NISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 185 ~~~~~~----------~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
..-... .....+|..|+|||.+.- ....+.++|||||||++|+|+.|..||...- + .|
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~-~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q-QG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h-cC
Confidence 432111 123467899999999732 2236889999999999999999999995311 1 01
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
....-. -....+.+|. ...+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 249 gSlaLA-----v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALA-----VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEe-----eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000000 0001122222 12479999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=320.93 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=210.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+-|.++..||+|+||.||+|.|+.+|..+|||+++-+. +...+|+.++++.+.+++|++|+.|+...+ ++|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeeh
Confidence 35788999999999999999999999999999997554 445689999999999999999999976555 99999
Q ss_pred eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|||+ |+..++++. .++++++.++..++..-+.||+|||.+ .-+|||||..|||++. ++..||+|||.|....+.
T Consensus 108 EYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhhh
Confidence 9999 666666653 567899999999999999999999995 7789999999999997 788999999999876543
Q ss_pred -CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
....+.+|||.|||||++.. -.|+.++||||||+...||..|++||..-.....+-.|-. .|+ .
T Consensus 183 MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PP-----------P 247 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPP-----------P 247 (502)
T ss_pred HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---CCC-----------C
Confidence 34457899999999999964 4599999999999999999999999987665543322111 000 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.++. ++.-|.++.||+++||.+.|++|.|+.++++|||+++
T Consensus 248 TF~K------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 248 TFKK------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred CCCC------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 1111 1224778999999999999999999999999999986
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.34 Aligned_cols=263 Identities=29% Similarity=0.440 Sum_probs=209.6
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhc-CCCceeeeceeeeecCC-CCc
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~ 102 (374)
|...++|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.+++.+ +|+||+++++++..... ...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 566789999999999999999999999899999999886543 2345799999998 79999999998865443 335
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++||||+++ +|.+.+......+..+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcc
Confidence 568899999996 6666665444345789999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCC-CcceeeeeccccchhhhhCC----CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+....... ......+++.|+|||.+... ..++.++|||||||++|+|++|..||........+..+... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~- 235 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP- 235 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC-
Confidence 87543322 22345678899999987432 34678999999999999999999999876555444443321 00
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.. ......+.++.+||.+||..||++|||+.++++|||+
T Consensus 236 ---------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ---------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=323.01 Aligned_cols=286 Identities=36% Similarity=0.645 Sum_probs=221.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC-Cc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~ 102 (374)
..++|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++...... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3568999999999999999999999999999999885421 1234799999999999999999988543221 12
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+++||||+++++...+. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 93 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence 3468999999877766554 3568999999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+....+.++++..+.+........
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754332 223466889999999865455889999999999999999999999998888888887776665554433222
Q ss_pred CcCCc-C--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 263 NPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 263 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
..... . ...+......+ ..+...+++.+.++|.+||+.||.+|||+.+++.||||+..+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 11000 0 00111111111 122346788999999999999999999999999999999876653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.40 Aligned_cols=254 Identities=31% Similarity=0.549 Sum_probs=212.6
Q ss_pred cceee--eeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.-|+| .+.||+|.||+||-|+++++|+.||||++.+.+ .....|+.+|+.+.||.||.+.-.| +...
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCc
Confidence 34666 479999999999999999999999999986543 3445799999999999999987777 4444
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC--CcEEEEeecc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGS 181 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~--~~ikl~Dfg~ 181 (374)
.+++|||-+.|++++.+.. ...+++++...+.++.||+.||.|||- ++|+|+||||+|||+.+.+ .++||||||.
T Consensus 637 rvFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred eEEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccc
Confidence 5899999999998888764 456889999999999999999999999 7999999999999997533 3799999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
|+.........+.+|||.|+|||++.. ..|+..-||||.|||+|.-+.|..||....+. -.+|.+
T Consensus 714 ARiIgEksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN------------ 778 (888)
T KOG4236|consen 714 ARIIGEKSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN------------ 778 (888)
T ss_pred eeecchhhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccch--hHHhhc------------
Confidence 998887777788999999999999965 45999999999999999999999999755322 112211
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+-+| ..+|.+ +++++.|||..+|+..-.+|.|++..|.|||++++
T Consensus 779 -----AaFMyP---p~PW~e-----is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 -----AAFMYP---PNPWSE-----ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -----cccccC---CCchhh-----cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 111111 234443 79999999999999999999999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=319.07 Aligned_cols=283 Identities=29% Similarity=0.516 Sum_probs=220.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC----
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---- 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 99 (374)
..++|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|||++++++++.....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3568999999999999999999999999999999885432 123469999999999999999988754331
Q ss_pred -CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 -KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 -~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
.+...+++|+||+++++...+.. ....+++..++.++.|++.||+|||+ +||+|+||+|+||+++. ++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCc
Confidence 12236899999999987766653 24578999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 179 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 179 fg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
||++........ .....++..|+|||.+.+...++.++||||+||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999976543321 122345778999999866555789999999999999999999999988888888888888777766
Q ss_pred HHHhhcCc--CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 257 EEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 257 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..++.... .+............+.. ....++..+.++|.+||+.||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 55443211 11110000101111111 223478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=319.54 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=217.5
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhc-CCCceeeeceeeeec
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
..-....+|..+.+||.|+||+|.+|..+.+.+.||||++.++.... ..|.++|... +-|.+++++.+|
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--- 419 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--- 419 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh---
Confidence 33445568999999999999999999999999999999887664332 2466666555 467889999888
Q ss_pred CCCCceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
+.-..+|+||||+.|+ |.-.++ .-+++.+..+..|+.+|+-||-+||+ +||++||||.+||++|. .+.+||
T Consensus 420 --QTmDRLyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi 491 (683)
T KOG0696|consen 420 --QTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKI 491 (683)
T ss_pred --hhhhheeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEe
Confidence 4444599999999974 443343 45789999999999999999999999 89999999999999997 778999
Q ss_pred Eeecccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 177 CDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 177 ~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
+|||+++.-.- .....+++|||.|+|||++.- .+|+.++|+||+||+||||+.|++||.+.+..+.++.|++.
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----- 565 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----- 565 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----
Confidence 99999986443 344567899999999999964 56999999999999999999999999999999999999873
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCccccccCCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 325 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~~~ 325 (374)
. ..+++.+|.++.++++.+|.+.|.+|... .++..||||+.+.|..
T Consensus 566 ------------n------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 566 ------------N------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred ------------c------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 1 12456789999999999999999999854 6899999999998864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.17 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=204.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.+.|++++.||.|+||.||+|++..+++.+|+|.+..... ...+|+.+++.++|+||+++++++.. ...+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEE
Confidence 3579999999999999999999999999999998864432 23468899999999999999998843 33589
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||++++.+..+.. .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 86 lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 86 IMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNV 161 (292)
T ss_pred EEEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceecc
Confidence 9999999754333221 234568999999999999999999999 79999999999999986 7889999999986533
Q ss_pred cCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 187 AGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
... ......+++.|+|||.+.+ ...++.++|+|||||++|+|++|..||...+......++... .++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------ 233 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------ 233 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc------
Confidence 221 2234567889999999842 234688999999999999999999999876655444333221 000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. ...+..++.++.++|.+||+.||++||+++++++||||..+...
T Consensus 234 ------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 234 ------T------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ------c------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 0 00123467899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.39 Aligned_cols=248 Identities=28% Similarity=0.490 Sum_probs=204.6
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 114 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g 114 (374)
+||.|.||+||-|++..|...+|||.++... +...+|+.+-+.|+|.|||++.+++ ..+.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 7999999999999999999999999886432 3346899999999999999999987 555578899999996
Q ss_pred -hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC-
Q 017270 115 -SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 190 (374)
Q Consensus 115 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~- 190 (374)
+|.++++. .=+++ .|..+-.|..||+.||+|||+ +.|||||||-+|+||+.-.|.+||+|||.++....-..
T Consensus 657 GSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 45555542 23455 889999999999999999999 79999999999999998889999999999987765433
Q ss_pred cceeeeeccccchhhhh-CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCC
Q 017270 191 NISYICSRFYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~-~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 269 (374)
..++.||..|||||++. |...|+.++|||||||++.||.||++||..........-.+-...
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK----------------- 795 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK----------------- 795 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----------------
Confidence 44688999999999994 455799999999999999999999999987654432211111111
Q ss_pred CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.+..+++.++.+++.||.+|+.+||.+||+|.++|.+||++.-
T Consensus 796 ---------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 796 ---------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1222455689999999999999999999999999999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=343.67 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=199.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcC-CCceeeece-eeeecCCCC-ceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKH-CFFSTTSKN-ELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~ 104 (374)
.+++|.+.|.+|||+.||+|.+...|..||+|++.... ....+|+++|+.|+ |+|||.+++ ........+ ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 37899999999999999999999888999999875432 34468999999997 999999999 443333333 355
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
+.|+||||. |+|.+++..+.. ..|++.++.+|++|+++|+.+||. .. |||||||-||||++. ++..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeCcccc
Confidence 789999999 699999987554 349999999999999999999999 47 999999999999996 77899999999
Q ss_pred ccccccCCC----------cceeeeeccccchhhh--hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017270 182 AKQLIAGEA----------NISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 182 a~~~~~~~~----------~~~~~~t~~y~aPE~l--~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 249 (374)
|.-...... ......|+.|+|||++ ......+.|+|||+|||+||.|+....||.......++ .
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----n 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----N 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----e
Confidence 864332221 1123458999999997 33445899999999999999999999999876432211 1
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..|.+|.. .+++..+++||+.||+.||.+||++.+++.
T Consensus 269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 23444431 357899999999999999999999998874
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=315.64 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhc-CCCceeeeceeeeecCCC-CceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~ 105 (374)
.+.|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....|+.+++.+ +|+||+++.+.+...... ....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 467999999999999999999999999999999885442 2345788888888 699999999988654322 23468
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||+++ +|.+.+.. .....+++..++.++.|++.||+|||+ ++|+|+||+|+||+++. ++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence 899999985 66666653 123568999999999999999999999 79999999999999996 77899999999875
Q ss_pred cccC-CCcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 185 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 185 ~~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
.... .......+++.|+|||++.+ ...++.++|+||+||++|+|++|..||...........+... +
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 4332 22234567889999999853 234788999999999999999999999766544333322110 0
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
........++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000112467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=315.55 Aligned_cols=274 Identities=38% Similarity=0.705 Sum_probs=225.5
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|++.+.||+|++|.||+|++..+++.||+|.+.... .....|+.+++.++|+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 677899999999999999999999999999886532 123468999999999999999998843 345889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||++++|.+.+... ...+++..++.++.|++.||++||+ +||+||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence 9999999888777642 2579999999999999999999999 79999999999999996 78899999999876543
Q ss_pred CC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 017270 188 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 265 (374)
Q Consensus 188 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 265 (374)
.. .......+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++.+..+.+....+......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223445778999999866546899999999999999999999999999988999999998888888777654322
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+.+..++..........++. ++..+.++|.+||..||++||+++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 22334444444444444433 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=324.66 Aligned_cols=276 Identities=21% Similarity=0.344 Sum_probs=198.0
Q ss_pred eeeeeecC--CCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 36 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 36 i~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
++++||+| +|++||++.++.+|+.||+|.+..+. ....+|+.+++.++||||+++++++.. +...++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 56789999 67899999999999999999886432 234578999999999999999998843 334889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ ++.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence 9999985 666665432 23458999999999999999999999 79999999999999996 7789999998654332
Q ss_pred cCCC--------cceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC---
Q 017270 187 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 254 (374)
Q Consensus 187 ~~~~--------~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--- 254 (374)
.... .....++..|+|||++.+. ..++.++||||+||++|+|++|..||............... ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 231 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL 231 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence 1111 1123456779999998653 35889999999999999999999999876544433332221 000
Q ss_pred -----CHHHHhhcCcCC--cCCCCCCC---------CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 255 -----TREEIRCMNPNY--TDFRFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 255 -----~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+.+. +.+.. .+...... ........+...+++.+.+||.+||++||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 232 DTTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred cccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 000000 00000 00000000 00000011223467899999999999999999999999999999
Q ss_pred cccc
Q 017270 319 DELR 322 (374)
Q Consensus 319 ~~~~ 322 (374)
+.+.
T Consensus 311 ~~~~ 314 (327)
T cd08227 311 KQIK 314 (327)
T ss_pred hhcc
Confidence 8754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=319.18 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=203.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. ....++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 47899999999999999999999999999999875431 23347999999999999999999883 344589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ .|...+.. ......+++..+..++.||+.||.|||+..+|+||||||+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 153 (286)
T cd06622 76 MCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence 99999997 55444432 1223479999999999999999999996249999999999999996 788999999998754
Q ss_pred ccCCCcceeeeeccccchhhhhCCC-----CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
... ......+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+......+.
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (286)
T cd06622 154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP----- 227 (286)
T ss_pred cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence 322 223345788899999985432 257899999999999999999999977654443333222111110
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
..++..+++++.+||.+||+.||.+||+++++++||||...+..
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01223478999999999999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=332.21 Aligned_cols=248 Identities=30% Similarity=0.470 Sum_probs=211.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|.=++.||.|+||.||.|++..|.+.||||++.-.. ..+.+|+..|+.++|||++.+.+||....+ .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence 4677899999999999999999999999999995432 233479999999999999999999965554 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+|||||-|+-.+++.- ..+++.+..+..|..+.+.||.|||+ ++.||||||..|||++. .+.|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence 89999999976666664 34689999999999999999999999 79999999999999995 889999999999765
Q ss_pred ccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.+ ..+++|||+|||||+++. .+.|+-++||||||++..||.-.++|+-..+.+..++-|.+.- .
T Consensus 177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-s---------- 242 (948)
T KOG0577|consen 177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S---------- 242 (948)
T ss_pred Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-C----------
Confidence 43 357899999999999853 3469999999999999999999999998988888888877621 1
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
|-+.... -|..++.|+..||++-|.+|||.+++|.|+|+..
T Consensus 243 --------PtLqs~e--------WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 243 --------PTLQSNE--------WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred --------CCCCCch--------hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1122222 3678899999999999999999999999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.94 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=202.0
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||.|++|.||++.+..+++.||+|++..+. ....+|+.+++.++|+|++++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 5899999999999999999999999999999885432 22356889999999999999987762 2234588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|||+++ ++.+.+... ....+++..++.++.|++.|+.+||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence 99999985 666666532 34568999999999999999999999 79999999999999996 788999999999765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....+++.|+|||++.+ ..++.++|+||+||++++|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------ 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 43222 234567889999999865 4588999999999999999999999987775554444333100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ ..+..+++++.+|+.+||+.||++|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=325.19 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=200.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
.+.+++.||+|-||.||.|.... ...||+|.+... .....+|+.+|++|+|++||++++++... ..+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 45678999999999999999753 347899987542 23445899999999999999999998432 2489999
Q ss_pred eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+. |+|++.|+. ..+..+...++..++.||+.|++||.+ +++|||||...||||+. +..+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccCCC
Confidence 9998 788888875 456789999999999999999999999 79999999999999996 889999999999944333
Q ss_pred CCccee--eeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 189 EANISY--ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 189 ~~~~~~--~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
...... -...-|.|||.+.. ..++.+||||||||+||||+| |+.||.+.+..+.+..+.+....|.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------- 425 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------- 425 (468)
T ss_pred ceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC----------
Confidence 332211 12445999999964 459999999999999999998 9999999999998888776433322
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
|..+|+++.+++..||+.+|++|||.+.+.
T Consensus 426 ------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 ------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 346899999999999999999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=325.38 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=192.0
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 468999999999999999999853 345679999885432 2344799999999 899999999877422
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
...+++||||+++ +|.+.+.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2347899999985 67666653211
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc---ceeeee
Q 017270 126 -----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICS 197 (374)
Q Consensus 126 -----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t 197 (374)
...++++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++........ ....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCC
Confidence 02358888999999999999999999 89999999999999996 788999999999765332211 123346
Q ss_pred ccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCC
Q 017270 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 276 (374)
Q Consensus 198 ~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (374)
+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+..... .
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---------------~------- 296 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---------------M------- 296 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC---------------C-------
Confidence 789999998654 58999999999999999997 99999876544333332221000 0
Q ss_pred CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 277 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 277 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...++.+.+++.+||+.||.+|||+.++++
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.90 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=204.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||.|++|.||+|.+..+++.||+|.+..+. ....+|+.+++.++|+|++++.+.+.. ...+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEE
Confidence 47999999999999999999999999999999886442 223578999999999999999998843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||+++ +|.+.+.. .++++..++.++.|++.|+.|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence 99999986 56555542 278999999999999999999999 79999999999999996 788999999999766
Q ss_pred ccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
... .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------ 215 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------ 215 (274)
T ss_pred cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC------------
Confidence 543 2233456788899999986544 89999999999999999999999987665444433322100
Q ss_pred CCcCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+ ..... +++.+.+++.+||..||++|||++++++||||++..
T Consensus 216 -------~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 216 -------P---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred -------C---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 0 01112 688999999999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.78 Aligned_cols=278 Identities=36% Similarity=0.625 Sum_probs=216.8
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhc---CCCceeeeceeeeecCCCCceE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.+ +|+|++++++++......+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 788999999999999999998889999999885321 1233577776665 5999999999986655444556
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++++|||+.+++.+.+... ....+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence 8999999998877766532 22368999999999999999999999 79999999999999997 68899999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........++..|+|||.+.+. .++.++|+||+||++|+|++|.+||.+....+.+.++.+..+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 6544443445678889999998654 48999999999999999999999999988888888888776665543332111
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
......++......+.. ....+++.+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00001112212222222 122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=330.79 Aligned_cols=248 Identities=30% Similarity=0.457 Sum_probs=204.0
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHH-hcCCCceeeeceeeeecCCCCceEE
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++. .-+||||+++.+++ .+....
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 345678999999999999999999999999999999999887666677886554 44799999999999 666669
Q ss_pred EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|||++.|+ +++.+. ....+. ..+..|++||+.|+.|||+ +|++||||||+|||++.+.+.++|+|||.++.
T Consensus 392 ~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999974 333322 223333 7788899999999999999 79999999999999953477899999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ..+.+-|..|.|||++. ...|+.++||||||++||+|++|+.||...... .++..+++.+.
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK--------- 530 (612)
T ss_pred Cchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc---------
Confidence 6544 23345588899999996 566999999999999999999999999887665 33333333332
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+...+|..++|||++||+.||.+|+++++++.||||
T Consensus 531 ------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 123589999999999999999999999999999999
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=315.94 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=205.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|.+.+.||.|+||.||+|.+..+++.+|+|.+..... ...+|+++++.++|+||+++++.+. ....+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 5689999999999999999999988999999998854322 2346999999999999999999884 334589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence 99999997 55555442 34579999999999999999999999 79999999999999996 788999999998654
Q ss_pred ccCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
.... ......+++.|+|||.+.. ...++.++|+|||||++|+|++|..||...+....+.++... .+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------ 225 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP------ 225 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC------
Confidence 3322 2234567899999999742 234678999999999999999999999887665544443221 00
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+.+ ..+..++.++.++|.+||+.||.+||++.++++||||.+.
T Consensus 226 -----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 -----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0123468899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=318.90 Aligned_cols=252 Identities=25% Similarity=0.457 Sum_probs=197.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+++++.++||||+++++.+.. ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 36889999999999999999999999999999886542 223469999999999999999998844 33488
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||++++.+... ..+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 76 ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecc
Confidence 99999997544322 347888999999999999999999 79999999999999996 7889999999997553
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 263 (374)
.. ......+|+.|+|||.+.+. .++.++|+|||||++|+|++|..||........ .....+....+.
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 216 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------- 216 (279)
T ss_pred cc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------
Confidence 32 23345788999999998654 589999999999999999999999965322110 001111100000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+ .......++++.+|+.+||+.||.+||+++++++||||....
T Consensus 217 -------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 217 -------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred -------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 00 001123678999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=312.06 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=204.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||.|+||+||+|.+..++..+|+|++.... ....+|+.+++.++|+|++++++.+.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 47999999999999999999998899999999885432 234578999999999999999988733 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|||++.+ +|.+.+... .....+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence 99999986 555555431 123568999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCCc-----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...... ....++..|+|||.+.....++.++|+|||||++|+|++|..||...+....+.++... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP----- 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC-----
Confidence 543222 23467889999999866546899999999999999999999999877665544444331 000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.++. ......+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 226 ---------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 ---------SLET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---------CcCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000 00013478899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=318.75 Aligned_cols=282 Identities=38% Similarity=0.716 Sum_probs=221.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|.+.+.||.|+||.||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++.++|... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 456899999999999999999999999999999987532 12344799999999999999999987432 22
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++||||+++++...+. ..++++..++.++.|++.||+|||+ +||+||||+|+||+++. ++.++|+|||.+.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence 478999999887766654 3468889999999999999999999 79999999999999996 7889999999987
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||...........+.+.++.++.+......
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 22345668889999987654568999999999999999999999999988877777778888877655443221
Q ss_pred cC-CcCC--CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 264 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 264 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
.. ..++ ..+.....++...+ ..+++.+.++|.+||+.||++|||+++++.||||...+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 10 0000 01111111222222 35788999999999999999999999999999998876654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=317.88 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=203.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+|...+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.++.++. |+||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcE
Confidence 46778889999999999999999999999999886432 22346888888886 9999999998743 2347
Q ss_pred EEEeecccchHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~-~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++|||+.+++....... ......+++..+..++.|++.||+|||+..+++||||||+||+++. ++.++|+|||++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHH
Confidence 899999987665544321 2234679999999999999999999997239999999999999996 77899999999976
Q ss_pred cccCCCcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...........+++.|+|||++.+. ..++.++||||+||++|+|++|+.||..... ....+.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~------- 228 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP------- 228 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-------
Confidence 5544333445678899999998654 3689999999999999999999999976542 2222222111100
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+.+ ....+..++.++.+||.+||+.||++|||+++++.||||+.....
T Consensus 229 ---------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 229 ---------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ---------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 000 001113478999999999999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=314.35 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
+-|++.+.||.|+||.||+|.+..++..+++|.+.... ....+|+.+++.++|+|++++++.+.. ....++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence 34789999999999999999999999999999885432 223468999999999999999998843 345889
Q ss_pred EeecccchHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g~l~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|+||++++.+ ..+.. ....+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEcccccccccc
Confidence 9999997543 33332 34579999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCC-Ccceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 187 AGE-ANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
... ......+++.|+|||++. ....++.++|+||+||++|+|++|.+||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 227 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------- 227 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------
Confidence 322 223356788999999974 22346789999999999999999999998877665555544311100
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
...+..++.++.+||.+||+.||.+||+++++++||||...
T Consensus 228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00123468899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.31 Aligned_cols=249 Identities=31% Similarity=0.453 Sum_probs=205.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++.+ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5899999999999999999999999999999885432 2344789999999999999999887 3344589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+... ....+++..++.++.|++.|++|||+ +|++|+||+|+||+++.+++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999986 676666532 24558999999999999999999999 799999999999999865667899999999876
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
..........+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------ 219 (256)
T ss_pred CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence 55444445667889999999865 44789999999999999999999999887765555444331000
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.++..+++++.+++.+||+.||++|||+.|+++||||
T Consensus 220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0223478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=308.46 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=206.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....|+.+++.++|+||+++++.+.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 5899999999999999999999999999999885432 123468899999999999999887743 2334578
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH-----~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
++|||+++ +|.+.+.........+++..++.++.||+.||.||| + .+++|+||+|+||+++. ++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence 99999985 777777765555678999999999999999999999 8 79999999999999996 7889999999
Q ss_pred cccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 181 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 181 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 225 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--------- 225 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence 9987654433 3345678999999998654 4889999999999999999999999887744433332221
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+ .++...+..+.+++.+||+.||.+||++.++++|||+
T Consensus 226 ----------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ----------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000 1233578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.31 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=205.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...+|++.+.||.|++|+||+|.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+. ....+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence 3467999999999999999999999999999999885432 22346899999999999999999884 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++|+||+.+ +|...+. ...+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~ 164 (296)
T cd06655 92 FVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchh
Confidence 999999986 4444443 2468999999999999999999999 79999999999999996 78899999999876
Q ss_pred cccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-------- 234 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE-------- 234 (296)
T ss_pred cccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------
Confidence 543322 223467889999999854 44789999999999999999999999887765554433221 1100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...+..+++.+.+||.+||..||++|||+.+++.||||+..+
T Consensus 235 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 -----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 001234788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.68 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=204.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
....+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+.. ...
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~ 91 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCE
Confidence 33469999999999999999999999999999999886433 234478999999999999999998843 335
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.|+||||+++ +|.+.+. ...+++.++..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~ 164 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 164 (296)
T ss_pred EEEeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccch
Confidence 8999999986 5655553 2458899999999999999999999 79999999999999986 7789999999987
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
....... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+... +.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------- 235 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE------- 235 (296)
T ss_pred hccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC-------
Confidence 5433222 223467889999999864 44789999999999999999999999877654443322210 1100
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
...+..+++.+.+|+.+||..||++|||+.++++||||...
T Consensus 236 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00123478899999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.86 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=202.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhc-CCCceeeeceeeeecCC-CCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~ 105 (374)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....|+.+++.+ +|+||+++++++..... .....+
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 468999999999999999999999999999999885543 2334678888888 69999999998854322 234568
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|++|||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+|+||+|+||+++. ++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhh
Confidence 899999986 666666532 24568899999999999999999999 79999999999999996 77899999999875
Q ss_pred cccC-CCcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 185 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 185 ~~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
.... .......+++.|+|||.+.. ...++.++|+|||||++|+|++|..||...........+... ..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 243 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP---- 243 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence 4322 22234567889999999742 234788999999999999999999999776544433322110 00
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.......++.++.+||.+||+.||.+|||+.|+++||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000112478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=311.38 Aligned_cols=246 Identities=32% Similarity=0.536 Sum_probs=198.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
+|++.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4888999999999999999999899999999885332 123468999999999999999998743
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
....++||||+++ +|...+. ....+++..++.++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence 3458899999986 5655554 34568999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCC-------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017270 179 FGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 179 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 251 (374)
||.++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876542211 112356788999999865 457899999999999999999999998766544443332200
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...++..++..+.++|.+||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=318.34 Aligned_cols=278 Identities=26% Similarity=0.403 Sum_probs=202.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||+|+||.||++.+..++..+|+|.+..+. ....+|+++++.++||||+++++++.. ...++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 37999999999999999999999999999999875432 223479999999999999999998843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+. ....+++..++.++.|++.||.|||+..+++||||||+||+++. ++.++|+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence 99999986 6666654 33678999999999999999999997238999999999999996 778999999998754
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.... ..+..................
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCccccc
Confidence 332 22345678899999998554 488999999999999999999999977653332 222211100000000000000
Q ss_pred CcCCCCCC----------CCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 266 YTDFRFPQ----------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 266 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
......+. .........-...++.++.+|+.+||..||++|||+.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000000 0000000000113678899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=310.35 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=198.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 47999999999999999999999999999999875321 1245689999999999999999877432 23
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++++||+++ +|.+.+. ....+++..++.++.|++.||+|||+ ++|+||||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCC
Confidence 457899999985 6666554 34568999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~----- 226 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT----- 226 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-----
Confidence 87543211 1122456888999999865 4588999999999999999999999987655444433222100
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
...++..+++.+.+|+ +||..||++||+++|+++||||+
T Consensus 227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0112234688899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.74 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+.+++.++|||++++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 588999999999999999999999999999987532 222346889999999999999999883 344689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence 99999975 676666532 24678999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+.+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 44322 2334678899999998654 478999999999999999999999988776555544433100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ .+...++..+.+++.+||+.+|++||++.++++|||+
T Consensus 219 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -------P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 0122468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.62 Aligned_cols=252 Identities=29% Similarity=0.524 Sum_probs=199.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
+|+..+.||+|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4888999999999999999999999999999885432 2334799999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 458899999996 5655554 34578999999999999999999999 79999999999999986455799999999
Q ss_pred ccccccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+........ .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-- 227 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence 876543321 123456888999999865 457899999999999999999999997654332222222110000
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
....++..+++++.+++.+||..||++||++.++++||||+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00112335788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=316.27 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. .....
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence 3478999999999999999999999999999999885432 22346889999999999999999883 33458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~ 164 (297)
T cd06656 92 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 164 (297)
T ss_pred EEeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceE
Confidence 899999986 5555443 2458899999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+.. .+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~-------- 234 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------- 234 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC--------
Confidence 443322 223467889999999855 4578999999999999999999999977654332221111 01100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
...+..+++.+.+|+.+||..||++||++.++++||||+..+.
T Consensus 235 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 235 -----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 0012347888999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=309.02 Aligned_cols=247 Identities=28% Similarity=0.472 Sum_probs=197.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
+|.+.+.||.|+||.||+|.+ .+++.+|+|.+.... ....+|+.+++.++|+||+++.+++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 588999999999999999986 578899999875332 22446999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++++|||+++ +|.+.+. ....+++..++.++.|++.||+|||+ .+|+|+||+|+||++++ ++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence 568999999986 5555554 33568999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccC-------CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 182 AKQLIAG-------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 182 a~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
+...... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8754221 11123457888999999855 44789999999999999999999999876654443333221010
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...++..++.++.++|.+||+.||.+||++.++++||||
T Consensus 227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011233578999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=339.40 Aligned_cols=282 Identities=20% Similarity=0.303 Sum_probs=198.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC-cEEEEE------------------Eeecc---ccchHHHHHHHHhcCCCcee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---RRYKNRELQLMRVMDHPNVI 88 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK------------------~~~~~---~~~~~~e~~~l~~l~h~~iv 88 (374)
.++|++++.||+|+||+||+|..+... ...+.| .+... .....+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765332 222222 11111 12235799999999999999
Q ss_pred eeceeeeecCCCCceEEEEEeecccchHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~-~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
++++++.. ....|+|++++.+++.+.+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 99998843 33488999999988777664321 112334567788999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCC-CCCC--ChHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGE--NAVD 242 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~--~~~~ 242 (374)
+. ++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |... ....
T Consensus 301 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 96 78899999999986544322 2345789999999999654 589999999999999999998754 4332 3455
Q ss_pred HHHHHHHHhCCCCHHHHhhcC---cCC-cCCCCCCCCCCChhhhc-ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 243 QLVEIIKVLGTPTREEIRCMN---PNY-TDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
.+.+++..++....+ ++... .++ ....+.... ......+ ...++.++.++|.+||++||.+|||+.|+|.|||
T Consensus 379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 666666655433221 11000 000 000000000 0011111 1246788999999999999999999999999999
Q ss_pred ccccc
Q 017270 318 FDELR 322 (374)
Q Consensus 318 ~~~~~ 322 (374)
|....
T Consensus 457 f~~~~ 461 (501)
T PHA03210 457 FSAEE 461 (501)
T ss_pred hhcCC
Confidence 98643
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.20 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=202.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+.. ...+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence 58999999999999999999999889999999886543 345579999999999999999998843 34589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|.+.+.. ....+++..++.++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence 99996 56555542 34678999999999999999999999 79999999999999996 778999999998865443
Q ss_pred C-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...........+... .
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~------------- 215 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P------------- 215 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-------------
Confidence 3 22334568889999998654 5899999999999999999999999876544332221110 0
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.+. ...+..++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 216 ---~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 ---PPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---CCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000 00122467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=306.45 Aligned_cols=248 Identities=33% Similarity=0.541 Sum_probs=201.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|+..+.||+|++|+||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 5788899999999999999998899999999875432 2344789999999999999999877 3334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+++++||+++ +|.+.+. ....+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence 58899999986 6655554 34568999999999999999999999 79999999999999996 788999999998
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.............+++.|+|||.+.....++.++|+||+||++|+|++|..||...........+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 220 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--------- 220 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence 76544433345567889999999854434789999999999999999999999876644443332221000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..++..+++.+.+|+.+||+.||.+||++.+++.|||+
T Consensus 221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01233578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.54 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+.. ...++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Confidence 458999999999999999999999999999999885432 123468999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+. ....+++..++.++.|++.|++|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEc
Confidence 99999986 6665554 34579999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCC-Ccceeeeeccccchhhhh--CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGE-ANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ......+++.|+|||.+. ....++.++|+|||||++|+|++|..||........+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----------- 225 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----------- 225 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-----------
Confidence 3322 223457889999999974 23347889999999999999999999997655433332221100
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
...+. +. ....++..+.++|.+||+.||++|||++++++|||
T Consensus 226 ------~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 ------FQPPK-----LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------CCCCc-----cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000 00 01136788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.70 Aligned_cols=246 Identities=29% Similarity=0.487 Sum_probs=199.9
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||.|++|.||+|.+..+++.+|+|.+.+.. ....+|+.+++.++|+||+++++.+. +...+++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999999999999999886432 22457899999999999999999874 334488999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
++ +|.+.+.. ...+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence 85 66666643 3568999999999999999999999 89999999999999996 778999999999876554333
Q ss_pred ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCCcCC
Q 017270 192 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269 (374)
Q Consensus 192 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 269 (374)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.... ..+...++.....
T Consensus 150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 211 (262)
T cd05572 150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------- 211 (262)
T ss_pred ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence 44567889999999854 458999999999999999999999998766 4444443332000
Q ss_pred CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
...++...++++.++|.+||+.||++||+ +.|+++||||+++.+.
T Consensus 212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 01122345889999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=325.63 Aligned_cols=237 Identities=28% Similarity=0.447 Sum_probs=201.7
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeeccc-ch
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ES 115 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~ 115 (374)
++-||+|+.|.||+++. .++.||||++.. ..+.+++-|++|+|+||+.+.+++ ....++|||||||. |-
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 67799999999999975 678999998853 345689999999999999999999 45556999999999 67
Q ss_pred HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceee
Q 017270 116 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195 (374)
Q Consensus 116 l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~ 195 (374)
|++.|+ .+.+++...+..|..+|+.|++|||. +.|||||||.-||||.. +..|||+|||.++.........++.
T Consensus 199 L~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhhhh
Confidence 888876 57789999999999999999999999 89999999999999996 7789999999999887777778899
Q ss_pred eeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCC
Q 017270 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 275 (374)
Q Consensus 196 ~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (374)
||..|||||++.. .+.+.|+|||||||+||||+||..||..-+....+- ..|
T Consensus 273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVG----------------------- 324 (904)
T KOG4721|consen 273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVG----------------------- 324 (904)
T ss_pred hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE----ecc-----------------------
Confidence 9999999999964 568999999999999999999999998766443221 111
Q ss_pred CCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 276 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
...+.-..+..+++.++=||++||+-.|..||+..++|.|==
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 112223345668889999999999999999999999998843
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.15 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=198.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++.+.. ...++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEE
Confidence 357999999999999999999999999999999885432 234579999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+. ....+++..+..++.|++.||+|||+ +||+||||+|+||+++. ++.++|+|||++...
T Consensus 83 iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceee
Confidence 99999996 5655554 34578999999999999999999999 79999999999999986 778999999999865
Q ss_pred ccCC-CcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ......+++.|+|||.+.+ ...++.++|+||+||++|+|++|..||......+....+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------ 224 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence 4322 2234567889999998742 334678999999999999999999999655433222111110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
.+..+.. .....++..+.+||++||+.||++|||++++++|+|
T Consensus 225 -----~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 -----NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000000 011246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.83 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=201.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 5899999999999999999999999999999886432 2334789999999999999999887 445569
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++|+||+.| +|...+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence 999999986 55555542 3579999999999999999999999 79999999999999996 77899999999886
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+. .+.+......
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 5544333445678889999998554 489999999999999999999999987764 2222221110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH--HHHhcCCcc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF 318 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~--~e~l~hp~~ 318 (374)
....++..++..+.++|.+||..||.+||++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011233478999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.44 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=203.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... ....+|+.+++.++|+||+++.+++ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5899999999999999999999999999999885321 2345789999999999999999987 4445689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+.+ +|.+.+.. .....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence 99999985 66666653 223468899999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....+++.|+|||.+.+. .++.++|+|||||++++|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP--------- 219 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC---------
Confidence 43322 1234578889999998654 4789999999999999999999999877766655554431 100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+..++.++.++|.+||+.||.+||++.++++||||
T Consensus 220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=308.28 Aligned_cols=263 Identities=26% Similarity=0.436 Sum_probs=203.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... ...+|+++++.++||||+++++++... ....+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 478999999999999999999999999999998864322 345799999999999999999887442 233588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~ 155 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence 99999985 6766665544456778999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 260 (374)
..... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... .+....+.. .....+
T Consensus 156 ~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~- 228 (287)
T cd06621 156 VNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL- 228 (287)
T ss_pred ccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence 33221 23456788999999854 4589999999999999999999999976521 222111111 000000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+. . .......++.+.+||.+||..||++|||+.|++.||||++...
T Consensus 229 -----------~~---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 229 -----------KD---E---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred -----------cc---C---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 00 0 0000124678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=306.04 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=202.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++.+.. ...+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEE
Confidence 358999999999999999999999999999999886542 234579999999999999999998843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 151 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQL 151 (262)
T ss_pred EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhh
Confidence 99999996 55444432 23679999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||...+.......+....-.+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 224 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------- 224 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------
Confidence 4332 22345678889999998543 2578899999999999999999999988776555443332100000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
. .......+.++.+|+.+||+.||.+|||+.+++.|||
T Consensus 225 ----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ----------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0011235788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=305.90 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=198.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|.+.+.||+|+||.||.|.+..+++.||+|.+..+. ....+|+.+++.++|+||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 47999999999999999999999999999999874321 123469999999999999999987633 223
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++++|||+++ +|.+.+. ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence 458899999985 5655554 33568899999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+.++.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT-- 226 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence 87543211 1223457888999999865 4589999999999999999999999987655544433221 110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
....+..++..+.++|.+||. +|.+||+++++++|||+.
T Consensus 227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011223467889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.92 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=204.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ....+|+.+++.++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5999999999999999999999999999999875432 23457999999999999999999984 344589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence 99999985 777766532 24578999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 4433 22345678999999998654 4789999999999999999999999887766665555431 100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.....++.++.+++.+||+.||.+||++.++++|||+
T Consensus 220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=308.86 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=198.2
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||+|+||+||+|.+..+|+.||+|.+.+.. .....|+++++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999999999999885421 1224689999999999999999888 3344589999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence 85 666555432 22468999999999999999999999 79999999999999996 778999999998765443333
Q ss_pred ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCC
Q 017270 192 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271 (374)
Q Consensus 192 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 271 (374)
....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+.+....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 212 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------ 212 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence 3456678899999986544 899999999999999999999999776542211122111000
Q ss_pred CCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 272 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
....++..+++.+.++|.+||+.||.+|| ++.++++||||..+.+..
T Consensus 213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 00112334789999999999999999999 899999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=312.34 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=203.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 37999999999999999999999999999999886432 1233688999999999999999887 33446
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+++||||++| +|.+.+. ....+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCcc
Confidence 8999999986 5655554 34578999999999999999999999 79999999999999996 7889999999986
Q ss_pred ccccCC----------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017270 184 QLIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247 (374)
Q Consensus 184 ~~~~~~----------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i 247 (374)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 321100 0112346778999999865 45899999999999999999999999887766555544
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCccccccCC
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 324 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~ 324 (374)
..... ..+. ....++.++.++|.+||+.||++||+ +.++++||||...++.
T Consensus 229 ~~~~~-----------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 229 ISDDI-----------------EWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred Hhccc-----------------CCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 33100 0000 01136889999999999999999997 7999999999876554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.59 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=202.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
+.|.....||+|+||.||++.+..+++.||||.+.... ....+|+.+++.++|+||+++++.+.. ....++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEE
Confidence 45666788999999999999999999999999875432 234478999999999999999998743 345899
Q ss_pred Eeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||++++ +.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus 97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhcc
Confidence 99999874 444332 3468999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....+..+........
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 238 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV---------- 238 (292)
T ss_pred cccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------
Confidence 322 2234567899999999854 4588999999999999999999999987766554443322111000
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+ ....++..+.+++.+||..||.+|||++++++||||.....+
T Consensus 239 ------~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 239 ------K----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ------c----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 012368899999999999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=309.27 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=190.6
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHH---hcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---VMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.||+|+||.||+|.+..+++.+|+|.+.+... ...+|..+++ ..+|++|+.+++.+.. ....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 48999999999999999999999998854321 1123333333 3479999999888833 3358899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+++ +|...+. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 999996 5544443 34679999999999999999999999 79999999999999996 78899999999875433
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||...... ..+..... .
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~------------- 213 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T------------- 213 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--c-------------
Confidence 22 223467899999999864455789999999999999999999999764321 11111110 0
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
....++..+++++.++|.+||..||.+|+ |+.++++||||+.+.+..
T Consensus 214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 00112345789999999999999999999 699999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=305.51 Aligned_cols=246 Identities=32% Similarity=0.511 Sum_probs=193.8
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccccc-------hHHHHH-HHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||.|+||.||+|.+..+++.||+|.+.+.... ...|.. +....+|+|++++++++. ....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 5799999999999999999999999988643211 122333 334558999999999883 344589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|...+. ....+++..++.++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence 99986 5655554 34578999999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
.....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------- 210 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 22345788899999986654 89999999999999999999999988776655544432100
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCccccccC
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE 323 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~ 323 (374)
.+.......+++.+.++|.+||+.||++||+ ++|+++||||++++|
T Consensus 211 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 211 ---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0111112247899999999999999999995 579999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.41 Aligned_cols=252 Identities=32% Similarity=0.534 Sum_probs=198.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ....+|+.+++.++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 6899999999999999999999899999999874211 12346889999999999999998873
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ ++++||||+|+||+++. ++.++|+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~ 150 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS 150 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence 33458899999985 56665543 3678999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCC---CcceeeeeccccchhhhhCCC-CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 178 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 178 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
|||++....... ......++..|+|||.+.... .++.++|+||||+++|+|++|..||...+......++......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 999987543221 122345688899999985443 4789999999999999999999999766554433322211000
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
..+.......++..+.++|.+||..||++|||++++++||||
T Consensus 231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000111223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.16 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=202.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++.+++... ..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence 46999999999999999999999999999999885322 1234789999999999999999988543 34
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||+.|++.+.+.. ....+++..+..++.||+.||.|||+ .|++||||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence 889999999987776653 23568999999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ....+++.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+.......+... ..+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~-------- 232 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------- 232 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC--------
Confidence 4322 23467888999998742 345788999999999999999999999877655544333221 000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.. .....+..+.++|.+||+.||++||++.+++.||||..
T Consensus 233 ----------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 233 ----------TL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----------CC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 01125778999999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.92 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=192.4
Q ss_pred ccceeeeeee--ecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~l--g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|.+.+.+ |+|+||.||++.+..+++.+|+|.+...... ..|+.....+ +|+|++++++.+.. ...+|+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~i 86 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVL 86 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEE
Confidence 3467777766 9999999999999999999999988654322 1234333323 79999999998843 335899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.+++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999985 77666653 3489999999999999999999999 7999999999999999744389999999987543
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. ....++..|+|||++.+. .++.++|+||+|+++|+|++|..||........ ...+......+
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 226 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK----------- 226 (267)
T ss_pred CC---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-----------
Confidence 22 234678899999998654 489999999999999999999999986543221 11111111000
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCcccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE 320 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~e~l~hp~~~~ 320 (374)
....+.+++.+.+||.+||+.||.+|++ .+++|+||||++
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 227 ---------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0012347999999999999999999996 599999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=306.82 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=192.0
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeeccccc-------hHHHH---HHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.||+|+||.||+|.+..+++.||+|.+.+.... ...|. .+++...||+|+.+.+.+ .....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999999999999988653211 11232 344456899999998888 334458899
Q ss_pred eecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+.|+ |...+. ....+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 9999864 444443 34679999999999999999999999 79999999999999996 78899999999875433
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhcCcC
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. .....++..|+|||.+.+...++.++|+||+||++|+|++|..||....... ....... .
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------- 213 (278)
T cd05606 150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T------------- 213 (278)
T ss_pred cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c-------------
Confidence 22 2345688999999998655458899999999999999999999997753221 1111110 0
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
. ...++..++.++.+++.+||..||.+|+ ++.++++||||+...+..
T Consensus 214 -~------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 214 -M------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred -c------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 0 0112334689999999999999999999 999999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=305.59 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=200.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+++++.++||||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 36889999999999999999999999999999886542 223478999999999999999998843 35589
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+++||++ ++|.+.+.. ....+++..++.++.|++.|++|||+..|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~ 151 (265)
T cd06605 76 ICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence 9999999 466666653 22678999999999999999999999239999999999999996 778999999998755
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...... ...++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+ ..+....+.. .+.
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----- 221 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP----- 221 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-----
Confidence 332222 26678889999998654 58999999999999999999999997652 1122222111 000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+. .+. .++.++.++|.+||..||.+|||+.+++.||||+.+
T Consensus 222 -----------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -----------PR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----------CC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 111 268899999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=301.06 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=201.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||.|+||.||++.+..+|..+|+|.+... .....+|+.+++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 589999999999999999999999999999988543 22345799999999999999999887 3444589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999985 66666543 223458999999999999999999999 799999999999999874456899999998765
Q ss_pred ccCCCc-ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...... ....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF------------ 219 (257)
T ss_pred cCCcccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC------------
Confidence 433221 23457888999998854 3588999999999999999999999987765555443332100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ .....++..+.++|.+||..+|++|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 -------A---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------C---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=314.85 Aligned_cols=282 Identities=31% Similarity=0.526 Sum_probs=227.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcC------CCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD------HPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~ 100 (374)
...+|.+....|.|-|++|..|.+..-|+.||||++.... ....+|+++|+.|+ --|++.++..| .
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----K 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----h
Confidence 3458999999999999999999999999999999997664 33458999999995 34788888888 5
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...++|+|||-+.-+|.++|+.+.. +-.+....++.|+.||+.||..|.. .||+|.||||+||||+.....+||||||
T Consensus 505 hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCc
Confidence 5566999999999999999998754 4568889999999999999999999 6999999999999999888899999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
.|....... ...+..+..|+|||+++|-. |+...|+||.||.||||.||+..|++.++..++...++.-|..+...+.
T Consensus 583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 583 SASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 998654433 34566788899999999865 9999999999999999999999999999999999999999988877665
Q ss_pred hc-------CcCCc--CCCCCCCCC-------------CChhhhcc--cCCC-------hhHHHHHHhhcCcCCCCCCCH
Q 017270 261 CM-------NPNYT--DFRFPQIKA-------------HPWHKVFH--KRMP-------PEAIDLASRLLQYSPSLRCTA 309 (374)
Q Consensus 261 ~~-------~~~~~--~~~~~~~~~-------------~~~~~~~~--~~~~-------~~~~~li~~~L~~dp~~R~s~ 309 (374)
.- +.++. ......+.. ..+...+. ++++ ..+++|+.+||..||++|+|+
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 31 11111 111111100 11111111 1122 368999999999999999999
Q ss_pred HHHhcCCcccc
Q 017270 310 LEACAHPFFDE 320 (374)
Q Consensus 310 ~e~l~hp~~~~ 320 (374)
.++|.||||..
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999974
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.84 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=200.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence 46888899999999999999999999999999875332 23457999999999999999999883 344589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+. ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccc
Confidence 99999996 5544443 3568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~----------- 217 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S----------- 217 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C-----------
Confidence 43322 1234568889999998654 5889999999999999999999999765544332221110 0
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...+...++..+.++|.+||+.||++||++.++++||||..+.
T Consensus 218 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 218 ---------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ---------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 0011234678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.77 Aligned_cols=240 Identities=17% Similarity=0.193 Sum_probs=192.4
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
..||+|++|.||+|.. +|+.||||.+.... ....+|+.++++++||||+++++++.+.. .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999987 78999999886432 22348999999999999999999885422 22345889999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
|+.+ +|.+.+. ....+++.....++.|++.||.|||+..+++||||||+||+++. ++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSPP 177 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhcccc
Confidence 9996 5666654 34578899999999999999999997238999999999999996 7889999999987643322
Q ss_pred CcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 190 ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 190 ~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
....+++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------------- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Confidence 245678899999998542 4589999999999999999999999998876666655543211110
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
++...++++.+|+.+||+.||++|||+.++++
T Consensus 243 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 --------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12246889999999999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.37 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 35799999999999999999986544 3579999886432 2234799999999 8999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
....+++|||||.+ +|.+.+.....
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 33458899999984 67766643211
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcc
Q 017270 126 -------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 192 (374)
Q Consensus 126 -------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~ 192 (374)
...++++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCccee
Confidence 12357889999999999999999999 79999999999999995 7889999999997654332111
Q ss_pred ---eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 193 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 193 ---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |..||........+..++.....+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-------------- 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-------------- 334 (374)
T ss_pred eccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------
Confidence 1223567999999864 458999999999999999997 999998765544443333310000
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+++++.+++.+||+.||.+|||+.++++
T Consensus 335 -------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.47 Aligned_cols=250 Identities=29% Similarity=0.469 Sum_probs=206.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||.|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+|++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 5899999999999999999999999999999886432 234578999999999999999998843 24588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+|++++ +|.+.+.........+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence 99999986 7777776544345789999999999999999999999 79999999999999996 788999999999765
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 220 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------ 220 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence 4433 22345678899999998554 488999999999999999999999987765544444332100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ .++..++..+.+++.+||..||++|||+.++|+||||
T Consensus 221 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 -------P---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=299.74 Aligned_cols=292 Identities=33% Similarity=0.569 Sum_probs=228.7
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.+|-+.-+.+--+.||-|+||+||.+.+..+|+.||+|++..- .....+|+++|..++|.|++...+......-
T Consensus 47 h~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 47 HPPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CCccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3444555677789999999999999999999999999998542 2334589999999999999998876633222
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
..-..+|+++|++..+|..++ .....++...++-+++||++||+|||+ .+|.||||||.|+|+++ +..+|||||
T Consensus 127 dfFqEiYV~TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDF 200 (449)
T KOG0664|consen 127 SFFQELYVLTELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDF 200 (449)
T ss_pred hHHHHHHHHHHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEeccc
Confidence 112236788888887665554 367789999999999999999999999 79999999999999997 899999999
Q ss_pred ccccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 180 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 180 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|+++....... ....+.|.+|+|||++.|...|+.+.||||.|||+.||+-.+..|...+..+++..|.+.+|+|..+
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 99986443332 2234568999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhhcCcCCcCCCCCCC-CCCChhhhc----ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 258 EIRCMNPNYTDFRFPQI-KAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.....-+.-....+..- +...+...+ +..-..+..+++.++|.+||.+|++.++++.|++..+.+.
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 77643222111111110 011111111 1133457889999999999999999999999999987544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.29 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=223.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.+..++..||-|+||.|=++........+|+|++.+.. .....|..+|...+.|.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 46788899999999999998876555568999775432 2334689999999999999999998 77788
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|++||-|-| .++..++ ..+.|.+..++.|+..++.|++|||+ +||++|||||+|++++. ++-+||.|||+|+
T Consensus 495 vYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFAK 568 (732)
T ss_pred hhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhHH
Confidence 9999999975 6777766 46789999999999999999999999 89999999999999996 8889999999999
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
....+....+++|||.|.|||+++... .+.++|.||||+++|||++|.+||.+.+.+..+..|++.+...
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------- 638 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------- 638 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence 999999999999999999999998654 7999999999999999999999999999999999998843211
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCCCC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA 326 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~~ 326 (374)
. |+.+++..+.+||+++-..+|.+|.. +.+|.+|-||.+.+|...
T Consensus 639 ------~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 639 ------E------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred ------h------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 1 44578999999999999999999985 789999999999988753
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.82 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=201.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|||++++++++.. ....++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEE
Confidence 34556668999999999999999899999999885322 233478899999999999999998843 345889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ +|...+. ...+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++....
T Consensus 96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence 9999996 4444332 2568999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+.+..+... +.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~---------- 234 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP---------- 234 (297)
T ss_pred cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC----------
Confidence 322 22345678999999998654 5899999999999999999999999877655544332210 00
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+ . ......+++.+.++|.+||+.||.+||++.++++||||.+...+
T Consensus 235 ------~-----~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 235 ------P-----K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred ------C-----C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 0 0 00112468899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.83 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=201.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..|...+.||.|+||.||.|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 46888999999999999999999999999999876432 12347899999999999999999884 344599
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||++| +|.+.+. ..++++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06640 79 IIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceec
Confidence 99999986 5655553 2468999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.. +.+
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~---------- 218 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP---------- 218 (277)
T ss_pred cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC----------
Confidence 43322 2234568889999998654 479999999999999999999999987665443322211 000
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+...++..+.+++.+||+.||++||++.++++||||...
T Consensus 219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ----------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 01122467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.57 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=198.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+ .+...+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 5899999999999999999999999999999875322 2334688999999999999999988 34445899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence 9999985 66665543 234568999999999999999999999 79999999999999996 7889999999987654
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.... .....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+.......+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 218 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------ 218 (255)
T ss_pred ccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------
Confidence 3322 234567889999999855 45899999999999999999999999887765555444321000
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.++..++..+.+||.+||+.||++|||+.++++-
T Consensus 219 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ----------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0123468899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=299.17 Aligned_cols=251 Identities=33% Similarity=0.519 Sum_probs=204.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ....+|+..+..++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 36899999999999999999999999999999886543 23457899999999999999999884 335589
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~-~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+||||++ ++|.+.+.. ...+++..++.++.|++.|+.|||+ . +++||||+|+||+++. ++.++|+|||.+..
T Consensus 76 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~ 149 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKV 149 (264)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCcccee
Confidence 9999999 466666653 3679999999999999999999998 6 9999999999999996 78899999999886
Q ss_pred cccCCCcc-eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 260 (374)
........ ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+ ..+....+... ..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~----- 220 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PP----- 220 (264)
T ss_pred cccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CC-----
Confidence 65433332 4567889999999855 458899999999999999999999998774 22222222210 00
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+ .+... ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus 221 -----------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 -----------P---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred -----------C---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 0 01223 688999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=307.46 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=191.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 89 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~ 89 (374)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3589999999999999999998532 34479999886432 22447999999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017270 90 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS---------------ANQRMPLIYVKLYTYQIFRGLAYIHTVP 153 (374)
Q Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~---------------~~~~l~~~~~~~i~~qll~al~~LH~~~ 153 (374)
+++++... ...++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~ 157 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L 157 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence 99988432 348899999985 67766653211 12347888899999999999999999 7
Q ss_pred CeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh
Q 017270 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 230 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 230 (374)
||+||||||+|||++. ++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 9999999999999996 788999999999765333211 122346789999998654 58999999999999999986
Q ss_pred --CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017270 231 --GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 308 (374)
Q Consensus 231 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 308 (374)
+..||...+..+.+..+......... ......+..+++.+.+|+.+||+.||.+|||
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGR---------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccc---------------------cccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 66888877665555443331110000 0000012346889999999999999999999
Q ss_pred HHHHh
Q 017270 309 ALEAC 313 (374)
Q Consensus 309 ~~e~l 313 (374)
+.++.
T Consensus 295 ~~~i~ 299 (304)
T cd05096 295 FSDIH 299 (304)
T ss_pred HHHHH
Confidence 99984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.42 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=202.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|.+.+.||+|+||+||++.+..++..||+|.+.... ....+|+.+++.++|||++++++.+.. ....
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~ 91 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDEL 91 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcE
Confidence 3579999999999999999999998899999999885432 223468889999999999999998843 3348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|+||+++ +|.+.+. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~ 164 (293)
T cd06647 92 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 164 (293)
T ss_pred EEEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceec
Confidence 899999986 5555543 2457889999999999999999999 79999999999999996 77899999998875
Q ss_pred cccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+.+..+.. .+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~-------- 234 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------- 234 (293)
T ss_pred ccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC--------
Confidence 543322 223457888999999855 4578999999999999999999999987665433322111 00000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...+..++..+.++|.+||..||++||++++++.||||+..+
T Consensus 235 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 -----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001224678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=299.28 Aligned_cols=247 Identities=29% Similarity=0.481 Sum_probs=192.3
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
...||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. .....++|+||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecC
Confidence 357999999999999999999999999875432 23457999999999999999998873 334588999999
Q ss_pred cc-hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 113 PE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l--~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
++ +|...+... ...+ ++..+..++.||+.||.|||+ +||+||||||+||+++.+.+.++|+|||++.......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 85 666666531 2334 788889999999999999999 7999999999999998656789999999987543322
Q ss_pred C-cceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 190 A-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 190 ~-~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.................
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------- 228 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence 2 2234578899999998543 3478999999999999999999999976433221110000000
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
....++..+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.81 Aligned_cols=278 Identities=20% Similarity=0.304 Sum_probs=196.8
Q ss_pred eeeecC--CCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
..||.| +||+||+|++..+|+.||+|++.... ....+|+.+++.++||||++++++|.. ....++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456666 99999999999999999999885432 233568888888999999999999843 34589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ ++.+.+... ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhcc
Confidence 99995 666666543 23458999999999999999999999 79999999999999996 778999999865432211
Q ss_pred CCc--------ceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 017270 189 EAN--------ISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 257 (374)
Q Consensus 189 ~~~--------~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 257 (374)
... ....++..|+|||++.+. ..++.++||||+||++|+|++|..||...................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 011235569999998653 347899999999999999999999998876655444333211100000
Q ss_pred -------HHhhcCcCCc----CCCCC-----CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 258 -------EIRCMNPNYT----DFRFP-----QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 258 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
........+. +.... ......+.......+++.+.+||++||+.||++|||++++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 00000 0000111111223467889999999999999999999999999999887
Q ss_pred cCC
Q 017270 322 REP 324 (374)
Q Consensus 322 ~~~ 324 (374)
...
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.02 Aligned_cols=265 Identities=28% Similarity=0.458 Sum_probs=208.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|..++.||-|+||.|.++....|...||+|.+.+... ....|..||..-+++-||++|..| ++...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 57889999999999999999999999999998865432 234688999999999999999999 555569
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||+|++| ++..+|. .-+-|.|..+++|+.+|.+|+++.|.+ |+|||||||+|||||. +|.|||+|||++.-
T Consensus 705 YFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDr-dGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEcc-CCceeeeecccccc
Confidence 999999996 5555554 357799999999999999999999995 9999999999999996 78899999999852
Q ss_pred cc---------cC-----------------CC-----------------cceeeeeccccchhhhhCCCCCCCchhhHhH
Q 017270 185 LI---------AG-----------------EA-----------------NISYICSRFYRAPELIFGATEYTTSIDIWSA 221 (374)
Q Consensus 185 ~~---------~~-----------------~~-----------------~~~~~~t~~y~aPE~l~~~~~~~~~~Diwsl 221 (374)
+. .+ .. .-+.+||+.|+|||++.. ..|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHh
Confidence 21 00 00 013478999999999965 459999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCc
Q 017270 222 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 301 (374)
Q Consensus 222 Gvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 301 (374)
|||||||+.|++||......+...++++. . ++ ++-.+..+++.++.+||.++.+
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw---------~----~~------------l~~~~~~~ls~e~~~li~kLc~- 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINW---------R----NF------------LHIPYQGNLSKEALDLIQKLCC- 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeeh---------h----hc------------cccccccccCHHHHHHHHHHhc-
Confidence 99999999999999887766554444331 0 00 1111234789999999998765
Q ss_pred CCCCCC---CHHHHhcCCccccccCCCCCCCCCCCCC
Q 017270 302 SPSLRC---TALEACAHPFFDELREPNARLPNGRPLP 335 (374)
Q Consensus 302 dp~~R~---s~~e~l~hp~~~~~~~~~~~~~~~~~~~ 335 (374)
+++.|. .++++..||||+.+.+...+......+|
T Consensus 912 sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP 948 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIP 948 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccchHhhhhccCCcCc
Confidence 788998 4788999999999887664433333333
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=305.44 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=202.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|...+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++|+|++++++++.+ ....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 4777788999999999999999999999999885432 123468899999999999999998844 3448
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||+.+++.+.+.. ....+++..+..++.||+.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~ 171 (313)
T cd06633 97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASKS 171 (313)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCccc
Confidence 89999999987777653 34568999999999999999999999 79999999999999996 778999999998643
Q ss_pred ccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.. .....++..|+|||.+.. ...++.++|+|||||++|+|++|..||...+.......+... ..+
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~--------- 238 (313)
T cd06633 172 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP--------- 238 (313)
T ss_pred CC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC---------
Confidence 22 224567889999999742 245788999999999999999999999887766555544321 000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
. ......+..+++|+.+||+.||.+||++.+++.||||+..
T Consensus 239 ---------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ---------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ---------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 0112357789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=305.04 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=198.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEE
Confidence 358999999999999999999999999999999875432 233479999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+++ +|...+. ..+.+++..++.++.|++.||.|||+.++++||||+|+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence 999999996 4544443 34578999999999999999999996348999999999999996 78899999999865
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHH
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-------LVEIIKVLGTPTRE 257 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~ 257 (374)
..... .....++..|+|||++.+. .++.++|+||+||++|+|++|..||........ +...........
T Consensus 154 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd06620 154 LINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-- 229 (284)
T ss_pred hhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence 43222 2245678899999998654 588999999999999999999999986543210 111111000000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+.+ ....++..+.+|+.+||+.||.+|||++|+++||||..
T Consensus 230 -------------~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 -------------PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -------------CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 00126788999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=300.03 Aligned_cols=245 Identities=20% Similarity=0.232 Sum_probs=192.0
Q ss_pred ccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence 357999999999999999999865 346789999886442 223478999999999999999998843 3
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++||||++++ |.+.+.. ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence 3488999999974 5444442 23578999999999999999999999 79999999999999996 78899999998
Q ss_pred ccccccCCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 182 AKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 182 a~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
+.......... ...++..|+|||.+.+ ..++.++||||+||++|++++ |..||......+.+..+.+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---- 228 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---- 228 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC----
Confidence 76432221111 2234567999999865 458999999999999999775 999998877666555443211100
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..++..+.+++.+||+.||.+||+++++++
T Consensus 229 ------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 12347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=298.98 Aligned_cols=250 Identities=29% Similarity=0.520 Sum_probs=197.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.+++.++|+||+++++.+ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 68999999999999999999988999999998865432 334799999999999999999877 3344588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||+.+ +|.+.+. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence 99999985 5555544 34568899999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCCcc-----eeeeeccccchhhhhCCC--CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 186 IAGEANI-----SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 186 ~~~~~~~-----~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
....... ...+++.|+|||.+.+.. .++.++||||+|+++|+|++|..||...+........... +...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4332211 235678899999985432 3789999999999999999999999765432222211111 1000
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
.++. ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0110 11358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=314.96 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=192.0
Q ss_pred ccceeeeeeeecCCCceEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||+||+|.+ ..++..||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 34899999999999999999974 3456789999885432 2234799999999 8999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
.....++|||||++ +|.+.+.....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 33348899999984 67766653210
Q ss_pred ------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 126 ------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 126 ------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccC
Confidence 12357888999999999999999999 79999999999999996 77899999999976543
Q ss_pred CCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 188 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 188 ~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+.+.+.....+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------- 336 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------- 336 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---------
Confidence 3221 112235679999998654 58999999999999999998 899998765544444333310000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...+.++.+|+.+||+.||++|||+.++++.
T Consensus 337 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 ------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0112357899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=302.53 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=200.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcC---CCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ |||++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 5888999999999999999999999999999875431 23457888998886 999999999874 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++||||+.+ +|.+.+. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 8899999986 5555443 2378999999999999999999999 79999999999999996 7889999999987
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
....... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 6544332 233467889999999865555789999999999999999999999876543322211110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+.+ ....++.++.+++.+||+.||.+||++.+++.||||++..
T Consensus 218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000 0112678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=304.72 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=200.8
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
+...++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.++... +|+||+++++++. .
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~ 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----T 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----c
Confidence 3455789999999999999999999998899999999864321 122455555555 5999999999884 3
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...+|++|||+++.+...+.. ....+++..+..++.|++.|+.|||+.+||+||||+|+||+++. ++.+||+|||+
T Consensus 86 ~~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~ 161 (296)
T cd06618 86 DSDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGI 161 (296)
T ss_pred CCeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECcccc
Confidence 345899999998876666543 23578999999999999999999996249999999999999995 78899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCC---CCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 257 (374)
+.............+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+.+..+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~--- 237 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PP--- 237 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CC---
Confidence 8765443333334567889999998543 2378899999999999999999999976432 23333222210 00
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
..+ ....+++++.+|+.+||..||.+||++++++.||||...+.
T Consensus 238 ------------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 238 ------------SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred ------------CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 000 01136889999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=301.13 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=199.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
-|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. ....+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4788899999999999999999999999999875332 23447899999999999999999883 3345889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ ++.+.+. ...+++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecc
Confidence 9999996 5554443 2468999999999999999999999 89999999999999996 7789999999987554
Q ss_pred cCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+... ..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------ 218 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------ 218 (277)
T ss_pred cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence 3321 223457888999999854 45788999999999999999999999876654443332210 00
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+...++.++.+++.+||+.||.+||++.++++||||.+.
T Consensus 219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00223468899999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.62 Aligned_cols=249 Identities=28% Similarity=0.495 Sum_probs=199.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47999999999999999999999999999999874321 1234689999999999999999887432 22
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++++||+++ +|.+.+. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence 357899999985 5655554 33568899999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccC----CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-- 226 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence 9764321 111234578899999998654 478999999999999999999999987665544433321 111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...++..+++.+.++|.+||. +|.+||++.++++|||.
T Consensus 227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 111344688999999999999 57999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=299.05 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=196.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 58999999999999999999999999999999774321 123469999999999999999998843 234
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++|+||+++ +|...+.........+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 8899999995 6766666544455668999999999999999999999 79999999999999996 7789999999987
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhh
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 261 (374)
....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ...+...+...+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543222 1234578889999998654 478999999999999999999999965432 122222222111111
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
......+..+.+++.+||+.||++||++.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011236788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.14 Aligned_cols=258 Identities=25% Similarity=0.328 Sum_probs=199.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 35689999999999999999997652 345799998754321 2346888999999999999999873
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC
Q 017270 100 KNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172 (374)
Q Consensus 100 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~ 172 (374)
.....++||||++ |+|.+.+...... ...++...+..++.|++.||.|||+ ++|+||||||+||+++. ++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~ 156 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DF 156 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CC
Confidence 2334889999998 5777777643211 2345677889999999999999999 79999999999999996 78
Q ss_pred cEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017270 173 QVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 248 (374)
Q Consensus 173 ~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 248 (374)
.++|+|||+++........ ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999998754332211 12234567999999854 458999999999999999998 789998877655444333
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCcccccc
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR 322 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~------hp~~~~~~ 322 (374)
.. +.+ ..+...++.+.+++.+||+.||.+|||+.++++ ||||..+.
T Consensus 236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 000 012246789999999999999999999999986 99998765
Q ss_pred C
Q 017270 323 E 323 (374)
Q Consensus 323 ~ 323 (374)
+
T Consensus 288 ~ 288 (288)
T cd05061 288 F 288 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.10 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=202.0
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.|.-.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+|++++++.+.. ....+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence 4566679999999999999999899999999875322 223578899999999999999998743 3348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
+||+.+ +|.+.+.. .++++..++.++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence 999985 56555542 568999999999999999999999 79999999999999996 78899999998865433
Q ss_pred CC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017270 188 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266 (374)
Q Consensus 188 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 266 (374)
.. ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... ..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 234 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK----------- 234 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence 22 22335678899999998654 4899999999999999999999999877665555443321 0000
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. .....++..+.+|+.+||+.||++|||+.++++||||++.+.+
T Consensus 235 -------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 235 -------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred -------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 0 0112368899999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=302.37 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=197.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC-----cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~----- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT----- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----
Confidence 358999999999999999999976555 679999885432 22357999999999999999999873
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
.....|++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~ 157 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLV 157 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEE
Confidence 33348899999985 67766654211 11568899999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 243 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 243 (374)
+. ++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 158 ~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 77899999999875433221 223455788999999855 458999999999999999998 9999988776655
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 244 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+.+.... ..+..+++++.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5444331000 0123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.13 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=196.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|.+.+.||+|+||.||+|.+..+++.+|+|.+..+.. ...+|+.+++.++|+||+++++++. ....++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence 469999999999999999999999999999998865432 2347999999999999999999873 33348899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+++ +|.+.+.. .....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence 999975 66666643 123568999999999999999999999 79999999999999986 78899999999876543
Q ss_pred CCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... ....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------ 223 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------ 223 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence 32211 1223567999999854 458999999999999999998 9999988776555444332100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..++.++.+++.+||+.||++|||+.++++
T Consensus 224 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ----------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0122457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=318.53 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=203.8
Q ss_pred cce-eeeeeeecCCCceEEEEEECCCCcEEEEEEe-----ecc---ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~-----~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
++| +....||+|+|-+||+|.+..+|..||--.+ .+. ......|+.+|+.|+|+|||+++..+.+...
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--- 115 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--- 115 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence 455 5577999999999999999999999884322 222 2455689999999999999999998866443
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..+.+|+|++. |+|...+ ...+++....++.|+.||+.||.|||++ .-|+|||||-+||+|+...|.|||+|+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred ceeeeeeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 56889999998 5554444 4567788999999999999999999993 3599999999999999888999999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
+|........ .+.+|||.|||||++. ..|+..+||||||+.+.||+|+..||.......++++-+.. |..+ ..
T Consensus 192 LAtl~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP-~s-- 264 (632)
T KOG0584|consen 192 LATLLRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKP-AA-- 264 (632)
T ss_pred HHHHhhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCH-HH--
Confidence 9986544333 3489999999999984 46999999999999999999999999887666555544332 2221 11
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
|.+--++++++||.+||.. .+.|+|+.|+|.||||..
T Consensus 265 ----------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 265 ----------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ----------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1122378999999999999 999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.42 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=204.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++.+++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 5899999999999999999999999999999885432 123468899999999999999988843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 99999975 6777766544445779999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+....
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------------- 217 (256)
T ss_pred ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 444 3334567889999999865 457889999999999999999999998877654443332210
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
++. .....+.++++++.+||+.||.+|||+.++++||++
T Consensus 218 -----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -----YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 010 112468899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=298.89 Aligned_cols=249 Identities=26% Similarity=0.484 Sum_probs=198.2
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.+.+.||+|+||.||++++..++..+++|.+... ......|+.+++.++||||+++++.+.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 589999999999999999999888777777655321 1123468889999999999999988743 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++ +|...+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++. +.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCce
Confidence 48899999985 6666666555556789999999999999999999999 79999999999999973 56999999998
Q ss_pred cccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.. +..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~------- 222 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT------- 222 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-------
Confidence 76543322 223456888999999854 4478899999999999999999999987665444443322 000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ .++..++.++.++|.+||..||++||++.++++||||
T Consensus 223 ----------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 ----------P---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------C---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=298.31 Aligned_cols=245 Identities=33% Similarity=0.561 Sum_probs=197.6
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||.|+||.||+|++..+|+.+|+|.+..... ...+|+.+++.++|+||+++++.+ ......|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999998865432 334688999999999999998877 3445589999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC--
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-- 189 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-- 189 (374)
.+ +|.+.+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence 85 66666653 3478999999999999999999999 79999999999999996 7789999999987543331
Q ss_pred -------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 190 -------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 190 -------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+.. +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GK--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC---------
Confidence 112345678899999986544 78999999999999999999999988776655544433 00
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCccccccC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE 323 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~---~e~l~hp~~~~~~~ 323 (374)
...+. ...++..+.+|+.+||+.||.+|||+ .++++||||+++.|
T Consensus 218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 00111 01248899999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=324.86 Aligned_cols=280 Identities=20% Similarity=0.260 Sum_probs=185.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCC----CcEEEEEEeeccccchHHHHHHHH---hcCCCceeeeceeeeecCC-CC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMR---VMDHPNVISLKHCFFSTTS-KN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~-~~ 101 (374)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++..... .|..+.. ...+.++..+...+..... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 457899999999999999999999988 89999998754322 2222222 2233334443333322111 34
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh----------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
...+++|+||+++ +|.+.+..... .........++.++.||+.||+|||+ ++|+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 4458899999985 56666643110 01112345577899999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCC--CcceeeeeccccchhhhhCCC---------------------CCCCchhhHhH
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWSA 221 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~---------------------~~~~~~Diwsl 221 (374)
||++.+++.+||+|||+|+...... ......+++.|+|||.+.... .+..++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9998656789999999997553322 223567899999999763221 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhh--hcccCCChhHHHHHHhhc
Q 017270 222 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK--VFHKRMPPEAIDLASRLL 299 (374)
Q Consensus 222 Gvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L 299 (374)
||++|||+++..++ .+....+..++...+... ..|....... ....+.. ...+..+....|||.+||
T Consensus 366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999876554 333444444444333322 2221111000 0000000 011123456779999999
Q ss_pred CcCCCCCCCHHHHhcCCccccccCC
Q 017270 300 QYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 300 ~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
++||.+|||+.++|+||||+.....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999999875543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=300.56 Aligned_cols=246 Identities=33% Similarity=0.594 Sum_probs=201.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcC-CCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 103 (374)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|..+++.++ |+||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 47999999999999999999999999999999886421 22346888999998 99999999988 3444
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++|||++. ++|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence 5899999995 577666653 3479999999999999999999999 79999999999999996 778999999998
Q ss_pred cccccCCC---------------------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH
Q 017270 183 KQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241 (374)
Q Consensus 183 ~~~~~~~~---------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 241 (374)
........ .....++..|+|||.+.+ ..++.++|+||||++++++++|..||...+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 75433221 122356788999999854 44889999999999999999999999988765
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCc
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPF 317 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~ 317 (374)
..+..+... .+ .++..+++.+.+||.+||+.||.+|||+ +++++|||
T Consensus 229 ~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 229 LTFQKILKL-----------------EY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHHhc-----------------CC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 555444321 01 1223468899999999999999999999 99999999
Q ss_pred c
Q 017270 318 F 318 (374)
Q Consensus 318 ~ 318 (374)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.15 Aligned_cols=248 Identities=30% Similarity=0.444 Sum_probs=202.7
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.|...+.||+|+||.||+|++..++..+|+|.+..... ...+|+.+++.++|+|++++++++.. ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 48899999999999999999999999999998864321 23468999999999999999998843 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+.|++.+.+.. ...++++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence 89999999987776653 34568999999999999999999999 79999999999999986 778999999998654
Q ss_pred ccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.. .....+++.|+|||.+.+ ...++.++|+||+||++|+|++|..||...+....+..+......+.
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 244 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-------- 244 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--------
Confidence 32 223467888999999742 23478999999999999999999999988766665555444211000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.....++.+.+++.+||+.||.+||++.++++|||+..
T Consensus 245 -------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 -------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01236788999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=305.94 Aligned_cols=276 Identities=21% Similarity=0.297 Sum_probs=195.3
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|.+.+.+| ++|.||.+++..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 4 ~~i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 76 (314)
T cd08216 4 TLIGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV 76 (314)
T ss_pred hhhhHhhc--CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence 33444444 44566777777799999999986441 234579999999999999999998843 344889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+++ ++.+.+... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeec
Confidence 9999995 566665532 23468999999999999999999999 79999999999999995 7889999999886543
Q ss_pred cCCC--------cceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 187 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 187 ~~~~--------~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
.... .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||........+..... +... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~-~ 229 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVP-C 229 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCc-c
Confidence 2221 1223457789999998543 3478999999999999999999999987665443322221 1110 0
Q ss_pred HHhh-----cCcCCcC----CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 258 EIRC-----MNPNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 258 ~~~~-----~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.+.. ....... ...+ .............++.++.+|+.+||++||++|||++++|+||||+.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred ccccCchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 0000 0000000 0000 001111122223456789999999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=302.17 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=200.8
Q ss_pred ceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
+|++.+.||.|+||.||+|++. .+|+.||+|.+.... ....+|+.+++.+ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999875 478999999885421 2234689999999 589999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+||||+++ +|.+.+. ....+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence 44568899999995 5655554 34578999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCC--CcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 180 GSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 180 g~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
|++....... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.+.....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 9987654322 12245678899999998543 246789999999999999999999997543322222222211000
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 325 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~ 325 (374)
...++..+++.+.+++.+||+.||.+|+ ++++++.||||+..++..
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 0002234788999999999999999997 899999999999887643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=304.77 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=192.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcE--EEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ....+|+.++..+ +|+||+++++++ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 346899999999999999999998877764 5777664321 1234689999999 899999999988 33
Q ss_pred ceEEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 168 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~ 168 (374)
...+|+||||+++ +|.+.+.... .....+++..++.++.||+.|++|||+ +|++||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 158 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence 4458999999984 6777665422 112468999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017270 169 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 247 (374)
Q Consensus 169 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 247 (374)
. ++.+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred C-CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 6 77899999999864322111112233567999999854 458999999999999999998 99999877655444332
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.... . ...+..+++++.+|+.+||+.||++||++++++.+
T Consensus 237 ~~~~------------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGY------------------R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCC------------------c----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1100 0 00112368899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=291.29 Aligned_cols=248 Identities=30% Similarity=0.496 Sum_probs=201.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
+|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|++++++.+++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence 4889999999999999999999899999999886544 344579999999999999999998843 3458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
+||+++ +|.+.+.. ....+++..++.++.|++.||++||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence 999995 66655543 22578999999999999999999999 79999999999999996 78899999999876654
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. ...+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~------------ 216 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPG------------ 216 (253)
T ss_pred cccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCC------------
Confidence 4323455678899999998654 478999999999999999999999987754444333222 00000
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
.+ ....++..+.++|.+||+.||++|||+.+++.|||
T Consensus 217 ---~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 ---LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 01124789999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=308.63 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=192.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||.||+|.... +++.||+|++.... ....+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 3489999999999999999997543 45789999885432 1234688999999 799999999877432
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
...++++|||+++ +|.+.+.....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 2347899999985 66666543211
Q ss_pred ----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeec
Q 017270 126 ----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSR 198 (374)
Q Consensus 126 ----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~ 198 (374)
....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........ .....++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12368999999999999999999999 79999999999999996 77899999999986543321 11234466
Q ss_pred cccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCC
Q 017270 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 277 (374)
Q Consensus 199 ~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (374)
.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.....+
T Consensus 240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 295 (337)
T cd05054 240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM----------------------- 295 (337)
T ss_pred cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-----------------------
Confidence 79999998654 58999999999999999998 999998755444333332210000
Q ss_pred ChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 278 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 278 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++++.+++.+||+.+|++||+++++++|
T Consensus 296 ----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ----RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.99 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=196.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 4579999999999999999998753 36789999885432 2345799999999999999999988443
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~----------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
...++||||+++ +|.+.+.... .....+++..+..++.|++.|++|||+ +|++||||||+||+++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence 448999999985 6666665421 123558899999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017270 170 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 245 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 245 (374)
++.++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+...
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 78899999999875432221 1233456789999998654 58999999999999999998 999998877665544
Q ss_pred HHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 246 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+... .. ...+..++..+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43321 00 0012347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.27 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=202.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..|...+.||.|+||.||+|++..+++.+|+|.+.... ....+|+.+++.++|+|++++.+++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 46888999999999999999999999999999885321 123468999999999999999998844 334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||+.+++...+.. ....+++..++.++.|++.|+.|||+ ++++||||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~ 164 (308)
T cd06634 90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 164 (308)
T ss_pred eEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCccccee
Confidence 889999999887766643 34568999999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+.... .+.
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~------- 233 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA------- 233 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCC-------
Confidence 4332 23467889999999752 2347889999999999999999999997766554444333210 000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
......+..+.+||.+||+.+|.+||+++++++|||+...
T Consensus 234 -------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0112467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.03 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=199.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.|.....||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+|++++++.+.. ....++|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEE
Confidence 3444578999999999999999999999999874322 223468899999999999999998843 3458899
Q ss_pred eecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||++++ |.+.+. ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceeccc
Confidence 9999874 444332 3468999999999999999999999 79999999999999996 77899999999875543
Q ss_pred CC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017270 188 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266 (374)
Q Consensus 188 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 266 (374)
.. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.........+.......
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------ 235 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------ 235 (292)
T ss_pred ccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc------------
Confidence 22 2233567889999998854 457899999999999999999999998876655444332211000
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+. ....+++.+.+++.+||+.||.+||++.+++.||||.....
T Consensus 236 ----~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 236 ----LK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ----cC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00 11236889999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.87 Aligned_cols=142 Identities=23% Similarity=0.381 Sum_probs=122.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|.+.+.||.|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||++++.++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 568999999999999999999999999999999986532 3345788999999999999998877 3334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence 58999999975 66666643 3568999999999999999999999 79999999999999996 788999999987
Q ss_pred c
Q 017270 183 K 183 (374)
Q Consensus 183 ~ 183 (374)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.21 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=193.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 45689999999999999999998652 356799998754321 234688999999999999999887
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~ 172 (374)
......++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CC
Confidence 333458899999985 676666532211 2346778889999999999999999 79999999999999996 78
Q ss_pred cEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017270 173 QVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 248 (374)
Q Consensus 173 ~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 248 (374)
.++|+|||++......... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999998754332211 12234678999999865 448999999999999999999 789998877655554433
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.. +.+ ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 31 000 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=328.89 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=192.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||.||+|.+..+++.||+|++..+. ....+|+.+++.++||||+++++++. +...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 58999999999999999999999999999999886432 22347999999999999999998873 3345
Q ss_pred EEEEeecccc-hHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
.|+||||++| +|.+.+..... ....++...+..++.||+.||+|||+ +||+||||||+||+++. ++.++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence 8899999986 66666653211 12345677788999999999999999 79999999999999996 778999
Q ss_pred EeeccccccccCC-------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCC
Q 017270 177 CDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237 (374)
Q Consensus 177 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 237 (374)
+|||++....... ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 01124689999999998654 489999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+....... .....+.. . . -...+++.+.+++.+||+.||++|++..+.+.+
T Consensus 234 ~~~~ki~~~--~~i~~P~~--------------~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 234 KKGRKISYR--DVILSPIE--------------V-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cchhhhhhh--hhccChhh--------------c-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 544322211 10010000 0 0 012478899999999999999999887665543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=291.44 Aligned_cols=246 Identities=33% Similarity=0.574 Sum_probs=202.0
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||+|++|.||++.+..+++.||+|.+..... ...+|+++++.++|+|++++.+++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 58899999999999999999999999999998865432 23578999999999999999988733 34588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|||+++ +|.+.+. ....+++..++.++.|++.||.+||+ +|++||||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence 99999986 5655554 33679999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+......++... .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------------ 215 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-D------------ 215 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-C------------
Confidence 54332 2335678889999998554 4889999999999999999999999876654443332210 0
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
...++..+++.+.+++.+||..||++|||+.+++.||||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 011234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=298.22 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=193.8
Q ss_pred cceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 47999999999999999999863 345679999885432 23457999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~---------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~ 172 (374)
..+++||||+++ +|.+.+.... .....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-CC
Confidence 458899999984 6766665322 122358999999999999999999999 79999999999999996 78
Q ss_pred cEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017270 173 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 248 (374)
Q Consensus 173 ~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 248 (374)
.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999975533221 112334678999999865 458999999999999999998 999998877665555443
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
... .. ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGR--VL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 310 00 011246889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.29 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=192.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (374)
++|++.+.||+|+||.||+|....++. .+++|.+.... ....+|+.++.++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 579999999999999999999877765 46888775321 2345689999888 799999999987 3334
Q ss_pred EEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 170 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~ 170 (374)
.++++|||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +||+||||||+||+++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence 5889999998 477777754221 12358899999999999999999999 79999999999999996
Q ss_pred CCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017270 171 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 171 ~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 249 (374)
++.+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+...++..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 77899999999864322111111222456999999854 448999999999999999997 9999988776665554432
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.... ..+..++..+.+|+.+||+.||.+|||++++++.
T Consensus 234 ~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1100 0123478899999999999999999999999755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.48 Aligned_cols=249 Identities=34% Similarity=0.521 Sum_probs=200.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+|.+.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 5888999999999999999999999999999886543 23457999999999999999998874321 24588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+++||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence 99999964 66655543 3389999999999999999999999 79999999999999996 788999999999876
Q ss_pred ccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 017270 186 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 186 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 261 (374)
..... .....++..|+|||.+.+. .++.++|+||||+++++|++|..||...+.. .....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS------------ 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc------------
Confidence 55443 3345678889999998554 4899999999999999999999999876621 11111110
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
......++...+..+.+||.+||+.||++||++.+++.||||
T Consensus 219 ---------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 ---------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000011234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=295.02 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=194.4
Q ss_pred eeeeeeeecCCCceEEEEEECCC---CcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 34 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
|.+.+.||+|+||.||.|....+ +..||+|.+..+.. ...+|+.+++.++|+||+++++.+..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987653 47899998864321 23468999999999999999987754333 3344
Q ss_pred EEEEEeecccc-hHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..+++|||+.+ +|...+..... ....+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence 57899999985 66666543221 23468999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~-- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R-- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C--
Confidence 99865433221 11233567999999854 458999999999999999999 999998877665544433210 0
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123478899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=292.39 Aligned_cols=243 Identities=21% Similarity=0.299 Sum_probs=192.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... ....+|+.+++.++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 47899999999999999999864 45679999875432 23457999999999999999999873 33448999
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||+|+||+++. ++.+||+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence 999985 66665542 23468999999999999999999999 79999999999999996 78899999999876533
Q ss_pred CCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||...+..+.+..+.+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------- 220 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------- 220 (256)
T ss_pred CceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence 22211 1233557999999854 458999999999999999999 99999888776666555431000
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...+..+.+++.+||+.||.+|||++++++
T Consensus 221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235778999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.46 Aligned_cols=304 Identities=28% Similarity=0.420 Sum_probs=228.9
Q ss_pred CCcccceEEeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHhcC---
Q 017270 10 DHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMD--- 83 (374)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l~--- 83 (374)
.+..|.+.+..++. +-..++|.+.++||=|-|++||+|.+..+.+.||+|++...... ...|+++|++++
T Consensus 60 dY~kGGYHpV~IGD----~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGD----VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred hhhcCCCceeeccc----cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 34566666666544 34447999999999999999999999999999999988655433 347999999873
Q ss_pred -----CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEee
Q 017270 84 -----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 158 (374)
Q Consensus 84 -----h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~ 158 (374)
..+||++++.|-... .+..++|+|+|+++.+|+..+... .-..++...++.|+.||+.||.|||...||+|.
T Consensus 136 p~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred CCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 357999999885433 566789999999999999999864 345689999999999999999999996699999
Q ss_pred cCCCCcEEEcCC--------------------------------------------------------------------
Q 017270 159 DLKPQNLLVDPL-------------------------------------------------------------------- 170 (374)
Q Consensus 159 dlkp~NIll~~~-------------------------------------------------------------------- 170 (374)
||||+|||+...
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 017270 171 -------------------------------------------------------------------------------- 170 (374)
Q Consensus 171 -------------------------------------------------------------------------------- 170 (374)
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence
Q ss_pred -----------------CCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 171 -----------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 171 -----------------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
+-++||+|||-|-.... -.+.-+.|..|+|||++.|.. |++.+||||++|+++||+||..
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDy 449 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDY 449 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCce
Confidence 00133333333322111 011235588899999999875 9999999999999999999999
Q ss_pred CCCCC------ChHHHHHHHHHHhCCCCHHHHhhcCcC------CcC-CCCCCCCCCChhhhcccC------CChhHHHH
Q 017270 234 LFPGE------NAVDQLVEIIKVLGTPTREEIRCMNPN------YTD-FRFPQIKAHPWHKVFHKR------MPPEAIDL 294 (374)
Q Consensus 234 pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~l 294 (374)
+|... .+.+-+..|++.+|..++.....-... ..+ ..+..++.+++...+.++ -..++.||
T Consensus 450 LFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdF 529 (590)
T KOG1290|consen 450 LFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDF 529 (590)
T ss_pred eecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHH
Confidence 99532 356789999999998887765422111 111 123444555555554432 23468899
Q ss_pred HHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 295 ASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 295 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
|.-||+++|++|+||.++|+|||++..-.
T Consensus 530 L~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 530 LSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHHhcCccccccHHHHhcCccccCCCC
Confidence 99999999999999999999999997644
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=294.84 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=194.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 4579999999999999999999977 77889999875432 1234688999999999999999987432
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC--CcE
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQV 174 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~--~~i 174 (374)
...++||||+.| +|.+.+..... ....+++..+..++.||+.||+|||+ ++++||||||+||+++..+ ..+
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 337899999975 77776654321 12358999999999999999999999 7999999999999998532 369
Q ss_pred EEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017270 175 KICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 250 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~ 250 (374)
||+|||+++........ .....+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865322111 112234679999998654 48999999999999999997 99999887765544333221
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+ .++..++..+.+++.+||+.||++|||+.++++|
T Consensus 238 -~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -CcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0123478899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=297.03 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=206.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..+.|.+.+.||+|++|.||+|.+..++..+|+|++..... ...+|+.+++.++|+|++++++.+... ...|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEE
Confidence 45579999999999999999999998899999998865432 345799999999999999999988443 4589
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||++ ++|.+.+... ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence 9999999 5777776642 1479999999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------- 235 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------- 235 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence 43322 1234567889999998654 5899999999999999999999999877665444433221 0000
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
. .....++..+.++|.+||+.||.+|||+.+++.||||++..
T Consensus 236 ---------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 236 ---------L-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred ---------C-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 0 00123678999999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=304.34 Aligned_cols=269 Identities=24% Similarity=0.389 Sum_probs=211.4
Q ss_pred cCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----------chHHHHHHHHhcCCCceeee
Q 017270 22 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----------YKNRELQLMRVMDHPNVISL 90 (374)
Q Consensus 22 ~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~ 90 (374)
.....+|...++|.++..||+|||+.||+|.+...++.||+|+-.-... ..-+|..+-+.|+||.||++
T Consensus 453 SQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 453 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred hhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 3456788899999999999999999999999999999999996532221 12378999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCeEeecCCCCcEEEcC
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~ivH~dlkp~NIll~~ 169 (374)
|++|.-. ...+|-|+|||+|+-++ .|...+..+++.+++.|+.||+.||.||.+. .-|+|-||||.|||+..
T Consensus 533 YDyfslD----tdsFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 533 YDYFSLD----TDSFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeec----cccceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence 9988422 22389999999985333 2334667899999999999999999999983 36999999999999853
Q ss_pred C--CCcEEEEeeccccccccCCCc--------ceeeeeccccchhhhh-C--CCCCCCchhhHhHHHHHHHHHhCCCCCC
Q 017270 170 L--THQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIF-G--ATEYTTSIDIWSAGCVLAELLLGQPLFP 236 (374)
Q Consensus 170 ~--~~~ikl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~l~-~--~~~~~~~~DiwslGvil~~ll~g~~pf~ 236 (374)
. .+.|||+|||+++.+...... ....||.||++||.+. + .+..+.++||||+|||+|.++.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 1 357999999999987665433 2357899999999973 2 3457899999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 237 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
.+.....+.+--.++ +-.+..||.. +.++.++++||++||++--++|..+.++-.||
T Consensus 686 hnqsQQdILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 686 HNQSQQDILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred CchhHHHHHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 765443322111110 1122333321 24899999999999999999999999999999
Q ss_pred cccc
Q 017270 317 FFDE 320 (374)
Q Consensus 317 ~~~~ 320 (374)
||.-
T Consensus 743 yllP 746 (775)
T KOG1151|consen 743 YLLP 746 (775)
T ss_pred cccc
Confidence 9964
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=291.53 Aligned_cols=238 Identities=22% Similarity=0.321 Sum_probs=185.7
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 46899999999999999999999999875432 234579999999999999999998843 33488999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence 86 56555542 34568999999999999999999999 79999999999999996 778999999998754322111
Q ss_pred c---eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 192 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 192 ~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 214 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------------- 214 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence 1 11224569999998554 48999999999999999997 8999977655443332222100
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+...+..+.+|+.+||+.||++|||+.++++
T Consensus 215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0012346889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.24 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=196.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|++++++++.+.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 5899999999999999999999999999999987431 2234579999999999999999998843 345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++||||+++ +|...+.........+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence 8899999985 7777776544455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHh
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 260 (374)
....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------- 223 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence 5543322 2345678889999998654 488999999999999999999999965431 1111111110
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.++. .....++..+.++|.+||..+|++|||+.++++
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001246789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=291.67 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=194.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence 468999999999999999999864 56779999875432 23347999999999999999988873 3344889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+++ +|.+.+.. .....+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence 9999974 77766653 234568899999999999999999999 79999999999999996 7889999999997654
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+.+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----------- 222 (261)
T ss_pred CCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 32211 12234567999999854 448899999999999999998 9999988776655544432110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+ ....++.++.+++.+||..||++||+++++++
T Consensus 223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 11246889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=295.51 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=195.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|.+.+.||+|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 57999999999999999999999999999999875321 223468999999999999999998843 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|||+++ +|.+.+.........+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence 8899999985 6777766544455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred ccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 017270 184 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 184 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 261 (374)
....... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.... ....+.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------- 224 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC---------
Confidence 6543322 223467889999999855 44789999999999999999999999764321 11111111000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.+. .....+++.+.+++.+||+.||++|||+.+++
T Consensus 225 ---------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~ 259 (267)
T cd08229 225 ---------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVY 259 (267)
T ss_pred ---------CCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence 000 01124688999999999999999999999775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=290.36 Aligned_cols=245 Identities=20% Similarity=0.278 Sum_probs=192.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..+|.+.+.||+|+||+||.|.+. .+..+|+|.+..... ...+|+.+++.++||||+++++++. ....+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 357999999999999999999864 345699998764432 2357999999999999999999873 2334789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.+||+|||.++...
T Consensus 77 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecC
Confidence 9999985 56665543 23468999999999999999999999 79999999999999996 7889999999987554
Q ss_pred cCCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....+
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 221 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY--------- 221 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---------
Confidence 332211 12345679999998654 48999999999999999998 999998777655555443311100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 222 -------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 -------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.72 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=190.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcE----EEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|++.+.||+|+||+||+|.+..+++. ||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 4799999999999999999998766654 8999875332 2334688999999999999999887431
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++++||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEccccc
Confidence 2568999988 467666653 23468899999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCCCcce---eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
++.......... ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+. ..++.....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~---- 229 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER---- 229 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCC----
Confidence 986654332221 223567999999865 458999999999999999997 9999987665443 233221000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+ .+...+.++.+++.+||..||++||++.+++.+
T Consensus 230 -------------~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 -------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 112367889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=307.75 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=191.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhcC-CCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (374)
.++|++++.||+|+||+||+|.+... +..||||++.... ....+|+.+++.++ ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 45889999999999999999987543 3469999885432 22347999999996 99999999988
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
......|+|||||++ +|.+.+.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 334458999999984 67666643211
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEE
Q 017270 126 ---------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 166 (374)
Q Consensus 126 ---------------------------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIl 166 (374)
....+++..+..++.||+.||+|||+ ++|+||||||+||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 12357888899999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHH
Q 017270 167 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 242 (374)
Q Consensus 167 l~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 242 (374)
++. ++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 996 77899999999976543222 1223456789999998654 58999999999999999997 999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...+.... .. ..+..++.++.+++.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~-----------------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGY-----------------RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCC-----------------CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333222100 00 012347889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=294.09 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=194.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|.+.+.||+|+||.||+|..... +..||+|.+..... ...+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 46899999999999999999987643 37899998754432 23478899999999999999998833
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 173 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ 173 (374)
....++||||++ ++|.+.+..... ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~ 157 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLT 157 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCC
Confidence 345889999997 577777654321 12347888999999999999999999 79999999999999996 788
Q ss_pred EEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017270 174 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 249 (374)
+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999875433221 1223456789999998544 48999999999999999998 9999988776554443331
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. +.+ .++...+.++.+++.+||+.||++|||+.++++
T Consensus 237 ~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 G-GHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 000 012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=289.30 Aligned_cols=238 Identities=34% Similarity=0.581 Sum_probs=195.5
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
||.|+||.||++.+..+++.+|+|.+..... ....|+.+++.++|+||+++++.+ ......|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999988899999998865432 345788999999999999999887 4455689999999
Q ss_pred c-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC-CC
Q 017270 113 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 190 (374)
Q Consensus 113 ~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~-~~ 190 (374)
+ ++|.+.+.. ...+++..++.++.|++.|+.|||+ ++++|+||+|+||+++. ++.++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence 5 577666653 3468999999999999999999999 79999999999999996 778999999998765443 22
Q ss_pred cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCC
Q 017270 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 270 (374)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. . ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~~- 210 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------PL- 210 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------CC-
Confidence 3345668889999998654 478899999999999999999999987776444443332 0 00
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCcc
Q 017270 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 318 (374)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~---~e~l~hp~~ 318 (374)
.++..++..+.+++++||..||++||++ +++++||||
T Consensus 211 -----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 -----------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1233468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=290.60 Aligned_cols=242 Identities=27% Similarity=0.394 Sum_probs=195.8
Q ss_pred eeeecCCCceEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+++++.++|+|++++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999999865 8899999886543 233479999999999999999998843 44589999
Q ss_pred eccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 110 EYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
||++ ++|.+.+...... ...+++..++.++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence 9996 5777776643211 4779999999999999999999999 89999999999999996 7889999999998
Q ss_pred ccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 184 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 184 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+.+. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~------ 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y------ 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------
Confidence 665432 12334567889999998654 58999999999999999999 69999888766555544331 0
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
....+..+++++.+++.+||+.||.+|||+.+++++
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001223468999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=297.09 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=193.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
.+|++.+.||.|+||+||+|.+..+ ++.||+|++..... ...+|+.++..++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----- 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----- 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence 4789999999999999999987543 57899998864432 23468889999999999999998833
Q ss_pred ceEEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 168 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~ 168 (374)
....++++||+.+ +|...+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 3348899999985 5655553211 112458888999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 017270 169 PLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 244 (374)
Q Consensus 169 ~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~ 244 (374)
. ++.+||+|||+++........ ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.+
T Consensus 159 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C-CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 778999999998765332211 123346789999998654 48999999999999999998 88999887776655
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 245 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+.+.... .++..++..+.+|+.+||+.||.+||++.+++.
T Consensus 237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 554431110 122357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.44 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=206.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
...+|.++++||+|+|++|.++++++|.+.||+|++.++- ...+.|..++.+- +||.+|.++.+| +.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----cc
Confidence 3468999999999999999999999999999999885432 3344566666554 799999999999 66
Q ss_pred ceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
+..+++|.||++|+ |.-.+ .....++++.++.|..+|+.||.|||+ +||++||||.+|+|+|. .+.+||+|+|
T Consensus 323 esrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikltdyg 396 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYG 396 (593)
T ss_pred cceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeecccc
Confidence 66699999999975 32222 345679999999999999999999999 89999999999999997 7789999999
Q ss_pred ccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCC-------CChHH-HHHHHHHHh
Q 017270 181 SAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-------ENAVD-QLVEIIKVL 251 (374)
Q Consensus 181 ~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~-------~~~~~-~~~~i~~~~ 251 (374)
+++.-.. +....+++|||.|.|||++.|. .|+..+|+|+|||+++||+.|+.||.- .+..+ .++-|++..
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 9986544 4455678999999999999765 599999999999999999999999952 11222 222233310
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCccccccCCC
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREPN 325 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~e~l~hp~~~~~~~~~ 325 (374)
++ ++..+|-.+..+++..|++||.+|.. ..++..||||+.+.|..
T Consensus 476 -----------------ir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 476 -----------------IR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred -----------------cc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 11 23457778889999999999999974 57999999999988763
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=338.97 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=206.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.-+|.-...||.|.||.||.|.+..||+..|+|-+.-. .....+|.+++..++|||+|+++++=.+...
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence 44778888999999999999999999999999966322 2334589999999999999999987644333
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|.||||.| +|.+.+. .+...++...+.|..|++.|+.|||+ +|||||||||.||+++. ++.+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeeccccee
Confidence 7799999996 5555554 34557888888999999999999999 79999999999999995 7899999999998
Q ss_pred ccccCC-----CcceeeeeccccchhhhhCCC--CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 184 QLIAGE-----ANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 184 ~~~~~~-----~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
...... ......|||.|||||++.+.. .-..+.|||||||+..||+||+.||...+..-++.--+.....|
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P-- 1460 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP-- 1460 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC--
Confidence 765442 224578999999999996643 35679999999999999999999998876654443333322222
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+++++|++.+|||.+||+-||.+|.++.|+|.|-|-+.-.+
T Consensus 1461 -------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1461 -------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred -------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 145568999999999999999999999999999998876443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=294.51 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=193.1
Q ss_pred ccceeeeeeeecCCCceEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|+||+||+|... .+++.+|+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----- 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence 357899999999999999999853 456789999886422 234579999999999999999998733
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhh-------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSS-------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~-------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
....|+||||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili 157 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI 157 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence 3348899999985 66666542110 12357889999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 243 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 243 (374)
+. ++.+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+.
T Consensus 158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 77899999999976533221 1223446679999998654 48999999999999999998 9999988765444
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 244 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+... ..+ ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3333221 000 0123478899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=290.47 Aligned_cols=244 Identities=19% Similarity=0.286 Sum_probs=192.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.+.. ....+|+.+++.++|+||+++++++ ......|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence 46899999999999999999875 56789999875432 2344799999999999999998887 333458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceeccc
Confidence 999985 66666543 23468999999999999999999999 79999999999999996 78899999999875433
Q ss_pred CCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL----------- 220 (256)
T ss_pred ccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-----------
Confidence 22111 1122346999999865 458999999999999999999 89999877666554443321100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 -----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0122468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=292.55 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=197.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..+|.+.+.||.|+||.||+|.+.. ++.+|+|.+..... ...+|+.+++.++|+||+++++++. .....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence 4579999999999999999999877 88999998865432 3457899999999999999998873 333488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhc
Confidence 99999985 777776542 34568999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCc-ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+.+..+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 224 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP--------- 224 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC---------
Confidence 332211 12334567999999854 458999999999999999998 899998877666665554311110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...++.+.+++.+||+.||.+|||+.++++
T Consensus 225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 -------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 12346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.88 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=194.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|.+.+.||+|+||.||++.+... ...+|+|.+.... ....+|+.+++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---- 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence 35899999999999999999987643 3679999886432 1234788999999 8999999999873
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEE
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 166 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIl 166 (374)
....++++|||+.+ +|...+.... .....+++..+..++.|++.||.|||+ ++|+||||||+||+
T Consensus 87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 33348999999985 6766665321 234678999999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHH
Q 017270 167 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 242 (374)
Q Consensus 167 l~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 242 (374)
++. ++.+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 996 788999999999865433211 11223567999999854 458999999999999999997 999998877655
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
....+..... ...+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5444332100 00122468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.55 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|++|.||+|.+. +++.||+|.+.... ....+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence 357999999999999999999864 45789999886543 23457999999999999999998873 3334889
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+. ++|.+.+... ....+++..+..++.|++.||.+||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEcc
Confidence 999996 5777766532 23568999999999999999999999 79999999999999996 7789999999998654
Q ss_pred cCCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+....+..+.+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---------- 223 (261)
T ss_pred CCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 322111 1122357999998854 458999999999999999999 99999887766555544331110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...+..+.+++.+||+.||.+||+++++++
T Consensus 224 ------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 012246889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=292.77 Aligned_cols=251 Identities=21% Similarity=0.269 Sum_probs=191.0
Q ss_pred eeeeeeeecCCCceEEEEEECCCCc--EEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCceE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 104 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 104 (374)
+.+.+.||+|+||.||+|....++. .+|+|.+.... ....+|+.+++.++|+||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877765 58999775331 223468899999999999999987643321 22234
Q ss_pred EEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
.+++|||+.+ +|.+.+.... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence 7899999984 6665553221 123458999999999999999999999 89999999999999996 77899999999
Q ss_pred ccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
++....... .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~--- 233 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRL--- 233 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC---
Confidence 986543321 112234667999999854 458999999999999999999 89999887665544433221 000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+..++..+.++|.+||+.||++|||+++++++
T Consensus 234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0123467889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=289.71 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=193.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC---CcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.++|.+.+.||+|+||+||+|.+..+ ...||+|.+..... ...+|+.+++.++|+||+++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 35799999999999999999998644 45799998754321 2346899999999999999999873 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccch
Confidence 448899999986 66666543 23478999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCCCc-c--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEAN-I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~-~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+......... . ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 228 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP--- 228 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9876422211 1 1223567999999854 458999999999999999998 999998776655544443211100
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+...++.+.+++.+||+.||++||++.+++++
T Consensus 229 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 -------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112468899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.83 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=193.2
Q ss_pred cceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|.+.+.||+|+||.||+|++.. ++..+++|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 479999999999999999998643 45668999875433 23457999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
...++||||+++ +|.+.+.... .....+++..++.++.||+.||+|||+ +||+||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 458899999984 6766665321 122458999999999999999999999 89999999999999996
Q ss_pred CCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017270 170 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 245 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 245 (374)
++.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+...
T Consensus 159 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred -CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 78899999999975443221 122345678999999865 458999999999999999998 999998776655444
Q ss_pred HHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 246 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+... .. + ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 33220 00 0 011236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.05 Aligned_cols=243 Identities=27% Similarity=0.329 Sum_probs=191.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
++|++.+.||+|+||.||+|.+..+ ..||+|++..... ...+|+.+++.++|+||+++++.+. . ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 5799999999999999999987655 4699998865332 3457999999999999999987652 1 126799
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccc
Confidence 999985 676666532 23467899999999999999999999 79999999999999996 77899999999975543
Q ss_pred CCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+....+....+......+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------- 223 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------- 223 (262)
T ss_pred cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC----------
Confidence 3221 12334567999998854 448999999999999999999 899998876655544433210000
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....++..+.+++.+||+.||++||++.++++
T Consensus 224 ------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 11246889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=286.83 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=207.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++.+-+..||.|+||+|++..|+.+|+..|||.+..... ....|.+ +++.-+.||||++++..+.... .
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence 345557789999999999999999999999999864432 2223443 3445579999999998865443 8
Q ss_pred EEEeecccchHHHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~-~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|.||+++-++..+.+. +......++|..+-.|....+.||.||.+..+|+|||+||+|||++. .|.+||||||++..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccchHh
Confidence 89999999766554432 33456779999999999999999999998558999999999999996 78899999999988
Q ss_pred cccCCCcceeeeeccccchhhhhCCCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
....-..+...|...|||||.+..... |+.+||+||||++|||+.||..||.+.+. .+++..+.. |.|+. ...
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~-l~~-- 292 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPI-LLF-- 292 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCe-ecC--
Confidence 776666666788889999999954443 89999999999999999999999988764 344443333 32221 000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
+. . --.++..++.||..||.+|-+.||.-++++++||++.+......
T Consensus 293 --~~----------~------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 293 --DK----------E------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred --cc----------c------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 00 0 01368899999999999999999999999999999876554433
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=286.65 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++++.||+|+||.||+|.. .+++.||+|.+..... ...+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEE
Confidence 45899999999999999999985 4678899998865432 33579999999999999999887521 13789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+.+ +|.+.+.. ..+..+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence 9999975 67666643 234578999999999999999999999 79999999999999996 7889999999997654
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+......+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 223 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP--------- 223 (260)
T ss_pred CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---------
Confidence 22211 12334567999999854 458899999999999999998 999998877655544433211100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...+.++.+++.+||+.||++|||++++++
T Consensus 224 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=285.94 Aligned_cols=242 Identities=22% Similarity=0.320 Sum_probs=191.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
.+|.+.+.||+|+||.||++.. .|..+|+|.+..+.. ...+|+.+++.++|+|++++++++.. .....+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 4899999999999999999976 477899998865432 34579999999999999999987643 223478999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceecccc
Confidence 99985 776666532 23458899999999999999999999 79999999999999996 788999999998754332
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
. .....+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 156 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred C--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2 22334567999999854 458999999999999999997 999998766554443332210
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.......+++.+.+++.+||+.||++|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=293.97 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=196.8
Q ss_pred ceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
+|.+.+.||+|++|.||+|.+. .+++.||+|.+.+.. ....+|+.++..+ +|+||+++.+.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4889999999999999999864 467889999885421 2234689999999 599999999887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+++||||+.+ +|...+. ....+++..++.++.|++.||.|||+ .+++||||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence 34458899999986 5555543 24568999999999999999999999 79999999999999996 778999999
Q ss_pred ccccccccCCC--cceeeeeccccchhhhhCCC-CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 180 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 180 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
|++........ .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 99876543322 12345788999999985432 3688999999999999999999999754322222222111000
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCccccccCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 324 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~ 324 (374)
.. ...+..++..+.++|.+||+.||++||| +.++|+||||+.+.+.
T Consensus 227 ----------~~------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 ----------SK------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------cC------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 00 0012346889999999999999999998 5678999999988764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=295.66 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=192.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
.++|.+.+.||+|+||.||+|++.. +...+|+|.+..+.. ...+|+.+++.+ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 4689999999999999999998643 235699998865321 234688999999 7999999999883
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
.....|+||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 33358899999985 77777764321 12358899999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
|+++. ++.+||+|||.+......... ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.
T Consensus 171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99996 778999999998755432211 112234679999998654 48999999999999999998 8999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+....+... .. ...+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcC-CC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4443332220 00 00123468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.94 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=194.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC----------------cEEEEEEeeccc-----cchHHHHHHHHhcCCCceee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 89 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~ 89 (374)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 458999999999999999999876543 457999886542 22346899999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCC
Q 017270 90 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 161 (374)
Q Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlk 161 (374)
+++++.. ....+++|||+.+ +|...+..... ....+++..++.++.|++.||.|||+ +|++|||||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 9998833 3458899999985 67766654321 12368999999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh--CCCCCC
Q 017270 162 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 236 (374)
Q Consensus 162 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~ 236 (374)
|+||+++. ++.++|+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999996 78899999999875433221 1223456789999998654 48999999999999999998 778887
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 237 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+.+..+......... ......+..++.++.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 76665555444332111000 0000012346789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.37 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=193.5
Q ss_pred ccccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++++ +|+||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI- 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence 34568999999999999999999853 345679999875432 1244799999999 79999999998733
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
....++||||+.+ +|.+.+.. .....+++..+..++.|++.||+|||+ ++|+|+||||+||+++. ++.++|
T Consensus 111 ----~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l 182 (302)
T cd05055 111 ----GGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKI 182 (302)
T ss_pred ----CCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEE
Confidence 3348899999984 67666653 122348999999999999999999999 79999999999999985 778999
Q ss_pred EeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 177 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+|||+++....... .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||......+.+.+.... +
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~ 260 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-G 260 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-C
Confidence 99999975543321 1122346789999998654 48999999999999999998 99999877655544443321 0
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+ ...+...++++.+|+.+||..||++|||+.++++
T Consensus 261 ~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 YR--------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 0012246889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=291.96 Aligned_cols=258 Identities=28% Similarity=0.367 Sum_probs=188.6
Q ss_pred cce-eeeeeeecCCCceEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y-~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
++| .+.+.||+|+||+||++. ...++..||+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 455 999999999999998865 33567889999886432 233479999999999999999987643 22
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence 3458899999996 55555532 459999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Q 017270 181 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~ 255 (374)
++......... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... +..+... .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 229 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT 229 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence 99865433221 12234567999999854 45899999999999999999999998654321 1111110 00000
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+... .........+..++.++.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 0000011123457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=293.87 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=192.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeee
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFS 96 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~ 96 (374)
..++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... ...+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 44699999999999999999998642 345689998764321 234688999999 6999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCC
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 163 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~ 163 (374)
....++++|||+++ +|.+.+..... ....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus 89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~ 163 (314)
T cd05099 89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR 163 (314)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence 33458899999985 77777754321 23458999999999999999999999 89999999999
Q ss_pred cEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCC
Q 017270 164 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 239 (374)
Q Consensus 164 NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~ 239 (374)
||+++. ++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 164 Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999996 77899999999976543221 111223457999999865 458999999999999999999 899998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 240 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+....+.... . ...+..++.++.+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGH--R--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCC--C--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 655554433210 0 0012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=287.35 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=191.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ....+|+.+++.++|+|++++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEE
Confidence 358999999999999999999865 56679999886532 23457999999999999999988762 1 12679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence 9999985 67666653 224568999999999999999999999 79999999999999996 7889999999997654
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---------- 222 (260)
T ss_pred CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 12233557999999854 458899999999999999999 89999887766555544321000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
..+...+..+.+|+.+||+.||++|||+.++.
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=285.59 Aligned_cols=242 Identities=25% Similarity=0.366 Sum_probs=193.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..+|++.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence 35899999999999999999986 478999999866543 34579999999999999999998843 334889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccc
Confidence 9999985 777766532 22368999999999999999999999 89999999999999996 7889999999998653
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.... ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------------- 216 (256)
T ss_pred cccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 2221 2233567999999854 458899999999999999997 999998776554433322200
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+..+++.+.++|.+||..+|++|||+.+++.
T Consensus 217 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 --------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00012346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=289.31 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=190.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|+||+||+|.+..++. .||+|.+.... ....+|+.+++.++|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 4589999999999999999999877776 48999875432 2234688899999999999998877321
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..++++||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~dfG 154 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDFG 154 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCCC
Confidence 2668999998 577666653 24568999999999999999999999 89999999999999985 7789999999
Q ss_pred cccccccCCCcc---eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+++......... ...+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .+.....++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~- 231 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP- 231 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC-
Confidence 998654332221 12335679999998654 58999999999999999998 999997765544332 222111100
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...+.++.+++.+||+.||++||++.+++.
T Consensus 232 --------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11236889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=291.69 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=189.3
Q ss_pred ceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ...+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47889999999999999998753 235688887754332 2447999999999999999998873 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCC
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 161 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlk 161 (374)
...++++||+.+ +|.+.+.... .....+++..++.++.|++.||+|||+ ++++|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 347899999994 6666654321 112458899999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCC
Q 017270 162 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 237 (374)
Q Consensus 162 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~ 237 (374)
|+||+++. ++.+||+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999996 78899999999875433221 112234567999999854 458999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+....+.+... ...+..++.++.+|+.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYR----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 765544332221100 0012347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=290.44 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=192.1
Q ss_pred cceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|.+.+.||+|+||.||+|... .++..+|+|.+.... ....+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 47889999999999999999753 346679999875432 234578999999999999999888733 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 170 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~ 170 (374)
...+++|||+++ +|.+.+..... ....+++..+..++.||+.|++|||+ +|++||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence 348899999985 67666653211 11358899999999999999999999 79999999999999996
Q ss_pred CCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017270 171 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 246 (374)
Q Consensus 171 ~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~ 246 (374)
++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 78899999999875433221 1123346789999998654 48999999999999999998 9999987766655544
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+..... . ..+..+++.+.+||.+||+.||++||++.+++.
T Consensus 237 ~~~~~~--~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE--L--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc--C--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 432100 0 012347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.71 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=189.6
Q ss_pred cceeeeeeeecCCCceEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
++|++.+.||+|+||+||+|.+ ..+++.||||.+.... ....+|+.++..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 5899999999999999999984 3467889999885432 2234799999999 689999999877432
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh------------------------------------------------------
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 125 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~------------------------------------------------------ 125 (374)
...+++|||||++ +|.+.+.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 2347899999995 66666643210
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc---ce
Q 017270 126 ---------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---IS 193 (374)
Q Consensus 126 ---------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~ 193 (374)
....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCC
Confidence 01347888889999999999999999 79999999999999996 788999999998764332211 11
Q ss_pred eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCC
Q 017270 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272 (374)
Q Consensus 194 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
..+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||........+...+.....+ .
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~-- 302 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------R-- 302 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC---------------C--
Confidence 2345679999998654 58999999999999999997 999998765433332222210000 0
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+...++++.+++.+||+.||.+|||+.++++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112357889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.35 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ...+|+.+++.++|+|++++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEE
Confidence 35799999999999999999987654 4699998765432 2357999999999999999987762 1 22679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEcc
Confidence 9999985 777777532 23458899999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---------- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 12334667999998854 448999999999999999999 99999887766555444321000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...+..+.+++.+||.+||++||+++++++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 ------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012346889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=287.11 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=192.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 3589999999999999999999865543 69999875432 23356899999999999999999873 33
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCc
Confidence 458899999985 56655542 23568999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCCCcc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+.......... ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||......+....+.+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--- 228 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL--- 228 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC---
Confidence 98654332211 1122457999999864 458999999999999999886 99999877665555444331110
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+ .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 229 ---------------~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ---------------P----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------C----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0 11246889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=290.06 Aligned_cols=252 Identities=17% Similarity=0.189 Sum_probs=184.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCC---CcEEEEEEeeccccchH---------------HHHHHHHhcCCCceeeecee
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN---------------RELQLMRVMDHPNVISLKHC 93 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~---------------~e~~~l~~l~h~~iv~~~~~ 93 (374)
.+|.+.+.||+|+||+||+|.+..+ +..+|+|+......... .+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4899999999999999999998877 66777775432222111 12233445689999999886
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc
Q 017270 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 173 (374)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ 173 (374)
..... ....+.+++++++..++...+.. ....++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence 64332 22345678899888776665543 2346788899999999999999999 79999999999999996 778
Q ss_pred EEEEeeccccccccCC--------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 017270 174 VKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~ 245 (374)
++|+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999997653221 1123468999999999865 458999999999999999999999998774322221
Q ss_pred HHHH--HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 246 EIIK--VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 246 ~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+ ......... . .....++.+.+++..|+..||++||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~----------~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGK----------I-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhh----------h-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 000000000 0 01236789999999999999999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=292.99 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=194.2
Q ss_pred cccceeeeeeeecCCCceEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeee
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 96 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 96 (374)
..++|.+.+.||+|+||.||+|++. .++..+|+|.+.... ....+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 4568999999999999999999753 234579999875432 2345799999999 8999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCC
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 163 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~ 163 (374)
.....++||||+++ +|.+.+..... ....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 33458899999985 77777654321 12457888899999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCC
Q 017270 164 NLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 239 (374)
Q Consensus 164 NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~ 239 (374)
||+++. ++.+||+|||+++........ ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+
T Consensus 167 Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999996 788999999999865432211 12234567999999855 458999999999999999998 889998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 240 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+....+..... ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6655544322100 00123478899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=288.12 Aligned_cols=228 Identities=25% Similarity=0.327 Sum_probs=180.4
Q ss_pred CCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHH
Q 017270 43 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK 121 (374)
Q Consensus 43 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~ 121 (374)
|.+|+||+|++..+++.||+|.+..... ..+|...+....||||+++++++. .....++||||++| +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999876543 334555556668999999999883 33458999999995 6666665
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeecccc
Q 017270 122 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 201 (374)
Q Consensus 122 ~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~ 201 (374)
. ...+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 3458999999999999999999999 79999999999999996 778999999987654332 12334567799
Q ss_pred chhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhh
Q 017270 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 281 (374)
Q Consensus 202 aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (374)
|||.+.+ ..++.++|+||+||++|+|++|..||....... . .....
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~~~------------ 195 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THTTL------------ 195 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccccc------------
Confidence 9998854 457899999999999999999998875332100 0 00000
Q ss_pred hcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCcc
Q 017270 282 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF 318 (374)
Q Consensus 282 ~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~ 318 (374)
.++..+++.+.+||.+||+.||++|+++ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1223478899999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=311.75 Aligned_cols=265 Identities=28% Similarity=0.430 Sum_probs=219.0
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
.-|...+-++|.+.||.|.+|+||+++++.+++..|+|+...+.. ..+.|.++|+.+ .|||++.++++|.-.....
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 346677889999999999999999999999999999998865432 344677888877 5999999999997655556
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++|||||+| +..++++... +.++.|+.+..|++.++.|+.+||. +.++|||+|-.|||++. ++.|||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeee
Confidence 6679999999995 6777777654 7899999999999999999999999 89999999999999996 7889999999
Q ss_pred cccccccC-CCcceeeeeccccchhhhhCCC----CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAG-EANISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++...+.. ....+.+|||+|||||++...+ .|+..+|+||||++..||..|.+|+....+...+-.|.. -|+
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP 245 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP 245 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC
Confidence 99876654 3445789999999999985433 367799999999999999999999988877765544332 111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
+. +. -+++-+.++.|||..||.+|-.+||+..++|.|||++.
T Consensus 246 Pk----------------Lk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 PK----------------LK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cc----------------cc-------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11 00 12335788999999999999999999999999999974
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=284.93 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=195.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+..+. ....+|+.+++.++|+||+++++++. .....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 4568999999999999999999965 55789999886543 23457999999999999999998873 333488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+.+ +|.+.+.. .....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceec
Confidence 99999985 67666653 223568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... .....+..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+....+..+......+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 224 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-------- 224 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 432111 12223567999999865 458999999999999999998 999998877666665554321111
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.+...+..+.+++.+||+.||++||++++++
T Consensus 225 --------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 225 --------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred --------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 1123578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=292.49 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=191.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC--------------cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLK 91 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~--------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~ 91 (374)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 358999999999999999999875432 358999886542 1234699999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp 162 (374)
+++. .....++||||+.+ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp 157 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT 157 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence 9883 33448899999985 66666543210 11247888999999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh--CCCCCCC
Q 017270 163 QNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 237 (374)
Q Consensus 163 ~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~ 237 (374)
+||+++. ++.+||+|||++......... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999995 778999999998754332211 112335689999998654 48999999999999999998 6788887
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+.+..+.+........ . + ...+...++.+.+|+.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-------~-----~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQ-------I-----Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhcccc-------c-----c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 76655554443311100000 0 0 0012236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=322.21 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=192.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeee----------
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFS---------- 96 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 96 (374)
.+|+.++.||+||||.||+|+++-+|+.||||+++-.. ....+|+++|.+|+|||||+++..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 46788999999999999999999999999999996542 234589999999999999997754310
Q ss_pred --------------------------------------------cC---------C------------------------
Q 017270 97 --------------------------------------------TT---------S------------------------ 99 (374)
Q Consensus 97 --------------------------------------------~~---------~------------------------ 99 (374)
.. +
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 00 0
Q ss_pred --------------------C-------CceEEEEEeecccchHHHHHHhhhhcCCCC-CHHHHHHHHHHHHHHHHHhhc
Q 017270 100 --------------------K-------NELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYIHT 151 (374)
Q Consensus 100 --------------------~-------~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l-~~~~~~~i~~qll~al~~LH~ 151 (374)
. ....+||-||||+..++..+.. .+... ....+|+++.||+.||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~---~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR---RNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH---hcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 0156899999999876665543 22222 577899999999999999999
Q ss_pred CCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc-------------------cCCCcceeeeeccccchhhhhCCC--
Q 017270 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------------AGEANISYICSRFYRAPELIFGAT-- 210 (374)
Q Consensus 152 ~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~l~~~~-- 210 (374)
.|||||||||.||++++ .+.|||+|||+|.... .....++.+||..|+|||++.+..
T Consensus 716 -~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 -QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 69999999999999996 7789999999997511 011234678999999999996655
Q ss_pred CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChh
Q 017270 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 290 (374)
Q Consensus 211 ~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (374)
.|+.|+||||||||++||+. ||.. .++....+.+ +..+. +|. . ..|..+--+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~-LR~g~---------------iP~---~---~~f~~~~~~~ 846 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTN-LRKGS---------------IPE---P---ADFFDPEHPE 846 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHh-cccCC---------------CCC---C---cccccccchH
Confidence 69999999999999999984 4643 3333322222 11111 111 0 1122223456
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 291 AIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 291 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
-..+|++||+.||++||||.|+|++.||-
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 67899999999999999999999999996
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=285.46 Aligned_cols=234 Identities=26% Similarity=0.330 Sum_probs=183.6
Q ss_pred eeecCCCceEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 39 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
.||+|+||.||+|.. ..++..+|+|++.... ....+|+.+++.++|+||+++++.+. +. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999964 4567899999875432 12346889999999999999988762 21 2679999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
|+++ +|.+.+. ....+++..+..++.|++.||+|||+ +||+||||||.||+++. ++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence 9995 5666554 34568999999999999999999999 79999999999999996 7789999999997654332
Q ss_pred Cc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 190 AN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 190 ~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.. ....+++.|+|||.+.. ..++.++|+|||||++|+|++ |..||...+..+....+.+.. .+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---------- 217 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RM---------- 217 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC----------
Confidence 21 11223568999998854 458899999999999999998 999998877665544443210 00
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
..+..+++++.++|.+||+.||++||+++++.
T Consensus 218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~ 249 (257)
T cd05116 218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE 249 (257)
T ss_pred -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence 02235789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=287.84 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=187.6
Q ss_pred eeeeeeecCCCceEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 35 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+.+.||.|+||.||+|... ..+..|+||.+.... ....+|++.++.++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 46789999999999999987 346779999884321 234579999999999999999999863222 8
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++|||||+ |+|.+.+... ....+++..+..++.||+.||.|||+ ++++|+||+++||+++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence 89999998 5788887742 34679999999999999999999999 79999999999999996 78999999999986
Q ss_pred cccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...... .........|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 532221 12234567899999986544 8999999999999999999 7899988877766665533111
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..++..+.++|.+||..||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123457899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=287.53 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=184.2
Q ss_pred eeeecCCCceEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|....++. .+|+|.+.... ....+|+.++..+ +||||+++++++. ....+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 368999999999999888776 46888775321 2334689999999 7999999999883 334488999
Q ss_pred eccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 110 EYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence 9998 577777654321 12358899999999999999999999 79999999999999996 788999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
+|||++..............+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---- 228 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 228 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence 99999863322111112223557999999854 458999999999999999997 999998766554444332100
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.. ..+..++.++.+++.+||..||.+|||+++++.
T Consensus 229 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 --------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.33 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=191.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+...+...||+|.||+||+|++.. .||||++..+. ..++.|+.++++-+|.||+-+.+++. ... +
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~ 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L 462 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence 456778999999999999999865 49999886443 34458999999999999999988872 222 4
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.||+.+|+| +|+..+.. ....|.....+.|+.|+++|+.|||. ++|+|||||..||++.+ +++|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccceee
Confidence 799999998 67766654 34679999999999999999999999 89999999999999996 78999999999864
Q ss_pred cccC---CCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 185 LIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 185 ~~~~---~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
-... .......+...|||||++.. ..+|+..+|||||||++|||++|..||........+-.+-+....|...
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s-- 615 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS-- 615 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch--
Confidence 3221 11123345678999999853 3468999999999999999999999999555444333222221122111
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+.+.++++|+..||.+++++||...++|.
T Consensus 616 ----------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 ----------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ----------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 122356789999999999999999999998874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=289.93 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=193.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 4589999999999999999998753 57889999886432 23446899999999999999998873
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCC
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYS------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 161 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlk 161 (374)
....+++||||+++ +|.+.+.... .....+++..++.++.|++.||.|||+ ++++|||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 33348899999985 7777765321 112357888999999999999999999 799999999
Q ss_pred CCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCC
Q 017270 162 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 237 (374)
Q Consensus 162 p~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~ 237 (374)
|+||+++. ++.++|+|||++........ ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986 78899999999875433221 1122345679999998654 58999999999999999997 8899987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+....+..... . ..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNV-------------------L---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCC-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 766655544332100 0 012346889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=300.65 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhcC-CCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (374)
.++|.+.+.||+|+||.||+|++. .+++.||+|++..... ...+|+.++..+. ||||+++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence 357888999999999999999864 3456899999864421 2346999999997 9999999998833
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh-----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 125 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------------------------------------------------- 125 (374)
....++|||||.+ +|.+.+.....
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 3348899999994 77777653211
Q ss_pred -----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 126 -----------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 126 -----------------------------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
....+++..++.++.||+.||+|||+ ++++||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~N 269 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARN 269 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcce
Confidence 11246778889999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
||++. ++.+||+|||+++....... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.....
T Consensus 270 iLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99996 78899999999975432211 123456788999999865 458999999999999999998 8999987655
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+.+...+..... ...+..++.++.+|+.+||+.||.+||+++++++.
T Consensus 348 ~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYR---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5544433321000 00123468899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=285.69 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=191.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.+|...+.||+|+||.||+|.+..+++ .+|+|.+.... .....|+++++.++|+|++++.+++. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence 478899999999999999999876654 69999875432 22346889999999999999999883 333
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++ +|...+.. ....+++..+..++.|++.|++|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccc
Confidence 48899999996 55555432 34578999999999999999999999 79999999999999996 778999999998
Q ss_pred cccccCCCcc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 183 KQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
.......... ....++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--- 230 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--- 230 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence 7654322211 1112456999999865 457999999999999999997 999998776655555443311111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.....+..+.+++.+||+.||++||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=286.29 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=191.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 479999999999999999999887665 59999875432 2334689999999999999999887 3334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccc
Confidence 48899999986 55555542 24568999999999999999999999 79999999999999996 778999999998
Q ss_pred cccccCCCccee---e---eeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 183 KQLIAGEANISY---I---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 183 ~~~~~~~~~~~~---~---~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
............ . .+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--- 229 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--- 229 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 755432221111 1 1346999999854 458999999999999999886 9999988776655544432111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+ .+..++..+.+++.+||+.||++||++.+++.
T Consensus 230 ---------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 ---------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=285.74 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=196.0
Q ss_pred ceeeeeeeecCCCceEEEEEECC-CCcEEEEEEeeccc--------------cchHHHHHHHHh-cCCCceeeeceeeee
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMRV-MDHPNVISLKHCFFS 96 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~--------------~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 96 (374)
.|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... .....|+.++.. ++|+||+++++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 48889999999999999999887 67889999874221 112356666654 79999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
.....+++|||+++ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++. ++.++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~ 154 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT 154 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence 34458999999985 6766665544456779999999999999999999995258999999999999996 77899
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.+....+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence 999999986554443345567888999999865 448999999999999999999999998776555444433311110
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.....+++.+.+++.+||+.||++||++.|+..+
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112368899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=295.09 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=192.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
..+|++.+.||+|+||.||+|.+... +..+|+|.+.... ....+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 34799999999999999999986432 2368999775432 2334789999999 7999999999883
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
....++++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+|
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N 164 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN 164 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence 33348899999985 77777654221 22457888899999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
|+++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99996 778999999998755432211 11223467999999865 458999999999999999998 8999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+....+..... ...+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 655544432100 00123468899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=313.04 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=201.4
Q ss_pred ceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
+-...+.||+|+||+||+|+... ....||||.+.+.. ..+++|++++..++|||||++++++. ..
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence 45668899999999999998653 34569999886543 34569999999999999999999994 33
Q ss_pred eEEEEEeeccc-chHHHHHHhhhh------c----CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSS------A----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~------~----~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
..+|+|+|||. |+|.++|..... . ..+++..+...|+.||+.|++||-+ +.+|||||-..|+||.+ +
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge-~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE-N 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-c
Confidence 34999999999 788888875321 1 2338999999999999999999999 79999999999999996 8
Q ss_pred CcEEEEeeccccccccCCCcce---eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017270 172 HQVKICDFGSAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 247 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 247 (374)
..|||+|||+++.....++... ..-...|||||.++.. .++.+|||||+||+|||+++ |..||.+..+.+.++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 8999999999997665554332 2335679999999754 59999999999999999998 99999999999888777
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~ 312 (374)
.+..-. .-+++.|.++.+|+..||+..|.+||+..||
T Consensus 719 ~~g~lL----------------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQLL----------------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCcc----------------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 652110 0245789999999999999999999999987
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.60 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=193.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECC----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4689999999999999999999876 35789999875432 2234789999999999999999876432
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~----~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
....+++++|++ ++|...+...... ...+++..++.++.|++.||+|||+ ++++||||||+||+++. ++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEEE
Confidence 234779999998 5776666543222 1568999999999999999999999 79999999999999986 788999
Q ss_pred EeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 177 CDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+|||+++.+...... ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence 999999865433211 112345679999998654 48999999999999999998 999998876654433222210
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+ ....+++++.+++.+||..||++|||+.++++
T Consensus 237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 11236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.43 Aligned_cols=236 Identities=24% Similarity=0.295 Sum_probs=183.2
Q ss_pred eeecCCCceEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeec
Q 017270 39 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
.||+|+||.||+|.+. .++..||+|.+.... ....+|+.+++.++|+||+++++++. . ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence 3899999999999765 345679999885442 22347899999999999999998762 1 137899999
Q ss_pred ccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC
Q 017270 112 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190 (374)
Q Consensus 112 ~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~ 190 (374)
+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence 985 56555542 34578999999999999999999999 79999999999999996 77899999999975433322
Q ss_pred cc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 191 NI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 191 ~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. ...+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+.+. ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~------------ 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KR------------ 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CC------------
Confidence 11 1122467999999854 448999999999999999996 99999887766554433321 00
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..++...++++.++|.+||..||++||++.++.+
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0022346899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.49 Aligned_cols=236 Identities=28% Similarity=0.379 Sum_probs=184.9
Q ss_pred eeeecCCCceEEEEEECCCC---cEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|....++ ..+|+|.+..... ...+|+.+++.++|+||+++++++. .. .+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 46999999999999876554 7899998865443 2346899999999999999988762 11 368999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ +|.+.+.. ...+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99985 67666653 3478999999999999999999999 79999999999999996 788999999998765433
Q ss_pred CCcc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 189 EANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 189 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+... . +
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~-~--------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E-R--------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-c---------
Confidence 2211 1122457999999854 458999999999999999998 99999877665544433221 0 0
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..++..+.++|.+||+.||.+||++.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.47 Aligned_cols=239 Identities=26% Similarity=0.361 Sum_probs=188.9
Q ss_pred eeeecCCCceEEEEEECC-CCc--EEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|++|.||+|.+.. +++ .+|||.+..... ...+|+.+++.++|+||+++++.+.. ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999865 333 689998865543 34479999999999999999988743 4588999
Q ss_pred eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||++ ++|.+.+..... ..+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence 9997 577776654221 568999999999999999999999 79999999999999996 688999999999865442
Q ss_pred CCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 189 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 189 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 219 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER---------- 219 (257)
T ss_pred ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence 211 12345678999999854 458999999999999999998 99999877766655554331000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 220 -----~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 -----L------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----C------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 011246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.25 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=193.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
.+|++.+.||.|+||.||+|+++.+ .+.+++|.+..... ...+|+.+++.++|+||+++++.+ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 5899999999999999999997643 46799998754332 245799999999999999999887 33
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
....++||||++ ++|.+.+...... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence 345889999998 4777666543211 1268999999999999999999999 79999999999999996 77899
Q ss_pred EEeeccccccccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 176 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 176 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
++|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999987443221 12234557789999998544 47899999999999999998 88999766554443332210
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+ .....++..+.+++.+||+.||++|||+.+++.+
T Consensus 235 ---------------~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ---------------KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 0123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.35 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=188.7
Q ss_pred cceeeeeeeecCCCceEEEEEE----CCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.+|++.+.||+|+||.||+|.. ..+++.||+|.+..... ...+|+.+++.++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 4899999999999999999974 45788999998854332 345799999999999999998876432 233
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCccc
Confidence 48899999974 67666643 23468999999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCCCcc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHH
Q 017270 183 KQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTRE 257 (374)
Q Consensus 183 ~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~ 257 (374)
.......... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..|+...... ....+..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence 8654332211 11224459999998654 5899999999999999999988776543221 1110000000 00000
Q ss_pred HH-hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+ ...... ... .....++.++.+|+.+||+.||++|||+.+++.
T Consensus 234 ~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNN---GRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcC---CcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 000000 000 012357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.16 Aligned_cols=236 Identities=18% Similarity=0.227 Sum_probs=180.4
Q ss_pred eeeecCCCceEEEEEECCCCc-------EEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 38 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+.||.|+||.||+|.+..++. .+|+|.+..... ...+|+.+++.++|||++++++.+.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 468999999999999865543 388887754322 2346888999999999999999885432 378
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-------cEEEEe
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKICD 178 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~-------~ikl~D 178 (374)
+||||+++ +|...+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++. .++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999986 56555542 23468999999999999999999999 79999999999999986332 279999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
||.+..... .....+++.|+|||++.+...++.++|||||||++|+|++| ..||...+..........
T Consensus 152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-------- 220 (258)
T cd05078 152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-------- 220 (258)
T ss_pred cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------
Confidence 999865432 22345678899999996655679999999999999999998 466665554433221111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.. .++...+.++.+|+.+||+.||++|||++++++.
T Consensus 221 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------RH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------cc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 0122356789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=281.29 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=191.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|++.+.||.|+||.||+|.+. ++..+|+|.+.... ....+|+++++.++|||++++++++. .....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence 47999999999999999999875 46789999886432 23457999999999999999998873 33458899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+.+ +|.+.+.. ....+++..++.++.|++.|+++||+ ++++|+||||+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence 999986 55444432 23568899999999999999999999 79999999999999995 77899999999875433
Q ss_pred CCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------ 219 (256)
T ss_pred CcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence 2211 12234567999999865 458899999999999999998 9999987776555544322100
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00112357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=280.78 Aligned_cols=242 Identities=28% Similarity=0.403 Sum_probs=192.6
Q ss_pred eeeeeeecCCCceEEEEEECCCC----cEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 35 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+.+.||.|+||.||+|.+..++ ..+|+|.+..... ....|+.+++.++|+||+++++.+.. ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence 56789999999999999998766 8899998865432 34479999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++|||+++ +|.+.+.... ...+++..+..++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCcee
Confidence 899999985 6666665321 1228999999999999999999999 79999999999999996 77899999999976
Q ss_pred cccCCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 185 LIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 185 ~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
........ ...+++.|+|||.+. ...++.++|+||+|+++|+|++ |.+||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 54432211 123567899999984 4558999999999999999998 8999988766655554433110
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+...+.++.+++.+||..||++|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0012236889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.91 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=189.5
Q ss_pred cceeeeeeeecCCCceEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeee
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL 90 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~ 90 (374)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999986532 34468999886432 233479999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCC
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~-------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp 162 (374)
++++.. ....++||||+.+ +|.+.+...... ...+++..++.++.|++.||+|||+ +|++||||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 998843 2348899999984 777666542211 1347788999999999999999999 7999999999
Q ss_pred CcEEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh--CCCCCCC
Q 017270 163 QNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 237 (374)
Q Consensus 163 ~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~ 237 (374)
+||+++. ++.++|+|||++......... .....++.|+|||...+. .++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999986 788999999998765332211 112335679999987654 58999999999999999998 7789977
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+............. .....+ .+..+++.+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQG-----------RQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhcc-----------ccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665554433222110000 000000 11246789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.71 Aligned_cols=236 Identities=16% Similarity=0.192 Sum_probs=176.9
Q ss_pred eeeecCCCceEEEEEECC------------CCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 38 RVVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~------------~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
+.||+|+||.||+|+... ....+|+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 468999999999998532 223588887654322 234678899999999999999987432
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-------cE
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QV 174 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~-------~i 174 (374)
...++||||++++.+..+.. .....+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++ .+
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred -CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCcee
Confidence 33789999999654333322 234568999999999999999999999 79999999999999975 33 38
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll-~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
+++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+... ....
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--- 224 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--- 224 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc---
Confidence 99999998654322 23456788999999865566899999999999999998 5888887654332211 1110
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
... .....++++.+||.+||+.||.+||+..+++++
T Consensus 225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 011246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=294.71 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=190.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+++|.-...||+|+||.||+|.. .+|..||||++.... .....|+.++.+++|||+|++++++.+... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 346777788999999999999985 455899999885533 336789999999999999999999854331 47
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--CeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 106 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 106 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
++|+||++ |+|.+.+...... .++|.....|+.+++.||+|||+.. -|+||||||+|||+|. +...||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCc
Confidence 89999999 6777777642211 8899999999999999999999942 3999999999999996 889999999999
Q ss_pred ccccc-CCCccee-eeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHH
Q 017270 183 KQLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEII-KVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~-~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~--~~~~~~~i~-~~~~~~~~~ 257 (374)
+.... .....+. .||..|+|||.+.. ...+.++|||||||++.|+++|+.+..... ....+.... ..+.....
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~- 302 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL- 302 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch-
Confidence 76554 3332333 78999999999854 458999999999999999999998877532 111111111 11111100
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.++.-+.+.... +.. ..-..+..+..+|++.+|..||++.|++
T Consensus 303 ---------~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 303 ---------REIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred ---------hheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 011001111000 000 0122366788999999999999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=283.29 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=192.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|+||+||+|.+..+|. .+|+|....... ...+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3589999999999999999999877665 589997755432 23478999999999999999998743
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...++||||+.+ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCc
Confidence 237899999984 66666653 34468999999999999999999999 89999999999999986 7789999999
Q ss_pred cccccccCCCcce---eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+++.......... ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 230 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL--- 230 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC---
Confidence 9986543322211 122457999999854 458999999999999999998 99999887765544443321000
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...+.++.+++.+||..||..||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 -------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011235788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=279.31 Aligned_cols=237 Identities=25% Similarity=0.368 Sum_probs=185.9
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
+.||.|+||.||+|.+.. ++.||+|.+.... ....+|+++++.++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 468999999999999877 9999999875432 23457999999999999999998874 333488999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
.+ +|.+.+.. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||.+.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence 75 56555542 34568899999999999999999999 89999999999999996 778999999998754422211
Q ss_pred ---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 192 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 192 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 112235569999998554 58999999999999999999 8999987765544433322100
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.86 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=184.6
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
+.||+|+||.||+|.. .++..+|+|.+..... ...+|+.+++.++||||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 4689999999999985 4688999998754321 23478999999999999999998733 33488999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCc
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~ 191 (374)
++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence 85 55555432 23468899999999999999999999 79999999999999986 788999999998754332211
Q ss_pred c--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcC
Q 017270 192 I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268 (374)
Q Consensus 192 ~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 268 (374)
. ...++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...........+.....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 212 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---------------- 212 (250)
T ss_pred cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 1 1233567999999854 458899999999999999998 9999988766554443322100
Q ss_pred CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..++..+.+++.+||+.||++||++.++++
T Consensus 213 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 ------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0012347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=307.24 Aligned_cols=206 Identities=27% Similarity=0.398 Sum_probs=171.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecC-CCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (374)
.-|..-+.||+||||.||+++++.+|+.||||.+.+.. ...-+|+++|++++|+|||+++++=-+.. ..-...-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45777889999999999999999999999999886532 23347999999999999999977542111 0002235
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC---CCcEEEEeecc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGS 181 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~---~~~ikl~Dfg~ 181 (374)
.+|||||.| +|...+.. ..+...+++.++..++.++..||.|||+ +||+||||||.||++-.. ...-||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 589999995 66666654 3455679999999999999999999999 899999999999998421 23589999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~ 239 (374)
|+...++....+.+||+.|.+||++..+..|+..+|.||+||++|+++||..||....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999988888899999999999999655779999999999999999999999996553
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=282.20 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=182.7
Q ss_pred eeeecCCCceEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||+||+|.... ....+|+|.+.... ....+|+.+++.++|+||+++++.+. ....+++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 368999999999996432 34568888764332 12346888999999999999999883 3344889999
Q ss_pred cccc-hHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 111 YVPE-SMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~-~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|+++ +|.+.+...... ....++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence 9985 777766543221 2345678889999999999999999 79999999999999996 788999999998654322
Q ss_pred CC---cceeeeeccccchhhhhC------CCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 189 EA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 189 ~~---~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
.. .....+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+.+..+.......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---- 229 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---- 229 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence 21 112234667999999742 2346889999999999999999 889998877666555544321110
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+ ...+...+++.+.+++..|+ .||++|||++++++
T Consensus 230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 01123357888999999998 59999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=281.69 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=190.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..+|.+.+.||.|+||.||+|.+... ...+|||...... ....+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~ 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C
Confidence 34799999999999999999987544 3468999875433 134469999999999999999987632 1
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~ 153 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGL 153 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCce
Confidence 25799999985 67666653 23468999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCCCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 182 AKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 182 a~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
+.......... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----- 227 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----- 227 (270)
T ss_pred eeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence 87654332211 1223457999999854 458999999999999999996 99999888766555443321000
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..++..+.+++.+||..+|.+|||+.+++.
T Consensus 228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=280.14 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=191.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||++... .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 458999999999999999999854 45679999876533 234579999999999999999888732 23789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence 9999984 777776532 34568888999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+.......+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------- 222 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC----------
Confidence 32211 12234567999999854 458999999999999999998 99999887665554443321100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+ .....+.++.+++.+||+.||++||++.+++
T Consensus 223 --------~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 223 --------P----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred --------C----------CcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 0 1134688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=282.81 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=187.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|++.+.||+|+||+||+|....+++ .+++|.+.... .....|+..+..++||||+++++++. +.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 589999999999999999999887776 47777764322 12234666788899999999998762 11
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++++||++ |+|.+.+.. ....+++..+..++.||+.||.|||+ ++++||||||+||+++. ++.+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCcc
Confidence 2668899988 577766653 34568999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....... ++++....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~-- 231 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLA-- 231 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC--
Confidence 9865433221 123346679999998654 58999999999999999998 99999887654432 2222100000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...+.++.+++.+||..||++|||+.|+++
T Consensus 232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11235678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=284.34 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=187.1
Q ss_pred ceeeeeeeecCCCceEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
-|++++.||+|+||.||+|+. ..++..||+|.+.... ....+|+.+++.++|+|++++.+++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 578999999999999999974 4568889999885332 2345799999999999999998877432 224
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccc
Confidence 47899999985 56655542 23468999999999999999999999 89999999999999996 778999999999
Q ss_pred cccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---
Q 017270 183 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 255 (374)
Q Consensus 183 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 255 (374)
......... ....++..|+|||.+.+. .++.++|||||||++|+|+++..|+..... ... +..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccc
Confidence 765433221 123446679999998654 588999999999999999998776533211 010 0000000
Q ss_pred -HH-HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 -RE-EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.. ........ .....+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 00000000 0001123578999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=281.40 Aligned_cols=246 Identities=20% Similarity=0.231 Sum_probs=181.9
Q ss_pred eeeecCCCceEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||.||+|... .++..+|+|.+.... ....+|+.+++.++||||+++++++. ....+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 46899999999999854 345779999875432 23346899999999999999998873 3334889999
Q ss_pred ccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 111 YVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 111 ~~~-g~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|++ |+|.+.+..... .....++..++.++.|++.|+.|||+ ++++||||||+||+++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence 998 467666654322 22356777888999999999999999 79999999999999996 788999999998754322
Q ss_pred CCc---ceeeeeccccchhhhhCCC------CCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 189 EAN---ISYICSRFYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 189 ~~~---~~~~~t~~y~aPE~l~~~~------~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
... ....+++.|+|||++.+.. .++.++|+|||||++|+|++ |..||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 211 1234567899999984321 35789999999999999996 99999877655544332221000
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+ ...+....++.+.+++.+|+ .||++|||+++++.
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00011236788999999999 68999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=284.49 Aligned_cols=235 Identities=19% Similarity=0.243 Sum_probs=177.5
Q ss_pred eeecCCCceEEEEEECCC------------------------CcEEEEEEeecccc----chHHHHHHHHhcCCCceeee
Q 017270 39 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISL 90 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~------------------------~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~ 90 (374)
.||+|+||.||+|....+ ...||+|.+..... ...+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999975322 23588887754322 23467889999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
++++... ...++||||++++ |...+. .....+++..+..++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence 9988433 3478999999975 433433 234678999999999999999999999 79999999999999974
Q ss_pred C------CCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHH-hCCCCCCCCChHH
Q 017270 170 L------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 242 (374)
Q Consensus 170 ~------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll-~g~~pf~~~~~~~ 242 (374)
. ...+|++|||++...... ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||......+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 2 124899999988643222 22356778999999866556899999999999999995 6999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 243 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
... .... ... ++...++.+.++|.+||+.||++|||+.+++++
T Consensus 230 ~~~-~~~~-----------------~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KER-FYEK-----------------KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHH-HHHh-----------------ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 322 1110 000 112246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=278.67 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=190.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
..+|++.+.||+|+||.||++. .+++.||+|.+..+. ....+|+.+++.++|||++++++++.. . ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~---~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---N---GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---C---CcEEE
Confidence 3589999999999999999986 378889999885432 234579999999999999999988732 1 16899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceeccc
Confidence 999985 777776532 23468999999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 266 (374)
.. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||...+..+....+.+...
T Consensus 153 ~~--~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 215 (254)
T cd05083 153 GV--DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------------- 215 (254)
T ss_pred cC--CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC--------------
Confidence 21 12233567999999854 458999999999999999997 9999988776554433322100
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. .....+++.+.+++.+||+.+|.+||++++++.
T Consensus 216 ----~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ----M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=282.32 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=186.1
Q ss_pred eeeecCCCceEEEEEECCCC------cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 38 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
+.||+|+||.||+|++.... +.+|+|.+.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 36899999999999976443 679999875432 233478999999999999999998743 33488
Q ss_pred EEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-----cEEEE
Q 017270 107 LVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKIC 177 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~-----~ikl~ 177 (374)
+||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++ .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999984 77777654322 22457889999999999999999999 79999999999999986 44 79999
Q ss_pred eeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 017270 178 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 178 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~ 231 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR 231 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc
Confidence 9999875433221 112344678999999865 458999999999999999998 99999877665544433210 00
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+ ..+..+++.+.++|.+||+.+|.+||+++++++
T Consensus 232 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L---------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c---------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 012346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.30 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=189.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+..... ...+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3578999999999999999999887776 468887754422 234688999999999999999977421
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..++++||++ |++.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg 154 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFG 154 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEcccc
Confidence 1568999998 566666542 23468899999999999999999999 79999999999999985 7789999999
Q ss_pred cccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...... ..++.....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-- 230 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL-- 230 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC--
Confidence 99865433221 12334678999999865 458999999999999999997 9999987654332 2222211100
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+ .+...+..+.+++.+||..||++||++.++++.
T Consensus 231 ---------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 112357789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=294.22 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=192.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCc---E-EEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
+-.+.+.||+|+||.||+|..+..+. . ||+|....+. ...-+|+++++.++|||||+++++...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~----- 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL----- 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----
Confidence 34456899999999999999775422 3 8999776422 122379999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++|||+|.| +|.+.|+. ....++..+...++.+.+.||+|||+ ++++||||-..|+|++. ++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCccc
Confidence 3338999999996 67777764 33369999999999999999999999 79999999999999996 6778999999
Q ss_pred cccccccCCCcc-eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 181 SAKQLIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 181 ~a~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
+++......... ...-...|+|||.+... .|+.++||||+||++||+++ |..||.+....+...+|...
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 987544111111 11224579999999544 69999999999999999998 88999999998888887541
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.++.+ .+...+.++..++.+|+..||++|||+.++.
T Consensus 379 ---------~~r~~----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 379 ---------GYRMP----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred ---------CccCC----------CCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 11111 2335688999999999999999999998875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.28 Aligned_cols=239 Identities=24% Similarity=0.383 Sum_probs=180.0
Q ss_pred eeeecCCCceEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.++||||+++++.+.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998653 34579999874322 233468889999999999999886532 223467999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||+.+ +|.+.+.. .....++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||++......
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99984 66666543 23456777888899999999999999 79999999999999996 778999999998754332
Q ss_pred CC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 189 EA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 189 ~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... .+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~------- 221 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL------- 221 (262)
T ss_pred cceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC-------
Confidence 11 112234667999999855 458999999999999999999 56778766655444333220 000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+++.+.+++.+||+.||++||++.++++
T Consensus 222 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 222 -------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011236788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=278.36 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=189.5
Q ss_pred eeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCc-e
Q 017270 34 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE-L 103 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~-~ 103 (374)
|.+.+.||+|+||.||+|... .+++.+|||.+..+.. ...+|+.+++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 3578899998865321 23478999999999999999997754432222 2
Q ss_pred EEEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..++++||+.+ ++...+.... .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence 35788999984 5555443211 122357899999999999999999999 89999999999999986 7789999999
Q ss_pred cccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+++....... .....+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~-~-- 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N-R-- 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C-c--
Confidence 9886543221 112234567999999854 457899999999999999999 89999877665544433321 0 0
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.. .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 234 ------------~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 234 ------------LK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11236789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=276.98 Aligned_cols=246 Identities=20% Similarity=0.254 Sum_probs=182.1
Q ss_pred eeeecCCCceEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.||+|+||+||++....+ ...+++|.+.... ....+|+.+++.++||||+++++.+. .....|+|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 3689999999999975433 3456677664332 23446888899999999999999884 3345889999
Q ss_pred cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 111 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 111 ~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
|+++ +|.+.+.........+++..++.++.||+.||+|||+ ++++||||||+|||++. ++.++|+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcch
Confidence 9995 7777766433334457788889999999999999999 79999999999999996 7789999999986432211
Q ss_pred ---CcceeeeeccccchhhhhCC------CCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 190 ---ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 190 ---~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
......++..|+|||++... ..++.++|||||||++|+|++ |..||......+.+..+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK----- 228 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-----
Confidence 12234567889999987421 135789999999999999997 678998777666665554321100
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+...+...+++.+.+++..|| .||++||+++++++
T Consensus 229 ------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011122346788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.64 Aligned_cols=233 Identities=18% Similarity=0.207 Sum_probs=178.6
Q ss_pred eeeecCCCceEEEEEECCCC----------cEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 38 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
+.||+|+||.||+|.+..++ ..+++|.+.... ....+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 46899999999999998776 357888765433 234578899999999999999998744 22
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-------cEEE
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKI 176 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~-------~ikl 176 (374)
.++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence 6799999996 55555543 22368999999999999999999999 79999999999999986 44 6999
Q ss_pred EeeccccccccCCCcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 177 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
+|||++..... .....++..|+|||.+.+. ..++.++|+|||||++|+|++ |..||...+..+....... .
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~ 222 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q 222 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C
Confidence 99999876443 2234456779999998654 358999999999999999999 6888876643322211110 0
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.. .+......+.++|.+||+.||.+|||+.++++
T Consensus 223 ------------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ------------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00112378999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=283.74 Aligned_cols=284 Identities=28% Similarity=0.472 Sum_probs=216.2
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECC---CCcEEEEEEeec--cccchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQ--DRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
.|...+.|.+++.||+|.|++||+|.+.. ..+.||+|.+.. .......|+++|..+ .+.||+++.+++ .
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 45667789999999999999999999887 678899998843 334567899999988 588999999988 5
Q ss_pred CceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.+....+|+||++.. ..++.. .++..+++.|++.++.||+++|. +|||||||||+|+|.+...+.-.|+||
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEec
Confidence 555588999999953 333332 36788899999999999999999 899999999999999988889999999
Q ss_pred ccccccc-----------------c-C---------------------------CCcceeeeeccccchhhhhCCCCCCC
Q 017270 180 GSAKQLI-----------------A-G---------------------------EANISYICSRFYRAPELIFGATEYTT 214 (374)
Q Consensus 180 g~a~~~~-----------------~-~---------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~ 214 (374)
|+|.... . . .......||++|+|||++...+.-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9986110 0 0 00012468999999999988887899
Q ss_pred chhhHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcC------------------cCCcCCCCCCCC
Q 017270 215 SIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCMN------------------PNYTDFRFPQIK 275 (374)
Q Consensus 215 ~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~ 275 (374)
++||||.|||+..+++++.||- ..++.+.+.+++..+|...-....... .+|.......+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999998874 456667777777776654433221111 111111101111
Q ss_pred C----CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 276 A----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 276 ~----~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
. ..+.....+..+..+.||+.+||+.||.+|+|++++|.||||.....
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0 12334444556779999999999999999999999999999986543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.20 Aligned_cols=246 Identities=22% Similarity=0.379 Sum_probs=199.1
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCc-----EEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.-...+.||+|+||.||.|....... .||||.+.+... .+.+|..+|+.++|||||+++++.++...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--- 769 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--- 769 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC---
Confidence 45678899999999999998764432 399998865432 33479999999999999999999976333
Q ss_pred eEEEEEeeccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
.+|++|||. |+|+.+|+.-+. ....++...+..++.||++|++||++ +++|||||...|+|++. ...+||+|
T Consensus 770 --~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKIaD 845 (1025)
T KOG1095|consen 770 --PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKIAD 845 (1025)
T ss_pred --cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEEcc
Confidence 779999999 578888875321 14568999999999999999999999 79999999999999997 68899999
Q ss_pred eccccccccCCCcce-e--eeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 179 FGSAKQLIAGEANIS-Y--ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 179 fg~a~~~~~~~~~~~-~--~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|+.......... . .-..-|||||.+.. ..++.++|||||||++||+++ |..||++.++.+.+....+.-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--- 921 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---
Confidence 999995544333221 1 12346999999964 569999999999999999998 999999999888877655521
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+++ .+..+++.+.+++.+||+.||++||+...+++
T Consensus 922 ---------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ---------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 111 13458999999999999999999999998876
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=275.80 Aligned_cols=260 Identities=27% Similarity=0.368 Sum_probs=189.4
Q ss_pred cceeeeeeeecCCCceEEEEEEC----CCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..|.+.+.||+|+||.||+|... .+++.+|+|.+..... ...+|+++++.++|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 47888999999999999999864 3478999998865433 34579999999999999999887633 224
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+ +|++|+||||+||+++. ++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence 458899999985 67666653 23368999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCcc----eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 017270 182 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 256 (374)
+.......... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... +... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~ 232 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV 232 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence 98665322211 12334569999998554 5899999999999999999999998654321100 0000 000000
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+...... .... ..+...+.++.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 233 TRLLELLKE--GERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHc--CCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000000 0000 012246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.22 Aligned_cols=274 Identities=22% Similarity=0.284 Sum_probs=182.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEEC----------------CCCcEEEEEEeecccc------------------chHH
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR 74 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~------------------~~~~ 74 (374)
...++|.+.+.||+|+||+||+|... ..++.||||++..+.. ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45679999999999999999999752 2356799998854321 1123
Q ss_pred HHHHHHhcCCCce-----eeeceeeeecCC---CCceEEEEEeecccc-hHHHHHHhhh-----------h---------
Q 017270 75 ELQLMRVMDHPNV-----ISLKHCFFSTTS---KNELFLNLVMEYVPE-SMYRVLKHYS-----------S--------- 125 (374)
Q Consensus 75 e~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~g-~l~~~l~~~~-----------~--------- 125 (374)
|+.++.+++|.++ +++++++..... ......++||||+++ +|.+.+.... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666677766654 555555532211 112347899999995 6666654211 0
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcce--eeeeccccch
Q 017270 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAP 203 (374)
Q Consensus 126 ~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~~t~~y~aP 203 (374)
....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||++........... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11235677889999999999999999 79999999999999996 77899999999975443322222 2347899999
Q ss_pred hhhhCCCC-------------------C--CCchhhHhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 204 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 204 E~l~~~~~-------------------~--~~~~DiwslGvil~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
|.+..... + ..+.|+||+||++|+|++|.. ||........-.+.. ......|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHh
Confidence 99743211 1 234799999999999999875 775432211110000 000011111
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCC---CCCCCHHHHhcCCcccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~s~~e~l~hp~~~~ 320 (374)
.. ...+.-......++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 456 ~~------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YK------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hc------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0001111234578999999999999876 68999999999999963
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=282.99 Aligned_cols=238 Identities=31% Similarity=0.459 Sum_probs=191.2
Q ss_pred eeeeeeecCCCceEEEEEECC--CC--cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 35 MAERVVGTGSFGIVFQAKCLE--TG--ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~--~~--~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+.+.||.|-||.||.|.... .| -.||||....+. ..+..|..+++.++|||||++++++... ..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence 346789999999999998642 23 348899875532 3344799999999999999999998321 27
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+||||+++ |.|.+.++. ....++...+..|++||+.||.|||+ +++|||||...|||+.+ ..-+||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhhh
Confidence 89999999 777777764 45678999999999999999999999 79999999999999997 66699999999998
Q ss_pred cccCCCcceeee--eccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 185 LIAGEANISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 185 ~~~~~~~~~~~~--t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
..+........+ ..-|||||.+.- ..++.+||||.|||.+||+++ |..||.+-.+.+.+..+.+.-..|
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------- 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------- 612 (974)
T ss_pred ccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------
Confidence 766654433333 445999999844 458999999999999999987 999999987777665554421111
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~ 312 (374)
.++++|+.+..|+.+||++||.+||...++
T Consensus 613 ---------------------~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 613 ---------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ---------------------CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 345799999999999999999999987654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.39 Aligned_cols=242 Identities=23% Similarity=0.384 Sum_probs=200.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+..+.+.||.|.||.||.+..++-.-.||||.+..+.. .+.+|+.+|+.++|||+|++.+++.. +..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEE
Confidence 45667899999999999999998888999998876643 34479999999999999999999833 33489999
Q ss_pred eccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|||. |+|++.|+.. +...++...+..++.||..|++||.. +++|||||...|+||.+ ++.+|++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcCC
Confidence 9987 8999998753 33457888889999999999999999 89999999999999996 889999999999987655
Q ss_pred CCcc--eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 189 EANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 189 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.+.. ......-|.|||.+. .+.++.++|||+|||+|||+.| |-.||++-+....+..+.+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk---------------- 481 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK---------------- 481 (1157)
T ss_pred ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc----------------
Confidence 4322 122245699999985 4458999999999999999998 9999999987776655544
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~ 312 (374)
+|++.. ++.+++.+.+|++.||+|.|.+||+..|+
T Consensus 482 --gyRM~~----------PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 482 --GYRMDG----------PEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --cccccC----------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 222221 35689999999999999999999998876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.13 Aligned_cols=250 Identities=31% Similarity=0.466 Sum_probs=191.5
Q ss_pred eeeeeeeecCCCce-EEEEEECCCCcEEEEEEeecccc-chHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEee
Q 017270 34 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 34 y~i~~~lg~G~~g~-V~~a~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
|.-.+.+|.|+-|+ ||+|.. .|+.||||.+..+.. ...+|+.+|+.- +|||||+++..= .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 44567899999986 698876 788999998876654 678999999888 599999986543 67778999999
Q ss_pred cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC----CCcEEEEeeccccccc
Q 017270 111 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQLI 186 (374)
Q Consensus 111 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~----~~~ikl~Dfg~a~~~~ 186 (374)
.|..+|.+++...............+.++.|++.||++||+ -+||||||||.||||+.. ..+++|+|||+++...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999887531111222225567889999999999999 599999999999999752 2579999999999876
Q ss_pred cCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 187 AGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 187 ~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
.+... .+..||.+|+|||++.+.. -+.++|||||||++|+.++| ..||...-. .-.+|+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~----------- 728 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG----------- 728 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC-----------
Confidence 65432 3457899999999997654 57799999999999999985 899976432 22233320
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+..-++ ......++.|||.+||++||..||+|.++|.||||-.
T Consensus 729 ------~~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 729 ------NYTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ------ccceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 1111110 0111228999999999999999999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=260.45 Aligned_cols=238 Identities=38% Similarity=0.644 Sum_probs=190.4
Q ss_pred CCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc-hHH
Q 017270 44 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMY 117 (374)
Q Consensus 44 ~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~ 117 (374)
+||.||+|.+..+++.+|+|++.... ....+|+..++.++|+|++++.+.+.. ....++++|++++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999999899999999886542 344589999999999999999988743 2458899999997 777
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeee
Q 017270 118 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 197 (374)
Q Consensus 118 ~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t 197 (374)
+.+.. ...+++..++.++.+++.++.+||+ .+++|+||+|+||+++. ++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence 66653 2338999999999999999999999 79999999999999996 688999999999876554444456678
Q ss_pred ccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCC
Q 017270 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 277 (374)
Q Consensus 198 ~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (374)
..|++||.+.+ ..++.++|+||+|+++++|++|..||..........+.........
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 206 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------------------- 206 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence 88999999864 4578899999999999999999999987433333333222100000
Q ss_pred ChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 278 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 278 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
......++.++.+++.+||..||++||++.++++||||
T Consensus 207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=288.62 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=204.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCC---cEEEEEEeec-----cccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.-.|.++||.|.||.|++++.+..| ..||||.+.. .+..+..|+.||-+++||||+++.++. .....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 4578899999999999999987666 4599998853 344556799999999999999999988 33334
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+-||+|||+ |+|..+|+. .++.|+..++..+++.|+.|++||-++ ++|||||...||||++ +-..|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNs-nLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeecc-ceEEEecccccee
Confidence 779999999 577777764 457799999999999999999999995 9999999999999997 8899999999999
Q ss_pred ccccCC-Ccceeee---eccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGE-ANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~-~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
...++. ...+..| ...|.|||.+. ..+++.+|||||+|++|||.++ |..||-...+.+.+..|.+..+.|++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence 765544 2223222 45799999995 4569999999999999999886 99999999999999999886666553
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
-++|..+.+|+..||++|-.+||...||++
T Consensus 857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 247899999999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=278.46 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=202.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-C--cEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-~--~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
++..+.+.||+|.||+|++|..... | ..||||++..+.. .+.+|+.+|.+|+|+|++++|+++.+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 4566788999999999999987643 3 3589999865543 3458999999999999999999985421
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.-+|||++. |+|++.|.. .....|....+..|+.||+.|+.||.+ ++.|||||...|+|+.. ...|||+|||+.
T Consensus 185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLM 259 (1039)
T ss_pred -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccce
Confidence 559999999 688888775 345678899999999999999999999 89999999999999986 778999999999
Q ss_pred cccccCCCcceeee----eccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 183 KQLIAGEANISYIC----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~~~~~~~~~----t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+....++..+.... ...|+|||.+.. ..++.+||+|++||++|||++ |..||.+......+.+|-+.-.
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er----- 333 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER----- 333 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-----
Confidence 87766555443222 345999999954 569999999999999999998 8999999998888776643111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
++ -++.+++++.+++.+||..+|++|||...|...-+..
T Consensus 334 -------------Lp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 334 -------------LP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -------------CC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 01 1235899999999999999999999998886544443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=272.75 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=198.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
....+++.||+|-||.|.+|.- ..+..||+|++..+. ..+.+|+++|.+|+||||+.+.+++..... +|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence 3578899999999999999984 446899999986442 445689999999999999999999854433 89
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||++ |+|.+++..... ..+......+|+.||+.|++||.+ -++|||||.+.|+|++. +..+||+|||+++..
T Consensus 612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCccccccc
Confidence 9999998 677777764321 224555566799999999999999 59999999999999996 888999999999977
Q ss_pred ccCCCcc---eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
..++... ..+-...|||+|.++- .+++.+||+|++|+++||+++ ...||....+.+...+....+..+.+.-+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 6665432 2344678999999964 459999999999999999875 789999888877776666544433322111
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
..+.-++..+.+++.+||..|-.+|||.+++-
T Consensus 767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 12234788999999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=242.21 Aligned_cols=212 Identities=23% Similarity=0.414 Sum_probs=174.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHH-HhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+...-+..||+|+||.|-+.+|..+|...|+|.+...... ..+|+++. +...+|.+|.+++.+++..+ +
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----v 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----V 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----E
Confidence 4555677899999999999999999999999988543321 12344433 23369999999998866544 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|.||.+.-++..+-.+....+..++|..+-+|+.-++.||.|||+.-.++|||+||+|||++. .+++|+||||++...
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEcccccceee
Confidence 8999999998888877777889999999999999999999999999558999999999999996 889999999999876
Q ss_pred ccCCCcceeeeeccccchhhhhC---CCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 017270 186 IAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIK 249 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~ 249 (374)
.+.-..+...|...|+|||.+.. +..|+-+|||||||+.+.||.+++.||... ++.+++.++++
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 66555554677888999999832 336899999999999999999999999876 56677776665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=303.55 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=181.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
.|...+.||+|+||.||+|++..++..||+|++........+|++.+++++|||||++++++... ...++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence 45667889999999999999999999999999876555556789999999999999999998433 3378999999
Q ss_pred cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 113 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 113 ~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH---~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
++ +|.+.+. .+++..+..++.|++.|++||| + .+|+||||||+||+++. +...++. |+.+.....
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc-
Confidence 85 6666653 3788999999999999999999 6 69999999999999996 5656664 665543221
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHh-CCCCHHHHhhcCcCC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVL-GTPTREEIRCMNPNY 266 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~~~~~ 266 (374)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+.+..+.. ....... +
T Consensus 835 --~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 904 (968)
T PLN00113 835 --DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM-------W 904 (968)
T ss_pred --CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh-------e
Confidence 123467899999999865 4589999999999999999999999854211 11111111100 0000000 0
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+ +.+... .........++.+++.+||+.||++|||+.|+++.
T Consensus 905 ~~---~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ID---PSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eC---ccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00 000000 00001123467889999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=265.67 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=173.7
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch------------HHHHHHHHhcC---CCceeee
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRVMD---HPNVISL 90 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------~~e~~~l~~l~---h~~iv~~ 90 (374)
+++...-+|..++.||+|+||.|++|.++.+...|+||.+.+++... -.|+.+|..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 45556678999999999999999999999999999999887665322 25999999997 9999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 168 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~ 168 (374)
.++| +++.++|++||--+. +|.+.+. ....++|.++..|+.|++.|+++||+ .||+|||||-+|+.++
T Consensus 635 LdfF-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd 704 (772)
T KOG1152|consen 635 LDFF-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVD 704 (772)
T ss_pred hhee-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEe
Confidence 9999 777789999998874 4555544 57889999999999999999999999 6999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCC
Q 017270 169 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237 (374)
Q Consensus 169 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 237 (374)
+ +|-+||+|||.|... .......+.||..|.|||++.|....+..-|||++|++||.++....||..
T Consensus 705 ~-~g~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 705 S-NGFVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred c-CCeEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7 788999999999754 444556789999999999997777668999999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.78 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=206.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
-.++|..+..+|+|+||.||+|+++.+++..|+|++.-+ .....+|+-+++..+|+|||.+++.|..... +
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----l 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----L 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----c
Confidence 356899999999999999999999999999999988543 3445689999999999999999999955443 8
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++.||||+|+.++.+. ...+++++.++..+.++.+.+++|||+ .|=+|||||-.||+++. .+.+|++|||.+..+
T Consensus 88 wicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhh
Confidence 9999999975444443 256889999999999999999999999 69999999999999995 788999999998766
Q ss_pred ccC-CCcceeeeeccccchhhh--hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAG-EANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~-~~~~~~~~t~~y~aPE~l--~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
..- .+..+++|||+|||||+- .....|...+|+|++|+...|+---++|--....+..+..+-+..-.|
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-------- 234 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-------- 234 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC--------
Confidence 543 345679999999999995 234468999999999999999988887765555555444333311111
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
|.++. ..+-++.+.+|++.+|.++|.+|||++.+|.|||...
T Consensus 235 ---------p~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 235 ---------PTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ---------CcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11111 1134677889999999999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=265.95 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=188.8
Q ss_pred eeeeeeeecCCCceEEEEEECC---C----CcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 34 YMAERVVGTGSFGIVFQAKCLE---T----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~---~----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
..+.+.||+|+||.|++|.-.. . ...||+|.+.... .....|+++++.+ .|+||+.+.+++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 3566799999999999997431 1 3569999875433 3345799999988 59999999998844
Q ss_pred CceEEEEEeeccc-chHHHHHHhhh---h-------cC--CCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYS---S-------AN--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~---~-------~~--~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
...+++|+|||. |+|...++..+ . .. ..++...+..+++||+.|++||++ ..++||||-..|||+
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 344889999999 78888888654 0 01 238999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCCcce--eee--eccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCC-hH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEANIS--YIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-AV 241 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~~--t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~-~~ 241 (374)
.. +..+||+|||+|+.......... ..+ ...|||||.+.. ..|+.++||||+||+|||+++ |..||++.. ..
T Consensus 452 ~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 TK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred cC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 96 78899999999986544333221 111 234999999965 669999999999999999998 999999855 33
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+. .+.++...+ . ..+..+++++.++++.||+.+|++||+..++.
T Consensus 530 ~l-~~~l~~G~r-----------------~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 530 EL-LEFLKEGNR-----------------M----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HH-HHHHhcCCC-----------------C----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 33 333321111 0 02345799999999999999999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=233.84 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=184.1
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHhc-CCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
...+.|.|.+.||+|-||.+.+|+|+.++..+++|.++..... ..+|...--.| -|.||+.-|++-+.. ..+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc----Cce
Confidence 4557899999999999999999999999999999998765432 23454433333 489999998876533 336
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE-cCCCCcEEEEeeccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA 182 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll-~~~~~~ikl~Dfg~a 182 (374)
+.+++||++ |+|.+-+. ...+.|...+.++.|++.|+.|||+ +++||||||.+|||| +++..+|||||||+.
T Consensus 97 YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccc
Confidence 889999999 56555443 2568899999999999999999999 899999999999998 444568999999998
Q ss_pred cccccCCCcceeeeeccccchhhhhCC----CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 257 (374)
+....--. ...-+..|.+||+.... -...+.+|+|.||+++|.+++|.+||......+ -+.+.++-.+.-
T Consensus 171 ~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk--- 245 (378)
T KOG1345|consen 171 RKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK--- 245 (378)
T ss_pred cccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc---
Confidence 74321111 11124458999986432 124678999999999999999999997432221 111222111110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCcccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDE 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~ 320 (374)
.+.. ...| ..+++.+..+.++-|..++.+|. ++..-...-|...
T Consensus 246 -------------~~~~-----P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 246 -------------NPAL-----PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred -------------CccC-----chhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 0000 0011 24789999999999999999994 4555556666643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=242.55 Aligned_cols=263 Identities=25% Similarity=0.291 Sum_probs=181.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHH--hcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--VMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
....+.+.||+|.||.||+|.. +++.||||+++... .....|.+|.+ .++|+||++++..=-... .....+++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 3567788999999999999975 66999999996543 34456666665 458999999876542222 224458899
Q ss_pred eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 109 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------PRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 109 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--------~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
++|.+ |+|.+.|.. ..+++....+++.-+++||+|||+- ..|+|||||..||||.+ +.+..|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeecc
Confidence 99998 788888874 5799999999999999999999982 36999999999999996 889999999
Q ss_pred ccccccccCCC---cceeeeeccccchhhhhCCCCCC-----CchhhHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHH
Q 017270 180 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKV 250 (374)
Q Consensus 180 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~-----~~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~ 250 (374)
|+|..+..... ....+||..|||||++.|..... .+.||||+|.+||||++.-.-+. +....-++---.+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99987764432 23478999999999997765544 47999999999999997543221 11000000000001
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhccc-CCChhHHHHHHhhcCcCCCCCCCHH
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTAL 310 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~ 310 (374)
...|..+.....- ..+..+..|...+.. .....+++.+..||..||+-|+|+.
T Consensus 441 G~hPt~e~mq~~V-------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELV-------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHH-------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1112222111100 000000011111111 1235688999999999999999985
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=253.29 Aligned_cols=240 Identities=28% Similarity=0.372 Sum_probs=191.0
Q ss_pred eeeeeeeecCCCceEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.+-.++||+|+||+||++.....|+ +||||++.... ....+|+-.|.+++|||+++++++.....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 3446799999999999999876654 48888775432 23347888999999999999999874322
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+-||++|++ |.|++.++. ...++.......|.+||++|++|||+ ++++||||-..|+||.+ -..+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchhh
Confidence 558999999 677777765 45678889999999999999999999 79999999999999996 6679999999999
Q ss_pred ccccCCCcceeee---eccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 184 QLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 184 ~~~~~~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
............+ .+-|+|-|.+.. ..|+.++||||+||.+||++| |..|+.+....+.-..+.+ +.
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----ge---- 917 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GE---- 917 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----cc----
Confidence 8776665544433 456999999864 569999999999999999998 9999988776544332222 10
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
. ++ -++..+-++.-++.+||..|+..||++.++-
T Consensus 918 --------R--Ls----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 918 --------R--LS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred --------c--CC----------CCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 0 11 1234788899999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=218.87 Aligned_cols=208 Identities=37% Similarity=0.589 Sum_probs=173.9
Q ss_pred eecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeeccc-
Q 017270 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP- 113 (374)
Q Consensus 40 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 113 (374)
||+|++|.||++....+++.+++|++..... ...+|+..++.++|++++++++.+.. ....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 6899999999999988899999999876643 46689999999999999999988843 245889999999
Q ss_pred chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC-Ccc
Q 017270 114 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANI 192 (374)
Q Consensus 114 g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-~~~ 192 (374)
++|.+.+... ...+++..++.++.+++.++++||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 5766666531 1468999999999999999999999 7999999999999999535789999999997654432 123
Q ss_pred eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCC
Q 017270 193 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272 (374)
Q Consensus 193 ~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
...+...|++||.+.....++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 355677899999985543678999999999999999
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1456899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=270.64 Aligned_cols=206 Identities=17% Similarity=0.173 Sum_probs=144.6
Q ss_pred cCC-CceeeeceeeeecC--CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEee
Q 017270 82 MDH-PNVISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 158 (374)
Q Consensus 82 l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~ 158 (374)
+.| +||+++++.|-... ......++.+||+++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 344 46666666652111 111234678899999998888763 34569999999999999999999999 899999
Q ss_pred cCCCCcEEEcC------------------CCCcEEEEeeccccccccCC-----------------Ccceeeeeccccch
Q 017270 159 DLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYRAP 203 (374)
Q Consensus 159 dlkp~NIll~~------------------~~~~ikl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aP 203 (374)
||||+|||++. .++.+|++|||+++...... ......+|++|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999953 13456666777665321100 00123578899999
Q ss_pred hhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhc
Q 017270 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 283 (374)
Q Consensus 204 E~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (374)
|++.+. .++.++|||||||+||||++|.+|+.... .....+... ..++. .
T Consensus 185 E~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~~--------------------------~ 234 (793)
T PLN00181 185 EEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPPQ--------------------------I 234 (793)
T ss_pred hhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcChh--------------------------h
Confidence 998665 48999999999999999999988875322 111111111 00000 0
Q ss_pred ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 284 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 284 ~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
....+...+++.+||++||.+||++.|+++||||...+
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 00234567899999999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=228.86 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=185.9
Q ss_pred eccCCCCCCccc-----cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHH--hcCCCceeeec
Q 017270 20 TIGGKNGEPKQT-----ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--VMDHPNVISLK 91 (374)
Q Consensus 20 ~~~~~~~~p~~~-----~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~--~l~h~~iv~~~ 91 (374)
++++-.|-|... .+-.+.+.||+|.||.||+|.. .|+.||||+|.... ..-.+|.++.+ .|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 444445555433 4788999999999999999987 67899999996543 33346666655 56999999988
Q ss_pred eeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCeEeecCCCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQ 163 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------~~ivH~dlkp~ 163 (374)
+.=.... ..-..+++|++|.+ |+|++.|.. ..++......++.-++.||++||.. ..|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7542222 23456999999998 799988874 5788899999999999999999972 46999999999
Q ss_pred cEEEcCCCCcEEEEeeccccccccCC-----CcceeeeeccccchhhhhCCCCC-----CCchhhHhHHHHHHHHHh---
Q 017270 164 NLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEY-----TTSIDIWSAGCVLAELLL--- 230 (374)
Q Consensus 164 NIll~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~-----~~~~DiwslGvil~~ll~--- 230 (374)
||||.+ ++..-|+|+|+|-...... .....+||..|||||++...... -..+||||||.++||++.
T Consensus 346 NILVKk-n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKK-NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEcc-CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 999996 8899999999997654432 23457899999999998543221 246999999999999873
Q ss_pred -C------CCCCCCC----ChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhc
Q 017270 231 -G------QPLFPGE----NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 299 (374)
Q Consensus 231 -g------~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 299 (374)
| ++||.+. ...+...+++-.... .|+ ....|.. ...-..+-.+++.||
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~---------RP~---------ipnrW~s---~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKL---------RPN---------IPNRWKS---DPALRVMAKLMKECW 483 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeeccc---------CCC---------CCccccc---CHHHHHHHHHHHHhh
Confidence 2 3677543 122222222110000 000 0011110 001234667899999
Q ss_pred CcCCCCCCCHHHHh
Q 017270 300 QYSPSLRCTALEAC 313 (374)
Q Consensus 300 ~~dp~~R~s~~e~l 313 (374)
.-+|.-|.|+--+.
T Consensus 484 ~~Np~aRltALriK 497 (513)
T KOG2052|consen 484 YANPAARLTALRIK 497 (513)
T ss_pred cCCchhhhHHHHHH
Confidence 99999999987653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=218.69 Aligned_cols=197 Identities=34% Similarity=0.582 Sum_probs=164.4
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
|.+.+.||.|++|.||++.+..+++.+|+|.+... .....+|+..++.++|+|++++++.+.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 67789999999999999999988999999988654 2344579999999999999999988733 2348899
Q ss_pred eecccc-hHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~-l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|++++ +|.+.+.. ... +++..++.++.+++.++.+||+ ++++|+||+|+||+++. ++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence 999997 77766653 223 8899999999999999999999 79999999999999996 6889999999998765
Q ss_pred cCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCC-CChH
Q 017270 187 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAV 241 (374)
Q Consensus 187 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~-~~~~ 241 (374)
... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 543 334456788899999874444578899999999999999999999977 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=217.43 Aligned_cols=247 Identities=19% Similarity=0.241 Sum_probs=190.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccccch-----HHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~-----~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
.+.+....+-+|.||.||.|..+.. .+.+.+|.+....... ..|..++..+.|||++++.++... +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence 4677888999999999999965532 2346677665443322 257777788899999999887753 2
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
....++++.+.+ |+|..++...+. .-..++..++..++.|++.|++|||+ +|++|.||...|+++|. .-++||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVkl 437 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKL 437 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEe
Confidence 233567788888 788777763322 12457888899999999999999999 89999999999999995 789999
Q ss_pred EeeccccccccCCCcc---eeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 177 CDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+|=.+++.....+... ..-...-||+||.+. ...|+.++|+|||||+||||+| |+.|+..-++.++...+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-- 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-- 514 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--
Confidence 9999998765544321 111244599999995 4569999999999999999998 99999999988877666552
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+++. -+-++|+++..++..||..+|++||+.+|+.
T Consensus 515 ----------------yRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 515 ----------------YRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred ----------------ceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 1111 1236899999999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=208.49 Aligned_cols=167 Identities=20% Similarity=0.166 Sum_probs=124.8
Q ss_pred chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcce
Q 017270 114 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193 (374)
Q Consensus 114 g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~ 193 (374)
|+|.+.+.. .+..+++..++.++.|++.||+|||+ ++ ||+|||++. ++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~----~ 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPE----Q 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeeccc----c
Confidence 456666653 24579999999999999999999999 67 999999996 777888 9998764332 2
Q ss_pred eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCC
Q 017270 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272 (374)
Q Consensus 194 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
..+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...... ..+..+.........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------------- 126 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence 3678999999999654 5899999999999999999999999765432 223333221110000
Q ss_pred CCCCCChhhhcccCCCh--hHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 273 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 273 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
. ..+ ....++. ++.++|.+||..||.+||++.+++.|+|+..
T Consensus 127 ~--~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 127 R--DRS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred c--ccc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 000 0111233 6999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=244.82 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=192.0
Q ss_pred ccce-eeeeeeecCCCceEEEEEECCCCcEEEEEEeecc----cc------chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 31 TISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RR------YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y-~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...| .....+|.|++|.|+.+......+.++.|.+... .. ....|..+-..+.|+|++.....+.....
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 5678899999999999888777777777655311 10 01235555667899999887666633222
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
..-+||||+++|...+. ....++...+..++.||+.|++|||+ .||.|||+||+|+++.. ++.+||+||
T Consensus 396 -----~~~~mE~~~~Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Df 464 (601)
T KOG0590|consen 396 -----ILQSMEYCPYDLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDF 464 (601)
T ss_pred -----chhhhhcccHHHHHHHh----cccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeec
Confidence 33349999997777665 33578899999999999999999999 69999999999999996 789999999
Q ss_pred ccccccccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|.+........ ....+|+..|+|||++.+...-....||||.|+++..|++|+.||......+....-.
T Consensus 465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------ 538 (601)
T KOG0590|consen 465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------ 538 (601)
T ss_pred CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------
Confidence 99986544332 2356789999999999776655678999999999999999999997654332211000
Q ss_pred CHHHHhhcCcCCc-CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 255 TREEIRCMNPNYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 255 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+. ...... . ...+...++.+.+.+|.+||++||.+|+|+++|++.+||+.+..
T Consensus 539 ----------~~~~~~~~~~---~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 539 ----------NYSDQRNIFE---G--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ----------cccccccccc---C--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000 000000 0 01122347889999999999999999999999999999998653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=199.63 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=171.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
..|++.+.||+|+||..+.+++.-+++.||||.-+.. ......|....+.|. .++|..++.+- +...+-.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhh
Confidence 4999999999999999999999999999999965433 234457888888874 67887765433 334445699
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC----CCCcEEEEeeccccc
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQ 184 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~----~~~~ikl~Dfg~a~~ 184 (374)
+|+++.+|.+++.- .+.+|+...+..++.|++.-++++|+ ++.|.|||||+|+||.. +.+.|.++|||+|+.
T Consensus 103 idLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99999999888763 46789999999999999999999999 89999999999999952 345799999999998
Q ss_pred cccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHH
Q 017270 185 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKV 250 (374)
Q Consensus 185 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~ 250 (374)
+.+... ..+..||..||+=-..+|.. -+.+.|+-|||-+++..+-|..||.+. +..+.+++|-+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 866543 34678899999988877765 699999999999999999999999875 445566666443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-26 Score=189.32 Aligned_cols=211 Identities=23% Similarity=0.324 Sum_probs=168.6
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCC-CceeeeceeeeecCCCCceEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...+.|++++.||+|+||.+|+|.+..+|+.||||.-.+.. .....|.++.+.|++ ..|..+..+. .+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence 34568999999999999999999999999999999775543 344579999998875 4565555544 444456
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeecccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 183 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~a~ 183 (374)
.+||++++.+|.+++.. -...++...+..++-|++.-++|+|. ++++||||||+|+|..- ..+++.++|||+|+
T Consensus 87 vlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchh
Confidence 79999999998887764 34678999999999999999999999 89999999999999753 34579999999999
Q ss_pred ccccCC--------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHH
Q 017270 184 QLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIK 249 (374)
Q Consensus 184 ~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~ 249 (374)
.+.+.. ......||..|.+=-...+.. -+...|+-|+|.+|..+.-|..||.+.... +.+.+|.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 775433 234567899999877665543 588999999999999999999999987544 34444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=203.93 Aligned_cols=250 Identities=19% Similarity=0.193 Sum_probs=186.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCC-cEEEEEEeeccc----cchHHHHHHHHhcCC----CceeeeceeeeecCCCCce
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRVMDH----PNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~----~~~~~e~~~l~~l~h----~~iv~~~~~~~~~~~~~~~ 103 (374)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... .....|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999988775 678888775432 145678999988863 57777766552 2455
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC----CcEEEEee
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT----HQVKICDF 179 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~----~~ikl~Df 179 (374)
+.|+||+.++.+|.++..... ...++...+..++.|++.+|++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 688999999999988776533 6789999999999999999999999 7999999999999998533 56999999
Q ss_pred cccc--ccccCC--------C-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017270 180 GSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248 (374)
Q Consensus 180 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 248 (374)
|+++ .+.... . .....||..|+++....+. ..+.+.|+||++.++.+++.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 322111 1 1234589999999988654 47999999999999999999999997765433333222
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+...... ... +....+.++.++...+-..+...+|....+..
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2100000 000 11124567777777777788889998776644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=221.89 Aligned_cols=236 Identities=27% Similarity=0.405 Sum_probs=188.9
Q ss_pred eeecCCCceEEEEEEC---CCCcEEEEEEeecc------ccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEEE
Q 017270 39 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|+|+||.|+++... ..+..||+|...+. ......|..++...+ ||.+|++...| +.+..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 3799999999987643 34677899866432 123335777888776 99999999888 444458899
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
+++..|+. +.........+.+...+.+...++.|++++|+ .+|+|||+|++||+++. .|.+++.|||+++.....
T Consensus 76 ld~~rgg~---lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGGD---LFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccch---hhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence 99998741 22223355678899999999999999999999 69999999999999997 778999999999876555
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhcCcCCc
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~ 267 (374)
... +||..|||||++. .....+|+||+|+++++|++|..||.+ +....|.+. .+
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--------------- 205 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--------------- 205 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC---------------
Confidence 443 8899999999985 367899999999999999999999988 444444441 11
Q ss_pred CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
++..++..+++++..++..+|..|.. ++++++|+||+.+.|.
T Consensus 206 ---------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 ---------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ---------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 23347889999999999999999985 4799999999998876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=208.12 Aligned_cols=160 Identities=19% Similarity=0.257 Sum_probs=121.3
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECC-CCcEEEEEEeecc---------ccchHHHHHHHHhcCCCceeeeceeeee
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFS 96 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (374)
.|...++|.+.+.||+|+||+||+|.+.. +++.+|||++... .....+|+++|+.++|+|++..+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34567899999999999999999999876 6778899986432 12346899999999999998532211
Q ss_pred cCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecC-CCCcEEEcCCCCcEE
Q 017270 97 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVK 175 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dl-kp~NIll~~~~~~ik 175 (374)
. ..|+|||||+|..+..+. . .. ...++.|++.||.|||+ +||+|||| ||+|||++. ++.+|
T Consensus 91 -~-----~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~ik 152 (365)
T PRK09188 91 -G-----KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEAA 152 (365)
T ss_pred -C-----CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCEE
Confidence 1 268999999975433221 1 11 14678899999999999 79999999 999999985 67899
Q ss_pred EEeeccccccccCCCc---------ceeeeeccccchhhh
Q 017270 176 ICDFGSAKQLIAGEAN---------ISYICSRFYRAPELI 206 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~l 206 (374)
|+|||+|+........ ....+++.|.|||.+
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 9999999865433211 234567778999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=226.16 Aligned_cols=226 Identities=27% Similarity=0.466 Sum_probs=170.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
+.-.+|..++.+..|+||.||+++|+.+.+.+|+ ++.++...... |..+-+ + .+.|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn------------ilt~a~---------n--pfvv 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN------------ILTFAG---------N--PFVV 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc------------cccccC---------C--ccee
Confidence 3446899999999999999999999999999999 46555433221 333211 1 1122
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|+....++ .-++++. +++.|++|||+ .||+|||+||+|.+|.. -+.+|++|||+++...-.
T Consensus 136 -----gDc~tllk----~~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLK----NIGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhcc----cCCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhhh
Confidence 33222332 2233433 33789999999 79999999999999997 788999999998743110
Q ss_pred ---------C-------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 189 ---------E-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 189 ---------~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
. .....+|||.|+|||+++. ..|+..+|||++|+|+|+.+.|..||.+.+..+.+...+....
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 0 0123478999999999975 4599999999999999999999999999999999888877322
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCccccccCC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 324 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~~ 324 (374)
. +++ . ...++++++++|.++|..+|..|. .+-++.+|+||+.+.|.
T Consensus 276 ~-----------------wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 E-----------------WPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c-----------------ccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1 121 1 124789999999999999999997 46788999999999887
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-24 Score=194.19 Aligned_cols=260 Identities=33% Similarity=0.477 Sum_probs=194.2
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCC-ceeeeceeeeecCCCCceEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 105 (374)
|.+.+.||.|+||.||.+.+. ..+++|.+..... ...+|+.++..+.|+ +++++.+.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 788999999999999999987 7889998854332 245788899999988 7999999882 22227
Q ss_pred EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++++++.+. +...+...... ..++......++.|++.++.|+|+ .+++|||+||+||+++.....++++|||.+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 8999999964 44233221100 379999999999999999999999 79999999999999997333799999999975
Q ss_pred cccCC-------CcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 017270 185 LIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 252 (374)
Q Consensus 185 ~~~~~-------~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 252 (374)
..... ......+|..|+|||.+.+. ..+....|+||+|++++++++|..||..... .......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54433 23567889999999999663 4689999999999999999999999887764 333333333222
Q ss_pred CC-CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 253 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 253 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+ ... +. ...........+.+++.+++..+|..|.+..+...++|......
T Consensus 232 ~~~~~~--------------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 232 TPSLAS--------------PL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred Cccccc--------------cc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 22 000 00 00000112367899999999999999999999998877765433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=188.25 Aligned_cols=237 Identities=24% Similarity=0.307 Sum_probs=143.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHH-------HHhcC----------CCceeeeceee-
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-------MRVMD----------HPNVISLKHCF- 94 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~-------l~~l~----------h~~iv~~~~~~- 94 (374)
.+...+.||.|+++.||.+.+..||+.+|+|++........++++- ...+. |-.++.-.+..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5678899999999999999999999999999885433222111111 11111 11111111111
Q ss_pred -------eecC-CCCce---EEEEEeecccchHHHHHHhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCeEeecC
Q 017270 95 -------FSTT-SKNEL---FLNLVMEYVPESMYRVLKHYSSANQ---RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 160 (374)
Q Consensus 95 -------~~~~-~~~~~---~~~lv~e~~~g~l~~~l~~~~~~~~---~l~~~~~~~i~~qll~al~~LH~~~~ivH~dl 160 (374)
.... ..... ..+++|+-+.++|...+........ .+.......+..|++..+++||+ .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 1111 01111 2468899888888777653222222 23333334556899999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCC-------CCCCCchhhHhHHHHHHHHHhCCC
Q 017270 161 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 161 kp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
+|+|++++. +|.+.|+||+......... .....+..|.+||..... -.++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-T-TS-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcC-CCCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999997 8899999998876432211 112335679999986332 236889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCC
Q 017270 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 306 (374)
Q Consensus 234 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 306 (374)
||......... ...|...- ++|+.+++||.++|+.||.+|
T Consensus 249 Pf~~~~~~~~~-------------------------------~~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-------------------------------EWDFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-------------------------------GGGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-------------------------------cccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 99765321000 00122222 589999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=208.41 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=171.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch--------HHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--------NRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.|...+.||++.|=+|.+|++. .| .|+||++.+..... .+|++ ...+++||.+.+..+. ..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 7888999999999999999874 34 49999986543211 13455 5667899999987654 44445
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.|+|-+|...+|++-+. ...-+...+.+-|+.||+.||..+|. .||+|||||.+|||+.+ -+=+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence 77888999988887765 33446777778899999999999999 69999999999999997 44599999988764
Q ss_pred cccCC---Ccceeee-----eccccchhhhhCCC---------C-CCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017270 185 LIAGE---ANISYIC-----SRFYRAPELIFGAT---------E-YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 245 (374)
Q Consensus 185 ~~~~~---~~~~~~~-----t~~y~aPE~l~~~~---------~-~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 245 (374)
..-.. ...++.. -.+|.|||.+.... . .+++-||||+||+++||++ |++||.-. ++-
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHH
Confidence 33222 2222221 34699999974311 1 4678999999999999998 89999421 111
Q ss_pred HHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 246 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+.... +....+. .+.+--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~-~~~~~e~-----------------------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSG-NADDPEQ-----------------------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhcc-CccCHHH-----------------------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11110 0011000 0111125578999999999999999999999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=182.04 Aligned_cols=195 Identities=23% Similarity=0.329 Sum_probs=142.1
Q ss_pred CCCceeeeceeeeecCC----------------------CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHH
Q 017270 83 DHPNVISLKHCFFSTTS----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140 (374)
Q Consensus 83 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~ 140 (374)
+|||||.+...|.+... .....+|+||.-...+|.+.+.. ...+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 59999999988743211 22456899999999888777753 4456667788999
Q ss_pred HHHHHHHHhhcCCCeEeecCCCCcEEEcCCC---CcEEEEeecccccccc-------CCCcceeeeeccccchhhhhCCC
Q 017270 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIA-------GEANISYICSRFYRAPELIFGAT 210 (374)
Q Consensus 141 qll~al~~LH~~~~ivH~dlkp~NIll~~~~---~~ikl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~l~~~~ 210 (374)
|+++|+.|||+ +||.|||+|.+|||+.-++ ..+.|+|||++-.... .......-|+-.-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 7999999999999984322 3689999998743222 11122344567789999974332
Q ss_pred CC-----CCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhccc
Q 017270 211 EY-----TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 285 (374)
Q Consensus 211 ~~-----~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (374)
.. -.++|.|+.|.+.||++....||.+......- ..+|.+-.+|. +++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence 21 24899999999999999999999885432110 01122223333 456
Q ss_pred CCChhHHHHHHhhcCcCCCCCCCHH
Q 017270 286 RMPPEAIDLASRLLQYSPSLRCTAL 310 (374)
Q Consensus 286 ~~~~~~~~li~~~L~~dp~~R~s~~ 310 (374)
.+++.+++++..+|+.||++|+++.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 7899999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=173.36 Aligned_cols=135 Identities=19% Similarity=0.251 Sum_probs=102.8
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHhcCCCc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHPN 86 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~~ 86 (374)
...||+|++|.||+|.+. +|+.||||++..... ...+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 899999998854321 1123888999998777
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCeEeecCCCCcE
Q 017270 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNL 165 (374)
Q Consensus 87 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L-H~~~~ivH~dlkp~NI 165 (374)
+....... . . . .++||||++|+.+.... .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~--~-~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--L--K-S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--e--c-C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64322211 1 1 1 36999999975322111 1235789999999999999999999 68 7999999999999
Q ss_pred EEcCCCCcEEEEeecccccc
Q 017270 166 LVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 166 ll~~~~~~ikl~Dfg~a~~~ 185 (374)
+++ ++.++|+|||+|...
T Consensus 150 li~--~~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH--DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEE--CCcEEEEEccccccC
Confidence 998 367999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=173.73 Aligned_cols=170 Identities=12% Similarity=0.107 Sum_probs=124.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cc---------hHHHHHHHHhcCCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRVMDHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (374)
.++|++.+.||.|+||.||++.. ++..+|||.+.... .. ..+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999755 57789999885321 11 35788899999999999988876543
Q ss_pred CCC---CceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc
Q 017270 98 TSK---NELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 173 (374)
Q Consensus 98 ~~~---~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ 173 (374)
... .....++||||++|. |.+.. .+++. ...+++.++..||+ .|++|||++|+||++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-
Confidence 211 123478999999984 43321 23332 45599999999999 79999999999999996 66
Q ss_pred EEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHH
Q 017270 174 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll 229 (374)
++|+|||.+.......... ..++. ..|..++|+||||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH-----------HHHHH-hHhcccccccceeEeehHHH
Confidence 9999999987543221110 12223 34678999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=161.24 Aligned_cols=182 Identities=17% Similarity=0.108 Sum_probs=132.2
Q ss_pred eeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHhcC-CCceeeeceeeeecCCCCceEE
Q 017270 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
-+...|++|+||+|+++.. .+..++.+.+..... ...+|+++|++|. +++++++++.. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3567899999999997764 677888777754432 3468999999995 47788886631 16
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecC-CCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dl-kp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+++|||+.|..+.... +.. ...++.|++.+|+++|+ +||+|||| ||+|||++. ++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence 7999999985332111 011 13477899999999999 79999999 799999986 77899999999985
Q ss_pred cccCCCcc--------------eeeeeccccchhhhhCCCCCC-CchhhHhHHHHHHHHHhCCCCCCCCC
Q 017270 185 LIAGEANI--------------SYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 239 (374)
Q Consensus 185 ~~~~~~~~--------------~~~~t~~y~aPE~l~~~~~~~-~~~DiwslGvil~~ll~g~~pf~~~~ 239 (374)
........ -...++.|++|+...-....+ ...++++.|+.+|.++|+..|+-+.+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 44333110 012477888998753222233 56789999999999999998875543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=163.57 Aligned_cols=137 Identities=18% Similarity=0.197 Sum_probs=104.6
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHhcCCC
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHP 85 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~ 85 (374)
+.+.||+|++|.||+|.+. +|+.||||++..... ....|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999998864321 113578888888888
Q ss_pred ceeeeceeeeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 86 NVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 86 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
++.....+.. . . .++||||++|. +..... ....++...+..++.|++.++.++|+.+||+||||||+|
T Consensus 80 ~i~~p~~~~~----~-~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N 148 (190)
T cd05145 80 GVPVPEPILL----K-K--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN 148 (190)
T ss_pred CCCCceEEEe----c-C--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence 8744332221 1 1 36999999975 222211 234678888999999999999999982399999999999
Q ss_pred EEEcCCCCcEEEEeeccccccc
Q 017270 165 LLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~ 186 (374)
|+++ ++.++|+|||++....
T Consensus 149 Ill~--~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH--DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE--CCCEEEEEcccceecC
Confidence 9998 5679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=185.36 Aligned_cols=201 Identities=20% Similarity=0.334 Sum_probs=150.1
Q ss_pred ccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHhcC---CCceeeeceeeee
Q 017270 21 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMRVMD---HPNVISLKHCFFS 96 (374)
Q Consensus 21 ~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~e~~~l~~l~---h~~iv~~~~~~~~ 96 (374)
++-....+...+.|.|.+.||+|+||+||.|.+.. |+.||+|+-...... ..-=..++.+|+ -+.|..+..++..
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 33334444556799999999999999999999876 999999965433211 111123344444 2344444444322
Q ss_pred cCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc------C
Q 017270 97 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD------P 169 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~------~ 169 (374)
... -++|+||.+ |+|++++. ..+.+++..+..++.|++..++.||. .+|||+||||+|+|+. .
T Consensus 766 ~~~-----S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 766 QNA-----SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred CCc-----ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCC
Confidence 222 559999999 78887776 67789999999999999999999999 6999999999999993 2
Q ss_pred CCCcEEEEeeccccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 170 LTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
+...++|+|||.+..+..-. ......+|-.+-.+|...|. .+++..|.|.++.+++.||.|+.
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence 23469999999987554332 33445668889999998664 59999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=153.81 Aligned_cols=134 Identities=18% Similarity=0.261 Sum_probs=101.1
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhc-----CCCceeeeceeeeecCCCCceE-E
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-----DHPNVISLKHCFFSTTSKNELF-L 105 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~-~ 105 (374)
-.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ +||||+++++++.+... ... +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEEE
Confidence 356899999999995 7777666 69987643 23456899999999 57999999999855432 223 3
Q ss_pred EEEeeccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCCeEeecCCCCcEEEcCC---CCcEEEEe
Q 017270 106 NLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHRDLKPQNLLVDPL---THQVKICD 178 (374)
Q Consensus 106 ~lv~e~~~---g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al-~~LH~~~~ivH~dlkp~NIll~~~---~~~ikl~D 178 (374)
.+|+||++ ++|.+.+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++.. +..++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 47899955 577777753 236555 35678888888 99999 799999999999999742 34799999
Q ss_pred eccc
Q 017270 179 FGSA 182 (374)
Q Consensus 179 fg~a 182 (374)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=158.48 Aligned_cols=139 Identities=16% Similarity=0.120 Sum_probs=105.2
Q ss_pred ceeeeeeeecCCCceEEEEE-ECCCCcEEEEEEeecccc----------------------------chHHHHHHHHhcC
Q 017270 33 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMD 83 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~----------------------------~~~~e~~~l~~l~ 83 (374)
.|.+.+.||+|++|.||+|. +..+|+.||+|++..... ...+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58999999999999999999 778999999998864310 1246888888887
Q ss_pred CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-eEeecCCC
Q 017270 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKP 162 (374)
Q Consensus 84 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-ivH~dlkp 162 (374)
+. .+.+..++.. . ..++||||++|..+.... .....+....+..++.|++.++++||+ +| ++||||||
T Consensus 109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-c-----CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 2332333311 1 146999999984322211 123456666778999999999999999 79 99999999
Q ss_pred CcEEEcCCCCcEEEEeeccccc
Q 017270 163 QNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 163 ~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhc
Confidence 999998 56799999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=156.86 Aligned_cols=239 Identities=18% Similarity=0.238 Sum_probs=175.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+..+..+|.+...|..|+++... ..+++|++.- ..+.+..|.-.|+.+.||||+.+.+.+ +....+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCc
Confidence 355667788999999999998754 4566665532 123455788888999999999999988 333447
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEee-cCCCCcEEEcCCCCcEE--EEeecc
Q 017270 106 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR-DLKPQNLLVDPLTHQVK--ICDFGS 181 (374)
Q Consensus 106 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~-dlkp~NIll~~~~~~ik--l~Dfg~ 181 (374)
.++..|++ |+|+..+... .+-..+..++.+++.+++.|+.|||++..++-| -|....+++|+ +-+.+ .+|--+
T Consensus 263 v~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kf 339 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKF 339 (448)
T ss_pred eEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheeccccee
Confidence 89999999 7888888742 344567788999999999999999996555554 57888999985 54444 334333
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCC--CCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+.+. ....-.|.|++||.+...+. .-.++|+|||++++|||.|...||....+.+.-.+|.-
T Consensus 340 sfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------- 403 (448)
T KOG0195|consen 340 SFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------- 403 (448)
T ss_pred eeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------
Confidence 3211 12233788999999854332 24589999999999999999999998887765444321
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
+-+...++..++..+..|++-|+..||.+||..+.++
T Consensus 404 -----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 -----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0112235567899999999999999999999887664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-20 Score=167.68 Aligned_cols=179 Identities=28% Similarity=0.427 Sum_probs=131.3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..++||.|++|.. +|.+.+. ........+......++.|+..|++| ++.+|+|+||.||+... +..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence 4468999999995 4544443 34455667888889999999999999 38999999999999984 6789999999
Q ss_pred cccccccCC-------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 181 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 181 ~a~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+........ ......||.+||+||.+.+.. |+.++||||||+||+|++. =...|.... .+..+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~----- 472 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIA---TLTDI----- 472 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhh-----
Confidence 988766555 445678999999999997654 9999999999999999997 222221111 11100
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
....|...+..+ .+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus 473 ----------------------r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 ----------------------RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ----------------------hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 011111111111 2345689999999999999988877777764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=164.65 Aligned_cols=203 Identities=27% Similarity=0.407 Sum_probs=148.4
Q ss_pred HHhcCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCe-E
Q 017270 79 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-C 156 (374)
Q Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i-v 156 (374)
|+.+.|.|+.++++..++. ...++|.+||. |+|.+.+.. ....+++.....++.+|+.||+|||.. -| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence 3578999999999988665 33889999999 688887764 456788888999999999999999994 44 9
Q ss_pred eecCCCCcEEEcCCCCcEEEEeeccccccccCC---CcceeeeeccccchhhhhCCC--C----CCCchhhHhHHHHHHH
Q 017270 157 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT--E----YTTSIDIWSAGCVLAE 227 (374)
Q Consensus 157 H~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~--~----~~~~~DiwslGvil~~ 227 (374)
|+.|+..|+++|. ...+||+|||+........ ......-...|.|||.+.+.. . .+.+.|+||+|++++|
T Consensus 72 hg~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 72 HGALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999999999996 8999999999987653211 111111234599999986531 1 3678999999999999
Q ss_pred HHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCC
Q 017270 228 LLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 303 (374)
Q Consensus 228 ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 303 (374)
+++...||...... +.+..+.+....+.+..+. ... .+++++..++.+||..+|
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~---------------------~~~-e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIE---------------------LLN-ELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchh---------------------hhh-hcchHHHHHHHHhcccCh
Confidence 99999999864322 2332222201111111110 000 256689999999999999
Q ss_pred CCCCCHHHHh
Q 017270 304 SLRCTALEAC 313 (374)
Q Consensus 304 ~~R~s~~e~l 313 (374)
..||+++++-
T Consensus 209 ~~rPs~~~i~ 218 (484)
T KOG1023|consen 209 EKRPSIEQIR 218 (484)
T ss_pred hhCccHHHHH
Confidence 9999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-20 Score=180.40 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=190.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-CcEEEEEEeeccc---c---chHHHHHHHHhcC-CCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR---R---YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~---~---~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (374)
...|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... . ....|..+-+.+. |+|++.+++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 45799999999999999988876444 3446666553221 1 1224666666776 99999998877 445
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCC-CCCHHHHHHHHHHHHHHHHHhh-cCCCeEeecCCCCcEEEcCCCC-cEEEEe
Q 017270 103 LFLNLVMEYVPES-MYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH-QVKICD 178 (374)
Q Consensus 103 ~~~~lv~e~~~g~-l~~~l~~~~~~~~-~l~~~~~~~i~~qll~al~~LH-~~~~ivH~dlkp~NIll~~~~~-~ikl~D 178 (374)
.+.+++++|..|+ +...+. ..+. ..+......++.|+..++.|+| . .++.|||+||+|.+++. .+ .++++|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d 168 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD 168 (601)
T ss_pred cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence 5588999997763 333331 2222 5677778899999999999999 8 89999999999999996 55 899999
Q ss_pred ecccccccc-CCCc---ceeee-eccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 179 FGSAKQLIA-GEAN---ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 179 fg~a~~~~~-~~~~---~~~~~-t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
||+|..+.. .... ...+| ++.|.|||...+.....+..|+||+|+++..+++|..|+..........
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------- 240 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------- 240 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------
Confidence 999987765 3322 24567 9999999998765567899999999999999999999997654332110
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
. .+... ........+..++....+++.++|..+|..|.+.+++..+||+..
T Consensus 241 -------------~--~~~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 -------------S--SWKSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------------e--eeccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00000 011122234568899999999999999999999999999999988
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=142.22 Aligned_cols=133 Identities=20% Similarity=0.162 Sum_probs=99.6
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------------------------cchHHHHHHHHhcCCCc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRVMDHPN 86 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------------------~~~~~e~~~l~~l~h~~ 86 (374)
.|.+.+.||+|+||.||++.. .+|+.+|||++.... .....|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488899999999999999986 489999999865322 01245777888887764
Q ss_pred --eeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 87 --VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 87 --iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
++..+. .. ..++||||++|..+..+.. ......++.+++.++.++|+ .|++||||+|+|
T Consensus 95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceee----cC-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 333221 11 2579999999853322211 02356788899999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccc
Q 017270 165 LLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~ 186 (374)
|+++. ++.++|+|||.+....
T Consensus 156 ill~~-~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDD-DEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcC-CCcEEEEECCccccCC
Confidence 99996 7889999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=140.93 Aligned_cols=129 Identities=20% Similarity=0.312 Sum_probs=100.1
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
+.||+|++|.||+|.+ +|..+++|+..... ....+|+.++..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999987 77789999754321 12346888999999888766555443322 26
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||++| +|.+.+.. . .. ....++.+++.+|.+||+ .|++|||++|.||+++ ++.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 799999987 55555432 1 11 677899999999999999 7999999999999998 56799999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=136.37 Aligned_cols=125 Identities=20% Similarity=0.307 Sum_probs=92.9
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.||+|++|+||++.. ++..+++|...... ....+|+++++.+.|+++....-.+.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 489999999999984 67889999754321 12236899999998876544333332221 257
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+||||++| ++.+.+.. ... .++.|++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999987 44444331 110 678899999999999 7999999999999998 57799999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=153.81 Aligned_cols=132 Identities=19% Similarity=0.250 Sum_probs=98.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------------ccchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
...|...+.||+|+||+||++.... ..+++|+.... .....+|+++++.++|++++..........
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3456778999999999999998643 34444432111 012347999999999999877654443221
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
..++||||++| +|.+.+. ....++.|++.+|.+||+ .|++||||||+||+++ ++.++|+
T Consensus 410 -----~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~li 469 (535)
T PRK09605 410 -----EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLI 469 (535)
T ss_pred -----CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEE
Confidence 26799999987 5544443 245688999999999999 7999999999999995 5679999
Q ss_pred eeccccc
Q 017270 178 DFGSAKQ 184 (374)
Q Consensus 178 Dfg~a~~ 184 (374)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=130.84 Aligned_cols=132 Identities=24% Similarity=0.189 Sum_probs=90.6
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccccch----------------------------HHHHHHHHhcCCCc--
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRVMDHPN-- 86 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------------------~~e~~~l~~l~h~~-- 86 (374)
.+.||+|+||+||+|.+. +++.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999976 89999999875432111 12333444443322
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchH-H-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 87 VISLKHCFFSTTSKNELFLNLVMEYVPESM-Y-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 87 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l-~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
+.+.+.+ . ..++||||++++. . ..+.... .. ..++.++.+++.++.++|..+||+||||||+|
T Consensus 81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222211 1 1579999999721 1 1122110 11 56788999999999999983499999999999
Q ss_pred EEEcCCCCcEEEEeeccccccc
Q 017270 165 LLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~ 186 (374)
|+++ ++.++|+|||.+....
T Consensus 146 ili~--~~~~~liDfg~a~~~~ 165 (187)
T cd05119 146 ILVD--DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEE--CCcEEEEECccccccc
Confidence 9999 6679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=155.10 Aligned_cols=270 Identities=24% Similarity=0.291 Sum_probs=194.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
-.+.+.+.+-+-+|+++.++.+.-..+|-..++|..... ......+-.++..-.+|.++.....+ .-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 445778888999999999999987777866666644222 12222333333333456555543322 112
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...+++++|+++ ++...+. ..+..+.+..+.++..+..++++||. ..+.|+|++|.|++... .+..++.||+.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence 227799999975 5555554 33467777888999999999999999 57999999999999986 77899999984
Q ss_pred cccccc------C--------------------------CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHH
Q 017270 182 AKQLIA------G--------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 229 (374)
Q Consensus 182 a~~~~~------~--------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll 229 (374)
...... . .......+|+.|.+||.+++.. ....+|+|+.|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 321100 0 0112346799999999998765 688999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH
Q 017270 230 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309 (374)
Q Consensus 230 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~ 309 (374)
+|.+||........+..|.... ..++. -+...+.++++++.++|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~-----------------~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD-----------------IPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC-----------------CCCCC---------CccccChhhhhhhhhhhccCchhccCc
Confidence 9999999998887776665521 11111 123478899999999999999999988
Q ss_pred H---HHhcCCccccccCCCCCCCCCCCCCCC
Q 017270 310 L---EACAHPFFDELREPNARLPNGRPLPPL 337 (374)
Q Consensus 310 ~---e~l~hp~~~~~~~~~~~~~~~~~~~~~ 337 (374)
. ++-.||||+...|..........+|..
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCCCC
Confidence 7 899999999998877655554445543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.3e-15 Score=127.97 Aligned_cols=133 Identities=18% Similarity=0.229 Sum_probs=95.5
Q ss_pred eeee-cCCCceEEEEEECCCCcEEEEEEeecc-----------------ccchHHHHHHHHhcCCCce--eeeceeeeec
Q 017270 38 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRVMDHPNV--ISLKHCFFST 97 (374)
Q Consensus 38 ~~lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~-----------------~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 97 (374)
..|| .|+.|+||.+.. .+..++||.+... .....+|+.++..++|+++ +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 888899998876 4778999877421 1123469999999998875 4444443221
Q ss_pred CCCCceEEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 98 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
. ......++|||+++| +|.+.+. ...+++.. +.||+.++.+||+ +||+||||||+|||++. ++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence 1 111123599999996 5555543 23455543 5689999999999 79999999999999996 66899
Q ss_pred EEeeccccc
Q 017270 176 ICDFGSAKQ 184 (374)
Q Consensus 176 l~Dfg~a~~ 184 (374)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=141.00 Aligned_cols=250 Identities=25% Similarity=0.281 Sum_probs=186.7
Q ss_pred ccceeeeeeeec--CCCceEEEEEE--CCCCcEEEEEEee------ccccchHHHHHHHHhcC-CCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRVMD-HPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~--G~~g~V~~a~~--~~~~~~vaiK~~~------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (374)
...+.+.+.+|. |.+|.||.+.+ ..++..+|+|.-. .......+|+...+.++ |++.++.+..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 346778899999 99999999998 8889999999631 22333346666666663 88888866655
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~----al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
.+....++-+|+|+.++..... ....-++...++.++.+... ||..+|+ ++++|-|+||.||+..++....+
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccceee
Confidence 5555588999999976554433 23344888999999999999 9999999 89999999999999987437899
Q ss_pred EEeeccccccccCCCcce------eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 017270 176 ICDFGSAKQLIAGEANIS------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVEI 247 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~------~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~--~~~~~~~~i 247 (374)
++|||+............ ..+..-|++||++.+ -++..+|++++|.++.+-.+|..++... +....+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~- 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ- 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence 999999987765543221 245667999999843 4799999999999999999887665433 22211111
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+...+-...+..+...+..|+..||..|+++..+++|+++...
T Consensus 341 -----------------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 -----------------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -----------------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 001111223456677779999999999999999999999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.7e-15 Score=118.96 Aligned_cols=131 Identities=20% Similarity=0.234 Sum_probs=101.8
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhcCC--CceeeeceeeeecCCCCceEEEEEeec
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
+++.||.|.++.||++... +..+++|....... ...+|..+++.+++ .++++++..+. .....+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence 4678999999999999974 37899998865542 45689999999976 47777766552 22348899999
Q ss_pred ccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 112 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 112 ~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+.|..... ++......++.+++.++..||.. .+++|+|++|+||++++ .+.++++|||.+..
T Consensus 75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 98742211 14455667888999999999983 26999999999999996 78899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=125.56 Aligned_cols=211 Identities=18% Similarity=0.198 Sum_probs=147.2
Q ss_pred HHHhcCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCe
Q 017270 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRV 155 (374)
Q Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~i 155 (374)
-+-.+-|.|||+++.++.+....+.....+++||+. |++...|+.-......+.....++|+-||+.||.|||+. .-|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999988876666556667889999998 788888888777888899999999999999999999993 359
Q ss_pred EeecCCCCcEEEcCCCCcEEEEeecccccccc-----CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh
Q 017270 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 230 (374)
Q Consensus 156 vH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 230 (374)
+|+++..+.|++.. ++-||+.--.-...... ........+-++|.|||.=. ....+.++|||++|....+|..
T Consensus 200 ihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHH
Confidence 99999999999995 77666543211110000 01111234567899999642 2346789999999999999988
Q ss_pred CCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH
Q 017270 231 GQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309 (374)
Q Consensus 231 g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~ 309 (374)
|..- -.+......-..+.+. +..--...-++++.+||+-.|+.||++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~--------------------------------i~~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV--------------------------------IIGLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred heeccCCCcceeehhhhhhhh--------------------------------eeeccCccccCcCcccccCCCCCCcch
Confidence 7643 2221111111111110 000012234578999999999999999
Q ss_pred HHHhcCCcccccc
Q 017270 310 LEACAHPFFDELR 322 (374)
Q Consensus 310 ~e~l~hp~~~~~~ 322 (374)
.+++-||.+-++.
T Consensus 326 r~llfHpllfeVh 338 (458)
T KOG1266|consen 326 RLLLFHPLLFEVH 338 (458)
T ss_pred hhhhcCceeeecc
Confidence 9999999986643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.1e-12 Score=119.98 Aligned_cols=181 Identities=22% Similarity=0.274 Sum_probs=126.8
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
-|.+ ...+-++.+..-.|..+.++.+|.+........ ...+-++-|+.++||||+++++.+ +.+..+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylv 87 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLV 87 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEE
Confidence 3555 334444444222455677888888886643332 234667888999999999999988 444469999
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
+|-+.. |...++. ++...+.--++||+.||.|||.-.+++|++|..+.|+|+. .|..||++|.++......
T Consensus 88 TErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~ 158 (690)
T KOG1243|consen 88 TERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGF 158 (690)
T ss_pred eecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccC
Confidence 999874 2234443 3366677788999999999985379999999999999997 889999999988644332
Q ss_pred CCc-ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC
Q 017270 189 EAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 231 (374)
Q Consensus 189 ~~~-~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g 231 (374)
... ....---.|..|+.+.. -.-..|.|.|||++++++.|
T Consensus 159 ~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 159 NAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 211 11111223667765421 12567999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-12 Score=126.15 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=90.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc----------------------------------------
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------------------------------------- 71 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------------------------------- 71 (374)
..|.. +.||+|++|.||+|+.+.+|+.||||+.......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999998888999999988543100
Q ss_pred ----hHHHHHHHHhc----CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcC---CCCCHHHHHHHHH
Q 017270 72 ----KNRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN---QRMPLIYVKLYTY 140 (374)
Q Consensus 72 ----~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~---~~l~~~~~~~i~~ 140 (374)
..+|+..+.++ .+...+.+-.+|.+.++ ..++||||+.|.-...+......+ ..+.+..+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 01222222222 23344444444433222 256999999984322222111111 1355555666666
Q ss_pred HHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC----cEEEEeecccccccc
Q 017270 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIA 187 (374)
Q Consensus 141 qll~al~~LH~~~~ivH~dlkp~NIll~~~~~----~ikl~Dfg~a~~~~~ 187 (374)
|++ . .|++|+|++|.||+++. ++ +++++|||++.....
T Consensus 275 Qif-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 654 4 69999999999999986 55 899999999876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-12 Score=107.30 Aligned_cols=132 Identities=20% Similarity=0.238 Sum_probs=93.1
Q ss_pred eeeeecCCCceEEEEEECC------CCcEEEEEEeec--------------ccc----------------chHHHHHHHH
Q 017270 37 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRR----------------YKNRELQLMR 80 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~--------------~~~----------------~~~~e~~~l~ 80 (374)
...||.|--+.||.|.... .+..+|||+... +.+ ...+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 357899997621 100 0126888888
Q ss_pred hcCC--CceeeeceeeeecCCCCceEEEEEeecccch-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCe
Q 017270 81 VMDH--PNVISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRV 155 (374)
Q Consensus 81 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L-H~~~~i 155 (374)
++.. -++...+.+. . -++||||++++ +. ..++ +..++...+..+..|++.++..| |+ .|+
T Consensus 82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 8753 2344443321 1 55999999863 21 1222 23455566777889999999998 88 799
Q ss_pred EeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 156 vH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+||++.||+++ ++.+.|+|||.+...
T Consensus 147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence 9999999999997 456999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-11 Score=113.46 Aligned_cols=168 Identities=22% Similarity=0.326 Sum_probs=130.2
Q ss_pred ceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc--hHHHH
Q 017270 46 GIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRV 119 (374)
Q Consensus 46 g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g--~l~~~ 119 (374)
.+.|+|....+|..|++|.+.-++. ..-.-++.++++.|.|+|++.++|. ...-++..+++|++|.++ +|++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHHH
Confidence 4789999999999999999843332 2235788999999999999999986 333566679999999985 66665
Q ss_pred HHhh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 120 LKHY-----------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 120 l~~~-----------~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
.... ...+...+|..+|.|+.||..||.++|+ .|..-+-|.|.+|+++. +.+++|...|.......+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecCC
Confidence 4321 1234557899999999999999999999 79999999999999996 558999988887654333
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
. . |.+.+ ..+-|.-.||.++..|.+|..
T Consensus 447 ~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 P-----------T--EPLES----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C-----------C--cchhH----HhhhhHHHHHHHHHHHhhccc
Confidence 2 0 11211 345789999999999999964
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-12 Score=121.89 Aligned_cols=137 Identities=20% Similarity=0.246 Sum_probs=88.0
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecccc-ch-------------------------------------------
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK------------------------------------------- 72 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~------------------------------------------- 72 (374)
.+.||+|++|.||+|+. .+|+.||||+...... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 46799999999999985 5899999998743210 00
Q ss_pred HHHHHHHHhc----CCCceeeeceeeeecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HH
Q 017270 73 NRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFR-GL 146 (374)
Q Consensus 73 ~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~-al 146 (374)
.+|+..+..+ ++.+-+.+-.++...++ ..++||||++|. +.+.... .. .... ...++.+++. .+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence 1233333333 23333444444432222 257999999974 3333221 11 1122 2334555555 46
Q ss_pred HHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 147 ~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
..+|. .|++|+|++|.||+++. +++++++|||++....
T Consensus 271 ~ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence 78899 79999999999999986 7889999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-13 Score=129.83 Aligned_cols=246 Identities=17% Similarity=0.223 Sum_probs=155.1
Q ss_pred CCCCcccceEEeeccCCCCCCccccceeeeeeeecCCCc---eEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCC
Q 017270 8 GSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG---IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH 84 (374)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h 84 (374)
...+..+.....++.+....|+...+|++.+.+|..+-| .+|.++....+.....|.. .....+....-+.+++|
T Consensus 13 ~~~~ss~~~t~e~~~~~l~~~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~--~~~~ld~~~~~~~~lr~ 90 (700)
T KOG2137|consen 13 DKFTSSTATTAETIVQVLPGPKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSA--VVWMLDKRASSLQQLRG 90 (700)
T ss_pred cccccccceeecceeEecCCcccccccccccceeecCCCchhhhhhhhccCccCcccccee--eeeecChhhhHHHHHhc
Confidence 334444555566667777888899999999988876554 4555554444433311111 00111122233344454
Q ss_pred CceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 85 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
. +. +...+|- .+. =+.+++.|+.|+|...++||++|.|++
T Consensus 91 -----~-~~-----------vs~aTe~-------~f~----------------nl~~v~dgl~flh~sAk~VH~ni~p~~ 130 (700)
T KOG2137|consen 91 -----L-DG-----------VSKATED-------GFA----------------NLGNVADGLAFLHRSAKVVHGNIQPEA 130 (700)
T ss_pred -----c-cc-----------hhhcccH-------hhh----------------hhhcccchhhhhccCcceeecccchhh
Confidence 0 10 0011111 111 011344899999997799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCC--------cce--eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHH-hCCC
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEA--------NIS--YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQP 233 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~--~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll-~g~~ 233 (374)
|.++. ++..||+.|+.+........ ... ..-...|.|||.+.+ ...+.++|++|+||++|.+. .|+.
T Consensus 131 i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 131 IVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred eeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccccccccceeeeeEEEEEecCCcc
Confidence 99997 88899999999865433111 001 122456999999966 45789999999999999998 5666
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 234 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.+...+.......-... ...-...+..++++++++=+.++|..|+..||++.+++
T Consensus 209 i~~a~~~~~~~~~~~~~-------------------------~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 209 IIAANGGLLSYSFSRNL-------------------------LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred hhhccCCcchhhhhhcc-------------------------cccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 66555432222111110 00001112356899999999999999999999999999
Q ss_pred cCCcccccc
Q 017270 314 AHPFFDELR 322 (374)
Q Consensus 314 ~hp~~~~~~ 322 (374)
.-|||.+..
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999998743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.4e-12 Score=104.61 Aligned_cols=124 Identities=15% Similarity=0.165 Sum_probs=89.0
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
.+.|+.|.++.||++.. .++.|++|...... ....+|+.+++.+.+.+++ +++... ... .++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 46789999999999986 47789999875543 2346899999988655543 333222 111 35899999
Q ss_pred cchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCe-----EeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 113 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 113 ~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i-----vH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|...... . .....++.+++.+|..||+ .++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 98422110 0 1123456789999999999 574 9999999999998 4579999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2e-12 Score=121.33 Aligned_cols=247 Identities=19% Similarity=0.185 Sum_probs=169.3
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-CCCcEEEEEEeeccccch------HHHHHHHHhc-CCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRVM-DHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++..+..||.|.|+.|+.+..+ .++..|++|.+.+..... -.|+-+...+ .|.+++.....+....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---- 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---- 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc----
Confidence 357888999999999999987755 677889999775443222 2355444444 5888888776663322
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..|+=-|||.+...++-. .....+.+...+.+..|++.++.++|+ ..++|+|++|+||++..+++..++.|||.+
T Consensus 340 -~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 -QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred -cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 255888999864333222 223457788889999999999999999 799999999999999864478899999998
Q ss_pred cccccCCCcceeeeecccc-chhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~-aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
....- ..........+. .+|.+.....+..+.|++|||.-+.+.++|...-....... .|.. +
T Consensus 415 t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~--~--------- 478 (524)
T KOG0601|consen 415 TRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS--G--------- 478 (524)
T ss_pred cccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec--c---------
Confidence 64211 111122233334 36666566668899999999999999999874332221110 0100 0
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..+. ......++..+.+.++..|+..|+.+.++..|+=|..
T Consensus 479 --------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 479 --------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 0123467888999999999999999999988876654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-10 Score=93.72 Aligned_cols=140 Identities=17% Similarity=0.214 Sum_probs=95.0
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
....+-+|+-+.|+++.. .|+.+.||.= .+. +....+|+++|.++.--.|.--.-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 567899999999998875 7888888843 222 1223468888877643222211112222222
Q ss_pred EEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcE--EEEee
Q 017270 104 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDF 179 (374)
Q Consensus 104 ~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~i--kl~Df 179 (374)
-+|+|||++| .+...+..... ..........++.+|-..+.-||. ++|+|+||..+||++.+++..+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4589999998 55555543222 223333346778888889999999 8999999999999998766554 89999
Q ss_pred cccccc
Q 017270 180 GSAKQL 185 (374)
Q Consensus 180 g~a~~~ 185 (374)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-10 Score=91.48 Aligned_cols=124 Identities=17% Similarity=0.278 Sum_probs=82.3
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEe-eccc-----------cchHHHHHHHHhcCCCc--eeeeceeeeecCCCCce
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDR-----------RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNEL 103 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~~-----------~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~ 103 (374)
..+++|+-+.+|.+.. -|..+++|.= ++.. ....+|+.++..+.--. ...++++. ++.
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~- 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN- 73 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC-
Confidence 4578999999998854 3445666632 2211 22236888888775332 23333322 222
Q ss_pred EEEEEeecccchHHH-HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~-~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..|+|||++|.++. .+.. . . -.++..+-..+.-||. +||+|+||.++||++.. +.+.++|||++
T Consensus 74 -~~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg 138 (204)
T COG3642 74 -GLIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLG 138 (204)
T ss_pred -CEEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcc
Confidence 44999999996544 4332 1 1 2345566667788999 89999999999999984 45999999999
Q ss_pred cc
Q 017270 183 KQ 184 (374)
Q Consensus 183 ~~ 184 (374)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.8e-09 Score=94.99 Aligned_cols=197 Identities=14% Similarity=0.143 Sum_probs=130.2
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch-HHHHHHHHh-cCCCceeeeceee---eecCCCCceEEEEEee
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRV-MDHPNVISLKHCF---FSTTSKNELFLNLVME 110 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~e~~~l~~-l~h~~iv~~~~~~---~~~~~~~~~~~~lv~e 110 (374)
..+.||+|+-+.+|-.-.. + ..+.|++....... .+.+..|-. -.||-+-.-+..- .... .......+.|+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence 4578999999999965432 2 23457775543222 122222222 2444332201000 1111 12223778899
Q ss_pred cccc--hHHHHHH--hhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 111 YVPE--SMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 111 ~~~g--~l~~~l~--~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
.+.| ....++. ..+..-....+..+.+....|+.|...||. +|.+-+|+.++|+|++. +..+.|.|-..-....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQINA 168 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceeecc
Confidence 9886 2222221 122334557899999999999999999999 79999999999999995 8889999866655444
Q ss_pred cCCCcceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhC-CCCCCCC
Q 017270 187 AGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLG-QPLFPGE 238 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~ 238 (374)
.+......+|.+.|.+||.-. ..-.-+..+|.|.||+++++++.| +.||.+-
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 455555667889999999852 112346789999999999999986 9999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=90.83 Aligned_cols=121 Identities=26% Similarity=0.295 Sum_probs=75.3
Q ss_pred eEEEEEECCCCcEEEEEEeecc--------------c----------------cchHHHHHHHHhcCCC--ceeeeceee
Q 017270 47 IVFQAKCLETGETVAIKKVLQD--------------R----------------RYKNRELQLMRVMDHP--NVISLKHCF 94 (374)
Q Consensus 47 ~V~~a~~~~~~~~vaiK~~~~~--------------~----------------~~~~~e~~~l~~l~h~--~iv~~~~~~ 94 (374)
.||.|.. ..|..+|+|..... . ....+|.+.|..+..- ++.+.+.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888885 56789999976321 0 1123699999999765 345554322
Q ss_pred eecCCCCceEEEEEeeccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCCeEeecCCCCcEEEcCCC
Q 017270 95 FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~-LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
. .++||||++ |.....+... .++......++.+++..+.. +|. .||+|+||.+.||+++. +
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence 1 349999999 6333333321 11133456677788885555 679 79999999999999995 4
Q ss_pred CcEEEEeecccccc
Q 017270 172 HQVKICDFGSAKQL 185 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~ 185 (374)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 7999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-08 Score=90.06 Aligned_cols=134 Identities=10% Similarity=0.061 Sum_probs=88.6
Q ss_pred ceEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhcCCCceeee--ceeeeecCCCCceEEEEE
Q 017270 46 GIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 46 g~V~~a~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv 108 (374)
..|.++.. .|+.|.||...... ....+|...+..+...+|... ..+...........-++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555443 56678888552211 124578888877754443332 222211111212346699
Q ss_pred eecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC------CCCcEEEEeec
Q 017270 109 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVKICDFG 180 (374)
Q Consensus 109 ~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~------~~~~ikl~Dfg 180 (374)
||++++ ++.+.+.... ....+......++.+++..+.-||. +||+|+|+++.|||++. .+..+.++||+
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999997 5666654321 2445667778899999999999999 89999999999999974 24579999999
Q ss_pred cccc
Q 017270 181 SAKQ 184 (374)
Q Consensus 181 ~a~~ 184 (374)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.9e-09 Score=89.78 Aligned_cols=140 Identities=18% Similarity=0.184 Sum_probs=90.9
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCc--eeeeceeeeecCCCCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
+.|+.|..+.||++... +|+.+++|...... .....|..+++.+.+.+ +.+++...... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999863 36889999875432 34568999999987643 44444433111 11123579999
Q ss_pred cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 017270 111 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------- 152 (374)
Q Consensus 111 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------------------------------------- 152 (374)
|++|....... ....+++.....++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRL----LRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99974211110 002345555555555666666555531
Q ss_pred -----------------CCeEeecCCCCcEEEcCC-CCcEEEEeeccccc
Q 017270 153 -----------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 184 (374)
Q Consensus 153 -----------------~~ivH~dlkp~NIll~~~-~~~ikl~Dfg~a~~ 184 (374)
..++|+|+.|.||+++.+ ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 347999999999999863 35588999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4e-08 Score=84.64 Aligned_cols=131 Identities=21% Similarity=0.170 Sum_probs=90.3
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec--------------------------cccchHHHHHHHHhcCCC-
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------------------------DRRYKNRELQLMRVMDHP- 85 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~--------------------------~~~~~~~e~~~l~~l~h~- 85 (374)
-+.+...||.|--|.||.|.+ ..|..+|||.=.- .+...++|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 356788999999999999995 4789999993210 012234788888888644
Q ss_pred -ceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 86 -NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 86 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
.+.+-++ .+...+||||++|-.+.-+ +++......++..|+.-+..+-. .||+|+|+.+-|
T Consensus 171 ~~VP~P~~---------~nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIA---------WNRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN 232 (304)
T ss_pred CCCCCccc---------cccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence 4444322 2236799999998422111 11233444555666666655556 699999999999
Q ss_pred EEEcCCCCcEEEEeecccc
Q 017270 165 LLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~ 183 (374)
|++++ ++.+.++||--+.
T Consensus 233 IlV~~-dg~~~vIDwPQ~v 250 (304)
T COG0478 233 ILVTE-DGDIVVIDWPQAV 250 (304)
T ss_pred EEEec-CCCEEEEeCcccc
Confidence 99996 7789999997664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.3e-07 Score=78.28 Aligned_cols=137 Identities=15% Similarity=0.162 Sum_probs=84.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchH-------------HHHHHHHhcCCCc---eeeeceee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRVMDHPN---VISLKHCF 94 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-------------~e~~~l~~l~h~~---iv~~~~~~ 94 (374)
..+|.+.+.+-......|.+.. .+|+.+++|.........+ +++..+..+.... ...++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4578888999888877776654 3678999997754332222 2333333332222 22222211
Q ss_pred eecCCCCceEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc
Q 017270 95 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 173 (374)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ 173 (374)
.-....-....+++|||++|- +.+.. .+++ .+.-.+..++.-||+ .|++|+|..|.|++++. +.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~--~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN--NG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC--Cc
Confidence 111112223366899999983 22211 1232 233567788999999 79999999999999984 45
Q ss_pred EEEEeeccccc
Q 017270 174 VKICDFGSAKQ 184 (374)
Q Consensus 174 ikl~Dfg~a~~ 184 (374)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.5e-07 Score=79.06 Aligned_cols=108 Identities=18% Similarity=0.216 Sum_probs=75.2
Q ss_pred chHHHHHHHHhcCCCce--eeeceeeeecCCCCceEEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 017270 71 YKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146 (374)
Q Consensus 71 ~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al 146 (374)
...+|...+..|..-.| .+.+.+..... ......++|+|++++ +|.+.+.. ....+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence 34578887777754333 22222222211 122446799999997 45555553 12266667788999999999
Q ss_pred HHhhcCCCeEeecCCCCcEEEcCCC--CcEEEEeeccccc
Q 017270 147 AYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQ 184 (374)
Q Consensus 147 ~~LH~~~~ivH~dlkp~NIll~~~~--~~ikl~Dfg~a~~ 184 (374)
.-||. +||+|+|+++.|||++..+ ..+.++||+.++.
T Consensus 132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 8999999999999998633 2799999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.4e-07 Score=75.37 Aligned_cols=137 Identities=12% Similarity=0.082 Sum_probs=95.0
Q ss_pred ecCCCceEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHhcCCCce--eeeceeeeecCCCCceEEEEE
Q 017270 41 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 41 g~G~~g~V~~a~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv 108 (374)
|+||.+-|+.... .|+.+-+|.-.. ......+|...+..|...++ .+.. ++-.........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888888664 344688886531 22345689998888854333 3332 2212222334557799
Q ss_pred eecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc--EEEEeeccccc
Q 017270 109 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQ 184 (374)
Q Consensus 109 ~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~--ikl~Dfg~a~~ 184 (374)
+|-++| +|.+.+... .-.+.+......++.+++.++.-||. .|+.|+|+.+.||+++. .+. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 998885 666655421 12355777778899999999999999 79999999999999984 344 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-07 Score=91.14 Aligned_cols=136 Identities=21% Similarity=0.320 Sum_probs=82.9
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccccc--------------------------------------------hH
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------KN 73 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~ 73 (374)
+.|+.++-|.||.|+- .+|+.||||+....-.. ..
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6788999999999995 56999999977432100 00
Q ss_pred HHHHHHHhc----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHH--HHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 017270 74 RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRV--LKHYSSANQRMPLIYVKLYTYQIFRGL 146 (374)
Q Consensus 74 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~--l~~~~~~~~~l~~~~~~~i~~qll~al 146 (374)
+|..-+.++ +...-+.+-.+|.+.++. -.++|||+.| .+.+. +.....+...+.+.-++.++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~--- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence 244433333 233334455555332222 4599999998 33333 221111111222333333333332
Q ss_pred HHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 147 ~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
. .|++|.|..|.||+++. ++++.+.|||+......
T Consensus 283 ----~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 ----R-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ----h-cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence 2 59999999999999997 78999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.1e-09 Score=100.00 Aligned_cols=244 Identities=20% Similarity=0.196 Sum_probs=163.4
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCc-eeeeceeeeecCCCCceEEEEEeec
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN-VISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
-|...+-+++|+++++++.+...+.... .+.+... ....-++++|.+.+||| .+..++-+ +.+.+..+++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 3566778899999999988765554333 5555443 34446899999999999 44433332 566678899999
Q ss_pred ccch--HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC
Q 017270 112 VPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189 (374)
Q Consensus 112 ~~g~--l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~ 189 (374)
++++ ..... ......+...+...+...-+.+++++|+ .-=+|+| ||+.. .+..+..||+....+....
T Consensus 316 ~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGS--EEEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccc--ccccccccccCCcccCccc
Confidence 9864 11100 0112234444555566677788999998 3457888 88887 3568999999988766655
Q ss_pred CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCC
Q 017270 190 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269 (374)
Q Consensus 190 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 269 (374)
...+..+++.++|||+.... .+..+.|.|++|+-..+|.-|.+|-..... .. ...|..+
T Consensus 386 ~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p-------------- 444 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGP-------------- 444 (829)
T ss_pred ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCC--------------
Confidence 56678899999999998544 488999999999887788777777544110 00 0000000
Q ss_pred CCCCCCC-CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 270 RFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 270 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.-+.+.. ..|...+.. ++...|+..-|..|+....++-|.+|+..
T Consensus 445 ~s~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 NSPMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CccccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0111111 233333322 67788999999999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.7e-07 Score=93.49 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=134.9
Q ss_pred HHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017270 73 NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151 (374)
Q Consensus 73 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~ 151 (374)
+.|...+..+.|+|++.++.+-+.....+ ....+..++|.. ++...+. .-...+....+.+..+++.||.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 35777888889999999876553332222 122244566664 4444443 34678889999999999999999999
Q ss_pred CCCeEeecCCCC---cEEEcCCCCcEEEE--eeccccccccCCCcceeeeeccccchhhhhCCC-CCCCchhhHhHHHHH
Q 017270 152 VPRVCHRDLKPQ---NLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVL 225 (374)
Q Consensus 152 ~~~ivH~dlkp~---NIll~~~~~~ikl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil 225 (374)
....|.-|..+ +--.+. .+.+.++ ||+.++................+.+||...... ..+...|+|++|...
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 55555555444 222332 3445555 888888776666666666677788888874322 123346999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC
Q 017270 226 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 305 (374)
Q Consensus 226 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 305 (374)
..+..|..+-.... ....++. ........+++.+|+.-|+++
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~l~-----------------------------------~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSLLD-----------------------------------VLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc---chhhhhc-----------------------------------cccchhhhhhhhhhcchhhhh
Confidence 99998775432111 0000000 011126788999999999999
Q ss_pred CCCHHHHhcCCccccc
Q 017270 306 RCTALEACAHPFFDEL 321 (374)
Q Consensus 306 R~s~~e~l~hp~~~~~ 321 (374)
|+++.+++.|||.+--
T Consensus 425 Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFP 440 (1351)
T ss_pred ccchhhhhhchhcccc
Confidence 9999999999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=73.77 Aligned_cols=133 Identities=19% Similarity=0.182 Sum_probs=87.3
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc----------------------------cchHHHHHHHHhcCCC--ce
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------------RYKNRELQLMRVMDHP--NV 87 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------------------------~~~~~e~~~l~~l~h~--~i 87 (374)
..|.+|--+.||+|.. .++..+|+|++.... .+..+|..-|+++... .+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677788889999983 678899999884221 0112566667766433 22
Q ss_pred eeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 88 v~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
.+-+.++ . -.+||||++... ...-.-..-.+....+..+..+++..+.-|-...++||+||+.-|||+
T Consensus 133 P~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 133 PEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 3332222 1 348999998530 111111223344446777888888888776552599999999999999
Q ss_pred cCCCCcEEEEeecccccc
Q 017270 168 DPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~ 185 (374)
. ++.+.|+|||-|...
T Consensus 201 ~--~~~p~iID~~QaV~~ 216 (268)
T COG1718 201 H--DGEPYIIDVSQAVTI 216 (268)
T ss_pred E--CCeEEEEECcccccc
Confidence 8 567999999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.9e-06 Score=71.45 Aligned_cols=74 Identities=19% Similarity=0.189 Sum_probs=48.7
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCc--eeeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++.... ........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEEEEEe
Confidence 4679999999999998643 58999987554 234457888888875333 344443221 112233478999999
Q ss_pred cc
Q 017270 113 PE 114 (374)
Q Consensus 113 ~g 114 (374)
+|
T Consensus 78 ~g 79 (239)
T PF01636_consen 78 PG 79 (239)
T ss_dssp SS
T ss_pred cc
Confidence 87
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.7e-06 Score=79.33 Aligned_cols=137 Identities=18% Similarity=0.230 Sum_probs=81.2
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccccch-----------------------------------------HHH
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----------------------------------------NRE 75 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~e 75 (374)
.+.||.-+.|.||+|+-+ +|+.||||+-...-... .+|
T Consensus 166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 468999999999999954 59999999663321000 022
Q ss_pred HH----HHHhcCCCc---eeeeceeeeecCCCCceEEEEEeecccc---hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHH
Q 017270 76 LQ----LMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPE---SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145 (374)
Q Consensus 76 ~~----~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~g---~l~~~l~~~~~~~~~l~~~~~~~i~~qll~a 145 (374)
++ +.+.++|-+ =|.+-.+|.+..+ .-.++||||+| +-.+.+.. ..++...+...+.+...-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHH
Confidence 22 222233444 1223334432222 25599999997 22233332 334444443333332221
Q ss_pred HHHhhcCCCeEeecCCCCcEEEcC---CCCcEEEEeeccccccc
Q 017270 146 LAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQLI 186 (374)
Q Consensus 146 l~~LH~~~~ivH~dlkp~NIll~~---~~~~ikl~Dfg~a~~~~ 186 (374)
. -++ .|++|+|-.|.||++.+ .+..+.+.|||+.....
T Consensus 316 q-If~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 Q-IFK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred H-HHh--cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 1 122 58999999999999984 36789999999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-05 Score=68.03 Aligned_cols=69 Identities=14% Similarity=0.077 Sum_probs=44.9
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCce--eeeceeeeecCCCCceEEEEEeeccc
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVP 113 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~ 113 (374)
..||+|..+.||+. .+..+++|...... ....+|.++++.+..-.+ .+.+.+. ......++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999973 25567889775432 234689999888754333 3333332 22222678999999
Q ss_pred ch
Q 017270 114 ES 115 (374)
Q Consensus 114 g~ 115 (374)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 83
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-05 Score=63.72 Aligned_cols=126 Identities=20% Similarity=0.285 Sum_probs=83.3
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeec
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
-+..+.||.|.+|.||++.. .|..+|+|+-..+. .....|+++|..++-.++-.-.-.+ + . .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence 35678999999999999976 56689999665443 4456899999998766554322111 1 1 3366999
Q ss_pred ccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCC--CcEEEcCCCCcEEEEeecccc
Q 017270 112 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP--QNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 112 ~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp--~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+.| .|.+.... .+.. -+..++.+---|-. .||-|+.|.- .||+++ ++.+.|+||..|+
T Consensus 94 i~G~~L~~~~~~-------~~rk----~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG-------GDRK----HLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc-------ccHH----HHHHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchh
Confidence 998 43332210 1222 22345555555666 5999999864 466665 4479999999987
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00014 Score=61.24 Aligned_cols=128 Identities=19% Similarity=0.293 Sum_probs=82.8
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------------------cchHHHHHHHHhcC------CCceeee
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRVMD------HPNVISL 90 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------------~~~~~e~~~l~~l~------h~~iv~~ 90 (374)
...||+|+.-.||. ........||+..... ....+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999985 3344556788875554 23346776666655 7889999
Q ss_pred ceeeeecCCCCceEEEEEeeccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~---g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
++...+... ..+|+|.+. |+....+..+.. ...+++ .++.. +-.-.++|-+ ++|+.+|++|.||++
T Consensus 83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLLD-HHIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHHH-cCCeecCCCcccEEE
Confidence 998844333 778888875 433334443332 344665 33332 3334467778 799999999999999
Q ss_pred cCCC--C-cEEEEe
Q 017270 168 DPLT--H-QVKICD 178 (374)
Q Consensus 168 ~~~~--~-~ikl~D 178 (374)
...+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5322 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00015 Score=60.74 Aligned_cols=126 Identities=22% Similarity=0.314 Sum_probs=85.9
Q ss_pred cceeeeeeeecCCC-ceEEEEEECCCCcEEEEEEeec--------------ccc-----------chHHHHHHHH---hc
Q 017270 32 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ--------------DRR-----------YKNRELQLMR---VM 82 (374)
Q Consensus 32 ~~y~i~~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~--------------~~~-----------~~~~e~~~l~---~l 82 (374)
.+++.++.||.|.- |.||+++. .|+.||+|.+.. ... ....|-...- .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999986 678999998311 000 0123444443 44
Q ss_pred CCCce--eeeceeeeecC-------------CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 017270 83 DHPNV--ISLKHCFFSTT-------------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147 (374)
Q Consensus 83 ~h~~i--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~ 147 (374)
.+.++ |++++++.-.. ........||.||+...- .++...+ .+|+.-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~----~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDI----PQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHH----HHHHHHHH
Confidence 55566 88888774331 012234568889887531 2333333 36777788
Q ss_pred HhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 148 ~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|. .||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence 8999 69999999999985 2 389999875
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00029 Score=72.85 Aligned_cols=77 Identities=18% Similarity=0.201 Sum_probs=50.1
Q ss_pred eeeeecCCCceEEEEEECCCC--cEEEEEEeecc-----ccchHHHHHHHHhcC-CCce--eeeceeeeecCCCCceEEE
Q 017270 37 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRVMD-HPNV--ISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~ 106 (374)
++.++.|.++.+|+......+ ..+++|+.+.. .....+|..+++.+. |.++ .+++..+.+.. .....|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence 567899999999998754332 46788876432 234568999999995 6654 44444332211 112367
Q ss_pred EEeecccch
Q 017270 107 LVMEYVPES 115 (374)
Q Consensus 107 lv~e~~~g~ 115 (374)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00014 Score=65.83 Aligned_cols=138 Identities=20% Similarity=0.231 Sum_probs=93.9
Q ss_pred eeeeeeecCCCceEEEEEECCCCcEEEEEEeec------cc------------------------cchHHHHHHHHhcCC
Q 017270 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DR------------------------RYKNRELQLMRVMDH 84 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~~------------------------~~~~~e~~~l~~l~h 84 (374)
.|...|..|--+.||.|. ..+|..+|||++.. ++ .+.++|+.-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 456678889999999998 56788999997731 11 112357777777765
Q ss_pred CceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 85 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
..|.----..+. ...+||+|+++. -.......+..++...++.+-.|++.-+.-|-+..+.||.||.--|
T Consensus 226 aGIP~PePIlLk-------~hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILLK-------NHVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceeee-------cceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 443221111110 145999999842 1111122345677778888888888888776554799999999999
Q ss_pred EEEcCCCCcEEEEeecccccc
Q 017270 165 LLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~ 185 (374)
+|+- ++.+.|+|.+-+...
T Consensus 296 ~Lyh--dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 296 LLYH--DGKLYIIDVSQSVEH 314 (520)
T ss_pred heEE--CCEEEEEEccccccC
Confidence 9997 678999999877543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0003 Score=61.76 Aligned_cols=69 Identities=16% Similarity=0.076 Sum_probs=42.1
Q ss_pred eecCCC-ceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEEEeecccch
Q 017270 40 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPES 115 (374)
Q Consensus 40 lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~ 115 (374)
|..|.. +.||++.. .+..+.+|..... .....+|+.+++.+. +-.+.+++.+... ....++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCCc
Confidence 445555 78898864 3467888876443 123557999888884 2233444443311 12366899999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=1.3e-05 Score=83.61 Aligned_cols=213 Identities=16% Similarity=0.029 Sum_probs=136.7
Q ss_pred HHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017270 75 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153 (374)
Q Consensus 75 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~ 153 (374)
|...++...|+++...+.-.... .....+.+++||. |.+...+..-......+....+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 44455566898887765544222 2223568899998 5666666654444455555544444444477777777743
Q ss_pred C----eEeecCCCCcEEEcCCCCcEEEEeecccccc-ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHH
Q 017270 154 R----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 228 (374)
Q Consensus 154 ~----ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~l 228 (374)
+ -+|++||+-|.++.. +..+|++++|+.+.. ..........+++.|++|++.. .-.++.++|+|+.|+-+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence 3 478999999999996 778999999999832 2223334567899999999874 34577789999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017270 229 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 308 (374)
Q Consensus 229 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 308 (374)
..|..+|. ..++.+++. ...+-..++.+.+ .|.++-.....+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~l------------~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEKL------------KPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHcC-----------ccccccccccccc------------CCCcccHHHHHHHHHHhhhcch
Confidence 99888773 222222221 1111112222221 2334444455555556678999
Q ss_pred HHHHhcCCcccc
Q 017270 309 ALEACAHPFFDE 320 (374)
Q Consensus 309 ~~e~l~hp~~~~ 320 (374)
-...+.-|.|.-
T Consensus 1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred hhhhcccccccc
Confidence 999888888754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0012 Score=57.50 Aligned_cols=69 Identities=16% Similarity=0.287 Sum_probs=43.8
Q ss_pred eeeeecCCCceEEEEEECC-CCcEEEEEEeecccc---chHHHHHHHHhcCCCce-eeeceeeeecCCCCceEEEEEeec
Q 017270 37 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
++.|..|-...+|++.... .++.|++|....... ...+|..+++.+...++ ++++..+ . -.++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEEEEe
Confidence 4567888888999987432 357899997654321 22478888888854443 3332221 1 1279999
Q ss_pred ccc
Q 017270 112 VPE 114 (374)
Q Consensus 112 ~~g 114 (374)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00022 Score=67.17 Aligned_cols=170 Identities=21% Similarity=0.249 Sum_probs=108.8
Q ss_pred HHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 017270 74 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153 (374)
Q Consensus 74 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~ 153 (374)
-...+++.+.|+|.....++-- .......+|||++.-++++.+.... +-.. +++ . +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-~ 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-H 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-c
Confidence 3466788899999988766541 2222377999999999888776321 1110 111 1 3
Q ss_pred CeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
++.|- | .++.+| .++.. | |- ...+++||||+|.++.++..|..
T Consensus 87 ~~~~~-----~--------~~~~td-~~~t~---------------~--~~------~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----N--------IIYITD-HFLTK---------------Y--PS------PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----h--------hhhccc-ccccc---------------C--CC------CCCcchhhhhHHHHHHHHHHhhH
Confidence 33331 2 233333 11100 0 11 12259999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 234 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.+......+.+..+.+....+.....--+ +..+.-.++....++..+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 99888887777777665443332111100 0012223678889999999999999999999999
Q ss_pred cCCccccc
Q 017270 314 AHPFFDEL 321 (374)
Q Consensus 314 ~hp~~~~~ 321 (374)
+|+-|..+
T Consensus 193 k~~i~~ev 200 (725)
T KOG1093|consen 193 KRCSFTEV 200 (725)
T ss_pred cCccHHHH
Confidence 99999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00085 Score=58.57 Aligned_cols=30 Identities=40% Similarity=0.579 Sum_probs=24.8
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|+|+.|.||+++. +...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence 35899999999999984 5445699999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00064 Score=60.20 Aligned_cols=133 Identities=17% Similarity=0.215 Sum_probs=73.2
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhcCCCcee-eeceeeeecCCCCceEEEEEeeccc
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYVP 113 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~ 113 (374)
.+..|-.+.+|++. .+++.+++|....... ...+|..+++.+....++ +++... . -++||||++
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEecc
Confidence 35568888999886 3567888987643322 235788899888644332 222211 1 248999998
Q ss_pred chHHH-----------HH----Hhhh---hcCCCCCH-HHHHHHHHHH---------HHHHHHhhc-------CCCeEee
Q 017270 114 ESMYR-----------VL----KHYS---SANQRMPL-IYVKLYTYQI---------FRGLAYIHT-------VPRVCHR 158 (374)
Q Consensus 114 g~l~~-----------~l----~~~~---~~~~~l~~-~~~~~i~~ql---------l~al~~LH~-------~~~ivH~ 158 (374)
|.... .+ ...- ....+++. ..+..+..++ ...+..+-. ...++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 73211 11 1100 01112221 1122222121 111222211 0258999
Q ss_pred cCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 159 DLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 159 dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+.|.||+++. ++ +.|+||..|..
T Consensus 152 Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeC-CC-CEEEeccccCc
Confidence 99999999985 44 88999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0028 Score=59.34 Aligned_cols=71 Identities=23% Similarity=0.339 Sum_probs=46.5
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhcC---CCceeeeceeeeecCCCCc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 102 (374)
.+.||.|.+..||++.....++.++||.-.. .......|.+.|+.+. ..++++++.+- .+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EE- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CC-
Confidence 4679999999999999754336899997431 1122346778887763 23566665532 11
Q ss_pred eEEEEEeecccc
Q 017270 103 LFLNLVMEYVPE 114 (374)
Q Consensus 103 ~~~~lv~e~~~g 114 (374)
..++|||++++
T Consensus 105 -~~~lVME~L~~ 115 (401)
T PRK09550 105 -LAVTVMEDLSD 115 (401)
T ss_pred -CCEEEEecCCC
Confidence 15699999975
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0047 Score=55.93 Aligned_cols=75 Identities=7% Similarity=-0.022 Sum_probs=48.7
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCC---CceeeeceeeeecCCCCceEEEEEee
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH---PNVISLKHCFFSTTSKNELFLNLVME 110 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e 110 (374)
-.+.||.|..+.||.... .++ .+++|..... ......|...|+.+.. -.+.++++++..... ....++|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCeEEEEe
Confidence 356799999999998863 223 5677764331 2356789999998854 245666554422211 223679999
Q ss_pred cccc
Q 017270 111 YVPE 114 (374)
Q Consensus 111 ~~~g 114 (374)
+++|
T Consensus 94 ~i~G 97 (297)
T PRK10593 94 RLRG 97 (297)
T ss_pred ccCC
Confidence 9986
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0007 Score=56.77 Aligned_cols=101 Identities=19% Similarity=0.156 Sum_probs=74.4
Q ss_pred HHHHHHHhcCC-CceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 017270 74 RELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151 (374)
Q Consensus 74 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~ 151 (374)
.|.-+++.+.+ ++++++++.+ . .++|.||.+. ++... ......-...++.....++.+++..+++|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 57888888876 6899998877 2 3468899884 33221 0000111346889999999999999999987
Q ss_pred C--CCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 152 V--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 152 ~--~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
. ..+.-.|++|+|+-++. ++++|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeC-CCcEEEEechhcchh
Confidence 1 24667899999999995 788999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.005 Score=56.41 Aligned_cols=30 Identities=30% Similarity=0.261 Sum_probs=25.4
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|+|+.|.||+++. +...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence 48999999999999984 4445799999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00042 Score=61.79 Aligned_cols=130 Identities=16% Similarity=0.181 Sum_probs=85.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec----------c----------------ccchHHHHHHHHhcCCC-
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------D----------------RRYKNRELQLMRVMDHP- 85 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~----------~----------------~~~~~~e~~~l~~l~h~- 85 (374)
-|.++..||-|--+.||.+-+ ..|++.++|.-.- . +....+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467888999999999999985 5688888883210 0 11123688888777432
Q ss_pred -ceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 86 -NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 86 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
.+.+.+ +....++|||++.|--+..+.+ ... ...+...+..-+.-|-. +|+||+|..-=|
T Consensus 172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN 232 (465)
T ss_pred CCCCCcc---------cccceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence 122222 2233789999998732111111 111 22344455556677788 799999999999
Q ss_pred EEEcCCCCcEEEEeecccc
Q 017270 165 LLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~ 183 (374)
|+++. ++.++++||--..
T Consensus 233 imv~d-d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 233 IMVKD-DDKIVVIDFPQMV 250 (465)
T ss_pred eEEec-CCCEEEeechHhh
Confidence 99995 7789999997654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0096 Score=54.24 Aligned_cols=145 Identities=17% Similarity=0.065 Sum_probs=75.9
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCc--eeeeceeeeec-CCCCceEEEEEee
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVME 110 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e 110 (374)
..+.++.|....+|++.. ++..+++|+.... ......|..++..|.... +.+++...... ........+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356678887789998864 3446888977543 233446777777774322 23332211000 0011234679999
Q ss_pred cccchH-----H-------HHHHhh--hhcCC--------CCC-HHH--HH----------HHHHHHHHHHHHhhc----
Q 017270 111 YVPESM-----Y-------RVLKHY--SSANQ--------RMP-LIY--VK----------LYTYQIFRGLAYIHT---- 151 (374)
Q Consensus 111 ~~~g~l-----~-------~~l~~~--~~~~~--------~l~-~~~--~~----------~i~~qll~al~~LH~---- 151 (374)
|++|.. . ..+... ...+. ..+ +.. .. .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 987621 0 111110 00100 000 000 00 001112233444431
Q ss_pred --CCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 152 --VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 152 --~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..+++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 158999999999999986 5556899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.006 Score=55.20 Aligned_cols=144 Identities=14% Similarity=0.036 Sum_probs=75.8
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeec-cccchHHHHHHHHhcCCCc--eeeeceeeeec-CCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 112 (374)
.+.|..|....+|++.. ++..+++|+... .......|+.++..+.+.. +.+++...-.. ........++|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 55677788889998864 345789998764 2233456888888775433 33332210000 001112357899999
Q ss_pred cchHH------------HHHHhh--hhcC--CC----CCHHHHHH------------HHHHHHHHHHHhhc------CCC
Q 017270 113 PESMY------------RVLKHY--SSAN--QR----MPLIYVKL------------YTYQIFRGLAYIHT------VPR 154 (374)
Q Consensus 113 ~g~l~------------~~l~~~--~~~~--~~----l~~~~~~~------------i~~qll~al~~LH~------~~~ 154 (374)
+|... ..+... .... .. ........ ....+..++.++.+ ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 86211 111100 0000 00 00000000 01112223333332 147
Q ss_pred eEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 155 ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 999999999999995 5556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.013 Score=54.31 Aligned_cols=30 Identities=33% Similarity=0.617 Sum_probs=26.2
Q ss_pred CeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++|+|+++.||+++..++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 689999999999998545679999998875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.023 Score=52.36 Aligned_cols=69 Identities=23% Similarity=0.244 Sum_probs=42.7
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhcC--CC-ceeeeceeeeecCCCCceE
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~ 104 (374)
.||.|....||++.....++.++||.-.. ...+..-|...|+... .| .+++++.+ +.. .
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e-----~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE-----M 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc-----c
Confidence 57999999999999754346899995421 1122235777777653 23 44555432 211 1
Q ss_pred EEEEeecccc
Q 017270 105 LNLVMEYVPE 114 (374)
Q Consensus 105 ~~lv~e~~~g 114 (374)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4589999963
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.025 Score=52.13 Aligned_cols=29 Identities=24% Similarity=0.371 Sum_probs=25.5
Q ss_pred eEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 155 ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|.|+.+.||++++.++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 68999999999997545789999999885
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.036 Score=50.45 Aligned_cols=29 Identities=28% Similarity=0.558 Sum_probs=25.1
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 48999999999999985 458999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.05 Score=49.37 Aligned_cols=31 Identities=32% Similarity=0.494 Sum_probs=26.2
Q ss_pred CCeEeecCCCCcEEEcCC---CCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~---~~~ikl~Dfg~a~ 183 (374)
..++|+|+.|.||+++.+ ++.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 368999999999999853 3679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.11 Score=47.19 Aligned_cols=31 Identities=29% Similarity=0.501 Sum_probs=26.6
Q ss_pred CeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
.++|+|+.+.|+++++ +.-+-+.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~-~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDP-GRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeC-CCeeEEEeccccccC
Confidence 3899999999999997 445999999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.059 Score=50.30 Aligned_cols=71 Identities=17% Similarity=0.214 Sum_probs=45.2
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHhcC--CC-ceeeeceeeeecCCCCce
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 103 (374)
.+.||.|.-..||++.+...++.++||.-.. ...+..-|.++|+... .| .+++++.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e----- 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV----- 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH-----
Confidence 6778999999999999743356899995421 1122345788887663 23 45555432 221
Q ss_pred EEEEEeecccc
Q 017270 104 FLNLVMEYVPE 114 (374)
Q Consensus 104 ~~~lv~e~~~g 114 (374)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 14589999963
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.11 Score=48.83 Aligned_cols=70 Identities=19% Similarity=0.247 Sum_probs=45.3
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhcC---CCceeeeceeeeecCCCC
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 101 (374)
..+.||.|....||++.+ .+..++||.-.. .......|...|+.+. ..++.+++.+. ++
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence 467789999999999886 345689996541 2222335677776654 23566666544 22
Q ss_pred ceEEEEEeecccc
Q 017270 102 ELFLNLVMEYVPE 114 (374)
Q Consensus 102 ~~~~~lv~e~~~g 114 (374)
. .+++||++++
T Consensus 109 ~--~vlvME~L~~ 119 (418)
T PLN02756 109 M--ALIGMRYLEP 119 (418)
T ss_pred C--CEEEEeecCC
Confidence 2 4588999975
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.028 Score=51.27 Aligned_cols=107 Identities=16% Similarity=0.167 Sum_probs=69.0
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.+..+.|++|++-++.+.. + .....+++..++++.+..+.-+...-..-|||+...|||++ .|.|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4556788999988875432 1 22345667788888777777776623678999999999999 577999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 222 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslG 222 (374)
-+++.......- .....--|-.+.|. -+..-+||-+-
T Consensus 366 klsRl~~~q~~i----sy~rldhp~lF~G~--dd~QFeIYrlM 402 (488)
T COG5072 366 KLSRLSYSQGII----SYNRLDHPDLFNGV--DDYQFEIYRLM 402 (488)
T ss_pred eeeecccCCcee----eccccCchhhhcCc--cceeeeHHHHH
Confidence 999854333211 11112234334332 25666776643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.13 Score=46.76 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.4
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|+|+.++|++++. ++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 47999999999999986 6679999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.35 Score=43.23 Aligned_cols=30 Identities=30% Similarity=0.543 Sum_probs=24.8
Q ss_pred CeEeecCCCCcEEEcCCCCc-EEEEeeccccc
Q 017270 154 RVCHRDLKPQNLLVDPLTHQ-VKICDFGSAKQ 184 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~-ikl~Dfg~a~~ 184 (374)
.++|+|+.|.||+++. ++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~-~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDE-DARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeC-CCCEEEEECcHhccc
Confidence 5899999999999985 344 56999999863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.48 Score=44.52 Aligned_cols=28 Identities=32% Similarity=0.387 Sum_probs=23.6
Q ss_pred CeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 154 ~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..+|.|+-+.||+.+ +..+.++||..|.
T Consensus 228 VfCHNDL~~gNIL~~--~~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDF--NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEec--CCCEEEEEecccc
Confidence 568999999999986 3459999998774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.5 Score=42.45 Aligned_cols=71 Identities=13% Similarity=0.145 Sum_probs=42.1
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhcC---CCceeeeceeeeecCCCCceEEEEEeec
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
-.+.++.|....+|+.. .+++.+.+|+-... ......|..-|+.|. --.+.+++.+... .+. -++||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~---~~~--~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY---DDD--AFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----SSC--CEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee---cCC--ceEEEEe
Confidence 35678889999999876 57889999977643 334567998888884 2234555554322 111 3799999
Q ss_pred cc
Q 017270 112 VP 113 (374)
Q Consensus 112 ~~ 113 (374)
++
T Consensus 94 l~ 95 (288)
T PF03881_consen 94 LE 95 (288)
T ss_dssp --
T ss_pred ec
Confidence 86
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.11 Score=49.19 Aligned_cols=30 Identities=27% Similarity=0.350 Sum_probs=24.0
Q ss_pred eEeecCCCCcEEEcCCCC----cEEEEeeccccc
Q 017270 155 VCHRDLKPQNLLVDPLTH----QVKICDFGSAKQ 184 (374)
Q Consensus 155 ivH~dlkp~NIll~~~~~----~ikl~Dfg~a~~ 184 (374)
++|+||...|||++.+++ -..|+||..+..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 689999999999987444 456889888754
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.77 Score=42.14 Aligned_cols=28 Identities=25% Similarity=0.315 Sum_probs=24.0
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~--d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc--C-CcEEEeCCCCC
Confidence 4789999999999995 3 47899999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.11 Score=48.19 Aligned_cols=60 Identities=30% Similarity=0.313 Sum_probs=38.3
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
..++-+|..| ++...++ ....++...+.++.-.+.|+--+--..+++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4466677776 5555544 2344555555565555666544333368999999999999954
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.089 Score=47.38 Aligned_cols=131 Identities=22% Similarity=0.251 Sum_probs=85.7
Q ss_pred eeeeeeecCCCceEEEEEEC------C----CCcEEEEEEeec-------------cc-----------------cchHH
Q 017270 35 MAERVVGTGSFGIVFQAKCL------E----TGETVAIKKVLQ-------------DR-----------------RYKNR 74 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~------~----~~~~vaiK~~~~-------------~~-----------------~~~~~ 74 (374)
.|..+|..|.-+.|+-|+-- . ....+|||++.. +. ...++
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 45567888888888877421 1 123589997621 10 01123
Q ss_pred HHHHHHhc-----CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 017270 75 ELQLMRVM-----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149 (374)
Q Consensus 75 e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L 149 (374)
|..-|.++ .+|-+|.+.. ..+||.|++.. .+..-...+-.++..+.+..-.|+..++.-|
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~l 399 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRL 399 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHH
Confidence 44444443 3677777644 33899999842 1121122345688888888888998888655
Q ss_pred -hcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 150 -HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 150 -H~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
|+ .-.||.||.--|+|..+ +.+-++|..-+.
T Consensus 400 Y~E-c~LVHADlSEyN~Lw~~--gKvw~IDVsQsv 431 (531)
T KOG2269|consen 400 YKE-CLLVHADLSEYNLLWTP--GKVWVIDVSQSV 431 (531)
T ss_pred HHh-hheeecchhhhhheecC--CceEEEechhcc
Confidence 55 68999999999999985 479999987664
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.26 Score=44.65 Aligned_cols=64 Identities=22% Similarity=0.215 Sum_probs=37.8
Q ss_pred EEEeecccchHHHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCCeEeecCCCCcEEEcC
Q 017270 106 NLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHT---VPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~-~~~~~~~~l~~~~~~~i~~qll~al~~LH~---~~~ivH~dlkp~NIll~~ 169 (374)
.||+++..++-.++-. .....+-.--.+-++.++.|++.-.-.+-+ ..+.+|-||||+|||+-+
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 3778876543222111 111222223445678888998876533322 247999999999999853
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.43 E-value=3.5 Score=39.58 Aligned_cols=70 Identities=14% Similarity=0.171 Sum_probs=41.6
Q ss_pred eeeeeecCCCceEEEEEECC--------CCcEEEEEEeecccc---chHHHHHHHHhcCCCcee-eeceeeeecCCCCce
Q 017270 36 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNEL 103 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~ 103 (374)
-++.|..|-...+|++.... +++.|.+++.-.... ....|..+++.+...+|- ++++.+ .+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----SG-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----CC--
Confidence 45667778888899887542 156789997744322 224588887777544432 333333 11
Q ss_pred EEEEEeecccc
Q 017270 104 FLNLVMEYVPE 114 (374)
Q Consensus 104 ~~~lv~e~~~g 114 (374)
+.|.||++|
T Consensus 182 --g~I~efi~g 190 (442)
T PTZ00296 182 --GRIEEWLYG 190 (442)
T ss_pred --CEEEEeeCC
Confidence 246777765
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.31 Score=43.34 Aligned_cols=48 Identities=25% Similarity=0.364 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHHHHhhcCC--CeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 135 VKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 135 ~~~i~~qll~al~~LH~~~--~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++..+..+-.++.-.+. . -++|+|+.|+|++.++ .+.+.|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~-~~~v~cH~Dl~~~N~l~t~-~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPK-DDLVPCHNDLNPGNLLLTD-KGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCC-CceeeecCCCCccceEEcC-CCcEEEEecccCCC
Confidence 34445555566666665 2 4899999999999995 57899999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 374 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-138 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-138 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-138 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-138 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-138 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-138 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-138 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-137 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-137 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-137 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-137 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-137 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-137 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-136 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-136 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-136 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-136 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-135 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-135 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-135 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-133 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-129 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-91 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-82 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-46 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-45 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-45 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-45 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-45 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-45 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-45 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-45 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-44 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-44 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-44 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-44 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-44 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-44 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-44 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-44 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-44 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-44 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-44 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-44 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-44 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-44 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-44 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-44 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-44 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-44 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-44 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-44 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-44 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-44 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-44 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-44 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-44 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-44 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-44 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-44 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-44 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-44 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-44 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-44 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-44 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-43 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-43 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-43 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-43 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-42 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-41 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-41 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-41 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-41 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-41 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-41 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-40 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-40 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-40 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-40 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-39 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-39 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-39 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-39 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-39 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-39 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-39 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-39 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-39 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-39 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-39 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-38 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-36 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-35 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-35 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-35 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-35 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-35 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-34 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-34 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-33 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-33 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-33 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-33 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-33 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-33 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-33 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-33 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-33 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-33 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-32 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-32 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-31 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-31 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-30 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-30 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-30 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-30 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-30 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-30 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-30 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-30 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-30 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-29 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-29 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-29 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-29 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-29 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-29 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-29 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-29 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-29 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-29 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-29 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-29 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-29 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-28 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-28 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-28 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-28 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-28 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-28 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-27 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-27 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-27 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-27 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-26 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-26 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-25 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-19 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-18 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-18 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 622 bits (1606), Expect = 0.0
Identities = 228/372 (61%), Positives = 290/372 (77%), Gaps = 4/372 (1%)
Query: 6 VDGSDHVTGHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK 63
+ S G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIK
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 64 KVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKH 122
KVLQD+R+KNRELQ+MR +DH N++ L++ F+S+ K +E++LNLV++YVPE++YRV +H
Sbjct: 86 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
Query: 123 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182
YS A Q +P+IYVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSA
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
KQL+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VD
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 302
QLVEIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 303 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 362
P+ R T LEACAH FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI 384
Query: 363 QLGLNFLHPAGT 374
Q + A
Sbjct: 385 QAAASTPTNATA 396
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 620 bits (1602), Expect = 0.0
Identities = 217/368 (58%), Positives = 283/368 (76%), Gaps = 4/368 (1%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
++ ++ D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+ E V
Sbjct: 10 LNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-V 67
Query: 61 AIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRV 119
AIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K +E+FLNLV+EYVPE++YR
Sbjct: 68 AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA 127
Query: 120 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179
+HY+ Q MP++ +KLY YQ+ R LAYIH++ +CHRD+KPQNLL+DP + +K+ DF
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 239
GSAK LIAGE N+SYICSR+YRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFPGE+
Sbjct: 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246
Query: 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 299
+DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL SRLL
Sbjct: 247 GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLL 306
Query: 300 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 359
+Y+PS R TA+EA HPFFDELR AR+PNGR LPPLFN+ +E P+L+++L+P H
Sbjct: 307 EYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQH 366
Query: 360 VKRQLGLN 367
+ +L
Sbjct: 367 AEAELLSR 374
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 589 bits (1520), Expect = 0.0
Identities = 154/357 (43%), Positives = 222/357 (62%), Gaps = 13/357 (3%)
Query: 14 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 71
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 72 KNRELQLMRVM---DHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSA 126
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP++++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 127 NQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +K+CDFGSAK+L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
E N++YICSR+YRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 302
EI++VLG P+RE +R +NP++TD K PW VF + EA DL S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 303 PSLRCTALEACAHPFFDELREPNARLPNGRPLPP-LFNF-KQELSGASPELVNKLIP 357
P R EA HP+FDEL +P +LPN + LP LF F E+ S KL+
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 568 bits (1466), Expect = 0.0
Identities = 166/381 (43%), Positives = 241/381 (63%), Gaps = 44/381 (11%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHP 85
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+V+DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 86 NVISLKHCFFSTTSK---------------------------------NELFLNLVMEYV 112
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 113 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172
P+++++VLK + + + +P+ + +Y YQ+FR + +IH++ +CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 173 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 232
+K+CDFGSAK+LI E +++YICSRFYRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 233 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 292
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ + P AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 293 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPPLFNF-KQ 342
DL ++L+Y P LR EA AHPFFD LR N+ P+G + +P LFNF
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 343 ELSGASPELVNKLIPDHVKRQ 363
ELS ++N+++P +
Sbjct: 360 ELSIIPGNVLNRILPKNFSPN 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 98/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
F K L L V EY ++ L Y + +P VK T+Q + + + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 212
HRD+KP+N+L+ +K+CDFG A+ L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 270
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 271 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
P + P F + A+ L L P+ R T + HP+F+ +RE L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 330 NGRPLPPLFNFKQ 342
P + Q
Sbjct: 299 KEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 2e-98
Identities = 96/295 (32%), Positives = 155/295 (52%), Gaps = 21/295 (7%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
K +L V E+V ++ L+ + + V+ Y +QI G+ + H+
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 212
+ HRD+KP+N+LV + VK+CDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 270
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 271 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
P+IK P + + ++ IDLA + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 2e-97
Identities = 99/326 (30%), Positives = 169/326 (51%), Gaps = 33/326 (10%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMD 83
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
H N+++L + S L LV EY+ + + + L + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLL 110
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFY 200
RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ +Y + + +Y
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 257
R P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
I + + +P+ +A R+ + DL ++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 318 FDELREPNARLPNGRPLPPLFNFKQE 343
F L E +LP+ + L + +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 7e-97
Identities = 88/313 (28%), Positives = 154/313 (49%), Gaps = 30/313 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 87
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 88 ISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 138
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 194
YQ+ RGL YIH+ V HRDLKP NL ++ +KI DFG A+ + ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 195 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 255 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312
E+ + + + P ++ + EA+D ++L +SP R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 313 CAHPFFDELREPN 325
+HP+ P
Sbjct: 304 LSHPYMSIYSFPM 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 6e-96
Identities = 105/346 (30%), Positives = 181/346 (52%), Gaps = 34/346 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+I++ + + +N + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YI 195
+H V HRDLKP NLL++ +K+CDFG A+ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 256 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
+ +P ++ P A P K+F + + P+ IDL R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 312 ACAHPFFDELREPNARLPNGRPLPPL-FNFKQELSGASPELVNKLI 356
A HP+ +PN P G P+PP F F + + + KLI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 9e-95
Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 90
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 207
+ HRDLKP NLL+D +K+ DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 264
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
+Y F P H +F + +DL L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 325 NARLPNGRPLPP 336
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-94
Identities = 87/303 (28%), Positives = 151/303 (49%), Gaps = 23/303 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVISLK 91
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 212 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 265
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 266 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ D + W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 322 REP 324
+
Sbjct: 327 VKD 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 4e-94
Identities = 97/332 (29%), Positives = 159/332 (47%), Gaps = 33/332 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 78
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 79 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 136
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
+ Y I GL +H V HRDL P N+L+ + + ICDF A++ A Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 257 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312
E++ +P +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 313 CAHPFFDELREPNARLPNGRPLPPLFNFKQEL 344
HP+F+ L +P L G F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-93
Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+ L L + EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 I---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 154 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 206
R HRDLKPQNLL+ +KI DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 263
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
P++ FP+ + +V + E +DL + +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 324 PNARLPNGRPLPP 336
P
Sbjct: 326 ---------DFDP 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 2e-92
Identities = 109/341 (31%), Positives = 177/341 (51%), Gaps = 36/341 (10%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 202
YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 263 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
N ++ P PW+++F +A+DL ++L ++P R +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 320 ELR----EPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
+ EP A F F EL E + +LI
Sbjct: 319 QYYDPSDEPIA--------EAPFKFDMELDDLPKEKLKELI 351
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-92
Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 210
R+ HRDLKPQNLL++ +K+ DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 267
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
F + PW + E IDL S +L + P+ R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 7e-92
Identities = 97/294 (32%), Positives = 160/294 (54%), Gaps = 28/294 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 210
RV HRDLKPQNLL++ ++KI DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 267
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-91
Identities = 105/304 (34%), Positives = 162/304 (53%), Gaps = 25/304 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 85
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH+ V HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 263
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 264 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ PQ + ++F R P+A DL ++L+ R TA +A HPFF+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 322 REPN 325
R+P
Sbjct: 313 RDPE 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-91
Identities = 104/335 (31%), Positives = 173/335 (51%), Gaps = 29/335 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 85
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI L F + ++ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH + HRDLKP NL V+ ++KI DFG A+Q A Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVTRWYRAPE 195
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 263
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 264 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
++ P+++ + + P A++L ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 322 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
+ P ++ + + + ++
Sbjct: 315 HDTED-----EPQVQKYDDSFDDVDRTLDEWKRVT 344
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 5e-90
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 93
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 210
V HRDLKPQNLL++ ++K+ +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 211 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 266
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
+ V ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 6e-90
Identities = 96/320 (30%), Positives = 159/320 (49%), Gaps = 41/320 (12%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 90
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAY 148
+ L LV E++ + + + + N + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 205
H ++ HRDLKPQNLL++ Q+K+ DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 266 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
T Q +V + +D LLQ +P +R +A +A HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 317 FFDELREPNARLPNGRPLPP 336
+F E A + R
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 2e-89
Identities = 107/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 85
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 86 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI L F S E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPE 199
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 263
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 264 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ ++ Q+ + VF P A+DL ++L R TA +A AH +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 322 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
+P+ P+ ++ E + L
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 3e-89
Identities = 99/337 (29%), Positives = 163/337 (48%), Gaps = 39/337 (11%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 85
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 86 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQI 142
N+I L + F S E + +VME + ++ +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 202
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 263 NPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTA 309
P + P+ + + K+F + +A DL S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 310 LEACAHPFFDELREPNARLPNGRPLPPLFNF-KQELS 345
EA HP+ + +P+ P P ++E +
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 99/325 (30%), Positives = 157/325 (48%), Gaps = 34/325 (10%)
Query: 40 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRVMDHPNVI 88
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L + + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 205
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ ++ + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 190
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245
Query: 266 YT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
Query: 323 EPNARLPNGRPLPPLFNFKQELSGA 347
L P EL+ A
Sbjct: 305 RCKENLD---SHLPPSQNTSELNTA 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-88
Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 31/300 (10%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRVMDHPNV 87
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L ++ + E+ + LV E+V + + L + +P +K Q RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPE 204
++H + HRDLKP+N+LV VK+ DFG A+ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVVVTLWYRAPE 189
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 265 NYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
FP P V M L +L ++P R +A A H + +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-88
Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 79/382 (20%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHP 85
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVG 168
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------------ 193
+ Y+H+ + HRDLKP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 194 ----------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 230
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 231 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 265
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 266 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ FP+ + + F +AI L R+L ++P+ R T E AHPFF E+R
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 324 PNARLPNGRPLPPLFNFKQELS 345
+ FN +
Sbjct: 406 AEVETNATEKVRLPFNDWMNMD 427
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 6e-88
Identities = 96/332 (28%), Positives = 166/332 (50%), Gaps = 36/332 (10%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 85
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 86 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+ISL + F + E + LVME + ++ +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 265 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 311
++ P+ + K+F +K +A DL S++L P+ R + +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 312 ACAHPFFDELREPNARLPNGRPLPPLFNFKQE 343
A HP+ + +P P P +++ + +
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLD 381
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-86
Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 36/320 (11%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 89
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++++ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 90 LK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRG 145
L S ++ + + LV ++ L S+ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANISY---ICSRFY 200
L YIH ++ HRD+K N+L+ +K+ DFG A+ L Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 257
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
+ Y + + P A+DL +LL P+ R + +A H
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 317 FFDELREPNARLPNGRPLPP 336
FF +P G
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-86
Identities = 91/361 (25%), Positives = 171/361 (47%), Gaps = 61/361 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRVM-DH 84
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N+++L + + + +++L V +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----------- 193
+ Y+H+ + HRD+KP N+L++ VK+ DFG ++ + +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 194 -----------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 243 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 288
QL II V+ P+ E++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 289 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 344
EA+DL +LLQ++P+ R +A +A HPF PN + N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
Query: 345 S 345
S
Sbjct: 359 S 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-85
Identities = 98/376 (26%), Positives = 164/376 (43%), Gaps = 75/376 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRVMDHP 85
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 86 NVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+I L +EL++ V+E + ++ K + ++K Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIKTILYNLL 139
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 193
G +IH + HRDLKP N L++ VK+CDFG A+ + + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 194 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-------- 232
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 233 ---PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF-- 269
PLFPG ++ DQL I ++GTPT ++++ + P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329
FP K + + + + I+L +L+++P+ R T +A HP+ ++R+
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376
Query: 330 NGRPLPPLFNFKQELS 345
+ + + F+ LS
Sbjct: 377 STKKIILPFDDWMVLS 392
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-81
Identities = 94/345 (27%), Positives = 157/345 (45%), Gaps = 40/345 (11%)
Query: 40 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 95
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 96 STTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIH 150
S + + L+ +Y ++ ++K + ++ ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 151 TVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSR----FYRAP 203
V HRDLKP N+LV +VKI D G A+ + ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 254
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 255 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 305
+ E + ++ + + + + +A L +LL P
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 306 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 350
R T+ +A P+F E +P + ++ L+ P+
Sbjct: 325 RITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-66
Identities = 97/339 (28%), Positives = 160/339 (47%), Gaps = 54/339 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 84
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
NVI + F T +N + + E + ++Y ++K + Q L V+ + + I +
Sbjct: 159 MNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQ 211
Query: 145 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
L +H R+ H DLKP+N LL +K+ DFGS+ + +YI SRFYRAP
Sbjct: 212 CLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--- 260
E+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 269 EVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 261 --------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA----ID 293
P Y R +++ P + + + +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 294 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 332
+ L++ P++R T +A HP+ R + P G
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 87/339 (25%), Positives = 146/339 (43%), Gaps = 42/339 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 85
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 86 NVISLKHC-----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 140
+ + H F+ N + + +V E + E++ ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYI 195
Q+ GL Y+H + H D+KP+N+L++ + +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSI 196
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 249
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 250 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 296
+LG +R N ++K P V ++ E D S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 297 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 335
+LQ P R A HP+ + R L
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 96/333 (28%), Positives = 150/333 (45%), Gaps = 56/333 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 84
Y + ++G GSFG V +A E VAIK + + + N E++L+ +M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
++ LK F +N L L V E + ++Y +L++ + + + L + + Q+
Sbjct: 116 YYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCT 168
Query: 145 GLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 202
L ++ T + H DLKP+N LL +P +KI DFGS+ Q G+ YI SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRS 226
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-- 260
PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 261 ---------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA------------ 291
+ + + K P + H + P
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 292 ----IDLASRLLQYSPSLRCTALEACAHPFFDE 320
DL R+L Y P R A H FF +
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-63
Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 54/334 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 83
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+ + F + + V E + S Y +K L +++ YQI
Sbjct: 76 TFRCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQIC 128
Query: 144 RGLAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQL 185
+ + ++H+ ++ H DLKP+N L V + +K+ DFGSA
Sbjct: 129 KSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
E + + + +R YRAPE+I ++ D+WS GC+L E LG +FP ++ + L
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 246 EIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP-------------E 290
+ ++LG + I+ Y R + + + P
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 291 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 75/335 (22%), Positives = 135/335 (40%), Gaps = 60/335 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 85
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
N++ F + + L + E + S+Y ++ + + +KLY +I +
Sbjct: 97 NIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKA 149
Query: 146 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICDFGS 181
L Y+ + + H DLKP+N LL DP +K+ DFG
Sbjct: 150 LNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241
A + + S I +R YRAPE+I + S D+WS GCVLAEL G LF +
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 242 DQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA- 291
+ L + ++ + + +N + +P+ + K+ P
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 292 -------IDLASRLLQYSPSLRCTALEACAHPFFD 319
D +LQ P+LR + E H F +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-62
Identities = 77/343 (22%), Positives = 130/343 (37%), Gaps = 54/343 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 83
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+ + F + + E + ++ + LK + Q PL +V+ YQ+
Sbjct: 81 KFLCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLC 133
Query: 144 RGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQL 185
L ++H ++ H DLKP+N L V+ +++ DFGSA
Sbjct: 134 HALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190
Query: 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
E + + + +R YR PE+I + D+WS GC+L E G LF + LV
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 246 EIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA----- 291
+ K+LG I + + K M ++
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 292 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 333
DL R+L++ P+ R T EA HPFF L R
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 86
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 87 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+I L + ++ +VME + LK + + K Y +
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 202
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 203 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 251
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281
Query: 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
+PN+ FP I + D+ L+ P R + E
Sbjct: 282 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 317
Query: 312 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 371
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 318 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-58
Identities = 74/348 (21%), Positives = 124/348 (35%), Gaps = 67/348 (19%)
Query: 11 HVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKV 65
H H S G Q++S Y + +G+G VFQ E + AIK V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 66 ----LQDRRYKN--RELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMY 117
++ + E+ + + + +I L + ++ +VME +
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLN 115
Query: 118 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177
LK + + K Y + + IH + H DLKP N L+ +K+
Sbjct: 116 SWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLI 168
Query: 178 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCV 224
DFG A Q+ ++ S + + Y PE I ++ + D+WS GC+
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 225 LAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 283
L + G+ F N + +L II +PN+ FP I
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAII--------------DPNHE-IEFPDI--------- 264
Query: 284 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 331
+ D+ L+ P R + E AHP+ P ++ G
Sbjct: 265 ---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 6e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 86
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 87 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 202
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 203 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 251
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234
Query: 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
+PN+ FP I + D+ L+ P R + E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 312 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 371
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-56
Identities = 71/341 (20%), Positives = 115/341 (33%), Gaps = 55/341 (16%)
Query: 8 GSDHVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAI 62
GS H H S + Y+ + +G G F V + L G A+
Sbjct: 2 GSSHHHHHHSSGREN--LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 63 KKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF-STTSKNELFLNLVMEYVPE-SM 116
K++L QDR RE + R+ +HPN++ L +K+E + L++ + ++
Sbjct: 60 KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTL 117
Query: 117 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176
+ ++ + + I RGL IH HRDLKP N+L+ Q +
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVL 175
Query: 177 CDFGSAK----------QLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCV 224
D GS Q + + + C+ YRAPEL D+WS GCV
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 225 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 284
L ++ G+ + V + V PQ
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA-VQN---------------QLSIPQ----------S 269
Query: 285 KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
R L + ++ P R + + P
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRVMDHP 85
S+ +G GS+G VF+ + E G A+K+ + +DR K E+ +V HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+ L+ + L L E S+ + + + +P V Y
Sbjct: 118 CCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 205
LA++H+ + H D+KP N+ + P + K+ DFG +L A Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ Y T+ D++S G + E+ L G QL +
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
F + E + +L+ P LR TA A P R+P
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-55
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 147 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 201
H V HRDLKP N+ +D VK+ DFG A+ L + + +Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
+ +F +I R E ++ +R+L R + E +P E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-55
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 51/301 (16%)
Query: 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVIS 89
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R D HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
K+ F + +E ++ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 149 IHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY---IC-SRFY 200
+H++ + HRDLKP N+L+ + I DFG K+L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 201 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257
APE++ + T ++DI+SAGCV ++ G F +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+ + P K A +L +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 318 F 318
F
Sbjct: 287 F 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 3e-54
Identities = 44/333 (13%), Positives = 90/333 (27%), Gaps = 57/333 (17%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHP 85
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 86 NVISLKHCFFSTTSKNELFLN---------------------LVMEYVP---ESMYRVLK 121
+ + + + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 122 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181
++ + + T Q+ R A + + + H P NL + P ++ + D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 182 AKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
+ L P + +P L R L
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338
Query: 301 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 332
+ R LEA P F +L+ E ++ L G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-54
Identities = 57/301 (18%), Positives = 119/301 (39%), Gaps = 21/301 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 88
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L TT+++ L+ME+ P S+Y VL+ S+A +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMN 126
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
++ + HR++KP N++ K+ DFG+A++L E +S + Y P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 205 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
+ A +Y ++D+WS G G F + E++ + T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+ P + + + + +L+ + A
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 318 F 318
Sbjct: 306 D 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-54
Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 59/312 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 90
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 91 KHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 141
+ T K + L + MEY ++Y ++ + QR Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR--- 198
I L+YIH+ + HRDLKP N+ +D + VKI DFG AK + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 199 ------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246
Y A E++ G Y ID++S G + E++ P G V
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236
Query: 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 306
I+K L + FP P F + L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 307 CTALEACAHPFF 318
A +
Sbjct: 276 PGARTLLNSGWL 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 44/294 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
VI F LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPE 204
L ++H+ RV HRD+KP N+ + T VK+ D G + + S + + +Y +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 263
I Y DIWS GC+L E+ Q F G+ + L + I +C
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+P + + E L + + P R
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 83/323 (25%), Positives = 137/323 (42%), Gaps = 60/323 (18%)
Query: 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-VM 82
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYVKLYT 139
DHPNVI +C +T + FL + +E ++ V +
Sbjct: 67 DHPNVIRY-YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAKQLIA 187
QI G+A++H++ ++ HRDLKPQN+LV ++ I DFG K+L +
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 188 GEANISYICSRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 235
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 236 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 295
+ + II+ F ++K + EA DL
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 296 SRLLQYSPSLRCTALEACAHPFF 318
S+++ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 50/297 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 93
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 94 F-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 141
+ +++ L + ME+ + ++ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 201
I +G+ YIH+ ++ +RDLKP N+ + T QVKI DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + L +LL P R E
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-52
Identities = 77/325 (23%), Positives = 127/325 (39%), Gaps = 50/325 (15%)
Query: 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 79
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 138
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 120
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 197
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 179 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 230
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
++ P + P A L ++LQ P+ R T E F
Sbjct: 231 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 318 FDELREPNARLPNGRPLPPLFNFKQ 342
F P +PP F+
Sbjct: 269 FTSGYIPARLPITCLTIPPRFSIAP 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-52
Identities = 69/318 (21%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 15 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 67
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 68 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA 126
+R RE+ ++ M HPN++ + F S L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK-- 118
Query: 127 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186
+ + QI L ++H ++ HRD+K QN+ + V++ DFG A+ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 187 AGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
+ + +Y +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 305
I ++ +Y + L S+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 306 RCTALEACAHPFFDELRE 323
R + F + E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 67/313 (21%), Positives = 116/313 (37%), Gaps = 48/313 (15%)
Query: 14 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 71
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 72 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM 130
+ EL + P ++ L +N+ ME + S+ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMG----CL 147
Query: 131 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
P Y Q GL Y+HT R+ H D+K N+L+ + +CDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 191 NISYICSR------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 244
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 304
++I P +I P L+ P
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299
Query: 305 LRCTALEACAHPF 317
R +A+E
Sbjct: 300 HRASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 50/304 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 93
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ + S+N F+ + ME VP S+ +L+ + I YT QI GL Y+H
Sbjct: 84 YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGAT 210
++ HRD+K N+L++ + +KI DFG++K+L ++ + Y APE+I
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 211 E-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y + DIWS GC + E+ G+P F +L E + F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236
Query: 270 RFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+ K HP +P EA + + P R A + F +
Sbjct: 237 KVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
Query: 326 ARLP 329
P
Sbjct: 290 KTQP 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 50/326 (15%)
Query: 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 79
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 138
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 96 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 146
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 197
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 147 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 205 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 256
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
++ P + P A L ++LQ P+ R T E F
Sbjct: 257 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 318 FDELREPNARLPNGRPLPPLFNFKQE 343
F P +PP F+
Sbjct: 295 FTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-50
Identities = 64/318 (20%), Positives = 120/318 (37%), Gaps = 60/318 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 88
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 89 SLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 140
+ + S +++L + M+ E++ + + +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 198
QI + ++H+ + HRDLKP N+ VK+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 199 -----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307
++ + +FP + + P + +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 308 TALEACAHPFFDELREPN 325
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-50
Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 26 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 77
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 136
+ + HP+++ L + F N ++ LV+E M R LK + + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLK---NRVKPFSENEAR 115
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
+ +QI G+ Y+H+ + HRDL NLL+ +KI DFG A QL +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 197 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
D+ P + + EA DL +LL+ +P+ R + H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 316 PFF 318
PF
Sbjct: 264 PFM 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-50
Identities = 78/341 (22%), Positives = 135/341 (39%), Gaps = 55/341 (16%)
Query: 17 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 68
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 69 RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYS 124
E+ +++++DHPN++ L F +++ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 125 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 182
+ Q+ G+ Y+H + HRDLKP+NLL++ +KI DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
+ + + +Y APE++ +Y D+WS G +L LL G P F G+ D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242
Query: 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 302
Q EI+ ++ + W V A DL ++LQ+
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279
Query: 303 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF-NFKQ 342
R +A +A HP+ E+ L N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-50
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 92
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ ST + + LV E + ++ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 152 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
+Y S+D+++ G + E+ + + Q+ + T
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
PE ++ ++ + R + + H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-50
Identities = 82/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 87
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 143
+ L ++ +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 201
G+ Y+H + HRDLKP+N+L++ +KI DFG + I + +Y
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ F W + +A DL ++L + PSLR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 322 REPNARLPNGRPLPPLF-NFKQ 342
+ + L N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-50
Identities = 87/322 (27%), Positives = 138/322 (42%), Gaps = 53/322 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 86
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQI 142
++ L F +++ + LV E E ++ +S Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 200
G+ Y+H ++ HRDLKP+NLL++ + ++I DFG + A + I + +Y
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
+ F W KV A DL ++L Y PS+R +A +A H +
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 321 LREPNARLPNGRPLPPLFNFKQ 342
+ + + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-50
Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 90
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
F ++ L++EY P ++YR L+ + Y ++ L+Y
Sbjct: 75 YGYFH---DATRVY--LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
H+ RV HRD+KP+NLL+ ++KI DFG + + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
+ +D+WS G + E L+G+P F + I +V +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328
F FP + + A DL SRLL+++PS R E HP+ +
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 329 PN 330
N
Sbjct: 272 QN 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-50
Identities = 53/307 (17%), Positives = 117/307 (38%), Gaps = 28/307 (9%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 88
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L TT+++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
++ + HR++KP N++ K+ DFG+A++L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 204 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
+ P + + + + +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299
Query: 317 FFDELRE 323
FF E +
Sbjct: 300 FFAETSD 306
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 62/328 (18%), Positives = 127/328 (38%), Gaps = 52/328 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN----------------REL 76
R + G F + + + + A+K + + R + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMP 131
Q++ + + ++ + T+ +E+++ + EY+ + + +P
Sbjct: 95 QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 132 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191
+ +K + +YIH +CHRD+KP N+L+D +VK+ DFG ++ ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIK 208
Query: 192 ISYIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
S + + PE + Y +DIWS G L + F + ++ +L I+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309
+ I P + F + + + E ID L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 310 LEACAHPFF-----DELREPNARLPNGR 332
+A H + ++LRE + L R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-49
Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 54/308 (17%)
Query: 26 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 79
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 135
+ +DHPN+I L F ++ + LVME E RV+ + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANIS 193
+ +AY H + V HRDLKP+N L + +K+ DFG A + G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 194 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252
+ +Y +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312
F FP W V P+A L RLL SP R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 313 CAHPFFDE 320
H +F++
Sbjct: 260 LEHEWFEK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-49
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 58/323 (17%)
Query: 15 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 67
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 68 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRV 119
E+++++ +DHPN+I + F ++ + +VME S
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 120 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKIC 177
K S YV Q+ LAY H+ V H+DLKP+N+L + +KI
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 178 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237
DFG A+ + E + + + Y APE+ + T DIWSAG V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 297
+ + + + + + P+A+DL +
Sbjct: 228 TSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQ 261
Query: 298 LLQYSPSLRCTALEACAHPFFDE 320
+L P R +A + H +F +
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 63/332 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 76
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPL 132
L++ +DHPN+I L F +++ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 190
QI G+ Y+H + HRD+KP+N+L++ +KI DFG +
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250
+ + +Y APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310
+++ + + W + EA +L +L Y + RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 311 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 342
EA + + + L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 19/317 (5%)
Query: 22 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 74
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 75 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPL 132
E+Q+M+ ++HPNV+S + L L MEY + + L + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKE 120
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEA 190
++ I L Y+H R+ HRDLKP+N+++ P + KI D G AK+L GE
Sbjct: 121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250
++ + Y APEL+ +YT ++D WS G + E + G F Q ++
Sbjct: 180 CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR- 237
Query: 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310
+ E I + +F + P H + + +L + R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 311 EACAHPFFDELREPNAR 327
+ F L +
Sbjct: 294 QNPNVGCFQALDSILSL 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-48
Identities = 76/342 (22%), Positives = 120/342 (35%), Gaps = 64/342 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVM-DHPNVI 88
RV+ G F V++A+ + +G A+K++L + R +E+ M+ + HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 89 SLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
S T + E L+ E + LK + + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146
Query: 144 RGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------------E 189
R + ++H P + HRDLK +NLL+ +K+CDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 190 ANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
I+ + YR PE+I + DIW+ GC+L L Q F +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307
R +N Y P H L +LQ +P R
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 308 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASP 349
+ E E+ P P+ L A+
Sbjct: 295 SIAEVVHQLQ--EIAAARNVNPK-SPITELLEQNGGYGSATL 333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 5e-48
Identities = 78/348 (22%), Positives = 132/348 (37%), Gaps = 84/348 (24%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRVMDH 84
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL----- 137
PN+ L + ++E ++ LVME + ++ + + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 138 ------------------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167
QIF L Y+H +CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 168 D-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTTSIDIWS 220
+ ++K+ DFG +K+ Y + ++ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 221 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 280
AG +L LL+G FPG N D + +++ F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 281 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328
+ P A DL S LL + R A+ A HP+ + + ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-48
Identities = 52/323 (16%), Positives = 93/323 (28%), Gaps = 80/323 (24%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVM-DHPN 86
+ +G+G FG VF+ G AIK+ D + RE+ V+ H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
V+ + + + EY S+ + +K Q+ RG
Sbjct: 73 VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIA 187
L YIH+ + H D+KP N+ + KI D G ++
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
+ + A E++ + DI++ + +PL
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 300
WH++ R+P E +L ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 301 YSPSLRCTALEACAHPFFDELRE 323
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 1e-47
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 90
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 208
H +V HRD+KP+NLL+ ++KI DFG + + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
+ +D+W AG + E L+G P F + + I+ V D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
+FP P+ + + DL S+LL+Y P R HP+
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-47
Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 46/339 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 89
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L F K E+ L++E++ E R+ ++ V Y Q GL
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 148 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
++H + H D+KP+N++ VKI DFG A +L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326
D+ F + V PEA D LLQ P R T +A HP+ L+ ++
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPW---LKGDHS 313
Query: 327 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG 365
L + P +Q++ +
Sbjct: 314 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFS 352
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 81
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 139
++HP +I +K+ F + +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC- 196
YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 197 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
+ Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314
+ F W +V +A+DL +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 315 HPFFDE 320
HP+ +
Sbjct: 400 HPWLQD 405
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-47
Identities = 65/355 (18%), Positives = 112/355 (31%), Gaps = 83/355 (23%)
Query: 18 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 66
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 67 QDRRYKNR---------------------ELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105
Q + R L++ +I ++ + FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 165
M+ ++ VL +SS ++ + T Q+ R LA +H + H L+P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 166 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----------FGATEYTTS 215
++D V + F + A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 216 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 275
D W+ G V+ + + A+ E I FR
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329
Query: 276 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 329
K +P L L+Y R L+A P +++LR +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 60/333 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 81
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKL 137
++HP +I +K+ FF +V+E + E +V+ A + L
Sbjct: 72 LNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 138 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 195
Y YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 196 C-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252
C + Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312
+ F W +V +A+DL +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 313 CAHPFFDELREPNARLPNGRPLPPLFNFKQELS 345
HP+ + Q L+
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 54/320 (16%)
Query: 15 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 68
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 69 RRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--H 122
+ RE++L++ +DHPN++ L ++ +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 123 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 180
+S Q+F G+ Y+H + HRDLKP+N+L++ +KI DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
+ I + +Y APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 300
D L + + F W + +A DL ++L
Sbjct: 228 YDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLT 262
Query: 301 YSPSLRCTALEACAHPFFDE 320
+ PSLR TA + HP+ +
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-46
Identities = 78/323 (24%), Positives = 130/323 (40%), Gaps = 51/323 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRVMDHP 85
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
NVI L ++ K ++++ VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRA 202
L Y+H+ + H+D+KP NLL+ +KI G + + S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 203 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ P P DL +L+Y P+ R + + H +F +
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 322 REPNARLPNGRPLPPLFNFKQEL 344
P P+PP + K
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 52/306 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 89
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 145
L+ + S + LVM+ V E R+L+ Y+ + L Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSA 118
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 202
+ Y+H + HRDLKP+NLL ++ I DFG +K + +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVA 175
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322
+ F + W + A D LL+ P+ R T +A +HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 323 EPNARL 328
+ +
Sbjct: 270 ALHRDI 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 75/317 (23%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 12 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 71
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 72 KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSA 126
E++++ R HPN+I+LK + + ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 127 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 183
+ I + + Y+H V HRDLKP N+L ++ICDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 184 QLIAGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 242
QL A + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 243 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 301
+ ++ G F W+ V A DL S++L
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264
Query: 302 SPSLRCTALEACAHPFF 318
P R TA HP+
Sbjct: 265 DPHQRLTAALVLRHPWI 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 75/312 (24%), Positives = 122/312 (39%), Gaps = 58/312 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 83
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 139
HPN+I+L F +K ++ L ++E V E + + + +
Sbjct: 67 HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 196
QI G+ Y+H+ R+ H DLKP+N+++ + ++K+ DFG A ++ AG I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 197 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
++ F + A D RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 316 PFFDELREPNAR 327
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 50/301 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRVMDHPNVISL 90
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLIYVKLYTYQIFRG 145
F S EL ++ E++ + R+ + + Y +Q+
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114
Query: 146 LAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAP 203
L ++H+ + H D++P+N++ + +KI +FG A+QL G+ N + + Y AP
Sbjct: 115 LQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP 172
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E + +T+ D+WS G ++ LL G F E +Q +II E I
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAE 219
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ + F +I EA+D RLL R TA EA HP+ + E
Sbjct: 220 YTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 324 P 324
Sbjct: 267 R 267
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 76/345 (22%), Positives = 132/345 (38%), Gaps = 47/345 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 89
Y +GTG+FG+V + TG A K V D+ +E+Q M V+ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L F + ++ E++ E +V ++ ++ + Y++ Q+ +GL
Sbjct: 219 LHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 148 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
++H H DLKP+N++ ++++K+ DFG L ++ + + APE+
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G D+WS G + LL G F GEN + T ++ + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326
D F I + D +LL P+ R T +A HP+ L NA
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPW---LTPGNA 419
Query: 327 RLPNGR-PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 370
+ + P + + L P H
Sbjct: 420 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 45/319 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 95
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 96 STTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ L ++ME + R + ++ I + ++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIMRDIGTAIQFL 144
Query: 150 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
H+ + HRD+KP+NLL +K+ DFG AK+ + C + +Y APE +
Sbjct: 145 HSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-V 200
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G +Y S D+WS G ++ LL G P F + + R Y
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY 250
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 325
F P W +V +A L LL+ P+ R T + HP+ + P
Sbjct: 251 -GFPNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
Query: 326 ARLPNGRPLPPLFNFKQEL 344
L R L + E+
Sbjct: 300 TPLHTARVLQEDKDHWDEV 318
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 59/327 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 83
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 139
H NVI+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 196
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 197 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
+ F + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 316 PFFDELREPNARLPNGRPLPPLFNFKQ 342
P+ + + + L NF++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRK 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-45
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 87
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 143
+ L + E F LV + V E ++ YS A+ QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 200
+AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ +P + W V PEA L +L +P R TA +A P+
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-45
Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 64/311 (20%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 79
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 135
+V HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
+ + +H + + HRDLKP+N+L+D +K+ DFG + QL GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 196 C-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309
+++F + W DL SR L P R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278
Query: 310 LEACAHPFFDE 320
EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 60/347 (17%)
Query: 15 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 63
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 64 --KVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMY 117
K L R ++ RE ++ R + HPN++ L + E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 118 RVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQ 173
++ YS A+ QI +AY H+ + HR+LKP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 174 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233
VK+ DFG A ++ EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 234 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 293
F E+ +I + +P + W V PEA
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263
Query: 294 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340
L +L +P R TA +A P+ + + + L F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 52/320 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y +G G+F +V + + G+ A + + RE ++ R++ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 143
+ L E L+ + V E ++ +YS A QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 144 RGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFY 200
+ + H + V HR+LKP+NLL L VK+ DFG A ++ + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
+ FP + W V PEA DL +++L +PS R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
Query: 321 LREPNARLPNGRPLPPLFNF 340
+ + + L F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-45
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 60/335 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRVMDH 84
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY----VKLY 138
P+++ L + ++ L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 139 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYI 195
QI L Y H + HRD+KP +L+ + + VK+ FG A QL
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 196 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
+ + APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245
Query: 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314
++ W + A DL R+L P+ R T EA
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286
Query: 315 HPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 347
HP+ E ++ + L FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 83
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 139
HPN+I+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 196
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 197 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
+ F + + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 316 PFFDELREPNARLPNGRPLPPLFNFKQ 342
P+ + + + L NFK+
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKK 299
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 73/327 (22%), Positives = 126/327 (38%), Gaps = 59/327 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 83
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 139
HPNVI+L + +K ++ L ++E V E + + + +
Sbjct: 73 HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 196
QI G+ Y+H++ ++ H DLKP+N+++ + ++KI DFG A ++ G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 197 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
NY +F + A D RLL P R T ++ H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 316 PFFDELREPNARLPNGRPLPPLFNFKQ 342
P+ ++ L + FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-44
Identities = 77/330 (23%), Positives = 134/330 (40%), Gaps = 34/330 (10%)
Query: 20 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 74
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 75 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLI 133
ELQ++ + P ++ F+S +++ ME++ S+ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQ 131
Query: 134 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
+ + + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 298
E + + P +F E D ++
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 299 LQYSPSLRCTALEACAHPFFDELREPNARL 328
L +P+ R + H F
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 92
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 93 CFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ L +VME + R + ++ I +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKSIGEAI 174
Query: 147 AYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
Y+H++ + HRD+KP+NLL P +K+ DFG AK+ + + + + +Y AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E + G +Y S D+WS G ++ LL G P F + + + R
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RIRM 281
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 282 GQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 92
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F + + ME + S+ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---A 209
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
PQ+ A + E +D S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 63/308 (20%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 80
Y + V+G G +V + TG A+K ++ + R RE ++R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 136
V HP++I+L + S++ F+ LV + + E + + S R
Sbjct: 156 VAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 196
+ ++++H + HRDLKP+N+L+D Q+++ DFG + L GE + +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260
Query: 197 -SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250
+ Y APE++ + + Y +D+W+ G +L LL G P F + L I++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310
++F + W DL SRLLQ P R TA
Sbjct: 321 -----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAE 355
Query: 311 EACAHPFF 318
+A HPFF
Sbjct: 356 QALQHPFF 363
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 80/318 (25%), Positives = 136/318 (42%), Gaps = 45/318 (14%)
Query: 21 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNREL 76
+ K G + ++G G FG V + + TG +A K + ++D+ E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY 134
+M +DH N+I L F SKN++ LVMEYV E R++ + + +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 135 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANIS 193
+K QI G+ ++H + + H DLKP+N+L V+ Q+KI DFG A++ E +
Sbjct: 193 MK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246
Query: 194 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252
+ + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303
Query: 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312
+ D + + EA + S+LL S R +A EA
Sbjct: 304 ------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340
Query: 313 CAHPFFDELREPNARLPN 330
HP+ + + +
Sbjct: 341 LKHPWLSDHKLHSRLSAQ 358
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 18 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 71
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 72 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQR 129
RE+ R + HPN++ K + L ++MEY E L R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGE-----LYERICNAGR 112
Query: 130 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAG 188
+ + Q+ G++Y H++ ++CHRDLK +N L+D ++KICDFG +K +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 189 EANISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307
T + I + + P R+ PE L SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 308 TALEACAHPFF 318
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 76/312 (24%), Positives = 131/312 (41%), Gaps = 44/312 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMD-HPNVISL 90
+ ++ +G GSF I + ++ + A+ K++ R N +E+ +++ + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGL 146
F ++L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 147 AYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 203
+++H V V HRDLKP+NLL D + ++KI DFG A+ + C + Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E + Y S D+WS G +L +L GQ F + ++++ ++I+
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
DF F W V EA DL LL P+ R + + + +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 324 -PNARLPNGRPL 334
+ L L
Sbjct: 280 LSSNPLMTPDIL 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 25 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 80
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 136
+ HPN+I LK F + E+ L V+E V E R+++ +YS +
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA------- 151
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISY 194
QI +AY+H + HRDLKP+NLL P +KI DFG +K + +
Sbjct: 152 DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 195 IC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313
C ++ F + W +V A DL +L+ P R T +A
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 314 AHP 316
HP
Sbjct: 305 QHP 307
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 52/297 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 88
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 203
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 204 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 261
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
PW K + + L ++L +PS R T + ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 55/343 (16%), Positives = 101/343 (29%), Gaps = 84/343 (24%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 80
V+G +A ETGE+ + R + ++ M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 81 ---------------VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 125
+I ++ + FL M+ ++ VL +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
++ + T Q+ R LA +H + H L+P ++++D V + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV-- 259
Query: 186 IAGEANISYICSRFYRAPELI---------FGATEYTTSIDIWSAGCVLAELLLGQPLFP 236
G + +S R + PE T T + D W+ G + +
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDL 294
+ A+ +F K +P L
Sbjct: 319 DDAALGGS-----------------------------------EWIFRSCKNIPQPVRAL 343
Query: 295 ASRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPLPP 336
L+Y R L+A P +++LR +A LP +
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-42
Identities = 84/330 (25%), Positives = 138/330 (41%), Gaps = 53/330 (16%)
Query: 20 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 73
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 74 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMP 131
RE+++M++++HPN++ L ++ L+ L+MEY E + Y A+ RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 132 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 191
+ QI + Y H R+ HRDLK +NLL+D +KI DFG + + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 192 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309
+R P + M + +L R L +P R T
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259
Query: 310 LEACAHPFFDELREPNARLPNGRPLPPLFN 339
+ + + E + P P + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-42
Identities = 84/308 (27%), Positives = 121/308 (39%), Gaps = 54/308 (17%)
Query: 22 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 74
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 75 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 132
E+Q +++ HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 191
+ + QI + Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 168
Query: 192 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250
S C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 169 TS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR- 224
Query: 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310
F P + + L +LQ P R T
Sbjct: 225 ---------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIK 257
Query: 311 EACAHPFF 318
+ H +F
Sbjct: 258 DIREHEWF 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 56/311 (18%)
Query: 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 87
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
I+L + + +E+ L ++EY + + + S + V Q
Sbjct: 92 INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYIC-SR 198
I G+ Y+H + H DLKPQN+L+ + +KI DFG ++++ + I +
Sbjct: 140 ILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
Y APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248
Query: 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + + V A D LL +P R TA +H +
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
Query: 319 DELREPNARLP 329
+ N P
Sbjct: 292 QQWDFENLFHP 302
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 50/313 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 88
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 203
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 204 ELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322
PW K + + L ++L +PS R T + ++++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 323 EPNARLPNGRPLP 335
+ A+ P
Sbjct: 270 KKGAKRPRVTSGG 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 73/311 (23%), Positives = 112/311 (36%), Gaps = 58/311 (18%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RVMDHPNVISLK 91
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 92 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 147
F + E LV E + + + K H++ + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSR---- 198
++H + HRDLKP+N+L H VKICDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 199 ----FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250
Y APE++ A+ Y D+WS G +L LL G P F G D + +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 251 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307
E I+ + FP W + A DL S+LL R
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288
Query: 308 TALEACAHPFF 318
+A + HP+
Sbjct: 289 SAAQVLQHPWV 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 78/329 (23%), Positives = 129/329 (39%), Gaps = 53/329 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 90
RV+G G FG VF + TG+ A KK+ + R K + Q V + ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ F T + L LVM + + Y + + N YT QI GL +
Sbjct: 251 AYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H + +RDLKP+N+L+D + V+I D G A +L AG+ + + APEL+
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
G EY S+D ++ G L E++ + F +E+
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL-------- 401
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 322
++ + + P + D LLQ P R + HP F ++
Sbjct: 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI- 455
Query: 323 EPN-ARLPNGRPLPPLFNFKQELSGASPE 350
+ +L G PP + + + +
Sbjct: 456 --SWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-41
Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 73/332 (21%)
Query: 22 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 73
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 74 ----------------------RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 111
+E+ +++ +DHPNV+ L +++ L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 112 VP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169
V M + + + Y + +G+ Y+H ++ HRD+KP NLLV
Sbjct: 120 VNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 170 LTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLA 226
+KI DFG + + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 227 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 286
+ GQ F E + L IK FP
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264
Query: 287 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ + DL +R+L +P R E HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-41
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 39/300 (13%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 92
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
F + ME + S + K+ YS + +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
++ HRD+KP N+L+D + +K+CDFG + QL+ A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 212 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328
PQ+ + F P I+ + L S R E HPF E +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-41
Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 76/299 (25%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 92
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 93 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT--------YQI 142
+ L +VME + E R+ A +T I
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASEIMKSI 126
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICS 197
+ Y+H++ + HRD+KP+NLL T + +K+ DFG AK+ +
Sbjct: 127 GEAIQYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFGFAKETTGEK-------- 174
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y S D+WS G ++ LL G P F + + +
Sbjct: 175 --------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------- 212
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
R Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 213 --RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 86
Y+ +G GSFG V A +T + VA+K + + + RE+ ++++ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+I L T+ ++ + V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRAPE 204
Y H ++ HRDLKP+NLL+D VKI DFG S S C S Y APE
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+ P + + P A L R++ P R T E P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 66/341 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 90
RV+G G FG V + TG+ A KK+ + R K + + ++ V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ + T L LV+ + + + + Y P Y +I GL
Sbjct: 250 AYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
+H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
YT S D W+ GC+L E++ GQ F REE+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV--------- 397
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELRE 323
+K P + + +R P+A L S+LL P+ R +A E HP F +L
Sbjct: 398 --ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL-- 451
Query: 324 PN-ARLPNGRPLPP------------LFNFKQELSGASPEL 351
N RL G PP + + +Q + EL
Sbjct: 452 -NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 61/318 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 83
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 84 H--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
VI L F + L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 200
+ + + H V HRD+K +N+L+D ++K+ DFGS L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 201 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
PE I Y S +WS G +L +++ G F + EII+
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
F +R+ E L L PS R T E HP+
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 320 ELREPNARLP-NGRPLPP 336
++ P + L P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 64/304 (21%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 90
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F +++ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 203
+H + HRDLKP+N+L++ H ++I DFG+AK L + F Y +P
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSP 201
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
EL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII-------------- 245
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPF 317
++ FP ++ P+A DL +LL + R AHPF
Sbjct: 246 --KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 318 FDEL 321
F+ +
Sbjct: 292 FESV 295
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 58/302 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPN 86
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
++ + + F + ++L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
GL ++H V +RDLKP N+L+D H V+I D G A + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 319
PE L LLQ + R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
Query: 320 EL 321
L
Sbjct: 455 SL 456
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-39
Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 46/301 (15%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 92
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 93 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
F + T + + ME + K +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----FG 208
V HRD+KP N+L+D Q+K+CDFG + +L+ +A Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYT 267
+Y D+WS G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 327
P + H + L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 328 L 328
+
Sbjct: 297 V 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 88/309 (28%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 23 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 74
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 75 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 132
E+Q +++ HP++I L ++ +++F+ VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDE 115
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 191
+ QI G+ Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 173
Query: 192 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249
S C S Y APE+I G Y +DIWS+G +L LL G F ++ V L + I
Sbjct: 174 TS--CGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC 229
Query: 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 309
F P + + P I L +LQ P R T
Sbjct: 230 ----------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATI 261
Query: 310 LEACAHPFF 318
+ H +F
Sbjct: 262 KDIREHEWF 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 58/297 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
+++G G+FG V K TG A+K +L+ + E ++++ HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
LK+ F T + L VMEY E + + S + + Y +I L
Sbjct: 213 LKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------M 363
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 318
+ RFP + + PEA L S LL+ P R A E H FF
Sbjct: 364 EEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-38
Identities = 34/316 (10%), Positives = 92/316 (29%), Gaps = 66/316 (20%)
Query: 33 SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRVMD 83
++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
+ +N L V E + + + ++ + MP V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLIAGEAN 191
+ + +H + H D+KP N ++ + + + D G + +
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 192 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 247
+ + ++ E++ + ID + + +L G + E + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307
+ R P + W++ FH +L
Sbjct: 299 FR--------------------RLPHL--DMWNEFFHV------------MLNIPDCHHL 324
Query: 308 TALEACAHPFFDELRE 323
+L+ ++
Sbjct: 325 PSLDLLRQKLKKVFQQ 340
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 94
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----L 66
Query: 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--T 151
+ + LVMEY S+Y VL H + + + Q +G+AY+H
Sbjct: 67 YGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
+ HRDLKP NLL+ +KICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 81/364 (22%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVM-----DHP 85
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 86 N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 142
N V+ L F + N + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLV----------------------------------- 167
+GL Y+HT R+ H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 168 -------------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 214
+ +VKI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 215 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 261
DIWS C+ EL G LF + D + II++LG R+ I
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 315
++K +V ++ D +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 316 PFFD 319
P+ +
Sbjct: 393 PWLN 396
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 59/297 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 89
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
LK+ F T + L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 318
+ RFP + + PEA L + LL+ P R A E H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 73/320 (22%), Positives = 113/320 (35%), Gaps = 62/320 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 83
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 84 ----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 139
HP VI L +F T LV+E + L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 198
Q+ + + H+ V HRD+K +N+L+D K+ DFGS L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 199 FYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y PE I +Y +WS G +L +++ G F + EI++
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 318 FDELREPNARLPNGRPLPPL 337
E P+ PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 60/299 (20%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 81
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
++H N+I + F +N+ F LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 200
+ + Y+ + HRD+K +N+++ +K+ DFGSA L G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 201 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P + E + L S LLQ P R T + P+
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 54/298 (18%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 90
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ F +F +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYS-FQDEED--MF--MVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF- 207
+ R+ HRD+KP N+L+D H V I DF A L + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 208 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 264
Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 321
T +P E + L +LL+ +P R + L P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 64/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 89 SLKH----------------------------------------------------CFFS 96
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 97 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 155
S +++L + M+ E++ + S R + + ++ QI + ++H+ +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSRFYRA 202
HRDLKP N+ VK+ DFG + A + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE I G Y+ +DI+S G +L ELL E ++++ ++R
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
+ +FP + + P+ + +L SP+ R A + + F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 30/219 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHP 85
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133
Query: 145 GLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANISYICSRF 199
G+ Y+ P + HRDL+ N+ + K+ DFG ++ + + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 200 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 237
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 88
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ F T L VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A + C + Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 318
+ +P + + EA DL +L P R HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 59/298 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L CF + + LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++H + +RDLK N+L+D H K+ DFG K+ I + C + Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 318
+ +P + +A + + +P++R HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRVMDHPNVI 88
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L F T K L V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
Y+H++ + +RDLKP+N+L+D H + + DFG K+ I + S C + Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 318
+ + A L LLQ + R +E +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 67/314 (21%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISL 90
+V+G G+F V K +TG+ A+K + + K E+ V+ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F +N L+ LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 203
+H + HRD+KP N+L+D H +++ DFGS +L A S + Y +P
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV---AVGTPDYLSP 232
Query: 204 ELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
E++ G Y D W+ G E+ GQ F ++ + I
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI--------- 282
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACA 314
++ P + +P EA D RLL P R A +
Sbjct: 283 ----VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327
Query: 315 HPFF-----DELRE 323
HPFF D LR+
Sbjct: 328 HPFFFGLDWDGLRD 341
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 318
+P K M EA+ + L+ P R + H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRVMDHPNVISL 90
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ F +++ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 203
+H + HRD+KP N+L+D H +++ DFGS +L+ S + Y +P
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV---AVGTPDYISP 245
Query: 204 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
E++ G Y D WS G + E+L G+ F E+ + + I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI----------- 293
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHP 316
MN F+FP + A DL RL+ S R + HP
Sbjct: 294 --MNHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHP 340
Query: 317 FF-----DELRE 323
FF D +R
Sbjct: 341 FFSGIDWDNIRN 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 69/304 (22%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRVMDHPN 86
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
++ L + F T K L L++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----- 199
L ++H + +RDLKP+N++++ H VK+ DFG K+ I F
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTFCGTIE 186
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
Y APE++ + + ++D WS G ++ ++L G P F GEN + ++ I + ++
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL 238
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 314
P + EA DL +LL+ + + R A E A
Sbjct: 239 ----------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 315 HPFF 318
HPFF
Sbjct: 277 HPFF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 50/305 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 85
Y + V+G+G+ +V A C E VAIK++ + + +E+Q M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI----YVKLYTY 140
N++S F K+EL+ LVM+ + S+ ++KH + + + +
Sbjct: 74 NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 198
++ GL Y+H HRD+K N+L+ V+I DFG + L A +I+ R
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDITRNKVRKT 185
Query: 199 -----FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313
N P ++ K K+ + S LQ P R TA E
Sbjct: 242 ---------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 314 AHPFF 318
H FF
Sbjct: 287 RHKFF 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVI 88
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+L+ N L LVME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 148 YIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAGEANISYICSR 198
Y+H + + HRDLK N+L+ +KI DFG A+ +S +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 318
F I + + +A + L P R + HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 59/298 (19%)
Query: 38 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRVMDHPNVI 88
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
L + F T K L L+++++ + R+ K VK Y ++ L
Sbjct: 90 KLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 205
++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 318
PQ + PEA L L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 62/304 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 90
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ F +++ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 203
IH++ HRD+KP N+L+D H +K+ DFG+ ++ Y +P
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT---AVGTPDYISP 238
Query: 204 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
E++ G Y D WS G L E+L+G F ++ V T +I
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYSKI- 285
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPF 317
MN FP + EA +L L +R E H F
Sbjct: 286 -MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
Query: 318 FDEL 321
F
Sbjct: 333 FKND 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 90
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
+ T L + V EY+ S+YR+L H S A +++ Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 150 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIF 207
H P + HR+LK NLLVD + VK+CDFG ++ + + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 237
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-35
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 407 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 559
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 318
+P K M EA+ + L+ P R + H FF
Sbjct: 560 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 89
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 206
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 318
F I + + +A + L P R C HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 61/366 (16%), Positives = 121/366 (33%), Gaps = 49/366 (13%)
Query: 15 HIISTTIGGKNGEPKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKV----LQD 68
H+ + G + + Y V+G G V A+ TGE V ++++ +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 69 RRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS 125
EL + ++ +HPN++ + F + L +V ++ S ++ +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLICTHF- 121
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
M + + + + L YIH + HR +K ++L+ + +V + S +
Sbjct: 122 -MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 178
Query: 186 IA--------GEANISYICSRFYRAPELIF-GATEYTTSIDIWSAGCVLAELLLGQPLFP 236
I+ + + + +PE++ Y DI+S G EL G F
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
Query: 237 GENAVDQLVEIIK-----------------VLGTPTREEIRCMNPNYTDFRFPQIKAHPW 279
A L+E + + ++ + T
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 280 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 339
+H+ P + LQ +P R +A H FF + LP L
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK-----QIKRRASEALPELLR 353
Query: 340 FKQELS 345
++
Sbjct: 354 PVTPIT 359
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 60/299 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 90
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ F K+ L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H++ + +RDLKP+NLL+D + +++ DFG AK++ + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIIL 211
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 321
RFP + DL LLQ + R L + H +F
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 74/306 (24%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 90
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 91 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F ++ + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANISYICSRFY 200
+H+ + +RDLKP+N+L+D H +KI DFG AK + + Y
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD----------Y 169
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
APE++ Y SID WS G ++ E+L G F N + E I
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------- 216
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAH 315
+ RFP + DL SRL+ S R L + H
Sbjct: 217 -----NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259
Query: 316 PFFDEL 321
P+F E+
Sbjct: 260 PWFKEV 265
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 53/296 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 86
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I + C+ ++ + LVMEY S +L+ + + + + + T+ +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPE 204
AY+H+ + HRD+K N+L L+ VK+ DFGSA + AN S++ + ++ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVGTPYWMAPE 220
Query: 205 LIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------N 268
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
P +++ W + F + LQ P R T+ H F
Sbjct: 269 ES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 65/306 (21%)
Query: 38 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHP 85
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+++L + F T +K L+L+++Y+ E + + +R V++Y +I
Sbjct: 120 FLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 199
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E F
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AYDFCGTI 224
Query: 200 -YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
Y AP+++ G + ++D WS G ++ ELL G F + + EI
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------R 276
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEA 312
I ++ +PQ M A DL RLL P R A E
Sbjct: 277 RIL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 313 CAHPFF 318
H FF
Sbjct: 320 KEHLFF 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 80
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 139
+PN+++ + +EL+ +VMEY+ S+ V+ M +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 198
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ + + +
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP +
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238
Query: 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+F D +R L+ R +A E H F
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 50/303 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ T L ++MEY+ S +L+ + + +I +GL
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLD 133
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYICSRFYRAPEL 205
Y+H+ + HRD+K N+L+ +VK+ DFG A QL + N +++ + F+ APE+
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEV 190
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
I + Y + DIWS G EL G+P + + L I K PT E
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG------- 241
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+ K + L PS R TA E H F +
Sbjct: 242 ------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
Query: 326 ARL 328
+ L
Sbjct: 282 SYL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 92
+ +G G +G V+ K GE VA+K + RE + +M H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 150
T S +L+L + +Y S+Y LK + A + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 151 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 198
T P + HRDLK +N+LV I D G A + I+ + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 199 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 229
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-VMDHPNVIS 89
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 90 LKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
F L LVME+ S+ ++K ++ + ++ +I RGL+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAP 203
++H +V HRD+K QN+L LT +VK+ DFG + QL G N ++I + ++ AP
Sbjct: 144 HLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 198
Query: 204 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
E+I Y D+WS G E+ G P + + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319
NP P++K+ W K F L + S R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 320 ELREPNARLP 329
+
Sbjct: 292 DQPNERQVRI 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 25 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 80
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 139
H NV+ + + EL+ ++ME++ ++ ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYL---VGEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 198
+ + LAY+H V HRD+K ++L+ L +VK+ DFG Q+ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258
++ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+H V D R+L P R TA E HPF
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 47/292 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 91
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+F +L+ +VMEY S+ +++ N+ + + +GL Y+H
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 151 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 206
+ R HRD+K N+L L K+ DFG A QL + N + I + F+ APE+I
Sbjct: 143 FM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVI 197
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y DIWS G E+ G+P + + + + I PT +
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
W F D + L SP R TA + HPF
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 22/211 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 90
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
S L+ ++P S+Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 150 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
HT+ P + L +++++D +I + + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 209 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 237
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 92
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 150
S S +L+L + Y S+Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 151 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 198
P + HRDLK +N+LV Q I D G A + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 199 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 229
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKH 92
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 93 CFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
F K LN + EY+ ++ ++K S + + P + I G+AY+
Sbjct: 72 -FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 201
H++ + HRDL N LV V + DFG A+ ++ + + S
Sbjct: 125 HSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 202 -------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245
APE+I G Y +D++S G VL E++ P
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 39/303 (12%)
Query: 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNV 87
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 88 IS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFR 144
+ + T+ +L+L + + + S+ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 145 GLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANIS 193
GLAY+H P + HRD+K +N+L+ I DFG A + AG +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTH 191
Query: 194 YIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
+R Y APE++ GA + ID+++ G VL EL G L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 308
++ P+ E+++ + P ++ + W K M + + R +
Sbjct: 252 EIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEARLS 305
Query: 309 ALE 311
A
Sbjct: 306 AGC 308
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 92
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 150
+ +L+L V +Y S++ L Y+ + + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 151 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 198
P + HRDLK +N+LV I D G A + + I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 199 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 229
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 90
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
F ++ +L + V ++ S+Y L ++ + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI 206
H + HRDLK N+ + + VKI DFG A + + + + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 207 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 58/301 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
+ +G G+FG V++AK ETG A K + L+D E++++ DHP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCDHPY 77
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
++ L ++ +L+ +++E+ P ++ ++ ++ + +++ Q+
Sbjct: 78 IVKLLGAYY---HDGKLW--IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEA 129
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYR 201
L ++H+ R+ HRDLK N+L +T +++ DFG + + + + + S+I + ++
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWM 184
Query: 202 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257
APE++ T Y DIWS G L E+ +P N + L++I K PT
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLL 243
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
W F D L +P R +A + HPF
Sbjct: 244 T-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPF 278
Query: 318 F 318
Sbjct: 279 V 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 41/245 (16%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 90
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 91 K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
C S L + + ++Y V++ A + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YRA 202
+H + H+DLK +N+ D +V I DFG +A R + A
Sbjct: 146 LHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 203 PELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
PE+I + ++ D+++ G + EL + F + A II +GT
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTG 258
Query: 255 TREEI 259
+ +
Sbjct: 259 MKPNL 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 48/306 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHC 93
++G G +G V++ VA+K +R+ E + RV M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT- 151
T+ + LVMEY P S+ + L ++S + + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130
Query: 152 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYI 195
P + HRDL +N+LV I DFG + +L A IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 196 CSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEI 247
+ Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 248 IKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 304
+V PT E+++ R P+ W + + +
Sbjct: 250 TEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDAE 301
Query: 305 LRCTAL 310
R TA
Sbjct: 302 ARLTAQ 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 15 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 68
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 69 ---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 125
+R++ RE+ + H N++S+ +++ + LVMEY+ L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEG---PTLSEYIE 103
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
++ + + +T QI G+ + H + R+ HRD+KPQN+L+D +KI DFG AK
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAK-- 159
Query: 186 IAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241
E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE AV
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 84
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 85 PNVISLKHCFFSTTSKNELFLN---LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
P ++++ + T +VMEYV L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICS 197
+ L + H + HRD+KP N+++ T+ VK+ DFG A+ + +++ I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 198 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241
Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 183 AQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 85
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 86 NVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
+++ + F T ++ + +VMEYV +S+ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSR 198
L+Y+H++ V + DLKP+N+++ Q+K+ D G+ ++ + G
Sbjct: 193 PALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-E 257
++APE++ T + DI++ G LA L L P G VD L E VL T
Sbjct: 243 -FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYG 298
Query: 258 EI--RCMNPNYTDFRFP 272
+ R ++P+ RF
Sbjct: 299 RLLRRAIDPDPRQ-RFT 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 26/219 (11%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRVMDHP 85
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+V+ + + L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 201
L H HRD+KP+N+LV + DFG A + + + + + +Y
Sbjct: 147 LDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240
APE + T DI++ CVL E L G P + G+
Sbjct: 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 37 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
+ K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 74 VKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 199
Y+ T R HRDL +N+LV+ ++VKI DFG K L + + + F
Sbjct: 128 EYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIF 182
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ APE + ++++ + D+WS G VL EL
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 37 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
I K C L LVMEYVP L+ Y + + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 200
Y+H HRDL +N+L+D VKI DFG AK + Y R F+
Sbjct: 149 YLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFW 203
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 247
APE + + + D+WS G L ELL +L+ I
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 37 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRVMDHPNVI 88
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 147
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 200
Y+ T R HRDL +N+LV+ ++VKI DFG K L + Y + F+
Sbjct: 160 YLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFW 214
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELL 229
APE + ++++ + D+WS G VL EL
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 37 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGL 146
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 199
Y+ + + HRDL +N+LV+ HQVKI DFG K + E + Y + F
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVF 194
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ APE + + + + D+WS G L ELL
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-22
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 88 ISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIF 143
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-- 201
G+ Y+ + HRDL +N ++ V + DFG ++++ +G+ +YR
Sbjct: 148 CGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YYRQG 196
Query: 202 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
A E L YT D+W+ G + E++ GQ + G
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 37 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
+ + + ++ L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 199
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y R F
Sbjct: 141 EYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIF 195
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELL 229
+ APE + ++ D+WS G VL EL
Sbjct: 196 WYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 39/227 (17%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 144
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 201
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ +YR
Sbjct: 159 GMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYRQGR 207
Query: 202 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 87
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
L + + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 204 E-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 246
E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 85
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPL 132
N+++L + L ++ EY + + + L
Sbjct: 88 NIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 133 IYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
L + YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 191 NISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 246
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 247 IIK 249
+IK
Sbjct: 260 MIK 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 94
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 152
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 208
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 189
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+++T D+WS G +L E+ G+ +P
Sbjct: 190 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 79
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 80 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYV 135
R ++HPNV++L E ++++ Y+ + L + + QR P LI
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
+ Q+ RG+ Y+ + HRDL +N ++D + VK+ DFG A+ ++ E Y
Sbjct: 129 --FGLQVARGMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----YY 180
Query: 196 CSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ +R A E L +TT D+WS G +L ELL G P +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 208
HR+L +N LV H VK+ DFG + +L+ G+ ++ ++F + APE +
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
++ D+W+ G +L E+ G +PG
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 87
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
+ L + L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
Y+ + HR+L +N+L+ QV++ DFG A L + + Y ++ + A
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 246
E I YT D+WS G + EL+ G + G + L+E
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 146
L TS + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 203
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 246
E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 152 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LI 206
HRDL +N LV + VK+ DFG ++ L+ G+ ++ ++F + APE L
Sbjct: 130 K-NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 207 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ +++ D+W+ G +L E+ G +PG
Sbjct: 186 YN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 208
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+T D+WS G +L EL G+ +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 94
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 152
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 208
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 361
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+++T D+WS G +L E+ G+ +P
Sbjct: 362 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 35 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRVMDHPN 86
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
++ + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 201
Y+ HRDL +N+L+ H KI DFG +K L A E +Y ++ +
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185
Query: 202 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 186 WYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 88
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 144
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 201
G+ Y+ + + HRDL +N ++D VK+ DFG A+ + E +Y
Sbjct: 140 GMKYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHN 188
Query: 202 -----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 189 KTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 208
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+T D+WS G +L EL G+ +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 91
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
++ + +VME V L+ + R+ + + G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LI 206
+ + HRDL +N LV + +KI DFG +++ G S + + APE L
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 207 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+G Y++ D+WS G +L E LG +P
Sbjct: 289 YG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 4e-18
Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)
Query: 40 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 78
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 79 MRVMDHPNVISLKHCFF---------------------------STTSKNELFLNLVMEY 111
I L ++LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 112 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171
+ ++ SS K +Q+ LA R HRDL N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 231
K+ + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 232 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 282
+ LF G+ D +I +++ +P +Y + + +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 283 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
K++ + + +L +S +A +
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 38 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 87
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLIYVKL--YTY 140
+ L S+ + L ++ME + + L+ ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 141 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 200
+I G+AY++ V HRDL +N +V VKI DFG + + + +Y
Sbjct: 146 EIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD---------YY 194
Query: 201 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 246
R +PE L G +TT D+WS G VL E+ L + + G + +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251
Query: 247 IIK 249
+
Sbjct: 252 FVM 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 38 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMD-HPN 86
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 133
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 134 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY----KDP 202
Query: 194 YICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 240
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 D-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 241 VDQLVEIIK 249
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
+ +K ++ ++ E++ L + +++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 207
HRDL+ N+LV + KI DFG A ++I + ++F + APE + F
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 208 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
G +T D+WS G +L E++ G+ +PG
Sbjct: 360 G--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 88
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 144
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 201
G+ ++ + + HRDL +N ++D VK+ DFG A+ + E +
Sbjct: 204 GMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----FDSVHNKTGAK 257
Query: 202 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 258 LPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RVMDHP 85
+ +G G+FG V +A G+ VA+K + ++ EL++M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSSANQRMPLIYVK 136
N+++L + L ++ EY + + A
Sbjct: 111 NIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 137 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 194
L ++ Q+ +G+A++ + HRD+ +N+L+ H KI DFG A+ ++ N S
Sbjct: 166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIM----NDSN 219
Query: 195 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 240
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 220 -----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272
Query: 241 VDQLVEIIK 249
+ +++K
Sbjct: 273 NSKFYKLVK 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 63/258 (24%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 85
+V+G+G+FG V A VA+K + +R EL++M ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESMYRVLKHYSSAN 127
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 128 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
L + L + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 186 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 231
++ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 232 QPLFPGENAVDQLVEIIK 249
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 151
++ ++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIF 207
HRDL+ N+LV T KI DFG A +LI + ++F + APE + +
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 208 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
G +T D+WS G +L E++ G+ +PG
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 43/346 (12%), Positives = 76/346 (21%), Gaps = 88/346 (25%)
Query: 1 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
S+A D V G G+ Y G +QA V
Sbjct: 12 ESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQV 59
Query: 61 AIKKVL----QDRRYKNR---ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 113
A+ V + +D P V + L +V E++
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIR 114
Query: 114 -ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172
S+ V + + H V P + V
Sbjct: 115 GGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSI-DG 166
Query: 173 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 232
V + DI G L LL+ +
Sbjct: 167 DVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVNR 199
Query: 233 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 292
P L + E ++ + +P +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD---------------------IPFQIS 237
Query: 293 DLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 338
+A+R +Q +R + + +++ A L P+
Sbjct: 238 AVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 35 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 87
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ L L LVME +++ L + +P+ V +Q+ G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGM 449
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 201
Y+ HR+L +N+L+ H KI DFG +K L A + SY +R
Sbjct: 450 KYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 202 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + F ++++ D+WS G + E L GQ +
Sbjct: 505 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 64/258 (24%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRVLKHYSSAN 127
VI L + L L++EY S
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 128 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
L L + +QI +G+ Y+ + ++ HRDL +N+LV ++KI DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 186 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 231
Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 Y----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 232 QPLFPGENAVDQLVEIIK 249
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L ++ L + +V EY+ S+ L+ + M L+ + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGMR 165
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR--A 202
Y+ + HRDL +N+LVD K+ DFG ++ ++ + + +Y + + R A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 203 PE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
PE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 223 PEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 35 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 87
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 146
+ L L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 201
Y+ HRDL +N+L+ H KI DFG +K L A ++ +Y
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 202 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 59/259 (22%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 78
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 79 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 127
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 128 QRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
+ L ++ QI G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 186 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 231
+ + +YR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 232 -QPLFPGENAVDQLVEIIK 249
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
L +K++ + +V EY+ S+ L+ + + + L+ I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGMK 161
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 201
Y+ + HRDL +N+L++ K+ DFG + L + + +R +
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWT 217
Query: 202 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 218 SPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ + LV E++ + L+ L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIFG 208
V HRDL +N LV +K+ DFG + + + S ++F + +PE F
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
Y++ D+WS G ++ E+ G+ +
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISL- 90
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IYVKLYTYQI 142
C +NE+ L + +Y+ ++ R L Y S M + I +
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICI-----GA 148
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 199
RGL Y+HT + HRD+K N+L+D KI DFG +K E + +++ +
Sbjct: 149 ARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTHLSTVVKGT 204
Query: 200 --YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 233
Y P EY T D++S G VL E+L +
Sbjct: 205 LGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 87
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQRMPLIYVKL 137
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 138 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
Q+ G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 196 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 240
+YR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 241 VDQLVEIIK 249
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 147
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 201
Y+ + V HRD+ +N+LV VK+ DFG ++ + + +Y + +
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWM 559
Query: 202 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + F +T++ D+W G + E+L G F G
Sbjct: 560 APESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 46/250 (18%), Positives = 83/250 (33%), Gaps = 49/250 (19%)
Query: 13 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 72
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 73 N---RELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPES 115
EL+ + + + I + T K + +VME +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 116 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQV 174
L+ S N V ++ L YIH V H D+K NLL+ QV
Sbjct: 138 ----LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQV 192
Query: 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSAG 222
+ D+G + + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 223 CVLAELLLGQ 232
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-16
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ SK +V EY+ + L+ + + L+ Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLESH 123
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------APE-L 205
+ HRDL +N LVD VK+ DFG + ++ + Y+ S + APE
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177
Query: 206 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 178 HYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 44/227 (19%)
Query: 37 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRVMDHP 85
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
+++ + + + LV E+V S+ LK + + + Q+
Sbjct: 73 HLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQLAA 124
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEANISYICS 197
+ ++ + H ++ +N+L+ + +K+ D G + ++ +
Sbjct: 125 AMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175
Query: 198 RFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+ PE I + D WS G L E+ G
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 142
++ + ++ +++E + + L + +Q L + L I
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 200
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 191 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240
Query: 201 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 37 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRVMDHPN 86
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRG 145
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR---- 201
+ Y+ + R HRDL +NLL+ VKI DFG + L + Y+ +
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFA 189
Query: 202 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE L ++ + D W G L E+ GQ + G
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 142
++ + ++ ++ME + + L + +Q L + L I
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 200
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 150 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199
Query: 201 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 90
Y R +G GSFG++F+ L + VAIK + E + +++ + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ + L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 151 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 201
V +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 202 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 232
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 37 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 83
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPL 132
H N+I+L +++ +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 133 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
L YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 191 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+Y+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 238 ENAVDQLVEIIK 249
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-16
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 147
L + + ++ME P Y L HY N+ + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 201
Y+ ++ HRD+ +N+LV VK+ DFG ++ + + Y + R
Sbjct: 128 YLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM 181
Query: 202 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 182 SPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 57/239 (23%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYV 135
V+ L +K++ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 136 KL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193
QI G+ Y+ + V H+DL +N+LV VKI D G +++ A +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 194 YICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 237
+Y+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 87
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I L SK + + ++ EY+ ++ + L+ + L+ I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGM 160
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR-- 201
Y+ + HRDL +N+LV+ K+ DFG ++ ++ + +Y S + R
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 202 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 218 APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 88
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 147
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 201
Y+ + R HRD+ +N+LV VK+ DFG ++ + +Y+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 202 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 68/268 (25%)
Query: 28 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 77
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 78 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYS 124
LM D+PN++ L + + L+ EY+ P ++ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 125 SANQRMPLIYVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176
S R+ + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 177 CDFGSAKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGC 223
DFG ++ + + + +Y+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 224 VLAELL-LG-QPLFPGENAVDQLVEIIK 249
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDH-PNVISL 90
+ + +G G+FG + K L T E VAIK + + E + + + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ + +V+E + S+ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 151 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 201
+ + +RD+KP+N L+ + + I DF AK+ YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 202 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 232
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 57/252 (22%)
Query: 37 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 83
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 132
H N+I+L +++ +++EY + + + +
Sbjct: 146 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 133 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDIN---- 254
Query: 191 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 255 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 238 ENAVDQLVEIIK 249
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)
Query: 37 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 83
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 132
H N+I+L +++ +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 133 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDI----N 208
Query: 191 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 209 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 94 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 152
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 208
+ HRDL +N LV+ VK+ DFG ++ + + S + S+F R PE L++
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
++++ DIW+ G ++ E+ LG+ +
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 70/296 (23%)
Query: 39 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRVMDHPNVIS 89
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQ 141
L S+ + LV Y+P S +L S + PL I
Sbjct: 95 LLGF--SSDGDDLC---LVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 199
G+ ++H + HRD+K N+L+D KI DFG A+ + + + + SR
Sbjct: 142 AANGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVG 197
Query: 200 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 250
Y APE + G E T DI+S G VL E++ G P AVD+ L++I +
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249
Query: 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 306
+ + ++ D ++ +AS+ L + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 41/252 (16%), Positives = 82/252 (32%), Gaps = 50/252 (19%)
Query: 13 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 64
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 65 VLQDRRYKNRELQLMRVMDHPNVISLK-----------HCFFSTTSKNELFLNLVMEYVP 113
+D R N + R V K C +++ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 114 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-H 172
S+ L + V ++ L ++H V H ++ +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQS 198
Query: 173 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWS 220
QV + +G A + +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 221 AGCVLAELLLGQ 232
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 91
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 92 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQIF 143
T L LV Y+ S+ L + PL I +
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG-----SA 141
Query: 144 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 199
RGLAY+H P++ HRD+K N+L+D + + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197
Query: 200 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 232
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 90
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ C + +VME + S+ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 151 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
+ HRD+KP N L+ + V I DFG AK+ + +I YR + + G
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 209 ATEYTTSI------------DIWSAGCVLAELLLGQ 232
Y SI D+ S G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 56/236 (23%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 88
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVKL 137
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 138 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSR-------GQEV- 194
Query: 196 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 237
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 195 ----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVM-DHPNVISL 90
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R++ + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ + LVM+ + S+ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 151 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
+ HRD+KP N L+ +QV I DFG AK+ + +I YR + + G
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTG 175
Query: 209 ATEYTTSI------------DIWSAGCVLAELLLGQ 232
Y S+ D+ S G VL L G
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 46/251 (18%), Positives = 79/251 (31%), Gaps = 50/251 (19%)
Query: 14 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 68
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 69 RRYKNRELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPE 114
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 115 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQ 173
+ K Y + +R V + +I L YIH V H D+K NLL++ Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQ 192
Query: 174 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSA 221
V + D+G A + + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 222 GCVLAELLLGQ 232
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 71 YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 128
YK + + + D+ I LK S TS + +E S +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED-LY 186
Query: 129 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186
+ L L Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 187 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 242
+ +R + APE IF YT D+WS G +L E+ LG +PG +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 243 QLVEIIK 249
+ +K
Sbjct: 304 EFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.46 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.5 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=473.22 Aligned_cols=319 Identities=33% Similarity=0.615 Sum_probs=255.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 104 (374)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++..... .+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999986432 223479999999999999999998754321 23456
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|+|||||+|+|...+. ..+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceeee
Confidence 89999999999888775 45789999999999999999999999 79999999999999996 78899999999986
Q ss_pred cccC-----CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 185 LIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 185 ~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
.... ....+.+||++|+|||++.+...|+.++||||+||++|+|++|++||.+.+..+++..|++..+.|+...+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5432 22346789999999999988777899999999999999999999999999999999999999999987655
Q ss_pred hhcCcCCc---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCC
Q 017270 260 RCMNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPP 336 (374)
Q Consensus 260 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 336 (374)
........ ...++.....+|...++ .++++++|||.+||++||.+|||++|+|+||||+++.++.... ...+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p----~~~~ 362 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP----DCAP 362 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC----CCSS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc----CCCC
Confidence 43221110 01234444556666554 5899999999999999999999999999999999887654321 2333
Q ss_pred CCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 337 LFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.+++..+....+.+.+++++.+++.
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~ 387 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIE 387 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHH
Confidence 4455555555666777766655544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-65 Score=453.22 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=203.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||+++++| .+.
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 3578999999999999999999999999999999986432 2345899999999999999999998 344
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+|||||+|+|.+.+.. .+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC
T ss_pred CEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCC
Confidence 55999999999998888763 4679999999999999999999999 89999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+.........+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+....+..+.+.
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------ 227 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------ 227 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------
Confidence 87666655667899999999999977665678999999999999999999999998877777666551
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+. +++.+|+++++||.+||++||++|||++|+++||||+.
T Consensus 228 -----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -----VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111 23458999999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-65 Score=458.28 Aligned_cols=256 Identities=30% Similarity=0.525 Sum_probs=221.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||+++++| ++.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 3468999999999999999999999999999999986432 2346899999999999999999999 445
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+|||||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCC
Confidence 569999999985 78777763 4679999999999999999999999 89999999999999996 78899999999
Q ss_pred ccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 182 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 182 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+...... ...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.+|.+.
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------- 249 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------- 249 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 98764332 23467899999999999764 5899999999999999999999999999888888887762
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCccccccCCCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 326 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e------~l~hp~~~~~~~~~~ 326 (374)
.+. +++.+|+++++||.+||++||.+|||++| +++||||++++|...
T Consensus 250 ---------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 ---------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ---------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ---------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 111 23458999999999999999999999987 689999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-63 Score=454.75 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=215.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 4699999999999999999999999999999998543 3345689999999999999999999954 345999
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|||||+| +|.+.+.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence 9999996 67666642 469999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.+.....
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------- 289 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------- 289 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------
T ss_pred CCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence 44 33456789999999999854 459999999999999999999999999998888777765521100
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+ ..+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus 290 -----~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 -----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp -----C----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----C----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 0 01235899999999999999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-63 Score=454.96 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=210.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||+++++|.+ ...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 469999999999999999999999999999999986543 234589999999999999999999943 445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|||||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccce
Confidence 9999999985 88888764 234568999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ...+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+..-
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------- 242 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF---------- 242 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------
T ss_pred eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------
Confidence 664432 23456899999999999654 599999999999999999999999999998888887776211
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
+ .++..+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 243 ---------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 ---------P---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------C---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0 022357999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=456.66 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=215.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence 5699999999999999999999999999999998543 2345689999999999999999999954 335999
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|||||+| +|.+++.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence 9999995 67666642 469999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.......
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------- 366 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------- 366 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred CCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence 43 34457899999999999965 459999999999999999999999999998888877765521100
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ ..+..+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus 367 -----~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 -----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -----C----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----C----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 0 0123589999999999999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=456.27 Aligned_cols=347 Identities=62% Similarity=1.101 Sum_probs=308.0
Q ss_pred ccceEEeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeece
Q 017270 13 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 92 (374)
Q Consensus 13 ~~~~~~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 92 (374)
...+......+..+. ....+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~~~~~~-~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~ 99 (394)
T 4e7w_A 22 NKVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99 (394)
T ss_dssp CCCEEEEEEESSSCC-EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEE
T ss_pred CceEEEEecCCCCCC-cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEE
Confidence 334444444555444 356789999999999999999999877665 899998877777778999999999999999999
Q ss_pred eeeecCC-CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 93 CFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 93 ~~~~~~~-~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
++..... .+..++++||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..+
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~ 178 (394)
T 4e7w_A 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPS 178 (394)
T ss_dssp EEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTT
T ss_pred EEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCC
Confidence 9866554 5566789999999999888887766677889999999999999999999999 7999999999999999558
Q ss_pred CcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017270 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 251 (374)
+.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++.+
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp TEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 89999999999877666666678899999999999776679999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCC
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 331 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~ 331 (374)
+.|..+.+..+.+++....++.....+|...++..+++++.+||.+||++||.+|||+.|+++||||+.+++.....+..
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 338 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNG 338 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988888888
Q ss_pred CCCCCCCCchhhhcCCCHHHHhhhcHHHHhh
Q 017270 332 RPLPPLFNFKQELSGASPELVNKLIPDHVKR 362 (374)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (374)
..+|+++++..+.....++++..++|++...
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (394)
T 4e7w_A 339 RELPPLFNWTKEELSVRPDLISRLVPQHAEA 369 (394)
T ss_dssp SCCCCSCCCCHHHHHTCGGGHHHHSCGGGCS
T ss_pred CCCCCcCCCCHHHhhcCHHHHHhhccHhhhh
Confidence 8899999999877778889999998887733
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=436.36 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=208.6
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|||||+++++|.... .+...+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986542 23458999999999999999999885432 34556899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|||||+| +|.+.+.. ...+++..++.|+.||+.||+|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999995 77777753 4679999999999999999999999 78 999999999999985467899999999985
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+....+...+.....|
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 33 334456789999999999854 49999999999999999999999998766555544433311111
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..++..+++++++||.+||++||++|||++|+|+||||++
T Consensus 249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123457899999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=442.49 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=210.3
Q ss_pred cceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
++|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+.+++.++|||||+++++|.+ .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 68999999999999999999985 46789999988543 2234579999999999999999999944 4
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEeccccc
Confidence 459999999995 77777763 4679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 182 AKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 182 a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
|+..... ....+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 9865433 334567899999999999764 5899999999999999999999999999988888877662
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..+|+++++||.+||++||++||| ++|+++||||++++|.
T Consensus 242 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 242 -------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred -------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 111 23458999999999999999999998 5899999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=452.26 Aligned_cols=331 Identities=67% Similarity=1.176 Sum_probs=293.6
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCC-CCceEE
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFL 105 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 105 (374)
......+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+.+++.++||||++++++|..... .+..++
T Consensus 49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3456678999999999999999999999999999999998777777789999999999999999998865432 456678
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+++..
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 8999999999888888777777889999999999999999999999 799999999999999975678999999999876
Q ss_pred ccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 186 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 186 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
..........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++.++++.+|.|..+.+..+.++
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 66555567789999999999977667999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchhhhc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 345 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (374)
+.++.++.+...+|...+...+++++++||.+||++||.+|||+.|+++||||+.++++....+.....+.++++.....
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHH
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHh
Confidence 99999999999999999999999999999999999999999999999999999999988877777777888888775544
Q ss_pred CCCHHHHhhhcHH
Q 017270 346 GASPELVNKLIPD 358 (374)
Q Consensus 346 ~~~~~~~~~~~~~ 358 (374)
...+.+...++|.
T Consensus 368 ~~~~~~~~~~~~~ 380 (420)
T 1j1b_A 368 SSNPPLATILIPP 380 (420)
T ss_dssp TTCGGGHHHHSCT
T ss_pred ccChhHHHhhCCH
Confidence 4555555544444
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-62 Score=444.48 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=213.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
..+.|++.+.||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.++|||||+++++|.+ ...+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEE
Confidence 34579999999999999999999999999999999976543 3479999999999999999999843 34589999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+.....
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99995 78887763 3579999999999999999999999 799999999999999974447999999999876543
Q ss_pred CC------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 189 EA------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 189 ~~------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.. ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++... .++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 22 1235799999999999764 5999999999999999999999999987766666666541 110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH-------------hcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~-------------l~hp~~~~~~~~ 324 (374)
...++..+|+++.+||.+||++||.+|||+.|+ |+|||+..++.+
T Consensus 275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 011345689999999999999999999999997 689999887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-61 Score=449.91 Aligned_cols=332 Identities=50% Similarity=0.961 Sum_probs=285.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCC----------
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---------- 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 99 (374)
..++|++.+.||+|+||+||+|.+..+|+.||||++..+.....+|+.+++.++||||++++++|.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3468999999999999999999999999999999998877777799999999999999999999865432
Q ss_pred -----------------------CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeE
Q 017270 100 -----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 156 (374)
Q Consensus 100 -----------------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~iv 156 (374)
.+..++++||||++++|.+.+..+...+..+++..++.++.||+.||+|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3455688999999999999988877788899999999999999999999999 7999
Q ss_pred eecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCC
Q 017270 157 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 236 (374)
Q Consensus 157 H~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~ 236 (374)
||||||+|||++..++.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999855789999999999877666666677889999999999776678999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 237 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
+.+..+.+..+++..|.|..+.+..+.+.+.+..++......|...++..+++++.+||.+||++||.+|||+.|+|+||
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-------CCCCCCCC--CCCCCCCCchh-hhcCCCHHHHhhhcHHHHhh
Q 017270 317 FFDELRE-------PNARLPNG--RPLPPLFNFKQ-ELSGASPELVNKLIPDHVKR 362 (374)
Q Consensus 317 ~~~~~~~-------~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 362 (374)
||+.+++ .....++. +.+|+++++.. ++....++...+++|++...
T Consensus 324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 379 (383)
T 3eb0_A 324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP 379 (383)
T ss_dssp GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence 9998765 23333443 66788888774 55556889999999886543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=441.95 Aligned_cols=283 Identities=28% Similarity=0.458 Sum_probs=218.9
Q ss_pred CCccccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeecccc--chHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
.|...++|++.+.||+|+||+||+|+++ .+++.||||++.+... ...+|+++|+.+ +|||||+++++|.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~---- 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK---- 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE----
Confidence 4666788999999999999999999875 4678999998865432 345899999988 69999999999943
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
...+|+|||||+| +|.+.+. .+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+||
T Consensus 92 -~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 92 -NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp -TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred -CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 4459999999985 6666552 48999999999999999999999 799999999999999975589999999
Q ss_pred ccccccccCC-----------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh
Q 017270 180 GSAKQLIAGE-----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 230 (374)
Q Consensus 180 g~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 230 (374)
|+|+...... ...+.+||++|+|||++.+...|+.++||||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9997543221 11245799999999999877779999999999999999999
Q ss_pred CCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCcC-------C--------------cCCCCCCC----CCCChhhhcc
Q 017270 231 GQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPN-------Y--------------TDFRFPQI----KAHPWHKVFH 284 (374)
Q Consensus 231 g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~ 284 (374)
|+.|| .+.+..+++..|.+..|.+........... . .+...|.. ..........
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99998 456778899999988886554333211100 0 00001100 0001111123
Q ss_pred cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 285 KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 285 ~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+|++++|||++||++||.+|+|++|+|+||||+++.
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 46899999999999999999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=420.94 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC------
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------ 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 99 (374)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++|.....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999999999999999985432 234579999999999999999999865442
Q ss_pred -CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 100 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 100 -~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
....++|+|||||.| +|.+.+.... ......+..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEc
Confidence 234568999999985 7777765321 12235567788999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCCC-------------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHH
Q 017270 178 DFGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 244 (374)
Q Consensus 178 Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~ 244 (374)
|||+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+.. +..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence 9999986543321 2345799999999999654 59999999999999999996 775432 222
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 245 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
..+........+.. ....++.+.+||.+||++||.+|||+.|+|+||||+++.++
T Consensus 235 ~~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 235 RTLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 22222211111111 11246778999999999999999999999999999988765
Q ss_pred C
Q 017270 325 N 325 (374)
Q Consensus 325 ~ 325 (374)
.
T Consensus 290 ~ 290 (299)
T 4g31_A 290 G 290 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=450.48 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=213.1
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHH---HHHHHHhcCCCceeeeceeeee
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRVMDHPNVISLKHCFFS 96 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~---e~~~l~~l~h~~iv~~~~~~~~ 96 (374)
.|.-.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+ ++.+++.++|||||+++++|
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-- 261 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-- 261 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--
Confidence 4566789999999999999999999999999999999986432 11223 35566677999999999999
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
++...+|+|||||+| +|...+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 262 ---~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~vK 332 (689)
T 3v5w_A 262 ---HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVR 332 (689)
T ss_dssp ---ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCEE
T ss_pred ---EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCEE
Confidence 445569999999995 77777753 4679999999999999999999999 79999999999999996 78899
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 252 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 252 (374)
|+|||+|+..... ...+.+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+. .+....+...
T Consensus 333 L~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-- 409 (689)
T 3v5w_A 333 ISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 409 (689)
T ss_dssp ECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--
T ss_pred ecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--
Confidence 9999999865443 345679999999999996555699999999999999999999999976432 2222222220
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCCC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 325 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~ 325 (374)
.. .++..+|+++++||.+||++||.+|++ ++|+++||||++++|..
T Consensus 410 ---------------~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 410 ---------------AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp ---------------CC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred ---------------CC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 01 133468999999999999999999998 79999999999988753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=443.94 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=222.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++| .+...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999999999999999886543 2345799999999999999999999 4455699
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC-CCcEEEEeeccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~-~~~ikl~Dfg~a~~ 184 (374)
+|||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999985 77766642 34679999999999999999999999 799999999999999853 37899999999998
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
........+.+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.....
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~---------- 375 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM---------- 375 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC----------
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC----------
Confidence 7766666778899999999999764 58999999999999999999999999999888888776632111
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
+ ......+|+++++||.+||++||.+|||++|+|+||||+...++
T Consensus 376 -------~--------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 376 -------D--------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp -------C--------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred -------C--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 1 11223589999999999999999999999999999999976654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-57 Score=404.90 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=207.6
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
.++|.+.+.||+|+||+||+|++. .+++.||||++.... ....+|+++|++++|||||++++++.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE----- 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence 358999999999999999999875 357889999986432 234589999999999999999999843
Q ss_pred ceEEEEEeeccc-chHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~---------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
...+|+|||||+ |+|.+.+.... .....+++..+..|+.||+.||+|||+ ++|+||||||+|||++. +
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-G
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-C
Confidence 334899999998 58888886532 234579999999999999999999999 79999999999999996 7
Q ss_pred CcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017270 172 HQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 247 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 247 (374)
+.+||+|||+|+........ ....||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 88999999999865443322 235689999999999754 59999999999999999998 99999998888777766
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+... + ..+..+|+++.+|+.+||+.||++|||++++ |+|++++.
T Consensus 244 ~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRV-L---------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 65211 0 0234589999999999999999999999999 56887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=420.47 Aligned_cols=286 Identities=31% Similarity=0.557 Sum_probs=229.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ++.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999999999999999986532 233479999999999999999999854432 233
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+||||+++++...+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC
T ss_pred CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEee
Confidence 4689999999998777664 348999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+............+|+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+++.++++.+|.|..+.+...
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 876655555668899999999999765 5899999999999999999999999999999999999999999998877654
Q ss_pred CcCCcCC--CCCCCCCCChhhhcccC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 263 NPNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
......+ ..+......+...++.. .++++++||.+||++||.+|||++|+|+||||+.+..+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 3211111 11222222333333322 15679999999999999999999999999999976554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=400.75 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=198.7
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..++.+.+.||+|+||+||+|++. .+++.||||++.... ....+|+++|++++|||||++++++.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 357999999999999999999865 368899999986432 234589999999999999999999843
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
...+|+|||||+ |+|.+.+..... ...++++.++..|+.||+.||+|||+ ++|+||||||+|||++.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 334899999999 578887765321 23569999999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017270 170 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 245 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 245 (374)
++.+||+|||+|+....... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88999999999986543322 234578999999999965 459999999999999999999 999999988887777
Q ss_pred HHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 246 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+.+... + ..+..+++++.+|+.+||+.||++|||++|++++
T Consensus 272 ~i~~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRE-L---------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCC-C---------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6655211 0 0234589999999999999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=417.72 Aligned_cols=322 Identities=30% Similarity=0.510 Sum_probs=238.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999999999999999986432 2344799999999999999999998665544555
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+||||++++|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 131 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~ 204 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLAR 204 (458)
T ss_dssp CEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred eEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccch
Confidence 689999999999888775 35679999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCC----------------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-----
Q 017270 184 QLIAGE----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL----- 230 (374)
Q Consensus 184 ~~~~~~----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~----- 230 (374)
...... .....+||++|+|||++.....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 654221 12345779999999988666679999999999999999998
Q ss_pred ------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCCc---CCCCCCCCCCChhh
Q 017270 231 ------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYT---DFRFPQIKAHPWHK 281 (374)
Q Consensus 231 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 281 (374)
|.++|.+.+ ..+++..+.+.+|.|..+.+........ ...++......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 788887754 3578888999999999887764331100 01123333334444
Q ss_pred hcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 282 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 282 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.++ .+++++.+||.+||++||.+|||++|+|+||||+.+++.........+... .+. +....+.+.++..+.+++.
T Consensus 365 ~~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 365 RFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRL--PFN-DWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp GST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCC--SSC-TTSCCCHHHHHHHHHHHHT
T ss_pred HCC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCC--Ccc-ccccCCHHHHHHHHHHHHH
Confidence 443 479999999999999999999999999999999998876543322222221 121 2234566777777766665
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=407.79 Aligned_cols=322 Identities=30% Similarity=0.491 Sum_probs=247.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4569999999999999999999999999999999986432 2345899999999999999999988654433335
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+||||++++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCcc
Confidence 589999999999888776 35679999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCC-----------------------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh----------
Q 017270 184 QLIAGE-----------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL---------- 230 (374)
Q Consensus 184 ~~~~~~-----------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~---------- 230 (374)
...... .....++|++|+|||++.....++.++|||||||++|+|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 654332 12457889999999998666779999999999999999998
Q ss_pred -CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCCc-C--CCCCCCCCCChhhhcccCCCh
Q 017270 231 -GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPP 289 (374)
Q Consensus 231 -g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~ 289 (374)
|.++|.+.+ ..+++..+++.+|.|..+.+........ . ..++.....++...++ .+++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~ 336 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP-SISD 336 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST-TSCH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC-CCCH
Confidence 556665544 4678899999999999887764331100 0 0122223333444443 4899
Q ss_pred hHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 290 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 290 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
++.+||.+||++||.+|||++|+|+||||+.+++..........+... +. +....+.+.++.++.+++.
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~e~~ 405 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILP--FD-DWMVLSETQLRYIFLKEVQ 405 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCS--SC-TTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCC--hh-hcccCCHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998775432222222222 21 2234566777776666665
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=393.15 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=195.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.+++.+.+.||+|+||+||+|++. ..||||++.... ....+|+.++++++|||||++++++.. + .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence 357889999999999999999854 359999885322 234579999999999999999997621 1 2
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|||||||+ |+|.+.+.. ...++++..+..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCce
Confidence 789999999 577777753 34679999999999999999999999 79999999999999996 8899999999998
Q ss_pred ccccCC---CcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
...... ...+..||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..++.....+
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 256 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS---- 256 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence 654322 23356899999999999643 358999999999999999999999999877666665555421111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
|. ....+..+++++.+|+.+||+.||++|||+.|++++
T Consensus 257 -------------p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 257 -------------PD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------CC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------CC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 011234589999999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=400.66 Aligned_cols=306 Identities=46% Similarity=0.874 Sum_probs=250.9
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHhcCCCceeeeceeeeecCC--CCce
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTS--KNEL 103 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~ 103 (374)
...++|++.+.||+|+||+||+|.+..+|+.||||++..+... ..+++..+..++||||+++++++..... ....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3457899999999999999999999999999999988655433 3356667788899999999999865443 3455
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--cCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
++++||||+++++...+.........+++..++.++.|++.||.||| + +||+||||||+|||++..++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 68899999999988888776667788999999999999999999999 9 79999999999999986578999999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+..+.+..
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98776655555677899999999997766689999999999999999999999999999999999999999999998888
Q ss_pred cCcCCcCCCCCCCCCCChhhhccc---CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 335 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~ 335 (374)
..+......+......+|...+.. ..++++.+||.+||++||.+|||+.|+|+||||+++..+....+....++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence 777666665555555666666554 36789999999999999999999999999999999988766655544444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=396.68 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=203.7
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..++++.+.||+|+||+||+|... .+++.||||++.... ....+|+.++++++|||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---- 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK---- 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence 357899999999999999999864 467889999985432 234689999999999999999999843
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
...+++|||||+ |+|.+.+..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 334889999998 588888864321 13468999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 243 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 243 (374)
+. ++.+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 179 ~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 7889999999998654332 22346789999999999754 59999999999999999998 8999999988777
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 244 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+..+.+....+ .++.+++++.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66655421111 234589999999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=403.24 Aligned_cols=288 Identities=31% Similarity=0.631 Sum_probs=224.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC-CCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++++.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++... +.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence 4568999999999999999999999999999999885432 22347999999997 99999999988542 23
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+|||||+++|...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCccc
Confidence 34889999999998887763 479999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccC----------------------CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh
Q 017270 183 KQLIAG----------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 240 (374)
Q Consensus 183 ~~~~~~----------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~ 240 (374)
+..... .......+|++|+|||++.+...++.++|||||||++|+|++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764321 1123467899999999997766799999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCC------CCCCCCChhhhc------------ccCCChhHHHHHHhhcCcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYS 302 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~d 302 (374)
.+++..++..++.|..+.+......+...-. .......+...+ ...+++++.+||.+||++|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 9999999999999998877644322111000 000000111111 1257899999999999999
Q ss_pred CCCCCCHHHHhcCCccccccCCCCC
Q 017270 303 PSLRCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 303 p~~R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
|.+|||++|+|+||||+.+..+...
T Consensus 317 P~~R~t~~e~l~Hp~~~~~~~~~~~ 341 (388)
T 3oz6_A 317 PNKRISANDALKHPFVSIFHNPNEE 341 (388)
T ss_dssp GGGSCCHHHHTTSTTTTTTCCGGGC
T ss_pred cccCCCHHHHhCCHHHHHhcCCccC
Confidence 9999999999999999988766543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=392.09 Aligned_cols=283 Identities=35% Similarity=0.668 Sum_probs=231.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|++++.||+|+||+||+|++. +|+.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccC
Confidence 34579999999999999999999985 58999999885432 2345799999999999999999998 344
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLA 166 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCc
Confidence 45899999999988887763 34569999999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
....... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 8654332 233457899999999997766789999999999999999999999999988889999999988887765543
Q ss_pred cCc--CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 262 MNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 262 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
... .+....+......+|.... ..+++++.+||.+||++||.+|||++|+|+||||+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhccchhhhcccccccCCcHHHhC-cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 321 1112223333344444433 458999999999999999999999999999999998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=387.62 Aligned_cols=280 Identities=34% Similarity=0.579 Sum_probs=228.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 58999999999999999999999999999999986432 233479999999999999999999843 3458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence 99999999988777653 45679999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4332 234467899999999997766689999999999999999987666 77778888899999988888776655433
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
........+..............+++++++||.+||++||++|||++|+|+||||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 2111111222222222222334689999999999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=390.01 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=219.9
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
......++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 84 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE---- 84 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 344667899999999999999999999999999999999865421 2347999999999999999999983
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
....+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~D 157 (328)
T 3fe3_A 85 -TEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIAD 157 (328)
T ss_dssp -CSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECS
T ss_pred -ECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEee
Confidence 34458999999974 77777653 3679999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++.............||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 229 (328)
T 3fe3_A 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------- 229 (328)
T ss_dssp TTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence 999987666555566789999999999987664568999999999999999999999998887777666551
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.+. ++..+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus 230 ---------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 230 ---------KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 111 123478999999999999999999999999999999876544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=394.36 Aligned_cols=294 Identities=33% Similarity=0.624 Sum_probs=234.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++.. ...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 589999999999999999999999999999998854322 23369999999999999999999843 33488
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence 9999999998887764 34579999999999999999999999 79999999999999996 7789999999997554
Q ss_pred cCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....++.....
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 2234577999999999977667899999999999999999999999999999999999999998887665433211
Q ss_pred --CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCC
Q 017270 266 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPP 336 (374)
Q Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 336 (374)
+..+.++......+... ...+++++.+||.+||++||.+|||++|+|+||||.++.......+....+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~ 303 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSH-APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFA 303 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGG
T ss_pred hhhcccccccccchhhhhh-cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhH
Confidence 12223333333333322 34589999999999999999999999999999999998776555544443333
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=396.96 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=203.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhcCC-CceeeeceeeeecCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSK 100 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 100 (374)
++|++.+.||+|+||+||+|.+..+ ++.||||.+.... ....+|+.+|..++| ||||++++++...
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~--- 140 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 140 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec---
Confidence 6899999999999999999997654 3679999886532 234579999999976 8999999987432
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
...+|+|||||+ |+|.+.++.... ....+++..+..|+.||+.||+|||+ ++|+||||||+|||+
T Consensus 141 -~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl 218 (353)
T 4ase_A 141 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 218 (353)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceee
Confidence 223789999999 588888875332 13458999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 243 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 243 (374)
+. ++.+||+|||+|+....... ..+..||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 219 ~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 219 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp CG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 78899999999986654432 2345789999999999764 59999999999999999998 9999998765555
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 244 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+..++.....+. .++.+++++.+|+.+||+.||++|||+.|+++|
T Consensus 297 ~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 544444211111 234579999999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=394.14 Aligned_cols=316 Identities=32% Similarity=0.559 Sum_probs=239.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999999999999999985432 223479999999999999999999854322 1223
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeeccc
Confidence 4689999998888877753 569999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+++..+.+..|.++.+.+....
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 6433 23456789999999999875679999999999999999999999999999999999999999999987765432
Q ss_pred cCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 264 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 264 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
..... ..++......+...+ ..+++.+.+||.+||+.||.+|||++|+|+||||+.+.+...... ...+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~-----~~~~~~ 328 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-----VQKYDD 328 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-----CCCCCC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCC-----CCCCCC
Confidence 11000 012333344444433 358999999999999999999999999999999999876643211 111222
Q ss_pred hhhhcCCCHHHHhhhcHHHHh
Q 017270 341 KQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+....+.+.+++++.+++.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~ 349 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVL 349 (367)
T ss_dssp C-----CCHHHHHHHHHHHHH
T ss_pred ChhhhcCCHHHHHHHHHHHHH
Confidence 222234556666666655554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=392.21 Aligned_cols=319 Identities=33% Similarity=0.615 Sum_probs=252.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999999999999999986432 233479999999999999999999865544444568
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence 99999999998887753 469999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 186 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 186 ~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
..... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43322 23457899999999987766689999999999999999999999999999999999999999999877654
Q ss_pred cCcCC---cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 017270 262 MNPNY---TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 338 (374)
Q Consensus 262 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
..... .....+.....+|...+ ..+++++.+||.+||++||.+|||+.|+|+||||+....+.... .....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~ 333 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF 333 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence 32100 00122333333444433 35899999999999999999999999999999999875443221 122234
Q ss_pred CchhhhcCCCHHHHhhhcHHHHh
Q 017270 339 NFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.+..+......+.+.+++.++..
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~e~~ 356 (364)
T 3qyz_A 334 KFDMELDDLPKEKLKELIFEETA 356 (364)
T ss_dssp CCC-----CCHHHHHHHHHHHTG
T ss_pred CcccccccCCHHHHHHHHHHHHH
Confidence 45555666777778877776655
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=384.44 Aligned_cols=285 Identities=30% Similarity=0.524 Sum_probs=231.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcC---CCceeeeceeeeec
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMD---HPNVISLKHCFFST 97 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 97 (374)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3569999999999999999999999999999999885322 23447887777664 99999999999776
Q ss_pred CCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 98 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.......+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEe
Confidence 65666678999999999988887642 23449999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+...
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876655555667889999999999765 48999999999999999999999999999999999999998888766
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.+..... .....++.....++.. ....+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5542211 1111222222233333 334689999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=385.56 Aligned_cols=288 Identities=32% Similarity=0.573 Sum_probs=218.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..+|++++.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 458999999999999999999999999999999886432 2345899999999999999999998 344458
Q ss_pred EEEeecccchHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 106 NLVMEYVPESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
++||||++++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCE
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccce
Confidence 99999999999888865432 22458999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+...
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 654332 2345678999999999976666899999999999999999999999999999999999998888776554432
Q ss_pred Cc--CCcCCCCCCCCCCCh----hhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCC
Q 017270 263 NP--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326 (374)
Q Consensus 263 ~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~ 326 (374)
.. .+. ..++......+ .......+++++.+||.+||+.||.+|||++|+|+||||++..+...
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 237 TKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp GGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred hhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 21 110 01111111111 12223468899999999999999999999999999999998776543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=381.11 Aligned_cols=278 Identities=35% Similarity=0.642 Sum_probs=223.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++.+.||+|+||+||+|.+ .+|+.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 5899999999999999999998 678999999985432 234589999999999999999999843 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence 99999999988887763 34679999999999999999999999 79999999999999996 788999999999765
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....++....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 4322 233457899999999997666689999999999999999999999999999999999998888876654443211
Q ss_pred CC-cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 265 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 265 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.. .+..++.....+|.. +...+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 011122222233333 335689999999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=388.71 Aligned_cols=284 Identities=33% Similarity=0.600 Sum_probs=231.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence 45679999999999999999999999999999999985432 233589999999999999999999843 3
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC----CCCcEEEEe
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICD 178 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~----~~~~ikl~D 178 (374)
..+++||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 45899999999988887763 4569999999999999999999999 79999999999999953 245699999
Q ss_pred eccccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 179 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 179 fg~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+...
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99997654332 23345779999999999776668999999999999999999999999999999999999998888766
Q ss_pred HHhhcC--cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 258 EIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 258 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+.... +.+ ...++......+...+...+++++.+||.+||++||.+|||++|+|+||||++..+
T Consensus 261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 261 TWPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TSTTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 554322 111 12344555556666666778999999999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=388.30 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=218.6
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
...++|.+.+.||+|+||+||+|.+..+|+.||+|.+.+.. ....+|+.+++.++||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---- 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---- 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence 45678999999999999999999999999999999986542 2345899999999999999999998
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC---cE
Q 017270 99 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 174 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~---~i 174 (374)
.+...+|+||||+. |+|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 85 -ENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred -EeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCE
Confidence 33445899999997 57776664 35679999999999999999999999 79999999999999986332 79
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999999987666555566789999999999865 458999999999999999999999999988888777766532211
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
. ..++..+++++++||.+||+.||.+|||++|+++||||+...
T Consensus 238 ~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 238 D-------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp C-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred C-------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1 112345899999999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=393.21 Aligned_cols=318 Identities=33% Similarity=0.551 Sum_probs=237.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3468999999999999999999999999999999985432 233479999999999999999998854321 122
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+|||+++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a 179 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLA 179 (367)
T ss_dssp CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC----
T ss_pred CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeecccc
Confidence 34789999998887766642 579999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..|.|..+.+...
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 76432 2345688999999999977567899999999999999999999999999999999999999999988776644
Q ss_pred CcCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCC
Q 017270 263 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 339 (374)
Q Consensus 263 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
...... ..++......+...++ .+++.+.+||.+||++||.+|||++|+|+||||+.+..+... +....++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~-----~~~~~~~ 331 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYD 331 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTT-TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC-----CCCCCCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCC-CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC-----CCCCCCC
Confidence 321000 0223333444554443 589999999999999999999999999999999988766432 1222344
Q ss_pred chhhhcCCCHHHHhhhcHHHHhh
Q 017270 340 FKQELSGASPELVNKLIPDHVKR 362 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~ 362 (374)
+..+......+.+.+++.+++..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 332 QSLESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp GGGSSCCCCHHHHHHHHHHHHHH
T ss_pred cchhhccCCHHHHHHHHHHHHHH
Confidence 44444456677777777776664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=392.72 Aligned_cols=320 Identities=30% Similarity=0.507 Sum_probs=235.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4579999999999999999999999999999999986532 223479999999999999999998854331 223
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC-
T ss_pred cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeecc
Confidence 4688999999998887764 358999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+++..+.+..+.+...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 866544444567889999999999664 5899999999999999999999999999999999999999998887766543
Q ss_pred CcCCcCC--CCCCCCCCChhhhccc-----------CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCC
Q 017270 263 NPNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329 (374)
Q Consensus 263 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~ 329 (374)
.+....+ ..+......+...++. ..++++++||.+||++||.+|||++|+|+||||+.+.++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~- 332 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE- 332 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHT-
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccC-
Confidence 2111000 0111111122222211 1257899999999999999999999999999998765432211
Q ss_pred CCCCCCCCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 330 NGRPLPPLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
.+.|.......+......+.++.++.+++.
T Consensus 333 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (371)
T 2xrw_A 333 --APPPKIPDKQLDEREHTIEEWKELIYKEVM 362 (371)
T ss_dssp --CCCCCCCTTTTCCCCCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCChhhccccCcHHHHHHHHHHHHH
Confidence 112222223333345667778888777665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=391.03 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=211.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34568999999999999999999999999999999986532 2234788899888 799999999998 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+|||||.| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence 44458999999985 77666653 3679999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++..... ....+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 999854332 334467899999999999654 4899999999999999999999999999988888877662
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||++||++||.+||++ +++++||||++++|.
T Consensus 240 ---------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 240 ---------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 111 223478999999999999999999998 899999999988764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=382.14 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=215.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++++.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 468999999999999999999999999999999986532 23457999999999999999999983 344
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccch
Confidence 58999999986 67666653 3579999999999999999999999 79999999999999996 788999999999
Q ss_pred ccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.... .....+..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 86433 333456789999999999865 45899999999999999999999999988877776666541
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||+.||.+|| +++|+++||||+.+.+.
T Consensus 221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 111 2335799999999999999999999 89999999999987664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=384.64 Aligned_cols=286 Identities=34% Similarity=0.594 Sum_probs=229.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34568999999999999999999999999999999885321 234579999999999999999999843
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....++||||+++++...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 84 --~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Df 156 (346)
T 1ua2_A 84 --KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADF 156 (346)
T ss_dssp --TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC
T ss_pred --CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEec
Confidence 334889999999988777653 34578999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....
T Consensus 157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 9998654332 334567899999999997666689999999999999999999999999999999999999988887766
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
+...........+......++... ...+++++++||.+||+.||.+|||++|+|+||||++...+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hhhhccCcccccccccCCCChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 554332211222233333333333 245889999999999999999999999999999998865543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=387.76 Aligned_cols=258 Identities=24% Similarity=0.448 Sum_probs=210.0
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
......++|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+|..++..+ +||||++++++|.
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-- 123 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-- 123 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--
Confidence 34455679999999999999999999999999999999986542 2245788888876 8999999999983
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
....+|+|||||+| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 124 ---~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL 194 (396)
T 4dc2_A 124 ---TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKL 194 (396)
T ss_dssp ---CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEE
T ss_pred ---ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEE
Confidence 44458999999986 67666653 3579999999999999999999999 79999999999999996 788999
Q ss_pred Eeeccccccc-cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Q 017270 177 CDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVE 246 (374)
Q Consensus 177 ~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~~~ 246 (374)
+|||+++... ......+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ......
T Consensus 195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred eecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 9999998633 33445567899999999999654 589999999999999999999999964321 112222
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCcccc
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDE 320 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~ 320 (374)
+.. .... ++..+++++++||++||++||.+||++ +|+++||||++
T Consensus 274 i~~-----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 274 ILE-----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHH-----------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred Hhc-----------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 222 0111 234589999999999999999999985 79999999999
Q ss_pred ccCC
Q 017270 321 LREP 324 (374)
Q Consensus 321 ~~~~ 324 (374)
++|.
T Consensus 325 i~w~ 328 (396)
T 4dc2_A 325 VDWD 328 (396)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 8764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=381.77 Aligned_cols=323 Identities=31% Similarity=0.586 Sum_probs=248.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999999999999999985432 12347999999999999999999875443334456
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||+.++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEecccccc
Confidence 899999999998887763 469999999999999999999999 79999999999999996 78899999999986
Q ss_pred cccCCC-----------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 185 LIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 185 ~~~~~~-----------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
...... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 123467999999999876667899999999999999999999999999988888888888877
Q ss_pred CCHHHHhhcCcC--CcC--CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCC
Q 017270 254 PTREEIRCMNPN--YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329 (374)
Q Consensus 254 ~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~ 329 (374)
+........... ..+ ...+.....++.. ....+++++.+||.+||+.||.+|||++|+++||||+.+..+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 320 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence 653211100000 000 0111112222222 22468999999999999999999999999999999999887654432
Q ss_pred CCCCCC-CCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 330 NGRPLP-PLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 330 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+.| ..+.+.........+.+++++.+++.
T Consensus 321 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 321 -GEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp -CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred -cCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 23333 34555555556777788877776653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=372.97 Aligned_cols=285 Identities=32% Similarity=0.589 Sum_probs=222.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence 4689999999999999999999999999999998855432 23479999999999999999999843 334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||++++++..+. .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence 88999999986554443 245679999999999999999999999 79999999999999996 78899999999986
Q ss_pred cccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.+..+...........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 55332 23456789999999999876678999999999999999999999999999999988888888877665433221
Q ss_pred --cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 264 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
..+.....+..............+++++.+||.+||++||.+|||++|+++||||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 11222222222221111222245899999999999999999999999999999999876553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=381.26 Aligned_cols=320 Identities=30% Similarity=0.549 Sum_probs=241.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhcCCCceeeeceee
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCF 94 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~ 94 (374)
..++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3468999999999999999999975 49999999885321 2345899999999999999999998
Q ss_pred eecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcE
Q 017270 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 174 (374)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~i 174 (374)
..........+|+||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~ 173 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDI 173 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCE
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCE
Confidence 7766566667899999999998887763 44579999999999999999999999 79999999999999996 7889
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999865555555567889999999999765668999999999999999999999999999999999999999998
Q ss_pred CHHHHhhcCcC----CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 017270 255 TREEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 330 (374)
Q Consensus 255 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~ 330 (374)
....+...... +............|.. ....+++.+.+||.+||+.||.+|||+.|+++||||+.+..+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~-- 330 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT-- 330 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT--
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc--
Confidence 87765432210 0011122222333333 3345789999999999999999999999999999999876543221
Q ss_pred CCCCCCCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 331 GRPLPPLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..++..+.+. ....+.....+.+..++.
T Consensus 331 -~~~~~~~~~~--~~~~~~~~~~~~~~~e~~ 358 (362)
T 3pg1_A 331 -EGLSERFHFD--ESVTDVYDMHKIFTAEVE 358 (362)
T ss_dssp -TTCCCCCCCC--TTCCCHHHHHHHHHHHHH
T ss_pred -cccccccChh--hhhhhHHHHHHHHHHHHH
Confidence 1222222222 234455556666555554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=380.64 Aligned_cols=291 Identities=27% Similarity=0.479 Sum_probs=229.3
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCC-
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS- 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (374)
.....++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 34467899999999999999999999999999999998854321 23479999999999999999998855332
Q ss_pred --CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 100 --KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 100 --~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....+|+||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~ 166 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLA 166 (351)
T ss_dssp -----CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEEC
T ss_pred cccCCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEc
Confidence 11345889999999988877764 34569999999999999999999999 79999999999999996 7789999
Q ss_pred eeccccccccC-----CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 178 DFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 178 Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+..+
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999765422 1223457799999999997766689999999999999999999999999999999999998888
Q ss_pred CCCHHHHhhcCcC--CcCCCCCCCCCCChhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 253 TPTREEIRCMNPN--YTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 253 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+....++..... +................+. ...++.+.+||.+||++||.+|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 7776544432211 1111111111111111111 12478899999999999999999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=379.06 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=218.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~ 77 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEE
Confidence 3568999999999999999999999999999999886432 234579999999999999999999843 33589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC-CCcEEEEeeccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~-~~~ikl~Dfg~a~~ 184 (374)
+|||||+| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999986 77766642 34579999999999999999999999 799999999999999853 57899999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 226 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------ 226 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence 7665555667889999999999654 479999999999999999999999999888888777776332222221
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 227 -------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 23479999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=391.15 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=220.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++.+.||+|+||+||+|++..+++.||+|++.+. .....+|+.++..++||||++++++| .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 46899999999999999999999999999999998642 22356899999999999999999988 3444
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||. |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhhh
Confidence 5899999997 577777753 24679999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCc--ceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 183 KQLIAGEAN--ISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 183 ~~~~~~~~~--~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+........ ...+||+.|+|||++. +...++.++|||||||++|+|++|+.||.+.+..+.+.+++.....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 299 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--- 299 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence 765544332 2367899999999986 2345899999999999999999999999999988888887652110
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCCCCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~~~~ 327 (374)
+.+|. ....+++++++||++||+.+|.+ |++++|+++||||+++.|...+
T Consensus 300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 11111 11247999999999999999988 9999999999999999887643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=382.61 Aligned_cols=316 Identities=34% Similarity=0.584 Sum_probs=241.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC-Cce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 103 (374)
.++|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999986532 2334799999999999999999998543321 112
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+||||+.++|.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 121 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCccc
Confidence 348999999998766552 459999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5432 23345779999999999765678999999999999999999999999999999999999999998877655432
Q ss_pred cCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 264 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 264 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
..... ...+......+... ...+++++.+||.+||++||.+|||+.|+|+||||+.++.+........++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~---- 345 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD---- 345 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC----
T ss_pred hhhhhhhhhccCCCcchhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc----
Confidence 11000 01122222233332 34589999999999999999999999999999999988766543322222222
Q ss_pred hhhhcCCCHHHHhhhcHHHHh
Q 017270 341 KQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+......+.+++.+.+++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIV 366 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHH
T ss_pred chhhcccchHHHHHHHHHHHH
Confidence 122234455566666655544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=380.28 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=213.5
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 97 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--- 97 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence 4567899999999999999999999999999999988532 2334689999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEE
Q 017270 100 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI 176 (374)
Q Consensus 100 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl 176 (374)
...+|+|||||. ++|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||
T Consensus 98 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 98 --DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp --TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred --CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEE
Confidence 345899999998 47777776655556679999999999999999999999 799999999999999752 234999
Q ss_pred EeeccccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 177 CDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+.+......
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence 99999986654332 3356789999999999654 58999999999999999999999998753 344444443211111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.. ....+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 253 PR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 11 1134799999999999999999999999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=373.08 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=215.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eC
Confidence 3568999999999999999999999999999999986432 23357999999999999999999983 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+||||+.| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~ 152 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGF 152 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSS
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCc
Confidence 458999999985 77777653 4679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
++.... ...+..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.++.+.
T Consensus 153 a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 218 (318)
T 1fot_A 153 AKYVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------- 218 (318)
T ss_dssp CEECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------
T ss_pred ceecCC--ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 986433 2345688999999999865 45899999999999999999999999998888777777652
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||+.||.+|| +++++++||||+++.+.
T Consensus 219 ------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 219 ------ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 111 2235789999999999999999999 89999999999987764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=382.32 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=211.9
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
+...++|++.+.||+|+||+||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++++++..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---- 80 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT---- 80 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----
Confidence 35667999999999999999999999999999999988543 1245689999999999999999999843
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||++|+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 81 -~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG 153 (336)
T 3h4j_B 81 -PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFG 153 (336)
T ss_dssp -SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSS
T ss_pred -CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEec
Confidence 345889999999998887764 3579999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+........
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------- 218 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------
Confidence 99877666555667899999999999765544789999999999999999999997653221100
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+. .....++..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 219 ------------~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 219 ------------KVN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ------------CCC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ------------HHH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000 0011134458999999999999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=387.73 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=217.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|.+.+.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||++++++| .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 456899999999999999999999999999999998542 23356899999999999999999998 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+|||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccce
Confidence 559999999974 77776653 469999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC--cceeeeeccccchhhhhCCCC---CCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~---~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++....... ..+.+||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+.+.++++....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 291 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--- 291 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence 986554432 235689999999999965432 789999999999999999999999999988888887653110
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCccccccCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 324 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~ 324 (374)
..+|. ...+++++++||.+||+.+|.+ |++++|+++||||+++.|.
T Consensus 292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 01111 1247999999999999999988 9999999999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=388.01 Aligned_cols=280 Identities=32% Similarity=0.570 Sum_probs=228.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhc------CCCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM------DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 100 (374)
...+|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 44689999999999999999999999999999999865532 334688888877 57799999998844
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc--EEEEe
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICD 178 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~--ikl~D 178 (374)
...+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|
T Consensus 171 -~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~D 245 (429)
T 3kvw_A 171 -RNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVID 245 (429)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEECC
T ss_pred -CCeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEee
Confidence 3458999999999998888753 23459999999999999999999999 79999999999999996 554 99999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++.... ....+..+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.++...
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99997533 233456889999999999765 489999999999999999999999999999999999999999999876
Q ss_pred HhhcCcC--------CcCC----------------------CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC
Q 017270 259 IRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 308 (374)
Q Consensus 259 ~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s 308 (374)
+...... +..+ .........|...+....++++.+||.+||++||.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 6532110 0000 000112335556666667899999999999999999999
Q ss_pred HHHHhcCCccccc
Q 017270 309 ALEACAHPFFDEL 321 (374)
Q Consensus 309 ~~e~l~hp~~~~~ 321 (374)
++|+|+||||++.
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=376.24 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=210.4
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 98 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 98 (374)
.+...++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ....+|..+++.+ +||||+++++++.
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--- 80 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--- 80 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE---
Confidence 4556779999999999999999999999999999999997543 1234688899887 8999999999983
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
....+|+||||+.| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 81 --~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~ 152 (345)
T 3a8x_A 81 --TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLT 152 (345)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEEC
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEE
Confidence 34458999999985 77666653 3579999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 017270 178 DFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEI 247 (374)
Q Consensus 178 Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---------~~~~~~~i 247 (374)
|||+++.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+
T Consensus 153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred eccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 9999986432 3334567889999999999654 58999999999999999999999997531 12222222
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCccccc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDEL 321 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~~ 321 (374)
... ... ++..+++++++||.+||+.||.+||++ +++++||||+++
T Consensus 232 ~~~-----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 232 LEK-----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHC-----------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HcC-----------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 220 011 234579999999999999999999995 899999999988
Q ss_pred cCC
Q 017270 322 REP 324 (374)
Q Consensus 322 ~~~ 324 (374)
.|.
T Consensus 283 ~w~ 285 (345)
T 3a8x_A 283 DWD 285 (345)
T ss_dssp CHH
T ss_pred CHH
Confidence 764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=383.28 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=218.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+.++..++||||++++++| .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 457899999999999999999999999999999998642 23356899999999999999999988 444
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+||||++ |+|.+.+.. .+..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence 56999999997 577777763 23579999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC--cceeeeeccccchhhhhC------CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 182 AKQLIAGEA--NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 182 a~~~~~~~~--~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
++....... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+.+++.....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 986654433 234578999999999862 345899999999999999999999999999888888777652100
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCccccccCCCCC
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNAR 327 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~~~~~~~~~~ 327 (374)
..+|. +...+|+++++||++||+ ||.+| ++++|+++||||+.+.|...+
T Consensus 289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 00110 123589999999999999 99998 599999999999999887643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=380.21 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=214.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|.+.+.||+|+||+||+|+++.+|+.||||++.+.. .....|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----- 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----- 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----
Confidence 34579999999999999999999999999999999986532 2234688888876 9999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF 162 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF 162 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence 34458999999975 77776653 3579999999999999999999999 79999999999999996 778999999
Q ss_pred cccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~----- 234 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N----- 234 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-----
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C-----
Confidence 99986433 2334567889999999999654 5899999999999999999999999998887777766541 0
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++++||.+||+.||.+||++. ++++||||+.+.|.
T Consensus 235 ----------~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 235 ----------PF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ----------CC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ----------CC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 01 2234799999999999999999999998 99999999988764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=368.21 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=212.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEE
Confidence 4568999999999999999999999999999999885432 2345799999999999999999998543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+||||+.| +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 999999974 77776653 368999999999999999999999 79999999999999996 77899999999886
Q ss_pred cccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 236 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-------- 236 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--------
T ss_pred cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 554332 3456789999999999764 589999999999999999999999999887776666554211100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 237 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 237 ------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0123578999999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=372.92 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=216.0
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
...++|.+.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 84 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--- 84 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence 44568999999999999999999999999999999886432 23458999999999999999999983
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC----c
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----Q 173 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~----~ 173 (374)
....+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .
T Consensus 85 --~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 156 (326)
T 2y0a_A 85 --NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPR 156 (326)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCC
T ss_pred --eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCC
Confidence 34458999999975 7777664 34679999999999999999999999 79999999999999986 44 7
Q ss_pred EEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 174 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
+||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp EEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 99999999987665555556788999999999854 45899999999999999999999999998887777666553221
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
... .....+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 236 ~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 FED-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CCH-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCc-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 111 1223578999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=383.26 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=213.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||++++++|. +
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 44679999999999999999999999999999999986432 23457999999999999999999984 3
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+||||+.| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEeccc
Confidence 4458999999975 6666654 45679999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~ 255 (374)
++..........+..||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... .+....+...
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----- 235 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----- 235 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence 9987766666667889999999999854 23489999999999999999999999975432 2222222220
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCccccccCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP 324 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~e~l~hp~~~~~~~~ 324 (374)
.. .++..+++++.+||.+||+.||.+||+ ++++++||||+++.|.
T Consensus 236 ------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 ------------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 00 123457999999999999999999998 8999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=388.73 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=214.1
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 45679999999999999999999999999999999986543 2345899999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Df 179 (374)
...|+|||||.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 558999999985 7766665 34679999999999999999999999 79999999999999984 2567999999
Q ss_pred ccccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---- 232 (444)
T 3soa_A 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF---- 232 (444)
T ss_dssp SSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred ceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----
Confidence 99976654332 345688999999999865 458999999999999999999999999988887777766521111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+. .....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 -------------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 -------------PS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -------------CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -------------Cc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 10 0113479999999999999999999999999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=375.31 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=217.8
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.+...++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 111 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK---- 111 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE----
Confidence 3456789999999999999999999999999999999985432 23447999999999999999999883
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
+...+|+||||++ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 112 -~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~D 184 (350)
T 1rdq_E 112 -DNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD 184 (350)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred -cCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcc
Confidence 3445899999997 577777763 3569999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||+++..... ..+..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 185 Fg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 253 (350)
T 1rdq_E 185 FGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------- 253 (350)
T ss_dssp CTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cccceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--------
Confidence 9999865432 3457899999999999654 5899999999999999999999999998888777777651
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||+.||.+||+ ++++++||||+.+.|.
T Consensus 254 ---------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 254 ---------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ---------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 111 23457999999999999999999998 9999999999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=386.32 Aligned_cols=291 Identities=32% Similarity=0.533 Sum_probs=213.6
Q ss_pred ccceee-eeeeecCCCceEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i-~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+.|.+ .+.||+|+||+||+|+++ .+++.||||++.... ....+|+.+++.++||||+++++++... ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence 456887 458999999999999976 568899999986543 2455899999999999999999998653 23458
Q ss_pred EEEeecccchHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc---CCCCcEEEE
Q 017270 106 NLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKIC 177 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~---~~~~~ikl~ 177 (374)
|+||||+.++|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 899999999998888654322 2359999999999999999999999 7999999999999993 236789999
Q ss_pred eeccccccccC----CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 017270 178 DFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQL 244 (374)
Q Consensus 178 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~ 244 (374)
|||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999865432 1223467899999999997766689999999999999999999999987654 4788
Q ss_pred HHHHHHhCCCCHHHHhhcCcC---------CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 245 VEIIKVLGTPTREEIRCMNPN---------YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 245 ~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+++.+|.|....|...... +....+.......+........++.+.+||.+||++||.+|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 889999998876655432110 00000000000011111222347899999999999999999999999999
Q ss_pred CccccccCCC
Q 017270 316 PFFDELREPN 325 (374)
Q Consensus 316 p~~~~~~~~~ 325 (374)
|||.....+.
T Consensus 335 p~f~~~~~~~ 344 (405)
T 3rgf_A 335 PYFLEDPLPT 344 (405)
T ss_dssp GGGTSSSCCC
T ss_pred hhhccCCCCc
Confidence 9998765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=379.74 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=215.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. +.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 45578999999999999999999999999999999986543 23457999999999999999999883 44
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Df 179 (374)
...|+|||||.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ ++.+||+||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 458999999986 6766654 34679999999999999999999999 799999999999999853 246999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 176 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------ 248 (362)
T 2bdw_A 176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 248 (362)
T ss_dssp TTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred CcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 99987665555556789999999999865 45899999999999999999999999998877777666552111
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
++. .....+++++++||.+||+.||.+|||+.++|+||||...
T Consensus 249 -----------~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 -----------YPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------CCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------CCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 110 0113479999999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=372.98 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=186.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|.+.+.||+|+||+||+|++ +|+.||||++..+... . +.|+..+..++|||||++++++.... .....+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 5799999999999999999987 6899999998654321 2 24555566789999999999986543 223458899
Q ss_pred eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 109 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 109 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--------~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
||||+ |+|.+.+.. .++++..+..++.|++.||+|||+ + +|+||||||+|||++. ++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence 99998 578777753 468999999999999999999997 6 8999999999999996 788999999
Q ss_pred ccccccccCCCc-----ceeeeeccccchhhhhCCC-----CCCCchhhHhHHHHHHHHHhCCCCCCCCCh---------
Q 017270 180 GSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA--------- 240 (374)
Q Consensus 180 g~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------- 240 (374)
|+|+........ ...+||+.|+|||++.+.. .++.++|||||||++|||+||.+||.....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999866543322 2357999999999996532 256799999999999999999877643221
Q ss_pred -----HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+.+.+.+...+. -|.++. .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~-----------------rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKL-----------------RPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCC-----------------CCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccC-----------------CCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111110000 000000 00001133578899999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=375.74 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=212.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
...++|++.+.||+|+||+||+|.++.+|+.||+|++.+......+|+.++..+ +||||+++++++ .+...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence 456789999999999999999999999999999999988777777899998888 799999999998 34456899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC---cEEEEeecccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAK 183 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~---~ikl~Dfg~a~ 183 (374)
|||||.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+...++ .+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999985 7777665 34679999999999999999999999 79999999999999854333 59999999998
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHH
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~ 259 (374)
...... ...+..+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------- 238 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------- 238 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---------
T ss_pred cCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---------
Confidence 654432 33456789999999998654 4889999999999999999999999863 333444444331
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+.++ ..++..+++++++||.+||+.||.+|||+.++++||||.++.
T Consensus 239 --------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 239 --------KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp --------CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred --------CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 11111 112245899999999999999999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=373.21 Aligned_cols=282 Identities=33% Similarity=0.595 Sum_probs=228.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+|+.+++.++||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CC
Confidence 45799999999999999999999999999999998854432 23479999999999999999999843 34
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCce
Confidence 5899999999876555432 45679999999999999999999999 79999999999999996 7789999999997
Q ss_pred ccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-
Q 017270 184 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC- 261 (374)
Q Consensus 184 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 261 (374)
...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.........
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 654332 233467899999999997765689999999999999999999999999999999999988888776654432
Q ss_pred -cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 -MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+.+.....+..............+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 233344445555444433344445689999999999999999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=376.23 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=214.6
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||+||+|++..+++.||||++.+.. .....|..++..+ +||+|+++++++ .
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----E
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----E
Confidence 34579999999999999999999999999999999986532 2234688888877 799999999998 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF 165 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF 165 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeC
Confidence 44458999999985 77776653 3569999999999999999999999 79999999999999996 788999999
Q ss_pred cccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 236 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------- 236 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred CcccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986433 233456789999999999965 45899999999999999999999999998888877777651
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||+.||.+||+ ++++++||||+.+.|.
T Consensus 237 ---------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 ---------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 111 23458999999999999999999994 6999999999988764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=365.55 Aligned_cols=293 Identities=33% Similarity=0.569 Sum_probs=235.6
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEEC-CCCcEEEEEEeeccc------cchHHHHHHHHhc---CCCceeeeceeee
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFF 95 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~ 95 (374)
+.....++|++.+.||+|+||+||+|.+. .+|+.||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34455679999999999999999999995 678899999885322 2345788877766 8999999999886
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 96 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 96 ~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
.........+++||||++++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEE
Confidence 4444456679999999999988887642 23459999999999999999999999 79999999999999996 78899
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999866544444556789999999999654 589999999999999999999999999999999999999888887
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
...+...... ....+......++ ..+...+++.+.+||.+||+.||.+|||+.++++||||+.+....
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 240 EEDWPRDVAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGGSCTTCSS-CGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cccCcccccc-chhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 6655422111 0011111111122 224456899999999999999999999999999999999876554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=369.14 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=206.0
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------------------------cchHHH
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRE 75 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------------------------~~~~~e 75 (374)
+.....++|++.+.||+|+||.||+|++..+++.||||++.... ....+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 44456779999999999999999999999999999999885432 234579
Q ss_pred HHHHHhcCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 017270 76 LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154 (374)
Q Consensus 76 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ 154 (374)
+.+++.++||||+++++++... ....+|+||||+++ +|.+. .....+++..++.++.||+.||+|||+ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ 157 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QK 157 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred HHHHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence 9999999999999999988542 23458899999986 43322 234679999999999999999999999 79
Q ss_pred eEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC-cceeeeeccccchhhhhCCCC--CCCchhhHhHHHHHHHHHhC
Q 017270 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLG 231 (374)
Q Consensus 155 ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~g 231 (374)
|+||||||+|||++. ++.+||+|||++........ .....+|+.|+|||++.+... ++.++|||||||++|+|++|
T Consensus 158 ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp EECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999996 77899999999986554332 234678999999999865432 37789999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH
Q 017270 232 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311 (374)
Q Consensus 232 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e 311 (374)
..||.+.+.......+.... ..++. ...+++++.+||.+||+.||++|||+.|
T Consensus 237 ~~pf~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCCCccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 99999887665555444310 01111 1347899999999999999999999999
Q ss_pred HhcCCcccc
Q 017270 312 ACAHPFFDE 320 (374)
Q Consensus 312 ~l~hp~~~~ 320 (374)
+++||||++
T Consensus 290 ~l~hp~~~~ 298 (298)
T 2zv2_A 290 IKLHPWVTR 298 (298)
T ss_dssp HTTCHHHHC
T ss_pred HhcCccccC
Confidence 999999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=370.27 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=208.5
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 77 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EG 77 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 346789999999999999999999999999999999885432 34568999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...|+|||||++ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~ 151 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGL 151 (323)
T ss_dssp SEEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CeEEEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeec
Confidence 458899999986 554443 345679999999999999999999999 79999999999999996 77899999999
Q ss_pred ccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 182 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 182 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
+....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...................
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 227 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---- 227 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----
Confidence 97654322 22356789999999999776545789999999999999999999998765432222211110000
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.. ....+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus 228 -----------------~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 -----------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------------CC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 1134789999999999999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=362.72 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=209.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|++.+.||+|+||+||+|.+..+++.+|+|++.... ....+|+.+++.++||||+++++++. +...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence 4468999999999999999999999999999999986543 23458999999999999999999983 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeecc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~ 181 (374)
.++||||+++ +|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+||+++. .++.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 8999999985 8888887665667889999999999999999999999 79999999999999953 246799999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.............+|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 243 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-------- 243 (285)
T ss_dssp CCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred ceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc--------
Confidence 98765555555677899999999984 35899999999999999999999999988766655444331000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
+. .....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 244 ---------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 244 ---------YA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------CC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------cc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 011236899999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=378.54 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=210.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc-------hHHHHHH-HHhcCCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||+||+|+++.+++.||||++.+.... ..+|..+ ++.++||||+++++++.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~----- 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ----- 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----
Confidence 3457899999999999999999999999999999998654321 2234444 46679999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+||||+.| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~DF 183 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDF 183 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEeeC
Confidence 34458999999986 67666653 3579999999999999999999999 79999999999999996 788999999
Q ss_pred cccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+++.... .....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 254 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------- 254 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--------
T ss_pred ccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------
Confidence 99986433 333456789999999999965 45899999999999999999999999998888877777652
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++++||.+||+.||.+||++ .++++||||+.+.|.
T Consensus 255 ---------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 255 ---------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp ---------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred ---------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 011 234589999999999999999999986 699999999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=388.16 Aligned_cols=254 Identities=30% Similarity=0.456 Sum_probs=216.7
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.....++|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--- 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--- 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 3456679999999999999999999999999999999986432 234589999999999999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
...+|+|||||+| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 88 --~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~D 159 (476)
T 2y94_A 88 --PSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIAD 159 (476)
T ss_dssp --SSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEe
Confidence 3458999999974 6666554 45679999999999999999999999 79999999999999996 77899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++..........+..||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++....
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 232 (476)
T 2y94_A 160 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------- 232 (476)
T ss_dssp CSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-------
T ss_pred ccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------
Confidence 9999876665555667899999999999765545789999999999999999999999888777666665421
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
+. .+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 233 ----------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 ----------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 01 12347899999999999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=377.04 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=215.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|.+.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEE
Confidence 4568999999999999999999999999999999886542 23457999999999999999999983 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC-CCCcEEEEeecccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 183 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~-~~~~ikl~Dfg~a~ 183 (374)
++||||+.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||++.
T Consensus 124 ~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 999999985 66665542 34579999999999999999999999 79999999999999974 24679999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 267 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW----------- 267 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred ecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 7665555556788999999999865 4589999999999999999999999999888777766654211
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.++ ......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 268 ------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 268 ------EFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ------CCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------CCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 011 011235799999999999999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=360.36 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=217.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 4579999999999999999999999999999999986543 2334799999999999999999988 3444
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg 180 (374)
..++||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.+ +..+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 58899999986 66666653 3569999999999999999999999 799999999999999752 2349999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 228 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---- 228 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence 99876655555567889999999999654 5899999999999999999999999998877776666552111110
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~ 328 (374)
.....+++++.+||.+||+.||.+|||++|+++||||++.+......
T Consensus 229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 275 (284)
T 3kk8_A 229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275 (284)
T ss_dssp ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence 01134789999999999999999999999999999998866554443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=371.80 Aligned_cols=316 Identities=34% Similarity=0.581 Sum_probs=239.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC-Cce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 103 (374)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999985432 2234799999999999999999988543221 112
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+||||+.++|.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence 35899999998765443 2459999999999999999999999 79999999999999996 7789999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+....
T Consensus 175 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 5432 23346789999999999765678999999999999999999999999999999999999999988876654432
Q ss_pred cCCcC---CCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 264 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 264 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
..... ...+......+.. ....+++++.+||.+||+.||.+|||++++++||||+.+..+........ .++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~----~~~~ 327 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ----PFDD 327 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS----CCCC
T ss_pred hHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC----CCcc
Confidence 11000 0111111222222 22357999999999999999999999999999999998776543322221 1222
Q ss_pred hhhhcCCCHHHHhhhcHHHHh
Q 017270 341 KQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+....+.+.+.+.+.+++.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~ 348 (353)
T 3coi_A 328 SLEHEKLTVDEWKQHIYKEIV 348 (353)
T ss_dssp TTTTCCCCHHHHHHHHHHHHH
T ss_pred chhhccCCHHHHHHHHHHHHH
Confidence 223345566666666666554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=379.49 Aligned_cols=258 Identities=27% Similarity=0.468 Sum_probs=196.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++++.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence 4568999999999999999999999999999999986543 334589999999999999999999843 34589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC--cEEEEeecccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~--~ikl~Dfg~a~ 183 (374)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++ .+||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCccc
Confidence 99999975 77776653 3579999999999999999999999 79999999999999985 43 49999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........++.....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------- 236 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------- 236 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----------
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----------
Confidence 5544444556789999999999977654445599999999999999999999876543323222221110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+.++. ...+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 237 ---~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 237 ---VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0011111 12478999999999999999999999999999999654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=377.69 Aligned_cols=289 Identities=20% Similarity=0.291 Sum_probs=210.1
Q ss_pred CCccccceeeeeeeecC--CCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 27 EPKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
.....++|++.+.||+| +||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 97 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-- 97 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--
Confidence 34456799999999999 99999999999999999999986543 233469999999999999999999854
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
...+|+|||||.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~ 170 (389)
T 3gni_B 98 ---DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLS 170 (389)
T ss_dssp ---TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEEC
T ss_pred ---CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEc
Confidence 3348999999984 777776542 23569999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCC--------CcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017270 178 DFGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248 (374)
Q Consensus 178 Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 248 (374)
|||.+....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999986543221 11234678899999999653 458999999999999999999999998876655554433
Q ss_pred HHhCCC--------CHHHHhhcC-----cCCcCC-----CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH
Q 017270 249 KVLGTP--------TREEIRCMN-----PNYTDF-----RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310 (374)
Q Consensus 249 ~~~~~~--------~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ 310 (374)
...-.. ......... ....+. ..+. ........++..+++++.+||.+||++||.+|||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 211000 000000000 000000 0000 000111123456899999999999999999999999
Q ss_pred HHhcCCccccccCCC
Q 017270 311 EACAHPFFDELREPN 325 (374)
Q Consensus 311 e~l~hp~~~~~~~~~ 325 (374)
|+|+||||+.+.+..
T Consensus 330 ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 330 TLLNHSFFKQIKRRA 344 (389)
T ss_dssp HHTTSGGGGGC---C
T ss_pred HHhcCHHHHHHhhcc
Confidence 999999999887643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=369.27 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=207.6
Q ss_pred ccccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhcCCCceeeeceeeeec
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFST 97 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (374)
...++|++.+.||+|+||+||+|++. .+++.||+|++.+.. ....+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT- 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence 44579999999999999999999985 689999999886432 223479999999999999999998843
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
...+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl 162 (327)
T 3a62_A 93 ----GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHVKL 162 (327)
T ss_dssp ----SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcEEE
Confidence 3348999999984 77766653 3568999999999999999999999 79999999999999996 788999
Q ss_pred EeeccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 177 CDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 177 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---- 237 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---- 237 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 999999754332 223345789999999999654 58999999999999999999999999988877777766521
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
.. ++..+++++.+||.+||+.||.+|| +++++++||||+.+.+.
T Consensus 238 -------------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 238 -------------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp -------------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred -------------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 11 2234789999999999999999999 89999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=371.58 Aligned_cols=279 Identities=25% Similarity=0.433 Sum_probs=222.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcC-----CCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----HPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++.+.||+|+||+||+|++..+++.||||++.... .....|+.+++.+. ||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~---- 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY---- 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET----
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC----
Confidence 4568999999999999999999999999999999986432 23456999999986 99999999988543
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC------------
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 169 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~------------ 169 (374)
...|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 109 -~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 -DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp -TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred -CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence 348999999988998888742 23469999999999999999999999 79999999999999973
Q ss_pred ------------CCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCC
Q 017270 170 ------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 237 (374)
Q Consensus 170 ------------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 237 (374)
.++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 267899999999975433 23456789999999999654 589999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCCcC---------CCCCCCCCC--------ChhhhcccCCChhHHHHHHhhcC
Q 017270 238 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTD---------FRFPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQ 300 (374)
Q Consensus 238 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~ 300 (374)
.+..+.+..+....+..+...+......... ..++..... .....+....++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 9999999988888887776655433211000 001110000 00001112245788899999999
Q ss_pred cCCCCCCCHHHHhcCCccc
Q 017270 301 YSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 301 ~dp~~R~s~~e~l~hp~~~ 319 (374)
+||.+|||++|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999995
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=367.10 Aligned_cols=283 Identities=28% Similarity=0.508 Sum_probs=219.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++... .....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEE
Confidence 457899999999999999999999999999999998643 344568999999997 99999999988542 2344889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|...+. .+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++....
T Consensus 111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999996 4444332 48999999999999999999999 7999999999999999645589999999998766
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhc-Cc
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCM-NP 264 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~-~~ 264 (374)
.........+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+.+..+.+........ ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 55555567889999999999765678999999999999999999999984 45666777777766664433222111 00
Q ss_pred CCcC---CCCCCCCCCChhhhc----ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 265 NYTD---FRFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 265 ~~~~---~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.... ..........|...+ ...+++++.+||.+||++||.+|||++|+|+||||+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0000 000011111222221 2237999999999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=389.15 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=215.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----------------cchHHHHHHHHhcCCCceeeec
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRVMDHPNVISLK 91 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------------~~~~~e~~~l~~l~h~~iv~~~ 91 (374)
...++|++++.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999999999999999986432 2235799999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 170 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~ 170 (374)
+++ .+...+|+|||||.| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 113 DVF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESST
T ss_pred EEE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecC
Confidence 998 344568999999985 77776653 3569999999999999999999999 799999999999999863
Q ss_pred C--CcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017270 171 T--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248 (374)
Q Consensus 171 ~--~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 248 (374)
+ ..+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3 2699999999987766655566789999999999853 58999999999999999999999999998888877776
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+......... +..+++++++||.+||++||.+|||++|+|+||||++...
T Consensus 261 ~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 261 KGKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HCCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 6322221111 2358999999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=364.09 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=215.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 85 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE---- 85 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence 4568999999999999999999999999999999886432 22458999999999999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC---cEE
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVK 175 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~---~ik 175 (374)
....+++||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++. .+|
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 86 -NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred -cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence 34458999999974 7777765 35679999999999999999999999 79999999999999986332 799
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 999999987665555556678999999999865 4589999999999999999999999999887777766654221111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+...+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus 239 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 239 -------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 112235789999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=356.74 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=216.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|++.+.||+|+||+||+|.+..++..+|+|++.... ....+|+.+++.++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 4568999999999999999999999999999999986532 34457999999999999999999883 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE---cCCCCcEEEEeecc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 181 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll---~~~~~~ikl~Dfg~ 181 (374)
++||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+||++ +. ++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~ 155 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFGL 155 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEeccc
Confidence 999999985 77666653 3569999999999999999999999 799999999999999 53 67899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.+.....+...+
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-- 231 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--
T ss_pred ceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--
Confidence 987666655566788999999999854 3899999999999999999999999998888777776663222222211
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 232 -----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 232 -----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 24789999999999999999999999999999998743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=386.90 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=214.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|++.+.||+|+||+||+|++..+++.||||++.+. .....+|+.+++.++||||+++++++. ..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cC
Confidence 3567999999999999999999999999999999998532 233458999999999999999999983 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Df 179 (374)
..+|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 458999999985 77666653 3579999999999999999999999 79999999999999963 2457999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 243 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--- 243 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 99987665555556789999999999864 4899999999999999999999999999888877776652111110
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+ .+..+++++++||.+||++||.+|||+.++|+||||+....
T Consensus 244 ------------~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 ------------P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ------------G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ------------c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 0 12347999999999999999999999999999999987643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=388.87 Aligned_cols=258 Identities=31% Similarity=0.524 Sum_probs=218.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||+||+|.+..+|+.||||++.+.. ....+|+.+++.++||||+++++++ ..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 45679999999999999999999999999999999985432 2345899999999999999999998 34
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEe
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD 178 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~D 178 (374)
...+|+|||||.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 4568999999985 6766665 35679999999999999999999999 79999999999999952 367899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.+.......
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 248 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-- 248 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 999987766655566789999999999965 4899999999999999999999999999888877777652111110
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
..+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 249 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 249 -----------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp -----------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred -----------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 012347999999999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=364.72 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=197.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccch------HHHHHHHH-hcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMR-VMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++|++.+.||+|+||+||+|++..+|+.||||++....... ..|+..+. ..+|+||+++++++. ....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 68999999999999999999999999999999875432211 23443333 448999999999984 3345
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeeee
Confidence 899999999998887764 34679999999999999999999999 79999999999999986 78899999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+.. +.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~----------- 268 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GY----------- 268 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TC-----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cC-----------
Confidence 655555555678999999999865 58999999999999999999977765533221 1111 00
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
....++..+++++.+||.+||++||++|||++|+++||||++
T Consensus 269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011233458999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=384.83 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=208.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+.+++.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----- 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence 34578999999999999999999999999999999986431 223468888999999999999999843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCC
Confidence 3348999999986 66666643 3579999999999999999999996149999999999999996 7889999999
Q ss_pred cccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 181 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 181 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 364 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------- 364 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------
Confidence 99864332 233456789999999999654 5899999999999999999999999998887777666541
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++.+||.+||++||.+|| |++|+++||||+++.+.
T Consensus 365 --------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 365 --------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 111 2335799999999999999999999 99999999999988664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.65 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=214.8
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
+...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----- 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE----- 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----
Confidence 345578999999999999999999999999999999986432 23357999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+||||++| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeec
Confidence 34458999999985 7777776544445679999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~ 254 (374)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+ ..+....+...
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---- 408 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---- 408 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----
T ss_pred ceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----
Confidence 99987654433 334589999999999965 458999999999999999999999998753 23333333331
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
.. .++..+++++.+||.+||++||.+||+ ++++++||||+.+.|.
T Consensus 409 -------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 409 -------------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp -------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred -------------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 00 123458999999999999999999995 5899999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=366.97 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=196.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++. ....++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence 45578999999999999999999999999999999986542 34457999999999999999999984 334588
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeecccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~a~ 183 (374)
+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||++.
T Consensus 125 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 125 LVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999985 7766664 34679999999999999999999999 79999999999999973 26789999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhc
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 262 (374)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+..+.+....
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------- 269 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------- 269 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---------
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---------
Confidence 66554444567789999999999654 58999999999999999999999998766544 33333331000
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ ...+...++.++.+||.+||+.||++|||+.|+|+||||...
T Consensus 270 --------~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 270 --------F--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp --------C--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred --------c--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 001223578999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=360.47 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=200.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||+||+|.+..+|+.||+|++...... ..++...++.++||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence 456999999999999999999999999999999988644211 12344457778999999999988543 3
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++++.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCc
Confidence 388999999999988888766677889999999999999999999999 8 9999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhh---hCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHH
Q 017270 183 KQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l---~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~ 258 (374)
.............+|+.|+|||++ .....++.++|||||||++|+|++|..||... .....+........ +
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-P---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-C----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-C----
Confidence 876555555556789999999997 34456899999999999999999999999874 34444444333100 0
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
......+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 001134789999999999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=386.96 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=213.7
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
|...++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----- 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE----- 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----
Confidence 455678999999999999999999999999999999985432 22357999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+...+|+||||++| +|...+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DF 330 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDL 330 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEec
Confidence 34459999999975 776666532 23459999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTR 256 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 256 (374)
|+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+...+....
T Consensus 331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---- 405 (576)
T 2acx_A 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---- 405 (576)
T ss_dssp TTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----
T ss_pred ccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----
Confidence 999876655555567899999999999654 589999999999999999999999987642 222222222100
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
..++..+++++++||.+||+.||.+|| +++|+++||||+++.|.
T Consensus 406 ------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 406 ------------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred ------------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 012345899999999999999999999 89999999999987664
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=363.76 Aligned_cols=287 Identities=30% Similarity=0.515 Sum_probs=221.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecC-------
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT------- 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 98 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4568999999999999999999999999999999886443 23457999999999999999998873321
Q ss_pred --CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 99 --SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 99 --~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
.......++||||++|+|.+.+. ..++++..++.++.||+.||+|||+ +||+||||||+||+++..++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEE
Confidence 12345688999999998887764 3579999999999999999999999 799999999999999865778999
Q ss_pred EeeccccccccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 177 CDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 177 ~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998654321 123345688999999987656789999999999999999999999999998888888888777
Q ss_pred CCCHHHHhhcCcCCcCC---CCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 253 TPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
................+ ... ....++. .+...+++++.+||.+||+.||.+|||++|+++||||+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMT-EPHKPLT-QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTT-SCCCCHH-HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCchhhhhhhhhcCccccccccc-CCCCChh-HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 66655443321111000 000 0011111 2334689999999999999999999999999999999986554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=368.76 Aligned_cols=266 Identities=27% Similarity=0.446 Sum_probs=212.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 98 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE---- 98 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc----
Confidence 34578999999999999999999999999999999885432 23457999999999999999999983
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc------------------------------------CCCCCHHHHHHHHHHH
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA------------------------------------NQRMPLIYVKLYTYQI 142 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~ql 142 (374)
+....++|||||+| +|.+.+..+... ...+++..++.++.||
T Consensus 99 -~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 99 -DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp -CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred -cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 34458999999974 776666421111 2235788899999999
Q ss_pred HHHHHHhhcCCCeEeecCCCCcEEEcCCC-CcEEEEeeccccccccCCC-----cceeeeeccccchhhhhCC-CCCCCc
Q 017270 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGA-TEYTTS 215 (374)
Q Consensus 143 l~al~~LH~~~~ivH~dlkp~NIll~~~~-~~ikl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~-~~~~~~ 215 (374)
+.||+|||+ +||+||||||+||+++.++ ..+||+|||++........ .....+|+.|+|||++.+. ..++.+
T Consensus 178 ~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 7999999999999998522 2799999999986543221 2356789999999998642 568999
Q ss_pred hhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHH
Q 017270 216 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 295 (374)
Q Consensus 216 ~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (374)
+|||||||++|+|++|..||.+.+..+....+......... .....+++++.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li 311 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLL 311 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHH
Confidence 99999999999999999999999888877776652111110 01124789999999
Q ss_pred HhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 296 SRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 296 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
.+||+.||.+|||+.++++||||+++.+..
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=384.69 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=212.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 4468999999999999999999999999999999986432 23458999999999999999999983 344
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg 180 (374)
.+|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 58999999985 67666653 3569999999999999999999999 799999999999999752 3459999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.+..+.........
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 258 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS---- 258 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----
T ss_pred CCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence 998776665556678999999999984 35899999999999999999999999999888877777653211111
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.....+++.+++||.+||++||.+|||+.++|+||||+...
T Consensus 259 ---------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 259 ---------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11235799999999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=372.93 Aligned_cols=255 Identities=28% Similarity=0.395 Sum_probs=207.4
Q ss_pred ceee--eeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....++
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 162 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIV 162 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 4555 678999999999999999999999999986532 33458999999999999999999884 334589
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc-CCCCcEEEEeeccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~-~~~~~ikl~Dfg~a~~ 184 (374)
+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999985 67666653 33568999999999999999999999 7999999999999984 2367899999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------- 308 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------- 308 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---------
T ss_pred cCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---------
Confidence 765555556678999999999854 4589999999999999999999999999988888877766311111
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
......+++++++||.+||+.||.+|||++|+|+||||+..+
T Consensus 309 ----------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 309 ----------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ----------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 011234799999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=368.90 Aligned_cols=283 Identities=32% Similarity=0.525 Sum_probs=218.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcC-CC-----ceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-HP-----NVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence 45789999999999999999999999999999999865432 2346888888775 44 48888888744
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCeEeecCCCCcEEEcC-CCCcEEEEe
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDP-LTHQVKICD 178 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~-~~~ivH~dlkp~NIll~~-~~~~ikl~D 178 (374)
...+|+||||++++|.+.+... ....+++..++.++.||+.||.|||+ ..||+||||||+|||++. .++.+||+|
T Consensus 128 -~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 -RNHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred -CCceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3358999999999998888753 23569999999999999999999994 159999999999999953 356799999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++...
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986533 23456789999999999765 589999999999999999999999999999999999999999888766
Q ss_pred HhhcCc-----------CCc-------CCCCCCCCCCChhhhccc-----------------CCChhHHHHHHhhcCcCC
Q 017270 259 IRCMNP-----------NYT-------DFRFPQIKAHPWHKVFHK-----------------RMPPEAIDLASRLLQYSP 303 (374)
Q Consensus 259 ~~~~~~-----------~~~-------~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~dp 303 (374)
+..... .|. ...+.......+...+.. ..++++++||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 542110 000 000000000111111100 001478999999999999
Q ss_pred CCCCCHHHHhcCCcccccc
Q 017270 304 SLRCTALEACAHPFFDELR 322 (374)
Q Consensus 304 ~~R~s~~e~l~hp~~~~~~ 322 (374)
++|||++|+|+||||+...
T Consensus 362 ~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTSCCHHHHTTSGGGCC--
T ss_pred hhCCCHHHHhcCcccccCC
Confidence 9999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=364.61 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=210.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..|.+.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 56999999999999999999999999999999986432 2235799999999999999999998543 34
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
.++||||+.|++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence 889999999988887753 34679999999999999999999999 79999999999999996 78999999999976
Q ss_pred cccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+..... +.
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~------- 272 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------- 272 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-------
Confidence 532 234678999999999853 34589999999999999999999999998887776666554210 00
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.....+++.+.+||.+||+.||.+|||++++++||||..
T Consensus 273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 011346889999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=365.04 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=212.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhc-CCCceeeeceeeeecC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 98 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 98 (374)
++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 57999999999999999999999999999999886432 2234789999998 7999999999883
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~ 242 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS 242 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence 34458999999986 77776653 3579999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhC-----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999987666555566788999999999853 23478899999999999999999999998887777766655322
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...... ...+++.+.+||.+||+.||.+|||++++++||||++
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 222111 1347899999999999999999999999999999973
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=362.49 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=189.1
Q ss_pred ccccceeee---eeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhcC-CCceeeeceeeeecCCCCce
Q 017270 29 KQTISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 29 ~~~~~y~i~---~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 103 (374)
+...+|.+. +.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.+. ||||+++++++. +..
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~ 79 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQL 79 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCC
Confidence 345678875 78999999999999999999999999987543 34568999999997 999999999983 444
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC--CcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~--~~ikl~Dfg 180 (374)
..|+||||+.| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 58999999986 77777653 4679999999999999999999999 7999999999999998522 279999999
Q ss_pred cccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhC
Q 017270 181 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLG 252 (374)
Q Consensus 181 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-------~~~~~i~~~~~ 252 (374)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. +.+..+...
T Consensus 155 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-- 231 (325)
T 3kn6_A 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-- 231 (325)
T ss_dssp TCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--
T ss_pred cceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--
Confidence 998654432 2345677999999999865 45899999999999999999999999875432 222222211
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.+.+ .......+++++++||.+||+.||.+|||++++++||||++.
T Consensus 232 ---------------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 232 ---------------DFSF--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------CCCC--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------CCCC--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 0000 111123579999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=393.33 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=215.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhc-CCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++++.||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +||+|+.++++| ++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4568999999999999999999999999999999986432 2234688888877 799999999988 44
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+||||++| +|...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeecc
Confidence 4569999999985 77766653 3579999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 181 SAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 181 ~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+++.... .....+..||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..|.+.
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------- 557 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 557 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 9986433 333456789999999999965 45899999999999999999999999999888888777651
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCccccccCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 324 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~~ 324 (374)
... ++..+++++++||++||++||.+|+++ +|+++||||+.++|.
T Consensus 558 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 558 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 111 234589999999999999999999997 999999999998765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=353.32 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=211.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 468999999999999999999999999999999886432 234589999999999999999998843
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC----cEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVK 175 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~----~ik 175 (374)
....++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++ .+|
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~~~~k 152 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLD-KNVPNPRIK 152 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESC-SSSSSCCEE
T ss_pred -CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEec-CCCCCCceE
Confidence 345889999997 577777653 3579999999999999999999999 79999999999999986 43 799
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+|||++.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+........
T Consensus 153 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp ECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred EEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 999999987655544455678999999999854 4589999999999999999999999999887776665544211111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~ 325 (374)
......+++.+.+||.+||+.||.+|||+.++++||||+.++...
T Consensus 232 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 -------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 112235789999999999999999999999999999999876554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=371.28 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=200.1
Q ss_pred cccceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|.+. +.||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..++|+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 45678877 7999999999999999999999999988643 3456788876 5568999999999884322 34567899
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeeccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQ 184 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg~a~~ 184 (374)
|||||.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999985 787777632 23469999999999999999999999 799999999999999853 56899999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 260 (374)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+..
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----------- 281 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----------- 281 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----------
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----------
Confidence 655544556788999999999854 468999999999999999999999998764321 1222221
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+.++. .....+++++.+||++||+.||.+|||+.|+++||||...
T Consensus 282 ------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 282 ------GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------TCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------CcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 0111111 0113479999999999999999999999999999999763
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=352.40 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=210.1
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
+...++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH----- 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----
Confidence 345679999999999999999999999999999999885432 23457999999999999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Df 153 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADF 153 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSC
T ss_pred cCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEec
Confidence 33458999999985 67766653 3569999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|++...... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+....
T Consensus 154 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 223 (279)
T 3fdn_A 154 GWSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------- 223 (279)
T ss_dssp CEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------
T ss_pred cccccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--------
Confidence 998644332 2345678999999999865 458999999999999999999999999888777666654411
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.. ++..+++.+.+||.+||+.||.+|||++|+++||||+....
T Consensus 224 ---------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 ---------FT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ---------CC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ---------CC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 11 22347899999999999999999999999999999987544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=369.93 Aligned_cols=284 Identities=28% Similarity=0.411 Sum_probs=221.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcC--------CCceeeeceeeeecC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD--------HPNVISLKHCFFSTT 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~--------h~~iv~~~~~~~~~~ 98 (374)
..++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++ |+||+++++++....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3468999999999999999999999999999999986543 23457999999885 788999999884322
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCC------
Q 017270 99 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLT------ 171 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~------ 171 (374)
.....+|+||||+++++.+.+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++
T Consensus 115 -~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 -VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp -TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred -CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhh
Confidence 245568999999999888877642 33569999999999999999999999 8 999999999999998532
Q ss_pred ------------------------------------------CcEEEEeeccccccccCCCcceeeeeccccchhhhhCC
Q 017270 172 ------------------------------------------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209 (374)
Q Consensus 172 ------------------------------------------~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~ 209 (374)
..+||+|||++...... .....+|+.|+|||++.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence 27999999999865432 3345789999999999765
Q ss_pred CCCCCchhhHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCCcCC-------CCCCCCC
Q 017270 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKA 276 (374)
Q Consensus 210 ~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 276 (374)
.++.++|||||||++|+|++|+.||.+.+ ....+..+.+..+.++...+.........+ .......
T Consensus 269 -~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 -GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp -CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred -CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 48999999999999999999999998654 566778888888888776553221110000 0011111
Q ss_pred CChhhh------cccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 277 HPWHKV------FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 277 ~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...... +....++.+.+||.+||++||.+|||++|+|+||||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 111010 11234567899999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=374.82 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=198.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 468999999999999999999999999999999986532 13458999999999999999999872
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVK 175 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ik 175 (374)
.. .+|+||||+.+ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++.. +..+|
T Consensus 211 --~~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SS-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cC-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 22 26899999986 544433 355789999999999999999999999 799999999999999742 33599
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987665555556789999999999853 345788999999999999999999999876443333322221111
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
. +.......+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0 0111223579999999999999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=363.00 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=207.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeee
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFS 96 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (374)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-- 98 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-- 98 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 34578999999999999999999999999999999886542 2334799999999999999999998
Q ss_pred cCCCCceEEEEEeeccc-c-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcE
Q 017270 97 TTSKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 174 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~-g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~i 174 (374)
.....+++||||+. | +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus 99 ---~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~ 169 (335)
T 3dls_A 99 ---ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTI 169 (335)
T ss_dssp ---ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCE
T ss_pred ---eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcE
Confidence 34445889999986 4 6666665 45679999999999999999999999 79999999999999996 7889
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~----- 238 (335)
T 3dls_A 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE----- 238 (335)
T ss_dssp EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----
T ss_pred EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----
Confidence 9999999987766665667789999999999976654588999999999999999999999652210 00
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
... ..+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 239 ------------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 ------------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ------------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ------------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000 012347899999999999999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=360.42 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=199.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC-----
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS----- 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 99 (374)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3568999999999999999999999999999999986432 234579999999999999999998855332
Q ss_pred -----------------------------------------------CCceEEEEEeecccc-hHHHHHHhhhhcCCCCC
Q 017270 100 -----------------------------------------------KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP 131 (374)
Q Consensus 100 -----------------------------------------------~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~ 131 (374)
....++++|||||.+ +|.+.+... ......+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchh
Confidence 123358999999986 677666542 2234457
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCC-------------Ccceeeeec
Q 017270 132 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------ANISYICSR 198 (374)
Q Consensus 132 ~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~-------------~~~~~~~t~ 198 (374)
+..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++....... ......+|+
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77789999999999999999 79999999999999996 7889999999998665432 123356899
Q ss_pred cccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCC
Q 017270 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 278 (374)
Q Consensus 199 ~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (374)
.|+|||++.+. .++.++|||||||++|+|++|..|+.. ....+..........
T Consensus 241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~--------------------- 293 (332)
T 3qd2_B 241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL--------------------- 293 (332)
T ss_dssp GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH---------------------
T ss_pred CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc---------------------
Confidence 99999999764 589999999999999999998776421 111111111111000
Q ss_pred hhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 279 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 279 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.....++++.+||.+||+.||.+|||++|+++||||+++
T Consensus 294 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ----ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 011247788999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=352.61 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=214.9
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhcC-CCceeeeceee
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCF 94 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~ 94 (374)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45679999999999999999999999999999999986432 22347899999995 99999999988
Q ss_pred eecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc
Q 017270 95 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 173 (374)
Q Consensus 95 ~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ 173 (374)
......++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~ 162 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMN 162 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCC
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCc
Confidence 334558999999984 77777753 3579999999999999999999999 79999999999999996 778
Q ss_pred EEEEeeccccccccCCCcceeeeeccccchhhhh-----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017270 174 VKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 248 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 248 (374)
+||+|||++.............+|+.|+|||++. ....++.++||||||+++|+|++|..||...+.......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 9999999998766555555677899999999985 23457899999999999999999999999888777666665
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
....... . .....+++.+.+||.+||+.||.+|||+.++++||||++....
T Consensus 243 ~~~~~~~-----------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 243 SGNYQFG-----------------S--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp HTCCCCC-----------------T--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cCCcccC-----------------c--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 5211110 0 0112478999999999999999999999999999999976543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=355.06 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=210.0
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+.....|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 41 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 115 (321)
T 2c30_A 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----E 115 (321)
T ss_dssp SCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred CCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----C
Confidence 334456889999999999999999999999999999986433 2345799999999999999999988543 3
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++ +|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~ 188 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFC 188 (321)
T ss_dssp EEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeee
Confidence 48899999986 5655543 3569999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..... +.
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~------ 260 (321)
T 2c30_A 189 AQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PK------ 260 (321)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC------
T ss_pred eecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC------
Confidence 8654432 2345678999999999865 4589999999999999999999999998887766655543110 00
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
. .....+++.+.+||.+||+.||++|||++++++||||...
T Consensus 261 ------------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 ------------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ------------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ------------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0 0112478999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=359.88 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=211.4
Q ss_pred ccccceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC-CCceeeeceeeeecCCC
Q 017270 29 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 100 (374)
...++|.+. +.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~ 99 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----E 99 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 345689888 89999999999999999999999999886432 23457999999985 69999999998 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEE
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKIC 177 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~ 177 (374)
....+++||||+.+ +|.+.+.. .....+++..++.++.||+.||+|||+ +||+||||||+||+++. .++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 44458999999986 55544431 234679999999999999999999999 79999999999999985 24689999
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 254 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE- 254 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred eCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-
Confidence 9999987655555556788999999999865 45899999999999999999999999998888777766653221111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~ 326 (374)
.....+++.+.+||.+||+.||.+|||++++|+||||+.+.+...
T Consensus 255 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 ------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp ------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred ------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 112347899999999999999999999999999999998876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=352.52 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=213.5
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.|...++|.+.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 85 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE---- 85 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec----
Confidence 4556679999999999999999999999999999999886542 22347999999999999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
.....++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~d 158 (294)
T 2rku_A 86 -DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGD 158 (294)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECC
T ss_pred -cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEe
Confidence 34458999999985 66665543 3579999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 179 FGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 179 fg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
||++...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------- 230 (294)
T 2rku_A 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 230 (294)
T ss_dssp CTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------
T ss_pred ccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------
Confidence 9999865432 22334678999999999865 45899999999999999999999999988776655544331
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++.+.+||.+||+.||++|||++++++||||.....+
T Consensus 231 ----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 231 ----------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ----------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ----------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 011 223578999999999999999999999999999999875443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=349.88 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=212.6
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH----- 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----
Confidence 345679999999999999999999999999999999985431 23457999999999999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.....++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEecc
Confidence 33458999999985 77777763 3569999999999999999999999 79999999999999996 778999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|++...... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+...
T Consensus 159 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 227 (284)
T 2vgo_A 159 GWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--------- 227 (284)
T ss_dssp TTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------
T ss_pred cccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc---------
Confidence 998754332 23456789999999998654 5899999999999999999999999988777666555431
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
+.. ++..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 228 --------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 --------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred --------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011 2235789999999999999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=348.59 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=209.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.....|++.+.||+|+||+||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 34457999999999999999999999999999999886432 22357999999999999999999875443 345
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
..+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+||+++..++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 668999999975 77777753 3569999999999999999999999 78 9999999999999844788999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|++..... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||..................
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 247 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------ 247 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------
Confidence 99974332 23345678999999998853 4899999999999999999999999886655444433321111
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...++...++++.+||.+||+.||.+|||++++++||||++
T Consensus 248 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 --------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11123456889999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=351.49 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=212.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... +
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence 3468999999999999999999999999999999885432 3345899999999999999999987532 2
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
....++||||+.+++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~ 155 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGV 155 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeecccc
Confidence 3348899999999887777643 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCC---CcceeeeeccccchhhhhCCC-CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+....... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------- 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------- 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------
Confidence 98654322 223456899999999986533 2477999999999999999999999988776666555441
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.+. ++..+++.+.+||.+||+.||.+|||++++++||||++....
T Consensus 229 ----------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 229 ----------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 001 223578999999999999999999999999999999876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=356.05 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=213.7
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
+....+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----- 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 445678999999999999999999999999999999986542 23457999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+...+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Df 185 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF 185 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCC
T ss_pred cCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeec
Confidence 34458999999985 66666543 3579999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 180 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 180 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...
T Consensus 186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------- 256 (335)
T 2owb_A 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 256 (335)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------
T ss_pred cCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------
Confidence 999865433 223446789999999999654 4899999999999999999999999988776665554431
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
... ++..+++.+.+||.+||+.||++|||++|+++||||.....+
T Consensus 257 ---------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 257 ---------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 111 223478999999999999999999999999999999875443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=350.11 Aligned_cols=252 Identities=28% Similarity=0.477 Sum_probs=186.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 4578999999999999999999999999999999985432 33457999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecc
Confidence 458999999975 67666653 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 182 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 182 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
+....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 226 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------- 226 (278)
T ss_dssp CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence 98654322 2334678999999999865 4579999999999999999999999987654332221100
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.++ .++..++.++.+||.+||+.||++|||++++++||||...
T Consensus 227 ------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 001 1233578999999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=349.24 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=203.1
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----- 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----
Confidence 45679999999999999999999999999999999885432 234579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeecc
Confidence 3458899999975 77777753 3568999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.............+|+.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------- 227 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence 99876555444556789999999999765544789999999999999999999998887666555544310
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.. ++..+++.+.+||.+||+.||.+|||++++++||||++
T Consensus 228 --------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 228 --------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred --------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 00 12347899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=355.87 Aligned_cols=259 Identities=26% Similarity=0.352 Sum_probs=197.6
Q ss_pred cccceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhc-CCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++. +.||+|+||+||+|.+..+++.||||++.... ....+|+.+++++ +||||+++++++.. ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence 34689995 78999999999999999999999999986543 2345799999884 79999999999844 33
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC--cEEEEeec
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~--~ikl~Dfg 180 (374)
.+|+||||+. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 5899999998 577777763 3579999999999999999999999 79999999999999986322 39999999
Q ss_pred cccccccCC--------CcceeeeeccccchhhhhCC----CCCCCchhhHhHHHHHHHHHhCCCCCCCCCh--------
Q 017270 181 SAKQLIAGE--------ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------- 240 (374)
Q Consensus 181 ~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-------- 240 (374)
++....... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987543221 12234589999999998541 3478999999999999999999999987542
Q ss_pred -------HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 241 -------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 241 -------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
......+..... .++ ......+++++++||.+||+.||.+|||++|++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~-----------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKY-----------------EFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCC-----------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccCc-----------------ccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 112222222100 011 011134789999999999999999999999999
Q ss_pred cCCccccccC
Q 017270 314 AHPFFDELRE 323 (374)
Q Consensus 314 ~hp~~~~~~~ 323 (374)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=347.66 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=206.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 78 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CC
Confidence 35679999999999999999999999999999999986433 234579999999999999999998843 34
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+++ +|.+.+ .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLA 152 (276)
T ss_dssp EEEEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCc
Confidence 48899999986 554443 345679999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHH
Q 017270 183 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREE 258 (374)
Q Consensus 183 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 258 (374)
....... ......+|+.|+|||++.+...++.++||||||+++|+|++|..||....... ....+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----- 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT----- 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT-----
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc-----
Confidence 7654322 12345689999999999665545789999999999999999999998765432 22222110 00
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..+ ....+++.+.+||.+||+.||.+|||++|+++||||++..
T Consensus 227 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 227 -----------YLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp -----------TST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------ccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 000 1134789999999999999999999999999999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=347.88 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=205.0
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
....++|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+..+..+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~---- 82 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE---- 82 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----
Confidence 345679999999999999999999999999999999986532 2234688888888 99999999998844
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC----------
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---------- 169 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~---------- 169 (374)
...+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 83 -DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-----------
T ss_pred -CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccc
Confidence 3358899999975 8888887665556789999999999999999999999 79999999999999973
Q ss_pred --------CCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH
Q 017270 170 --------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241 (374)
Q Consensus 170 --------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 241 (374)
....+||+|||.+....... ...+|+.|+|||++.+...++.++|||||||++|+|++|.+|+......
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred cccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 23479999999998654332 3458999999999976555678999999999999999999877554322
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+.+. .. ..++..+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 238 ---~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 ---HEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp ---HHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred ---HHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222210 00 01234579999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=357.93 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=199.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCC--CceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 102 (374)
..+|++.+.||+|+||+||+|.+ .+++.||||++.... ....+|+.+++.++| +||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 45899999999999999999987 568999999986432 223579999999987 99999999884 34
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeecccc
Confidence 45899999888888888763 4679999999999999999999999 7999999999999997 567999999999
Q ss_pred cccccCCC---cceeeeeccccchhhhhC----------CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 017270 183 KQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 248 (374)
Q Consensus 183 ~~~~~~~~---~~~~~~t~~y~aPE~l~~----------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~ 248 (374)
........ .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 86544322 234678999999999853 245789999999999999999999999875432 3333222
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.. . . ...++...++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 235 ~~---~------------~------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 235 DP---N------------H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CT---T------------S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cC---C------------c------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 20 0 0 0112334678999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=362.99 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=199.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC--CCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 103 (374)
.+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+++.++ ||||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 469999999999999999999764 8999999986543 23357999999997 5999999998843 33
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 4899999877888887763 4578999999999999999999999 7999999999999996 5679999999998
Q ss_pred ccccCCC---cceeeeeccccchhhhhCC----------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH
Q 017270 184 QLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 249 (374)
Q Consensus 184 ~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~ 249 (374)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..++.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 6543322 2346789999999998641 3588999999999999999999999987543 333333332
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.. .... ++...++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 283 ~~---------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 283 PN---------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp TT---------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred cc---------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 10 0011 22335789999999999999999999999999999986443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=360.19 Aligned_cols=277 Identities=20% Similarity=0.297 Sum_probs=208.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 468999999999999999999999999999999986432 2335899999999999999999987543 22347
Q ss_pred EEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE----cCCCCcEEEEeec
Q 017270 106 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 180 (374)
Q Consensus 106 ~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll----~~~~~~ikl~Dfg 180 (374)
++||||++ ++|.+.+... .....+++..++.++.||+.||+|||+ +||+||||||+|||+ +. .+.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEEccCC
Confidence 89999998 5777777643 233449999999999999999999999 799999999999998 53 6679999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhC-------CCCCCCchhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 249 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~ 249 (374)
++.............+|+.|+|||++.. ...++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987766655566788999999999852 3458999999999999999999999997543 2334444443
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
.........+........++ .. .-+....+...+++.+.+||.+||++||++|||++|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDW--SG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEE--ES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCcccc--Cc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21111101000000000000 00 000111122345678999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=354.16 Aligned_cols=283 Identities=27% Similarity=0.490 Sum_probs=219.8
Q ss_pred cccceeeeeeeecCCCceEEEEEE-CCCCcEEEEEEeeccc---cchHHHHHHHHhcCCC------ceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ....+|+.+++.++|+ +++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--- 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--- 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence 446999999999999999999998 5678999999986543 2345788899888665 48999888843
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC---------
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 170 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--------- 170 (374)
...+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 89 --~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 --HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred --CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCc
Confidence 3358999999988998888642 23468999999999999999999999 799999999999999853
Q ss_pred ---------CCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH
Q 017270 171 ---------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241 (374)
Q Consensus 171 ---------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 241 (374)
++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 44699999999975432 23456789999999999654 5899999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcC-C---cCCCCCCCC---------CCChhh--hcccCCChhHHHHHHhhcCcCCCCC
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPN-Y---TDFRFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLR 306 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R 306 (374)
+....+.+..+..+...+...... + ....+.... ..++.. ......++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 888888888887776655432210 0 000000000 000000 0011235679999999999999999
Q ss_pred CCHHHHhcCCccccccC
Q 017270 307 CTALEACAHPFFDELRE 323 (374)
Q Consensus 307 ~s~~e~l~hp~~~~~~~ 323 (374)
||+.|+++||||+.++.
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 99999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=355.51 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=204.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeeec
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFST 97 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (374)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 4568999999999999999999999999999999885432 234589999999999999999998732
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC--CcE
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQV 174 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~--~~i 174 (374)
.. +|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ ..+
T Consensus 87 ----~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 87 ----ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ----SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCE
T ss_pred ----Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeE
Confidence 11 7899999985 6666554 45679999999999999999999999 7999999999999998522 249
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhh--CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
||+|||++.............+|+.|+|||++. +...++.++|||||||++|+|++|..||........+...+....
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 999999998665443334567899999999974 345689999999999999999999999987544322222222111
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.. +.......+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 237 ~~------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 237 YN------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CC------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cc------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 10 0111223578999999999999999999999999999999763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=359.61 Aligned_cols=292 Identities=30% Similarity=0.489 Sum_probs=223.6
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcC-----------CCceeeec
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLK 91 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~ 91 (374)
+.+...++|++.+.||+|+||+||+|++..+++.||||++..+. ....+|+.+++.++ |+||++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 34456679999999999999999999999999999999986543 23457888888876 89999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcC-
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDP- 169 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~- 169 (374)
+++.... .+...+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.
T Consensus 93 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEE
T ss_pred HHhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEecc
Confidence 9885433 334568999999988998888753 23569999999999999999999999 8 9999999999999952
Q ss_pred ----CCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC------
Q 017270 170 ----LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------ 239 (374)
Q Consensus 170 ----~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------ 239 (374)
....+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 2347999999999765432 3345789999999999765 48999999999999999999999998654
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcC-------CcCCCCCCCCCCChhhh------cccCCChhHHHHHHhhcCcCCCCC
Q 017270 240 AVDQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQYSPSLR 306 (374)
Q Consensus 240 ~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R 306 (374)
..+.+..+.+.++.++...+...... ............+.... ++..+++++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 55677888888888776554322100 00000111111111111 223456789999999999999999
Q ss_pred CCHHHHhcCCccccccCC
Q 017270 307 CTALEACAHPFFDELREP 324 (374)
Q Consensus 307 ~s~~e~l~hp~~~~~~~~ 324 (374)
||++|+|+||||++....
T Consensus 326 pt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp BCHHHHHTCGGGTTCTTC
T ss_pred CCHHHHhhChhhhcccCc
Confidence 999999999999975443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=351.37 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=211.4
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
...++|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCE
Confidence 34568999999999999999999999999999999986542 23458999999999999999999883 3445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE---cCCCCcEEEEeec
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFG 180 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll---~~~~~~ikl~Dfg 180 (374)
+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||++ +. ++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg 154 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEE-NSKIMITDFG 154 (304)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSST-TCCEEBCSCS
T ss_pred EEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCC-CCCEEEccCC
Confidence 8999999985 77776653 3569999999999999999999999 799999999999999 43 6789999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.+....
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------- 225 (304)
T 2jam_A 155 LSKMEQN-GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE------- 225 (304)
T ss_dssp TTCCCCC-BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-------
T ss_pred cceecCC-CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 9875432 22334568999999999865 45899999999999999999999999988877776666552111
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ ...+...+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 226 ----------~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 ----------F--------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ----------C--------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ----------C--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0 111224578999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=345.34 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=214.3
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
|...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---T 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---G
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---C
Confidence 566789999999999999999999999999999999986432 2345799999999999999999987542 2
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----eEeecCCCCcEEEcCCCCcEE
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-----ivH~dlkp~NIll~~~~~~ik 175 (374)
...+++||||+++ +|.+.+.........+++..++.++.||+.||+|||+ +| |+||||||+||+++. ++.+|
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~k 156 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVK 156 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEE
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEE
Confidence 3458899999985 8888887665556679999999999999999999999 78 999999999999996 78899
Q ss_pred EEeeccccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 176 ICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|+|||++........ .....+|+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 233 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred EecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence 999999976543322 2245679999999999754 489999999999999999999999998877666555544110
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ .++..+++++.++|.+||+.||.+|||++|+++|||+..-
T Consensus 234 -----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -----------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 1223578999999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=365.47 Aligned_cols=266 Identities=14% Similarity=0.123 Sum_probs=188.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhc--CCCceeeeceee-------
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM--DHPNVISLKHCF------- 94 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l--~h~~iv~~~~~~------- 94 (374)
..+|.+.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3469999999999999999999999999999999976432 223565444444 699988855333
Q ss_pred eecCC------------CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHhhcCCCeE
Q 017270 95 FSTTS------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVC 156 (374)
Q Consensus 95 ~~~~~------------~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~------~~i~~qll~al~~LH~~~~iv 156 (374)
..... .....+|+|||||+++|.+.+..... .+.+... ..++.||+.||+|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 21111 01145899999999999998876422 2344444 5667999999999999 7999
Q ss_pred eecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhC-CCCCCCchhhHhHHHHHHHHHhCCCCC
Q 017270 157 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLF 235 (374)
Q Consensus 157 H~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf 235 (374)
||||||+|||++. ++.+||+|||+++.... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus 217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECT-TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECC-CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999996 78899999999985432 2224566799999999964 145899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 236 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 236 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..... ...+............+.......+++.+.+||.+||+.||++|||+.++|+|
T Consensus 294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8764210 00011111111111111111224689999999999999999999999999999
Q ss_pred CccccccC
Q 017270 316 PFFDELRE 323 (374)
Q Consensus 316 p~~~~~~~ 323 (374)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=348.23 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=212.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCC
Confidence 3468999999999999999999999999999999985432 23457999999999999999999884 334
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg 180 (374)
.+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.. +..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 58899999975 77666653 3569999999999999999999999 799999999999999753 2369999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
++.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 242 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----- 242 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 9987655544455678999999999854 389999999999999999999999999887766665544211000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+ ....+++++.+||.+||+.||.+|||+.++++||||++..+
T Consensus 243 ----------~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ----------LP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ----------SG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ----------ch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 00 11347899999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=374.06 Aligned_cols=256 Identities=19% Similarity=0.222 Sum_probs=194.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHH---HHHhcCCCceeeeceeee----
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQ---LMRVMDHPNVISLKHCFF---- 95 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~---~l~~l~h~~iv~~~~~~~---- 95 (374)
..++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+. +++.++|||||++++.+.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3568999999999999999999999999999999986331 23347884 455558999999984332
Q ss_pred ---ecC---------CCCce---EEEEEeecccchHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEe
Q 017270 96 ---STT---------SKNEL---FLNLVMEYVPESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 157 (374)
Q Consensus 96 ---~~~---------~~~~~---~~~lv~e~~~g~l~~~l~~~~~~---~~~l~~~~~~~i~~qll~al~~LH~~~~ivH 157 (374)
... ..+.. ..|+||||++|+|.+.+...... ...+++..++.++.||+.||+|||+ +||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 111 11111 37899999999999888753221 1234568888999999999999999 79999
Q ss_pred ecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCC----------CCCCCchhhHhHHHHHHH
Q 017270 158 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAE 227 (374)
Q Consensus 158 ~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~ 227 (374)
|||||+|||++. ++.+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|+
T Consensus 230 rDikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 230 TYLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp SCCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999996 7889999999998532 23334566 999999999765 258999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC
Q 017270 228 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 307 (374)
Q Consensus 228 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 307 (374)
|++|+.||.+.+.......+. .....+++++.+||.+||+.||.+||
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCC
Confidence 999999997654321111000 01135799999999999999999999
Q ss_pred CHHHHhcCCccccccC
Q 017270 308 TALEACAHPFFDELRE 323 (374)
Q Consensus 308 s~~e~l~hp~~~~~~~ 323 (374)
|+.++++||||+.++.
T Consensus 353 t~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 353 LPLQAMETPEYEQLRT 368 (377)
T ss_dssp CHHHHHTSHHHHHHHH
T ss_pred CHHHHhhChHHHHHHH
Confidence 9999999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=357.20 Aligned_cols=284 Identities=25% Similarity=0.425 Sum_probs=219.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCC-cEEEEEEeeccc---cchHHHHHHHHhcCCCc------eeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRVMDHPN------VISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||+||+|.+..++ +.||+|++.... ....+|+.+++.++|++ ++.+.+++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 4469999999999999999999998877 689999986532 23457899999887655 7888777733
Q ss_pred CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC----------
Q 017270 100 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---------- 169 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~---------- 169 (374)
...+++||||+++++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 94 --~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 --HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred --CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccc
Confidence 3358999999999888877642 23579999999999999999999999 79999999999999932
Q ss_pred --------CCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH
Q 017270 170 --------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241 (374)
Q Consensus 170 --------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 241 (374)
.++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 267899999999975432 23456789999999999654 5899999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcC----CCCCCCC---------CCChhhh--cccCCChhHHHHHHhhcCcCCCCC
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTD----FRFPQIK---------AHPWHKV--FHKRMPPEAIDLASRLLQYSPSLR 306 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R 306 (374)
+.+..+.+..+..+...+......... ..++... ..++... .....+.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 888888888888776655432210000 0000000 0000000 001124588999999999999999
Q ss_pred CCHHHHhcCCccccccCC
Q 017270 307 CTALEACAHPFFDELREP 324 (374)
Q Consensus 307 ~s~~e~l~hp~~~~~~~~ 324 (374)
||+.|+|+||||+.+...
T Consensus 326 pt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CCHHHHTTSGGGGGCCHH
T ss_pred cCHHHHhcChhhcCCChh
Confidence 999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=352.19 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=208.6
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 345689999999999999999999999999999999865421 2347888899999999999999885443 22
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....|+||||++ ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg 161 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCS
T ss_pred CcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeecc
Confidence 345689999997 477777653 3579999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240 (311)
T ss_dssp CC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence 9976543322 2235689999999999764 5899999999999999999999999998877766665552221111
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 241 -------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 -------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 112357999999999999999999999999999999986543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=345.65 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=207.1
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----Ce
Confidence 45678999999999999999999999999999999885432 2345799999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+++||||+++ +|...+.. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence 8899999986 56555543 34679999999999999999999999 79999999999999996 7789999999875
Q ss_pred ccccC-CCcceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~-~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
..... .......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---- 241 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence 43221 1223457899999999984 34458999999999999999999999999888776666554421100
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...+..++..+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus 242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 001234788999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=359.53 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=204.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhc-CCCceeeeceeeee
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFS 96 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 96 (374)
...++|++.+.||+|+||+||+|++. .+++.||||++.+.. ....+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999985 589999999885321 2334799999999 69999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
...+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 131 -----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~k 199 (355)
T 1vzo_A 131 -----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVV 199 (355)
T ss_dssp -----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEE
T ss_pred -----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcEE
Confidence 3348899999985 77777653 3569999999999999999999999 79999999999999996 78899
Q ss_pred EEeeccccccccCC--CcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChH----HHHHHHH
Q 017270 176 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEII 248 (374)
Q Consensus 176 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~----~~~~~i~ 248 (374)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... .....+.
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99999998654322 22345789999999999653 34789999999999999999999999754322 2222222
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccC
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 323 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~ 323 (374)
. .. ..++..+++.+.+||.+||+.||.+|| |++++++||||+.+.+
T Consensus 280 ~--~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 280 K--SE---------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp H--CC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred c--cC---------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 1 00 012345789999999999999999999 9999999999998765
Q ss_pred C
Q 017270 324 P 324 (374)
Q Consensus 324 ~ 324 (374)
.
T Consensus 331 ~ 331 (355)
T 1vzo_A 331 D 331 (355)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=347.52 Aligned_cols=264 Identities=24% Similarity=0.388 Sum_probs=207.8
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhc-CCCceeeeceeeeecCCC-C
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-N 101 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~-~ 101 (374)
.+...++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+ +||||+++++++...... .
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 344567999999999999999999999999999999988543 23445899999998 799999999998654321 1
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg 174 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFG 174 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCT
T ss_pred cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCc
Confidence 3468899999986 888777643 23568999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++....... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||........+..+.... .+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~- 252 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-AP- 252 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cc-
Confidence 987654322 2334578999999999852 3457899999999999999999999998887766555443310 00
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
......+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus 253 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 -------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123478999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=344.17 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=206.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++... ..+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEE
Confidence 4568999999999999999999999999999999986543 3346899999999999999999988543 34889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhhh
Confidence 9999986 77776652 35679999999999999999999999 79999999999999996 7789999999997654
Q ss_pred cCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+..... +
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------- 243 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P----------- 243 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------
T ss_pred hhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-----------
Confidence 432 23345789999999998654 589999999999999999999999998876655544333100 0
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+ ..+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 244 --~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 --TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00 01234688999999999999999999999999999998643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.97 Aligned_cols=267 Identities=22% Similarity=0.354 Sum_probs=186.8
Q ss_pred Cccccceeeee-eeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 28 PKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 28 p~~~~~y~i~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
....++|.+.+ .||+|+||+||+|.+..+|+.||||++........+....++.++||||+++++++.... .+...++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 102 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLL 102 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEE
Confidence 34567999965 699999999999999999999999999766555445555677889999999999885432 3356689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeecccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg~a~ 183 (374)
+|||||.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++.+ ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999986 887777642 23579999999999999999999999 799999999999999752 3459999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 247 (336)
T 3fhr_A 180 ETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---------- 247 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----------
Confidence 54432 2335677999999999854 45889999999999999999999999776543322111110000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
....++ ......+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 248 ---~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 ---GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000000 01123579999999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=349.79 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=192.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|++.+.||+|+||+||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----E 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----C
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----C
Confidence 3468999999999999999999999999999999875432 23347888999999999999999885433 3
Q ss_pred EEEEeeccc-chHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~----~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.++||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEec
Confidence 889999997 477777764322 24569999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCC------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 017270 180 GSAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253 (374)
Q Consensus 180 g~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 253 (374)
|++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987554321 1234568999999999865445899999999999999999999999887765554433321100
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. .............+++++.+||.+||+.||.+|||+.++++||||++.+..
T Consensus 246 ~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 246 S-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp C-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred c-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 0 000000111234578999999999999999999999999999999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=359.65 Aligned_cols=282 Identities=25% Similarity=0.412 Sum_probs=207.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence 3568999999999999999999999999999999986542 234579999999999999999998854 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
+++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCCC
Confidence 8899999985 77777753 3569999999999999999999998 5 8999999999999996 778999999998
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhh
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 261 (374)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +.........
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 754322 23346789999999999654 58999999999999999999999999877655433221111 1110000000
Q ss_pred cC--cCCcCCCCCCCCC------------CChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 262 MN--PNYTDFRFPQIKA------------HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~--~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.. .....+....... ..........+++++.+||.+||++||++|||++|+|+||||+.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 00 0000000000000 000011123478899999999999999999999999999999986544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=347.84 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=192.3
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.....++|++.+.||+|+||.||+|.+..+|+.||||++..... ...++..+++.++||||+++++++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~---- 95 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT---- 95 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----
Confidence 34556799999999999999999999999999999999865432 12234456788899999999998843
Q ss_pred CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
...+++||||+++.+...... ....+++..++.++.||+.||.|||+ + ||+||||||+||+++. ++.+||+||
T Consensus 96 -~~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~df 169 (318)
T 2dyl_A 96 -NTDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDF 169 (318)
T ss_dssp -SSEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCC
T ss_pred -CCcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEEC
Confidence 345899999997655544432 35679999999999999999999998 6 9999999999999996 778999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhh----CCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~ 254 (374)
|++.............+|+.|+|||++. ....++.++|||||||++|+|++|..||... ...+.+..+.... +
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~ 247 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--P 247 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--C
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--C
Confidence 9997665544445567899999999984 2345789999999999999999999999874 3444444444310 0
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
. .++ ....+++++.+||.+||+.||.+|||++++++||||+++..
T Consensus 248 ~--------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 248 P--------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp C--------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred C--------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 0 000 01247899999999999999999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=342.89 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=209.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 357999999999999999999999999999999986432 334579999999999999999998854 3348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+++ +|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeeccccee
Confidence 899999986 6666553 3579999999999999999999999 79999999999999996 78899999999976
Q ss_pred cccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.+. .+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 236 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP--------- 236 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC---------
T ss_pred cCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC---------
Confidence 54433 2234678999999999965 45899999999999999999999999988776655544331 00
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..+...+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01233578999999999999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=349.15 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=205.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcC--CCceeeeceeeee
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFS 96 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 96 (374)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++ |+||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 45678999999999999999999999999999999986432 23447999999996 599999999884
Q ss_pred cCCCCceEEEEEeeccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcE
Q 017270 97 TTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 174 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~--g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~i 174 (374)
.....++|||++. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence 3345889999997 577777763 3579999999999999999999999 7999999999999998547899
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|||++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||..... +.. +.
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~- 259 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ- 259 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC-
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc-
Confidence 99999999865432 233467899999999987665457899999999999999999999965321 111 00
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..++..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus 260 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 --------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 002345799999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=339.99 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=204.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 4568999999999999999999999999999999885432 2335799999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+||||++| +|.+.+.. ..++++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 157 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGI 157 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCSS
T ss_pred CeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCCC
Confidence 458999999986 77777653 3579999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 182 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 182 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+........ .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+......+.+... .+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~----- 230 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP----- 230 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC-----
T ss_pred ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC-----
Confidence 986543322 2345689999999999764 48999999999999999999999999888766554444311 11
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.....+...+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus 231 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 ------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111223446899999999999999999999766666677765443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=340.23 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=200.9
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
+|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 3444459999999999999999999999999886543 234579999999999999999998843 3358899
Q ss_pred eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||++ ++|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99997 4777766542 223457899999999999999999999 79999999999999986577899999999986543
Q ss_pred CC-CcceeeeeccccchhhhhCC-CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 188 GE-ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 188 ~~-~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. ......+|+.|+|||++.+. ..++.++||||||+++|+|++|..||..................
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 243 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------ 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence 22 23345789999999998643 23789999999999999999999999765433221111111110
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
...++..+++++.+||.+||+.||++|||++++++||||+...
T Consensus 244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0112345799999999999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=339.39 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=199.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCC-------
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTS------- 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------- 99 (374)
..++|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3568999999999999999999999999999999986543 234579999999999999999998754321
Q ss_pred -CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 100 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 100 -~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....+|+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEe
Confidence 345678999999985 88877764 34568889999999999999999999 79999999999999996 7789999
Q ss_pred eeccccccccC---------------CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-H
Q 017270 178 DFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-V 241 (374)
Q Consensus 178 Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~ 241 (374)
|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++ ||..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999765321 122345689999999999766568999999999999999998 5543322 2
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.....+... . ..+ ...+....++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 236 ~~~~~~~~~-~----------------~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 236 NILKKLRSV-S----------------IEF--------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHST-T----------------CCC--------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHhcccc-c----------------ccc--------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 222222110 0 001 11133456788999999999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=363.03 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=192.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEEe
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
.+|.+.+.||+|+||+|+. ....+|+.||||++..+. ....+|+.+++.+ +|||||++++++. +...+|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEE
Confidence 3799999999999999763 445689999999986543 4467899999999 7999999998883 344589999
Q ss_pred ecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC----CCcEEEEeecccccc
Q 017270 110 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQL 185 (374)
Q Consensus 110 e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~----~~~ikl~Dfg~a~~~ 185 (374)
|||+|+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.. ...+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999998888864 23345555677899999999999999 799999999999999531 236889999999866
Q ss_pred ccCC----CcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 186 IAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 186 ~~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......... .+. +...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~--- 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS--- 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC---
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC---
Confidence 5432 2234678999999999864 3456889999999999999999 99999765433221 111 1100
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.+... .....+..+.+||.+||+.||.+|||++++++||||..+.
T Consensus 247 ------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 247 ------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp ------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000 0012356789999999999999999999999999997653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=347.03 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=187.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+. +++.++||||+++++++.. ..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence 34689999999999999999999999999999999865421 1123444 6677899999999998843 33
Q ss_pred EEEEEeecccchHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCC-CeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~-~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++||||+.++|.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCC
Confidence 5889999999988877764322 35779999999999999999999999 8 9999999999999996 78999999999
Q ss_pred ccccccCCCcceeeeeccccchhhhh---CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 257 (374)
+.............+|+.|+|||++. ....++.++|||||||++|+|++|..||...... +.+..+..
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------- 244 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK-------- 244 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--------
Confidence 98765544444557899999999983 2345899999999999999999999999865422 11100000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
...+ .+.......+++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus 245 -----------~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 245 -----------GDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp -----------SCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred -----------CCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 0000 1111122357899999999999999999999999999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=348.17 Aligned_cols=274 Identities=20% Similarity=0.331 Sum_probs=207.0
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------------------cchHHHHHHHHhcCCCce
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRVMDHPNV 87 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------------------~~~~~e~~~l~~l~h~~i 87 (374)
...++|++.+.||+|+||.||+|.+ +++.||+|.+.... ....+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4567999999999999999999998 89999999985431 345689999999999999
Q ss_pred eeeceeeeecCCCCceEEEEEeecccc-hHHHHHHhh--hhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCC
Q 017270 88 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 162 (374)
Q Consensus 88 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~--~~~--~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp 162 (374)
+++++++.. ...+++||||+++ +|.+.+... ... ...+++..++.++.||+.||.|||+.+||+||||||
T Consensus 106 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred ceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 999999843 3458999999986 555441100 112 577999999999999999999999723999999999
Q ss_pred CcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCC-chhhHhHHHHHHHHHhCCCCCCCCCh-
Q 017270 163 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA- 240 (374)
Q Consensus 163 ~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~~DiwslGvil~~ll~g~~pf~~~~~- 240 (374)
+||+++. ++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||.....
T Consensus 181 ~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 181 SNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred HhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999996 778999999999865433 3345678999999999976534555 99999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+....+.......+. ....+..+ ... .........+++++.+||.+||+.||.+|||++|+++||||++
T Consensus 259 ~~~~~~i~~~~~~~~~--------~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYPL--------DRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCCC--------SSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCcc--------chhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 4444443321000000 00000000 000 0011122468999999999999999999999999999999987
Q ss_pred c
Q 017270 321 L 321 (374)
Q Consensus 321 ~ 321 (374)
.
T Consensus 329 ~ 329 (348)
T 2pml_X 329 T 329 (348)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=340.86 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=195.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
...+|++.+.||+|+||+||+|++ +|+.||+|++..... ...+|+.+++.++||||+++++++.. ..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 346899999999999999999987 688999998865432 23479999999999999999998843 33
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
.+++||||+.+ +|.+.+.... ....+++..++.++.||+.||+|||+ +| |+||||||+||+++. ++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCC
Confidence 48899999985 7777775321 12249999999999999999999999 79 999999999999996 7889999999
Q ss_pred cccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 181 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 181 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----- 258 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----- 258 (309)
T ss_dssp -----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred CCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence 997543332 23356789999999999654 58999999999999999999999999888776655543311110
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCccc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFD 319 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~ 319 (374)
.++..+++++.+||.+||+.||.+|||+.++++ +++++
T Consensus 259 ----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 259 ----------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 123458999999999999999999999999986 44444
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=340.48 Aligned_cols=249 Identities=19% Similarity=0.216 Sum_probs=200.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.+ +||||+++++++.. ....+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccE
Confidence 446899999999999999999999999999999988643 33467899999999 99999999998844 33588
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc-----EEEEeecc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGS 181 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~-----ikl~Dfg~ 181 (374)
+||||++++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|||+
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCTT
T ss_pred EEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEccc
Confidence 99999987888887642 4679999999999999999999999 79999999999999985 555 99999999
Q ss_pred ccccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Q 017270 182 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKV 250 (374)
Q Consensus 182 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~ 250 (374)
++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+ ..+.+..+...
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 986544322 235678999999999965 458999999999999999999999998743 33344444332
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+... .....+ ++.++|.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111110 112244 9999999999999999999988764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=338.70 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=197.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcC--CCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 101 (374)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++ |+||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence 4468999999999999999999975 58899999986432 23357999999997 599999999884 3
Q ss_pred ceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 102 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 102 ~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...+++|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ ++.+||+|||+
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccc
Confidence 345899999888888888763 4578999999999999999999999 7999999999999997 47899999999
Q ss_pred ccccccCCC---cceeeeeccccchhhhhCC----------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 017270 182 AKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEI 247 (374)
Q Consensus 182 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i 247 (374)
+........ .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 986543322 2345689999999998541 3578899999999999999999999987543 2233222
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.... .. ..++...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 253 ~~~~---------------~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 253 IDPN---------------HE------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HCTT---------------SC------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred Hhcc---------------cc------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 2200 00 012234688999999999999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=332.26 Aligned_cols=250 Identities=18% Similarity=0.218 Sum_probs=203.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.+ +|+|++++++++. .....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeE
Confidence 456899999999999999999999999999999988543 34556899999999 7999999998873 334588
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc-----EEEEeecc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGS 181 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~-----ikl~Dfg~ 181 (374)
+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++. +||+|||+
T Consensus 83 lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred EEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence 9999998888888764 34569999999999999999999999 79999999999999975 443 99999999
Q ss_pred ccccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHH
Q 017270 182 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKV 250 (374)
Q Consensus 182 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~ 250 (374)
+........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 986544322 2345789999999998654 5899999999999999999999999874 334444444432
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+.... +...+++++.+||.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22121111 12357999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=348.16 Aligned_cols=255 Identities=18% Similarity=0.219 Sum_probs=204.9
Q ss_pred ccceeeeeeeecCCCceEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||+||+|. +..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 4689999999999999999999 45577899999985432 234479999999999999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcE
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQV 174 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~i 174 (374)
....++|||||.+ +|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +..+
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence 3347899999974 88888875432 22469999999999999999999999 799999999999999842 3359
Q ss_pred EEEeeccccccccC---CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 017270 175 KICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 250 (374)
Q Consensus 175 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~ 250 (374)
||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999754322 222345678999999998654 58999999999999999998 99999998877766655542
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...+ .+..+++.+.+||.+||+.||.+|||+.++++|.++-.
T Consensus 303 ~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1100 12357899999999999999999999999999988753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=339.39 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=200.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++.+.||+|+||+||+|.+..+++ .||||++.... ....+|+.+++.++||||+++++++ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 45689999999999999999999986655 49999986532 2345799999999999999999998 34
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....|+||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCCC
Confidence 4458899999975 77777653 34679999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 274 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP- 274 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-
Confidence 99865443221 123447789999999654 48999999999999999999 999999988877766655421111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12357899999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.41 Aligned_cols=255 Identities=24% Similarity=0.432 Sum_probs=202.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ...
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----Cee
Confidence 3569999999999999999999999999999999885432 2345799999999999999999998543 348
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeeccccee
Confidence 899999986 77777763 35679999999999999999999999 79999999999999996 78899999999976
Q ss_pred cccCCCc---------------ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017270 185 LIAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 185 ~~~~~~~---------------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 249 (374)
....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~----- 231 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----- 231 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----
Confidence 5432221 14578999999999965 45899999999999999999999998754211000
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.............+..+++.+.+||.+||+.||++|||+.++++ |++.++.
T Consensus 232 ---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 232 ---------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp ---------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred ---------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 00000000111123468899999999999999999999999986 7766543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.58 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=200.8
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
.++|.+.+.||+|+||+||+|++. .++..||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468999999999999999999975 345679999986542 2345799999999 8999999999883
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
....+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N 233 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN 233 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence 33348899999985 88888765321 23468999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
||++. ++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 234 Ill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99996 78899999999986543322 2234567899999999764 58999999999999999999 9999998776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+....+..... ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 312 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 655544433100 01223578999999999999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.08 Aligned_cols=246 Identities=19% Similarity=0.311 Sum_probs=202.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 3468999999999999999999976 57789999986543 33458999999999999999999883 334488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEeccccccccc
Confidence 99999985 67776653 34569999999999999999999999 79999999999999986 778999999999754
Q ss_pred ccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------- 226 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------
Confidence 3321 12234557789999999654 48999999999999999999 99999998887776665442111
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++.+.+++.+||+.||.+|||+.++++|
T Consensus 227 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0123468999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=333.65 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=209.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecC-----------
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT----------- 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------- 98 (374)
...+|++.+.||+|+||.||+|.+..+++.||+|.+........+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 346899999999999999999999999999999999877777889999999999999999999874311
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
......+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEEC
Confidence 1234568999999996 888877643 24579999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.... .....+..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~-------- 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD-------- 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--------
T ss_pred cchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--------
Confidence 99999876655555566789999999999654 58999999999999999999998874211 11111111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..++..+++.+.+||.+||+.||.+|||+.|+++|++.-.
T Consensus 234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0012347889999999999999999999999999988753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=340.54 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=197.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhc----CCCceeeeceee
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVM----DHPNVISLKHCF 94 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l----~h~~iv~~~~~~ 94 (374)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999999999999999985432 2334699999998 899999999988
Q ss_pred eecCCCCceEEEEEeec-cc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC
Q 017270 95 FSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172 (374)
Q Consensus 95 ~~~~~~~~~~~~lv~e~-~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~ 172 (374)
. .....++|||+ +. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++..++
T Consensus 108 ~-----~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 108 E-----TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT
T ss_pred e-----cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC
Confidence 3 33447899998 55 577777764 3569999999999999999999999 79999999999999984478
Q ss_pred cEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 173 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 173 ~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
.+||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.... .+...
T Consensus 178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-- 248 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-- 248 (312)
T ss_dssp EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence 8999999999865433 33456789999999998765544568999999999999999999997532 11110
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.. .++..+++++.+||.+||+.||++|||++|+++||||+.....
T Consensus 249 ---------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 249 ---------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp ---------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred ---------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 00 0224578999999999999999999999999999999875443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.68 Aligned_cols=259 Identities=30% Similarity=0.432 Sum_probs=191.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhc-CCCceeeeceeeeecCCCCceEEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++..+. ....+|+.+++.+ +||||+++++++ .....+|+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv 87 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA 87 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence 346788899999999999875 45689999999886543 2345799999876 899999999887 344568999
Q ss_pred eecccchHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC------------CCc
Q 017270 109 MEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------------THQ 173 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~---l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~------------~~~ 173 (374)
||||+|+|.+.+......... .++..++.++.||+.||+|||+ +||+||||||+|||++.. +..
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceE
Confidence 999999998888753222111 1333467899999999999999 799999999999999742 347
Q ss_pred EEEEeeccccccccCCC-----cceeeeeccccchhhhhC------CCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChH
Q 017270 174 VKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 241 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~ 241 (374)
+||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654322 124578999999999864 2458999999999999999999 99999766443
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
. ..+.... +..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2 2222210 0111100 0011235688999999999999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=337.47 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=189.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...++|++.+.||+|+||+||+|.+..++. .||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999887765 79999885432 234579999999999999999998855433
Q ss_pred CC-ceEEEEEeecccc-hHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 100 KN-ELFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 100 ~~-~~~~~lv~e~~~g-~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
.+ ....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~k 177 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVC 177 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEE
Confidence 21 1234899999986 77777754332 22369999999999999999999999 79999999999999996 78899
Q ss_pred EEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017270 176 ICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 251 (374)
|+|||++......... ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999865443221 234457789999998654 58999999999999999999 999999888776666554421
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-------HHHHhcCCccccc
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDEL 321 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-------~~e~l~hp~~~~~ 321 (374)
.. ..+..+++++.+||.+||+.||.+||| +++++.|||+...
T Consensus 257 ~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CC----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 10 012357899999999999999999999 7788999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=339.77 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=202.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEE--EEEEeecc-----ccchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----
Confidence 44579999999999999999999999888865 99988542 23345799999999 89999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
...+++||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||++
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 175 (327)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred -CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence 3458999999975 8888776432 223579999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 246 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~ 246 (374)
+. ++.+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cC-CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 86 778999999999754433333445668899999998654 47999999999999999998 9999998877665544
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+..... ...+..+++++.+||.+||+.||.+|||++++++|
T Consensus 254 ~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 332100 00123478999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.04 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=201.2
Q ss_pred ccceeeeeeeecCCCceEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence 4689999999999999999999 55677899999986532 2345799999999 789999999988432
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc----------------------------------------------------
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA---------------------------------------------------- 126 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~---------------------------------------------------- 126 (374)
...+++|||||.+ +|.+.+......
T Consensus 99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 2337899999985 788877653221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC---cce
Q 017270 127 ----------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 193 (374)
Q Consensus 127 ----------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~ 193 (374)
...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccc
Confidence 1228999999999999999999999 79999999999999996 77899999999986543322 234
Q ss_pred eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCC
Q 017270 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272 (374)
Q Consensus 194 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (374)
..+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.....+.
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 316 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------- 316 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-----------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-----------------
Confidence 5678899999998654 58999999999999999998 9999988765555544444211110
Q ss_pred CCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..+++++.++|.+||+.||.+|||+.|+++|
T Consensus 317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 123478999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=325.70 Aligned_cols=246 Identities=19% Similarity=0.290 Sum_probs=201.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ ......+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 3568999999999999999999865 56789999986543 2345899999999999999999988 3444488
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccceec
Confidence 99999975 67777764 23469999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
...... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------- 224 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence 443221 223456789999999654 48999999999999999999 99999988877766655442110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++.+.++|.+||+.||.+|||+.++++|
T Consensus 225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123468899999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.01 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=186.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcC-CCceeeeceeeeecCC---CCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS---KNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~ 103 (374)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 48999999999999999999999999999999885443 23357899999996 9999999998854322 4556
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
.+++||||+.|+|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++. ++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence 689999999999988886532 35679999999999999999999999 79 999999999999996 77899999999
Q ss_pred ccccccCCCc-------------ceeeeeccccchhhhh--CCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017270 182 AKQLIAGEAN-------------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246 (374)
Q Consensus 182 a~~~~~~~~~-------------~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 246 (374)
+......... ....+|+.|+|||++. ....++.++|||||||++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9865433221 1446899999999983 234578899999999999999999999976543221110
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
. ...+ .....++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus 265 ~---------------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---------------------YSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---------------------ccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 0000 11246788999999999999999999999998744
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=341.26 Aligned_cols=257 Identities=15% Similarity=0.142 Sum_probs=195.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-----CcEEEEEEeeccccchHHHHH---------------HHHhcCCCceeeec
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRELQ---------------LMRVMDHPNVISLK 91 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~e~~---------------~l~~l~h~~iv~~~ 91 (374)
++|++.+.||+|+||+||+|.+..+ ++.||||++........+|++ .++.++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998764 588999998766544444444 44556799999999
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc--C
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--P 169 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~--~ 169 (374)
+++.... .+..+.|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9885533 34567899999997788887764 34679999999999999999999999 7999999999999998 4
Q ss_pred CCCcEEEEeeccccccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH
Q 017270 170 LTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 241 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 241 (374)
++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 190 -PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp -TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred -CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 67899999999976543221 1234589999999999654 4899999999999999999999999864332
Q ss_pred HHHHHHHHH-hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 242 DQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 242 ~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
......... ............. ....+++++.+|+.+||+.||.+||+++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222222211 1111111111000 01347899999999999999999999998874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.00 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=200.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++. ....
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence 3468999999999999999999999999999999886432 23457999999999999999999983 3334
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCCCce
Confidence 889999998 577777763 33468999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 184 QLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 184 ~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------ 334 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------ 334 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 54332211 123457789999998654 48999999999999999998 99999988776655444331100
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+++++.+||.+||+.||++|||++++++
T Consensus 335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 022347899999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=339.57 Aligned_cols=267 Identities=23% Similarity=0.264 Sum_probs=196.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|++. ++.||||++..... ...+|+.+++.++||||+++++++..... ....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 368999999999999999999874 78999999865432 23458888999999999999999865432 2445789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC----------CeEeecCCCCcEEEcCCCCcEEE
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------RVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~----------~ivH~dlkp~NIll~~~~~~ikl 176 (374)
|||||++ +|.+.+.. ..+++..++.++.|++.||+|||+ . ||+||||||+|||++. ++.+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeEEE
Confidence 9999985 88777753 459999999999999999999999 8 9999999999999996 788999
Q ss_pred EeeccccccccCCC---cceeeeeccccchhhhhCC----CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017270 177 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 249 (374)
+|||+++....... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976544322 2335789999999999653 2355688999999999999999999976543211111111
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+....+...... ....+. +...+. ...++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH--KKKRPV-----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTT--SCCCCC-----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhc--ccCCCC-----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1222222222111000 000000 000000 123456999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=340.26 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=202.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
.++|.+.+.||+|+||+||+|++..+ +..||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 46899999999999999999997543 3579999886542 2344799999999 9999999999883
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 98 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
....+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N 221 (382)
T 3tt0_A 146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 221 (382)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGG
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcce
Confidence 33348899999985 88888775331 12469999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 222 Ill~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 222 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99996 7889999999998654332 22334568899999999764 58999999999999999999 9999998887
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+....+...... ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6665554431110 0123578999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=328.12 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=201.0
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++|++++..+..+.. .....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence 45679999999999999999999999999999999885433 345689999999999887776665533 233578
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc--CCCCcEEEEeeccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~--~~~~~ikl~Dfg~a~~ 184 (374)
+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++ ..++.+||+|||++..
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999998888888763 34579999999999999999999999 7999999999999994 2367899999999986
Q ss_pred cccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 017270 185 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 253 (374)
Q Consensus 185 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~ 253 (374)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ...+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 554322 2345789999999999654 489999999999999999999999986432 2233333321111
Q ss_pred CCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+. ..+...+++++.+||.+||+.||.+|||++++++
T Consensus 237 ~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred Cch------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111 1122357899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=353.51 Aligned_cols=273 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 458999999999999999999999999999999986432 23358999999999999999999875432 2347
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE----cCCCCcEEEEeec
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 180 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll----~~~~~~ikl~Dfg 180 (374)
++|||||.+ +|.+.+... .....+++..++.++.||+.||+|||+ +||+||||||+|||+ +. ++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEEecCC
Confidence 899999975 777766542 223449999999999999999999999 799999999999998 53 6679999999
Q ss_pred cccccccCCCcceeeeeccccchhhhhCC-------CCCCCchhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 017270 181 SAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 249 (374)
Q Consensus 181 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~ 249 (374)
+++............+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.... ..+.+.++..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99876655555567789999999998541 346789999999999999999999997532 3344444443
Q ss_pred HhCCCCHHHHhhcCc-CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 250 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
+.|. ..+..... ....+.+.. ..+....+...+++.+.++|.+||++||++|||++++++
T Consensus 242 --~~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2221 11110000 000000000 000111122345678899999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=332.31 Aligned_cols=259 Identities=23% Similarity=0.274 Sum_probs=190.2
Q ss_pred EeeccCCCCCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeee
Q 017270 18 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISL 90 (374)
Q Consensus 18 ~~~~~~~~~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~ 90 (374)
++........+...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++
T Consensus 20 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~ 99 (309)
T 2h34_A 20 HMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99 (309)
T ss_dssp --------------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccccccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 3444444455567789999999999999999999999999999999986442 234579999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 91 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
++++.. ...+|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 100 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~ 169 (309)
T 2h34_A 100 HDFGEI-----DGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA 169 (309)
T ss_dssp EEEEEE-----TTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT
T ss_pred EEEEee-----CCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC
Confidence 998844 3348899999985 77777763 3579999999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeeccccccccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017270 170 LTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 247 (374)
Q Consensus 170 ~~~~ikl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i 247 (374)
++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+... +...
T Consensus 170 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~ 246 (309)
T 2h34_A 170 -DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAH 246 (309)
T ss_dssp -TSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHH
T ss_pred -CCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHH
Confidence 7789999999987654332 1234578999999999865 458999999999999999999999998765542 2222
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-CHHHHhc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 314 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-s~~e~l~ 314 (374)
+.. ..+ ....++..+++++.++|.+||+.||.+|| |++++++
T Consensus 247 ~~~-~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 247 INQ-AIP------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHS-CCC------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcc-CCC------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 221 000 01112346899999999999999999999 7777763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=338.44 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=201.8
Q ss_pred cccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|++. .+++.||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence 3478999999999999999999987 345889999986542 234579999999999999999998833
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEee
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 158 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~ 158 (374)
...+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 3348899999985 888887653211 2679999999999999999999999 799999
Q ss_pred cCCCCcEEEcCCCCcEEEEeeccccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCC
Q 017270 159 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 234 (374)
Q Consensus 159 dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~p 234 (374)
||||+||+++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 199 Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999996 7789999999997543322 12345678899999998654 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 235 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 235 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
|.+.+..+....+.+... ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 998887766655543100 0122357899999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=333.41 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=201.1
Q ss_pred cccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...+|.+.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 3568999999999999999999983 455889999986542 23347999999999999999999883
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEee
Q 017270 100 KNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 158 (374)
Q Consensus 100 ~~~~~~~lv~e~~~-g~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~ 158 (374)
.....++||||+. ++|.+.+..... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 3334889999998 588888765332 12458999999999999999999999 799999
Q ss_pred cCCCCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCC
Q 017270 159 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 234 (374)
Q Consensus 159 dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~p 234 (374)
||||+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 175 dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999996 78899999999986544322 1234557889999998654 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 235 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 235 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
|.+.........+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 988776555444332100 0122357999999999999999999999999986
Q ss_pred C
Q 017270 315 H 315 (374)
Q Consensus 315 h 315 (374)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=330.41 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=194.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECC---CCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
...++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 445789999999999999999998765 45689999886432 224579999999999999999999865544
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
.+....++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEE
Confidence 444457899999985 7777765322 234679999999999999999999999 79999999999999996 778999
Q ss_pred EeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 177 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999976543321 223456788999999965 458999999999999999999 9999988877665555443110
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01224578999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=326.30 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=196.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---- 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence 3468999999999999999999999999999999885322 2345799999999999999999987
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCc--
Q 017270 99 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQ-- 173 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~-- 173 (374)
.+.. ++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +| |+||||||+||+++. ++.
T Consensus 93 -~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~~ 164 (287)
T 4f0f_A 93 -HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDENA 164 (287)
T ss_dssp -TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTTC
T ss_pred -cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCCC
Confidence 2222 58999998 577666653 45679999999999999999999999 79 999999999999985 444
Q ss_pred ---EEEEeeccccccccCCCcceeeeeccccchhhhhC-CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 017270 174 ---VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVEI 247 (374)
Q Consensus 174 ---ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~--~~~i 247 (374)
+||+|||++..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||........ ...+
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999974332 3345678999999999843 33468899999999999999999999987653322 2222
Q ss_pred HHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 248 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.. .+. ...++..+++++.+||.+||+.||.+|||++++++
T Consensus 243 ~~-~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE-EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH-SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc-cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22 110 11123457999999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=325.07 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=189.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 46899999999999999999997 48899999885432 23457999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC---eEeecCCCCcEEEcCC-------C
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---VCHRDLKPQNLLVDPL-------T 171 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~---ivH~dlkp~NIll~~~-------~ 171 (374)
...++||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +| |+||||||+||+++.. +
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence 458899999985 5555543 4579999999999999999999999 78 8999999999999852 5
Q ss_pred CcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 017270 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 251 (374)
+.+||+|||++....... .....+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 679999999997554332 2356789999999998654 48999999999999999999999999887766555443310
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
. ...++..+++.+.++|.+||+.||.+|||+.|+++|
T Consensus 231 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 L---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 011234578999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=326.54 Aligned_cols=252 Identities=23% Similarity=0.262 Sum_probs=197.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++|++++..+..+.. .....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceE
Confidence 3457899999999999999999999999999999976433 3456789999999999888877766543 233578
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE---cCCCCcEEEEeecccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll---~~~~~~ikl~Dfg~a~ 183 (374)
+||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||+ +. ++.+||+|||++.
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTCE
T ss_pred EEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCccce
Confidence 9999998888887763 34579999999999999999999999 799999999999999 54 7789999999998
Q ss_pred ccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 017270 184 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG 252 (374)
Q Consensus 184 ~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 252 (374)
....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 6544322 2345789999999999654 4899999999999999999999999875322 22222222111
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+. ......+++++.+||.+||+.||++|||++++++
T Consensus 236 ~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1111 1122357899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.84 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.8
Q ss_pred ccceeeeeeeecCCCceEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||+||+|.+ ..+++.||+|.+.... ....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence 46899999999999999999985 4567899999986543 2345799999999 99999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 3347899999985 88888765321 12358999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
|+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 176 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99996 78899999999986554432 2234568899999998654 58999999999999999999 9999988765
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.......+.....+ ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555444421110 0123478999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.67 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=200.2
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|.+.+.||+|+||+||+|.+. .+++.||+|.+.... ....+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee---
Confidence 468999999999999999999973 456789999985432 2345899999999 89999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeec
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 159 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~d 159 (374)
...+++||||+++ +|.+.+...... ...+++..++.++.||+.||+|||+ +||+|||
T Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 3348899999975 888887643211 1348999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCC
Q 017270 160 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 235 (374)
Q Consensus 160 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf 235 (374)
|||+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus 198 ikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999996 78999999999986544332 2235668899999998654 58999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 236 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 236 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+......+..++.....+ ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8876555555444421100 0123478999999999999999999999999876
Q ss_pred C
Q 017270 316 P 316 (374)
Q Consensus 316 p 316 (374)
.
T Consensus 329 l 329 (344)
T 1rjb_A 329 L 329 (344)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.92 Aligned_cols=255 Identities=14% Similarity=0.121 Sum_probs=191.2
Q ss_pred cceeeeeeeecCCCceEEEEEECC---CCcEEEEEEeeccccc---------------hHHHHHHHHhcCCCceeeecee
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRVMDHPNVISLKHC 93 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~---------------~~~e~~~l~~l~h~~iv~~~~~ 93 (374)
++|++.+.||+|+||+||+|.+.. ++..+|+|++...... ..+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 589999999999999999999987 7889999988654322 2256677788899999999998
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-
Q 017270 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH- 172 (374)
Q Consensus 94 ~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~- 172 (374)
+.... .+....|+||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~ 189 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KNP 189 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SST
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CCC
Confidence 86533 34567899999997787776653 3379999999999999999999999 79999999999999986 44
Q ss_pred -cEEEEeeccccccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHH
Q 017270 173 -QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVD 242 (374)
Q Consensus 173 -~ikl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~ 242 (374)
.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 899999999976533211 1345789999999999764 5899999999999999999999999653 2222
Q ss_pred HHHHHH-HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 243 QLVEII-KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 243 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...... ......+. .+.... -...+++++.+||.+||+.||.+|||++++++
T Consensus 269 ~~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQ-SVLKWA-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTH-HHHHHS-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccH-HHHhhc-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222 21111111 111000 01147899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=326.45 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=204.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...+|++.+.||+|+||+||+|.+..+++.||+|.+..+. ....+|+.+++.++||||+++++++. ....++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCEE
Confidence 4568999999999999999999999999999999986554 23458999999999999999999883 334489
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+. ++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCccceec
Confidence 9999998 5888777642 34569999999999999999999999 79999999999999986 778999999999865
Q ss_pred ccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
..... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 230 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------- 230 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------
Confidence 54332 2234568889999999654 58999999999999999999 9999988776655444433111
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0122357899999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=336.11 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=202.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|++.+.||+|+||+||+|.+ .+++.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCc
Confidence 346899999999999999999984 478999999885432 234689999999999999999999843 334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---CeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---RVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~---~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
.++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ + ||+||||||+|||++. ++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence 7899999985 8888887655556679999999999999999999999 8 9999999999999996 7789999999
Q ss_pred cccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 017270 181 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 254 (374)
Q Consensus 181 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~ 254 (374)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9986543332 2234589999999998654 48999999999999999999999995211 0000111110
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...................+....++.+.+++.+||+.||.+|||+.++++|-.-..
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000011111111111122222334578999999999999999999999998765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.43 Aligned_cols=246 Identities=18% Similarity=0.266 Sum_probs=199.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ .....++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCeE
Confidence 4568999999999999999999875 67789999986543 3345899999999999999999988 3344488
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+. ++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEccccccccc
Confidence 9999997 477777753 23569999999999999999999999 79999999999999996 778999999999755
Q ss_pred ccCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+....+.+.....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 241 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------- 241 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred cccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------
Confidence 3321 11233457889999999654 48999999999999999998 999999988777766655421111
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 242 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 --------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 123468899999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=332.83 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=196.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcE----EEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+..+++. ||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 346899999999999999999999888876 6777663321 23457999999999999999999772
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+ ...++||||+. |+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECCC
Confidence 1 22789999998 577776653 23578999999999999999999999 79999999999999986 788999999
Q ss_pred ccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 180 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 180 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 235 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--- 235 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence 99987644332 2334567789999999654 48999999999999999999 9999998776555444433100
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00122467889999999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=324.67 Aligned_cols=247 Identities=27% Similarity=0.345 Sum_probs=190.1
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 34567999999999999999999998754 4569999875432 234579999999999999999998721
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
...++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D 159 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGD 159 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC
T ss_pred ---CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECc
Confidence 126799999985 77777753 34579999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 179 FGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 179 fg~a~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~-- 236 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-- 236 (281)
T ss_dssp -------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC--
Confidence 9999865443321 234557889999998654 58999999999999999997 99999988776665554431100
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 237 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 237 --------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 022457999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=327.55 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=193.2
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 104 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED---- 104 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence 35578999999999999999999999999999999886421 2234799999999999999999988543
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
..+++||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 105 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg 181 (310)
T 2wqm_A 105 -NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLG 181 (310)
T ss_dssp -TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC-
T ss_pred -CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEecc
Confidence 348899999986 8888887666667789999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHH
Q 017270 181 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 181 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 258 (374)
++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+... ...+...+.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 255 (310)
T 2wqm_A 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----- 255 (310)
T ss_dssp -----------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS-----
T ss_pred ceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC-----
Confidence 9876543322 234578999999999865 4589999999999999999999999976431 1122222211110
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+. .....+++++.+||.+||+.||.+|||+.++++ .++++
T Consensus 256 -------------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l 295 (310)
T 2wqm_A 256 -------------PP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM 295 (310)
T ss_dssp -------------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -------------CC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 00 011347899999999999999999999999985 34444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=329.03 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=193.4
Q ss_pred cccceeeeeeeecCCCceEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...+|++.+.||+|+||+||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++... +
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---H
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 34689999999999999999998 56789999999986543 2345799999999999999999987432 2
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccCc
Confidence 2237899999974 888777642 3459999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||...... ... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~---~~~~~~~ 233 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR---MIGNDKQ 233 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---HHCTTCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---hhcCccc
Confidence 9986543322 1223457789999999654 4899999999999999999999998654221 111 1111100
Q ss_pred H------HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 E------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. ........ . ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 GQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp THHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhcc-C------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000000 0 00123457899999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=330.75 Aligned_cols=259 Identities=24% Similarity=0.297 Sum_probs=208.5
Q ss_pred cccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ...+|+.+++.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 98 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 98 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc----
Confidence 4468999999999999999999876 3578899999864432 2347999999999999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 172 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~ 172 (374)
.....++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++
T Consensus 99 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~-~~ 175 (322)
T 1p4o_A 99 -QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 175 (322)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TC
T ss_pred -cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-CC
Confidence 33347899999985 888877653321 2467999999999999999999999 79999999999999996 78
Q ss_pred cEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017270 173 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 248 (374)
Q Consensus 173 ~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 248 (374)
.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 899999999976543321 2234668899999998654 48999999999999999999 899999887776665554
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC------Ccccccc
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDELR 322 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h------p~~~~~~ 322 (374)
+.... ..+..+++.+.+||.+||+.||.+|||+.++++| |+|+.+.
T Consensus 255 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 255 EGGLL----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp TTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred cCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 31000 0123578999999999999999999999999876 7777655
Q ss_pred CC
Q 017270 323 EP 324 (374)
Q Consensus 323 ~~ 324 (374)
..
T Consensus 307 ~~ 308 (322)
T 1p4o_A 307 FY 308 (322)
T ss_dssp ST
T ss_pred cc
Confidence 44
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=327.91 Aligned_cols=243 Identities=16% Similarity=0.207 Sum_probs=194.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCC-------cEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
..++|++.+.||+|+||+||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 4569999999999999999999998877 469999885443 234579999999999999999999843
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCc----
Q 017270 99 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ---- 173 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~---- 173 (374)
....++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.
T Consensus 84 ---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 155 (289)
T 4fvq_A 84 ---GDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKTG 155 (289)
T ss_dssp ---TTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGGT
T ss_pred ---CCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCccccc
Confidence 333789999998 588777764 23449999999999999999999999 79999999999999986 444
Q ss_pred ----EEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 017270 174 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEII 248 (374)
Q Consensus 174 ----ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~ 248 (374)
+||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+.........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99999999865422 22345788999999997646689999999999999999995 55665555443332222
Q ss_pred HHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 249 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.. ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus 233 ~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 233 DR------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TT------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 00123457889999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=327.45 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=194.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHh--cCCCceeeeceeeeecCCCCceEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...++|++.+.||+|+||+||+|++ +++.||||++..... ...+|.+++.. ++||||+++++++.... .....+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 4567999999999999999999987 789999999865432 23457777766 79999999999875433 345568
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCeEeecCCCCcEEEcCCCCcEEE
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKI 176 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--------~~~~ivH~dlkp~NIll~~~~~~ikl 176 (374)
++||||+++ +|.+.+. ...+++..++.++.||+.||+||| + +||+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEE
Confidence 899999985 7777764 357999999999999999999999 8 79999999999999996 788999
Q ss_pred EeeccccccccCCCc-----ceeeeeccccchhhhhCCC-----CCCCchhhHhHHHHHHHHHhC----------CCCCC
Q 017270 177 CDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLFP 236 (374)
Q Consensus 177 ~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g----------~~pf~ 236 (374)
+|||++......... ....||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999765443322 2347899999999996543 234699999999999999999 88886
Q ss_pred CCC----hHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 017270 237 GEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 312 (374)
Q Consensus 237 ~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~ 312 (374)
... ............+. .+... ...+....++++.+||.+||+.||.+|||+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQ-----------------RPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCC-----------------CCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCCCCcchhhhhHHHhccCC-----------------CCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 532 22222222211010 00000 011222356789999999999999999999999
Q ss_pred hc
Q 017270 313 CA 314 (374)
Q Consensus 313 l~ 314 (374)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=336.25 Aligned_cols=267 Identities=22% Similarity=0.231 Sum_probs=199.3
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
...++|.+.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++. ....
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCe
Confidence 4567999999999999999999995 478999999886443 23457999999999999999999883 3334
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeeccccc
Confidence 8899999985 6665554332333469999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 184 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 184 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........ ....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~- 260 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH- 260 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH-
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc-
Confidence 643322 22345689999999998654 4899999999999999999999999765432111000000 0000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
....+...........+....+..+.+++.+||+.||++|||+.|+++|.
T Consensus 261 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 261 ------NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ------TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00001111111111222234567899999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=330.26 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=200.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|.+.+.||+|+||+||+|.+..+++ .||+|.+.... ....+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence 4689999999999999999999987664 79999886542 2345799999999 89999999998833
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhh----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 168 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~----------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~ 168 (374)
...+++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence 3348899999985 88888765332 14568999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 017270 169 PLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 244 (374)
Q Consensus 169 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~ 244 (374)
. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.......
T Consensus 199 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 N-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp G-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred C-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 6 78899999999986544332 2234568889999998654 48999999999999999998 99999887655555
Q ss_pred HHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 245 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 245 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+......+ ..+...++.+.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5544421111 012346889999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=328.08 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=199.8
Q ss_pred cccceeeeeeeecCCCceEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeee
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 96 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 96 (374)
..++|++.+.||+|+||+||+|++. .+++.||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 3479999999999999999999976 457789999986542 2235799999999 8999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCC
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 163 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~ 163 (374)
....+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~ 186 (334)
T 2pvf_A 112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 186 (334)
T ss_dssp ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccc
Confidence 33348899999985 88887765321 12358999999999999999999999 79999999999
Q ss_pred cEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCC
Q 017270 164 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 239 (374)
Q Consensus 164 NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~ 239 (374)
||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 187 NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999996 78899999999986544322 2234557889999998654 48999999999999999999 999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 240 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 240 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+....+...... ..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76665554442110 0123578999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=323.95 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=193.9
Q ss_pred cceeeeeeeecCCCceEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 469999999999999999999 56789999999986432 3345899999999999999999988543 22
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECcccc
Confidence 348899999985 77777753 34569999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..|+.... .... ...+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~~~~ 246 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--ALFL---KMIGPTHGQ 246 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHH---HHHCSCCGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--hHHh---hccCCcccc
Confidence 986654432 2234567889999998654 47899999999999999999998864321 1111 111111000
Q ss_pred ----HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 ----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+........ ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKEGK------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhccC------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000000 00123458899999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=332.39 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=198.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 358999999999999999999999999999999885432 23457999999999999999999885432 2445688
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcchhc
Confidence 99999996 8888887766667889999999999999999999999 79999999999999986 778999999998754
Q ss_pred ccCCC----------cceeeeeccccchhhhhCCC--CCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 017270 186 IAGEA----------NISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLG 252 (374)
Q Consensus 186 ~~~~~----------~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~ 252 (374)
..... .....+|+.|+|||++.+.. .++.++|||||||++|+|++|..||...... .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 32111 11235689999999985432 2688999999999999999999999531100 001111110
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
....+ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00011 113478999999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=321.26 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=196.9
Q ss_pred CccccceeeeeeeecCCCceEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
....++|.+.+.||+|+||+||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 4456799999999999999999998654 34569999886542 234579999999999999999998732
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
. ..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus 85 --~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D 156 (281)
T 3cc6_A 85 --E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGD 156 (281)
T ss_dssp --S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECC
T ss_pred --C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCc
Confidence 1 25799999984 77777753 34569999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 179 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 179 fg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP- 234 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-
Confidence 999986544322 2234557889999998654 58999999999999999998 999998776665554443311100
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 235 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 ---------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 123478999999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=322.24 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=189.8
Q ss_pred ccccceeee-eeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhcCCCceeeeceeeeecCCCCceEEE
Q 017270 29 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 29 ~~~~~y~i~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+...++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence 455688887 7899999999999999999999999988654 3455788877 6679999999999884322 3356689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeecccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg~a~ 183 (374)
+||||+.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+||+++.. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999985 888877642 33579999999999999999999999 799999999999999853 5679999999986
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... ...++.++|||||||++|+|++|..||.+.........+..
T Consensus 169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------------- 212 (299)
T 3m2w_A 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------- 212 (299)
T ss_dssp ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence 422 13478899999999999999999999977654321110000
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
..... ...+.......+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus 213 ----~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 ----RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ----SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ----HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000 00111112245899999999999999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=329.22 Aligned_cols=256 Identities=18% Similarity=0.214 Sum_probs=200.3
Q ss_pred cccceeeeeeeecCCCceEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence 45699999999999999999999 55678899999985432 234579999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCc
Q 017270 100 KNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQ 173 (374)
Q Consensus 100 ~~~~~~~lv~e~~~-g~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ 173 (374)
....|+||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. .+..
T Consensus 105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 334789999996 588888775322 12458999999999999999999999 79999999999999984 2446
Q ss_pred EEEEeeccccccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017270 174 VKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 174 ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 249 (374)
+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999987543322 12234568899999998654 58999999999999999998 9999998877665554443
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
... + ..+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 261 ~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGR-M---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-C---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 110 0 012357899999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.46 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=192.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|++..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 4468999999999999999999998887654 77766432 22345799999999999999999988431
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
. .++|+||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Df 161 (327)
T 3poz_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEccC
Confidence 1 668888887 577777653 35679999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 180 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 180 g~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~- 239 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP- 239 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-
Confidence 999865443322 233457889999999754 58999999999999999999 999998877655443333211000
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 240 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 ---------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 123468899999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=318.74 Aligned_cols=245 Identities=19% Similarity=0.307 Sum_probs=200.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++.. ...+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence 468999999999999999999976 67889999986543 334589999999999999999998843 334889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccccccc
Confidence 9999985 77777753 34568999999999999999999999 79999999999999986 7789999999997653
Q ss_pred cCC--CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... ......+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---------- 224 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------- 224 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC----------
Confidence 321 11234567889999998654 48999999999999999999 89999988877666655441110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 225 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0123468899999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=347.55 Aligned_cols=253 Identities=20% Similarity=0.203 Sum_probs=191.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCC-Cceeeec---------ee-
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDH-PNVISLK---------HC- 93 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h-~~iv~~~---------~~- 93 (374)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++| +|...+. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 46899999999999999999999999999999886322 233578888888876 2221111 11
Q ss_pred -----------eeecCCCCceEEEEEeecccchHHHHHHhh---hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeec
Q 017270 94 -----------FFSTTSKNELFLNLVMEYVPESMYRVLKHY---SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 159 (374)
Q Consensus 94 -----------~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~---~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~d 159 (374)
+..........++++|+++.++|.+++... ......+++..+..++.||+.||+|||+ +||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 100000112237789999999888877533 2234568888999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhh---------CCCCCCCchhhHhHHHHHHHHHh
Q 017270 160 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELLL 230 (374)
Q Consensus 160 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~---------~~~~~~~~~DiwslGvil~~ll~ 230 (374)
|||+|||++. ++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|+|++
T Consensus 237 iKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999996 778999999998754332 334566 9999999983 33347889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH
Q 017270 231 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 310 (374)
Q Consensus 231 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ 310 (374)
|+.||...+..+....+ +. -...+++++.+||.+||+.||.+|||+.
T Consensus 313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999775432111100 00 0124789999999999999999999999
Q ss_pred HHhcCCcccccc
Q 017270 311 EACAHPFFDELR 322 (374)
Q Consensus 311 e~l~hp~~~~~~ 322 (374)
++++||||+.+.
T Consensus 360 ~~l~~~~~~~~~ 371 (413)
T 3dzo_A 360 QAMETPEYEQLR 371 (413)
T ss_dssp HHTTSHHHHHHH
T ss_pred HHHhCHHHHHHH
Confidence 999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=326.03 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred cccceeeeeeeecCCCceEEEEEE-----CCCCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeecC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTT 98 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 98 (374)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++..... ...+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 356899999999999999999985 35678999999865432 334799999999 689999999987432
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 165 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~------------~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NI 165 (374)
...+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 179 (316)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred ---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceE
Confidence 2347899999985 888777643221 1238999999999999999999999 7999999999999
Q ss_pred EEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChH
Q 017270 166 LVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 241 (374)
Q Consensus 166 ll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~ 241 (374)
+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 180 l~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 180 LLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 9985 77899999999986544332 2235678899999998654 48999999999999999998 99999887654
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 242 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+.+...+.....+ ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444333321110 0123478999999999999999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.69 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=206.6
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
+|...++|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.++|++.+..+..+.. ....
T Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~ 77 (483)
T 3sv0_A 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDY 77 (483)
T ss_dssp CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTE
T ss_pred CCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCE
Confidence 466778999999999999999999999999999999987543 3456689999999988655554444432 2335
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc--CCCCcEEEEeeccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSA 182 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~--~~~~~ikl~Dfg~a 182 (374)
.++||||+.++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||++
T Consensus 78 ~~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 789999998888888764 34679999999999999999999999 7999999999999993 23778999999999
Q ss_pred cccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Q 017270 183 KQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVL 251 (374)
Q Consensus 183 ~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~ 251 (374)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... .+.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 86654332 1256789999999999654 589999999999999999999999987543 33344333321
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh----------cCCccccc
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC----------AHPFFDEL 321 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l----------~hp~~~~~ 321 (374)
.....+ .+...+++++.+||.+||+.||.+||++++++ .++|+..+
T Consensus 233 ~~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~ 288 (483)
T 3sv0_A 233 VATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVF 288 (483)
T ss_dssp HHSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred ccccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCc
Confidence 111111 12235789999999999999999999998765 46776555
Q ss_pred cC
Q 017270 322 RE 323 (374)
Q Consensus 322 ~~ 323 (374)
.|
T Consensus 289 dW 290 (483)
T 3sv0_A 289 DW 290 (483)
T ss_dssp HH
T ss_pred Cc
Confidence 44
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=335.23 Aligned_cols=253 Identities=13% Similarity=0.135 Sum_probs=195.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCC--------CcEEEEEEeeccccchHHHHHHHHhcCCCceeeec------------
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLK------------ 91 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~--------~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~------------ 91 (374)
++|++.+.||+|+||.||+|++..+ ++.||+|.+... ....+|+.+++.++||||++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 5899999999999999999999874 889999988765 4566899999999999999843
Q ss_pred ---eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEc
Q 017270 92 ---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 168 (374)
Q Consensus 92 ---~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~ 168 (374)
+++.. .....|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 33321 23458899999977888888742 23679999999999999999999999 7999999999999999
Q ss_pred CCCC--cEEEEeeccccccccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC
Q 017270 169 PLTH--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 238 (374)
Q Consensus 169 ~~~~--~ikl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~ 238 (374)
. ++ .+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 194 ~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 P-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp T-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred C-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 6 55 899999999976543221 1234789999999998654 5899999999999999999999999876
Q ss_pred C-hHHHHHHHHHHh-CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 239 N-AVDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 239 ~-~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. ....+....... ..+. .+.. .......+++++.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~---------~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG---------PFVG-----------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC---------CEEC-----------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh---------hhhh-----------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 333333322211 1110 0000 00011247899999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=363.27 Aligned_cols=285 Identities=26% Similarity=0.338 Sum_probs=206.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC-CCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 104 (374)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999999999999999886432 234579999999999999999888633111 12445
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC--cEEEEeecc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~--~ikl~Dfg~ 181 (374)
.++|||||+| +|.+.+... .....+++..++.++.||+.||+|||+ +||+||||||+||+++.++. .+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999974 777777642 223468999999999999999999999 79999999999999985322 499999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........... .......+..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCS
T ss_pred ccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhh
Confidence 987766555566788999999999865 458999999999999999999999998765432211100 0000000000
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.........+.. ..+....+...+++.+.+||.+||++||.+|||+.++++||||+.+..
T Consensus 247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000011111111 111122233456789999999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=320.52 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=199.1
Q ss_pred ccceeeee-eeecCCCceEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~---- 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE---- 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence 45787776 9999999999999864 467889999986532 2345799999999999999999987 221
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL 156 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECcccc
Confidence 27899999986 67666642 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
+......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---- 231 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence 9865433221 223457889999998654 48999999999999999998 9999998877665554433100
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
..++..+++++.++|.+||+.||.+|||+.++++|.+
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0123457999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=335.31 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=188.5
Q ss_pred ccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..+|.+.+.||+|+||.||+|++. .++..||||.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 458999999999999999999876 467789999886432 23457999999999999999999883 33
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++||||++ ++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~ 193 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSDFGL 193 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECcCcc
Confidence 34889999997 578777753 34579999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+......+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-- 270 (373)
T ss_dssp --------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC--
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 9865433211 122346789999999654 58999999999999999998 999999888776665544321111
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++.+.+||.+||+.||.+||++.++++
T Consensus 271 --------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 --------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 12247889999999999999999999998875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=317.14 Aligned_cols=246 Identities=18% Similarity=0.248 Sum_probs=198.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...++|++.+.||+|+||+||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PA 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CC
Confidence 3457999999999999999999998 48899999886432 2345788999999999999999988432 12
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEee
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
...++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||+ +| |+||||||+||+++. ++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEec
Confidence 447899999985 88887763 223368999999999999999999999 79 999999999999996 778999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCC--CCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|++..... ....+|+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 158 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 230 (271)
T 3kmu_A 158 DVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--- 230 (271)
T ss_dssp GSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---
T ss_pred cceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---
Confidence 88754222 23567999999999976432 2338999999999999999999999888777666554421111
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.++..+++++.++|.+||+.||.+|||++++++
T Consensus 231 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123458999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=328.24 Aligned_cols=265 Identities=25% Similarity=0.307 Sum_probs=199.2
Q ss_pred ccccceeeeeeeecCCCceEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 445699999999999999999999 56789999999986543 224589999999999999999998753 3
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
+...+++||||++ ++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEccc
Confidence 4455889999996 5777777642 3469999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 180 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 180 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .......+.
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccccccccc
Confidence 99986544332 1234568889999998654 47999999999999999999999997543221100 000000000
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+....... .....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 250 LSRLLELLEEG------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHTT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcc------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000000000 0001234579999999999999999999999999643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=346.76 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=202.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..+|.+.+.||+|+||.||+|.+..++..||||.+..+. ....+|+.+++.++||||+++++++.. ...+|+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEEE
Confidence 457999999999999999999999889999999986543 334589999999999999999999833 334889
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+. |+|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceecc
Confidence 999998 5888877642 33568999999999999999999999 79999999999999986 7889999999998654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 437 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------- 437 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------
T ss_pred CCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 3322 1223456789999999654 48999999999999999999 9999998876655544332110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 438 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 -----------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0123457899999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=337.57 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=197.8
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|++.+.||+|+||.||+|.+ +++.||||++..+. ....+|+.+++.++||||+++++++.... ..+|+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence 346899999999999999999987 47799999986543 33458999999999999999999875432 24889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCccccc
Confidence 9999985 888887642 23347999999999999999999999 79999999999999996 7889999999998543
Q ss_pred cCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------- 404 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 404 (450)
T ss_dssp --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred cc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 22 2233568889999999754 58999999999999999998 9999998776655554433110
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123457999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.46 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=195.2
Q ss_pred ccceeeee-eeecCCCceEEEEE--ECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 31 TISYMAER-VVGTGSFGIVFQAK--CLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~-~lg~G~~g~V~~a~--~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..+|.+.+ .||+|+||+||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 45899998 99999999999995 45668899999886442 2345799999999999999999987 221
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
.+++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 162 (291)
T 1xbb_A 91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFG 162 (291)
T ss_dssp --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccCC
Confidence 2789999998 477777653 4569999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
++......... ....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+..+....+.... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-- 238 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R-- 238 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C--
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--
Confidence 99865443322 123456889999999654 47899999999999999999 999999887766554443310 0
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0022357999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=324.34 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=193.5
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
...+|.+.+.||+|+||+||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 3468999999999999999999987553 359999886432 2234799999999999999999988 3
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
.....++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEECCC
Confidence 34458899999986 77777653 34679999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+....+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 999865433211 123457789999999654 58999999999999999999 999999887766665554321110
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..+++.+.++|.+||+.||.+||++.+++++
T Consensus 271 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123478999999999999999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=327.86 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=190.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
..++|++.+.||+|+||+||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 3468999999999999999999998888765 56655322 22345799999999999999999988432
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
. .++|++|+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 90 --~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~Df 161 (327)
T 3lzb_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp --S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred --C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEccC
Confidence 1 668888887 577777654 34679999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 180 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 180 g~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 239 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP- 239 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 999865433222 234457789999999754 58999999999999999999 999999887665544443311100
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 ---------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12347889999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.46 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=186.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||+||+|++. ..+|+|++.... ....+|+.+++.++||||++++++.. ..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CC
Confidence 3458999999999999999999854 359999885432 23457999999999999999988541 11
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~ 167 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLA 167 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC--
T ss_pred ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEccceec
Confidence 26799999985 66666642 34679999999999999999999999 79999999999999996 789999999999
Q ss_pred cccccC---CCcceeeeeccccchhhhhC--CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 183 KQLIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~---~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
...... .......+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+....+.+..++.....+..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 246 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD- 246 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-
Confidence 754332 12234568999999999852 345788999999999999999999999987766666555543221110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 ----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01122357899999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.65 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=195.6
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
+....+|++.+.||+|+||+||+|.+..++ ..+|+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 97 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR--- 97 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC---
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc---
Confidence 345568999999999999999999976443 358999885432 233479999999999999999998643
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
.....++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus 98 -~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~D 171 (298)
T 3f66_A 98 -SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVAD 171 (298)
T ss_dssp -SSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECS
T ss_pred -CCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECc
Confidence 23347799999986 77777753 34668999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCC-----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 017270 179 FGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 179 fg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
||++....... ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 99997654322 12234567889999999654 58999999999999999999 6778877766555544443111
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 L----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 012347889999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.90 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=192.6
Q ss_pred CccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 28 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 28 p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
....++|++.+.||+|+||+||+|.+ +|+.||+|.+..+. ....+|+.+++.++||||+++++++... ...+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 34457999999999999999999987 58899999986543 2345799999999999999999986432 2347
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
++||||+++ +|.+.+.... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeecccccc
Confidence 899999986 8888776432 2348899999999999999999999 79999999999999996 78899999999875
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+.+..
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------ 231 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------ 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence 4332 2234568899999998654 58999999999999999998 999998876655444332210
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00123457899999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.87 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=199.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|.+.+.||+|+||+||+|.+. ++..||||++.... ....+|+.+++.++||||+++++++. ...+++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~l 259 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYI 259 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccEE
Confidence 468999999999999999999975 46789999986543 23458999999999999999998873 112789
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+. |+|.+.+.... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCceEcC
Confidence 999998 58888876432 2358889999999999999999999 79999999999999996 7889999999998654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------- 405 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------- 405 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---------
T ss_pred CCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 3211 1223457789999999654 58999999999999999999 999999988877776665421111
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++++.+||.+||+.||.+|||+++++.
T Consensus 406 -------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 -------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12357899999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=319.37 Aligned_cols=244 Identities=30% Similarity=0.429 Sum_probs=186.3
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|++.+.||+|+||+||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++. +. .++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence 346899999999999999999987 47889999986543 33458999999999999999998773 22 679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
||||+++ +|.+.+... .....+++..++.++.|++.||+|||+. +||+||||||+||+++.++..+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999985 777777532 1123478999999999999999999983 38999999999999986444589999999975
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 262 (374)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.. +..
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------- 222 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR-------- 222 (307)
T ss_dssp -----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC--------
T ss_pred cccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC--------
Confidence 4322 234568999999999965 45899999999999999999999999764322 11111111 100
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
......+++.+.+||.+||+.||.+|||++++++
T Consensus 223 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 223 ------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122357899999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=325.05 Aligned_cols=277 Identities=23% Similarity=0.313 Sum_probs=192.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-chHHHHHH--HHhcCCCceeeeceeeeecCCCCceEE
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...++|++.+.||+|+||+||+|++ +++.||||++..... ....|.++ +..++||||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4567999999999999999999976 789999999865432 22234444 445899999999987655555666678
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---------CeEeecCCCCcEEEcCCCCcEE
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---------RVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~---------~ivH~dlkp~NIll~~~~~~ik 175 (374)
++|||||++ +|.+.+.. ...++..++.++.||+.||.|||+ + ||+||||||+|||++. ++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcEE
Confidence 999999974 88777753 345889999999999999999999 8 9999999999999996 78899
Q ss_pred EEeeccccccccCC---------CcceeeeeccccchhhhhCC------CCCCCchhhHhHHHHHHHHHhCCCCCCC-CC
Q 017270 176 ICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPG-EN 239 (374)
Q Consensus 176 l~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslGvil~~ll~g~~pf~~-~~ 239 (374)
|+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 11234689999999998652 2356789999999999999999766533 22
Q ss_pred hHHHHHHHH-HHhCCCCHHHHhhcC-cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH-----
Q 017270 240 AVDQLVEII-KVLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA----- 312 (374)
Q Consensus 240 ~~~~~~~i~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~----- 312 (374)
.......+. .....+....+.... .......++.. |. ....+++++.+||.+||+.||++|||+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----CC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----cc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 111000000 011112211111100 00000011100 00 001234579999999999999999999999
Q ss_pred -hcCCcccc
Q 017270 313 -CAHPFFDE 320 (374)
Q Consensus 313 -l~hp~~~~ 320 (374)
+.++|-++
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 45666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=315.18 Aligned_cols=245 Identities=25% Similarity=0.314 Sum_probs=198.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+|+.+++.++||||+++++++.. . ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcE
Confidence 3468999999999999999999965 56789999886543 334589999999999999999988731 1 267
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||+. ++|.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCcccccc
Confidence 9999997 5777766532 12368999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 186 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 186 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
..... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence 44322 1234457789999998654 48999999999999999999 9999998887766655543110
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
...+..+++++.+||.+||+.||++|||++++++
T Consensus 229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0122357899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=315.33 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=196.3
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
.|.....|.+.+.||+|+||+||+|.+..+++ .||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 34555688899999999999999999765554 79999886432 23347999999999999999999884322
Q ss_pred CCCceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
...++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus 96 ----~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~ 166 (298)
T 3pls_A 96 ----GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVA 166 (298)
T ss_dssp ----SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEEC
T ss_pred ----CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeC
Confidence 22479999996 577777653 35678999999999999999999999 79999999999999996 7789999
Q ss_pred eeccccccccCC-----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 017270 178 DFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 251 (374)
Q Consensus 178 Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 251 (374)
|||++....... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence 999997543321 2223456889999999965 458999999999999999999 556666665554444433311
Q ss_pred CCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+ .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 RLP----------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 100 12347899999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=336.57 Aligned_cols=244 Identities=26% Similarity=0.328 Sum_probs=195.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|.+.. +..||||++.... ....+|+.+++.++||||+++++++.. ..+++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence 4689999999999999999999864 4679999986543 234689999999999999999988732 22789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccceecC
Confidence 9999985 888877632 23568999999999999999999999 79999999999999985 7789999999998654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------- 401 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------- 401 (452)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 3322 1234457789999998654 58999999999999999999 999999988777666554321111
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++.+.+||.+||+.||++|||++++++
T Consensus 402 -------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 402 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12357899999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=323.92 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=187.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHhc--CCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM--DHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||+|++. ++.||||++..... ...+|.+++..+ +||||+++++++.... .....+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence 468999999999999999999874 88999999865432 223455555544 8999999999885543 22245889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--------~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEEe
Confidence 9999985 88877753 469999999999999999999998 8 9999999999999996 77899999
Q ss_pred eccccccccCCCc-----ceeeeeccccchhhhhCCCCCCC------chhhHhHHHHHHHHHhC----------CCCCCC
Q 017270 179 FGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLG----------QPLFPG 237 (374)
Q Consensus 179 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~------~~DiwslGvil~~ll~g----------~~pf~~ 237 (374)
||++......... ....||+.|+|||++.+.. +.. ++|||||||++|+|++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999765433222 2457899999999996543 344 39999999999999999 677754
Q ss_pred CC----hHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 238 EN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 238 ~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.. ............... ..++ .......+++++.+||.+||+.||.+|||+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLR--------------PSFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCC--------------CCCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccC--------------cccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 32 122222222110000 0000 0001123567899999999999999999999998
Q ss_pred cC
Q 017270 314 AH 315 (374)
Q Consensus 314 ~h 315 (374)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.85 Aligned_cols=248 Identities=22% Similarity=0.350 Sum_probs=187.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
....|.+.+.||+|+||+||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---- 162 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 162 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence 4457899999999999999999976443 458999885432 2334789999999999999999976432
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
....++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeecc
Confidence 2347799999985 77777753 34568999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 181 SAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 181 ~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+..+....+.+. ..
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~~ 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--CC
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--CC
Confidence 9986543321 1234567889999998654 58999999999999999999 78889876655444443321 00
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123478999999999999999999999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=321.52 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=193.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.|...+.||+|+||+||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence 455669999999999999986 68899999885421 234579999999999999999998843 334
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++||||++ ++|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence 889999997 5777777643 335679999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--CCHHH
Q 017270 184 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREE 258 (374)
Q Consensus 184 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~ 258 (374)
....... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+.+.... +....
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6543322 223568999999999854 4789999999999999999999999876543322222221111 11111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+. . +.. .......++.+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~--~--------~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YI--D--------KKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HS--C--------SSC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hc--c--------ccc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0 000 00112245789999999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=316.09 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-CCc--EEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||+||+|.+.. +++ .||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3589999999999999999998643 333 68999875431 2334799999999999999999988431
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
. .++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 94 --~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df 165 (291)
T 1u46_A 94 --P-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 165 (291)
T ss_dssp --S-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred --C-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence 1 679999998 578777764 23568999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 180 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 180 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+......+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 999866443321 234557789999998654 47899999999999999999 999999888776665554311100
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ .+..+++++.++|.+||+.||.+|||+.++++ +++++
T Consensus 245 -----------------~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~ 282 (291)
T 1u46_A 245 -----------------P----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA 282 (291)
T ss_dssp -----------------C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -----------------C----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence 0 12357899999999999999999999999986 45443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=320.15 Aligned_cols=257 Identities=28% Similarity=0.367 Sum_probs=192.4
Q ss_pred cccce-eeeeeeecCCCceEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 30 QTISY-MAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 30 ~~~~y-~i~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
..++| ++++.||+|+||+||++.. ..+++.||||++..+. ....+|+.+++.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence 33455 9999999999999987753 4578899999986543 2345899999999999999999988553
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
+...+++||||+++ +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~D 177 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGD 177 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred -CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECC
Confidence 23458899999985 77666642 359999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 179 FGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 179 fg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+..
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~ 251 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIA 251 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSC
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhccc
Confidence 999987654432 2234568889999999654 478999999999999999999999975432110 000000
Q ss_pred CHH----HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 255 TRE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 255 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
... .+........ ....+..+++++.+||.+||+.||.+|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGE------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHHhccc------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 0000000000 01123457899999999999999999999999984
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=325.76 Aligned_cols=247 Identities=13% Similarity=0.196 Sum_probs=190.3
Q ss_pred ccceeeeeeeecCCCceEEEE-----EECCCCcEEEEEEeeccc-cchHHHHHHHHhcC---CCceeeeceeeeecCCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 101 (374)
.++|.+.+.||+|+||+||+| .+..+++.||+|++.... ....+|+.+++.++ |+||+++++++....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--- 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--- 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence 468999999999999999999 467789999999986543 33457888888887 899999999885433
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC---------
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 170 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--------- 170 (374)
..|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence 3889999998 588888875443 35679999999999999999999999 799999999999999741
Q ss_pred -CCcEEEEeecccccccc---CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017270 171 -THQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 246 (374)
Q Consensus 171 -~~~ikl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 246 (374)
++.+||+|||+|+.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 57899999999975432 2223456789999999999765 48999999999999999999999996542210
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCc
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 317 (374)
+..... +.. + ..++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus 293 ----------------------~~~~~~----~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 ----------------------CKPEGL----FRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ----------------------EEECSC----CTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ----------------------eeechh----ccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 000000 000 0 13678899999999999999976655554443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.22 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=195.2
Q ss_pred cccceeeeeeeecCCCceEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++... +
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence 44689999999999999999998 46689999999986543 2345899999999999999999987432 2
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CCcEEEecCc
Confidence 2347899999985 88877764 34569999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
++......... ....++..|+|||++.+. .++.++|||||||++|+|++|..||..... .. .+..+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~ 264 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQ 264 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccc
Confidence 99866443321 223457789999998654 478999999999999999999999864321 11 111111110
Q ss_pred H-----HH-hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 E-----EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
. .+ ...... . . ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~-~--~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLKNN-G--R----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHHTT-C--C----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhhcC-C--C----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00 000000 0 0 0122457899999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.69 Aligned_cols=247 Identities=20% Similarity=0.192 Sum_probs=183.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcC---------CCceee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMD---------HPNVIS 89 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~---------h~~iv~ 89 (374)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36899999999999999999998 78999999986542 33468999998886 666655
Q ss_pred ecee-----------------eeecC--------CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHH
Q 017270 90 LKHC-----------------FFSTT--------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 143 (374)
Q Consensus 90 ~~~~-----------------~~~~~--------~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll 143 (374)
+.++ |.... ..+...+|+|||||.+ ++++.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 5544 32200 0123458999999975 3444442 25689999999999999
Q ss_pred HHHHHhh-cCCCeEeecCCCCcEEEcCCCC--------------------cEEEEeeccccccccCCCcceeeeeccccc
Q 017270 144 RGLAYIH-TVPRVCHRDLKPQNLLVDPLTH--------------------QVKICDFGSAKQLIAGEANISYICSRFYRA 202 (374)
Q Consensus 144 ~al~~LH-~~~~ivH~dlkp~NIll~~~~~--------------------~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~a 202 (374)
.||+||| + +||+||||||+|||++. ++ .+||+|||+|+..... ...||+.|+|
T Consensus 172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 9999999 9 79999999999999986 44 8999999999865432 4588999999
Q ss_pred hhhhhCCCCCCCchhhHhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChh
Q 017270 203 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 280 (374)
Q Consensus 203 PE~l~~~~~~~~~~DiwslGvi-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (374)
||++.+.. +.++||||+|++ .++++.|..||....... ....+....... .. . .
T Consensus 246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~---~-~ 301 (336)
T 2vuw_A 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------TK---C-N 301 (336)
T ss_dssp SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------SC---C-C
T ss_pred hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------cc---c-c
Confidence 99996543 889999998777 777888999985422111 122222210100 00 0 0
Q ss_pred hhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh-cCCccc
Q 017270 281 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD 319 (374)
Q Consensus 281 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l-~hp~~~ 319 (374)
......+++++++||++||++| |++|+| +||||+
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1122347889999999999987 999999 999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.99 Aligned_cols=244 Identities=26% Similarity=0.328 Sum_probs=198.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+.+++.++|+||+++++++.. ..+|+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence 4689999999999999999999864 4679999986543 334689999999999999999988732 23789
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
||||+.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceecC
Confidence 9999985 888877642 23568999999999999999999999 79999999999999985 7789999999998654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+.+....+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------- 484 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------- 484 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence 3211 1223457789999998654 58999999999999999999 999999988777666554321110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+..+++.+.+||.+||+.||++|||++++++
T Consensus 485 -------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 485 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12357899999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.26 Aligned_cols=236 Identities=25% Similarity=0.300 Sum_probs=189.9
Q ss_pred eeeecCCCceEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|.+ ..+++.||||++.... ....+|+.+++.++|||||++++++.. . .+++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~-~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C-CEEEEE
Confidence 4899999999999954 4567899999886432 234579999999999999999998721 1 277999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|||.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCccccccC
Confidence 99985 6777765 35679999999999999999999999 79999999999999996 788999999999865443
Q ss_pred CC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 189 EA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 189 ~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.. .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.+....
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 591 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 591 (635)
T ss_dssp ------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred ccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22 1223457889999999654 58999999999999999998 99999998887766655442110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+++++.+||.+||+.||++|||++++++
T Consensus 592 ------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 022357999999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.62 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=196.3
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.....++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+|+.+++.++||||+++++++...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 101 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--- 101 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS---
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---
Confidence 34456799999999999999999998754 49999885321 2345799999999999999999988543
Q ss_pred CceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
..+++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++ ++.+||+||
T Consensus 102 --~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Df 173 (319)
T 2y4i_B 102 --PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDF 173 (319)
T ss_dssp --SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCC
T ss_pred --CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeec
Confidence 338899999984 67666642 34579999999999999999999999 7999999999999998 467999999
Q ss_pred ccccccccC------CCcceeeeeccccchhhhhC--------CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHH
Q 017270 180 GSAKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 245 (374)
Q Consensus 180 g~a~~~~~~------~~~~~~~~t~~y~aPE~l~~--------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~ 245 (374)
|++...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||..........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 998654221 12223457899999999864 2347889999999999999999999999888766655
Q ss_pred HHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 246 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.+....... .....+++++.++|.+||+.||.+|||+.++++ .++.+..
T Consensus 254 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~ 302 (319)
T 2y4i_B 254 QMGTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK 302 (319)
T ss_dssp HHHTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred HhccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence 543311000 011247889999999999999999999999985 4444433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=339.33 Aligned_cols=247 Identities=26% Similarity=0.311 Sum_probs=194.0
Q ss_pred ceeeee-eeecCCCceEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
++.+.+ .||+|+||+||+|.+. .++..||||++.... ....+|+.+++.++|||||++++++.. ..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 455555 8999999999999875 356679999986532 234589999999999999999998742 12
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+++|||||.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccCcc
Confidence 8899999985 67666642 35679999999999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
........ ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+....
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~----- 558 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----- 558 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-----
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 65433221 123346789999999654 58999999999999999998 99999998877766555441100
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh---cCCccc
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFFD 319 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l---~hp~~~ 319 (374)
.++..+++++.+||.+||+.||.+|||+.+++ ++.|+.
T Consensus 559 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 -----------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12345899999999999999999999999874 444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=316.17 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=192.3
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHh--cCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
++|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|+++++. ++||||+++++++.... .....+++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 6899999999999999999987 58999999986543 234578888887 78999999999885433 112358899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--------~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
|||+.+ +|.+.+.. ..+++..++.++.|++.||.||| + +||+||||||+||+++. ++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEEC
Confidence 999986 88877753 46999999999999999999999 8 79999999999999996 778999999
Q ss_pred ccccccccCCC-----cceeeeeccccchhhhhCCCC-----CCCchhhHhHHHHHHHHHhC----------CCCCCCCC
Q 017270 180 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 239 (374)
Q Consensus 180 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~-----~~~~~DiwslGvil~~ll~g----------~~pf~~~~ 239 (374)
|++........ .....+|+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99976554432 234578999999999865432 23689999999999999999 78886542
Q ss_pred h----HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 240 A----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 240 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
. ...+...+...... ..++. ......+++.+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~--------------~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLR--------------PNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCC--------------CCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhC--------------CCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 22222221100000 00000 00111245679999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=340.23 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=197.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++.. +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 456899999999999999999998654 4569999875432 234579999999999999999998721 1
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
.+|+||||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DFG 536 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFG 536 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEecC
Confidence 2679999998 577777753 34569999999999999999999999 79999999999999996 7889999999
Q ss_pred cccccccCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 181 SAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 181 ~a~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--- 612 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--- 612 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 99865443222 234457889999999654 58999999999999999997 999999988877766665421110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 613 -------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 -------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22357899999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=298.15 Aligned_cols=232 Identities=15% Similarity=0.055 Sum_probs=178.0
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
+.+...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.++..++||||+++++++..
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-- 102 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-- 102 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--
Confidence 33345578999999999999999999999999999999986542 234578999999999999999999844
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
....|+||||++| +|.+.+.. . .....+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 103 ---~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~ 171 (286)
T 3uqc_A 103 ---RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLA 171 (286)
T ss_dssp ---TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEEC
T ss_pred ---CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEE
Confidence 3348999999985 77766632 2 3556788899999999999999 79999999999999996 7789987
Q ss_pred eeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 178 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 178 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+++ |++ .++.++|||||||++|+|++|+.||.+.+....+....
T Consensus 172 ~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------- 215 (286)
T 3uqc_A 172 YPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------- 215 (286)
T ss_dssp SCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------
T ss_pred ecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------
Confidence 443 333 26899999999999999999999998765321100000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
.... ........+...+++++.+||.+||+.||.+| |+.|+++ .+..+.
T Consensus 216 ------------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~~ 264 (286)
T 3uqc_A 216 ------------RDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQAT 264 (286)
T ss_dssp ------------BCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHHH
T ss_pred ------------HHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHHh
Confidence 0000 00111122345689999999999999999999 9999986 344443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=342.39 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=195.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECC-CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+|+.+++.++||||+++++++......+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34789999999999999999999976 78999999885432 2234799999999999999999998766554555
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..|+||||++| +|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. +.+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~--~~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE--EQLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS--SCEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC--CcEEEEecccc
Confidence 67999999986 4443332 379999999999999999999999 79999999999999985 37999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~---------- 283 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------G---------- 283 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------S----------
T ss_pred hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------c----------
Confidence 865433 346789999999998653 588999999999999999999988652110 0
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.+. ..+ ....++.+.+||.+||++||.+||+..+++.|+|+.-+
T Consensus 284 --------~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------LPE--DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------CCT--TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------ccc--ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 000 01246789999999999999999999999999998643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-33 Score=275.13 Aligned_cols=179 Identities=19% Similarity=0.088 Sum_probs=123.7
Q ss_pred eeecCCCceEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhc-CCCceeeeceeeeecCCCCce
Q 017270 39 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 39 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (374)
..+.|+.|.+..++....|+.||+|.+.++. ....+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4567777777777777789999999986542 2234799999999 699999999998 5556
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|||||||+| +|.+.+. ..+++++. .|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence 69999999997 7777765 35667764 478999999999999 79999999999999996 788999999999
Q ss_pred cccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCC
Q 017270 183 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 233 (374)
Q Consensus 183 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 233 (374)
+...... ...+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 8665432 3446789999999999865 36788999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-28 Score=234.15 Aligned_cols=179 Identities=17% Similarity=0.211 Sum_probs=133.1
Q ss_pred eeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
...+.||+|+||+||+|. ..++.+++|+..... ....+|+++++.++||||+++..+......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 446799999999999994 467889999764321 123589999999999999955444433222
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
.|+|||||+ ++|.+.+.. +..++.|++.||+|||+ +||+||||||+|||++. .+||+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 579999998 577666542 45789999999999999 79999999999999994 899999999
Q ss_pred ccccccCCC--------cceeeeeccccchhhhhC-CCCCCCchhhHhHHHHHHHHHhCCCCCC
Q 017270 182 AKQLIAGEA--------NISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFP 236 (374)
Q Consensus 182 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~ 236 (374)
++....... ..+..||+.|+|||++.+ ...|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987654322 135678999999999854 1347888999999999988888776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=191.25 Aligned_cols=137 Identities=18% Similarity=0.211 Sum_probs=107.7
Q ss_pred eeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhcCCCceeeece
Q 017270 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLKH 92 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~~ 92 (374)
.+.+.||+|+||.||+|.+ .+|+.||+|.+.... ....+|+.+++.++ | +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3449999999999999999 889999999885321 12458999999999 5 67766
Q ss_pred eeeecCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 93 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 93 ~~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
++.. ...|+||||++| +|.+ +. ......++.|++.||.|||+ +||+||||||+|||++ +
T Consensus 169 ~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~--~ 228 (282)
T 1zar_A 169 VYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS--E 228 (282)
T ss_dssp EEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--T
T ss_pred EEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--C
Confidence 5521 226899999986 5443 21 12345799999999999999 7999999999999999 6
Q ss_pred CcEEEEeeccccccccCCCcceeeeeccccchhhhh
Q 017270 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~ 207 (374)
+.+||+|||+|.. +..+.|||.+.
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 7899999999863 34578999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=169.79 Aligned_cols=135 Identities=19% Similarity=0.239 Sum_probs=102.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcE--EEEEEeeccc----------------------------cchHHHHHHHHhc
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRVM 82 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~----------------------------~~~~~e~~~l~~l 82 (374)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998788999 9999864321 1345799999999
Q ss_pred CCCceeeeceeeeecCCCCceEEEEEeecccc------hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCCe
Q 017270 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRV 155 (374)
Q Consensus 83 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g------~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH-~~~~i 155 (374)
.|+++.. ...+.. ...++||||+++ .|.+.... .++..+..++.|++.||.||| + +||
T Consensus 128 ~~~~i~~-p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSV-PQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCC-CCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCC-CeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 8876421 111211 125799999953 44433211 234567789999999999999 9 799
Q ss_pred EeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 156 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 156 vH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999984 7999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=157.58 Aligned_cols=140 Identities=14% Similarity=0.082 Sum_probs=89.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc------------------hHHHHHHHHhcCCCceeeeceee
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------------------KNRELQLMRVMDHPNVISLKHCF 94 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------~~~e~~~l~~l~h~~iv~~~~~~ 94 (374)
-|.+.+.||+|++|.||+|.+ .+|+.||||++...... ...+.++.....|+|++++++..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 389999999999999999996 47999999986422100 00112222222233333333221
Q ss_pred eecCCC-CceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC-
Q 017270 95 FSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH- 172 (374)
Q Consensus 95 ~~~~~~-~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~- 172 (374)
...... .....++||||++|..+ ... ........++.||+.+|.+||+ +|||||||||.|||++. ++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L---~~l------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~-dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPM---RQV------SSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIRE-EKD 243 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEG---GGC------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEE-EEC
T ss_pred CCCCeeeeccCceEEEEecCCccH---hhh------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeC-CCC
Confidence 110000 00013599999997422 111 1112345788999999999999 79999999999999985 33
Q ss_pred ---------cEEEEeeccccc
Q 017270 173 ---------QVKICDFGSAKQ 184 (374)
Q Consensus 173 ---------~ikl~Dfg~a~~ 184 (374)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.6e-11 Score=107.98 Aligned_cols=136 Identities=15% Similarity=0.090 Sum_probs=99.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
...|.+...++.|+.+.||++.. .++.+++|.... ......+|+.+++.+. +..+.+++++... ....
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 35799999999999999999874 368899998763 2345678999999885 5566677766532 2347
Q ss_pred EEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 017270 106 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------- 152 (374)
Q Consensus 106 ~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------------------------------- 152 (374)
|+|||+++|. +.+.+. +......++.++..+|..||+.
T Consensus 86 ~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 8999999984 332210 1112346777888899999971
Q ss_pred --------------------------CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 --------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 --------------------------~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++|+|++|.||+++. +..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 24899999999999984 5556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.7e-10 Score=99.79 Aligned_cols=134 Identities=14% Similarity=0.062 Sum_probs=90.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhcCCCc--eeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|.+....+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.+ +.+++.+... ....++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEE
Confidence 356665555566779999986 456788999987543 234568999999886544 4446555422 1237899
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------------------------------- 153 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~----------------------------------- 153 (374)
|||++|.... .. ... ...++.++..+|..||+..
T Consensus 94 ~e~i~G~~l~-~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL-SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT-TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC-cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999984222 10 111 1245567777777777621
Q ss_pred ----------------------CeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 154 ----------------------RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 154 ----------------------~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.++|+|++|.||+++. +..+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 2999999999999984 5556699999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.6e-10 Score=101.25 Aligned_cols=141 Identities=16% Similarity=0.172 Sum_probs=98.2
Q ss_pred eeeeeeecCCCceEEEEEECCCCcEEEEEEee--cc-----ccchHHHHHHHHhcCC--CceeeeceeeeecCCCCceEE
Q 017270 35 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 35 ~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~-----~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.-.+.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.+.. ..+++++..+.+.. .....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSC
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCe
Confidence 3467789999999999875 34688899775 22 2355689999999974 34566665542221 11236
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------- 152 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--------------------------------- 152 (374)
|+||||++|... .. ..-..++......++.+++.+|..||+.
T Consensus 117 ~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 799999998421 10 1123467788888899999999999962
Q ss_pred ------------------------CCeEeecCCCCcEEEcCCCC-cEEEEeeccccc
Q 017270 153 ------------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 184 (374)
Q Consensus 153 ------------------------~~ivH~dlkp~NIll~~~~~-~ikl~Dfg~a~~ 184 (374)
..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999986433 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=7.3e-10 Score=99.62 Aligned_cols=185 Identities=16% Similarity=0.201 Sum_probs=108.7
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCceeeeceeeeecC-CCCceEEEEEeeccc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFLNLVMEYVP 113 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~ 113 (374)
.+.++.|....||++. ..+++|..... .....+|..+++.+....-+.+-.++.... .......|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3558999999999763 46899976433 234568999998884322122222221111 111223468999999
Q ss_pred ch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 017270 114 ES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------------- 152 (374)
Q Consensus 114 g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~---------------------------------------- 152 (374)
|. +..... ..++..+...++.|+...+..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 73 221111 2345555566666666666666641
Q ss_pred -----------------CCeEeecCCCCcEEEcCC-CCcEEEEeeccccccccCCCcceee------e---------ecc
Q 017270 153 -----------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYI------C---------SRF 199 (374)
Q Consensus 153 -----------------~~ivH~dlkp~NIll~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~------~---------t~~ 199 (374)
..++|+|++|.||+++.+ +..+.|+||+.+............. + ...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 247999999999999853 3457899999986432211100000 0 001
Q ss_pred ccc-hhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCC
Q 017270 200 YRA-PELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 235 (374)
Q Consensus 200 y~a-PE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf 235 (374)
... |+.... ...-.+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222210 122368999999999999999776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-06 Score=76.31 Aligned_cols=69 Identities=10% Similarity=-0.056 Sum_probs=44.6
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCc---eeeeceeeeecCCCCceEEEEEeec
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
.+.++.|....||++ +..+++|+-... .....+|..+|+.+.+.. +.+.+.+.. . .....++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence 456788988899987 567899975322 134468999999997532 333333221 1 12235699999
Q ss_pred ccc
Q 017270 112 VPE 114 (374)
Q Consensus 112 ~~g 114 (374)
++|
T Consensus 95 i~G 97 (306)
T 3tdw_A 95 VQG 97 (306)
T ss_dssp CCS
T ss_pred cCC
Confidence 997
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.8e-05 Score=69.37 Aligned_cols=130 Identities=15% Similarity=0.140 Sum_probs=79.9
Q ss_pred eecCCCc-eEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhcCC-CceeeeceeeeecCCCCceEEEEEeecccch-
Q 017270 40 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPES- 115 (374)
Q Consensus 40 lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~- 115 (374)
+..|..| .||+......+..+++|.-.... ....+|...|+.+.. -.+.+++.+..+ ....++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence 4445555 69988877677889999765432 234579999988852 224444444422 22477999999973
Q ss_pred HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 017270 116 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 152 (374)
Q Consensus 116 l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~------------------------------------------- 152 (374)
+.+.... .......+..++...|.-||..
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 3332211 0011123334444444444431
Q ss_pred --------------CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 --------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 --------------~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++|+|+.+.||+++. ++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 02789999999999985 5556799999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.2e-05 Score=72.96 Aligned_cols=30 Identities=27% Similarity=0.589 Sum_probs=26.4
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 58999999999999975 5679999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-05 Score=73.70 Aligned_cols=72 Identities=19% Similarity=0.188 Sum_probs=44.7
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhcCC--Cc-eeeeceeeeecCCCC
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDH--PN-VISLKHCFFSTTSKN 101 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~ 101 (374)
-.+.||.|..+.||++....+++.+++|...... .....|..+++.+.. +. +.+++.+ +. +
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~ 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---E 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---T
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---C
Confidence 3567999999999999765567889999754221 123568888887742 33 3344332 21 1
Q ss_pred ceEEEEEeecccc
Q 017270 102 ELFLNLVMEYVPE 114 (374)
Q Consensus 102 ~~~~~lv~e~~~g 114 (374)
. .++|||+++|
T Consensus 109 ~--~~lvmE~l~g 119 (397)
T 2olc_A 109 M--AVTVMEDLSH 119 (397)
T ss_dssp T--TEEEECCCTT
T ss_pred c--cEEEEEeCCC
Confidence 1 4599999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.9e-05 Score=70.92 Aligned_cols=78 Identities=12% Similarity=0.079 Sum_probs=48.6
Q ss_pred eeeeee-ecCCCceEEEEEEC--C----CCcEEEEEEeeccc-------cchHHHHHHHHhcCC---Cceeeeceeeeec
Q 017270 35 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRVMDH---PNVISLKHCFFST 97 (374)
Q Consensus 35 ~i~~~l-g~G~~g~V~~a~~~--~----~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h---~~iv~~~~~~~~~ 97 (374)
...+.| +.|..+.+|++... . ++..+++|...... ....+|..+++.+.. -.+.+++....+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88888999988643 0 25678999765432 345689998888743 2345555443211
Q ss_pred CCCCceEEEEEeecccc
Q 017270 98 TSKNELFLNLVMEYVPE 114 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g 114 (374)
. .....++|||+++|
T Consensus 103 ~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 D--VLGTPFFLMDYVEG 117 (357)
T ss_dssp T--TTSSCEEEEECCCC
T ss_pred C--ccCCceEEEEecCC
Confidence 1 01235689999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00057 Score=60.74 Aligned_cols=65 Identities=15% Similarity=0.098 Sum_probs=40.7
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCce-eeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
.+.|+.|....+|++ ..+++|+..... ....+|..+++.+....+ .+++... .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 678999999999998 468899775432 123578888877743333 3333322 111 24789999
Q ss_pred -cc
Q 017270 113 -PE 114 (374)
Q Consensus 113 -~g 114 (374)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 64
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0014 Score=54.59 Aligned_cols=97 Identities=18% Similarity=0.072 Sum_probs=62.5
Q ss_pred hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcce
Q 017270 115 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 193 (374)
Q Consensus 115 ~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L-H~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~ 193 (374)
+|.++|.. .+.+++++++|.++.|.+.+|.-+ +. +.-..+=+.|..|++.. +|.|.+.+ +.+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWR-DGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEET-TSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEec-CCceeccc-cccc----------
Confidence 67788875 468999999999999999998776 21 11112334568899986 67676553 1110
Q ss_pred eeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh
Q 017270 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 230 (374)
Q Consensus 194 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 230 (374)
.....+.|||... ...+.+.-|+|||+++|..+-
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888752 335788899999999999885
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0027 Score=55.91 Aligned_cols=70 Identities=17% Similarity=0.163 Sum_probs=48.1
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCC---ceeeeceeeeecCCCCceEEE
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHP---NVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..-++.+|.|..+.||++. ..+|+.|++|+-.... .....|+..|+.|... .+.+++.. . . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~--~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---D--D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---E--T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---c--C----ce
Confidence 3456789999999999997 4678999999765432 2346899999988532 23333321 1 1 25
Q ss_pred EEeeccc
Q 017270 107 LVMEYVP 113 (374)
Q Consensus 107 lv~e~~~ 113 (374)
+|||++.
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 8899986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0015 Score=60.98 Aligned_cols=79 Identities=13% Similarity=-0.041 Sum_probs=46.6
Q ss_pred hcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCCcceeee--eccccchhhhhCCCC--CCCchhhHhHHHHH
Q 017270 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATE--YTTSIDIWSAGCVL 225 (374)
Q Consensus 150 H~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~l~~~~~--~~~~~DiwslGvil 225 (374)
+. ..++|+|++|.||+++. ++ +.|+||+.+.............. ...|.+|+....... .....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 68999999999999985 44 99999999864322111111111 234666655421110 11234455777777
Q ss_pred HHHHhC
Q 017270 226 AELLLG 231 (374)
Q Consensus 226 ~~ll~g 231 (374)
|..+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0036 Score=55.90 Aligned_cols=144 Identities=13% Similarity=0.038 Sum_probs=73.1
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeec--cccchHHHHHHHHhcCCCc--eeeeceeeeecCC--CCceEEEEEe
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVM 109 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~ 109 (374)
-.+.|+.|....+|++... +..+++|.... .......|..+++.+.... +.+++... .... ......+++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEE
Confidence 3456788888999998753 33688998865 2334557888887774322 22222110 0000 0012357899
Q ss_pred ecccchH------------HHHH---Hhhhhc-CCC----CCHHHHHHH---------------HHHHHHHHHHhhc---
Q 017270 110 EYVPESM------------YRVL---KHYSSA-NQR----MPLIYVKLY---------------TYQIFRGLAYIHT--- 151 (374)
Q Consensus 110 e~~~g~l------------~~~l---~~~~~~-~~~----l~~~~~~~i---------------~~qll~al~~LH~--- 151 (374)
++++|.. ...+ ...... ..+ ......... ...+...++.+..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998621 0111 111000 000 111000000 0012333444431
Q ss_pred ---CCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 152 ---VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 152 ---~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
..+++|+|+.+.||+++. +..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 147999999999999985 4445799999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.007 Score=57.01 Aligned_cols=70 Identities=14% Similarity=0.230 Sum_probs=45.0
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCce-eeeceeeeecCCCCceEEEEEeec
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY 111 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~ 111 (374)
-.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.|...++ .++++.+ .+ ..||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 34568888889999998654457899997743321 12589999999875555 3454444 21 258999
Q ss_pred ccc
Q 017270 112 VPE 114 (374)
Q Consensus 112 ~~g 114 (374)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 975
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0046 Score=57.86 Aligned_cols=70 Identities=14% Similarity=0.238 Sum_probs=45.9
Q ss_pred eeeeeecCCCceEEEEEECC-------CCcEEEEEEeec-cc-cchHHHHHHHHhcCCCce-eeeceeeeecCCCCceEE
Q 017270 36 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~-~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 105 (374)
-.+.|+.|....||++.... +++.+++|+... .. ....+|..+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence 35678888889999998642 257899998744 22 334478888888753333 4444443 22
Q ss_pred EEEeecccc
Q 017270 106 NLVMEYVPE 114 (374)
Q Consensus 106 ~lv~e~~~g 114 (374)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 278999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0041 Score=55.46 Aligned_cols=71 Identities=14% Similarity=0.038 Sum_probs=49.4
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhcC---CCceeeeceeeeecCCCCceEEEEEeecc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVMEYV 112 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 112 (374)
.+.|+.|....+|++.. ++..+++|...... .....|...|+.|. ...+++++..... ....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence 46789999999999874 46789999775442 33567888888874 2445555554321 23478999999
Q ss_pred cc
Q 017270 113 PE 114 (374)
Q Consensus 113 ~g 114 (374)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 85
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0064 Score=55.74 Aligned_cols=138 Identities=14% Similarity=0.198 Sum_probs=76.0
Q ss_pred eeeeecCCCceEEEEEECC-------CCcEEEEEEeecc---ccchHHHHHHHHhcCCCce-eeeceeeeecCCCCceEE
Q 017270 37 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 105 (374)
.+.|..|-...+|++.... +++.+++|+.... .....+|..+++.+...++ .+++..+ ++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence 3567778888999988532 3578999976332 2223478888887743222 4444443 22
Q ss_pred EEEeecccchH---------------HHHHHhhhhc----CCCC--CHHHHHHHHHHHHH-------------------H
Q 017270 106 NLVMEYVPESM---------------YRVLKHYSSA----NQRM--PLIYVKLYTYQIFR-------------------G 145 (374)
Q Consensus 106 ~lv~e~~~g~l---------------~~~l~~~~~~----~~~l--~~~~~~~i~~qll~-------------------a 145 (374)
.+||||++|.. ...+...-.. .... .+.++..++.++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28899998511 1111111111 1112 24556666654422 1
Q ss_pred HHH----hhc---CCCeEeecCCCCcEEEcCC---CCcEEEEeecccc
Q 017270 146 LAY----IHT---VPRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 183 (374)
Q Consensus 146 l~~----LH~---~~~ivH~dlkp~NIll~~~---~~~ikl~Dfg~a~ 183 (374)
+.. |.. ...++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 222 1258999999999999863 2579999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0072 Score=54.10 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=43.0
Q ss_pred eeeecCCCceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhcCCCc--eeeeceeeeecCC--CCceEEEEEee
Q 017270 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVME 110 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e 110 (374)
..|+ |....||++.. .+|+.+++|..... ......|..+++.+.... +++++.. +... ......+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 4566 88889998763 45678999988632 233456888887774222 3333321 1000 01224578999
Q ss_pred cccc
Q 017270 111 YVPE 114 (374)
Q Consensus 111 ~~~g 114 (374)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.014 Score=52.32 Aligned_cols=32 Identities=41% Similarity=0.476 Sum_probs=26.9
Q ss_pred CCeEeecCCCCcEEEcCC---CCcEEEEeeccccc
Q 017270 153 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 184 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~---~~~ikl~Dfg~a~~ 184 (374)
..++|+|+.+.||+++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 579999999999999852 15799999999864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.004 Score=56.93 Aligned_cols=69 Identities=13% Similarity=0.136 Sum_probs=40.6
Q ss_pred eeeeecCCCceEEEEEECC--------CCcEEEEEEeecccc---chHHHHHHHHhcCCCce-eeeceeeeecCCCCceE
Q 017270 37 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF 104 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~ 104 (374)
.+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 4567788889999987643 136889997754322 23578888887753333 3444332 1
Q ss_pred EEEEeecccc
Q 017270 105 LNLVMEYVPE 114 (374)
Q Consensus 105 ~~lv~e~~~g 114 (374)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1478999876
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.013 Score=52.96 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=26.4
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
..++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence 36999999999999985 56799999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.15 Score=47.40 Aligned_cols=69 Identities=12% Similarity=0.156 Sum_probs=43.9
Q ss_pred eeeeecCCCceEEEEEECCC-------CcEEEEEEeecccc---chHHHHHHHHhcCCCce-eeeceeeeecCCCCceEE
Q 017270 37 ERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 105 (374)
++.|..|-...+|++..... ++.+++|+...... ...+|..+++.+...++ .++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence 45677788889999886421 57899997644321 23578888888753333 3343322 2 1
Q ss_pred EEEeecccc
Q 017270 106 NLVMEYVPE 114 (374)
Q Consensus 106 ~lv~e~~~g 114 (374)
+.||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 478999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 374 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-123 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-61 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-60 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 357 bits (917), Expect = e-123
Identities = 225/346 (65%), Positives = 281/346 (81%), Gaps = 3/346 (0%)
Query: 17 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 76
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 77 QLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 135
Q+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
KLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
CSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
RE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 316 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 361
FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-74
Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRVMDHPNVI 88
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPE 204
IH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 262
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 263 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
P PW+++F +A+DL ++L ++P R +A AHP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 322 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 362
+P+ F F EL E + +LI + R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 7e-71
Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 31/305 (10%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
F+S +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 267
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 268 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313
+ I P K+ E D ++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 314 AHPFF 318
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 4e-70
Identities = 96/304 (31%), Positives = 150/304 (49%), Gaps = 23/304 (7%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 88
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L F ++ ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 207
+H + HRDLKP NLL+D +K+ DFG AK + ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 325
F P H +F + +DL L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 326 ARLP 329
+LP
Sbjct: 293 CQLP 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 1e-67
Identities = 104/337 (30%), Positives = 164/337 (48%), Gaps = 23/337 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 87
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
I L F S E ++ ++ + + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 207
YIH+ + HRDLKP NL V+ KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 208 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 268 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
Q+ + VF P A+DL ++L R TA +A AH +F + +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 325 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 361
+ P+ ++ E + L D V
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-66
Identities = 103/316 (32%), Positives = 167/316 (52%), Gaps = 21/316 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 88 ISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I L F + ++ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 267 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
P+++ + + P A++L ++L R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 324 PNARLPNGRPLPPLFN 339
P + F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-66
Identities = 101/307 (32%), Positives = 167/307 (54%), Gaps = 21/307 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L E L LV E++ + + + + SA +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 206
+ H+ RV HRDLKPQNLL++ +K+ DFG A+ + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 265
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
FP+ + KV + + L S++L Y P+ R +A A AHPFF ++ +P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 326 ARLPNGR 332
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 209 bits (533), Expect = 8e-66
Identities = 89/300 (29%), Positives = 148/300 (49%), Gaps = 21/300 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RVMDHPNVISLK 91
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 152 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 211
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 212 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 271 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322
F I W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-65
Identities = 81/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++++ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 88 ISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
++L + S + + + LV ++ + S+ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-----SYICSRF 199
GL YIH ++ HRD+K N+L+ +K+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 260 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316
++ + +K ++ P A+DL +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 317 FFDELREPN 325
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (529), Expect = 9e-65
Identities = 71/325 (21%), Positives = 127/325 (39%), Gaps = 41/325 (12%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 89
Y +GTG+FG+V + TG A K V+ D+ +E+Q M V+ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L F NE+ + + E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 150 HTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
H H DLKP+N++ ++++K+ DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 326
+ + D +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 327 RLPNGRPLPPLFNFKQELSGASPEL 351
++P+ R + K + L
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 3e-64
Identities = 97/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 34 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRVM---D 83
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-63
Identities = 101/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L ++ L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELI 206
+ H+ V HRDLKPQNLL++ ++K+ +FG A+ S + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 207 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
+P A ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-62
Identities = 72/328 (21%), Positives = 133/328 (40%), Gaps = 32/328 (9%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 95
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 96 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 155 VCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 212
+ HRD+KP+NLL +K+ DFG AK+ + + + + +Y APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272
S D+WS G ++ LL G P F + + + + IR + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242
Query: 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 331
++ E L LL+ P+ R T E HP+ + P L
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 332 RPLPPLFNFKQELSGASPELVNKLIPDH 359
R L +++ + + D+
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 199 bits (506), Expect = 3e-62
Identities = 96/295 (32%), Positives = 157/295 (53%), Gaps = 20/295 (6%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 87
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 206
Y H RV HRDLKPQNLL++ ++KI DFG A+ I I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 265
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
D F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-61
Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 44/301 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPEL 205
+H + HRD+KP+NLL+D +KI DFG A + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 206 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+PW K+ + L ++L +PS R T + ++++ +
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
Query: 326 A 326
A
Sbjct: 271 A 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (499), Expect = 3e-60
Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 42/322 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 89
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L F K E+ L ++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 150 HTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
H + H D+KP+N++ + VKI DFG A +L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 328
+ PEA D LLQ P R T +A HP+ + ++ L
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL---KGDHSNL 293
Query: 329 PNGRPLPPLFNFKQELSGASPE 350
+ P +Q++ +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYAD 315
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-60
Identities = 99/355 (27%), Positives = 176/355 (49%), Gaps = 34/355 (9%)
Query: 24 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 75
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 76 LQLMRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIY 134
L LM+ ++H N+ISL + F + E + LVME + ++ +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 135 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 194
+ YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 195 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
+ +R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 255 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 301
E ++ + P ++ P+ + K+F +K +A DL S++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 302 SPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
P+ R + +A HP+ + +P P P +++ + + + E +LI
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 349
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-60
Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 90
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 151 T-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 209
T P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE- 187
Query: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 269
+Y S+D+++ G + E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 270 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
F K PE ++ ++ + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-60
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 45/296 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 87
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 147 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYR 201
H V HRDLKP N+ +D VK+ DFG A+ L + +++ + +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
+F +I E ++ +R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 8e-60
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 44/294 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 89
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L F+ + L +++E+ + + +++ Q L Y+
Sbjct: 74 LLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFG 208
H ++ HRDLK N+L +K+ DFG + + S+I + ++ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 209 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
T Y D+WS G L E+ +P N + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
K+ P R D + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 1e-59
Identities = 98/357 (27%), Positives = 160/357 (44%), Gaps = 49/357 (13%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM 82
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 83 DHPNVISLKH----------CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 132
+ + F+ N + + +V E + E++ ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 133 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIA 187
IYVK + Q+ GL Y+H + H D+KP+N+L++ + Q+KI D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 241
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 242 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 288
D + +II++LG +R T F ++K P V F K
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 289 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 338
E D S +LQ P R A HP+ +E+R P+ L +G +P F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-59
Identities = 77/332 (23%), Positives = 128/332 (38%), Gaps = 52/332 (15%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 86
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
I + C+ E LVMEY S + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
AY+H+ + HRD+K N+L+ VK+ DFGSA + S++ + ++ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 207 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
+ + + LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 325 NARLPNGRPLPPLFNFKQELSGASPELVNKLI 356
+ + + +EL + K++
Sbjct: 277 TVIMD---LIQRTKDAVRELDNLQYRKMKKIL 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-58
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 48/292 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 86
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
++ L F T + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
+Y H+ RV HRD+KP+NLL+ ++KI DFG + + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMI 176
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISL 90
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 91 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
F S L ++ E++ ++ + ++ + + Y +Q+ L ++
Sbjct: 67 HESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 150 HTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 208
H+ + H D++P+N++ +KI +FG A+QL G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 209 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 268
+T+ D+WS G ++ LL G F E + I+ T E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 269 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
K + EA+D RLL R TA EA HP+ + E
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 74/325 (22%), Positives = 133/325 (40%), Gaps = 52/325 (16%)
Query: 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRV 81
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 82 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
+PN+++ + +EL++ VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 200
+ L ++H+ +V HRD+K N+L+ VK+ DFG Q+ ++ S + + ++
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 201 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260
APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320
+ + P +++ D +R L R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 321 LREPNARLPNGRPLPPLFNFKQELS 345
+ L PL +E +
Sbjct: 276 AKPL-------SSLTPLIAAAKEAT 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (470), Expect = 5e-57
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 54/306 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 80
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 81 -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 139
V HPN+I LK + + F LV + + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKIM 116
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 199
+ + +H + HRDLKP+N+L+D + +K+ DFG + QL GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 200 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314
M+ NY F P+ DL SR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 315 HPFFDE 320
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 7e-57
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 42/303 (13%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+L + S L+L +M+ V L +Q+ + Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
+H + HRDLKP+NLL L ++ I DFG +K G + + Y APE++
Sbjct: 123 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 326
+ + A D L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 327 RLP 329
+
Sbjct: 276 NIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-56
Identities = 82/320 (25%), Positives = 127/320 (39%), Gaps = 59/320 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 86
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+ L F +L+ + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAP 203
Y+H + HRDLKP+N+L++ ++I DFG+AK L S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
EL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 317
++ FP+ + P+A DL +LL + R E AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 318 FDELREPNARLPNGRPLPPL 337
F+ + L P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-54
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 51/324 (15%)
Query: 29 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 76
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 77 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 136
+++ + HPNVI+L + +N+ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 137 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANIS 193
+ QI G+ Y+H+ ++ H DLKP+N+++ ++KI DFG A ++ G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 194 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 253
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 254 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313
E + A D RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 314 AHPFFDELREPNARLPNGRPLPPL 337
HP+ A L + P
Sbjct: 270 QHPWIKPKDTQQA-LSSAWSHPQF 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-53
Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHP 85
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+ + F + + L VMEY+ L ++ + + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 204
L ++H+ + +RDLK N+L+D H KI DFG K+ + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 205 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
++ G +Y S+D WS G +L E+L+GQ F G++ + IR NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 323
Y + + EA DL +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
Query: 324 PNARLPNGRPLPP----------LFNFKQELSGASPEL 351
L PP NF +E P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 64/303 (21%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 83
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 84 --HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 141
VI L F S L++E L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQ 118
Query: 142 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 201
+ + + H V HRD+K +N+L+D ++K+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 322 REP 324
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (436), Expect = 6e-51
Identities = 72/320 (22%), Positives = 121/320 (37%), Gaps = 55/320 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD 83
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
P ++ + + F + L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 203
GL ++H V +RDLKP N+L+D H V+I D G A + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
E++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 318
PE L LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 319 DELREPNARLPNGRPLPPLF 338
L + ++ + PP
Sbjct: 269 RSL---DWQMVFLQKYPPPL 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (431), Expect = 1e-50
Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 86
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
+I + F ++ + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 117
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 206
Y+H+ + +RDLKP+N+L+D H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 207 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 321
+ RFP + DL SRL+ S R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-48
Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 51/299 (17%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISL 90
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 91 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L +V ++ S+Y L + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 206
H + HRDLK N+ + VKI DFG A + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 207 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ P + P L + L+ R + A + L
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 4e-48
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 86
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 146
++++ + T L +VMEYV L+ M + L
Sbjct: 69 IVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 147 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRA 202
+ H + HRD+KP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 203 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
H+ + + + + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-48
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 53/311 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 90
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
+ V +RD+K +NL++D +KI DFG K+ I+ A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
+Y ++D W G V+ E++ G+ F ++ I+ + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 325
FP + + PEA L + LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 326 ARLPNGRPLPP 336
+ + LPP
Sbjct: 270 QDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-45
Identities = 53/282 (18%), Positives = 100/282 (35%), Gaps = 45/282 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 95
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 96 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
L +V EY+ + S+ L+ S + + ++ + + Y+
Sbjct: 71 EEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 214
HRDL +N+LV + K+ DFG K+ + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 215 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 273
D+WS G +L E+ G+ +P D + + K ++
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220
Query: 274 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
PP ++ ++R + L+
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 2e-44
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 45/302 (14%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 91
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ + +VME + S+ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 152 VPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--------SYICSRFYR 201
HRD+KP N L+ + V I DFG AK+ + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 202 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 318
+ Y P E + + + + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 319 DE 320
+
Sbjct: 279 RQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (382), Expect = 7e-44
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 24/267 (8%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 91
Y R +G GSFG++F+ L + VAIK + E + +++ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 151
+ F L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 152 VPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI--------SYICSRF 199
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKR 286
R + + + F + + + F
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 1e-41
Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 57/313 (18%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 90
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 210
++ + +RDLKP+NLL+D +++ DFG AK++ + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS-K 213
Query: 211 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDELREPN 325
F + DL LLQ +L+ + H +F +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301
Query: 326 ARLPNGRPLPPLF 338
R + F
Sbjct: 302 WIAIYQRKVEAPF 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-41
Identities = 73/332 (21%), Positives = 131/332 (39%), Gaps = 58/332 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRVM 82
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 142
+ H F T +K L+L+++Y+ L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAFQTETK----LHLILDYI---NGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 143 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRF 199
L ++H + +RD+K +N+L+D V + DFG +K+ +A E +Y +
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 314
P + + M A DL RLL P R A E
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 315 HPFFDELREPNARLPNGRPLPPLFNFKQELSG 346
H FF ++ L + P FK +
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP---FKPVIRD 318
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-41
Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVIS 89
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 90 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ + L LV +Y S++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 149 IHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 199
+H P + HRDLK +N+LV I D G A + + I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 200 ---YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 251
Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 252 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
P+ EE+R + +++ + ++ + + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-40
Identities = 65/296 (21%), Positives = 103/296 (34%), Gaps = 47/296 (15%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
S+ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 211
HRDL+ N+LV K+ DFG A+ + E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 212 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 324
P DL + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-40
Identities = 48/291 (16%), Positives = 98/291 (33%), Gaps = 45/291 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 94
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
+ LV E++ + + + + + G+AY+
Sbjct: 70 LEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEY 212
V HRDL +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 213 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 272
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 273 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323
+ + + + + P R E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-40
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 47/293 (16%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 90
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 91 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 150
++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 151 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFG 208
HRDL+ N+LV KI DFG A+ + E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 209 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 267
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 268 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 318
+ V P E L + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 37 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 88
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPE 204
+ HRDL +N+L+ H KI DFG +K L A E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 205 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 320
R P E DL + Y R + ++D
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 321 LRE 323
+ E
Sbjct: 272 VNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-39
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 38 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRVMDHPNV 87
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 147
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 148 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 204
Y+ + R HRDL +NLL+ VKI DFG + L + + + F
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 205 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
R P+ + P + ++ + + P R T +
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 2e-39
Identities = 55/294 (18%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 93
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 94 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 153
++ E++ + Q + + + QI + Y+
Sbjct: 82 CTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 211
HRDL +N LV H VK+ DFG ++ + A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 212 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271
++ D+W+ G +L E+ + Q+ E+++ D+R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 272 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 325
+ P + +L Q++PS R + E H F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-39
Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 53/304 (17%)
Query: 38 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 88
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR---FYRAPEL 205
+ R+ HRDL +N+LV H VKI DFG AK L A E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 206 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324
R P + + + R E F R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 325 NARL 328
L
Sbjct: 275 QRYL 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 3e-39
Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 54/309 (17%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDH 84
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 85 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 144
PNVI L+ +T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 145 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------ 198
G+ Y+ HRDL +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 199 FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 257
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248
Query: 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 317
D+R P P L Q + R +
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 318 FDELREPNA 326
+R PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-39
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 70/314 (22%)
Query: 37 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RVMDHP 85
+V+G+G+FG V A +T VA+K + + EL++M ++ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK-------------------HYSS 125
N+++L T ++ L+ EY + L+
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 126 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185
+ + + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 186 IAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 241
++ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 242 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 301
++I+ F+ E + +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306
Query: 302 SPSLRCTALEACAH 315
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 45/284 (15%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 94
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 95 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 154
T + +F ++ EY+ +L + R + + + Y+ + +
Sbjct: 69 ---TKQRPIF--IITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 155 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATEY 212
HRDL +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 213 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 271
++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222
Query: 272 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
P + + + R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-37
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 51/293 (17%)
Query: 37 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 88
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 148
SL ++E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 149 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 203
+ + + HRDL +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
E + ++TT D+WS G +L EL+ G P +P N D V +++ R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
P Y P ++ + +R + E +
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 54/303 (17%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVIS 89
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 90 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 149
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 150 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAPEL 205
HRDL +N+L+ H KI DFG +K L A ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 206 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 321
PPE L S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 322 REP 324
+
Sbjct: 275 SKV 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-36
Identities = 61/300 (20%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 37 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 88
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 89 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSSANQRMPLIYV 135
+L + +L L +EY P ++ L+ +S + +
Sbjct: 75 NLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 136 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 195
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 196 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
+R E DL + + P R + +
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-36
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 65/305 (21%)
Query: 37 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 85
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY--------------SSANQRM 130
N+++L T + + EY + L+ +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 131 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190
L + ++YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 191 NISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 246
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 306
+IK + + + P E D+ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 307 CTALE 311
T +
Sbjct: 293 PTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-35
Identities = 68/293 (23%), Positives = 101/293 (34%), Gaps = 50/293 (17%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDHP 85
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 86 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 145
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 146 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAP 203
LAY+ + R HRD+ +N+LV VK+ DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 204 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315
PP L ++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 55/292 (18%), Positives = 95/292 (32%), Gaps = 50/292 (17%)
Query: 33 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMD 83
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 84 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 143
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 144 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRF 199
G+ Y+ HRDL +N+LV+ K+ DFG ++ L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 200 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 311
FR P P L + Q + R +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-35
Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)
Query: 34 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRVM 82
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 83 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSANQR 129
H NV++L L +++E+ ++ L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 130 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 189
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 190 ANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 245
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 246 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 305
+K T R P PE PS
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 306 RCTALEACAHPFFDELREPNA 326
R T E H L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 8e-34
Identities = 67/321 (20%), Positives = 108/321 (33%), Gaps = 73/321 (22%)
Query: 38 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 87
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 88 ISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMYRVLKHYSSA 126
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 127 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186
+ Q+ G+AY+ + HRDL +N LV VKI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 187 AGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 242
+ + A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 243 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 302
+ + I A P + P E +L
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 303 PSLRCTALEACAHPFFDELRE 323
P+ R + H + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-33
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)
Query: 34 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 80
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 81 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSAN 127
+ H N+I+L + L +++EY + ++ L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 128 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187
+++ + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 188 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 243
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 303
L +++K R E + P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278
Query: 304 SLRCTALEA 312
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-31
Identities = 62/312 (19%), Positives = 111/312 (35%), Gaps = 63/312 (20%)
Query: 37 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 86
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 87 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI------YVKLYT 139
V+ L ++ME + + L+ A P++ +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 140 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--- 196
+I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 197 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 255
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 309
P +L QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 310 LEACAHPFFDEL 321
++ P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 2e-19
Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 24/200 (12%)
Query: 38 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 97
+++G G VF E +K + ++++ R + L
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 98 TSKNELFL---NLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVP 153
+ L + Y E +++ + + + I +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-R 122
Query: 154 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIF 207
+ H DL N+LV + I DF + ++ ++ I + F R
Sbjct: 123 GIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174
Query: 208 GATEYTTSIDIWSAGCVLAE 227
Y T DI SA + +
Sbjct: 175 ---TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 374 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.46 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-65 Score=473.61 Aligned_cols=325 Identities=68% Similarity=1.195 Sum_probs=288.8
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhcCCCceeeeceeeeecCC-CCceEEEEEee
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFLNLVME 110 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~e 110 (374)
.+|+.+++||+|+||+||+|++..+|+.||||++.++.....+|+.+|+.++||||++++++|..... .+..++|+|||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 47999999999999999999999999999999998877777799999999999999999999865443 45667899999
Q ss_pred cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccCCC
Q 017270 111 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 190 (374)
Q Consensus 111 ~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~ 190 (374)
||++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99998888887777778889999999999999999999999 79999999999999997556899999999987766666
Q ss_pred cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCC
Q 017270 191 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 270 (374)
Q Consensus 191 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 270 (374)
..+..||+.|+|||.+.+...++.++||||+||++|+|++|++||...+..+.+.++.+..|.+..+.+....+.+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 66788999999999987777799999999999999999999999999999999999999999999999999998888888
Q ss_pred CCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchhhhcCCCHH
Q 017270 271 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 350 (374)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (374)
++.....++........++++.+||.+||++||++|||+.|+|+||||+.++.+...++..+..+.+.++..+.....++
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 338 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCGG
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCcc
Confidence 99988888988888899999999999999999999999999999999999998888888877788888877655556666
Q ss_pred HHhhhcH
Q 017270 351 LVNKLIP 357 (374)
Q Consensus 351 ~~~~~~~ 357 (374)
....++|
T Consensus 339 ~~~~~~p 345 (350)
T d1q5ka_ 339 LATILIP 345 (350)
T ss_dssp GHHHHSC
T ss_pred ccccCCC
Confidence 6555555
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-62 Score=433.05 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=209.0
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++.+ ...
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 4679999999999999999999999999999999985432 345689999999999999999999944 345
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|+|||||+| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhe
Confidence 8999999986 6555443 45689999999999999999999999 79999999999999996 7789999999998
Q ss_pred ccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 184 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 184 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
...... ...+.+||+.|+|||++.+...++.++|||||||++|+|++|++||...................
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------ 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------ 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Confidence 764432 23456899999999999776655788999999999999999999998765433332222210000
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
......+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0012347999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=426.44 Aligned_cols=248 Identities=29% Similarity=0.502 Sum_probs=213.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ....+|+.+++.++|||||++++++. +..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence 468999999999999999999999999999999985421 23457999999999999999999984 444
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence 58999999995 77776653 4579999999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 865433 34456899999999999764 5899999999999999999999999998887777666541
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
... +++.+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 220 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 23458999999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-61 Score=434.44 Aligned_cols=278 Identities=35% Similarity=0.613 Sum_probs=230.6
Q ss_pred eeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 36 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 36 i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++.. ...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence 4678999999999999999999999999885432 234589999999999999999999943 34488
Q ss_pred EEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 107 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 107 lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
+|||||.+++...+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence 999999987655554 356779999999999999999999999 79999999999999996 7889999999998655
Q ss_pred cCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 017270 187 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 265 (374)
Q Consensus 187 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 265 (374)
... ...+.++|+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+++.++.+..+.+..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345678999999999977667899999999999999999999999999999999999999999887766544333
Q ss_pred CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 266 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.....+......++...+ ..++++++|||.+||++||++|||++|+|+||||++...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 333333444444555444 3589999999999999999999999999999999875433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=430.03 Aligned_cols=255 Identities=30% Similarity=0.525 Sum_probs=215.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++++.++||||++++++| .+..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence 368999999999999999999999999999999986432 2345899999999999999999998 3445
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||+| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccccc
Confidence 58999999995 6766655 34679999999999999999999999 79999999999999996 778999999999
Q ss_pred cccccCC---CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 183 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 183 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
+...... ...+..||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------- 225 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 225 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred eecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence 8764332 23356799999999999765 5899999999999999999999999998888877776651
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCccccccCCCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA 326 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e------~l~hp~~~~~~~~~~ 326 (374)
.+. +++.+++++++||++||++||.+|||++| +++||||++++|...
T Consensus 226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 111 23458999999999999999999999987 689999999887643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-61 Score=429.16 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=213.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||+++++|.+ ...+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEE
Confidence 348999999999999999999999999999999986433 234589999999999999999999954 33489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|||||+| +|.+.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 94 ivmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheee
Confidence 99999996 6655443 2469999999999999999999999 79999999999999996 788999999999876
Q ss_pred ccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+..... +.
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~--------- 235 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE--------- 235 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC---------
T ss_pred ccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC---------
Confidence 5433 3455679999999999965 4589999999999999999999999999888877776665311 10
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
...+..+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 236 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0123458999999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-61 Score=424.66 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=206.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
+.++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+|+++++.++|||||++++++.+. ...
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~ 78 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 78 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCC
Confidence 3578999999999999999999999999999999986543 2235799999999999999999988542 233
Q ss_pred EEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----eEeecCCCCcEEEcCCCCcEEEE
Q 017270 104 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 104 ~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-----ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.+|+|||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++.+||+
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~ 156 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLG 156 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEEC
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEe
Confidence 4889999998 58888887766677889999999999999999999998 56 999999999999996 7889999
Q ss_pred eeccccccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 178 DFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 178 Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
|||+|+...... ...+..||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+...++.+. ..
T Consensus 157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~~-- 231 (269)
T d2java1 157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--KF-- 231 (269)
T ss_dssp CHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC--
T ss_pred eccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC--
Confidence 999998765433 2345788999999999965 45899999999999999999999999998887777666551 00
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 318 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 318 (374)
+ .++..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 232 ---------------~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 ---------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------C---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 1234589999999999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=427.11 Aligned_cols=283 Identities=35% Similarity=0.661 Sum_probs=233.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++++.||+|+||+||+|++..+|+.||||++..+. ....+|++++++++|||||++++++.+ ...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 68999999999999999999999999999999985432 234579999999999999999999954 3348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+|||||.+++...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence 99999999987776653 345679999999999999999999999 79999999999999996 778999999999866
Q ss_pred ccC-CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
... .......+|+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 443 3344568899999999987776678999999999999999999999999999999999999888877655443221
Q ss_pred C-CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 265 N-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 265 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
. .....++......+.... ..++++++|||++||++||++|||++|+|+||||+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 111122333333333333 3588999999999999999999999999999999987655
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-60 Score=429.03 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=202.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||++++++ .+...
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3467999999999999999999999999999999986542 2234799999999999999999998 34455
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeecc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGS 181 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~ 181 (374)
+|+|||||+ |+|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+.. .++.+||+|||+
T Consensus 82 ~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccce
Confidence 899999998 57877775 35679999999999999999999999 79999999999999953 357899999999
Q ss_pred ccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 182 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 182 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
|+.........+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+.+.....
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------- 228 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF------- 228 (307)
T ss_dssp ----------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-------
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-------
Confidence 987666655667889999999999965 458999999999999999999999999988887777766521111
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.......+|+++++||.+||++||++|||++|+++||||++
T Consensus 229 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 229 ------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11123458999999999999999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=424.74 Aligned_cols=288 Identities=34% Similarity=0.579 Sum_probs=236.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCC-CcEEEEEEeecc------ccchHHHHHHHHhc---CCCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRVM---DHPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~ 98 (374)
...++|++++.||+|+||+||+|++..+ ++.||||++..+ .....+|+.+++.+ +||||++++++|....
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457999999999999999999999766 567999988532 22345788887766 7999999999987666
Q ss_pred CCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 99 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
......++++||||.+++...... .....+++..++.++.|++.||+|||+ +||+||||||+|||++. .+.+||+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~d 159 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLAD 159 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECS
T ss_pred cccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecc
Confidence 566778999999999876655443 345679999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||+++............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+++..+.+....
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9999876666666678899999999999654 599999999999999999999999999999999999999999888766
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
+....... ...+......++ ..+...+++.++|||.+||++||++|||++|+|+||||+++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 239 WPRDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp SCTTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 54322111 111111122222 2344568999999999999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-60 Score=434.83 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=221.7
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++.+ ...+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 4568999999999999999999999999999999986543 234579999999999999999999844 3458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC-CCCcEEEEeecccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 183 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~-~~~~ikl~Dfg~a~ 183 (374)
|+|||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|+
T Consensus 99 ~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 999999985 77666642 34679999999999999999999999 79999999999999964 25689999999999
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.........+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 245 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------
T ss_pred ecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 87766666778899999999999764 489999999999999999999999999988888887766322111
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
......+|+++++||.+||++||.+|||++|+|+||||+....+
T Consensus 246 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 246 -----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp -----------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 11223589999999999999999999999999999999876544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-60 Score=423.73 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=212.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.+.|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++++.++|||||++++++.+ ...+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEE
Confidence 357999999999999999999999999999999985432 345689999999999999999999854 33489
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+|||||+| +|...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 86 lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhcc
Confidence 99999985 66555543 34679999999999999999999999 79999999999999996 788999999999754
Q ss_pred ccCC-CcceeeeeccccchhhhhC----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 017270 186 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 260 (374)
Q Consensus 186 ~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 260 (374)
.... ...+..||+.|+|||++.+ ...|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.. ++
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~----- 233 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP----- 233 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC-----
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC-----
Confidence 4322 2335688999999999842 3457899999999999999999999999988887777766521 10
Q ss_pred hcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 261 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
. ...+..+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 234 ------------~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------------T-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------C-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------C-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 0012357999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-60 Score=416.96 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=207.5
Q ss_pred ceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
.|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+++++.++|||||++++++.+.. .+...+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence 3478889999999999999999999999999886432 23457999999999999999999885543 3455689
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--eEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ ++ |+||||||+|||++..++.+||+|||+|+
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999985 77666653 4679999999999999999999999 78 99999999999997547789999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... .....+..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.+.+.. +.++
T Consensus 164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~-------- 231 (270)
T d1t4ha_ 164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP-------- 231 (270)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC--------
T ss_pred ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC--------
Confidence 533 333456789999999999854 4899999999999999999999999876655544433321 1110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
..++...++++++||.+||++||++|||++|+|+||||+
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 113345789999999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=422.87 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=218.7
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcCCCceeeeceeeeecC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 98 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (374)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~---- 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---- 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence 34578999999999999999999999999999999985432 2245899999999999999999998
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCC---cE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 174 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~---~i 174 (374)
.+...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+
T Consensus 83 -~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 83 -ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCE
T ss_pred -EECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccce
Confidence 444559999999985 77777653 3579999999999999999999999 79999999999999985332 59
Q ss_pred EEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 175 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
||+|||+|..........+..+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.+.....
T Consensus 157 kl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp EECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999999987766666667789999999999965 458999999999999999999999999998888877776532211
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
. ..++..+|+++++||++||+.||.+|||++|+|+||||+...+
T Consensus 236 ~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 236 E-------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp C-------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred C-------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 1 1223458999999999999999999999999999999987544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=428.82 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=217.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||++++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 468999999999999999999999999999999986432 2345799999999999999999999 4455
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||+| +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence 69999999996 6666554 34679999999999999999999999 79999999999999996 788999999999
Q ss_pred ccccc-CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+.... .....+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------- 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence 86544 3344567899999999999654 5899999999999999999999999999888777766551
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
... ++..+|+++++||++||++||.+|++ ++|+++||||+++.+.
T Consensus 221 ------~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 111 23468999999999999999999994 9999999999987553
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-59 Score=430.55 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=219.2
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++|. +...+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 3467999999999999999999999999999999986543 23457999999999999999999983 44558
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC-CCCcEEEEeecccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 183 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~-~~~~ikl~Dfg~a~ 183 (374)
|+|||||+| +|.+.+. ....++++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|+
T Consensus 102 ~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 102 VLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccce
Confidence 999999995 6655443 345679999999999999999999999 79999999999999973 35789999999999
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.........+..+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 247 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF--------- 247 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred ecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 8777666677889999999999965 458999999999999999999999999999888887776632111
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
+ ......+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus 248 --------~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 --------D--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------C--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------C--------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1 11223589999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-59 Score=423.68 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=211.2
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
..|++++.||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++|||||++++++.+ ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 469999999999999999999999999999999865432 23479999999999999999999854 334
Q ss_pred EEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 105 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 105 ~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
+|+|||||.++++..+. ....++++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeecccccc
Confidence 89999999987555433 245689999999999999999999999 79999999999999996 88999999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
... .....||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------- 233 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 433 3456899999999998642 358999999999999999999999999988887777766521100
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..+..+|+++++||.+||+.||.+|||++|+|+||||.+
T Consensus 234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 012347899999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-60 Score=430.72 Aligned_cols=282 Identities=26% Similarity=0.434 Sum_probs=207.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
.++|++++.||+|+||+||+|+++.+|+.||+|++..+. ....+|+.+|+.++|||||+++++|. +...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 568999999999999999999999999999999986442 23457999999999999999999994 34458
Q ss_pred EEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccc
Q 017270 106 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 184 (374)
Q Consensus 106 ~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~ 184 (374)
|+|||||.| +|.+.+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccc
Confidence 999999995 77777653 3579999999999999999999996138999999999999996 78899999999986
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcC
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... ...+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+.........
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 5432 33467899999999999765 599999999999999999999999987654332 22222222222111000000
Q ss_pred cC--CcCC---CCCCC---------CCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCC
Q 017270 264 PN--YTDF---RFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 324 (374)
Q Consensus 264 ~~--~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~ 324 (374)
.. .... ..+.. ............+|.+++|||.+||++||.+|||++|+|+||||++..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence 00 0000 00000 00000001112368899999999999999999999999999999875443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-59 Score=420.64 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=215.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.++|||||++++++. +..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCC
Confidence 358999999999999999999999999999999986432 23457999999999999999999984 445
Q ss_pred EEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||.|+ +...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence 599999999974 444443 46778999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+.... ...+..||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 216 (316)
T d1fota_ 152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------ 216 (316)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Confidence 86543 33457899999999999654 5899999999999999999999999999888888777652
Q ss_pred CcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 263 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
... ++..++++++++|.+||++||.+|+ |++++++||||+++.+.
T Consensus 217 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 217 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 111 2335899999999999999999996 89999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-58 Score=411.49 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=217.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-------------chHHHHHHHHhcC-CCceeeeceeeee
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------YKNRELQLMRVMD-HPNVISLKHCFFS 96 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------~~~~e~~~l~~l~-h~~iv~~~~~~~~ 96 (374)
.++|++.+.||+|+||+||+|++..+|+.||||++.+... ...+|+.+++.++ |||||++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 4689999999999999999999999999999999865421 2347999999997 99999999999
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 97 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 97 ~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
.++..+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k 150 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK 150 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence 444569999999985 88887763 4579999999999999999999999 79999999999999996 78899
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhC-----CCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 250 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 250 (374)
|+|||+++............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+..+....+.+.
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999987766655666789999999999853 334788999999999999999999999999888877777662
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.-.+. .....++|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 231 ~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 11110 11123589999999999999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=421.68 Aligned_cols=317 Identities=32% Similarity=0.552 Sum_probs=239.9
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCc
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 102 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 102 (374)
..++|++++.||+|+||+||+|.++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|..... ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3568999999999999999999999999999999986432 233479999999999999999999854432 233
Q ss_pred eEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 103 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 103 ~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
..+|+|||||+.++...... .++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+|
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred ceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-ccccccccccce
Confidence 45789999998777666542 579999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 017270 183 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 262 (374)
Q Consensus 183 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 262 (374)
+.... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+...
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 86543 3345788999999999987777899999999999999999999999999999999999999999988766543
Q ss_pred CcCCc---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCC
Q 017270 263 NPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 339 (374)
Q Consensus 263 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 339 (374)
..... ....+......+...+ ..++++++|||.+||++||.+|||++|+|+||||+.+.+...... .+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~-----~~~~~ 320 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-----VQKYD 320 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-----CCCCC
T ss_pred cchhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc-----CCCCC
Confidence 32110 0122333334444333 468999999999999999999999999999999998865543211 11112
Q ss_pred chhhhcCCCHHHHhhhcHHHHh
Q 017270 340 FKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
...+....+.+.+++++-+++.
T Consensus 321 ~~~~~~~~~~~e~k~~~~~e~~ 342 (346)
T d1cm8a_ 321 DSFDDVDRTLDEWKRVTYKEVL 342 (346)
T ss_dssp CC-----CCHHHHHHHHHHHHH
T ss_pred CchhhhhcCHHHHHHHHHHHhh
Confidence 2222233555666666655554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=420.61 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=219.4
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..++|++++.||+|+||+||+|.++.+|+.||||++..... ...+|+.+|+.++|||||+++++|.+ ...+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~ 77 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 35789999999999999999999999999999999865432 34589999999999999999999943 34599
Q ss_pred EEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC-CCcEEEEeeccccc
Q 017270 107 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 184 (374)
Q Consensus 107 lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~-~~~ikl~Dfg~a~~ 184 (374)
+|||||+| +|.+.+.. ....+++.+++.|+.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999995 77776652 34579999999999999999999999 799999999999999752 35799999999987
Q ss_pred cccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 185 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 185 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
...........+|+.|+|||.+.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+.+.....+..
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 225 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE------- 225 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-------
T ss_pred cccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh-------
Confidence 7666556677889999999998654 58999999999999999999999999999888888887743222222
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
....+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 226 ------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 ------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 22347999999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-58 Score=412.61 Aligned_cols=277 Identities=35% Similarity=0.642 Sum_probs=225.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++++.||+|+||+||+|+++ +|+.||||++.... ....+|+.+++.++|||||++++++... ...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 68999999999999999999985 78999999985432 2345899999999999999999999543 348
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
+++|||+.+++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||.|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence 89999999987666653 46789999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
..... .....+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 44332 34457899999999998777789999999999999999999999999999999999999988887766543321
Q ss_pred CCc-CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 265 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 265 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
... ...+......++. .+...+++.++|||++||++||++|||++|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111 1122222223333 344568999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-58 Score=422.18 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=217.4
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCC
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (374)
.+...++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++.
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~---- 111 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK---- 111 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc----
Confidence 3445689999999999999999999999999999999986432 22357999999999999999999983
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEe
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 178 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~D 178 (374)
....+++||||+.| ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 112 -~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~D 184 (350)
T d1rdqe_ 112 -DNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD 184 (350)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred -cccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeee
Confidence 44458999999985 66666543 3579999999999999999999999 79999999999999996 78899999
Q ss_pred eccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 179 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 179 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
||+|+..... ..+..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 185 FG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------ 255 (350)
T d1rdqe_ 185 FGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------ 255 (350)
T ss_dssp CTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred ceeeeecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------
Confidence 9999875433 3467899999999999764 589999999999999999999999999988887777765210
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
. ++..+++++.+||++||++||.+|+ |++++++||||+++.+.
T Consensus 256 -----------~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 256 -----------R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp -----------C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred -----------C------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 1 2345899999999999999999995 99999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-58 Score=426.37 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=208.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHH---HHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+ |+.+++.++|||||+++++|.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 468999999999999999999999999999999985432 11223 466677778999999999984
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
....+|+|||||+ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence 3445899999999 477777653 4678999999999999999999999 79999999999999996 788999999
Q ss_pred ccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 017270 180 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 259 (374)
Q Consensus 180 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 259 (374)
|+|+..... ......||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.+..+... +.+.....
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~----- 224 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM----- 224 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC-----
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC-----
Confidence 999865443 33456899999999999766668999999999999999999999998765432222 22111100
Q ss_pred hhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCccccccCC
Q 017270 260 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 324 (374)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~ 324 (374)
...++..+|+++++||.+||++||.+||| ++|+++||||+++.|.
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 01123468999999999999999999999 7999999999987654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=416.56 Aligned_cols=319 Identities=33% Similarity=0.611 Sum_probs=244.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
..+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4589999999999999999999999999999999864332 23479999999999999999999865554445567
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
|+++++++|+|.+.+.. .++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|...
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceeec
Confidence 88888888899888763 469999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 186 IAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 186 ~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
.... ......+|+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.........+.+.......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 4332 234567899999999986666789999999999999999999999999999888888888888887665432
Q ss_pred cCcC---CcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 017270 262 MNPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 338 (374)
Q Consensus 262 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
.... ......+.....+|...++ .+++++++||.+||++||.+|||++|+|+||||+....+.... ......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~ 314 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF 314 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCT-TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCC-CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCcc
Confidence 2100 0011233444445555443 5899999999999999999999999999999999765543221 122334
Q ss_pred CchhhhcCCCHHHHhhhcHHHHh
Q 017270 339 NFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
++..+......+.+++++.++..
T Consensus 315 ~~~~~~~~~~~~~l~~l~~~e~~ 337 (345)
T d1pmea_ 315 KFDMELDDLPKEKLKELIFEETA 337 (345)
T ss_dssp --------CCHHHHHHHHHHHSG
T ss_pred CCChhhhhCCHHHHHHHHHHHHH
Confidence 55556666777777776655433
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=409.90 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhcC--CCceeeeceeeeec
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFST 97 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~ 97 (374)
..++|++.+.||+|+||+||+|++..+|+.||||++.++. ....+|+.+++.++ |||||++++++.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-- 79 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-- 79 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--
Confidence 3568999999999999999999999999999999986432 22348999999987 899999999984
Q ss_pred CCCCceEEEEEeecccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEE
Q 017270 98 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 175 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~g--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ik 175 (374)
+...+|+||||+.+ ++.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+|
T Consensus 80 ---~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 80 ---RPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp ---CSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEE
T ss_pred ---eCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEE
Confidence 34458999999974 5555554 34679999999999999999999999 79999999999999997567999
Q ss_pred EEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 176 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 176 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
|+|||+|+.... ....+..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+.
T Consensus 152 l~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~----- 219 (273)
T d1xwsa_ 152 LIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG----- 219 (273)
T ss_dssp ECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred ECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-----
Confidence 999999976433 334567899999999999766656788999999999999999999997632 12220
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
.. .++..+|+++++||.+||++||++|||++|+|+||||+++
T Consensus 220 ------------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 220 ------------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 1334689999999999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-58 Score=413.83 Aligned_cols=251 Identities=29% Similarity=0.510 Sum_probs=211.6
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH-HhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
++|++++.||+|+||+||+|+++.+|+.||||++.++. .....|..++ +.++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 68999999999999999999999999999999996432 1223455555 478999999999998 4445
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||+| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccchh
Confidence 59999999985 7776665 34679999999999999999999999 79999999999999996 788999999999
Q ss_pred cccccCC-CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 017270 183 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 261 (374)
Q Consensus 183 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 261 (374)
+...... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+...++... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 8654433 33456889999999999754 5899999999999999999999999998888777766541 11
Q ss_pred cCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCccccccC
Q 017270 262 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 323 (374)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-e~l~hp~~~~~~~ 323 (374)
. +++.+|+++++||++||++||.+|||+. ++++||||+++++
T Consensus 221 --------~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 --------F------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------C------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------C------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 1 2345899999999999999999999995 8999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=416.60 Aligned_cols=319 Identities=30% Similarity=0.526 Sum_probs=233.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||+++++|..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999986542 234589999999999999999999854332 3456
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+|+|||||.++++..+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhh
Confidence 799999999998776653 468999999999999999999999 79999999999999996 7789999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......+++...+.+..+.+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 77666666677899999999999764 58999999999999999999999999999999999999999998887775433
Q ss_pred cCCcCC--CCCCCCCCChhhhc-----------ccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 017270 264 PNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 330 (374)
Q Consensus 264 ~~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~ 330 (374)
.....+ ..+......+...+ ....+++++|||++||++||++||||+|+|+||||+...++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~--- 323 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV--- 323 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH---
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc---
Confidence 221110 00111111111111 12346789999999999999999999999999999986543221
Q ss_pred CCCCCCCCCchhhhcCCCHHHHhhhcHHHHh
Q 017270 331 GRPLPPLFNFKQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (374)
....|...+...+....+.+.+++++-.++.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 324 EAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp TCCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 1122334444434445666667666655543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-58 Score=416.68 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=210.9
Q ss_pred ccccceeeee-eeecCCCceEEEEEECCCCcEEEEEEeeccccchHHHHHHHH-hcCCCceeeeceeeeecCCCCceEEE
Q 017270 29 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 29 ~~~~~y~i~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
...++|.+.+ .||+|+||+||+|++..+++.||||++.+. ....+|+.++. .++|||||+++++|.+.. .....+|
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ 85 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 85 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEE
Confidence 4567898875 699999999999999999999999988654 45668998865 458999999999885432 3356689
Q ss_pred EEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCC--CCcEEEEeecccc
Q 017270 107 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 183 (374)
Q Consensus 107 lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~--~~~ikl~Dfg~a~ 183 (374)
+|||||+ |+|.+.+.. .....+++.+++.|+.||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence 9999998 488887763 234579999999999999999999999 799999999999999852 3579999999998
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
............||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~---------- 231 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---------- 231 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS----------
T ss_pred eccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc----------
Confidence 7776666677889999999999855 45899999999999999999999999877654443333221110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
..+.+|. .....+|+++++||++||++||++|||++|+++||||.+
T Consensus 232 ---~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 232 ---GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ---CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ---CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 1111111 112347999999999999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-57 Score=412.99 Aligned_cols=283 Identities=28% Similarity=0.486 Sum_probs=224.9
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++ ||||++++++|... ....+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEE
Confidence 468999999999999999999999999999999986543 34568999999995 99999999988542 33458899
Q ss_pred eecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 109 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 109 ~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
||||.++.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999753221 23579999999999999999999999 799999999999999975667999999999877666
Q ss_pred CCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCcCCc
Q 017270 189 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYT 267 (374)
Q Consensus 189 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 267 (374)
.......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+.+.++.+....+........
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 66667788999999999987777899999999999999999999999754 55666777777777655444332211111
Q ss_pred CC----CCCCCCCCChhhh----cccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccC
Q 017270 268 DF----RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 323 (374)
Q Consensus 268 ~~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 323 (374)
.. ..+......+... ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00 0111111122221 12357899999999999999999999999999999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=407.11 Aligned_cols=289 Identities=27% Similarity=0.472 Sum_probs=225.9
Q ss_pred CCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCC-
Q 017270 27 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS- 99 (374)
Q Consensus 27 ~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (374)
.....++|++++.||+|+||+||+|++..+|+.||||++..+. ....+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 4456789999999999999999999999999999999885432 224589999999999999999998854321
Q ss_pred --CCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 100 --KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 100 --~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
.....+|+|||||.+++..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~ 159 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLA 159 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEEC
T ss_pred ccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEee
Confidence 2234588999999987665543 355789999999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCC-----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 017270 178 DFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 252 (374)
Q Consensus 178 Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 252 (374)
|||+++...... ...+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997654322 223467899999999998777789999999999999999999999999999999999999888
Q ss_pred CCCHHHHhhcCcCCc--CCCCCCCCCCChhhhcc-cCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccc
Q 017270 253 TPTREEIRCMNPNYT--DFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 320 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 320 (374)
.+..+.+........ .+.............+. ...+++++|||.+||++||++|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 877655443321111 11111111111111111 135788999999999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=411.10 Aligned_cols=316 Identities=34% Similarity=0.550 Sum_probs=245.2
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhcCCCceeeeceeeeecCC-CCce
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 103 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 103 (374)
.++|++++.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|+.++|||||++++++..... ++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999865432 23479999999999999999998854432 2333
Q ss_pred EEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 104 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 104 ~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.+++++++++|+|.+.+. ..++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence 455666666678877664 3579999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 184 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 184 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... ....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 543 233457789999999998777778999999999999999999999999999999999999998888876554322
Q ss_pred cCCc---CCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 017270 264 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 340 (374)
Q Consensus 264 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 340 (374)
.... ....+......+...+ ..++++++|||.+||++||.+|||++|+|+||||+++..+.. .+....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~-----~~~~~~~~~ 321 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD-----EPVADPYDQ 321 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS-----CCCCCCCCC
T ss_pred chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc-----CCCCCCCCC
Confidence 1100 0122333334444433 358999999999999999999999999999999998765432 233444455
Q ss_pred hhhhcCCCHHHHhhhcHHHHh
Q 017270 341 KQELSGASPELVNKLIPDHVK 361 (374)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~ 361 (374)
..+......+.++.++.+++.
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~ 342 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVI 342 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHH
T ss_pred cccchhcCHHHHHHHHHHHhh
Confidence 555556666777776666544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=400.02 Aligned_cols=281 Identities=34% Similarity=0.575 Sum_probs=227.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 105 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (374)
++|++++.||+|+||+||+|++..+|+.||||++..+. ....+|+.+++.++||||+++++++. +....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 58999999999999999999999999999999985432 23358999999999999999999984 34458
Q ss_pred EEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccc
Q 017270 106 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 185 (374)
Q Consensus 106 ~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~ 185 (374)
++|++++.++.+..+. .....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence 8999999986555443 356789999999999999999999999 79999999999999996 778999999999876
Q ss_pred ccCCC-cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 186 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 186 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... .....+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+.+.++....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54433 33456688999999997766679999999999999999999877 56677788888888888887765554332
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCcccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 322 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 322 (374)
........+..............+++.+.|||++||++||.+|||++|+|+||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 22122222222222233334456899999999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-55 Score=388.02 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=203.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
...++|++.+.||+|+||+||+|++..+|+.||||++.++. ....+|+.+++.++|||||++++++.... ..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence 34568999999999999999999999999999999986432 12457999999999999999999886543 33
Q ss_pred ceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
...+|+|||||+| +|...+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~ 156 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFG 156 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCT
T ss_pred CceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhh
Confidence 4568899999996 5555544 34679999999999999999999999 79999999999999996 7789999999
Q ss_pred cccccccCC----CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 181 SAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 181 ~a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
.+....... ...+..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++++....++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP- 234 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-
Confidence 987543322 23456789999999999654 589999999999999999999999999988887777665211111
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 319 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 319 (374)
......+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 235 ------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112345899999999999999999999544445577764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-54 Score=385.47 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=202.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|.++.+|+.||||++..+.. ...+|+.+++.++|||||++++++.+ ...+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeEE
Confidence 3589999999999999999999999999999999865533 34589999999999999999999843 334889
Q ss_pred Eeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|||||+ |++...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeecC
Confidence 999999 577777653 245679999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cCCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
..... ....+|+.|+|||++.+. .|+.++|||||||++|||++|..|| .+.+... +.+++.....
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~---------- 234 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYR---------- 234 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCC----------
T ss_pred CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCC----------
Confidence 44322 234678999999998654 5899999999999999999966555 4444443 4333331100
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 321 (374)
..++..+++++.+||.+||+.||.+|||++|+++ +|+.+
T Consensus 235 -----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 235 -----------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred -----------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 1123458999999999999999999999999965 55543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=390.31 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=202.1
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
++|++.+.||+|+||+||+|++..+++ .||+|.+.... ....+|+.+++.+ +|||||++++++.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---- 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---- 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence 689999999999999999999876554 68999885432 2345799999888 89999999999843
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecC
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 160 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dl 160 (374)
...+|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ ++|+||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 344889999998 588888764321 12458999999999999999999999 79999999
Q ss_pred CCCcEEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCC
Q 017270 161 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 236 (374)
Q Consensus 161 kp~NIll~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~ 236 (374)
||+|||++. ++.+||+|||+|+........ .+..+|+.|+|||++.+. .++.++|||||||++|||++ |..||.
T Consensus 191 Kp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999996 789999999999876554432 245679999999998654 58999999999999999997 899999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 237 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 237 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+.+....+.++++....+ ..+..+|+++++||.+||+.||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 877666666666521111 1234579999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=377.32 Aligned_cols=244 Identities=19% Similarity=0.303 Sum_probs=192.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.+|++.+.||+|+||+||+|.+. +++.||||++..+. ....+|+++++.++|||||++++++... ..+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence 47999999999999999999975 67789999986543 3345899999999999999999998433 338899
Q ss_pred eecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheeccC
Confidence 999984 67666653 44678999999999999999999999 79999999999999996 78899999999986654
Q ss_pred CCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ....||+.|+|||++.+. .++.++|||||||++|||++ |.+||...+..+.+..+......
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------- 221 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------- 221 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 3322 235679999999999654 58999999999999999999 57777777776666665542110
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+...++++.+||.+||+.||++|||++|+++|
T Consensus 222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0223478999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=379.87 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=196.8
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.++|++.+.||+|+||+||+|+.. ..||||++.... ....+|+.+++.++|||||+++++... + .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence 468999999999999999999753 369999885332 234579999999999999999987521 1 2
Q ss_pred EEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+++|||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEcccccee
Confidence 689999999 577777753 34679999999999999999999999 79999999999999996 7889999999997
Q ss_pred ccccCC---CcceeeeeccccchhhhhCC--CCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 184 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 184 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
...... ...+..||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+....+..++.....++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--- 229 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--- 229 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence 654322 22345789999999998643 3478999999999999999999999998877666655554321111
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
....++..+++++.+||.+||+.||.+|||++|+++|
T Consensus 230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111334589999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-53 Score=381.92 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=190.5
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..+|++.+.||+|+||+||+|+++.+++ .||||.+.... ....+|+.+|++++|||||++++++.. .
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----S 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 4689999999999999999999987765 58899875432 234589999999999999999999843 3
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+++|||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCccc
Confidence 348899999996 56555542 34579999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc------ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 017270 182 AKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 182 a~~~~~~~~~------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|+........ ....+|+.|+|||.+.+. .++.++|||||||++|||+| |..||.+....+.+..+.+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9865443221 124568899999999654 58999999999999999998 899999988877766655421111
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123578999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=379.66 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=202.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|.++ +++.||||++..+. ....+|+.++++++|||||++++++.. + .+++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeEE
Confidence 368999999999999999999975 67889999986543 234589999999999999999997621 1 2679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|||||++ +|.+.+... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEcc
Confidence 9999995 666554432 23469999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+|+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.+....
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---------- 229 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---------- 229 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 4332 2345678999999998654 489999999999999999995 5666666666666555431110
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~~ 320 (374)
..+..+++++.+||.+||+.||++|||++++++ |+||..
T Consensus 230 ------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 ------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 123458999999999999999999999999988 888864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=372.34 Aligned_cols=244 Identities=18% Similarity=0.258 Sum_probs=203.7
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
++|++.+.||+|+||+||+|+++ +++.||||++.++. ....+|+++++.++||||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence 58999999999999999999974 78899999986543 334589999999999999999998843 3348999
Q ss_pred eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||++ |++...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheeccC
Confidence 99998 466555442 44578999999999999999999999 89999999999999996 78899999999986544
Q ss_pred CCCc--ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 017270 188 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 264 (374)
Q Consensus 188 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 264 (374)
.... ....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....+
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 221 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---------- 221 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----------
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence 3322 235679999999999754 58999999999999999998 899999998887776665421111
Q ss_pred CCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 265 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.+...++++.+||.+||+.||++|||++++++|
T Consensus 222 ------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 ------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 223578999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=375.13 Aligned_cols=250 Identities=26% Similarity=0.309 Sum_probs=201.9
Q ss_pred cceeeeee-eecCCCceEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCce
Q 017270 32 ISYMAERV-VGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 103 (374)
Q Consensus 32 ~~y~i~~~-lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (374)
++|.+.+. ||+|+||+||+|.++.+ +..||||++.... ....+|++++++++|||||++++++.. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~----- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-----
Confidence 57888885 99999999999987644 4579999985432 234579999999999999999998732 1
Q ss_pred EEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccc
Q 017270 104 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 182 (374)
Q Consensus 104 ~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a 182 (374)
.+|+|||||++ +|.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccchhh
Confidence 27899999995 6666553 244679999999999999999999999 89999999999999996 789999999999
Q ss_pred cccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 183 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 183 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
+........ ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+... +
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~--- 231 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-M--- 231 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-C---
T ss_pred hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C---
Confidence 876543321 234678999999999654 58999999999999999998 9999998887766655543110 0
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCccccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDEL 321 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~~~~ 321 (374)
.+++.+|+++.+||.+||+.||++|||+.++ |+|+|+.-.
T Consensus 232 ------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 232 ------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1234589999999999999999999999877 788988643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=387.44 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=207.5
Q ss_pred ccceeeeeeeecCCCceEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhcCC-CceeeeceeeeecC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDH-PNVISLKHCFFSTT 98 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 98 (374)
.++|++++.||+|+||+||+|++. .+|+.||||++.+.. ....+|++++++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 478999999999999999999974 468999999885321 234479999999977 799999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEE
Q 017270 99 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 177 (374)
Q Consensus 99 ~~~~~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~ 177 (374)
...++++|||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 101 ---~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~ 171 (322)
T d1vzoa_ 101 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLT 171 (322)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEES
T ss_pred ---CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEEe
Confidence 3458999999995 67666653 4568899999999999999999999 79999999999999996 7889999
Q ss_pred eeccccccccCC--CcceeeeeccccchhhhhCCC-CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 017270 178 DFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 254 (374)
Q Consensus 178 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 254 (374)
|||+|+...... ...+..+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+.....
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999998654432 234567899999999996543 46889999999999999999999998775544444443321100
Q ss_pred CHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCccccccCC
Q 017270 255 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 324 (374)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~ 324 (374)
...++..+|+++++||.+||++||.+|| |++|+++||||+.+++.
T Consensus 252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 0012345899999999999999999999 58999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=375.05 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=194.3
Q ss_pred eeeecCCCceEEEEEEC--CCCcEEEEEEeeccc------cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEEe
Q 017270 38 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 109 (374)
Q Consensus 38 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 109 (374)
+.||+|+||+||+|.+. .+++.||||++..+. ....+|++++++++|||||++++++.. + ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----S-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----C-CEEEEE
Confidence 47999999999999864 456789999885432 234589999999999999999998732 1 167999
Q ss_pred ecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccccC
Q 017270 110 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 188 (374)
Q Consensus 110 e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~~ 188 (374)
|||++ +|.+.+. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhhhcccc
Confidence 99985 6766655 45679999999999999999999999 79999999999999996 789999999999865543
Q ss_pred CCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 189 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 189 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
... ....||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+.. .+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~--------- 229 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM--------- 229 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC---------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CC---------
Confidence 322 234678999999999654 48999999999999999998 899999988776655554310 00
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCcccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE 320 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~~~ 320 (374)
.++..+|+++.+||.+||+.||++|||++++ |+|+|+.-
T Consensus 230 ------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 230 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 1234589999999999999999999999988 56777653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=370.23 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=197.7
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|++..+ +.||||++..+. ....+|+.+++.++|||||++++++.. +. +++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eEE
Confidence 46899999999999999999998654 579999986543 334589999999999999999998721 11 679
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeeccccccc
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 186 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~ 186 (374)
|||||.+ ++...+.. .....+++.++..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhhcc
Confidence 9999995 56555543 234569999999999999999999999 79999999999999996 7889999999998654
Q ss_pred cCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 017270 187 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 263 (374)
Q Consensus 187 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 263 (374)
.... .....+|+.|+|||++.+. .++.++|||||||++|||++| .+||.+....+.+..+.+....+
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~--------- 234 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------- 234 (285)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence 3322 2335679999999999654 589999999999999999995 55566666666665554421111
Q ss_pred cCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCccccc
Q 017270 264 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL 321 (374)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~--hp~~~~~ 321 (374)
.+..+++++++||.+||+.||++|||++++++ |+||...
T Consensus 235 -------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 23457999999999999999999999999987 8898764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=368.20 Aligned_cols=245 Identities=27% Similarity=0.350 Sum_probs=190.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.++|++.+.||+|+||+||+|++..++ ..||||.+.... ....+|+.+++.++|||||++++++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 358999999999999999999987654 458899874322 234579999999999999999998731
Q ss_pred eEEEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
..+|+|||||++ ++...+. .....+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchh
Confidence 237899999995 5555544 245679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC--cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 017270 182 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 258 (374)
Q Consensus 182 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 258 (374)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.+....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----- 228 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----- 228 (273)
T ss_dssp ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 986544322 2345678999999999654 58999999999999999998 89999998887777666542110
Q ss_pred HhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 259 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
.++..+|+++.+||.+||+.||.+|||++|+++|
T Consensus 229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1234689999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=373.63 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=194.9
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCc----EEEEEEeecc-----ccchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
.+|++++.||+|+||+||+|.+..+|+ .||+|++... .....+|+.+++.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 479999999999999999999988876 4788877432 22345899999999999999999988432
Q ss_pred eEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
. .++++||+. ++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence 1 456677766 577766553 46789999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 182 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 182 a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+.. .++
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~-- 233 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP-- 233 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC--
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC--
Confidence 9876543332 234679999999999765 58999999999999999998 899998887666554444311 110
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 316 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~hp 316 (374)
.+..+++++.+||.+||+.||.+|||+.|+++|.
T Consensus 234 -------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 234 -------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 2235789999999999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=363.18 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=187.5
Q ss_pred cceeeeeeeecCCCceEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCc
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (374)
..|.+.+.||+|+||+||+|.++.++ ..||||++.... ....+|+.+++.++|||||++++++.. .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----C
Confidence 47999999999999999999987654 469999985432 223579999999999999999998843 3
Q ss_pred eEEEEEeecccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecc
Q 017270 103 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 181 (374)
Q Consensus 103 ~~~~lv~e~~~g~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~ 181 (374)
...++|||||.++ +...+. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence 3488999999964 444443 345679999999999999999999999 79999999999999996 78899999999
Q ss_pred ccccccCCC----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCH
Q 017270 182 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTR 256 (374)
Q Consensus 182 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 256 (374)
|+....... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||...+..+.+..+.+... +
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~-- 232 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-L-- 232 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-C--
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-C--
Confidence 986544322 1234578999999999654 589999999999999999995 555555555555444433111 0
Q ss_pred HHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 257 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 122357899999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=367.28 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=189.7
Q ss_pred cceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+|..++.++ .|+||+.+++++..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~---- 88 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---- 88 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc----
Confidence 689999999999999999999754 456899998864321 223566666665 68899999887643
Q ss_pred CceEEEEEeeccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
....+++|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 2234789999998 578887765332 23458999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQ 243 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~ 243 (374)
+. ++.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+....+.
T Consensus 168 ~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 78899999999986544332 2346789999999999764 589999999999999999986 578887766555
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 244 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 244 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+..++.....+. ++..+++++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555544211111 234578999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=368.43 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=203.8
Q ss_pred ccccceeeeeeeecCCCceEEEEEECCCCcE--EEEEEeecc-----ccchHHHHHHHHhc-CCCceeeeceeeeecCCC
Q 017270 29 KQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 29 ~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (374)
...++|++.+.||+|+||+||+|+++.+|.. ||||.+... .....+|+++|+.+ +|||||++++++...
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--- 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--- 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET---
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC---
Confidence 3457999999999999999999999888865 677876432 23456899999998 799999999998543
Q ss_pred CceEEEEEeeccc-chHHHHHHhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEE
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 167 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~------------~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll 167 (374)
..+++|||||+ |+|.+.+... ......+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 84 --~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 --GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 160 (309)
T ss_dssp --TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred --CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEE
Confidence 34899999999 5788877543 1235679999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCC-CCCCCCChHHHHHH
Q 017270 168 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVE 246 (374)
Q Consensus 168 ~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~-~pf~~~~~~~~~~~ 246 (374)
+. ++.+||+|||+|+............+|+.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+....
T Consensus 161 ~~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 161 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp CG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cC-CCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 96 778999999999866555444556789999999999654 5899999999999999999964 67888877776655
Q ss_pred HHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 247 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 247 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
+.+... ..++..+++++.+||.+||+.||++|||++|+++|
T Consensus 239 i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 239 LPQGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGGTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCC----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443100 01234579999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=360.39 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=190.4
Q ss_pred cceeeeeeeecCCCceEEEEEECCC-C--cEEEEEEeeccc-------cchHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~-~--~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
++|++.+.||+|+||+||+|++..+ + ..||||++.++. ....+|+.+++.++|||||++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5799999999999999999986533 3 368999875431 234589999999999999999998832
Q ss_pred ceEEEEEeeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeec
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 180 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg 180 (374)
. .+++|||||+ |++.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccch
Confidence 1 2679999998 466655543 34569999999999999999999999 89999999999999996 7899999999
Q ss_pred cccccccCCCc----ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 017270 181 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 255 (374)
Q Consensus 181 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 255 (374)
+++........ ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+.+....+
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL- 234 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence 99876444332 223467789999999754 58999999999999999998 899999998888877765521111
Q ss_pred HHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 256 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
..+..+|+++.+||.+||+.||.+|||+++++
T Consensus 235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12345889999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=364.06 Aligned_cols=261 Identities=23% Similarity=0.268 Sum_probs=200.1
Q ss_pred cccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 30 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 30 ~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|++++..+..+.. .....++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence 345899999999999999999999999999999987543 3456689999999998876665554432 2334889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC--CCCcEEEEeecccccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL 185 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~--~~~~ikl~Dfg~a~~~ 185 (374)
||||+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+..
T Consensus 81 vme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 81 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999987766553 45679999999999999999999999 79999999999999864 2447999999999876
Q ss_pred ccCCC--------cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 017270 186 IAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 257 (374)
Q Consensus 186 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 257 (374)
..... ..+..||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-
Confidence 44321 2345789999999999654 4899999999999999999999999876655443333221100000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCcccc
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE 320 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~---e~l~hp~~~~ 320 (374)
.+ .......+|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 235 -------------------~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 -------------------TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------------SC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00 1112345899999999999999999999987 5578887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=358.59 Aligned_cols=244 Identities=21% Similarity=0.318 Sum_probs=194.1
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhcCCCceeeeceeeeecCCCCceEEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 108 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 108 (374)
.++|++.+.||+|+||.||+|.+ +|..||||++.++. ....+|++++++++||||+++++++... ...+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEEE
Confidence 45899999999999999999997 57789999996553 3345899999999999999999987432 2237899
Q ss_pred eeccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccccccc
Q 017270 109 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 187 (374)
Q Consensus 109 ~e~~~-g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~~~~~ 187 (374)
|||++ |+|.+.+... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceecCC
Confidence 99998 4787777542 22358999999999999999999999 79999999999999996 78899999999986433
Q ss_pred CCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 017270 188 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 266 (374)
Q Consensus 188 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 266 (374)
......+|+.|+|||++.+. .++.++|||||||++|||++ |++||...+..+....+.+..
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------- 217 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred --CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 23345678899999999754 58999999999999999998 799998877666655543310
Q ss_pred cCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 267 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
...++..+++++.+||++||+.||.+|||+.+++++
T Consensus 218 -------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 -------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 011334578999999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=360.19 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=195.0
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCC-------cEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeec
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 97 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 97 (374)
.++|++.+.||+|+||.||+|++..++ ..||||++.++.. ...+|...+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 479999999999999999999986654 3699998865432 223577777777 89999999999943
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 98 TSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 98 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
+..+++|||||. |++.+.+.... .....+++..+..++.||+.||+|||+ ++|+||||||+|
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 344889999998 57777776432 123569999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
||++. ++.+||+|||+++....... .....+|+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 166 iLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99996 77899999999986654332 234678999999999965 459999999999999999998 7999988887
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+....+.+. ..+ .++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6655544331 111 123458999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-50 Score=361.73 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=200.3
Q ss_pred ccceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 100 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (374)
.++|++.+.||+|+||+||+|+.+. +++.||||++..+. ....+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 4689999999999999999999753 56789999986432 2345899999999999999999988433
Q ss_pred CceEEEEEeeccc-chHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeec
Q 017270 101 NELFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 159 (374)
Q Consensus 101 ~~~~~~lv~e~~~-g~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~d 159 (374)
...++||||+. |+|.+.+.... .....+++..+..++.||+.||+|||+ ++|+|||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 33889999998 57877775321 123458999999999999999999999 7999999
Q ss_pred CCCCcEEEcCCCCcEEEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCC-CCC
Q 017270 160 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 235 (374)
Q Consensus 160 lkp~NIll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~-~pf 235 (374)
|||+|||++. ++.+||+|||+|+....... ..+..+|+.|+|||.+.+. .|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999996 78899999999986543322 2345678999999999754 5899999999999999999985 789
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 236 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 236 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+.+..+.+..+.+... + ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNI-L---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888877766554110 0 123458999999999999999999999999954
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=359.21 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=206.1
Q ss_pred cceeeeeeeecCCCceEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhcCCCceeeeceeeeecCCCC
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 101 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (374)
++|.+.+.||+|+||+||+|.+.. ++..||||++..... ...+|+.++++++|||||++++++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----- 94 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----- 94 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-----
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-----
Confidence 699999999999999999998853 357899999865332 23589999999999999999998833
Q ss_pred ceEEEEEeeccc-chHHHHHHhhh------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcE
Q 017270 102 ELFLNLVMEYVP-ESMYRVLKHYS------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 174 (374)
Q Consensus 102 ~~~~~lv~e~~~-g~l~~~l~~~~------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~i 174 (374)
....++|||||. |+|.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-CceE
Confidence 333889999998 57777665432 122457899999999999999999999 79999999999999996 7889
Q ss_pred EEEeeccccccccCCC---cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 017270 175 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKV 250 (374)
Q Consensus 175 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~ 250 (374)
||+|||+|+....... .....+|+.|+|||.+.+. .++.++|||||||++|||++| .+||.+.+..+.+..+.+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999999986544322 2345789999999999654 589999999999999999997 5889888888777766542
Q ss_pred hCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCccccc
Q 017270 251 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL 321 (374)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~------hp~~~~~ 321 (374)
.. + ..+..+++.+.+||.+||+.||++|||++++++ +|+|+++
T Consensus 252 ~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 252 GL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp CC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 11 0 022357899999999999999999999999987 7777654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=355.28 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=201.1
Q ss_pred ccceeeeeeeecCCCceEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhc-CCCceeeeceeeeecCC
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTS 99 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (374)
.++|++.+.||+|+||.||+|++. .+++.||||++..... ...+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 479999999999999999999863 4567899999865432 234788999998 69999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCc
Q 017270 100 KNELFLNLVMEYVPE-SMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 164 (374)
Q Consensus 100 ~~~~~~~lv~e~~~g-~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~N 164 (374)
...+++|||||++ ++...+.... .....+++..+..++.||+.||+|||+ ++|+||||||+|
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence 3348899999984 7777765432 123468999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccccccCCCc---ceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 017270 165 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 240 (374)
Q Consensus 165 Ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 240 (374)
|+++. ++.+|++|||+++........ ....+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+.
T Consensus 176 Il~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99996 788999999999876543322 23577999999999965 458999999999999999998 7777877776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 241 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 241 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
.+.+.++++....+. .+...++++.+||.+||+.||.+|||++++++
T Consensus 254 ~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666666665321111 22347899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-49 Score=365.23 Aligned_cols=290 Identities=30% Similarity=0.479 Sum_probs=212.7
Q ss_pred CCCccccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcC-----------CCceeeec
Q 017270 26 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLK 91 (374)
Q Consensus 26 ~~p~~~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~ 91 (374)
|++-..++|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.++ |+||++++
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 34444457999999999999999999999999999999997653 23357888888775 57899998
Q ss_pred eeeeecCCCCceEEEEEeecc--cchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC
Q 017270 92 HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 169 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~--~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~ 169 (374)
+++.... .. ..+++++++ .++...... ......+++..++.++.||+.||+|||+..||+||||||+|||++.
T Consensus 87 ~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 87 DHFNHKG-PN--GVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp EEEEEEE-TT--EEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEeeecc-cc--ceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 8774322 22 244455444 444333332 3456789999999999999999999996358999999999999975
Q ss_pred CCC-----cEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC-----
Q 017270 170 LTH-----QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----- 239 (374)
Q Consensus 170 ~~~-----~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~----- 239 (374)
.+. .++++|||.+..... ......+|+.|+|||++.+. .++.++|+||+||++++|++|+.||....
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCcccccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 222 499999999975433 33456789999999999764 58999999999999999999999997543
Q ss_pred -hHHHHHHHHHHhCCCCHHHHhhcCcC-------CcCCCCCCCCCCChhhhc------ccCCChhHHHHHHhhcCcCCCC
Q 017270 240 -AVDQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKVF------HKRMPPEAIDLASRLLQYSPSL 305 (374)
Q Consensus 240 -~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~ 305 (374)
..+.+...+..+|.++...+...... ............++.... ....+++++|||.+||++||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 34567777888888877665432111 001112222222222222 2235678999999999999999
Q ss_pred CCCHHHHhcCCccccccC
Q 017270 306 RCTALEACAHPFFDELRE 323 (374)
Q Consensus 306 R~s~~e~l~hp~~~~~~~ 323 (374)
|||++|+|+||||++...
T Consensus 319 Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 319 RADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp CBCHHHHHTCGGGTTCTT
T ss_pred CcCHHHHhcCcccCCCCC
Confidence 999999999999996543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-48 Score=345.12 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=199.6
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhcCC-CceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
.++|++.+.||+|+||+||+|++..+|+.||||++... .....+|++.++.++| +|++.+++++. .....++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEE
Confidence 35899999999999999999999999999999987543 3445689999999976 89999888773 3345889
Q ss_pred EeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcC----CCCcEEEEeecccc
Q 017270 108 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAK 183 (374)
Q Consensus 108 v~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~----~~~~ikl~Dfg~a~ 183 (374)
||||++++|...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ..+.+||+|||+|+
T Consensus 79 vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 79 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999998887653 44679999999999999999999999 79999999999999963 24679999999998
Q ss_pred ccccCC--------CcceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhC
Q 017270 184 QLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLG 252 (374)
Q Consensus 184 ~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~ 252 (374)
...... ...+..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. .......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 654321 2234578999999999965 458999999999999999999999998653 3333333333211
Q ss_pred CCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 017270 253 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 313 (374)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l 313 (374)
.+.... +..++|+++.+++..|+..+|++||+.+.+.
T Consensus 234 ~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 111111 2235789999999999999999999987664
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=349.52 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=189.0
Q ss_pred ceeeeeeeecCCCceEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhcCCCceeeeceeeeecCCCCceE
Q 017270 33 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 104 (374)
Q Consensus 33 ~y~i~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (374)
.+...++||+|+||+||+|++..++ ..||||.+.+.. ....+|++++++++|||||++++++... +..
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 103 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 103 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCc
Confidence 3344688999999999999987653 358999885321 2345899999999999999999987543 234
Q ss_pred EEEEeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 105 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 105 ~~lv~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
+++|||||++ ++.+.+. .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLAR 178 (311)
T ss_dssp EEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGC
T ss_pred eEEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchh
Confidence 8899999996 5555544 245568888899999999999999999 79999999999999996 7889999999998
Q ss_pred ccccCCC-----cceeeeeccccchhhhhCCCCCCCchhhHhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Q 017270 184 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTRE 257 (374)
Q Consensus 184 ~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 257 (374)
....... .....+|+.|+|||.+.+. .++.++||||||+++|||++|..||...... +....+.+. ..+
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~--- 253 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL--- 253 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCC---
T ss_pred hccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC---
Confidence 6544322 2235679999999998654 5899999999999999999977777654332 333332221 000
Q ss_pred HHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 017270 258 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 315 (374)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~h 315 (374)
..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 254 ------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 254 ------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1224578999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=345.25 Aligned_cols=268 Identities=22% Similarity=0.224 Sum_probs=187.4
Q ss_pred ccceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHhcCCCceeeeceeeeecCCCCceEEEE
Q 017270 31 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 107 (374)
Q Consensus 31 ~~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 107 (374)
..+|.+.+.||+|+||+||+|++ +|+.||||++..+... . +.|+..+..++|||||++++++.+.. .....+|+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 45899999999999999999986 6889999998654322 2 23444555789999999999986544 33446889
Q ss_pred Eeecccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCeEeecCCCCcEEEcCCCCcEEEEee
Q 017270 108 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDF 179 (374)
Q Consensus 108 v~e~~~g-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------~~ivH~dlkp~NIll~~~~~~ikl~Df 179 (374)
|||||++ +|...+.. ..+++.....++.|++.||.|||+. +||+||||||+|||++. ++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCC
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEec
Confidence 9999984 78777763 3689999999999999999999962 59999999999999996 789999999
Q ss_pred ccccccccCCC-----cceeeeeccccchhhhhCCC-----CCCCchhhHhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017270 180 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 249 (374)
Q Consensus 180 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 249 (374)
|+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++|..||............ .
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c
Confidence 99987654332 23467899999999985432 1467899999999999999999887432211000000 0
Q ss_pred HhCCCCHHHHhhcCcCCcCCCCCCCCCCChhhhcccCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 017270 250 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 314 (374)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e~l~ 314 (374)
....+....+..... ....-|.+. ...........+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000001011100000 000000000 00001113356889999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1e-25 Score=187.88 Aligned_cols=165 Identities=18% Similarity=0.127 Sum_probs=115.6
Q ss_pred eeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhcCCCceeeec
Q 017270 34 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK 91 (374)
Q Consensus 34 y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~ 91 (374)
|.+.+.||+|+||+||+|++ .+|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56889999999999999997 478999999763211 0112477888899999988876
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCeEeecCCCCcEEEcCCC
Q 017270 92 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 171 (374)
Q Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~ivH~dlkp~NIll~~~~ 171 (374)
+.. . .+++|||+++... ..+++..+..++.|++.|+.|||+ +||+||||||+|||+++
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET--
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC--
Confidence 543 1 3589999997411 124445567899999999999999 79999999999999984
Q ss_pred CcEEEEeeccccccccCCCcceeeeeccccchhhhhCCCCCCCchhhHhHHHH
Q 017270 172 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 224 (374)
Q Consensus 172 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvi 224 (374)
+.++|+|||.|......... .+...-...-.+.+ ...|+.++|+||+.--
T Consensus 139 ~~~~liDFG~a~~~~~~~~~-~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWR-EILERDVRNIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TEEEECCCTTCEETTSTTHH-HHHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcH-HHHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence 45999999999754332211 11000000001222 2347899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=4.3e-06 Score=70.83 Aligned_cols=77 Identities=17% Similarity=0.105 Sum_probs=50.0
Q ss_pred cceeeeeeeecCCCceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhcC-CCceeeeceeeeecCCCCceEEE
Q 017270 32 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 32 ~~y~i~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 106 (374)
..|++.+..+.++.+.||++. .+++.+++|...... ....+|...++.+. +-.+.+++... .+....+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence 467888776656667899875 366778889775432 23467888888774 22234444433 2223477
Q ss_pred EEeecccch
Q 017270 107 LVMEYVPES 115 (374)
Q Consensus 107 lv~e~~~g~ 115 (374)
+||++++|.
T Consensus 87 lv~~~l~G~ 95 (263)
T d1j7la_ 87 LLMSEADGV 95 (263)
T ss_dssp EEEECCSSE
T ss_pred EEEEecccc
Confidence 999999873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=9.8e-05 Score=61.74 Aligned_cols=69 Identities=13% Similarity=0.060 Sum_probs=43.1
Q ss_pred eecCC-CceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhcCCCc--eeeeceeeeecCCCCceEEEEEeecccc
Q 017270 40 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPE 114 (374)
Q Consensus 40 lg~G~-~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~g 114 (374)
+..|. -+.||++. ..++..+++|...... .....|...++.+.... +.+++.+.. +....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence 34444 36789887 4567778889765443 23567888888775433 344444332 22237799999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=0.00025 Score=63.43 Aligned_cols=71 Identities=20% Similarity=0.141 Sum_probs=43.1
Q ss_pred eeeeecCCCceEEEEEECCCCcEEEEEEeecc-----------ccchHHHHHHHHhcC-C--CceeeeceeeeecCCCCc
Q 017270 37 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD-H--PNVISLKHCFFSTTSKNE 102 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 102 (374)
.+.||.|....||++.+..+++.+++|.-... ......|...|+.+. + ..+++++.+ +.. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~---~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE---M 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC---C
Confidence 45689999999999987777889999964321 112345888887663 2 234444432 222 1
Q ss_pred eEEEEEeecccc
Q 017270 103 LFLNLVMEYVPE 114 (374)
Q Consensus 103 ~~~~lv~e~~~g 114 (374)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3489999974
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.74 E-value=0.0043 Score=55.08 Aligned_cols=69 Identities=14% Similarity=0.231 Sum_probs=44.7
Q ss_pred eeeeecCCCceEEEEEECC-------CCcEEEEEEeecccc--chHHHHHHHHhcCCCce-eeeceeeeecCCCCceEEE
Q 017270 37 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR--YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLN 106 (374)
Q Consensus 37 ~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~ 106 (374)
++.|+.|-.-.+|++.... .++.|.+++...... ...+|..+++.+.-.++ .++++++ ++ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 4678888889999998642 345688887653222 23478888887753344 3555554 22 3
Q ss_pred EEeecccc
Q 017270 107 LVMEYVPE 114 (374)
Q Consensus 107 lv~e~~~g 114 (374)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.45 E-value=0.01 Score=51.03 Aligned_cols=71 Identities=17% Similarity=0.003 Sum_probs=40.0
Q ss_pred CCCceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhcCCCce--eeeceeeeecCCCCceEEEEEeecccc
Q 017270 43 GSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVPE 114 (374)
Q Consensus 43 G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g 114 (374)
+.-..||++. ..+|+.|++|+..... .....|...+..|....+ +.....-.........+.+.++++++|
T Consensus 33 s~EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3346899987 4678899999875543 334568888877743222 111110000000123346788888864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.46 E-value=0.1 Score=44.04 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=25.7
Q ss_pred CCeEeecCCCCcEEEcCCCCcEEEEeecccc
Q 017270 153 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 183 (374)
Q Consensus 153 ~~ivH~dlkp~NIll~~~~~~ikl~Dfg~a~ 183 (374)
.|++|+|+.++||+++. +...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc-ccceeEecccccc
Confidence 47999999999999995 5556899999874
|